Citrus Sinensis ID: 014362

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420------
Protein Sequence
MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDDHGKNARSASNREEVKSSGQCLSNGVNT
Secondary Structure (PSIPRED)
ccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEEcccccccccHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccHHHcccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEccccccEEEEEEEcccccccHHHHHHHHHHHHHHHcccHHEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEEcccHcHEEccccccccHcHccccEEcccccccEEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mgcfrcsgksnkklDEEIDNKNKNLnkqadkkqliadtprvdsnanlkkeevsndgqlsmdvknlnlkddsnnsgksakpftfDELAAAtgnfrsdcclgeggfgkvYKGCLEKIEQVVAIKQldhrgvqgVREFSAEVMTlgsadhpnLVKLIGYCAEGDQRLLVYEymplgsldkhlhdlrpdtrpldwntRMKIAAGASRGLQYLHEQLkqpviyrdlkcsnilleegyhpklsdfglakmgpsgdkthvstrvmgtygycapdyamtgqltfksdIYSFGVVLLELITGRkaidqtkdrkELNLVAWArpmfkdrknfsqmvdpslqgqypvRGLYQALAIAAMCvqeqpnmrpaITDVVMALNYLasqkydpqnppsrssrkspsclgvnkdddhgknarsasnreevkssgqclsngvnt
Flexible Loop (DISEMBL)
mgcfrcsgksnkkldeEIDNKnknlnkqadkkqliadtprvdsnanlkkeevsndgqlsmDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITgrkaidqtkdrkelNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQkydpqnppsrssrkspsclgvnkdddhgknarsasnreevkssgqclsngvnt
Low Complexity Region (SEG)
MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNppsrssrkspsCLGVNKDDDHGKNARSASNREEVKSSGQCLSNGVNT
Disordered region (IsUnstruct)
********************************************************************************FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG****KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA*******************************************************
Disordered Region (DISOPRED)
MG*****************************************************************************PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY*********************************************************
Disordered Region (DISEMBL)
***********KKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK******************GVNKD*****************************
Disordered Region (DISPRO)
****************************************************************************SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK****************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGCFRCSGKSxxxxxxxxxxxxxxxxxxxxxKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDDHGKNARSASNREEVKSSGQCLSNGVNT
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	426	2.2.26 [Sep-21-2011]
Q9LQQ8	423	Probable serine/threonine	no	no	0.908	0.914	0.699	1e-160
Q9FE20	456	Serine/threonine-protein	no	no	0.910	0.850	0.574	1e-130
Q9SFT7	414	Serine/threonine-protein	no	no	0.786	0.809	0.561	1e-110
Q9LFP7	493	Probable receptor-like pr	no	no	0.753	0.651	0.497	8e-91
Q8GXZ3	410	Serine/threonine-protein	no	no	0.720	0.748	0.540	1e-90
O49840	426	Protein kinase 2B, chloro	no	no	0.699	0.699	0.519	6e-88
Q9SRH7	490	Receptor-like serine/thre	no	no	0.687	0.597	0.524	2e-87
O49839	426	Protein kinase 2A, chloro	no	no	0.694	0.694	0.516	1e-86
P43293	389	Probable serine/threonine	no	no	0.699	0.766	0.507	1e-83
Q9FM85	408	Probable receptor-like pr	no	no	0.678	0.708	0.511	7e-83

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  566 bits (1459), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 281/402 (69%), Positives = 323/402 (80%), Gaps = 15/402 (3%)

Query: 1   MGCFRCSGKSNKKLDEEIDNK-NKNL----------NKQADKKQLIADTPRVDSNANLKK 49
           MGCF CS KS+K+ +   D   N+ +          +K+ D+ Q  +D+ +V    ++  
Sbjct: 1   MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60

Query: 50  EE-VSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY 108
           E  V  + QLS+DVK LNL D    +GK A+ FTF ELA ATGNFRSDC LGEGGFGKV+
Sbjct: 61  EGGVGKEDQLSLDVKGLNLNDQV--TGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVF 118

Query: 109 KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168
           KG +EK++QVVAIKQLD  GVQG+REF  EV+TL  ADHPNLVKLIG+CAEGDQRLLVYE
Sbjct: 119 KGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYE 178

Query: 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228
           YMP GSL+ HLH L    +PLDWNTRMKIAAGA+RGL+YLH+++  PVIYRDLKCSNILL
Sbjct: 179 YMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILL 238

Query: 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 288
            E Y PKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL
Sbjct: 239 GEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 298

Query: 289 ELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAM 348
           ELITGRKAID TK RK+ NLV WARP+FKDR+NF +MVDP LQGQYPVRGLYQALAI+AM
Sbjct: 299 ELITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAM 358

Query: 349 CVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPS 390
           CVQEQP MRP ++DVV+ALN+LAS KYDP N PS SS K+PS
Sbjct: 359 CVQEQPTMRPVVSDVVLALNFLASSKYDP-NSPSSSSGKNPS 399

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  465 bits (1197), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 234/407 (57%), Positives = 279/407 (68%), Gaps = 19/407 (4%)

Query: 1   MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSN------ANLKKEEVSN 54
           MGCF C   S+ +    +D  N    KQ+         P V +N         K    +N
Sbjct: 1   MGCFSCFDSSDDEKLNPVDESNHGQKKQSQ--------PTVSNNISGLPSGGEKLSSKTN 52

Query: 55  DGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK 114
            G      + L L  D      +A  F F ELAAAT NF  D  LGEGGFG+VYKG L+ 
Sbjct: 53  GGS----KRELLLPRDGLGQ-IAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDS 107

Query: 115 IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS 174
             QVVA+KQLD  G+QG REF  EV+ L    HPNLV LIGYCA+GDQRLLVYE+MPLGS
Sbjct: 108 TGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGS 167

Query: 175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234
           L+ HLHDL PD   LDWN RMKIAAGA++GL++LH++   PVIYRD K SNILL+EG+HP
Sbjct: 168 LEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHP 227

Query: 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           KLSDFGLAK+GP+GDK+HVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV LELITGR
Sbjct: 228 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 287

Query: 295 KAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQP 354
           KAID      E NLVAWARP+F DR+ F ++ DP L+G++P R LYQALA+A+MC+QEQ 
Sbjct: 288 KAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQA 347

Query: 355 NMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDDHG 401
             RP I DVV AL+YLA+Q YDP    SR +R       + ++DD G
Sbjct: 348 ATRPLIADVVTALSYLANQAYDPSKDDSRRNRDERGARLITRNDDGG 394

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  400 bits (1027), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 193/344 (56%), Positives = 252/344 (73%), Gaps = 9/344 (2%)

Query: 38  TPRVDSNANLKKEEVS---NDGQLSMDVKNLNLKDDSNNSGK------SAKPFTFDELAA 88
            PR   N+  +  EV+   N+     + K +N ++ +N+  K      +A+ F+F ELA 
Sbjct: 15  VPRDSDNSYRRNGEVTGRDNNKTHPENPKTVNEQNKNNDEDKEVTNNIAAQTFSFRELAT 74

Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP 148
           AT NFR +C +GEGGFG+VYKG LEK   +VA+KQLD  G+QG +EF  EV+ L    H 
Sbjct: 75  ATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHK 134

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           +LV LIGYCA+GDQRLLVYEYM  GSL+ HL DL PD  PLDW+TR++IA GA+ GL+YL
Sbjct: 135 HLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYL 194

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H++   PVIYRDLK +NILL+  ++ KLSDFGLAK+GP GDK HVS+RVMGTYGYCAP+Y
Sbjct: 195 HDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEY 254

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
             TGQLT KSD+YSFGVVLLELITGR+ ID T+ + E NLV WA+P+FK+   F ++ DP
Sbjct: 255 QRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADP 314

Query: 329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
           SL+G +P + L QA+A+AAMC+QE+  +RP ++DVV AL +L +
Sbjct: 315 SLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGT 358

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  334 bits (857), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 171/344 (49%), Positives = 225/344 (65%), Gaps = 23/344 (6%)

Query: 51  EVSND---GQLSMDVKNLNLKDDSN--------NSGKSAKPFTFDELAAATGNFRSDCCL 99
           E SND   GQ+S      N +  S+        N     + FTF++L  +T NFR +  L
Sbjct: 89  EKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLL 148

Query: 100 GEGGFGKVYKGCLEK---------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
           GEGGFG V+KG +E+             VA+K L+  G+QG +E+ AE+  LG+  HPNL
Sbjct: 149 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNL 208

Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           VKL+GYC E DQRLLVYE+MP GSL+ HL      + PL W+ RMKIA GA++GL +LHE
Sbjct: 209 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKGLSFLHE 265

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
           +  +PVIYRD K SNILL+  Y+ KLSDFGLAK  P   KTHVSTRVMGTYGY AP+Y M
Sbjct: 266 EALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVM 325

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
           TG LT KSD+YSFGVVLLE++TGR+++D+ +   E NLV WARP   D++ F +++DP L
Sbjct: 326 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRL 385

Query: 331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK 374
           +G + ++G  +   +AA C+   P +RP ++DVV AL  L   K
Sbjct: 386 EGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLK 429

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  333 bits (855), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 172/318 (54%), Positives = 213/318 (66%), Gaps = 11/318 (3%)

Query: 61  DVKNLNLKDDSNNSGKSAK--PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQV 118
           D      +DDS      A+  PFT  EL   T +FR D  LGEGGFG VYKG ++   +V
Sbjct: 35  DPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRV 94

Query: 119 ------VAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172
                 VA+K L+  G+QG RE+  EV  LG   HPNLVKLIGYC E D RLLVYE+M  
Sbjct: 95  GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLR 154

Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232
           GSL+ HL   R  T PL W+ RM IA GA++GL +LH   ++PVIYRD K SNILL+  Y
Sbjct: 155 GSLENHL--FRKTTAPLSWSRRMMIALGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDY 211

Query: 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             KLSDFGLAK GP GD+THVSTRVMGTYGY AP+Y MTG LT +SD+YSFGVVLLE++T
Sbjct: 212 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLT 271

Query: 293 GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQE 352
           GRK++D+T+  KE NLV WARP   D++   Q++DP L+ QY VR   +A ++A  C+ +
Sbjct: 272 GRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQ 331

Query: 353 QPNMRPAITDVVMALNYL 370
            P  RP ++DVV  L  L
Sbjct: 332 NPKARPLMSDVVETLEPL 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  324 bits (831), Expect = 6e-88,   Method: Compositional matrix adjust.
 Identities = 161/310 (51%), Positives = 212/310 (68%), Gaps = 12/310 (3%)

Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---------VVAIKQL 124
           S  + K FTF+EL  AT NFR D  LGEGGFG V+KG ++             VVA+K+L
Sbjct: 64  SSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKL 123

Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP 184
              G QG +E+  EV  LG   HPNLVKL+GYC EG+ RLLVYE+MP GSL+ HL   R 
Sbjct: 124 KTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHL--FRR 181

Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
             +PL W  RMK+A GA++GL +LH+   Q VIYRD K +NILL+  ++ KLSDFGLAK 
Sbjct: 182 GAQPLTWAIRMKVAIGAAKGLTFLHDAKSQ-VIYRDFKAANILLDAEFNSKLSDFGLAKA 240

Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
           GP+GDKTHVST+VMGT+GY AP+Y  TG+LT KSD+YSFGVVLLEL++GR+A+D++K   
Sbjct: 241 GPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM 300

Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           E +LV WA P   D++   +++D  L GQYP +G Y A ++A  C+     +RP +++V+
Sbjct: 301 EQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVL 360

Query: 365 MALNYLASQK 374
             L+ L S K
Sbjct: 361 AKLDQLESTK 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  323 bits (827), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 160/305 (52%), Positives = 209/305 (68%), Gaps = 12/305 (3%)

Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK---------IEQVVAIKQLDHRGV 129
           K F+F +L  AT NFR +  LGEGGFG V+KG +E+             VA+K L+  G+
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181

Query: 130 QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
           QG +E+ AE+  LG+  HPNLVKL+GYC E DQRLLVYE+MP GSL+ HL      + PL
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPL 238

Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
            W+ RMKIA GA++GL +LHE+  +PVIYRD K SNILL+  Y+ KLSDFGLAK  P   
Sbjct: 239 PWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEG 298

Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           KTHVSTRVMGTYGY AP+Y MTG LT KSD+YSFGVVLLE++TGR+++D+ +   E NLV
Sbjct: 299 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 358

Query: 310 AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
            WARP   D++ F +++DP L+G + V+G  +   +AA C+     +RP +++VV  L  
Sbjct: 359 EWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKP 418

Query: 370 LASQK 374
           L   K
Sbjct: 419 LPHLK 423

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  320 bits (820), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 159/308 (51%), Positives = 208/308 (67%), Gaps = 12/308 (3%)

Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---------VVAIKQL 124
           S  + K FTF+EL  AT NFR D  LGEGGFG V+KG +++            VVA+KQL
Sbjct: 67  SSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQL 126

Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP 184
              G QG +E+  EV  LG   HPNLV L+GYCAEG+ RLLVYE+MP GSL+ HL   R 
Sbjct: 127 KPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHL--FRR 184

Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
             +PL W  RMK+A GA++GL +LHE   Q VIYRD K +NILL+  ++ KLSDFGLAK 
Sbjct: 185 GAQPLTWAIRMKVAVGAAKGLTFLHEAKSQ-VIYRDFKAANILLDADFNAKLSDFGLAKA 243

Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
           GP+GD THVST+V+GT+GY AP+Y  TG+LT KSD+YSFGVVLLELI+GR+A+D +    
Sbjct: 244 GPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGN 303

Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           E +LV WA P   D++   +++D  L GQYP +G + A  +A  C+     +RP +++V+
Sbjct: 304 EYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVL 363

Query: 365 MALNYLAS 372
           + L  L S
Sbjct: 364 VTLEQLES 371

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  310 bits (795), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 161/317 (50%), Positives = 209/317 (65%), Gaps = 19/317 (5%)

Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---------VVAIKQLDHRGV 129
           K F+  EL +AT NFR D  +GEGGFG V+KG +++            V+A+K+L+  G 
Sbjct: 54  KNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGF 113

Query: 130 QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
           QG RE+ AE+  LG  DHPNLVKLIGYC E + RLLVYE+M  GSL+ HL       +PL
Sbjct: 114 QGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPL 173

Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
            WNTR+++A GA+RGL +LH    Q VIYRD K SNILL+  Y+ KLSDFGLA+ GP GD
Sbjct: 174 SWNTRVRMALGAARGLAFLHNAQPQ-VIYRDFKASNILLDSNYNAKLSDFGLARDGPMGD 232

Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            +HVSTRVMGT GY AP+Y  TG L+ KSD+YSFGVVLLEL++GR+AID+ +   E NLV
Sbjct: 233 NSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLV 292

Query: 310 AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAM---CVQEQPNMRPAITDVVMA 366
            WARP   +++   +++DP LQGQY    L +AL IA +   C+      RP + ++V  
Sbjct: 293 DWARPYLTNKRRLLRVMDPRLQGQY---SLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349

Query: 367 LNYLASQKY---DPQNP 380
           +  L  QK    + QNP
Sbjct: 350 MEELHIQKEASKEQQNP 366

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  308 bits (788), Expect = 7e-83,   Method: Compositional matrix adjust.
 Identities = 154/301 (51%), Positives = 204/301 (67%), Gaps = 12/301 (3%)

Query: 81  FTFDELAAATGNFRSDCCLGEGGFGKVYKGCL------EKIEQVVAIKQLDHRG---VQG 131
           FT++EL   T NFR D  LG GGFG VYKG +      +++ + + +    H G    QG
Sbjct: 64  FTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHDGDNSFQG 123

Query: 132 VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
            RE+ AEV+ LG   HPNLVKLIGYC E + R+L+YEYM  GS++ +L        PL W
Sbjct: 124 HREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRV--LLPLSW 181

Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
             RMKIA GA++GL +LHE  K+PVIYRD K SNILL+  Y+ KLSDFGLAK GP GDK+
Sbjct: 182 AIRMKIAFGAAKGLAFLHEA-KKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKS 240

Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
           HVSTR+MGTYGY AP+Y MTG LT  SD+YSFGVVLLEL+TGRK++D+++  +E NL+ W
Sbjct: 241 HVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDW 300

Query: 312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           A P+ K++K    +VDP +  +YPV+ + +A  +A  C+   P  RP + D+V +L  L 
Sbjct: 301 ALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQ 360

Query: 372 S 372
           +
Sbjct: 361 A 361

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	426
449462095	421	PREDICTED: probable serine/threonine-pro	0.927	0.938	0.720	1e-171
7573596	405	protein kinase 1 [Populus nigra]	0.931	0.980	0.731	1e-168
255582077	385	receptor serine-threonine protein kinase	0.845	0.935	0.785	1e-168
7573598	406	protein kinase 2 [Populus nigra]	0.931	0.977	0.722	1e-167
356541273	581	PREDICTED: probable serine/threonine-pro	0.931	0.683	0.712	1e-165
356542581	415	PREDICTED: probable serine/threonine-pro	0.960	0.985	0.699	1e-165
356557471	485	PREDICTED: probable serine/threonine-pro	0.910	0.8	0.729	1e-163
224104505	382	predicted protein [Populus trichocarpa]	0.884	0.986	0.740	1e-163
297849082	422	kinase family protein [Arabidopsis lyrat	0.908	0.917	0.708	1e-162
334182370	538	putative serine/threonine-protein kinase	0.927	0.734	0.688	1e-159

>gi|449462095|ref|XP_004148777.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Cucumis sativus] gi|449531771|ref|XP_004172859.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Cucumis sativus]

 Score =  607 bits (1566), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 297/412 (72%), Positives = 342/412 (83%), Gaps = 17/412 (4%)

Query: 1   MGCFRCSGKSNKKLDEEIDNKNKN-LNKQ---------ADKKQLIADTPRVDSNANLKKE 50
           MGCFRC+G S+KK  E+I+ K+ N  N +         +DK ++I++  + DS+    K 
Sbjct: 1   MGCFRCTGSSSKK-SEDIEQKDPNTFNSKTHKPDDRTPSDKAKVISNLVKRDSDV---KV 56

Query: 51  EVSNDGQLSMDVKNLNLKDDSNNSGKS---AKPFTFDELAAATGNFRSDCCLGEGGFGKV 107
            VS + QL++DVK LNLK++ +  G++   AK FTF+ELAAATGNFRSDC LGEGGFGKV
Sbjct: 57  VVSKNDQLALDVKKLNLKNEVSEEGEANGRAKTFTFEELAAATGNFRSDCFLGEGGFGKV 116

Query: 108 YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY 167
           YKG LEK+ +VVAIKQLD  G+QG+REF  EV+TL  ADHPNLVKLIG+CAEGDQRLLVY
Sbjct: 117 YKGYLEKVNEVVAIKQLDRNGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVY 176

Query: 168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL 227
           EYMPLGSL+ HLHDLRP  + +DWNTRMKIAAGA+RGL+YLHE++K PVIYRDLKCSNIL
Sbjct: 177 EYMPLGSLENHLHDLRPGAKVIDWNTRMKIAAGAARGLEYLHEKMKPPVIYRDLKCSNIL 236

Query: 228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
           L EGYHPKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL
Sbjct: 237 LGEGYHPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 296

Query: 288 LELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAA 347
           LELITGRKAID +K   E NLVAWARPMF+DRK FSQMVDP LQG YPVRGLYQ+LAIAA
Sbjct: 297 LELITGRKAIDHSKPHSEQNLVAWARPMFRDRKKFSQMVDPMLQGHYPVRGLYQSLAIAA 356

Query: 348 MCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDD 399
           MCVQEQPNMRP ITDVV ALNYLASQKYDPQ  P+++S+K PS   + + DD
Sbjct: 357 MCVQEQPNMRPVITDVVTALNYLASQKYDPQTQPNQNSQKRPSSHKMERGDD 408

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7573596|dbj|BAA94509.1| protein kinase 1 [Populus nigra]

 Score =  597 bits (1540), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 294/402 (73%), Positives = 337/402 (83%), Gaps = 5/402 (1%)

Query: 1   MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNAN-LKKEEVSNDGQLS 59
           MG   CSGK +K+L+    N+N +  K+ D+  + + + ++    N L KE  S D QLS
Sbjct: 1   MGFLCCSGKPSKRLESSSINENNSNIKRKDQTHVTSGSLKMKPYVNNLSKEGESKDDQLS 60

Query: 60  MDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI 115
           +DVK+LN+KD    D  ++GK A+ FTF+ELAAAT NFRSDC LGEGGFGKVYKG L+KI
Sbjct: 61  LDVKSLNMKDEISKDRRSNGKQAQTFTFEELAAATSNFRSDCFLGEGGFGKVYKGYLDKI 120

Query: 116 EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175
            Q VAIKQLD  GVQG+REF  EV+TL  ADHPNLVKLIG+CAEGDQRLLVYEYMPLGSL
Sbjct: 121 NQAVAIKQLDRNGVQGIREFVVEVVTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPLGSL 180

Query: 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235
           + HLHD+ P+ +PLDWNTRMKIAAGA++GL+YLH ++K PVIYRDLKCSNILL EGYHPK
Sbjct: 181 ENHLHDIPPNRQPLDWNTRMKIAAGAAKGLEYLHNEMKPPVIYRDLKCSNILLGEGYHPK 240

Query: 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
           LSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK
Sbjct: 241 LSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 300

Query: 296 AIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPN 355
           AIDQ K+R E NLVAWARPMFKDR+NFS MVDP LQGQYP+RGLYQALAIAAMCVQEQPN
Sbjct: 301 AIDQRKERGEQNLVAWARPMFKDRRNFSCMVDPLLQGQYPIRGLYQALAIAAMCVQEQPN 360

Query: 356 MRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKD 397
           MRPA++D+VMALNYLAS KYDPQ    + SR+SPS  G++KD
Sbjct: 361 MRPAVSDLVMALNYLASHKYDPQVHSVQDSRRSPSRPGLDKD 402

Source: Populus nigra

Species: Populus nigra

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255582077|ref|XP_002531835.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223528531|gb|EEF30555.1| receptor serine-threonine protein kinase, putative [Ricinus communis]

 Score =  597 bits (1538), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 286/364 (78%), Positives = 316/364 (86%), Gaps = 4/364 (1%)

Query: 40  RVDSNANLKKEEVSNDGQLSMDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRS 95
           +V   +N +KEE S D QLS+DVKNLNL D    D+ N+ K A+ FTF+ELAAATGNFR 
Sbjct: 5   KVKPYSNAQKEEDSKDDQLSIDVKNLNLTDEVSKDARNNAKRAQTFTFEELAAATGNFRL 64

Query: 96  DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           DC LGEGGFGKVYKG LEKI QVVAIKQLD  G+QG REF  EV+TL  ADHPNLVKLIG
Sbjct: 65  DCFLGEGGFGKVYKGYLEKINQVVAIKQLDPNGLQGTREFVIEVLTLSLADHPNLVKLIG 124

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
           +CAEGDQRLLVYEYMPLGSL+ HLHDL  + +PLDWN RMKIAAGA++GL+YLHE++K P
Sbjct: 125 FCAEGDQRLLVYEYMPLGSLEHHLHDLPSNRQPLDWNNRMKIAAGAAKGLEYLHEKMKPP 184

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           VIYRDLKCSNILL EGYHPKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT
Sbjct: 185 VIYRDLKCSNILLGEGYHPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 244

Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP 335
           FKSD+YSFGVVLLELITGRKAIDQT+D+ E NLV WARP+FKDRKNF  MVDPSL+G YP
Sbjct: 245 FKSDVYSFGVVLLELITGRKAIDQTRDKNEQNLVGWARPLFKDRKNFPSMVDPSLEGHYP 304

Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVN 395
           VRGLYQALAIAAMCVQEQPNMRPA++DVVMALNYLASQ YDPQ  P   SRK+PSC G+ 
Sbjct: 305 VRGLYQALAIAAMCVQEQPNMRPAVSDVVMALNYLASQIYDPQIHPVHGSRKNPSCPGLR 364

Query: 396 KDDD 399
           KD+D
Sbjct: 365 KDND 368

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7573598|dbj|BAA94510.1| protein kinase 2 [Populus nigra]

 Score =  595 bits (1535), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 292/404 (72%), Positives = 335/404 (82%), Gaps = 7/404 (1%)

Query: 1   MGCFRCSGKSNKKLD-EEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEE-VSNDGQL 58
           MG    SGKS+K+ +   ID  N N+ K+ D+ QL + + +V    N  +EE  S D QL
Sbjct: 1   MGFLCFSGKSSKRSENSSIDENNSNI-KRKDQTQLTSGSMKVKPYVNDSREEGASKDDQL 59

Query: 59  SMDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK 114
           S+DVK+LNLKD    D  N+G  A+ FTF+EL AAT NFRSDC LGEGGFGKVYKG LEK
Sbjct: 60  SLDVKSLNLKDEISKDIRNNGNPAQTFTFEELVAATDNFRSDCFLGEGGFGKVYKGYLEK 119

Query: 115 IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS 174
           I QVVAIKQLD  G+QG+REF  EV+TL  AD+PNLVKLIG+CAEGDQRLLVYEYMPLGS
Sbjct: 120 INQVVAIKQLDQNGLQGIREFVVEVLTLSLADNPNLVKLIGFCAEGDQRLLVYEYMPLGS 179

Query: 175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234
           L+ HLHD+ P+ +PLDWN RMKIAAGA++GL+YLH ++  PVIYRDLKCSNILL EGYHP
Sbjct: 180 LENHLHDIPPNRQPLDWNARMKIAAGAAKGLEYLHNEMAPPVIYRDLKCSNILLGEGYHP 239

Query: 235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           KLSDFGLAK+GPSGD THVSTRVMGTYGYCAPDYAMTGQLTFKSD+YSFGVVLLELITGR
Sbjct: 240 KLSDFGLAKVGPSGDHTHVSTRVMGTYGYCAPDYAMTGQLTFKSDVYSFGVVLLELITGR 299

Query: 295 KAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQP 354
           KAIDQTK+R E NLVAWARPMFKDR+NFS MVDP LQGQYP++GLYQALAIAAMCVQEQP
Sbjct: 300 KAIDQTKERSEQNLVAWARPMFKDRRNFSGMVDPFLQGQYPIKGLYQALAIAAMCVQEQP 359

Query: 355 NMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDD 398
           NMRPA++DVV+ALNYLAS KYDPQ  P +  R+ PS  G++KD+
Sbjct: 360 NMRPAVSDVVLALNYLASHKYDPQIHPFKDPRRRPSHPGLDKDN 403

Source: Populus nigra

Species: Populus nigra

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356541273|ref|XP_003539103.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max]

 Score =  587 bits (1514), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 287/403 (71%), Positives = 330/403 (81%), Gaps = 6/403 (1%)

Query: 1   MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
           MG F C GKS+KK   E D ++    K  +      D+ +VD   N  KE+ S   QL++
Sbjct: 1   MGWFCCQGKSSKKSVAEEDYRDSLDQKPTNFTA--TDSVKVDFKVNGNKEDGSKGDQLAL 58

Query: 61  DVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE 116
           DVK+LNLK+    D  ++G  A+ F+F+EL AATGNFR DC LGEGGFGKVYKG LE+I 
Sbjct: 59  DVKSLNLKEEVSQDRKDNGNRAQTFSFNELEAATGNFRVDCFLGEGGFGKVYKGHLERIN 118

Query: 117 QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
           QVVAIKQLD  G+QG+REF  EV+TL  ADH NLVKLIG+CAEG+QRLLVYEYMPLGSL+
Sbjct: 119 QVVAIKQLDPNGLQGIREFVVEVLTLSLADHTNLVKLIGFCAEGEQRLLVYEYMPLGSLE 178

Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
            HL D+RP  +PLDWNTRMKIAAGA+RGL+YLH+++K PVIYRDLKCSNILL EGYHPKL
Sbjct: 179 DHLLDIRPGRKPLDWNTRMKIAAGAARGLEYLHDKMKPPVIYRDLKCSNILLGEGYHPKL 238

Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
           SDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA
Sbjct: 239 SDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 298

Query: 297 IDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM 356
           ID TK  KE NL+AWARP+F+DR+ FS+MVDP L+GQYPVRGLYQALAIAAMCVQEQPNM
Sbjct: 299 IDHTKPAKEQNLIAWARPLFRDRRKFSRMVDPLLEGQYPVRGLYQALAIAAMCVQEQPNM 358

Query: 357 RPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDD 399
           RP I DVV ALNYLASQKYDPQ  P+++SR+SP    + +DDD
Sbjct: 359 RPVIVDVVTALNYLASQKYDPQLHPAQTSRRSPPSQIMKRDDD 401

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542581|ref|XP_003539745.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max]

 Score =  587 bits (1513), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 291/416 (69%), Positives = 336/416 (80%), Gaps = 7/416 (1%)

Query: 1   MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
           MG F C GKS+KK   E  + +  LN Q        D+ +VD   N  KE+ S   QL++
Sbjct: 1   MGWFCCPGKSSKKSVTE--DYSDTLN-QKPINFTATDSVKVDFRVNGNKEDGSKGDQLAL 57

Query: 61  DVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE 116
           DVK+LNLK+    D  ++G  A+ F+F+EL AATG+FR DC LGEGGFGKVYKG LE+I 
Sbjct: 58  DVKSLNLKEEASQDRKDNGNRAQTFSFNELEAATGSFRLDCFLGEGGFGKVYKGHLERIN 117

Query: 117 QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
           QVVAIKQLD  G+QG+REF  EV+TL  ADHPNLVKLIG+CAEG+QRLLVYEYMPLGSL+
Sbjct: 118 QVVAIKQLDPNGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGEQRLLVYEYMPLGSLE 177

Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
            HL D+RP  +PLDWNTRMKIAAGA+RGL+YLH+++K PVIYRDLKCSNILL EGYHPKL
Sbjct: 178 DHLLDIRPGRKPLDWNTRMKIAAGAARGLEYLHDKMKPPVIYRDLKCSNILLGEGYHPKL 237

Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
           SDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA
Sbjct: 238 SDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 297

Query: 297 IDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM 356
           ID TK  KE NLVAWARP+F+DR+ FSQMVDP L+GQYPVRGLYQALAIAAMCVQEQPNM
Sbjct: 298 IDHTKPAKEQNLVAWARPLFRDRRKFSQMVDPLLEGQYPVRGLYQALAIAAMCVQEQPNM 357

Query: 357 RPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDDHGKNARSASNREE 412
           RP I DVV ALNYLASQKYDPQ  P+++SR+SP    + +DDD  ++  S  +  +
Sbjct: 358 RPVIVDVVTALNYLASQKYDPQLHPAQTSRRSPPSQMMKRDDDDHRHILSIEHETD 413

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356557471|ref|XP_003547039.1| PREDICTED: probable serine/threonine-protein kinase RLCKVII-like [Glycine max]

 Score =  582 bits (1499), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 288/395 (72%), Positives = 327/395 (82%), Gaps = 7/395 (1%)

Query: 1   MGCFRCSGKSNKKLDEE-IDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVS-NDGQL 58
           MGCFRC+GKS+KK +   I++  K+ N   ++K   AD  +VD N N K+E+ +    QL
Sbjct: 1   MGCFRCTGKSSKKTNNNNINHAEKHTNH--NEKHTAADKVKVDLNVNGKQEDNNPKPDQL 58

Query: 59  SMDVKNLNLKDDSNN---SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI 115
           S+DV+NLNLK+ SN    +   A+ FTF ELAAATGNFRSDC LGEGGFGKVYKG +EKI
Sbjct: 59  SLDVENLNLKEVSNEGKVNSYRAQTFTFAELAAATGNFRSDCFLGEGGFGKVYKGRIEKI 118

Query: 116 EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175
            QVVAIKQLD  G+QG+REF  EV+TL  ADHPNLVKLIG+CAEG+QRLLVYEYMPLGSL
Sbjct: 119 NQVVAIKQLDPHGLQGIREFVVEVLTLSLADHPNLVKLIGFCAEGEQRLLVYEYMPLGSL 178

Query: 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235
           + HLHDL    +P+DWNTRMKIAAGA+RGL+YLH ++K PVIYRDLKCSNILL EGYH K
Sbjct: 179 ENHLHDLPRGRKPIDWNTRMKIAAGAARGLEYLHNKMKPPVIYRDLKCSNILLGEGYHSK 238

Query: 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
           LSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE+ITGRK
Sbjct: 239 LSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEIITGRK 298

Query: 296 AIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPN 355
           AID TK  KE NLVAWA+P+FK+RK F +MVDP L+GQYP+RGLYQALAIAAMCVQEQPN
Sbjct: 299 AIDNTKPAKEQNLVAWAKPLFKNRKRFCEMVDPLLEGQYPIRGLYQALAIAAMCVQEQPN 358

Query: 356 MRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPS 390
           MRP  TDVV ALNYLASQKYDPQ    +S RK  S
Sbjct: 359 MRPETTDVVTALNYLASQKYDPQVHSIQSCRKGLS 393

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104505|ref|XP_002313458.1| predicted protein [Populus trichocarpa] gi|222849866|gb|EEE87413.1| predicted protein [Populus trichocarpa]

 Score =  579 bits (1493), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 283/382 (74%), Positives = 323/382 (84%), Gaps = 5/382 (1%)

Query: 1   MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNAN-LKKEEVSNDGQLS 59
           MG   CSGK +K+ +    N+N +  K+ D+ Q+ + + ++    N L KE  S D QLS
Sbjct: 1   MGFLCCSGKPSKRSESSSINENNSNIKRKDQTQVTSGSLKMKPYVNNLSKEGGSKDDQLS 60

Query: 60  MDVKNLNLKD----DSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI 115
           +DVK+LN+KD    D  ++GK A+ FTF+ELAAAT NFRSDC LGEGGFGKVYKG L+KI
Sbjct: 61  LDVKSLNMKDEISKDRRSNGKQAQTFTFEELAAATSNFRSDCFLGEGGFGKVYKGYLDKI 120

Query: 116 EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL 175
            Q VAIKQLD  GVQG+REF  EV+TL  ADHPNLVKLIG+CAEGDQRLLVYEYMPLGSL
Sbjct: 121 NQAVAIKQLDRNGVQGIREFVVEVVTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPLGSL 180

Query: 176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK 235
           + HLHD+ P+ +PLDWN RMKIAAGA++GL+YLH +++ PVIYRDLKCSNILL EGYHPK
Sbjct: 181 ENHLHDIPPNRQPLDWNARMKIAAGAAKGLEYLHNEMEPPVIYRDLKCSNILLGEGYHPK 240

Query: 236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 295
           LSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK
Sbjct: 241 LSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK 300

Query: 296 AIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPN 355
           AIDQ K+R E NLVAWARPMFKDR+NFS MVDP LQGQYP+RGLYQALAIAAMCVQEQPN
Sbjct: 301 AIDQRKERGEQNLVAWARPMFKDRRNFSCMVDPLLQGQYPIRGLYQALAIAAMCVQEQPN 360

Query: 356 MRPAITDVVMALNYLASQKYDP 377
           MRPA++D+VMALNYLAS KYDP
Sbjct: 361 MRPAVSDLVMALNYLASHKYDP 382

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849082|ref|XP_002892422.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297338264|gb|EFH68681.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 284/401 (70%), Positives = 324/401 (80%), Gaps = 14/401 (3%)

Query: 1   MGCFRCSGKSNKKLDEEIDNK-NKNL----------NKQADKKQLIADTPRVDSNANLKK 49
           MGCF CS KS+K+ +   D   N+ +          +K+ D+ Q  +D+ +V    ++  
Sbjct: 1   MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVVKSDKRDDQAQPSSDSTKVSPYRDVNN 60

Query: 50  EEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYK 109
           E V  + QLS+DVK LNL D    +GK A+ FTF ELA ATGNFRSDC LGEGGFGKV+K
Sbjct: 61  EGVGKEDQLSLDVKGLNLNDQV--TGKKAQTFTFQELAVATGNFRSDCFLGEGGFGKVFK 118

Query: 110 GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169
           G +EK++QVVAIKQLD  GVQG+REF  EV+TL  ADHPNLVKLIG+CAEGDQRLLVYEY
Sbjct: 119 GTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEY 178

Query: 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE 229
           MP GSL+ HLHDL    +PLDWNTRMKIAAGA+RGLQYLH+++  PVIYRDLKCSNILL 
Sbjct: 179 MPQGSLEDHLHDLPSGKKPLDWNTRMKIAAGAARGLQYLHDRMTPPVIYRDLKCSNILLG 238

Query: 230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 289
           E Y PKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE
Sbjct: 239 EDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 298

Query: 290 LITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMC 349
           LITGRKAID TK RK+ NLV WARP+FKDR+NF +MVDP LQGQYPVRGLYQALAI+AMC
Sbjct: 299 LITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMC 358

Query: 350 VQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPS 390
           VQEQP+MRP + DVV ALN+LAS KYDP N PS SSRK+PS
Sbjct: 359 VQEQPSMRPVVCDVVSALNFLASSKYDP-NSPSSSSRKNPS 398

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|334182370|ref|NP_001184932.1| putative serine/threonine-protein kinase RLCKVII [Arabidopsis thaliana] gi|332190074|gb|AEE28195.1| putative serine/threonine-protein kinase RLCKVII [Arabidopsis thaliana]

 Score =  568 bits (1464), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 283/411 (68%), Positives = 328/411 (79%), Gaps = 16/411 (3%)

Query: 1   MGCFRCSGKSNKKLDEEIDNK-NKNL----------NKQADKKQLIADTPRVDSNANLKK 49
           MGCF CS KS+K+ +   D   N+ +          +K+ D+ Q  +D+ +V    ++  
Sbjct: 1   MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60

Query: 50  EE-VSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY 108
           E  V  + QLS+DVK LNL D    +GK A+ FTF ELA ATGNFRSDC LGEGGFGKV+
Sbjct: 61  EGGVGKEDQLSLDVKGLNLNDQV--TGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVF 118

Query: 109 KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE 168
           KG +EK++QVVAIKQLD  GVQG+REF  EV+TL  ADHPNLVKLIG+CAEGDQRLLVYE
Sbjct: 119 KGTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYE 178

Query: 169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL 228
           YMP GSL+ HLH L    +PLDWNTRMKIAAGA+RGL+YLH+++  PVIYRDLKCSNILL
Sbjct: 179 YMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILL 238

Query: 229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 288
            E Y PKLSDFGLAK+GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL
Sbjct: 239 GEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLL 298

Query: 289 ELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAM 348
           ELITGRKAID TK RK+ NLV WARP+FKDR+NF +MVDP LQGQYPVRGLYQALAI+AM
Sbjct: 299 ELITGRKAIDNTKTRKDQNLVGWARPLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAM 358

Query: 349 CVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPSCLGVNKDDD 399
           CVQEQP MRP ++DVV+ALN+LAS KYDP N PS SS K+PS    ++DD+
Sbjct: 359 CVQEQPTMRPVVSDVVLALNFLASSKYDP-NSPSSSSGKNPS-FHRDRDDE 407

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	426
TAIR|locus:2056613	424	AT2G28590 [Arabidopsis thalian	0.877	0.882	0.676	4.1e-136
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.784	0.883	0.684	4.9e-127
TAIR|locus:2183018	513	AT5G18610 [Arabidopsis thalian	0.856	0.711	0.630	3.6e-121
TAIR|locus:2179857	456	PBS1 "avrPphB susceptible 1" [	0.981	0.916	0.539	2.1e-116
TAIR|locus:2085720	386	AT3G20530 [Arabidopsis thalian	0.816	0.901	0.583	5.1e-106
TAIR|locus:2034344	381	ASG5 "ALTERED SEED GERMINATION	0.816	0.913	0.592	4.2e-102
TAIR|locus:2087263	363	AT3G24790 [Arabidopsis thalian	0.715	0.840	0.622	1.4e-101
TAIR|locus:2075517	558	AT3G02810 [Arabidopsis thalian	0.713	0.544	0.604	4.6e-101
TAIR|locus:2098580	414	AT3G07070 [Arabidopsis thalian	0.838	0.862	0.541	1e-100
TAIR|locus:2036818	389	AT1G61860 [Arabidopsis thalian	0.680	0.745	0.643	1.7e-100

TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)]

 Score = 1333 (474.3 bits), Expect = 4.1e-136, P = 4.1e-136
 Identities = 259/383 (67%), Positives = 303/383 (79%)

Query:     1 MGCFRCSGKSNKKLDEEIDNKN----KNLNKQADKKQLI---ADTPRVDSNANLKKEEVS 53
             MGCF  + KSNK+ D +    N    K L   A++ +L    +D  +V    ++ KE V+
Sbjct:     1 MGCFGRTPKSNKRSDTKTTKNNDFTPKKLTVNANRDKLTQPSSDCLKVSICGDVSKEIVT 60

Query:    54 NDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLE 113
                QL++D K+ N++D+     K A+ FTF+EL+ +TGNF+SDC LGEGGFGKVYKG +E
Sbjct:    61 KKDQLALDAKDTNVEDEV--IVKKAQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIE 118

Query:   114 KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173
             KI QVVAIKQLD  G QG+REF  EV+TL  ADHPNLVKLIG+CAEG QRLLVYEYMPLG
Sbjct:   119 KINQVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLG 178

Query:   174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233
             SLD HLHDL     PL WNTRMKIAAGA+RGL+YLH+ +K PVIYRDLKCSNIL++EGYH
Sbjct:   179 SLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYH 238

Query:   234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
              KLSDFGLAK+GP G +THVSTRVMGTYGYCAPDYA+TGQLTFKSD+YSFGVVLLELITG
Sbjct:   239 AKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITG 298

Query:   294 RKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQ 353
             RKA D T+ R   +LV WA P+FKDRKNF +MVDP L+G YPVRGLYQALAIAAMCVQEQ
Sbjct:   299 RKAYDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQ 358

Query:   354 PNMRPAITDVVMALNYLASQKYD 376
             P+MRP I DVVMAL++LAS KYD
Sbjct:   359 PSMRPVIADVVMALDHLASSKYD 381

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 4.9e-127, Sum P(2) = 4.9e-127
 Identities = 232/339 (68%), Positives = 270/339 (79%)

Query:    44 NANLKKEEVSNDGQLSMDVKNL--NLKDDSNNSGKS---AKPFTFDELAAATGNFRSDCC 98
             N + K +  S+D  +S   K+   +   +S + G     A+ FTF ELA AT NFR +C 
Sbjct:    19 NGDHKLDRKSSDCSVSTSEKSRAKSSLSESKSKGSDHIVAQTFTFSELATATRNFRKECL 78

Query:    99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
             +GEGGFG+VYKG L    Q  AIKQLDH G+QG REF  EV+ L    HPNLV LIGYCA
Sbjct:    79 IGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 138

Query:   159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +GDQRLLVYEYMPLGSL+ HLHD+ P  +PLDWNTRMKIAAGA++GL+YLH++   PVIY
Sbjct:   139 DGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIY 198

Query:   219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
             RDLKCSNILL++ Y PKLSDFGLAK+GP GDK+HVSTRVMGTYGYCAP+YAMTGQLT KS
Sbjct:   199 RDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKS 258

Query:   279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
             D+YSFGVVLLE+ITGRKAID ++   E NLVAWARP+FKDR+ FSQM DP LQGQYP RG
Sbjct:   259 DVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRG 318

Query:   339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
             LYQALA+AAMCVQEQPN+RP I DVV AL+YLASQK+DP
Sbjct:   319 LYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDP 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)]

 Score = 1192 (424.7 bits), Expect = 3.6e-121, P = 3.6e-121
 Identities = 237/376 (63%), Positives = 277/376 (73%)

Query:     2 GCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMD 61
             GC  C G S K             +K + KK+L A    V  + ++  ++ S   +    
Sbjct:     3 GCLPCFGSSAKDA----------ASKDSVKKELSAKDGSVTQSHHISLDK-SKSRRGPEQ 51

Query:    62 VKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAI 121
              K L    +   +  +A+ FTF ELAAAT NFR +C LGEGGFG+VYKG LE   Q+VA+
Sbjct:    52 KKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAV 111

Query:   122 KQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD 181
             KQLD  G+QG REF  EV+ L    HPNLV LIGYCA+GDQRLLVYEYMPLGSL+ HLHD
Sbjct:   112 KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 171

Query:   182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
             L PD  PLDW+TRM IAAGA++GL+YLH++   PVIYRDLK SNILL +GYHPKLSDFGL
Sbjct:   172 LPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGL 231

Query:   242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301
             AK+GP GDKTHVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAID  +
Sbjct:   232 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNAR 291

Query:   302 DRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT 361
                E NLVAWARP+FKDR+ F +M DPSLQG+YP+RGLYQALA+AAMC+QEQ   RP I 
Sbjct:   292 APGEHNLVAWARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIG 351

Query:   362 DVVMALNYLASQKYDP 377
             DVV AL YLASQ +DP
Sbjct:   352 DVVTALTYLASQTFDP 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1147 (408.8 bits), Expect = 2.1e-116, P = 2.1e-116
 Identities = 232/430 (53%), Positives = 288/430 (66%)

Query:     1 MGCFRCSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSM 60
             MGCF C   S+ +    +D  N    KQ+  +  +++      +   K    +N G    
Sbjct:     1 MGCFSCFDSSDDEKLNPVDESNHGQKKQS--QPTVSNNISGLPSGGEKLSSKTNGGSK-- 56

Query:    61 DVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVA 120
               + L L  D      +A  F F ELAAAT NF  D  LGEGGFG+VYKG L+   QVVA
Sbjct:    57 --RELLLPRDGLGQ-IAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVA 113

Query:   121 IKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180
             +KQLD  G+QG REF  EV+ L    HPNLV LIGYCA+GDQRLLVYE+MPLGSL+ HLH
Sbjct:   114 VKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH 173

Query:   181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240
             DL PD   LDWN RMKIAAGA++GL++LH++   PVIYRD K SNILL+EG+HPKLSDFG
Sbjct:   174 DLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFG 233

Query:   241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
             LAK+GP+GDK+HVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAID  
Sbjct:   234 LAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSE 293

Query:   301 KDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI 360
                 E NLVAWARP+F DR+ F ++ DP L+G++P R LYQALA+A+MC+QEQ   RP I
Sbjct:   294 MPHGEQNLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLI 353

Query:   361 TDVVMALNYLASQKYDPQNXXXXXXXXXXXCLGVNKDDDHGKNARS----ASNREEV-KS 415
              DVV AL+YLA+Q YDP                + ++DD G +        S +E+  + 
Sbjct:   354 ADVVTALSYLANQAYDPSKDDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRE 413

Query:   416 SGQCLSNGVN 425
             + + L+  +N
Sbjct:   414 TARILNRDIN 423

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0009816 "defense response to bacterium, incompatible interaction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0006952 "defense response" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)]

 Score = 1049 (374.3 bits), Expect = 5.1e-106, P = 5.1e-106
 Identities = 209/358 (58%), Positives = 261/358 (72%)

Query:    22 NKNLNKQADKKQLIADTPRVDSNANLKK-EEVSNDGQLSMDVKNLNLKDDSNNSGK---S 77
             ++  N+++  +Q I D   +D+  N+   + +S     S   +   + ++    GK   S
Sbjct:    12 HRRFNRRSSSRQSIKDC--IDAKNNITTFDNISFKTDSS---RRRYISEEIAKLGKGNIS 66

Query:    78 AKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA 137
             A  FTF EL  AT NF  D  LGEGGFG+VYKG +E  EQVVA+KQLD  G QG REF  
Sbjct:    67 AHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLV 126

Query:   138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMK 196
             EVM L    H NLV L+GYCA+GDQR+LVYEYM  GSL+ HL +L R   +PLDW+TRMK
Sbjct:   127 EVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMK 186

Query:   197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
             +AAGA+RGL+YLHE    PVIYRD K SNILL+E ++PKLSDFGLAK+GP+G +THVSTR
Sbjct:   187 VAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTR 246

Query:   257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF 316
             VMGTYGYCAP+YA+TGQLT KSD+YSFGVV LE+ITGR+ ID TK  +E NLV WA P+F
Sbjct:   247 VMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLF 306

Query:   317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK 374
             KDR+ F+ M DP L+G+YP++GLYQALA+AAMC+QE+   RP ++DVV AL YLA  K
Sbjct:   307 KDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTK 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 208/351 (59%), Positives = 251/351 (71%)

Query:    25 LNKQADKKQLIADTPRVDSNANLKKEEVSND--GQLSMDVKNLNLKDDSNNSGKSAKPFT 82
             LN +    ++  D  R +S          +D  G  S+    +N K +S   G  A+ FT
Sbjct:     8 LNPRTKDIRVDIDNARCNSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPGGGARSFT 67

Query:    83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL 142
             F ELAAAT NFR    LGEGGFG+VYKG L+   QVVAIKQL+  G+QG REF  EV+ L
Sbjct:    68 FKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIVEVLML 126

Query:   143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
                 HPNLV LIGYC  GDQRLLVYEYMP+GSL+ HL DL  +  PL WNTRMKIA GA+
Sbjct:   127 SLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVGAA 186

Query:   203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             RG++YLH     PVIYRDLK +NILL++ + PKLSDFGLAK+GP GD+THVSTRVMGTYG
Sbjct:   187 RGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGTYG 246

Query:   263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
             YCAP+YAM+G+LT KSDIY FGVVLLELITGRKAID  + + E NLV W+RP  KD+K F
Sbjct:   247 YCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQKKF 306

Query:   323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ 373
               +VDPSL+G+YP R L  A+AI AMC+ E+ + RP I D+V+AL YLA+Q
Sbjct:   307 GHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQ 357

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1007 (359.5 bits), Expect = 1.4e-101, P = 1.4e-101
 Identities = 191/307 (62%), Positives = 233/307 (75%)

Query:    66 NLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD 125
             N    SNN G  A+ FTF ELA AT NFR +C +GEGGFG+VYKG LE   QVVA+KQLD
Sbjct:    22 NANGPSNNMG--ARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLD 79

Query:   126 HRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD 185
               G+QG REF  EV+ L    H NLV LIGYCA+GDQRLLVYEYMPLGSL+ HL DL P 
Sbjct:    80 RNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPG 139

Query:   186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
              +PLDWNTR+KIA GA++G++YLH++   PVIYRDLK SNILL+  Y  KLSDFGLAK+G
Sbjct:   140 QKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLG 199

Query:   246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
             P GD  HVS+RVMGTYGYCAP+Y  TG LT KSD+YSFGVVLLELI+GR+ ID  +   E
Sbjct:   200 PVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHE 259

Query:   306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM 365
              NLV WA P+F+D   + Q+ DP L+G YP + L QA+A+AAMC+ E+P +RP ++DV+ 
Sbjct:   260 QNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVIT 319

Query:   366 ALNYLAS 372
             AL++L +
Sbjct:   320 ALSFLGA 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075517 AT3G02810 [Arabidopsis thaliana (taxid:3702)]

 Score = 975 (348.3 bits), Expect = 4.6e-101, Sum P(2) = 4.6e-101
 Identities = 185/306 (60%), Positives = 236/306 (77%)

Query:    73 NSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV 132
             + G S K FTF ELA AT NFR +C LGEGGFG+VYKG L+   QVVA+KQLD  G+ G 
Sbjct:    44 SEGTSLKIFTFRELATATKNFRQECLLGEGGFGRVYKGTLKSTGQVVAVKQLDKHGLHGN 103

Query:   133 REFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN 192
             +EF AEV++LG  DHPNLVKLIGYCA+GDQRLLVY+Y+  GSL  HLH+ + D+ P+DW 
Sbjct:   104 KEFQAEVLSLGQLDHPNLVKLIGYCADGDQRLLVYDYISGGSLQDHLHEPKADSDPMDWT 163

Query:   193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP-SGDKT 251
             TRM+IA  A++GL YLH++   PVIYRDLK SNILL++ + PKLSDFGL K+GP +GDK 
Sbjct:   164 TRMQIAYAAAQGLDYLHDKANPPVIYRDLKASNILLDDDFSPKLSDFGLHKLGPGTGDKM 223

Query:   252 H-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
               +S+RVMGTYGY AP+Y   G LT KSD+YSFGVVLLELITGR+A+D T+   E NLV+
Sbjct:   224 MALSSRVMGTYGYSAPEYTRGGNLTLKSDVYSFGVVLLELITGRRALDTTRPNDEQNLVS 283

Query:   311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             WA+P+F+D K +  M DP L+ ++  RGL QA+AIA+MCVQE+ + RP I+DV++AL++L
Sbjct:   284 WAQPIFRDPKRYPDMADPVLENKFSERGLNQAVAIASMCVQEEASARPLISDVMVALSFL 343

Query:   371 ASQKYD 376
             +    D
Sbjct:   344 SMPTED 349

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)]

 Score = 999 (356.7 bits), Expect = 1.0e-100, P = 1.0e-100
 Identities = 202/373 (54%), Positives = 260/373 (69%)

Query:     1 MGCFRCSG-KSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLS 59
             M CF C      KK+  + DN  +  N +         T R D+N    K    N   ++
Sbjct:     1 MNCFSCFYFHEKKKVPRDSDNSYRR-NGEV--------TGR-DNN----KTHPENPKTVN 46

Query:    60 MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVV 119
                KN N +D    +  +A+ F+F ELA AT NFR +C +GEGGFG+VYKG LEK   +V
Sbjct:    47 EQNKN-NDEDKEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIV 105

Query:   120 AIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL 179
             A+KQLD  G+QG +EF  EV+ L    H +LV LIGYCA+GDQRLLVYEYM  GSL+ HL
Sbjct:   106 AVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHL 165

Query:   180 HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF 239
              DL PD  PLDW+TR++IA GA+ GL+YLH++   PVIYRDLK +NILL+  ++ KLSDF
Sbjct:   166 LDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDF 225

Query:   240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299
             GLAK+GP GDK HVS+RVMGTYGYCAP+Y  TGQLT KSD+YSFGVVLLELITGR+ ID 
Sbjct:   226 GLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDT 285

Query:   300 TKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA 359
             T+ + E NLV WA+P+FK+   F ++ DPSL+G +P + L QA+A+AAMC+QE+  +RP 
Sbjct:   286 TRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPL 345

Query:   360 ITDVVMALNYLAS 372
             ++DVV AL +L +
Sbjct:   346 MSDVVTALGFLGT 358

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)]

 Score = 997 (356.0 bits), Expect = 1.7e-100, P = 1.7e-100
 Identities = 188/292 (64%), Positives = 230/292 (78%)

Query:    81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM 140
             F F EL AAT NF  DC +GEGGFG+VYKG L  + QVVA+K+LD  G+QG REF AEVM
Sbjct:    73 FKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVM 132

Query:   141 TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAA 199
              L  A HPNLV LIGYC E +QR+LVYE+MP GSL+ HL DL P+  P LDW TRM+I  
Sbjct:   133 VLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDL-PEGSPSLDWFTRMRIVH 191

Query:   200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
             GA++GL+YLH+    PVIYRD K SNILL+  ++ KLSDFGLA++GP+  K HVSTRVMG
Sbjct:   192 GAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMG 251

Query:   260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
             TYGYCAP+YAMTGQLT KSD+YSFGVVLLE+I+GR+AID  +  +E NL++WA P+ KDR
Sbjct:   252 TYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDR 311

Query:   320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
             + F+Q+VDP+L G YPV+GL+QALAIAAMC+QE+   RP + DVV AL +LA
Sbjct:   312 RMFAQIVDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLA 363

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	426
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-52
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-37
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-34
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-27
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-26
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-26
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-26
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-26
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-24
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-23
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-23
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	6e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-23
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-22
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-20
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-18
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-17
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-14
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-14
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-13
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	8e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-08
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (448), Expect = 1e-52
 Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 12/199 (6%)

Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FG+VYKG L+    K +  VA+K L +    Q + EF  E   +   DHPN+VKL
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G C E +   +V EYM  G L  +L   RP    L  +  +  A   +RG++YL     
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLES--- 120

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           +  I+RDL   N L+ E    K+SDFGL++     D             + AP+    G+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179

Query: 274 LTFKSDIYSFGVVLLELIT 292
            T KSD++SFGV+L E+ T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  175 bits (446), Expect = 3e-52
 Identities = 75/199 (37%), Positives = 105/199 (52%), Gaps = 11/199 (5%)

Query: 99  LGEGGFGKVYKGCLEKI----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FG+VYKG L+      E  VA+K L +    Q + EF  E   +   DHPN+VKL
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G C E +  ++V EYMP G L  +L   RP    L  +  +  A   +RG++YL     
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLES--- 121

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           +  I+RDL   N L+ E    K+SDFGL++     D   V         + AP+    G+
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180

Query: 274 LTFKSDIYSFGVVLLELIT 292
            T KSD++SFGV+L E+ T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  172 bits (439), Expect = 1e-51
 Identities = 71/195 (36%), Positives = 97/195 (49%), Gaps = 11/195 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LGEGGFG VY    +K  + VAIK +       + E    E+  L   +HPN+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            + +   LV EY   GSL   L +       L  +  ++I      GL+YLH      +I
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS---NGII 114

Query: 218 YRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD-YAMTGQLT 275
           +RDLK  NILL  +    KL+DFGL+K         +   ++GT  Y AP+     G  +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 276 FKSDIYSFGVVLLEL 290
            KSDI+S GV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  169 bits (430), Expect = 7e-50
 Identities = 68/200 (34%), Positives = 100/200 (50%), Gaps = 11/200 (5%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FG+VYKG L    E  E  VA+K L +    +   EF  E   +    HPN+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G C +G+   +V EYMP G L   L         L     +++A   ++G++YL     
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLES--- 120

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           +  ++RDL   N L+ E    K+SDFGL++     D             + AP+    G+
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 274 LTFKSDIYSFGVVLLELITG 293
            T KSD++SFGV+L E+ T 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  168 bits (428), Expect = 2e-49
 Identities = 75/200 (37%), Positives = 103/200 (51%), Gaps = 12/200 (6%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIG 155
            LG G FG VYK   +   ++VA+K L  R    +  +    E+  L    HPN+V+LI 
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              + D   LV EY   G L  +L    P    L  +   KIA    RGL+YLH      
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQILRGLEYLHSN---G 118

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL- 274
           +I+RDLK  NILL+E    K++DFGLAK       + ++T V GT  Y AP+  + G   
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGY 176

Query: 275 TFKSDIYSFGVVLLELITGR 294
             K D++S GV+L EL+TG+
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (412), Expect = 3e-47
 Identities = 72/197 (36%), Positives = 100/197 (50%), Gaps = 11/197 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LGEG FGKVY    +K  ++VAIK +  + ++  RE    E+  L    HPN+V+L    
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            + D+  LV EY   G L   L      +       R          L+YLH    + ++
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---AR-FYLRQILSALEYLH---SKGIV 119

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDLK  NILL+E  H KL+DFGLA+    G+K    T V GT  Y AP+  +       
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYMAPEVLLGKGYGKA 176

Query: 278 SDIYSFGVVLLELITGR 294
            DI+S GV+L EL+TG+
Sbjct: 177 VDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  161 bits (409), Expect = 1e-46
 Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 42/285 (14%)

Query: 99  LGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLI 154
           LGEG FG+VYKG L+        VA+K L      +  ++F  E   +    HPN+V+L+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLH 209
           G C E +   LV EYM  G L  +L   R     P+   L     +  A   ++G++YL 
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
               +  ++RDL   N L+ E    K+SDFGL++     D     T       + AP+  
Sbjct: 123 S---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 270 MTGQLTFKSDIYSFGVVLLELIT-------GRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
             G  T KSD++SFGV+L E+ T       G    +                + +  +  
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------------VLEYLRKG 223

Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
            ++  P      P   LY+   +   C Q  P  RP  +++V  L
Sbjct: 224 YRLPKPEY---CPDE-LYE---LMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  136 bits (344), Expect = 3e-37
 Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 97  CCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
             LG G FG VY    +   +++A+K   L     + +     E+  L S  HPN+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 155 GYC--AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHE 210
           G     E +   +  EY+  GSL   L        P+   + TR  +      GL YLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQIL-----EGLAYLHS 119

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                +++RD+K +NIL++     KL+DFG AK     +    +  V GT  + AP+   
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
             +    +DI+S G  ++E+ TG+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  130 bits (328), Expect = 8e-35
 Identities = 70/203 (34%), Positives = 100/203 (49%), Gaps = 16/203 (7%)

Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV     +       + VA+K L+H G  Q   +F  E+  L + DH N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C +   R   L+ EY+P GSL  +L   R     ++    +  ++   +G+ YL  Q
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICKGMDYLGSQ 128

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST--RVMGTYGYCAPDYA 269
                I+RDL   NIL+E     K+SDFGLAK+ P     +          + Y AP+  
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
            T + +  SD++SFGV L EL T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  128 bits (325), Expect = 1e-34
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 9/197 (4%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            +G+GGFG+VYK   ++  + VAIK +     +   +   E+  L    HPN+VK  G  
Sbjct: 7   KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            + D+  +V E+   GSL   L       + L  +    +     +GL+YLH      +I
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH---SNGII 120

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +NILL      KL DFGL+         +    ++GT  + AP+        +K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYDYK 177

Query: 278 SDIYSFGVVLLELITGR 294
           +DI+S G+  +EL  G+
Sbjct: 178 ADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 7e-33
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 19/206 (9%)

Query: 99  LGEGGFGKVYKGC----LEKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG VYKG      EK++  VAIK L +    +  +E   E   + S DHP++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHE 210
           +G C    Q  L+ + MPLG L  ++ + + +      L+W    +IA    +G+ YL E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIA----KGMSYLEE 127

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
           +    +++RDL   N+L++   H K++DFGLAK+    +K + +        + A +  +
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRK 295
               T KSD++S+GV + EL+T G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  125 bits (314), Expect = 3e-32
 Identities = 88/343 (25%), Positives = 145/343 (42%), Gaps = 26/343 (7%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           ++R    LGEG FG+VY     +  ++VA+K L  +     + V  F  E+  L S +HP
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 149 -NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            N+VKL  +  +     LV EY+  GSL+  L        PL  +  + I A     L+Y
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALEY 116

Query: 208 LHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKM----GPSGDKTHVSTRVMGTYG 262
           LH    + +I+RD+K  NILL  +G   KL DFGLAK+    G +     + +  +GT G
Sbjct: 117 LHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173

Query: 263 YCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
           Y AP+  +       +  SDI+S G+ L EL+TG    +  K+    +       +    
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKIILELPT 232

Query: 320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQN 379
            + +  + PS     P      A  +    + + P  R + +  +   + L +     ++
Sbjct: 233 PSLASPLSPSN----PELISKAASDLLKKLLAKDPKNRLSSSSDL--SHDLLAHLKLKES 286

Query: 380 PPSRSSRKSPSCLGVNKDDDHGKNARSASNREEVKSSGQCLSN 422
             S   +   S           +   S+ N   +  S   L +
Sbjct: 287 DLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDD 329

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  121 bits (306), Expect = 5e-32
 Identities = 71/204 (34%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   ++ A+K L  + +   + V     E   L   +HP +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58

Query: 156 YCAEGDQR--LLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           + A   +    LV EY P G L  HL       + R      R   AA     L+YLH  
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARF-YAAEIVLALEYLHSL 112

Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
               +IYRDLK  NILL  +G H KL+DFGLAK   S   +  +T   GT  Y AP+  +
Sbjct: 113 ---GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPEVLL 166

Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
                   D +S GV+L E++TG+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (302), Expect = 3e-31
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 15/207 (7%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPN 149
           +      LG+G  G VYK   +   ++ A+K   +D       ++   E+ TL S + P 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR-KQLLRELKTLRSCESPY 60

Query: 150 LVKLIG-YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           +VK  G +  EG+  + V EYM  GSL     DL      +       IA    +GL YL
Sbjct: 61  VVKCYGAFYKEGEISI-VLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLDYL 115

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPD 267
           H +     I+RD+K SN+L+      K++DFG++K +  + D+ +  T V GT  Y +P+
Sbjct: 116 HTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPE 170

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
                  ++ +DI+S G+ LLE   G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  120 bits (302), Expect = 4e-31
 Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LGEG FGKVYKG L           VAIK L       V+ EF  E   +    HPN+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHL------------HDLRPDTRPLDWNTRMKIAAG 200
           L+G C +     +++EY+  G L + L                     LD +  + IA  
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
            + G++YL        ++RDL   N L+ EG   K+SDFGL++   S D   V ++ +  
Sbjct: 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
             +  P+  + G+ T +SDI+SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  119 bits (300), Expect = 6e-31
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 19/210 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVK 152
           LGEG FGKV+ G    +E      +VA+K L        R+ F  E   L +  H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHL--HD--------LRPDTRPLDWNTRMKIAAGAS 202
             G C EGD  ++V+EYM  G L+K L  H                L  +  ++IA   +
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+ YL     Q  ++RDL   N L+      K+ DFG+++   + D   V    M    
Sbjct: 133 SGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +  P+  M  + T +SD++SFGVVL E+ T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 4e-29
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 13/201 (6%)

Query: 97  CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLI 154
             +G G FG VYKG   +    VAIKQ+    +  + ++    E+  L +  HPN+VK I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G     D   ++ EY   GSL + +        P   +          +GL YLHEQ   
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ--- 118

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
            VI+RD+K +NIL  +    KL+DFG+A K+            V+GT  + AP+      
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEMSG 175

Query: 274 LTFKSDIYSFGVVLLELITGR 294
            +  SDI+S G  ++EL+TG 
Sbjct: 176 ASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  110 bits (278), Expect = 6e-28
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 99  LGEGGFGKVYKGCLEKIE--QVVAIKQLD-HRGVQGVREFS-AEVMTLGSADHPNLVKLI 154
           +G+G FGKVY   + +    ++  +K++D     +  RE +  EV  L   +HPN++K  
Sbjct: 8   IGKGSFGKVYL--VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
               E  +  +V EY   G L + +   + + +P      +         L+YLH +   
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD------Y 268
            +++RD+K  NI L      KL DFG++K+  S       T V GT  Y +P+      Y
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQNKPY 180

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKA 296
                  +KSDI+S G VL EL T +  
Sbjct: 181 ------NYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  110 bits (276), Expect = 9e-28
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 8/194 (4%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V++G L K    VAIK L    +   ++F  EV  L    H +L+ L   C+
Sbjct: 14  LGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            G+   ++ E M  GSL   L    P+ + L   + + +A   + G+ YL E   Q  I+
Sbjct: 73  VGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QNSIH 127

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   NIL+ E    K++DFGLA++           ++   Y + AP+ A  G  + KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKS 185

Query: 279 DIYSFGVVLLELIT 292
           D++SFG++L E+ T
Sbjct: 186 DVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 65/198 (32%), Positives = 98/198 (49%), Gaps = 11/198 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L   G      F  E   +    H  LV+L   C+
Sbjct: 14  LGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E +   +V EYM  GSL   L     + + L     + +AA  + G+ YL  +     I+
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RDL   NIL+ E    K++DFGLA++    + T     +      + AP+ A  G+ T K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184

Query: 278 SDIYSFGVVLLELIT-GR 294
           SD++SFG++L E++T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  107 bits (268), Expect = 2e-26
 Identities = 74/205 (36%), Positives = 107/205 (52%), Gaps = 21/205 (10%)

Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V     + ++    +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   LV EY+P GSL  +L  H  R D R L     +  A+   +G++YL  
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQICKGMEYLGS 126

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG---TYGYCAPD 267
              +  ++RDL   NIL+E     K+ DFGL K+ P  DK +   R  G    + Y AP+
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APE 181

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                + +  SD++SFGVVL EL T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  106 bits (266), Expect = 3e-26
 Identities = 63/202 (31%), Positives = 107/202 (52%), Gaps = 18/202 (8%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG V+KG      + I+  VAIK +  R G Q  +E +  ++ +GS DH  +V+L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHE 210
           +G C  G    LV +  PLGSL  H+   R    P   L+W  ++      ++G+ YL E
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLEE 127

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                +++R+L   NILL+     +++DFG+A +    DK +  +       + A +  +
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
            G+ T +SD++S+GV + E+++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  106 bits (265), Expect = 4e-26
 Identities = 78/282 (27%), Positives = 124/282 (43%), Gaps = 37/282 (13%)

Query: 99  LGEGGFGKVYKG-CL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+   C     E+ + +VA+K L        ++F  E   L    H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
            G C EG   L+V+EYM  G L++ L    PD +            L     + IA+  +
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+ YL        ++RDL   N L+ +G   K+ DFG+++   S D   V  R M    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN 321
           +  P+  +  + T +SDI+SFGVVL E+ T G++   Q  + + +  +   R + + R  
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTC 249

Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
             ++                   I   C Q +P  R  I D+
Sbjct: 250 PPEVYA-----------------IMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 6e-26
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 18/200 (9%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
            +G+G FG V  G      Q VA+K L D       + F AE   + +  HPNLV+L+G 
Sbjct: 13  TIGKGEFGDVMLGDYRG--QKVAVKCLKDD--STAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +G+   +V EYM  GSL   +  LR   R  +    ++  A     G++YL E   + 
Sbjct: 69  VLQGNPLYIVTEYMAKGSL---VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KN 122

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
            ++RDL   N+L+ E    K+SDFGLAK      +   S ++     + AP+     + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFS 177

Query: 276 FKSDIYSFGVVLLELIT-GR 294
            KSD++SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  105 bits (263), Expect = 1e-25
 Identities = 83/288 (28%), Positives = 127/288 (44%), Gaps = 35/288 (12%)

Query: 99  LGEGGFGKV-----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV     Y  C E+ + +VA+K L        ++F  E   L +  H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---------RPLDWNTRMKIAAGASRG 204
            G C EGD  ++V+EYM  G L+K L    PD            L  +  + IA   + G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           + YL     Q  ++RDL   N L+ E    K+ DFG+++   S D   V    M    + 
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M  + T +SD++S GVVL E+ T G++   Q  + + +  +   R +        
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-------- 241

Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
                    Q P     +   +   C Q +P+MR  I ++   L  LA
Sbjct: 242 ---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  103 bits (258), Expect = 4e-25
 Identities = 79/269 (29%), Positives = 125/269 (46%), Gaps = 32/269 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+VYKG   + ++VVAIK +D    +  + +   E+  L   D P + +  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +G +  ++ EY+  GS    L  L+P   PL+      I     +GL YLH + K   I
Sbjct: 72  LKGTKLWIIMEYLGGGSA---LDLLKPG--PLEETYIATILREILKGLDYLHSERK---I 123

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+        FK
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G          + L L+    P             P+L+GQY  P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQYSKP 228

Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
            +   +A      C+ + P  RP   +++
Sbjct: 229 FKEFVEA------CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  106 bits (265), Expect = 2e-24
 Identities = 89/317 (28%), Positives = 144/317 (45%), Gaps = 36/317 (11%)

Query: 63  KNLNLKDDSNNSG---------KSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLE 113
            NL LK   N  G         K +K  T +++ ++    + +  +  G  G  YKG   
Sbjct: 656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSL---KEENVISRGKKGASYKGKSI 712

Query: 114 KIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL 172
           K      +K++ D   +      S+E+  +G   HPN+VKLIG C       L++EY+  
Sbjct: 713 KNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767

Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY 232
            +L + L       R L W  R KIA G ++ L++LH +    V+  +L    I+++   
Sbjct: 768 KNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD 820

Query: 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            P L    L  +  +  K  +S+       Y AP+   T  +T KSDIY FG++L+EL+T
Sbjct: 821 EPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLT 873

Query: 293 GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPV--RGLYQALAIAAMCV 350
           G+   D        ++V WAR  + D  +    +DPS++G   V    + + + +A  C 
Sbjct: 874 GKSPADAEFGVHG-SIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931

Query: 351 QEQPNMRPAITDVVMAL 367
              P  RP   DV+  L
Sbjct: 932 ATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  100 bits (251), Expect = 3e-24
 Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQG---VREFSAEVMTLGSADHPNLVKL 153
           LG G FG VY+G         A+K+  L   G  G   V++   E+  L    HPN+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G   E D   +  E +P GSL K L        P+      +I  G    L+YLH++  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLHDR-- 121

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-----GTYGYCAPDY 268
              ++RD+K +NIL++     KL+DFG+AK         V          G+  + AP+ 
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAPEV 172

Query: 269 AM-TGQLTFKSDIYSFGVVLLELITGR 294
               G     +DI+S G  +LE+ TG+
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  100 bits (251), Expect = 5e-24
 Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 29/227 (12%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQG-VREFSAEVMTLGSA 145
           N      LGEG FGKV K    +++       VA+K L        +R+  +E   L   
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--------------------PD 185
           +HP+++KL G C++    LL+ EY   GSL   L + R                    PD
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
            R L     +  A   SRG+QYL E     +++RDL   N+L+ EG   K+SDFGL++  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
              D     ++      + A +       T +SD++SFGV+L E++T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 24/205 (11%)

Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGV--REFSAEVMTLGSADHPNLVKL 153
           +G G FG+V +G L+   K E  VAIK L   G       +F  E   +G  DHPN+++L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            G   +    +++ EYM  GSLDK    LR +         + +  G + G++YL E   
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDKF---LRENDGKFTVGQLVGMLRGIASGMKYLSE--- 124

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPD 267
              ++RDL   NIL+      K+SDFGL++     + T+       T G      + AP+
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAPE 178

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                + T  SD++SFG+V+ E+++
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 99.3 bits (248), Expect = 7e-24
 Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           F     LGEG +G VYK   ++  QVVAIK +       ++E   E+  L   D P +VK
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAA---GASRGLQYL 208
             G   +     +V EY   GS+     D+   T + L   T  +IAA      +GL+YL
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVS----DIMKITNKTL---TEEEIAAILYQTLKGLEYL 115

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPD 267
           H   K   I+RD+K  NILL E    KL+DFG++ ++  +  K +    V+GT  + AP+
Sbjct: 116 HSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPE 169

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
                    K+DI+S G+  +E+  G+
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.1 bits (247), Expect = 9e-24
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 32/265 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +G+G FG V+K   +  ++V A+KQ+D   +       A  E   L   D   +++    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  +  +V EY   G L K L   R   RPL  +   +       GL +LH    + +
Sbjct: 68  FLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLH---SKKI 122

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RD+K  N+ L+   + K+ D G+AK+    D T+ +  ++GT  Y +P+         
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNE 180

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY-P 335
           KSD+++ GVVL E  TG+   D        N  A    +              ++G + P
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDAN------NQGALILKI--------------IRGVFPP 220

Query: 336 VRGLY-QALA-IAAMCVQEQPNMRP 358
           V  +Y Q LA +   C+ +    RP
Sbjct: 221 VSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 1e-23
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 8/196 (4%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG VYKG L K    VA+K         ++  F  E   L   DHPN+VKLIG C
Sbjct: 3   IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +     +V E +P GSL   L  LR     L     ++++  A+ G++YL     +  I
Sbjct: 62  VQKQPIYIVMELVPGGSL---LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCI 115

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E    K+SDFG+++    G  T           + AP+    G+ T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 278 SDIYSFGVVLLELITG 293
           SD++S+G++L E  + 
Sbjct: 176 SDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 99.2 bits (247), Expect = 1e-23
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 20/210 (9%)

Query: 99  LGEGGFGKVYKGCLEKI------EQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNL 150
           LG G FG+VY+G    I         VA+K L  +G   Q  +EF  E   + + +HPN+
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-RKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQY 207
           VKL+G C   + + ++ E M  G L  +L D R +      L     + I    ++G  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 208 LHEQLKQPVIYRDLKCSNILL-EEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           L EQ+    I+RDL   N L+ E+GY      K+ DFGLA+     D        +    
Sbjct: 122 L-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + AP+  + G+ T +SD++SFGV++ E++T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 99.7 bits (248), Expect = 1e-23
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 38/291 (13%)

Query: 99  LGEGGFGKV-----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV     Y     K + +VA+K L    +   ++F  E   L +  H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RPLDWNTR------MKIAAGA 201
            G C +GD  ++V+EYM  G L+K L    PD       +P            + IA+  
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
           + G+ YL     Q  ++RDL   N L+      K+ DFG+++   S D   V    M   
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRK 320
            +  P+  M  + T +SD++SFGV+L E+ T G++   Q  + + +  +   R + + R 
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 249

Query: 321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
              ++ D                 I   C Q +P  R  I ++   L+ L 
Sbjct: 250 CPKEVYD-----------------IMLGCWQREPQQRLNIKEIYKILHALG 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 1e-23
 Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 33/282 (11%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G  + +     E  VAIK ++       R EF  E   +   +  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  + G   L+V E M  G L  +L   RP+        P      +++AA  + G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL    K   ++RDL   N ++ E    K+ DFG+ +     D      + +    + AP
Sbjct: 134 YLAA-KK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE-LNLVAWARPMFKDRKNFSQM 325
           +    G  T KSD++SFGVVL E+ T  +   Q    +E L  V        D  +    
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV-------IDGGHLDL- 242

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
                    P     + L +  MC Q  P MRP   ++V +L
Sbjct: 243 ---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 3e-23
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V++G L      VA+K L   G    ++F AE   +    HP L++L   C 
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   +V E M  GSL ++L       R L     + +AA  + G+ YL  Q     I+
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RDL   N+L+ E    K++DFGLA++            +      + AP+ A+  + + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184

Query: 278 SDIYSFGVVLLELIT-GR 294
           SD++SFG++L E++T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 32/269 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + ++VVAIK +D    +  + +   E+  L   D P + K  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +  +  ++ EY+  GS    L  L P   PLD      I     +GL YLH + K   I
Sbjct: 72  LKDTKLWIIMEYLGGGSA---LDLLEPG--PLDETQIATILREILKGLDYLHSEKK---I 123

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G     +    K L L+    P             P+L+G Y  P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 228

Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++   +A      C+ ++P+ RP   +++
Sbjct: 229 LKEFVEA------CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 26/205 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVK 152
           LG G  G V K       +++A+K +    +      Q +RE       L   + P +V 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTI-RLEINEAIQKQILRELD----ILHKCNSPYIVG 63

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGASRGLQYLHE 210
             G         +  EYM  GSLDK L +++     R L      KIA    +GL YLHE
Sbjct: 64  FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHE 118

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           + K  +I+RD+K SNIL+      KL DFG++ ++  S  KT V     GT  Y AP+  
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
                + KSDI+S G+ L+EL TGR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 97.5 bits (243), Expect = 4e-23
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKG----CLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKL 153
           LG+G FG V +G       K+  V A+K L    +   + +F  E   + S DH NL++L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPV-AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD--WNTRMKIAAGASRGLQYLHEQ 211
            G        ++V E  PLGSL   L         +    +  ++IA G    ++YL  +
Sbjct: 62  YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLESK 116

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST---RVMGTYGYCAPDY 268
                I+RDL   NILL      K+ DFGL +  P  +  +V     +V   + +CAP+ 
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171

Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
             T   +  SD++ FGV L E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.4 bits (243), Expect = 4e-23
 Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGKVYKGC-LEKIEQV--VAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  L K  +   VA+K L       G +EF  E   +   DHP +V+LI
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G C +G+  +LV E  PLG L K+L   R  P +   +   ++      + G+ YL  + 
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESK- 114

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
               ++RDL   N+LL   +  K+SDFG+++ +G   D    +T       + AP+    
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 272 GQLTFKSDIYSFGVVLLELIT 292
           G+ + KSD++S+GV L E  +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.1 bits (242), Expect = 4e-23
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 10/212 (4%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSA-EVMTLGSADHPNLVKLIGY 156
           LG+G +G VYK       Q  A+K++D   + Q  RE +  E+  L S +HPN++     
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +G++  +V EY P G L K +   +   + +      +I     RGLQ LHEQ    +
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RDLK +NILL      K+ D G++K+     K +++   +GT  Y AP+       ++
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVWKGRPYSY 180

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNL 308
           KSDI+S G +L E+ T      + +  ++L  
Sbjct: 181 KSDIWSLGCLLYEMATFAPPF-EARSMQDLRY 211

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 97.7 bits (243), Expect = 6e-23
 Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C +       ++VA+K L    G Q    +  E+  L +  H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C+E   +   L+ EY+PLGSL  +L    P  + L+    +  A     G+ YLH Q
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHK-LNLAQLLLFAQQICEGMAYLHSQ 126

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VSTRVMGTYGYCAPDYAM 270
                I+RDL   N+LL+     K+ DFGLAK  P G + + V         + A +   
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
             + ++ SD++SFGV L EL+T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 97.1 bits (242), Expect = 7e-23
 Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI-GYC 157
           LG+G FGKVYK   ++     A K +     + + +F  E+  L    HPN+V L   Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            E    +L+ E+   G+LD  + +L    R L       +       L +LH      VI
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSHK---VI 125

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDLK  NILL      KL+DFG++    S  +   +   +GT  + AP+       TFK
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACE--TFK 181

Query: 278 S-------DIYSFGVVLLELITGR 294
                   DI+S G+ L+EL    
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 97.2 bits (242), Expect = 8e-23
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 27/218 (12%)

Query: 99  LGEGGFGKVYK----GCLEKIEQ-VVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +G+G FG+V++    G L      +VA+K L +        +F  E   +   DHPN+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP----------------DTRPLDWNT--R 194
           L+G CA G    L++EYM  G L++ L    P                   PL  +   +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
           + IA   + G+ YL E   +  ++RDL   N L+ E    K++DFGL++   S D    S
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                   +  P+     + T +SD++++GVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.5 bits (240), Expect = 1e-22
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 21/201 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 73  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 127

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKM-------GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           RDL   N L+ E +  K++DFGL+++         +G K  +         + AP+    
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179

Query: 272 GQLTFKSDIYSFGVVLLELIT 292
            + + KSD+++FGV+L E+ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 73/207 (35%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 97  CCLGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLI 154
             +G G    VY   CL   E  VAIK++D    Q  V E   EV  +   +HPN+VK  
Sbjct: 7   EVIGVGATAVVYAAICLPNNE-KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA---GASRGLQYLHEQ 211
                GD+  LV  Y+  GS    L D+   + P        IA       +GL+YLH  
Sbjct: 66  TSFVVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH-- 119

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTH-VSTRVMGTYGYCAPDYA 269
                I+RD+K  NILL E    K++DFG+ A +   GD+T  V    +GT  + AP+  
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-V 177

Query: 270 MTGQ--LTFKSDIYSFGVVLLELITGR 294
           M       FK+DI+SFG+  +EL TG 
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 37/222 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD------HRGVQGV-REFSAEVMTLGSADHPNLV 151
           +GEG F  V     ++  +  AIK LD       + V+ V  E   EV+T     HP ++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE--KEVLTR-LNGHPGII 65

Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           KL  Y  + ++ L  V EY P G L +++         LD       AA     L+YLH 
Sbjct: 66  KLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLH- 119

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM------------ 258
              + +I+RDLK  NILL++  H K++DFG AK+         +                
Sbjct: 120 --SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 259 ------GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
                 GT  Y +P+          SD+++ G ++ +++TG+
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 68/212 (32%), Positives = 100/212 (47%), Gaps = 21/212 (9%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGE  FGK+YKG L        Q+VAIK L D    Q   EF  E   +    HPN+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-------------RPLDWNTRMKIAAG 200
           +G   +     +++EY+  G L + L    P +               LD    + IA  
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
            + G++YL        +++DL   NIL+ E  H K+SD GL++   S D   V  + +  
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             +  P+  M G+ +  SDI+SFGVVL E+ +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 37/213 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQG-----VREFSAEVMTLGSADHPNLVK 152
           +GEG +G+VYK   +K  ++VA+K++      +G     +R    E+  L    HPN+V+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR----EIKLLQKLRHPNIVR 62

Query: 153 LIGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR------- 203
           L        +    +V+EYM         HDL   T  LD +  +K      +       
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMD--------HDL---TGLLD-SPEVKFTESQIKCYMKQLL 110

Query: 204 -GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            GLQYLH      +++RD+K SNIL+      KL+DFGLA+   +   +   T  + T  
Sbjct: 111 EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLW 166

Query: 263 YCAPDYAM-TGQLTFKSDIYSFGVVLLELITGR 294
           Y  P+  +   +   + D++S G +L EL  G+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 67/200 (33%), Positives = 98/200 (49%), Gaps = 17/200 (8%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           C+G+G FG+VYK   ++  QVVAIK +D       + +   E+  L     P + K  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +G +  ++ EY   GS    L  L+P    LD      I      GL+YLHE+ K   
Sbjct: 68  FLKGSKLWIIMEYCGGGSC---LDLLKP--GKLDETYIAFILREVLLGLEYLHEEGK--- 119

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ 273
           I+RD+K +NILL E    KL+DFG+     SG  T   ++    +GT  + AP+      
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGV-----SGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 274 LTFKSDIYSFGVVLLELITG 293
              K+DI+S G+  +EL  G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 9e-22
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQG--VREFSAEVMTLGSADHPNLV 151
            LGEG +G VYK   +K  ++VA+K++    +  G+    +RE S     L    HPN+V
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS----LLKELKHPNIV 61

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           KL+       +  LV+EY  +  L K+L        PL  N    I     RGL Y H  
Sbjct: 62  KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
               +++RDLK  NIL+      KL+DFGLA+      +T+ +  V+ T  Y AP+  + 
Sbjct: 118 R---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEILL- 171

Query: 272 GQLTFKS--DIYSFGVVLLELITGR 294
           G   + +  DI+S G +  E+ITG+
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 19/215 (8%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG VYKG      E ++  VAIK L+   G +   EF  E + + S DHP+LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHE 210
           +G C     +L V + MP G L  ++H+ + +      L+W  ++      ++G+ YL E
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
           +    +++RDL   N+L++   H K++DFGLA++    +K + +        + A +   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304
             + T +SD++S+GV + EL+T G K  D    R+
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 39/278 (14%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G+G FG VY G L   +  +   A+K L+    ++ V +F  E + +    HPN++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 155 GYC--AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQYL 208
           G C  +EG   L+V  YM  G L    + +R +T     N  +K   G     ++G++YL
Sbjct: 63  GICLPSEGSP-LVVLPYMKHGDL---RNFIRSETH----NPTVKDLIGFGLQVAKGMEYL 114

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAP 266
             +     ++RDL   N +L+E +  K++DFGLA+          H  T       + A 
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+      
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVY---LLQGRR------ 220

Query: 327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              LQ +Y    LY+   +   C   +P MRP  +++V
Sbjct: 221 --LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.7 bits (225), Expect = 1e-20
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G        VAIK L  +G      F AE   +    HP LV+L     
Sbjct: 14  LGAGQFGEVWMG-YYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + +   ++ EYM  GSL   L    P+   L  N  + +AA  + G+ ++  +     I+
Sbjct: 72  Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIH 125

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLTF 276
           RDL+ +NIL+ E    K++DFGLA++    + T    R    +   + AP+    G  T 
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTI 182

Query: 277 KSDIYSFGVVLLELIT-GR 294
           KSD++SFG++L E++T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 64/201 (31%), Positives = 90/201 (44%), Gaps = 23/201 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G +G VYK       ++VAIK +             E+  L    HPN+V   G   
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA---AGASRGLQYLHEQLKQP 215
             D+  +V EY   GSL       R    PL   + ++IA       +GL YLHE  K  
Sbjct: 71  RRDKLWIVMEYCGGGSLQDIYQVTR---GPL---SELQIAYVCRETLKGLAYLHETGK-- 122

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYA--- 269
            I+RD+K +NILL E    KL+DFG+     S   T    +    +GT  + AP+ A   
Sbjct: 123 -IHRDIKGANILLTEDGDVKLADFGV-----SAQLTATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 270 MTGQLTFKSDIYSFGVVLLEL 290
             G    K DI++ G+  +EL
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 33/284 (11%)

Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G       + +E  VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR---PLDWNTRMKIAAGASRGLQYLH 209
           LIG   E   R ++ E M  G L   L + RP       L     +  A   ++G +YL 
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133

Query: 210 EQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           E      I+RD+   N LL     G   K++DFG+A+            R M    +  P
Sbjct: 134 E---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
           +  + G  T K+D++SFGV+L E+ + G        +++ +  V     +          
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL---------- 240

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
            DP      PV   Y+   I   C Q  P  RP    ++  + Y
Sbjct: 241 -DPPKGCPGPV---YR---IMTDCWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQV---VAIK--QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FG V +G L + +     VA+K  +LD      + EF +E   +   DHPN++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGL 205
           IG C E          +++  +M  G L   L   R    P     +   K     + G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD---KTHVSTRVMGTYG 262
           +YL     +  I+RDL   N +L E     ++DFGL+K   SGD   +  ++   +    
Sbjct: 127 EYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---K 180

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + A +       T KSD+++FGV + E+ T
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)

Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIGYCA 158
           G +G+V+    +    + AIK +    +    +      E   L  A  P +VKL  Y  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           +G + L LV EY+P G L   L ++      LD +      A     L+YLH      +I
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENVGS----LDEDVARIYIAEIVLALEYLH-SNG--II 115

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS------TRVMGTYGYCAPDYAMT 271
           +RDLK  NIL++   H KL+DFGL+K+G    + +++       R++GT  Y AP+  + 
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 272 GQLTFKSDIYSFGVVLLELITG 293
              +   D +S G +L E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 67/202 (33%), Positives = 93/202 (46%), Gaps = 23/202 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G+VYK       + VAIK++  R  Q       E++ +    HPN+V       
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN-TRMK---IAAGAS---RGLQYLHEQ 211
            GD+  +V EYM  GSL          T  +  N  RM    IA       +GL+YLH  
Sbjct: 86  VGDELWVVMEYMDGGSL----------TDIITQNFVRMNEPQIAYVCREVLQGLEYLH-- 133

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
             Q VI+RD+K  NILL +    KL+DFG A           S  V+GT  + AP+    
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKR 190

Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                K DI+S G++ +E+  G
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 72/206 (34%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
           LG GGFG+V    ++   +  A+K +  R +    +    FS E   L   +HP +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKL- 58

Query: 155 GYCAEGDQRLLVY---EYMPLGSLDKHLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLH 209
            Y    D++  +Y   EY   G L   L D     R L  ++  R    A      +YLH
Sbjct: 59  -YRTFKDKKY-IYMLMEYCLGGELWTILRD-----RGLFDEYTARF-YIACVVLAFEYLH 110

Query: 210 EQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
            +    +IYRDLK  N+LL   GY  KL DFG AK   SG KT       GT  Y AP+ 
Sbjct: 111 NR---GIIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEI 163

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
            +     F  D +S G++L EL+TGR
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.1 bits (221), Expect = 5e-20
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGFG+V    ++   ++ A K+LD + +   +G +    E   L       +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           Y  E    L LV   M  G L  H++++            +  AA    GL++LH++   
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR-- 115

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            ++YRDLK  N+LL++  + ++SD GLA     G K        GT GY AP+       
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVY 171

Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
            F  D ++ G  L E+I GR    Q K++ E
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 99  LGEGGFGKVYK------GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FGKVY       G L  ++++  I+  D + ++ + +   E+  L    HPNLVK
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIAD---EMKVLELLKHPNLVK 63

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             G     ++  +  EY   G+L++ L       R LD +           GL YLH   
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG 119

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV---MGTYGYCAPDYA 269
              +++RD+K +NI L+     KL DFG A    +   T +   V    GT  Y AP+  
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPEVI 175

Query: 270 MTGQLTFK---SDIYSFGVVLLELITGRK 295
             G+       +DI+S G V+LE+ TG++
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 71/211 (33%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLGSAD 146
           FR    LG G FGKV     +K  ++ AIK L          V+ +        T  S  
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 147 HPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRG 204
           HP LV L   C + +  +  V EY   G L  H+H             R    AA    G
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP------RAVFYAACVVLG 113

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYG 262
           LQYLHE     ++YRDLK  N+LL+     K++DFGL K  MG  GD+T  ST   GT  
Sbjct: 114 LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTPE 166

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           + AP+       T   D +  GV++ E++ G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 88.1 bits (219), Expect = 8e-20
 Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 13/199 (6%)

Query: 100 GEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGY 156
           G+G FGKV        +++ A+K ++ +       VR    E   L   +HP LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             + +   LV + +  G L  HL      +       +  I       L+YLH +    +
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWICEIVL-ALEYLHSKG---I 121

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           I+RD+K  NILL+E  H  ++DF +A        T   T   GT GY AP+       + 
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSV 178

Query: 277 KSDIYSFGVVLLELITGRK 295
             D +S GV   E + G++
Sbjct: 179 AVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 88.3 bits (219), Expect = 9e-20
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)

Query: 99  LGEGGFGKVYKG-----CLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG G FG+V+         E  E +V +K L     + ++ EF  E+       H N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHL-----HDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           L+G C E +   ++ EY  LG L + L      D +    PL    ++ +    + G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           L        ++RDL   N L+      K+S   L+K   + +   +   ++    + AP+
Sbjct: 133 LS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                  + KSD++SFGV++ E+ T
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 31/281 (11%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G  + +     E  VAIK ++       R EF  E   +   +  ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L++ E M  G L  +L  LRP+        P      +++A   + G+ 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+       ++RDL   N ++ E +  K+ DFG+ +     D      + +    + +P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E+ T  +   Q    +++        +     N   M+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDML 250

Query: 327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
                             +  MC Q  P MRP+  +++ ++
Sbjct: 251 ----------------FELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 64/196 (32%), Positives = 97/196 (49%), Gaps = 11/196 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + +QVVAIK +D    +  + +   E+  L   D P + K  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +G +  ++ EY+  GS    L  LR    P D      +     +GL YLH + K   I
Sbjct: 72  LKGTKLWIIMEYLGGGSA---LDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKK---I 123

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181

Query: 278 SDIYSFGVVLLELITG 293
           +DI+S G+  +EL  G
Sbjct: 182 ADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 14/214 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L   G      F  E   +    H  LV+L    +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKV-AVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E +   +V EYM  GSL   L D   + R L     + +AA  + G+ Y+    +   I+
Sbjct: 72  E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLTF 276
           RDL+ +NIL+ +G   K++DFGLA++    + T    R    +   + AP+ A+ G+ T 
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGRFTI 182

Query: 277 KSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
           KSD++SFG++L EL+T GR       +R+ L  V
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GVQGVREFSA--EVMTLGSADHPNLVK 152
           LGEG +  VYK   ++  ++VAIK+  L  R     G+  F+A  E+  L    HPN++ 
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI-NFTALREIKLLQELKHPNIIG 66

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L+          LV+E+M    L+K + D      P D  + M +     RGL+YLH   
Sbjct: 67  LLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLHSNW 122

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-T 271
              +++RDLK +N+L+      KL+DFGLA+   S     ++ +V+ T  Y AP+     
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV-TRWYRAPELLFGA 177

Query: 272 GQLTFKSDIYSFGVVLLELITGR 294
                  D++S G +  EL+   
Sbjct: 178 RHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.0 bits (215), Expect = 3e-19
 Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 15/201 (7%)

Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLI 154
           +G G FG+V++G L+   + E  VAIK L     +  R +F +E   +G   H N+++L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G   +    +++ EYM  G+LDK+L D   +         ++   G + G++YL +    
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD---M 126

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
             ++RDL   NIL+      K+SDFGL+++    P G  T    ++     + AP+    
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIAY 184

Query: 272 GQLTFKSDIYSFGVVLLELIT 292
            + T  SD++SFG+V+ E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 24/206 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-------HRGVQGVREFSAEVMTLGSADHPNLV 151
           LGEG  G V K  L+    + A+K +         +  Q +RE         S   P +V
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK--QILRELE----INKSCKSPYIV 62

Query: 152 KLIG-YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           K  G +  E    + +  EY   GSLD     ++     +      KIA    +GL YLH
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDY 268
            +    +I+RD+K SNILL      KL DFG++ ++  S   T       GT  Y AP+ 
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPER 174

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
                 +  SD++S G+ LLE+   R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 5e-19
 Identities = 77/268 (28%), Positives = 114/268 (42%), Gaps = 39/268 (14%)

Query: 99  LGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LG G FG V+ G    KI+  VAIK +   G     +F  E   +    HPNLV+L G C
Sbjct: 12  LGSGQFGVVHLGKWRGKID--VAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +     +V EYM  G L   L+ LR     L     + + +     ++YL        I
Sbjct: 69  TKQRPIFIVTEYMANGCL---LNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFI 122

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQL 274
           +RDL   N L+ E    K+SDFGLA+     D  + S+   GT     +  P+     + 
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRF 178

Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG-- 332
           + KSD++SFGV++ E+ +  K                   M  +R + S++V+    G  
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK-------------------MPYERFSNSEVVESVSAGYR 219

Query: 333 -QYPVRGLYQALAIAAMCVQEQPNMRPA 359
              P     +   I   C  E+P  RPA
Sbjct: 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPA 247

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 63/215 (29%), Positives = 113/215 (52%), Gaps = 19/215 (8%)

Query: 93  FRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADH 147
           F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D+
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRG 204
           P++ +L+G C     +L + + MP G L  ++ + + +      L+W  ++      ++G
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           + YL E+    +++RDL   N+L++   H K++DFGLAK+  + +K + +        + 
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
           A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 63/192 (32%), Positives = 98/192 (51%), Gaps = 9/192 (4%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
           LG+G FG+V+KG L+  +  VA+K       Q ++ +F +E   L   DHPN+VKLIG C
Sbjct: 3   LGKGNFGEVFKGTLKD-KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
               QR  +Y  M L      L  LR     L     +K A  A+ G+ YL     +  I
Sbjct: 62  T---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E    K+SDFG+++    G  +    + +    + AP+    G+ + +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSE 174

Query: 278 SDIYSFGVVLLE 289
           SD++S+G++L E
Sbjct: 175 SDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 21/208 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-VVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIG 155
           +G G FG V+  C  K +Q +V IKQ+    +      +A  E   L    HPN+++   
Sbjct: 8   VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHD----LRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
              E    ++V EY P G+L +++      L  +   L +  ++ +A      L ++H +
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTK 120

Query: 212 LKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
           L   +++RDLK  NILL++     K+ DFG++K+     K+   T V+GT  Y +P+   
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAID 298
                 KSDI++ G VL EL + ++A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 42/220 (19%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLI 154
            +G+G FG V K   +   +++  K++D+  +   +E     +EV  L    HPN+V+  
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYY 65

Query: 155 G---------------YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA 199
                           YC  GD          L  L +     + + + ++     +I  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGD----------LAQLIQKC---KKERKYIEEEFIWRILT 112

Query: 200 GASRGLQYLH--EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD---KTHVS 254
                L   H        V++RDLK +NI L+   + KL DFGLAK+        KT+V 
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV- 171

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
               GT  Y +P+         KSDI+S G ++ EL    
Sbjct: 172 ----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 20/218 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +GEG +G VYK   +   ++VAIK++  R        +A  E+  L   +HPN++KL+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 157 CAEGDQRLLVYEYMPLGSLDKHL-HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                   LV+E+M     D  L   ++   R L  +          +GL + H      
Sbjct: 67  FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTRVMGTYGYCAPDYAMT- 271
           +++RDLK  N+L+      KL+DFGLA+    P    TH V TR      Y AP+  +  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGD 173

Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
              +   DI+S G +  EL++ R       +  +L  +
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 23/202 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K +D +  + + ++  E+  L S DHPN+VKL+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGAS-RGLQYLHEQLKQPV 216
             +   ++ E+   G++D  + +L RP T P     ++++    +   L YLHE     +
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEP-----QIRVVCKQTLEALNYLHE---NKI 124

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ 273
           I+RDLK  NIL       KL+DFG+     S   T    R    +GT  + AP+  M   
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 274 -----LTFKSDIYSFGVVLLEL 290
                  +K+D++S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 13/215 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +GEG  G V+K    +  + VA+K++  R ++G     A  E+  L +  HP +VKL+  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
              G   +LV EYMP   L + L D     RPL             +G+ Y+H      +
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH---ANGI 120

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RDLK +N+L+      K++DFGLA++    +    S +V  T  Y AP+  + G   +
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LYGARKY 178

Query: 277 KS--DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
               D+++ G +  EL+ G        D ++L +V
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 20/208 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIG-- 155
           +GEG +GKVYK   +K  Q+VAIK +D    +   E   E   L   ++HPN+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE-EIKEEYNILRKYSNHPNIATFYGAF 72

Query: 156 ----YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
                    DQ  LV E    GS+   +  LR   + L       I     RGL YLHE 
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP---- 266
               VI+RD+K  NILL +    KL DFG+ A++  +  + +      GT  + AP    
Sbjct: 133 K---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEVIA 186

Query: 267 -DYAMTGQLTFKSDIYSFGVVLLELITG 293
            D         +SD++S G+  +EL  G
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 67/211 (31%), Positives = 94/211 (44%), Gaps = 41/211 (19%)

Query: 99  LGEGGFGKV----YKG--------CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
           LG G FG+V    +KG         L K  ++V +KQ++H           E   L S  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEH--------VLNEKRILQSIR 59

Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGL 205
           HP LV L G   +     LV EY+P G L  HL   R   R P     R   AA     L
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARF-YAAQVVLAL 114

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYG 262
           +YLH      ++YRDLK  N+LL+   + K++DFG AK         V  R     GT  
Sbjct: 115 EYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPE 163

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y AP+  ++       D ++ G+++ E++ G
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 22/216 (10%)

Query: 96  DCCLGEGGFGKVYKGCLEKIE-----QVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHP 148
              LGEG FG+V K     ++       VA+K L D    + + +  +E+  +     H 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------DTRPLDWNTRMK---- 196
           N++ L+G C +     +V EY   G+L   L   RP        D RP +     K    
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
            A   +RG+++L  +     I+RDL   N+L+ E +  K++DFGLA+     D    +T 
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                 + AP+       T +SD++SFGV+L E+ T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT----LGSA-DHPNLVKL 153
           LG+G FGKV    L+  +++ A+K L  + V    +     MT    L  A  HP L +L
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVL-KKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
              C +   RL  V EY+  G L  H+          D       AA    GLQ+LHE+ 
Sbjct: 62  HS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER- 115

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +IYRDLK  N+LL+   H K++DFG+ K G  G  T  ++   GT  Y AP+     
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQ 171

Query: 273 QLTFKSDIYSFGVVLLELITGR 294
                 D ++ GV+L E++ G+
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 11/195 (5%)

Query: 99  LGEGGFGKVYKGC-LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G G FG V+ G  LEK +  VAIK +   G     +F  E   +    HP LV+L G C
Sbjct: 12  IGSGQFGLVWLGYWLEKRK--VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            E     LV+E+M  G L  +   LR         T + +      G+ YL       VI
Sbjct: 69  TERSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVI 122

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 278 SDIYSFGVVLLELIT 292
           SD++SFGV++ E+ +
Sbjct: 182 SDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 23/226 (10%)

Query: 85  ELAAATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVRE-FSAE 138
           E+  +T  F  +  LGE  FGKVYKG L      +  Q VAIK L  +    +RE F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMK 196
            M      HPN+V L+G   +     +++ Y     L + L    P  D    D +  +K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 197 ----------IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
                     I    + G+++L       V+++DL   N+L+ +  + K+SD GL +   
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + D   +    +    + +P+  M G+ +  SDI+S+GVVL E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 41/286 (14%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EF--SAEVMTLGSADHPNL 150
           LG+G FG VY+G    I     E  VA+K ++       R EF   A VM   +  H  +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--V 71

Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-----RPLDWNTRM-KIAAGASRG 204
           V+L+G  ++G   L+V E M  G L  +L  LRP+      RP      M ++AA  + G
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           + YL+    +  ++RDL   N ++   +  K+ DFG+ +     D      + +    + 
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           AP+    G  T  SD++SFGVVL E+ +                   A   ++   N  Q
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS------------------LAEQPYQGLSN-EQ 229

Query: 325 MVDPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
           ++   + G Y   P     +   +  MC Q  P MRP   ++V  L
Sbjct: 230 VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 6e-18
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 18/206 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGV----REFSAEVMTLGSADHPNLVK 152
           LG+G +G VY G L    Q++A+KQ  LD   V        +   EV  L S  H N+V+
Sbjct: 8   LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            +G C + +   +  E++P GS+   L+   P   P+      +I  G +    YLH   
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHNNC 122

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----MGPSGDKTHVSTRVMGTYGYCAPDY 268
              V++RD+K +N++L      KL DFG A+    +G  G  +++   + GT  + AP+ 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
                   KSDI+S G  + E+ TG+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 78/283 (27%), Positives = 132/283 (46%), Gaps = 37/283 (13%)

Query: 97  CCLGEGGFGKVYKGCLEKIEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKLI 154
             +GEG +G V+K    +  Q+VAIK+ ++      +++ +  E+  L    HPNLV LI
Sbjct: 7   SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKH--LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
                  +  LV+EY        H  L++L  + R +  +   KI     + + + H   
Sbjct: 67  EVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH--- 117

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKT-HVSTRVMGTYGYCAPDYA 269
           K   I+RD+K  NIL+ +    KL DFG A++  GP  D T +V+TR      Y AP+  
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL- 171

Query: 270 MTGQLTFKS--DIYSFGVVLLELIT------GRKAIDQT-KDRKEL-NLVAWARPMFKDR 319
           + G   +    D+++ G V  EL+T      G+  +DQ    RK L +L+   + +F   
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231

Query: 320 KNFSQMVDPSLQGQYPVRGLYQALAIAAM-----CVQEQPNMR 357
           + F  +  P  + + P+   +  ++  A+     C+Q  P  R
Sbjct: 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 26/217 (11%)

Query: 99  LGEGGFGKVY----KGCLEKIEQ----------VVAIKQLDHRGVQGVR-EFSAEVMTLG 143
           LGEG FG+V+    +G  E + +          +VA+K L     +  R +F  E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--------PLDWNTRM 195
              +PN+++L+G C   D   ++ EYM  G L++ L     ++          +     +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
            +A   + G++YL        ++RDL   N L+   Y  K++DFG+++   SGD   +  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           R +    + A +  + G+ T  SD+++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 69/212 (32%), Positives = 94/212 (44%), Gaps = 14/212 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLI 154
           LG+G FGKV+   L+   Q  AIK L    V     V     E   L  A +HP L  L 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                 +    V EY+  G L  H+          D       AA    GLQ+LH +   
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK--- 115

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            ++YRDLK  NILL+   H K++DFG+ K    GD    +    GT  Y AP+  +  + 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKY 173

Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
               D +SFGV+L E++ G+       D +EL
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPF-HGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 42/287 (14%)

Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSAD 146
            GNF+ +  +G+G F  VYK       +VVA+K++   +    +  ++   E+  L   D
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           HPN++K +    E ++  +V E    G L + +   +   R +   T  K        L+
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           ++H    + +++RD+K +N+ +      KL D GL +   S  KT  +  ++GT  Y +P
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSP 175

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +        FKSDI+S G +L E                  + A   P + D+ N   + 
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLC 217

Query: 327 DPSLQGQYP----------VRGLYQALAIAAMCVQEQPNMRPAITDV 363
               +  YP          +R L       + C+   P  RP I+ V
Sbjct: 218 KKIEKCDYPPLPADHYSEELRDL------VSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
           LGEG +  VYKG      ++VA+K++     +G     +RE S     +    H N+V+L
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS----LMKELKHENIVRL 63

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                  ++ +LV+EYM    L K++ D       LD NT         +G+ + HE   
Sbjct: 64  HDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHEN-- 119

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             V++RDLK  N+L+ +    KL+DFGLA+       T  +  V  T  Y APD  + G 
Sbjct: 120 -RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLL-GS 175

Query: 274 LTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            T+ +  DI+S G ++ E+ITGR     T +  +L  +
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 15/197 (7%)

Query: 99  LGEGGFGKVYKGCLE--KIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +  K E+ VA+K L  D+       E   E   +   D+P +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K L   +  T         ++    S G++YL E    
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE----KNITELVHQVSMGMKYLEET--- 114

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 273 QLTFKSDIYSFGVVLLE 289
           + + KSD++SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 60/233 (25%)

Query: 97  CCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-----------RGVQGVREFSAEVMTLGSA 145
             LG+G FG VY    ++  ++VAIK++             R V+ +R+ +         
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE-------- 56

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASR 203
            HPN+VKL     E D+   V+EYM     + +L+ L      +P   +    I     +
Sbjct: 57  -HPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----MGPSGDKTHVSTRVMG 259
           GL ++H   K    +RDLK  N+L+      K++DFGLA+      P  D  +VSTR   
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD--YVSTR--- 162

Query: 260 TYGYCAPDYAMTGQLTFKS-------DIYSFGVVLLELIT------GRKAIDQ 299
              Y AP      ++  +S       DI++ G ++ EL T      G   IDQ
Sbjct: 163 --WYRAP------EILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)

Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
           +GEG FG+V K  ++K  +    AIK++ ++      R+F+ E+  L     HPN++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
           G C       L  EY P G+L   L   R  +T P           L     +  AA  +
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RG+ YL ++     I+RDL   NIL+ E Y  K++DFGL++    G + +V  + MG   
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 174

Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + A +       T  SD++S+GV+L E+++
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 67/198 (33%), Positives = 93/198 (46%), Gaps = 19/198 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           +G G FG VY     +  +VVAIK++ + G Q   ++     EV  L    HPN ++  G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV EY  LGS    L   +   +PL       I  GA +GL YLH   +  
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSHER-- 136

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD--YAM-TG 272
            I+RD+K  NILL E    KL+DFG A +         +   +GT  + AP+   AM  G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEG 189

Query: 273 QLTFKSDIYSFGVVLLEL 290
           Q   K D++S G+  +EL
Sbjct: 190 QYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 72/288 (25%), Positives = 106/288 (36%), Gaps = 38/288 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQV--VAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           +G G FGKV  G   +      V +K+L           F  EV      +HPN+++ +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQYLH 209
            C E    LLV E+ PLG L  +L   R                  ++A   + GL +LH
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD-----VLQRMACEVASGLLWLH 117

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--- 266
              +   I+ DL   N  L      K+ D+GLA      D             + AP   
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN 321
                  +    T KS+I+S GV + EL T   +      D + L  V         R+ 
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV--------REQ 226

Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
             ++  P L  +Y  R  Y+ +    +     P  RP   +V   L Y
Sbjct: 227 DIKLPKPQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 63/224 (28%), Positives = 93/224 (41%), Gaps = 32/224 (14%)

Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDH------RGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           G FG VY           AIK L          V  V+   A +M  G +  P + KL  
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGES--PYVAKLYY 64

Query: 156 YCAEGDQRLLVYEYMP---LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
                D   LV EY+      SL K L  L     P DW    +  A    G++ LH   
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLIKTLGGL-----PEDWAK--QYIAEVVLGVEDLH--- 114

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
           ++ +I+RD+K  N+L+++  H KL+DFGL++ G        + + +GT  Y AP+  +  
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGV 168

Query: 273 QLTFKSDIYSFGVVLLELITG-----RKAIDQTKDRKELNLVAW 311
                SD +S G V+ E + G      +  D   D      + W
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.1 bits (200), Expect = 2e-17
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 14/209 (6%)

Query: 99  LGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIG 155
           LG G FG V KG   + K +  VAIK L +   + VR E   E   +   D+P +V++IG
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            C E +  +LV E    G L+K L   + D   +  +  +++    S G++YL  +    
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFLSGKK-DEITV--SNVVELMHQVSMGMKYLEGK---N 115

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQ 273
            ++RDL   N+LL   ++ K+SDFGL+K     D ++   R  G +   + AP+     +
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 274 LTFKSDIYSFGVVLLELIT-GRKAIDQTK 301
            + +SD++S+G+ + E  + G+K   + K
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYKKMK 203

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 15/198 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG-YC 157
           LG+G FGKVYK   ++   + A K ++ +  + + ++  E+  L + +HP +VKL+G + 
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +G   +++ E+ P G++D  + +L    R L       I       LQYLH      +I
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHS---MKII 132

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-- 275
           +RDLK  N+LL      KL+DFG++       +   S   +GT  + AP+  M   +   
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190

Query: 276 ---FKSDIYSFGVVLLEL 290
              +K+DI+S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 80.9 bits (199), Expect = 3e-17
 Identities = 70/222 (31%), Positives = 112/222 (50%), Gaps = 16/222 (7%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 64

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 65  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 119

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDY 268
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T    R    +   + AP+ 
Sbjct: 120 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT---ARQGAKFPIKWTAPEA 174

Query: 269 AMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
           A+ G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 64/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 99  LGEGGFGKVY-------KGCLEKIEQ---------VVAIKQLDHRGVQGVR-EFSAEVMT 141
           LGEG FG+V+       +   EK            +VA+K L        R +F  EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDT-----RPLDWNTR 194
           L     PN+ +L+G C       ++ EYM  G L++ L  H           + L ++T 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132

Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
           + +A   + G++YL E L    ++RDL   N L+ + Y  K++DFG+++   S D   V 
Sbjct: 133 LYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            R      + A +  + G+ T KSD+++FGV L E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 74/290 (25%), Positives = 114/290 (39%), Gaps = 47/290 (16%)

Query: 97  CCLGEGGFGKVYKGCLEK-IEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKL 153
             +GEG +G V K C  K   ++VAIK+  +    + V++ +  EV  L    H N+V L
Sbjct: 7   GVVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 154 IGYCAEGDQRLLVYEYMP---LGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLH 209
                   +  LV+EY+    L  L+     L PD  R   W           + + Y H
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCH 117

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD-- 267
                 +I+RD+K  NIL+ E    KL DFG A+   +   + ++  V  T  Y AP+  
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELL 173

Query: 268 --YAMTGQLTFKSDIYSFGVVLLELITGR------KAIDQ-----------TKDRKELNL 308
                 G      D+++ G ++ EL+ G         IDQ               +EL  
Sbjct: 174 VGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230

Query: 309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP 358
              + P F            SL+ +YP +    AL     C++  P  R 
Sbjct: 231 ---SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.9 bits (199), Expect = 3e-17
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 14/206 (6%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R D  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 7   SLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLV 64

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L    +E +   +V E+M  GSL   L +   D + L     + +AA  + G+ Y+   
Sbjct: 65  PLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIE-- 119

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYA 269
            +   I+RDL+ +NIL+ +    K++DFGLA++    + T    R    +   + AP+ A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAA 175

Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GR 294
           + G+ T KSD++SFG++L EL+T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAE--VMTLGSADHPNLVKL 153
           LG+G FGKV    L+   +  AIK L    V     V     E  V+ L    HP L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE-HPFLTHL 61

Query: 154 IGYCA--EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
             +C     +    V EY+  G L  H+      +   D       AA    GLQ+LH  
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLH-- 113

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            K+ +IYRDLK  N+LL++  H K++DFG+ K   +G+    ++   GT  Y AP+    
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170

Query: 272 GQLTFKSDIYSFGVVLLELITGR 294
            +     D +SFGV+L E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 66/276 (23%), Positives = 118/276 (42%), Gaps = 31/276 (11%)

Query: 99  LGEGGFGKVYK------GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG G F   Y+      G L  ++QV  ++       + V     E+  +   +HP++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           ++G   E     L  E+M  GS+   L         +  N   ++     RGL YLHE  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLHE-- 121

Query: 213 KQPVIYRDLKCSNILLEE-GYHPKLSDFGLA-KMGPSGDKT-HVSTRVMGTYGYCAPDYA 269
              +I+RD+K +N+L++  G   +++DFG A ++   G        +++GT  + AP+  
Sbjct: 122 -NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS 329
              Q     D++S G V++E+ T +   +  K    L L+          K  S    PS
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---------KIASATTAPS 231

Query: 330 LQGQYPVRGLYQALA-IAAMCVQEQPNMRPAITDVV 364
           +        L   L  +   C++ QP  RP   +++
Sbjct: 232 IPEH-----LSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----------DHRGVQGVREFSAEVMTLGSADHP 148
           +G+G +G+VY        +++A+KQ+          D R    V+   +E+ TL   DH 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+V+ +G+    +   +  EY+P GS+   L         L      ++      GL YL
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYL 124

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H    + +++RDLK  N+L++     K+SDFG++K          +  + G+  + AP+ 
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181

Query: 269 AMTGQLTF--KSDIYSFGVVLLELITGRK 295
             +    +  K DI+S G V+LE+  GR+
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 30/225 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VY+       ++VA+K++      D   +  +RE    +  L +  HPN+V+
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLRE----ITLLLNLRHPNIVE 70

Query: 153 LIGYCAEGDQR---LLVYEY--MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           L      G       LV EY    L SL      L     P   +    +     RGLQY
Sbjct: 71  LK-EVVVGKHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LHE     +I+RDLK SN+LL +    K++DFGLA+    G      T  + T  Y AP+
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART--YGLPAKPMTPKVVTLWYRAPE 178

Query: 268 --YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
                T   T   D+++ G +L EL+  +  +    + ++L+L+ 
Sbjct: 179 LLLGCTTY-TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 19/218 (8%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS------AD 146
           FR    LG+GGFG+V    +    ++ A K+L+ + +   ++   E M L         +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKQILEKVN 58

Query: 147 HPNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
              +V L  Y  E  D   LV   M  G L  H++++       D    +  AA  + GL
Sbjct: 59  SRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGL 115

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           + LH   ++ ++YRDLK  NILL++  H ++SD GLA   P G+   +  RV GT GY A
Sbjct: 116 EDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMA 169

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           P+     + TF  D +  G ++ E+I G+    Q K++
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G FG+V +G L+   K E  VAIK L      +  R+F +E   +G  DHPN++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G   +    +++ E+M  G+LD     LR +         + +  G + G++YL E    
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSF---LRQNDGQFTVIQLVGMLRGIAAGMKYLSE---M 125

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMG---TYGYCAPDYA 269
             ++RDL   NIL+      K+SDFGL++     + D T+ S+  +G      + AP+  
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTAPEAI 183

Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
              + T  SD++S+G+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 80.7 bits (199), Expect = 7e-17
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-------VMTLGSADHPNLV 151
           LG+G FGKV    L+  ++V AIK L    +  +++   +       ++ L +A HP L 
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILAL-AAKHPFLT 59

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L       D+   V EY+  G L   +      +R  D       AA  +  L +LH  
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLH-- 113

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            +  VIYRDLK  NILL+   H KL+DFG+ K G     T  +T   GT  Y AP+    
Sbjct: 114 -RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQE 170

Query: 272 GQLTFKSDIYSFGVVLLELITGR 294
            +     D ++ GV++ E++ G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 80.0 bits (197), Expect = 8e-17
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 26/212 (12%)

Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGVQG-VREFSAEVMTLGS-ADHPNLVKLI 154
           +GEG FG+V +  ++K  ++   AIK L     +   R+F+ E+  L     HPN++ L+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
           G C       +  EY P G+L   L   R  +T P           L     ++ A+  +
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+QYL E  KQ  I+RDL   N+L+ E    K++DFGL++    G++ +V  + MG   
Sbjct: 130 TGMQYLSE--KQ-FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGRLP 181

Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + A +       T KSD++SFGV+L E+++
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.8 bits (197), Expect = 8e-17
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 35/287 (12%)

Query: 99  LGEGGFGKVYKGCLEK-IEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKLIG 155
           +GEG +G V K C  K   Q+VAIK+ L+    + V++ +  E+  L    H NLV LI 
Sbjct: 9   VGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                 +  LV+E++    LD    DL      LD +   K      RG+++ H      
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCH---SHN 120

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKT-HVSTRVMGTYGYCAPDYAMTG 272
           +I+RD+K  NIL+ +    KL DFG A+    P    T +V+TR      Y AP+  + G
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL-LVG 174

Query: 273 QLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKEL--------NLVAWARPMFKDRKNF 322
              +    DI++ G ++ E++TG        D  +L        NL+   + +F+    F
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234

Query: 323 SQMVDPSLQGQYPVRGLY-----QALAIAAMCVQEQPNMRPAITDVV 364
           + M  P ++   P+   +       L +A  C++  P+ RP+ + ++
Sbjct: 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.5 bits (196), Expect = 9e-17
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G +G VY       +  +AIK++  R  + V+    E+       H N+V+ +G  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS--RGLQYLHEQLKQPV 216
           E     +  E +P GSL      LR    PL  N +  I        GL+YLH+     +
Sbjct: 76  ENGFFKIFMEQVPGGSLSAL---LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQI 129

Query: 217 IYRDLKCSNILLEEGYHP--KLSDFG----LAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
           ++RD+K  N+L+   Y    K+SDFG    LA + P       +    GT  Y AP+   
Sbjct: 130 VHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEVID 182

Query: 271 TGQLTF--KSDIYSFGVVLLELITGR 294
            G   +   +DI+S G  ++E+ TG+
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 64/201 (31%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAE--VMTLGSADHPNLVKL 153
           LG+G FGKV    L+   +  A+K L    V     V     E  V+ L + ++P L  L
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL-AWENPFLTHL 61

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                  +    V E++  G L  H+ D        D       AA    GLQ+LH +  
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-- 115

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +IYRDLK  N++L+   H K++DFG+ K    GD    ++   GT  Y AP+     +
Sbjct: 116 -GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172

Query: 274 LTFKSDIYSFGVVLLELITGR 294
            TF  D +SFGV+L E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 79/275 (28%), Positives = 115/275 (41%), Gaps = 41/275 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           +G G FG VY        +VVA+K++ + G Q   ++     EV  L    HPN ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              +     LV EY  LGS    L   +   +PL       I  GA +GL YLH      
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNM-- 142

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---G 272
            I+RD+K  NILL E    KL+DFG      S  K+  +   +GT  + AP+  +    G
Sbjct: 143 -IHRDIKAGNILLTEPGQVKLADFG------SASKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           Q   K D++S G+  +EL   +  +        L  +A             Q   P+LQ 
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------------QNDSPTLQS 242

Query: 333 QY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
                  RG          C+Q+ P  RPA  +++
Sbjct: 243 NEWTDSFRGFVD------YCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG++ +GCL+   K E  VAI  L      +  R F AE +TLG  DH N+V+L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G    G+  ++V EYM  G+LD     LR     L     M +  G + G++YL E    
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLASGMKYLSE---M 126

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG---YCAPDYAMT 271
             +++ L    +L+      K+S F         DK+      M       + AP+    
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQE-DKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD++SFG+V+ E+++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 65/198 (32%), Positives = 92/198 (46%), Gaps = 19/198 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           +G G FG VY     +  +VVAIK++ + G Q   ++     EV  L    HPN ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV EY  LGS    L   +   +PL       I  GA +GL YLH      
Sbjct: 93  CYLREHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---N 145

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---G 272
           +I+RD+K  NILL E    KL+DFG A +    +        +GT  + AP+  +    G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199

Query: 273 QLTFKSDIYSFGVVLLEL 290
           Q   K D++S G+  +EL
Sbjct: 200 QYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 27/218 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQ----------------VVAIKQLDHRGVQGVR-EFSAEVMT 141
           LGEG FG+V+    E +E+                +VA+K L     +  R +F  E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------DTRPLDWNTR 194
           +     PN+++L+  C   D   ++ EYM  G L++ L    P       D   + ++T 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
           + +A   + G++YL        ++RDL   N L+ + Y  K++DFG+++   SGD   + 
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            R +    + + +  + G+ T  SD+++FGV L E++T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 15/199 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIG-Y 156
           LG G  G V K        V+A K +       VR +   E+  +     P +V   G +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             E +   +  E+M  GSLD+      P    +      KIA     GL YL+   +  +
Sbjct: 73  LNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR--I 125

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLT 275
           ++RD+K SNIL+      KL DFG+     SG+  + ++   +GT  Y +P+    G+ T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYT 180

Query: 276 FKSDIYSFGVVLLELITGR 294
            KSD++S G+ ++EL  G+
Sbjct: 181 VKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKL 153
           +G G FG+V  G L+   K E  VAIK L   +   Q  R+F +E   +G  DHPN++ L
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNIIHL 70

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G++YL + 
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASGMKYLSD- 124

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPDY 268
                ++RDL   NIL+      K+SDFGL+++    P    T    ++     + AP+ 
Sbjct: 125 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEA 180

Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
               + T  SD++S+G+V+ E+++
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQV--VAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLI 154
           LGEG FG V +G L + + +  VA+K +         + +F +E + +   DHPN+++LI
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 155 GYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQ 206
           G C +  +       +++  +M  G L   L   R    P    T+M  K     + G++
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL     +  I+RDL   N +L E  +  ++DFGL+K   +GD             + A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
           +       T KSD++SFGV + E+ T
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 67/221 (30%), Positives = 104/221 (47%), Gaps = 25/221 (11%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H 147
           FR    LG+GGFG+V    +    ++ A K+L+ + +   ++   E M L         +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGESMALNEKQILEKVN 58

Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGAS 202
              V  + Y  E  D   LV   M  G L  H++ +      + R + +      AA   
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFY------AAEIC 112

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            GL+ LH   ++ ++YRDLK  NILL++  H ++SD GLA   P G    +  RV GT G
Sbjct: 113 CGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVG 166

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           Y AP+     + TF  D ++ G +L E+I G+    Q K +
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 5e-16
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 20/199 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG FG V +G  E   Q VA+K +  +     + F  E   +    H NLV+L+G   
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL-DWNTRMKIAAGASRGLQYLHEQLKQPVI 217
             +   +V E M  G+L   ++ LR   R L      ++ +   + G++YL  +    ++
Sbjct: 70  H-NGLYIVMELMSKGNL---VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           +RDL   NIL+ E    K+SDFGLA++G  G D + +  +      + AP+     + + 
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176

Query: 277 KSDIYSFGVVLLELIT-GR 294
           KSD++S+GV+L E+ + GR
Sbjct: 177 KSDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 70/280 (25%), Positives = 115/280 (41%), Gaps = 30/280 (10%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADH 147
            NFR +  +G G F +VY+         VA+K++   D    +   +   E+  L   +H
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           PN++K      E ++  +V E    G L + +   +   R +   T  K        L++
Sbjct: 62  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           +H +    V++RD+K +N+ +      KL D GL +   S  KT  +  ++GT  Y +P+
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE 176

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                   FKSDI+S G +L E                  + A   P + D+ N   +  
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLCK 218

Query: 328 PSLQGQY---PVRGLYQAL-AIAAMCVQEQPNMRPAITDV 363
              Q  Y   P     + L  +  MC+   P  RP IT V
Sbjct: 219 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 67/212 (31%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
           +GEG FG+V K  ++K  +    AIK++ ++      R+F+ E+  L     HPN++ L+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
           G C       L  EY P G+L   L   R  +T P           L     +  AA  +
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RG+ YL +  KQ  I+RDL   NIL+ E Y  K++DFGL++    G + +V  + MG   
Sbjct: 135 RGMDYLSQ--KQ-FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 186

Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + A +       T  SD++S+GV+L E+++
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 68/222 (30%), Positives = 95/222 (42%), Gaps = 36/222 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG----SADHPNLVKLI 154
           LG G +G V K        ++A+K++  R     +E    +M L     S D P  V   
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 155 GYC-AEGDQRLLVYEYMPL--GSLDK-----HLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           G    EGD    V+  M +   SLDK     +   L      L      KIA    + L+
Sbjct: 67  GALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALE 117

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYC 264
           YLH +L   VI+RD+K SN+L+      KL DFG+     SG        T   G   Y 
Sbjct: 118 YLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAKTIDAGCKPYM 170

Query: 265 AP---DYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKD 302
           AP   +  +  +    KSD++S G+ ++EL TGR   D  K 
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 23/218 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF----SAEVMTLGSADHPNLVKLI 154
           +G G + KV    L+K +Q+ A+K +    V    +     + + +   ++ +P LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
             C +   RL LV EY+  G L  H+   R  P+     +   + IA      L +LHE+
Sbjct: 63  S-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHER 115

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPDYA 269
               +IYRDLK  N+LL+   H KL+D+G+ K  +GP GD T   +   GT  Y AP+  
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEIL 168

Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN 307
              +  F  D ++ GV++ E++ GR   D   D  ++N
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 17/217 (7%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H 147
           FR    LG+GGFG+V    +    ++ A K+L+ + +   ++   E M L         +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI---KKRKGEAMALNEKRILEKVN 58

Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
              V  + Y  E  D   LV   M  G L  H++++       D    +  AA    GL+
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLE 116

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
            L    ++ ++YRDLK  NILL++  H ++SD GLA   P G+   V  RV GT GY AP
Sbjct: 117 DLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAP 170

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           +     + TF  D +  G ++ E+I G+    + K+R
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 11/194 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
           +G G FG+V+ G L      VA+K         ++ +F  E   L    HPN+V+LIG C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
               Q+  +Y  M L      L  LR +   L     +++   A+ G++YL  +     I
Sbjct: 63  T---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDYAMTGQLT 275
           +RDL   N L+ E    K+SDFG+++     D  + ST  M      + AP+    G+ +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 276 FKSDIYSFGVVLLE 289
            +SD++SFG++L E
Sbjct: 175 SESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 18/201 (8%)

Query: 99  LGEGGFGKVY--KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +GEG FGK+Y  K   +    V+    L    V+       EV+ L    HPN+V     
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             E  +  +V EY   G L K ++  R     + + L W  ++      S GL+++H++ 
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------SLGLKHIHDR- 120

Query: 213 KQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
              +++RD+K  NI L + G   KL DFG+A+     D   ++   +GT  Y +P+    
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176

Query: 272 GQLTFKSDIYSFGVVLLELIT 292
                K+DI+S G VL EL T
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 68/277 (24%), Positives = 118/277 (42%), Gaps = 41/277 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V+ G   + +  VAIK ++  G     +F  E   +    HP LV+L G C 
Sbjct: 12  LGSGQFGVVHLGKW-RAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V E+M  G L   L+ LR     L  +  + +      G++YL    +   I+
Sbjct: 70  QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIH 123

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAK-------MGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           RDL   N L+      K+SDFG+ +          SG K  V         +  P+    
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK--------WSPPEVFNF 175

Query: 272 GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
            + + KSD++SFGV++ E+ T G+   ++  + + + +++    +++          P L
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----------PKL 225

Query: 331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
                   +Y        C  E+P  RP   +++ A+
Sbjct: 226 ASMTVYEVMY-------SCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 23/209 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADH 147
           +      +G G FG+V+    ++I E   A+K +    V  +++      E   L    H
Sbjct: 2   DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 148 PNLVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           P +++L  +  E DQR L  + EY+P G L  +L +    +     +T +  A+     L
Sbjct: 61  PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSN----STGLFYASEIVCAL 114

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYC 264
           +YLH +    ++YRDLK  NILL++  H KL+DFG AK      K    T  + GT  Y 
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYL 165

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITG 293
           AP+   +       D ++ G+++ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 14/197 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L   G   V+ F  E   + +  H  LV+L     
Sbjct: 14  LGAGQFGEVWMGYYNNSTKV-AVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           + +   ++ EYM  GSL   L  L+ D    +     +  +A  + G+ Y+    ++  I
Sbjct: 72  KEEPIYIITEYMAKGSL---LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYI 125

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLT 275
           +RDL+ +N+L+ E    K++DFGLA++    + T    R    +   + AP+    G  T
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFT 182

Query: 276 FKSDIYSFGVVLLELIT 292
            KSD++SFG++L E++T
Sbjct: 183 IKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 43/297 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQV----------------VAIKQLDHRGVQGVR-EFSAEVMT 141
           LGEG FG+V+   +   + +                VA+K L     +  R +F  EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRP----------- 188
           L     PN+++L+G C + D   ++ EYM  G L++ L  H L                 
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 189 --LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
             + +++ + +A   + G++YL        ++RDL   N L+ E    K++DFG+++   
Sbjct: 133 PAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           +GD   +  R +    + A +  + G+ T  SD+++FGV L E++   K     +   E 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE- 248

Query: 307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
            ++  A   F+D+     +  P    Q    GLY+   +   C       RP+ +D+
Sbjct: 249 QVIENAGEFFRDQGRQVYLFRPPPCPQ----GLYE---LMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV    Y    +   + VA+K L    G   + +   E+  L +  H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C E       L+ E++P GSL ++L     +   ++   ++K A    +G+ YL  +
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR--VMGTYGYCAPDYA 269
                ++RDL   N+L+E  +  K+ DFGL K     DK + + +  +     + AP+  
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
           +  +    SD++SFGV L EL+T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 99  LGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREF---SAEVMT-LGSADHPN 149
           LG G FGKV +     L K + V  VA+K L        RE      ++M+ LG+  H N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HEN 100

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V L+G C  G   L++ EY   G L   L   R     L     +  +   ++G+ +L 
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPD 267
            +     I+RDL   N+LL  G   K+ DFGLA+  M  S      + R+     + AP+
Sbjct: 159 SK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMAPE 213

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                  TF+SD++S+G++L E+ +
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 30/279 (10%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHP 148
           NF+ +  +G G F +VY+       + VA+K++   +    +  ++   E+  L   +HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N++K +    E ++  +V E    G L + +   +   R +   T  K        ++++
Sbjct: 63  NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H +    V++RD+K +N+ +      KL D GL +   S  KT  +  ++GT  Y +P+ 
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 177

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
                  FKSDI+S G +L E                  + A   P + D+ N   +   
Sbjct: 178 IHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLFSLCQK 219

Query: 329 SLQGQY---PVRGLYQAL-AIAAMCVQEQPNMRPAITDV 363
             Q  Y   P     + L  + +MC+   P+ RP I  V
Sbjct: 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 24/214 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYKG  +K  Q+VA+K++    +  GV    +RE S     L    HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS----LLKELQHPNIVC 63

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L     +  +  L++E++ +  L K+L  L    + +D            +G+ + H   
Sbjct: 64  LQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKG-QYMDAELVKSYLYQILQGILFCH--- 118

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
            + V++RDLK  N+L++     KL+DFGLA+    G    V T  + T  Y AP+  +  
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 273 QL-TFKSDIYSFGVVLLELIT------GRKAIDQ 299
              +   DI+S G +  E+ T      G   IDQ
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 77/231 (33%), Positives = 116/231 (50%), Gaps = 27/231 (11%)

Query: 99  LGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQGVREFSAEVM---TLGSADHPNL 150
           LG+G FGKV+   + KI      Q+ A+K L    ++ VR+     M    L   +HP +
Sbjct: 4   LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFI 60

Query: 151 VKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           VKL  Y  + + +L L+ +++  G L      L  +    + + +  +A  A   L +LH
Sbjct: 61  VKL-HYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELA-LALDHLH 115

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                 +IYRDLK  NILL+E  H KL+DFGL+K     +K   S    GT  Y AP+  
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVV 170

Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE-LNLVAWAR---PMF 316
                T  +D +SFGV++ E++TG     Q KDRKE + ++  A+   P F
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKDRKETMTMILKAKLGMPQF 220

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 16/211 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGFG+V    ++   ++ A K+LD + ++   G +    E   L   + P +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           Y  E    L LV   M  G L  H++++    R L+    +  +A  + G+ +LH     
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM--- 114

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            ++YRD+K  N+LL++  + +LSD GLA     G      T+  GT GY AP+       
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171

Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
           ++  D ++ G  + E++ GR      KD KE
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF---KDHKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 75.9 bits (186), Expect = 4e-15
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF----SAEVMTLGSADHPNLVKLI 154
           +G G + KV    L+K E++ A+K +    V    +     + + +   +++HP LV L 
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 155 GYCAEGDQRLL-VYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
             C + + RL  V EY+  G L  H+   R  P+     ++  + +A      L YLHE+
Sbjct: 63  S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHER 115

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAM 270
               +IYRDLK  N+LL+   H KL+D+G+ K G   GD T   +   GT  Y AP+   
Sbjct: 116 ---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILR 169

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAID 298
                F  D ++ GV++ E++ GR   D
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)

Query: 98  CLGEGGFGKVYKGCLEKIEQV---VAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG VY+G     E     VA+K   +     VRE F  E   +   DHP++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E +   +V E  PLG L  +L   +     LD  + +  +   S  L YL     
Sbjct: 73  IGVITE-NPVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQLSTALAYLE---S 125

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           +  ++RD+   N+L+      KL DFGL++     +  + +++      + AP+     +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 274 LTFKSDIYSFGVVLLELI 291
            T  SD++ FGV + E++
Sbjct: 185 FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 17/206 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF---SAEVMTLGSA-DHPNLVKLI 154
           +G G + KV    L+K  ++ A+K +    V    +      E     +A +HP LV L 
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
             C + + RL  V E++  G L  H+   R   +  + + R   +A  S  L +LHE+  
Sbjct: 63  S-CFQTESRLFFVIEFVSGGDLMFHMQRQR---KLPEEHARF-YSAEISLALNFLHER-- 115

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAMTG 272
             +IYRDLK  N+LL+   H KL+D+G+ K G   GD T   +   GT  Y AP+     
Sbjct: 116 -GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGE 171

Query: 273 QLTFKSDIYSFGVVLLELITGRKAID 298
              F  D ++ GV++ E++ GR   D
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-----EVMTLGSADHPNLVKL 153
           LG+G FGKV    L++  ++ A+K L    +    +         +++L + +HP L +L
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSL-ARNHPFLTQL 61

Query: 154 IGYCAEGDQRLL-VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
              C +   RL  V E++  G L  H+      +R  D       AA  +  L +LH++ 
Sbjct: 62  Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK- 115

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +IYRDLK  N+LL+   H KL+DFG+ K G    KT  ++   GT  Y AP+     
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171

Query: 273 QLTFKSDIYSFGVVLLELITG 293
                 D ++ GV+L E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 93  FRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADH 147
                 L EG FG+++ G L       E+ V +K + DH     V     E   L    H
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTR--MKIAAGAS 202
            N++ ++  C E G+   ++Y YM  G+L   L   R      P   +T+  + +A   +
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPS-----GDKTHVSTR 256
            G+ YLH   K+ VI++D+   N +++E    K++D  L++ + P      GD  +   +
Sbjct: 128 CGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            M      A +  +  + +  SD++SFGV+L EL+T
Sbjct: 185 WM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 5e-15
 Identities = 67/246 (27%), Positives = 107/246 (43%), Gaps = 17/246 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAIKQ++ +          E++ +    HPN+V  +    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 138

Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW-ARPMFKDRKN----FSQMVDPSLQG 332
            DI+S G++ +E++ G          + L L+A    P  ++ +     F   ++  L+ 
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 255

Query: 333 QYPVRG 338
               RG
Sbjct: 256 DVEKRG 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 33/265 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G +G VY+G      +VVA+K +        V  ++   A +  L  +  PN+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G   +G +  ++ EY   GS+   +       + +    R  + A     L+Y+H   K 
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA-----LKYIH---KV 120

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            VI+RD+K +NIL+    + KL DFG+A +         ST V GT  + AP+    G+ 
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFV-GTPYWMAPEVITEGKY 178

Query: 275 -TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ 333
              K+DI+S G+ + E+ TG          + + L+  ++P             P L+  
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-------------PRLED- 224

Query: 334 YPVRGLYQALA-IAAMCVQEQPNMR 357
               G  + L    A C+ E+P  R
Sbjct: 225 ---NGYSKLLREFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 19/215 (8%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG VYKG      E ++  VAIK L ++   +  +E   E   +     P + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPL-DWNTRMKIAAGASRGLQYLHE 210
           +G C     +L V + MP G L  ++  +  R  ++ L +W  ++      ++G+ YL E
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                +++RDL   N+L++   H K++DFGLA++    +  + +        + A +  +
Sbjct: 128 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK 304
             + T +SD++S+GV + EL+T G K  D    R+
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 8e-15
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 17/217 (7%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H 147
           FR    LG+GGFG+V    +    ++ A K+L+ + +   ++   E M L         +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI---KKRKGESMALNEKQILEKVN 58

Query: 148 PNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
              V  + Y  E  D   LV   M  G L  H++++       +    +  AA    GL+
Sbjct: 59  SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLE 116

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
            LH   ++  +YRDLK  NILL++  H ++SD GLA   P G+   +  RV GT GY AP
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAP 170

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           +     + T   D +  G ++ E+I G+      K++
Sbjct: 171 EVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 71/232 (30%), Positives = 94/232 (40%), Gaps = 51/232 (21%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT----LGSADHPNLVKLI 154
           +G G FG+V+    +   QV A+K L    +   R   A V      L  AD P +VKL 
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKL- 66

Query: 155 GYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA----AGASRGLQYL 208
            Y +  D+  L  V EYMP G L   L  +R D  P +   R  IA    A     L  +
Sbjct: 67  -YYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVLA-----LDSV 117

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT----------------- 251
           H   K   I+RD+K  NIL++   H KL+DFGL K                         
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 252 -----HVSTRVM-----GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
                H   RV      GT  Y AP+         + D +S GV+L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 76/239 (31%), Positives = 111/239 (46%), Gaps = 32/239 (13%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDH----RGVQGVREFSAEVMTLGSADHPN 149
           LG+GG+GKV++  + K+      ++ A+K L      R  +      AE   L +  HP 
Sbjct: 4   LGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V LI     G +  L+ EY+  G L  HL   R      D  T     +  S  L++LH
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLE--REGIFMED--TACFYLSEISLALEHLH 117

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-GDKTHVSTRVMGTYGYCAPDY 268
              +Q +IYRDLK  NILL+   H KL+DFGL K     G  TH      GT  Y AP+ 
Sbjct: 118 ---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEI 171

Query: 269 AMTGQLTFKSDIYSFGVVLLELITG---------RKAIDQTKDRKELNLVAWARPMFKD 318
            M        D +S G ++ +++TG         +K ID+   + +LNL  +  P  +D
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL-KGKLNLPPYLTPEARD 229

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.0 bits (187), Expect = 1e-14
 Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 19/193 (9%)

Query: 117 QVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIGYCAEGDQRLL-VYEYMPL 172
             VAIK L     +   +   F  E        HPN+V L+         L  V+EY+P 
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP- 62

Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-- 230
               + L ++      L      ++       L   H    Q +++RDLK  NI++ +  
Sbjct: 63  ---GRTLREVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116

Query: 231 -GYHPKLSDFGLAKMGP---SGDKTHVS--TRVMGTYGYCAPDYAMTGQLTFKSDIYSFG 284
              H K+ DFG+  + P     D   ++  T V+GT  YCAP+      +T  SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 285 VVLLELITGRKAI 297
           ++ LE +TG++ +
Sbjct: 177 LIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 66/199 (33%), Positives = 92/199 (46%), Gaps = 21/199 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           +G G FG VY     +  +VVAIK++ + G Q   ++     EV  L    HPN ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV EY  LGS    L   +   +PL       +  GA +GL YLH      
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHN 135

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT--- 271
           +I+RD+K  NILL E    KL DFG A  M P+          +GT  + AP+  +    
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPEVILAMDE 188

Query: 272 GQLTFKSDIYSFGVVLLEL 290
           GQ   K D++S G+  +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 26/221 (11%)

Query: 99  LGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGSADHPNLV 151
           +G GGFG+VY GC +    ++ A+K LD + +   QG     +  +M   + + D P +V
Sbjct: 2   IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
            +       D+   + + M  G L  HL  H +  +     + T + +      GL+++H
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
            +    V+YRDLK +NILL+E  H ++SD GLA    S  K H S   +GT+GY AP+  
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167

Query: 270 MTGQLTFKS-DIYSFGVVLLELITGRKAIDQ--TKDRKELN 307
             G     S D +S G +L +L+ G     Q  TKD+ E++
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 16/213 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +  +++ AIK L    +     V     E   L     P  +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            C +   RL  V EY+  G L  H+  +     P      +  AA  + GL +LH    +
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLH---SK 120

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQ 273
            +IYRDLK  N++L+   H K++DFG+ K    G KT   TR   GT  Y AP+      
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQP 177

Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
                D ++FGV+L E++ G+   D  +D  EL
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 73/275 (26%), Positives = 119/275 (43%), Gaps = 37/275 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   +    H  LV+L G C 
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V EYM  G L   L+ LR   +    +  +++      G+ YL    KQ  I+
Sbjct: 70  KQRPIYIVTEYMSNGCL---LNYLREHGKRFQPSQLLEMCKDVCEGMAYLES--KQ-FIH 123

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
           RDL   N L+++    K+SDFGL++     D  + S+  +G+     +  P+  +  + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179

Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ-- 333
            KSD+++FGV++ E+ +  K                   M  +R N S+ V+   QG   
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK-------------------MPYERFNNSETVEKVSQGLRL 220

Query: 334 -YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
             P     +  AI   C  E+   RP    ++ ++
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ-----LDHRGVQGVREFSAEVMTLGSAD 146
           N+R    LG+G FG+VY        + +A+KQ           + V     E+  L +  
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 147 HPNLVKLIGYCAEGDQRLLVY-EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           H  +V+  G C   D+ L ++ EYMP GS+   L      T  +   TR K       G+
Sbjct: 63  HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTRQILEGV 117

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVMG 259
           +YLH  +   +++RD+K +NIL +   + KL DFG +K         +G K+     V G
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VTG 169

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           T  + +P+         K+D++S G  ++E++T
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 65/238 (27%), Positives = 93/238 (39%), Gaps = 42/238 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           LG+G  G+V+   L+   ++ A+K LD + +     V+    E   L + DHP L  L  
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV +Y P G L   L   +P     +   R   AA     L+YLH      
Sbjct: 69  SFQTETYLCLVMDYCPGGELF-RLLQRQPGKCLSEEVARF-YAAEVLLALEYLH---LLG 123

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---------------------- 253
           ++YRDLK  NILL E  H  LSDF L+K                                
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 254 --STRVM---GTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGR-----KAIDQT 300
             S R     GT  Y AP+  ++G       D ++ G++L E++ G         D+T
Sbjct: 184 EPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 24/208 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL----GSADHPNLVKLI 154
           +G G FG V K   +    ++A+K++  R     +E    +M L     S+D P +VK  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 155 GYC-AEGDQRLLVYEYMPLGSLD---KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G    EGD   +  E M + SLD   K+++++      +      KIA    + L YL E
Sbjct: 70  GALFREGDC-WICMELMDI-SLDKFYKYVYEVLKSV--IPEEILGKIAVATVKALNYLKE 125

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           +LK  +I+RD+K SNILL+   + KL DFG++ ++  S  K    TR  G   Y AP+  
Sbjct: 126 ELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPERI 179

Query: 270 MTGQLT---FKSDIYSFGVVLLELITGR 294
                     +SD++S G+ L E+ TG+
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 69/223 (30%), Positives = 110/223 (49%), Gaps = 43/223 (19%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDH--RGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK   +   ++VA+K+  L+    GV    +RE S     L   +HPN+V+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS----LLKELNHPNIVR 62

Query: 153 L--IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS---RGLQ 206
           L  + +    + +L LV+E++ L  L K++     D+ PL       I +      +G+ 
Sbjct: 63  LLDVVHS---ENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIA 113

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MG-PSGDKTHVSTRVMGTYGYC 264
           Y H      V++RDLK  N+L++     KL+DFGLA+  G P    TH    V+ T  Y 
Sbjct: 114 YCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYR 166

Query: 265 APDYAMTGQLTFKS--DIYSFGVVLLELITGR------KAIDQ 299
           AP+  + G   + +  DI+S G +  E++  R        IDQ
Sbjct: 167 APE-ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 20/200 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G FG V  G     +  VA+K + +      + F AE   +    H NLV+L+G   
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQPV 216
           E    L +V EYM  GSL  +L   R   R  L  +  +K +      ++YL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNF 123

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-GDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           ++RDL   N+L+ E    K+SDFGL K   S  D   +  +      + AP+     + +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177

Query: 276 FKSDIYSFGVVLLELIT-GR 294
            KSD++SFG++L E+ + GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 74/277 (26%), Positives = 130/277 (46%), Gaps = 44/277 (15%)

Query: 99  LGEGGFGK--VYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG+  +Y+   E    VV  K+++   +  +  R+   E++ L    HPN++   
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 155 GYCAEGDQRLLVYEYMPLGSL-DKHLH---DLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
            +  + +  L+  EY   G+L DK +     L  +   L +  ++  A      + Y+H 
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA------VSYIH- 118

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             K  +++RD+K  NI L +    KL DFG++K+   G +  ++  V+GT  Y +P+   
Sbjct: 119 --KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQ 174

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
             +  FKSDI++ G VL EL+T ++  D T                    N   +V   +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDAT--------------------NPLNLVVKIV 214

Query: 331 QGQY-PVRGLYQALAIAAM--CVQEQPNMRPAITDVV 364
           QG Y PV  +Y +  I+ +   +Q+ P  RP   +V+
Sbjct: 215 QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 48/224 (21%)

Query: 101 EGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQG-----VREFSAEVMTLGSADHPNLVKL- 153
           EG +G VY+   +K  ++VA+K+L   +  +G     +RE +     L    HPN+V + 
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN----ILLKLQHPNIVTVK 70

Query: 154 -IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS---------- 202
            +   +  D+  +V EY+         HDL+           MK     S          
Sbjct: 71  EVVVGSNLDKIYMVMEYVE--------HDLK------SLMETMKQPFLQSEVKCLMLQLL 116

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+ +LH+     +++RDLK SN+LL      K+ DFGLA+    G      T+++ T  
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLW 171

Query: 263 YCAPDYAM-TGQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
           Y AP+  +   + +   D++S G +  EL+T      G+  IDQ
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 13/214 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-EVMTLGSADHPNLVKLIGYC 157
           LGEG +  V+KG  +  E +VA+K++     +G    +  EV  L    H N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPV 216
                  LV+EY     LDK L     D   +     +KI      RGL Y H   ++ V
Sbjct: 74  HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKV 125

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLT 275
           ++RDLK  N+L+ E    KL+DFGLA+      KT+ +  V  T  Y  PD  + + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183

Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            + D++  G +  E+ +GR     +    EL+L+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 30/211 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ----LDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G +G VYK         +A+K+    LD      +     E+  L  A  P +V   
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQI---IMELDILHKAVSPYIVDFY 65

Query: 155 G-YCAEGDQRLLVY---EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G +  EG     VY   EYM  GSLDK L+     T  +  +   +I     +GL++L E
Sbjct: 66  GAFFIEGA----VYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDY- 268
           +    +I+RD+K +N+L+      KL DFG++  +  S  KT++     G   Y AP+  
Sbjct: 121 EHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERI 173

Query: 269 ---AMTGQLTF--KSDIYSFGVVLLELITGR 294
                    T+  +SD++S G+ +LE+  GR
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL---------DHRGVQGVREFSAEVMTLGSADHPN 149
           +G G FG VY G      +++A+KQ+           R    +   + E+  L    H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V+ +G   + D   +  EY+P GS+   L++       L  N   +I     +GL YLH
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYLH 123

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM----GPSGDKTHVSTRVMGTYGYCA 265
               + +I+RD+K +NIL++     K+SDFG++K       S         + G+  + A
Sbjct: 124 ---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           P+       T K+DI+S G +++E++TG+
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 72.5 bits (178), Expect = 4e-14
 Identities = 66/202 (32%), Positives = 87/202 (43%), Gaps = 18/202 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-VVAIKQLDHRGVQGVREFSAEVMT----LGSADHPNLVKL 153
           LG+G FGKV     EK      A+K L  + V   ++  A  +T    L +  HP L  L
Sbjct: 3   LGKGTFGKVIL-VREKATGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                  D+   V EY   G L  HL   R  +       R   A   S  L YLH    
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVS-ALGYLHSC-- 114

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-GDKTHVSTRVMGTYGYCAPDYAMTG 272
             V+YRDLK  N++L++  H K++DFGL K G S G          GT  Y AP+     
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLEDN 170

Query: 273 QLTFKSDIYSFGVVLLELITGR 294
                 D +  GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 71/240 (29%), Positives = 109/240 (45%), Gaps = 45/240 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LGEG FG+VYK    K  +VVA+K++      D   +  +R    E+  L    HPN+V 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR----EIKILKKLKHPNVVP 71

Query: 153 LIGYCAE-----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR---- 203
           LI    E       +R  VY   P   +D   HDL   +  L+ N  +K+     +    
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPY--MD---HDL---SGLLE-NPSVKLTESQIKCYML 122

Query: 204 ----GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---------MGPSGDK 250
               G+ YLHE     +++RD+K +NIL++     K++DFGLA+          G  G  
Sbjct: 123 QLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 251 THVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           T   T ++ T  Y  P+  +   + T   DI+  G V  E+ T R  +    D  +L+L+
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 78/284 (27%), Positives = 120/284 (42%), Gaps = 30/284 (10%)

Query: 99  LGEGGFGKVYKGCLEK---IEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G FGKV  G +       QVV +K+L     VQ   +F  E     S  H NL++ +
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           G C E    LLV E+ PLG L  +L   R  +    D  T  ++A   + GL +LH   K
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA--MT 271
              I+ DL   N LL      K+ D+GL+      D      ++     + AP+    + 
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 272 GQL-----TFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
           G L     T +S+++S GV + EL   G +      D + L            R+   ++
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV--------REQQLKL 230

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
             P L+     R  Y+ +    +    QP  RP+  +V + L+Y
Sbjct: 231 PKPRLKLPLSDR-WYEVMQFCWL----QPEQRPSAEEVHLLLSY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+     K  +V A+K +   G   V  F AE   + +  H  LVKL     
Sbjct: 14  LGAGQFGEVWMATYNKHTKV-AVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + +   ++ E+M  GSL   L       +PL     +  +A  + G+ ++    ++  I+
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIE---QRNYIH 125

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTGQLTF 276
           RDL+ +NIL+      K++DFGLA++    + T    R    +   + AP+    G  T 
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTI 182

Query: 277 KSDIYSFGVVLLELIT-GR 294
           KSD++SFG++L+E++T GR
Sbjct: 183 KSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 15/226 (6%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V K    K   ++  ++L H  ++  +R +   E+  L   + P 
Sbjct: 6   DFERISELGAGNGGVVTK-VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L +     + +      K++    RGL YL 
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLR 120

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 174

Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM 315
                + +SDI+S G+ L+EL  GR  I    D KEL  + + RP+
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI-PPPDAKELEAI-FGRPV 218

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 18/200 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +GEG FG+         +Q  A+K++   +    V +   E + L    HPN+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF-KES 66

Query: 158 AEGDQRL-LVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            E D  L +V EY   G L + +   R    P+   L W  +M +      G+Q++HE+ 
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RD+K  NI L +    KL DFG A++  +    +  T V GT  Y  P+     
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYVPPEIWENM 175

Query: 273 QLTFKSDIYSFGVVLLELIT 292
               KSDI+S G +L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 21/212 (9%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V K  L +   ++  ++L H  +   +R +   E+  L   + P 
Sbjct: 2   DFEKLGELGAGNGGVVTK-VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 150 LVKLIG-YCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQ 206
           +V   G + ++G+  + + E+M  GSLD+ L      P+      N   KI+    RGL 
Sbjct: 61  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE------NILGKISIAVLRGLT 113

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCA 265
           YL E+ K  +++RD+K SNIL+      KL DFG++ ++  S   + V TR      Y +
Sbjct: 114 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMS 166

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAI 297
           P+       T +SDI+S G+ L+E+  GR  I
Sbjct: 167 PERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 68/220 (30%), Positives = 101/220 (45%), Gaps = 21/220 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           LGEG +  VYKG      Q+VA+K +  +  +GV  F+A  E   L    H N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71

Query: 157 CAEGDQRLLVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
               +    V+EYM       + +H   L P      +N R+ +     RGL Y+H    
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRLFMFQ-LLRGLAYIH---G 121

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           Q +++RDLK  N+L+      KL+DFGLA+      +T+ S  V  T  Y  PD  + G 
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGA 178

Query: 274 LTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
             + S  DI+  G + +E++ G+ A     D  E     W
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 66/202 (32%), Positives = 89/202 (44%), Gaps = 19/202 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           +G+G FGKV     +   +  A+K L  + +   +E    +M      L +  HP LV L
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVGL 61

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
                  D+   V +Y+  G L  HL   R  P+ R      R   A  AS  L YLH  
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR-----ARFYAAEIAS-ALGYLHSL 115

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
               +IYRDLK  NILL+   H  L+DFGL K G    KT  ++   GT  Y AP+    
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRK 170

Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                  D +  G VL E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP                + +   +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 72/222 (32%), Positives = 111/222 (50%), Gaps = 28/222 (12%)

Query: 99  LGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGSADHPNLV 151
           +G GGFG+VY GC +    ++ A+K LD + +   QG     +  +M   + + D P +V
Sbjct: 2   IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKI-AAGASRGLQYL 208
            +       D+   + + M  G L  HL  H +  +         M+  AA    GL+++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHM 113

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H +    V+YRDLK +NILL+E  H ++SD GLA    S  K H S   +GT+GY AP+ 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166

Query: 269 AMTGQLTFKS-DIYSFGVVLLELITGRKAIDQ--TKDRKELN 307
              G     S D +S G +L +L+ G     Q  TKD+ E++
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 12/213 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G V+        Q VAIKQ++ +          E++ +    +PN+V  +    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 87  VGDELFVVMEYLAGGSLTDVVTETCMD--------EAQIAAVCRECLQALEFLHANQVIH 138

Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  N+LL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E++ G          + L L+A
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 23/219 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
           LGEG +  V+KG  +  E +VA+K++     +G     +RE S     L +  H N+V L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS----LLKNLKHANIVTL 68

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA-GASRGLQYLHEQL 212
                      LV+EY     LD  L     +   L     +KI      RGL Y H   
Sbjct: 69  HDIIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH--- 120

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
           K+ +++RDLK  N+L+ E    KL+DFGLA+      KT+ +  V  T  Y  PD  + G
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD-VLLG 177

Query: 273 QLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
              + +  D++  G +L E+ TGR     +  ++EL+L+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           LGEG +  VYKG  +   ++VA+K +  +  +G   F+A  E   L    H N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71

Query: 157 CAEGDQRLLVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
               +   LV+EY+       +DKH   L P+   L     +       RGL Y+H++  
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RGLSYIHQRY- 123

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +++RDLK  N+L+ +    KL+DFGLA+       +H  +  + T  Y  PD  + G 
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD-VLLGS 178

Query: 274 LTFKS--DIYSFGVVLLELITGRKAIDQTKD 302
             + +  D++  G + +E+I G  A    KD
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 21/218 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
           LGEG +  VYKG  +  + +VA+K++     +G     +RE S     L    H N+V L
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHANIVTL 69

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQL 212
                      LV+EY     LDK L     D         +K+      RGL Y H   
Sbjct: 70  HDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--- 121

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-T 271
           ++ V++RDLK  N+L+ E    KL+DFGLA+      KT+ +  V  T  Y  PD  + +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGS 179

Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
              + + D++  G +  E+ TGR     +   ++L+ +
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 66/232 (28%), Positives = 109/232 (46%), Gaps = 35/232 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRG----VQGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G+VYK   +   ++VA+K+  LD+      +  +RE    +  L   +H N+V 
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIRE----IKILRQLNHRNIVN 70

Query: 153 LIGYCAEGDQRL----------LVYEYMP---LGSLDKHLHDLRPDTRPLDWNTRMKIAA 199
           L     +    L          LV+EYM    +G L+  L     D       + MK   
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED----HIKSFMK--- 123

Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
               GL Y H   K+  ++RD+KCSNILL      KL+DFGLA++  S +    + +V+ 
Sbjct: 124 QLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179

Query: 260 TYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           T  Y  P+  +  +    + D++S G +L EL T +      ++  +L L++
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 20/199 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           LG G  G VYK       +++A+K   LD   V+  ++  +E+  L   D P ++   G 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
               ++  +  E+M  GSLD +        R +  +   +IA    +GL YL   LK  +
Sbjct: 68  FFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW-SLK--I 116

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           ++RD+K SN+L+      KL DFG++ ++  S  KT+V     GT  Y AP+     Q  
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171

Query: 276 FKSDIYSFGVVLLELITGR 294
             SD++S G+  +EL  GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEVMTLGSAD-HPN 149
           LGEG FG+V +     I++        VA+K L D+   + + +  +E+  +     H N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRMKI 197
           ++ L+G C +     ++ EY   G+L + L   RP                L +   +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL  +     I+RDL   N+L+ E    K++DFGLA+     D    ++  
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 24/215 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGV-QGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L      + + +  +E+ M      H N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------DT-----RPLDWNTRMKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP       DT       L +   +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV+L E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 27/215 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   +HPN+VK
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKELNHPNIVK 63

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L+      ++  LV+E++    L K +        PL             +GL + H   
Sbjct: 64  LLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCHSH- 119

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RDLK  N+L+      KL+DFGLA+    G      T  + T  Y AP+  +  
Sbjct: 120 --RVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGC 175

Query: 273 QL-TFKSDIYSFGVVLLELITGRKA-------IDQ 299
           +  +   DI+S G +  E++T R+A       IDQ
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 3e-13
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 139

Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E+I G          + L L+A
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 4e-13
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 24/209 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYC 157
           +G G +G+VYKG   K  Q+ AIK +D  G +   E   E+  L   + H N+    G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 158 AE------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            +       DQ  LV E+   GS+   + + + +T   +W     I     RGL +LH+ 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR--VMGTYGYCAP--- 266
               VI+RD+K  N+LL E    KL DFG++      D+T V  R   +GT  + AP   
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVI 183

Query: 267 --DYAMTGQLTFKSDIYSFGVVLLELITG 293
             D        FKSD++S G+  +E+  G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.0 bits (168), Expect = 5e-13
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAIKQ++ +          E++ +    +PN+V  +    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALDFLHSNQVIH 138

Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E++ G          + L L+A
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 63/204 (30%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK----QLDHRG--VQGVREFSAEVMTLGSADHPNLVK 152
           +G G +G VYK         VA+K    Q +  G  +  VRE  A +  L + DHPN+V+
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66

Query: 153 LIGYCAEG--DQRL---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           L+  CA    D+     LV+E++    L  +L  + P   P +  T   +     RGL +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDF 123

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS-TRVMGTYGYCAP 266
           LH      +++RDLK  NIL+  G   KL+DFGLA++        ++ T V+ T  Y AP
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAP 176

Query: 267 DYAMTGQLTFKSDIYSFGVVLLEL 290
           +  +        D++S G +  E+
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 68/216 (31%), Positives = 101/216 (46%), Gaps = 25/216 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           LGEG +  VYKG  +   Q+VA+K++     +G   F+A  E   L    H N+V L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHDI 71

Query: 157 CAEGDQRLLVYEYM--PLGS-LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                   LV+EY+   L   +D     L         N R+ +     RGL Y H   +
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRLFLFQ-LLRGLAYCH---Q 121

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGL--AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           + V++RDLK  N+L+ E    KL+DFGL  AK  PS  KT+ +  V  T  Y  PD  + 
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVV--TLWYRPPD-VLL 176

Query: 272 GQLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKE 305
           G   + +  D++  G +  E+ TGR     + D ++
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 45/215 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ----LDHRGV--QGVREFSAEVM-TLGSADHPNLV 151
           +GEG +G VYK       + VA+K+    L   G+    +RE +  ++  L S +HPN+V
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA--LLKQLESFEHPNIV 64

Query: 152 KLIGYCA--EGDQRL---LVYEYMPLGSLDKHLHD---------LRPDTRPLDWNTRMKI 197
           +L+  C     D+ L   LV+E++     D+ L           L P+T  +    R  +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPET--IKDLMRQLL 117

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                RG+ +LH      +++RDLK  NIL+      K++DFGLA++          T V
Sbjct: 118 -----RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSV 166

Query: 258 MGTYGYCAPDYAMTGQLTFKS--DIYSFGVVLLEL 290
           + T  Y AP+  +  Q ++ +  D++S G +  EL
Sbjct: 167 VVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-VVAIKQLDHRGV---QGVREFSAEVMTLGSA--------D 146
           LG G FG VYK   +   Q ++A+K+++       +  RE    +  + S          
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD----WNTRMKIAAGAS 202
           HPN+V+      E D+  +V + +    L +H + L+   +       WN  +++     
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA-- 125

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             L+YLH++ +  +++RDL  +NI+L E     ++DFGLAK      K    T V+GT  
Sbjct: 126 --LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTIL 178

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           Y  P+         K+D+++FG +L ++ T
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 69/234 (29%), Positives = 101/234 (43%), Gaps = 76/234 (32%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA------------EVMTLGS-A 145
           LG+G +G V+K    + ++VVA+K++          F A            E+M L    
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIMFLQELG 64

Query: 146 DHPNLVKLIG-YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA-- 201
           DHPN+VKL+    AE D+ + LV+EYM     +  LH +              I A    
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANILE 105

Query: 202 -----------SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPS 247
                       + L+Y+H      VI+RDLK SNILL      KL+DFGLA+       
Sbjct: 106 DVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162

Query: 248 GDKTHVSTRVMGTYGYCAPD-------YAMTGQLTFKSDIYSFGVVLLELITGR 294
             +  V T  + T  Y AP+       Y      T   D++S G +L E++ G+
Sbjct: 163 NPENPVLTDYVATRWYRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 68.2 bits (167), Expect = 7e-13
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 10/195 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V     +   + VA+K++D R  Q       EV+ +    HPN+V++     
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR ++      +     + L +LH    Q VI+
Sbjct: 87  VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIATVCLAVLKALSFLH---AQGVIH 138

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+         + 
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196

Query: 279 DIYSFGVVLLELITG 293
           DI+S G++++E++ G
Sbjct: 197 DIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 16/213 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +  +++ AIK L    V     V     E   L   D P  +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            C +   RL  V EY+  G L  H+  +     P      +  AA  S GL +LH   ++
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLH---RR 120

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQ 273
            +IYRDLK  N++L+   H K++DFG+ K         V+TR   GT  Y AP+      
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
                D +++GV+L E++ G+   D  +D  EL
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.5 bits (165), Expect = 9e-13
 Identities = 63/226 (27%), Positives = 96/226 (42%), Gaps = 33/226 (14%)

Query: 99  LGEGGFGKVYKGCLEK----------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP 148
           LG+G F  +YKG L             E  V +K L       +  F      +    H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           +LVKL G C   D+ ++V EY+  G LD  LH    +   L W  ++ +A   +  L YL
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYL 117

Query: 209 HEQLKQPVIYRDLKCSNILL-----EEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            +   + +++ ++   NIL+      EGY P  KLSD G+        +     R+    
Sbjct: 118 ED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168

Query: 262 GYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
            + AP+    GQ  LT  +D +SFG  LLE+ +  +    T    E
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 62/199 (31%), Positives = 88/199 (44%), Gaps = 13/199 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
           +G+G FGKV     +   +  A+K L  + V   +E     +   + L +  HP LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                 ++   V +++  G L  HL   R    P     R   A  AS  L YLH  +  
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAAEIAS-ALGYLH-SIN- 116

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            ++YRDLK  NILL+   H  L+DFGL K G +   T  +T   GT  Y AP+       
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQPY 173

Query: 275 TFKSDIYSFGVVLLELITG 293
               D +  G VL E++ G
Sbjct: 174 DNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 67.6 bits (165), Expect = 1e-12
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT--LGSADHPNLVKLIGY 156
           LG+GGFG+V    +    ++ A K+L+ + ++  + +   ++   + +  H   +  + Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 157 CAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +    L LV   M  G L  H++++  +             A    GL++LH++    
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
           +IYRDLK  N+LL+   + ++SD GLA   K G S  K +      GT G+ AP+     
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQGE 172

Query: 273 QLTFKSDIYSFGVVLLELITGR 294
           +  F  D ++ GV L E+I  R
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 69/244 (28%), Positives = 104/244 (42%), Gaps = 41/244 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G+GG+G+V+    +   ++VA+K++    +     VR    E   L +     LVKL+ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRP---DTRPLDWN------TRMKIAAGASRGL 205
           Y  + D+ L L  EY+P G       D R    +   L  +        M  A  A   L
Sbjct: 68  YAFQDDEYLYLAMEYVPGG-------DFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
            Y+H         RDLK  N L++   H KL+DFGL+K   +      +  V+G+  Y A
Sbjct: 121 GYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMA 166

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAID-QTKDRKELNLVAWA----RPMFKD-R 319
           P+        F  D +S G +L E + G       T +    NL  W     RP++ D R
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPR 226

Query: 320 KNFS 323
            N S
Sbjct: 227 FNLS 230

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 73/223 (32%), Positives = 105/223 (47%), Gaps = 19/223 (8%)

Query: 83  FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-REFSAEVMT 141
            + L   T  +     +G+G +GKVYK   +K   + A+K LD   +  V  E  AE   
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD--PISDVDEEIEAEYNI 71

Query: 142 LGS-ADHPNLVKLIG--YCAE---GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
           L S  +HPN+VK  G  Y A+   G Q  LV E    GS+ + +  L    + LD     
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMIS 131

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
            I  GA  GLQ+LH      +I+RD+K +NILL      KL DFG++    S  +   +T
Sbjct: 132 YILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-RLRRNT 187

Query: 256 RVMGTYGYCAPDYAMTGQ-----LTFKSDIYSFGVVLLELITG 293
            V GT  + AP+     Q        + D++S G+  +EL  G
Sbjct: 188 SV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 40/275 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV--REFSAEVMTLGSADHPNLVKLIGY 156
           +GEG FGK      ++  +   IK+++   +      E   EV  L +  HPN+V+    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             E     +V +Y   G L K ++  R    P+ + LDW  ++ +A      L+++H++ 
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDR- 120

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +++RD+K  NI L +    KL DFG+A++  S     ++   +GT  Y +P+     
Sbjct: 121 --KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS--TVELARTCIGTPYYLSPEICENR 176

Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
               KSDI++ G VL E+ T + A +                      N   +V   ++G
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEA--------------------GNMKNLVLKIIRG 216

Query: 333 QYP---VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
            YP       Y    + +   +  P  RP++  ++
Sbjct: 217 SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 78/264 (29%), Positives = 116/264 (43%), Gaps = 35/264 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM-----TLGSADHPNLVKL 153
           +G G  G+VYK   +K   V+A+KQ+  R   G +E +  ++      L S D P +VK 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM-RR--TGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            GY        +  E M    LDK L  ++    P+  +   K+     + L YL E  K
Sbjct: 80  YGYFITDSDVFICMELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--K 133

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG----DKTHVSTRVMGTYGYCAPDY- 268
             VI+RD+K SNILL+   + KL DFG+     SG     K    TR  G   Y AP+  
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGI-----SGRLVDSKAK--TRSAGCAAYMAPERI 186

Query: 269 ---AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL--NLVAWARPMFKDRKNFS 323
                  +   ++D++S G+ L+EL TG+      K   E+   ++    P     + FS
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246

Query: 324 QM----VDPSLQGQYPVRGLYQAL 343
                 VD  L   +  R  Y+ L
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYREL 270

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 73/257 (28%), Positives = 109/257 (42%), Gaps = 28/257 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGY- 156
           +G G +G+VYKG   K  Q+ AIK +D    +   E   E+  L   + H N+    G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 157 -----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
                    DQ  LV E+   GS+   + + + +    DW     I     RGL +LH  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH-- 138

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR--VMGTYGYCAP--- 266
               VI+RD+K  N+LL E    KL DFG++      D+T V  R   +GT  + AP   
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMAPEVI 193

Query: 267 --DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW-ARPMFKDR---K 320
             D        ++SDI+S G+  +E+  G   +      + L L+     P  K +   K
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253

Query: 321 NFSQMVDPSLQGQYPVR 337
            F   ++  L   Y  R
Sbjct: 254 KFIDFIEGCLVKNYLSR 270

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG G FG+V     +   +  AIK L  R +   + V+  + E   L    HP +V ++ 
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLD----WNTRMKIAAGASRGLQYLHE 210
              + ++   + E++  G L  HL   R   R P D    ++  + +A       +YLH 
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLA------FEYLHS 136

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
           +    +IYRDLK  N+LL+   H K++DFG AK  P  D+T     + GT  Y AP+   
Sbjct: 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQ 188

Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
           +       D ++ GV+L E I G
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 61/236 (25%), Positives = 108/236 (45%), Gaps = 17/236 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    ++   ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR ++      +     + L  LH    Q VI+
Sbjct: 88  VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIAAVCLAVLKALSVLH---AQGVIH 139

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF-- 276
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+  +  +L +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPE--LISRLPYGP 195

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           + DI+S G++++E++ G          K + ++   R     +      V PSL+G
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHKVSPSLKG 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 18/208 (8%)

Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +  L K E    Q VA+K L  D      + EF  E   +   DHPN++K
Sbjct: 7   LGKGEFGSVREAQL-KSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 153 LIGYC--AEGDQRL----LVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRG 204
           LIG    +    RL    ++  +M  G L   L   R    P  L   T ++     + G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           ++YL  +     I+RDL   N +L E     ++DFGL+K   SGD             + 
Sbjct: 126 MEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           A +       T  SD+++FGV + E++T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 46/223 (20%)

Query: 98  CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSA----EVMTLGSADHPNLV 151
           C+G G +G+VYK   +  K  +  AIK+      Q     S     E+  L    H N+V
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-GISQSACREIALLRELKHENVV 65

Query: 152 KLIGYCAEGDQRL--LVYEYMPLGSLDKHLHDL--------RPDTRPLDWNTRMKIAAGA 201
            L+    E   +   L+++Y          HDL        +     +  +    +    
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKM--GP-----SGDK 250
             G+ YLH      V++RDLK +NIL+     E    K+ D GLA++   P       D 
Sbjct: 118 LNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174

Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELIT 292
                 V+ T  Y AP+  +  +   K+ DI++ G +  EL+T
Sbjct: 175 ------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 10/93 (10%)

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYG 262
           L +LH QL   +IYRD+K  NILL+   H  L+DFGL+K  +    ++ +      GT  
Sbjct: 118 LDHLH-QLG--IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIE 171

Query: 263 YCAPDYAMTGQLTFKS--DIYSFGVVLLELITG 293
           Y AP+    G        D +S GV+  EL+TG
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 62/200 (31%), Positives = 88/200 (44%), Gaps = 15/200 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
           +G+G FGKV     +  E+  A+K L  + +   +E     S   + L +  HP LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
                 D+   V +Y+  G L  HL   R    P     R +  AA  +  L YLH    
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL-- 115

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             ++YRDLK  NILL+   H  L+DFGL K     + T  ++   GT  Y AP+      
Sbjct: 116 -NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQP 172

Query: 274 LTFKSDIYSFGVVLLELITG 293
                D +  G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS---------ADHPN 149
           +G+G FG+VY+   +   ++ A+K L  + +   +E +    T+G           + P 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA---HTIGERNILVRTLLDESPF 57

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHL-HDLR-PDTRPLDWNTRMKIAAGASRGLQY 207
           +V L           LV +YM  G L  HL  + R  + R   +   + +A      L++
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA------LEH 111

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH   K  ++YRDLK  NILL+   H  L DFGL+K   + +KT  +    GT  Y AP+
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPE 166

Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITG 293
             +  +  T   D +S GV++ E+  G
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 12/196 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V     +   + VA+K++D R  Q       EV+ +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR ++      +     R L YLH    Q VI+
Sbjct: 90  VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIATVCLSVLRALSYLH---NQGVIH 141

Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  +ILL      KLSDFG  A++     K      ++GT  + AP+         +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKSLVGTPYWMAPEVISRLPYGTE 198

Query: 278 SDIYSFGVVLLELITG 293
            DI+S G++++E+I G
Sbjct: 199 VDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)

Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          EK  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197

Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSA---EVMTLGSAD 146
           N+R    LG+G FG+VY        + +A+KQ+  D    +  +E +A   E+  L +  
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 147 HPNLVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
           H  +V+  G   +  +R L    E+MP GS+   L      T     N   K       G
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE----NVTRKYTRQILEG 118

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVM 258
           + YLH  +   +++RD+K +NIL +   + KL DFG +K      +  +G K+     V 
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           GT  + +P+         K+DI+S G  ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 62/201 (30%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE----FSAEVMTLGSADHPNLVKLI 154
           +G+G FGKV     +      A+K L  + +   +E     +   + L +  HP LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQL 212
            Y  +  ++L  V +Y+  G L  HL   R    P     R +  AA  +  + YLH   
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAAEVASAIGYLHSL- 115

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +IYRDLK  NILL+   H  L+DFGL K G   ++T  ++   GT  Y AP+     
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171

Query: 273 QLTFKSDIYSFGVVLLELITG 293
                 D +  G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 18/171 (10%)

Query: 127 RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--P 184
           +G++   E+S E +T+     PN+V L  Y    D   LV ++   G L  H+      P
Sbjct: 24  KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83

Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAK 243
           +     W   M +A      L  LH +    ++ RDL  +NILL++  H +L+ F   ++
Sbjct: 84  EECVKRWAAEMVVA------LDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134

Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           +  S D   V         YCAP+     + T   D +S G +L EL+TG+
Sbjct: 135 VEDSCDGEAVENM------YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 12/195 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G +G VYK       ++ AIK +     +       E++ +    H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             D+  +  E+   GSL     D+   T PL  +    ++    +GL YLH + K   ++
Sbjct: 77  RRDKLWICMEFCGGGSL----QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLT 275
           RD+K +NILL +  H KL+DFG++    +      S   +GT  + AP+ A     G   
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGYN 187

Query: 276 FKSDIYSFGVVLLEL 290
              DI++ G+  +EL
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 62/208 (29%), Positives = 88/208 (42%), Gaps = 30/208 (14%)

Query: 99  LGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH 147
           LG+G FGKV           Y   + + E ++A  ++ H           E   L +  H
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------VTESRVLQNTRH 54

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQ 206
           P L  L       D+   V EY   G L  HL   R  T       R +   A     L+
Sbjct: 55  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-----ERARFYGAEIVSALE 109

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YLH +    V+YRD+K  N++L++  H K++DFGL K G S   T  +    GT  Y AP
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAP 164

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
           +           D +  GVV+ E++ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 28/219 (12%)

Query: 99  LGEGGFGKVYKGC-LEKIEQVVAIK----QLDHRG--VQGVREFSAEVMTLGSADHPNLV 151
           +GEG +GKV+K   L+   + VA+K    Q    G  +  +RE  A +  L + +HPN+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPNVV 67

Query: 152 KLIGYCA----EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           +L   C     + + +L LV+E++    L  +L  +     P +  T   +     RGL 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE--TIKDMMFQLLRGLD 124

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           +LH      V++RDLK  NIL+      KL+DFGLA++          T V+ T  Y AP
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAP 178

Query: 267 DYAMTGQLTFKSDIYSFGVVLLE------LITGRKAIDQ 299
           +  +        D++S G +  E      L  G   +DQ
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.6 bits (154), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 25/216 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSA---EVMTLGSAD 146
           N+R    LG+G FG+VY        + +A KQ+  D    +  +E SA   E+  L +  
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 147 HPNLVKLIGYCAEGDQRLLV--YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
           H  +V+  G   +  ++ L    EYMP GS+   L      T  +      +I  G S  
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS-- 120

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVM 258
             YLH  +   +++RD+K +NIL +   + KL DFG +K      M  +G ++     V 
Sbjct: 121 --YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-----VT 170

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           GT  + +P+         K+D++S G  ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPNLVKLIGY 156
           LG G  G V+K    K   ++  ++L H  ++  +R +   E+  L   + P +V   G 
Sbjct: 13  LGAGNGGVVFK-VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                +  +  E+M  GSLD+ L         +      K++    +GL YL E  K  +
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE--KHKI 125

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+       + 
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYSV 181

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPI-PPPDAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 32/207 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
           +G G FG V     +   Q VAIK++       ++ FS          E+  L    H N
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELKLLKHLRHEN 70

Query: 150 LVKLIG-YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           ++ L   + +  +    V E +     D  LH L   +RPL+            RGL+Y+
Sbjct: 71  IISLSDIFISPLEDIYFVTELL---GTD--LHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H      V++RDLK SNIL+ E    K+ DFGLA++       +VSTR      Y AP+ 
Sbjct: 125 HSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEI 176

Query: 269 AMTGQ-LTFKSDIYSFGVVLLELITGR 294
            +T Q    + DI+S G +  E++ G+
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 58/197 (29%), Positives = 91/197 (46%), Gaps = 16/197 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSA-EVMTLGSADHPNLVKLIG 155
           +GEG +G V+K    +  ++VA+K  +LD    +GV   +  E+  L    H N+V+L  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYD 66

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                D++L LV+EY     L K+      D   +D            +GL + H     
Sbjct: 67  -VLHSDKKLTLVFEYCD-QDLKKYFDSCNGD---IDPEIVKSFMFQLLKGLAFCHSH--- 118

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            V++RDLK  N+L+ +    KL+DFGLA+    G      +  + T  Y  PD     +L
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 275 TFKS-DIYSFGVVLLEL 290
              S D++S G +  EL
Sbjct: 177 YSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 69/229 (30%), Positives = 101/229 (44%), Gaps = 19/229 (8%)

Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-REF 135
           S K   FD     +  +     +G+G +GKV+K   +K     A+K LD   +  +  E 
Sbjct: 4   SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD--PIHDIDEEI 61

Query: 136 SAEVMTLGS-ADHPNLVKLIGY-----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
            AE   L + +DHPN+VK  G         GDQ  LV E    GS+   +         +
Sbjct: 62  EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121

Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
           +      I   A  GLQ+LH       I+RD+K +NILL      KL DFG++    S  
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-- 176

Query: 250 KTHVSTRVMGTYGYCAPDY-AMTGQL--TF--KSDIYSFGVVLLELITG 293
                   +GT  + AP+  A   QL  T+  + D++S G+  +EL  G
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 21/203 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
           +G G  G VYK       ++ A+K +       VR +   E+  L   +HPN+VK     
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
               +  ++ E+M  GSL+         T   D      +A     G+ YLH   ++ ++
Sbjct: 142 DHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLH---RRHIV 190

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT----G 272
           +RD+K SN+L+    + K++DFG+++ +  + D  + S   +GT  Y +P+   T    G
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHG 247

Query: 273 QLT-FKSDIYSFGVVLLELITGR 294
               +  DI+S GV +LE   GR
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD---HRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           +G G +G+V      K  + VAIK+L       +   R +  E+  L   DH N++ L+ 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81

Query: 156 YCAEGDQRLL----VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
                   L     VY    L   D + + ++   + L  +    +     RGL+Y+H  
Sbjct: 82  -VFTPASSLEDFQDVYLVTHLMGADLN-NIVK--CQKLSDDHIQFLVYQILRGLKYIHSA 137

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
               +I+RDLK SNI + E    K+ DFGLA+        +V+TR      Y AP+  + 
Sbjct: 138 ---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLN 189

Query: 272 -GQLTFKSDIYSFGVVLLELITGR 294
                   DI+S G ++ EL+TG+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 59/198 (29%), Positives = 89/198 (44%), Gaps = 12/198 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           +G+G FGKV +      +++ A+K +    +    E +   AE   L   + P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                ++  LV  ++  G L    H L+ + R      R   A      L+ LH+     
Sbjct: 61  SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAE-LLCALENLHKF---N 113

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           VIYRDLK  NILL+   H  L DFGL K+    D    +    GT  Y AP+  +    T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYT 171

Query: 276 FKSDIYSFGVVLLELITG 293
              D ++ GV+L E++TG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 11/97 (11%)

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY- 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA+     D  H  T  +  Y 
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYV 170

Query: 262 ---GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
               Y AP+  +  +   K+ DI+S G +L E+++ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 62/207 (29%), Positives = 86/207 (41%), Gaps = 27/207 (13%)

Query: 99  LGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH 147
           LG+G FGKV           Y   + K E +VA  ++ H           E   L ++ H
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNSRH 54

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P L  L       D+   V EY   G L  HL       R    +      A     L Y
Sbjct: 55  PFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDY 110

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH +  + V+YRDLK  N++L++  H K++DFGL K G     T  +    GT  Y AP+
Sbjct: 111 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 166

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
                      D +  GVV+ E++ GR
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGS-ADHPNLVKLIG 155
           +GEG F +V K    K  +  AIK +    + ++ V     E+  L   + HPN+++LI 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65

Query: 156 --YCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             +  +  +  LV+E M     D +L++L +   RPL             + L ++H   
Sbjct: 66  VLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH--- 117

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT- 271
           +  + +RD+K  NIL+ +    KL+DFG  +           T  + T  Y AP+  +T 
Sbjct: 118 RNGIFHRDIKPENILI-KDDILKLADFGSCR---GIYSKPPYTEYISTRWYRAPECLLTD 173

Query: 272 GQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
           G    K DI++ G V  E+++      G   +DQ
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ 207

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 63/207 (30%), Positives = 88/207 (42%), Gaps = 28/207 (13%)

Query: 99  LGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH 147
           LG+G FGKV           Y   + K E ++A  ++ H           E   L +  H
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNTRH 54

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P L  L       D+   V EY+  G L  HL   R  +      TR   A   S  L Y
Sbjct: 55  PFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED---RTRFYGAEIVS-ALDY 110

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH      ++YRDLK  N++L++  H K++DFGL K G +   T  +    GT  Y AP+
Sbjct: 111 LHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPE 165

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
                      D +  GVV+ E++ GR
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 38/221 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK       + +A+K++    +  GV    +RE S     L    H N+V+
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS----LLKEMQHGNIVR 65

Query: 153 L--IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQY 207
           L  + +    ++RL LV+EY+ L  L KH+ D  PD      N R+         RG+ Y
Sbjct: 66  LQDVVHS---EKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYLYQILRGIAY 117

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
            H      V++RDLK  N+L++   +  KL+DFGLA+    G      T  + T  Y AP
Sbjct: 118 CHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAP 172

Query: 267 DYAMTGQLTFKS--DIYSFGVVLLELIT------GRKAIDQ 299
           +  + G   + +  DI+S G +  E++       G   ID+
Sbjct: 173 E-ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212

Length = 294

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 39/225 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVK--- 152
           +G+G +G+V         +   IK+L+ R     RE  A   E   L    HPN+V    
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 153 -----------LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201
                      ++G+C  GD    +Y       L +    L P+ + ++W  ++ +A   
Sbjct: 67  SWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA--- 114

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
              LQYLHE+    +++RDLK  N+ L      K+ D G+A++  +  +  +++ ++GT 
Sbjct: 115 ---LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTP 166

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            Y +P+        +KSD+++ G  + E+ T + A +  KD   L
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSA---EVMTLGSAD 146
           N+R    LG G FG+VY        + +A+KQ+  D    +  +E +A   E+  L +  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 147 HPNLVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
           H  +V+  G   + +++ L    EYMP GS+   L      T     N   +      +G
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE----NVTRRYTRQILQG 118

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK------MGPSGDKTHVSTRVM 258
           + YLH  +   +++RD+K +NIL +   + KL DFG +K      M  +G K+     V 
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           GT  + +P+         K+D++S    ++E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 22/231 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +  +++ AIK L    V     V     E   L  +  P  +  + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            C +   RL  V EY+  G L   +  +     P      +  AA  + GL +LH +   
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSK--- 120

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQ 273
            +IYRDLK  N++L+   H K++DFG+ K         V+T+   GT  Y AP+      
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177

Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL------NLVAWARPMFKD 318
                D ++FGV+L E++ G+   +  +D  EL      + VA+ + M K+
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEHNVAYPKSMSKE 227

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQV---VAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           +GEG  G V   C+ + +     VA+K +D R  Q       EV+ +    H N+V++  
Sbjct: 29  IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
               G++  ++ E++  G+L   +   R     L+      +     + L YLH Q    
Sbjct: 86  SYLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLHSQ---G 137

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           VI+RD+K  +ILL      KLSDFG  A++     K      ++GT  + AP+       
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRTPY 194

Query: 275 TFKSDIYSFGVVLLELITG 293
             + DI+S G++++E++ G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 4e-10
 Identities = 61/223 (27%), Positives = 93/223 (41%), Gaps = 53/223 (23%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G +G V     ++  + VAIK++    D   +   R    E+  L    H N++ L+
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDL-IDAKRILR-EIKLLRHLRHENIIGLL 65

Query: 155 G-------------YCAEGDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRMK-IA 198
                         Y        +V E M   L  + K    L  D         ++   
Sbjct: 66  DILRPPSPEDFNDVY--------IVTELMETDLHKVIKSPQPLTDD--------HIQYFL 109

Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKT-----H 252
               RGL+YLH      VI+RDLK SNIL+      K+ DFGLA+ + P  D+      +
Sbjct: 110 YQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
           V TR      Y AP+  ++     K+ DI+S G +  EL+T +
Sbjct: 167 VVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-----EFSAEVMTLGSADHPNLVKL 153
           LG+G FG VY    +K      +K L    V  +      + + E   L   DHP +VK 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQY 207
                E D   ++ EY     LD  L +L+       + +  +W  ++ +      G+ Y
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           +H+   + +++RDLK  NI L+     K+ DFG+++  MG S D   ++T   GT  Y +
Sbjct: 122 MHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCD---LATTFTGTPYYMS 173

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLEL 290
           P+         KSDI+S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 47/229 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD----HRGVQGVRE--------FSA--EVMTLGS 144
           LGEG +GKV K       ++VAIK++        V   R+        F+   E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK------IA 198
             H N++ L+    EGD   LV + M          DL+   + +D   R+       I 
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA--------SDLK---KVVDRKIRLTESQVKCIL 125

Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-------MGP-SGDK 250
                GL  LH   K   ++RDL  +NI +      K++DFGLA+           S D+
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 251 THVSTRVMG----TYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGR 294
           T      M     T  Y AP+  M   +  F  D++S G +  EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.1 bits (143), Expect = 9e-10
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK----QLDHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +GKVYK   +   ++VA+K    ++D  G+    +RE S   M    ++   +V+
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML---SESIYIVR 65

Query: 153 LIGYCAE------GDQRL-LVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASR 203
           L+    E      G   L LV+EY  L S  K   D   R   RPL   T         +
Sbjct: 66  LL--DVEHVEEKNGKPSLYLVFEY--LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMG--PSGDKTHVSTRVMGT 260
           G+ + H   K  V++RDLK  N+L++ +    K++D GL +    P    TH     + T
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVT 174

Query: 261 YGYCAPDYAMTGQLTFKS--DIYSFGVVLLELITG 293
             Y AP+  + G   + +  DI+S G +  E+   
Sbjct: 175 LWYRAPE-VLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 52/195 (26%), Positives = 88/195 (45%), Gaps = 18/195 (9%)

Query: 107 VYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL- 164
           +YKG     E ++   +  H+G +  +     E+  L   D  N++K+ G+  +    L 
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 165 ---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL 221
              L+ EY   G L + L       + L + T++ +A    +GL  L++   +P  Y++L
Sbjct: 96  RLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 222 KCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSD 279
              + L+ E Y  K+   GL K+  S    +V+  V     Y +         + T K D
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDD 204

Query: 280 IYSFGVVLLELITGR 294
           IYS GVVL E+ TG+
Sbjct: 205 IYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 57/185 (30%), Positives = 85/185 (45%), Gaps = 16/185 (8%)

Query: 148 PNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA-SRGL 205
           P LV L  Y  + D +L L+ +Y+  G L  HL       R       ++I +G     L
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYINGGELFTHL-----SQRERFKEQEVQIYSGEIVLAL 118

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           ++LH   K  +IYRD+K  NILL+   H  L+DFGL+K     D+   +    GT  Y A
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMA 174

Query: 266 PDYAMTGQLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
           PD    G        D +S GV++ EL+TG      T D ++ +    +R + K    + 
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--TVDGEKNSQAEISRRILKSEPPYP 232

Query: 324 QMVDP 328
           Q +  
Sbjct: 233 QEMSA 237

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 57.6 bits (139), Expect = 5e-09
 Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 25/219 (11%)

Query: 96  DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKL 153
              LG G  G V         +  A+K +D  G+         AEV  L + D  ++VK 
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 154 IGYCAEGDQR--------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
               A+ D R         LV +Y   G L + +       R                GL
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---------REHEAGL 147

Query: 206 QYL------HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
            ++      H    + +I+RD+K +NILL      KL DFG +KM  +     V     G
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
           T  Y AP+       + K+D++S GV+L EL+T ++  D
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 50/288 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-------EQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPN 149
           LG+G F K++KG   ++       +  V +K LD  HR        +A +M+  S  H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS--HKH 60

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           LV   G C  GD+ ++V EY+  GSLD +L     +   + W  ++++A   +  L +L 
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLE 117

Query: 210 EQLKQPVIYRDLKCSNILL--EE----GYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTY 261
           +   + + + ++   N+LL  EE    G  P  KLSD G++       K  +  R+    
Sbjct: 118 D---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVP 172

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLVAWARPMFKDRK 320
             C  +      L+  +D +SFG  L E+ +G  K +     +K+L         ++DR 
Sbjct: 173 PECIEN---PQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YEDRH 222

Query: 321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
                       Q P     +   +   C+  +P+ RP+   ++  LN
Sbjct: 223 ------------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 10/165 (6%)

Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
           E M L + +HP+++++      G    +V   +P  S D + + L   +RPL  +  + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-LTKRSRPLPIDQALII 162

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                 GL+YLH Q    +I+RD+K  NI + +     + D G A+  P      +   +
Sbjct: 163 EKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--L 216

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302
            GT    AP+     +   K+DI+S G+VL E++     I +   
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261

Length = 357

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 33/213 (15%)

Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           G +G VY    ++  Q  A+K+++ + +     +++   E   L  A++P +V +  +C+
Sbjct: 12  GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM--FCS 69

Query: 159 -EGDQRL-LVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            E  + L +V EY+  G   +L K++  L     P+D   RM  A      L+YLH    
Sbjct: 70  FETKRHLCMVMEYVEGGDCATLLKNIGAL-----PVDM-ARMYFAE-TVLALEYLH---N 119

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-------STR------VMGT 260
             +++RDLK  N+L+    H KL+DFGL+K+G     T++        TR      V GT
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  +        D ++ G++L E + G
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 65/267 (24%), Positives = 129/267 (48%), Gaps = 36/267 (13%)

Query: 56  GQLSMDVKNLNLKDDSNNS-----GKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKG 110
           G+  M+ K L+ ++ S+N+         K    D   +   +++    +G G FG VY+ 
Sbjct: 26  GKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEA 85

Query: 111 -CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY----CAEGDQRLL 165
            C++  E+ VAIK++    +Q  +  + E++ + + +H N++ L  Y    C + +++ +
Sbjct: 86  ICIDTSEK-VAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140

Query: 166 ----VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL 221
               V E++P  ++ K++     +   L        +    R L Y+H +    + +RDL
Sbjct: 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDL 196

Query: 222 KCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS-- 278
           K  N+L++   H  KL DFG AK   +G +   S   + +  Y AP+  M G   + +  
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPEL-MLGATNYTTHI 252

Query: 279 DIYSFGVVLLELI------TGRKAIDQ 299
           D++S G ++ E+I      +G+ ++DQ
Sbjct: 253 DLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Length = 440

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 31/98 (31%), Positives = 54/98 (55%), Gaps = 7/98 (7%)

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGT 260
           RGL+Y+H      VI+RDLK SN+L+ E    ++ DFG+A+       +  +  T  + T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 261 YGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAI 297
             Y AP+  ++  + T   D++S G +  E++ GR+ +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 46/146 (31%), Positives = 66/146 (45%), Gaps = 10/146 (6%)

Query: 102 GGFGKVY---KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           G FGKVY   K    K+  V  +K+ D      V +  AE   L  +  P +V L     
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   LV EY+  G +   LH         D    +K  +  +  L YLH   +  +I+
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLH---RHGIIH 127

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKM 244
           RDLK  N+L+    H KL+DFGL+K+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 3/177 (1%)

Query: 137 AEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK 196
           +E+  L + DH  +VK        D+ LL+ EY   G L+K +     +  P       +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ---EYE 170

Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
           +     + +  L E   + +++RDLK +NI L      KL DFG +K         V++ 
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230

Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR 313
             GT  Y AP+     + + K+D++S GV+L EL+T  +       R+ +  V + +
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287

Length = 478

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 22/205 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V     +  +QV A+K L    +    +   F  E   +  A+   +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL-- 108

Query: 156 YCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           + A  D + L  V EYMP G L   + +      P  W  R   A      L  +H    
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI---PEKW-ARFYTAE-VVLALDAIH---S 160

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT- 271
              I+RD+K  N+LL++  H KL+DFG   KM  +G      T V GT  Y +P+   + 
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQ 218

Query: 272 ---GQLTFKSDIYSFGVVLLELITG 293
              G    + D +S GV L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 30/234 (12%)

Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL---HDLRPDTRPLDWNTRMKIAAGASR 203
           HPN+++ +G C E    LLV+EY  LG L  +L      R +++ L      ++A   + 
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAA 110

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ ++H   K   ++ DL   N  L      K+ D+G+       D             +
Sbjct: 111 GVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167

Query: 264 CAP-------DYAMTGQLTFKSDIYSFGVVLLELI-TGRKAIDQTKDRKELNLVAWARPM 315
            AP          +T + T  S++++ GV L EL     +      DR+ LN V      
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------ 221

Query: 316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
            KD++   ++  P L+  Y  R  Y+ L    +     P  R    +V   L Y
Sbjct: 222 IKDQQ--VKLFKPQLELPYSER-WYEVLQFCWL----SPEKRATAEEVHRLLTY 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 10/198 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL-DHRGVQGVREFS-AEVMTLGSADHPNLVKLIGY 156
           +GEG +G V K   ++ +++VAIK+  D    + V+E +  E+  L +    N+V+L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                +  LV+EY+    L+  L +  P+  P +     K+ +   + ++ +H   K  +
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHKNDI 121

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RD+K  N+L+      KL DFG A+    G   +  T  + T  Y +P+  +      
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAPYGK 180

Query: 277 KSDIYSFGVVLLELITGR 294
             D++S G +L EL  G+
Sbjct: 181 AVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
            +G G +G V      +  + VAIK++    D+R +   R    E+  L   DH N++ +
Sbjct: 12  PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLR-EIKLLRHLDHENVIAI 69

Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
                    R       +VYE M     D  LH +   ++ L  +          RGL+Y
Sbjct: 70  KD-IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           +H      V++RDLK SN+LL      K+ DFGLA+   + +K    T  + T  Y AP+
Sbjct: 124 IHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178

Query: 268 YAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKD 302
             +   + T   D++S G +  EL+ GRK +   KD
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKD 213

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 65/269 (24%), Positives = 113/269 (42%), Gaps = 36/269 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G  G V+       ++ VA+K++     Q V+    E+  +   DH N+VK+     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 159 EGDQRL--------------LVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGAS 202
                L              +V EYM          DL    +  PL             
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET--------DLANVLEQGPLSEEHARLFMYQLL 124

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK-MGPS-GDKTHVSTRVMG 259
           RGL+Y+H      V++RDLK +N+ +  E    K+ DFGLA+ + P    K ++S  ++ 
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 260 TYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
            + Y +P   ++    T   D+++ G +  E++TG+       + +++ L+  + P+ ++
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 319 R-KNFSQMVDPSL---QGQYPVRGLYQAL 343
             +N    V PS     G  P R L   L
Sbjct: 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLL 269

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 63/258 (24%), Positives = 97/258 (37%), Gaps = 52/258 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V          + A+K L    V          AE   L  AD+  +VKL  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              + D    V +Y+P G +   L  +R      D   R  IA      ++ +H   K  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDL-ARFYIAELTC-AIESVH---KMG 121

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA---------------------KMGPSGDKTHVS 254
            I+RD+K  NIL++   H KL+DFGL                       M PS + + + 
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 255 TRVM--------------------GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
              +                    GT  Y AP+  +    T   D +S GV+L E++ G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 295 KA-IDQTKDRKELNLVAW 311
              +  T    +L ++ W
Sbjct: 242 PPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 47/241 (19%)

Query: 99  LGEGGFGKVY----KGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN 149
           +G+GG G+VY      C     L+KI + ++   L  +       F  E        HP 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK------RFLREAKIAADLIHPG 63

Query: 150 LVKLIGYCAEGDQRLLVYEYMP------LGSLDKHLHDLRPDTRPLDWNTRMK----IAA 199
           +V +   C++GD    VY  MP      L SL K +      ++ L   T +     I  
Sbjct: 64  IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-------------GP 246
                ++Y+H +    V++RDLK  NILL       + D+G A                 
Sbjct: 121 KICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 247 SGDKTHVST---RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
                   T   +++GT  Y AP+  +    +  +DIY+ GV+L +++T      + K R
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Query: 304 K 304
           K
Sbjct: 238 K 238

Length = 932

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 37/108 (34%), Positives = 55/108 (50%), Gaps = 9/108 (8%)

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182

Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +         DI+S G ++ EL+TGR     T    +L L+
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 14/196 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G +G VYK       ++ A+K +             E+  +    H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             ++  +  EY   GSL     D+   T PL       +     +GL YLH + K   ++
Sbjct: 77  SREKLWICMEYCGGGSL----QDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129

Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQL 274
           RD+K +NILL +    KL+DFG+ AK+  +  K       +GT  + AP+ A     G  
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 275 TFKSDIYSFGVVLLEL 290
               DI++ G+  +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 70/262 (26%), Positives = 107/262 (40%), Gaps = 56/262 (21%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG G FG+V   C      + A+K L  + V     V    AE   L  AD+  +VKL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              + D    V +Y+P G +   L  +R +  P +   R  IA   +  ++ +H   K  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLL--IRMEVFP-EVLARFYIAE-LTLAIESVH---KMG 121

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLA---------------------KMGPS------- 247
            I+RD+K  NIL++   H KL+DFGL                       M PS       
Sbjct: 122 FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 248 ----GD----------KTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
               GD          K H   ++  ++GT  Y AP+  +    T   D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 291 ITGRKA-IDQTKDRKELNLVAW 311
           + G+   +  T    +L ++ W
Sbjct: 242 LVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 92  NFRSDCCLGEGGFGKVY---------KG------CLEKIEQVVAIKQLDH-RGVQGVREF 135
           NF     LG G +GKV+          G       L+K   V   K ++H R  + V E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTR 194
             +         P LV L  Y  + + +L L+ +Y+  G +  HL+      R       
Sbjct: 61  VRQS--------PFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQ-----RDNFSEDE 106

Query: 195 MKIAAGAS-RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253
           ++  +G     L++LH   K  ++YRD+K  NILL+   H  L+DFGL+K   S +K   
Sbjct: 107 VRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163

Query: 254 STRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITG 293
            +   GT  Y AP+         K+ D +S G+++ EL+TG
Sbjct: 164 YS-FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 19/210 (9%)

Query: 97  CCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           C +G G +G VYK   +  K E+  A+KQ++  G+        E+  L    HPN++ L 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQ 64

Query: 155 G-YCAEGDQRL-LVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQYL 208
             + +  D+++ L+++Y    L  + K     + + +P+     M   +      G+ YL
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 209 HEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTR-VMGTYGY 263
           H      V++RDLK +NIL+     E    K++D G A++  S  K       V+ T+ Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 264 CAPDYAMTGQLTFKS-DIYSFGVVLLELIT 292
            AP+  +  +   K+ DI++ G +  EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPN 149
           + S   +G G +G V     ++  + VAIK+L  R  Q     +    E+  L    H N
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 150 LVKLIGY---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           ++ L+        GD+    Y  MP    D  L  +     PL  +    +      GL+
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM--GHPLSEDKVQYLVYQMLCGLK 131

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           Y+H      +I+RDLK  N+ + E    K+ DFGLA+   +    +V TR      Y AP
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAP 183

Query: 267 DYAMTGQLTFKS-DIYSFGVVLLELITGR 294
           +  +      ++ DI+S G ++ E++TG+
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 32/93 (34%), Positives = 51/93 (54%), Gaps = 5/93 (5%)

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+YLH      +++RD+K  N+L+      K+ DFGLA++    +  H++  V+  Y 
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 263 YCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGR 294
           Y AP+  M  +  T   DI+S G +  EL+  R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 9/104 (8%)

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS---TRVMG 259
            GL+Y+H      V++RDLK  N+L+      K+ DFGLA+ G S +    +   T  + 
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVA 171

Query: 260 TYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
           T  Y AP+  ++ Q   K+ D++S G +L EL+ GRK + + KD
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKD 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 18/206 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V     +    + A+K +    +   + V  F  E   L  ++ P + +L  
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              + D   LV EY P G L   L  L       D +      A     +  +H+     
Sbjct: 69  AFQDKDNLYLVMEYQPGGDL---LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---G 122

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--- 271
            ++RD+K  N+L++   H KL+DFG  A++  + +K   S   +GT  Y AP+   T   
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 272 ---GQLTFKSDIYSFGVVLLELITGR 294
              G    + D +S GV+  E+I GR
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 58/240 (24%)

Query: 99  LGEGGFGKVYKGCLEKIE-QVVAIKQLD-----HRG-VQGVREFSAEVMTLGSADHPNLV 151
           +G G FG+V +   +K    + A+K+L       +  V  VR   AE   L  AD+P +V
Sbjct: 9   IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR---AERDILAEADNPWVV 64

Query: 152 KLIGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           KL  Y +  D+    L+ EY+P G +   L  ++ DT   +  TR  IA      +  +H
Sbjct: 65  KL--YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEE-ETRFYIAETI-LAIDSIH 118

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL------------------AKMGPSGD-- 249
            +L    I+RD+K  N+LL+   H KLSDFGL                  A      D  
Sbjct: 119 -KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 250 -KTHVSTR---------------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            K   S R                +GT  Y AP+  +      + D +S GV++ E++ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G +G V      +    VAIK+L +R  Q     +    E+  L    H N++ L+ 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81

Query: 156 YCAEG---DQRLLVYEYMP-----LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
                   D+    Y  MP     LG L KH          L  +    +     +GL+Y
Sbjct: 82  VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKY 133

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           +H      +I+RDLK  N+ + E    K+ DFGLA+   S    +V TR      Y AP+
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPE 185

Query: 268 YAMTG-QLTFKSDIYSFGVVLLELITGR 294
             +     T   DI+S G ++ E++TG+
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 27/217 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV---REFSAEVMTLGSADHPNLVKLIG 155
           +G G +G V      ++ Q VA+K+L  R  Q +   R    E+  L    H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 156 Y---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
                   +    VY    L   D  L+++    +  D + +  I     RGL+Y+H   
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGAD--LNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIHSA- 137

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +I+RDLK SN+ + E    ++ DFGLA+        +V+TR      Y AP+  M  
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE-IMLN 189

Query: 273 QLTFKS--DIYSFGVVLLELITGR------KAIDQTK 301
            + +    DI+S G ++ EL+ G+        IDQ K
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V     +  ++V A+K L    +    +   F  E   +  A+ P +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108

Query: 156 YCAEGDQRLL--VYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           +CA  D + L  V EYMP G L   + +   P+     +   + +A  A   +  +H   
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
                 RD+K  N+LL++  H KL+DFG   KM  +G      T V GT  Y +P+   +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLKS 217

Query: 272 ----GQLTFKSDIYSFGVVLLELITG 293
               G    + D +S GV L E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 50/239 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRG--VQGVREFSAEVMTLGSADHPNLVK 152
           +G+G FG+V+K   +K +Q+VA+K++    +  G  +  +RE    +  L    H N+V 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLKHENVVN 75

Query: 153 LIGYC---AEGDQR-----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR- 203
           LI  C   A    R      LV+E+          HDL      L  N  +K      + 
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAG----LLSNKNVKFTLSEIKK 123

Query: 204 -------GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHV 253
                  GL Y+H   +  +++RD+K +NIL+ +    KL+DFGLA+   +  +      
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 254 STRVMGTYGYCAPDYAMTGQLTF--KSDIYSFGVVLLELITGRKAIDQ-TKDRKELNLV 309
           + RV+ T  Y  P+  + G+  +    D++  G ++ E+ T R  I Q   ++ +L L+
Sbjct: 181 TNRVV-TLWYRPPEL-LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLI 236

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 65/250 (26%), Positives = 105/250 (42%), Gaps = 47/250 (18%)

Query: 62  VKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKV----YKG------C 111
           +KNL L     +S  + +P   +++     NF     LG G FG+V    YK        
Sbjct: 4   LKNLQL-HKKKDSDSTKEPKRKNKMKYEDFNFIR--TLGTGSFGRVILATYKNEDFPPVA 60

Query: 112 LEKIEQ--VVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169
           +++ E+  ++  KQ+DH          +E   L   +HP  V L G   +     LV E+
Sbjct: 61  IKRFEKSKIIKQKQVDH--------VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112

Query: 170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ--YLHEQLKQ-PVIYRDLKCSNI 226
           +  G     L            N R     G     Q   + E L+   ++YRDLK  N+
Sbjct: 113 VIGGEFFTFLRR----------NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162

Query: 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQLTFKSDIYSF 283
           LL++    K++DFG AK+        V TR   + GT  Y AP+  +       +D ++ 
Sbjct: 163 LLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTL 214

Query: 284 GVVLLELITG 293
           G+ + E++ G
Sbjct: 215 GIFIYEILVG 224

Length = 340

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 19/210 (9%)

Query: 97  CCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           C +G G +G VYK   +  K ++  A+KQ++  G+        E+  L    HPN++ L 
Sbjct: 7   CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQ 64

Query: 155 G-YCAEGDQRL-LVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQYL 208
             + +  D+++ L+++Y    L  + K     + + +P+     M   +      G+ YL
Sbjct: 65  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 209 HEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTR-VMGTYGY 263
           H      V++RDLK +NIL+     E    K++D G A++  S  K       V+ T+ Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 264 CAPDYAMTGQLTFKS-DIYSFGVVLLELIT 292
            AP+  +  +   K+ DI++ G +  EL+T
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 24/179 (13%)

Query: 183 RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
             D+ PLD +  ++ ++  ++G+ +L     +  I+RD+   N+LL +G   K+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 243 K--MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
           +  M  S      + R+     + AP+       T +SD++S+G++L E+ +  K+    
Sbjct: 260 RDIMNDSNYVVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS---- 313

Query: 301 KDRKELNLVAWARP-MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP 358
                        P +  + K F +MV    Q   P     +  +I  MC   +P  RP
Sbjct: 314 -----------PYPGILVNSK-FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 30/246 (12%)

Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-----RGVQGVREFSAE 138
           +++  +T  F+    LGEG FGKV +    K ++  A+K + +     R  +   +F  +
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181

Query: 139 VMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTR 194
           V     AD   L+K+  Y     G   +++ +Y P  L  + KH         P      
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH--------GPFSHRHL 233

Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-----------YHPKLSDFGLAK 243
            +I       L Y H +L   +++ DLK  NIL+E               P      +  
Sbjct: 234 AQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           +G   D+ H  T ++ T  Y +P+  +     + +D++S G ++ EL TG+   D   + 
Sbjct: 292 LGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351

Query: 304 KELNLV 309
           + L+L+
Sbjct: 352 EHLHLM 357

Length = 467

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 48/172 (27%), Positives = 74/172 (43%), Gaps = 24/172 (13%)

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRVM 258
           +RG+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V   S R+ 
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL- 238

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
               + AP+       T +SD++SFGV+L E+ +               L A   P  + 
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------------LGASPYPGVQI 282

Query: 319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
            + F Q +    + + P     +   I   C Q  P  RP  + +V  L  L
Sbjct: 283 NEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 69/265 (26%), Positives = 110/265 (41%), Gaps = 62/265 (23%)

Query: 99  LGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+V   CL +    + + A+K L  + V     V    AE   L  AD+  +V+
Sbjct: 9   LGIGAFGEV---CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L     + D    V +Y+P G +   L  +R    P D   R  IA   +  ++ +H   
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLL--IRMGIFPEDL-ARFYIAE-LTCAVESVH--- 118

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL---------AKMGPSGD-------------- 249
           K   I+RD+K  NIL++   H KL+DFGL         +K   SGD              
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 250 -------------------KTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
                              + H   ++  ++GT  Y AP+  +    T   D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 288 LELITGRKA-IDQTKDRKELNLVAW 311
            E++ G+   + QT    ++ ++ W
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 35/219 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-------REFSAEVMTLGSADHPNLV 151
           +G G  G V         Q VAIK+L  R  Q V       RE    +M L   +H N++
Sbjct: 24  IGSGAQGIVCAAYDTVTGQNVAIKKLS-RPFQNVTHAKRAYREL--VLMKL--VNHKNII 78

Query: 152 KLIGYCAEGDQRLL-----VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            L+       Q+ L     VY  M L  +D +L  +      LD      +      G++
Sbjct: 79  GLLN--VFTPQKSLEEFQDVYLVMEL--MDANLCQVI--QMDLDHERMSYLLYQMLCGIK 132

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           +LH      +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y AP
Sbjct: 133 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-YRAP 186

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
           +  +        DI+S G ++ E+I       G   IDQ
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V    L+  ++V A+K L+   +    E   F  E   L + D+   +  + 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLH 67

Query: 156 YCAEGDQRL-LVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           Y  + +  L LV +Y   G   +L     D  P+     +   M IA  +   L Y+H  
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH-- 125

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY--A 269
                  RD+K  NIL++   H +L+DFG + +    D T  S+  +GT  Y +P+   A
Sbjct: 126 -------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 270 M---TGQLTFKSDIYSFGVVLLELITG 293
           M    G+   + D +S GV + E++ G
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS-TRVMGTY 261
           R L+Y+H      V +RDLK  NIL       K+ DFGLA++  +   T +  T  + T 
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 262 GYCAPDY--AMTGQLTFKSDIYSFGVVLLELITGR 294
            Y AP+   +   + T   DI+S G +  E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 53/165 (32%), Positives = 82/165 (49%), Gaps = 32/165 (19%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE--QVVAIK-----------QLDHRGVQGVREFSAE 138
           +F +   +G+G FG+V    ++K +  ++ A+K           QL H     V+   AE
Sbjct: 2   DFHTVKVIGKGAFGEVR--LVQKKDTGKIYAMKTLLKSEMFKKDQLAH-----VK---AE 51

Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
              L  +D P +V L  Y  +  Q L L+ E++P G L   L  ++ DT   D  TR  +
Sbjct: 52  RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML--IKYDTFSEDV-TRFYM 107

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
           A      ++ +H   K   I+RD+K  NIL++ G H KLSDFGL+
Sbjct: 108 AE-CVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 52/276 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIG 155
           +G G FG+V+    ++ ++    K + +RG++  RE S    EV  +    H N+V+ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYID 79

Query: 156 -YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            +  + +Q+L ++ E+   G L +++         ++ +  + I       L Y H    
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139

Query: 214 QP----VIYRDLKCSNILLEEGYH-----------------PKLSDFGLAKMGPSGDKTH 252
            P    V++RDLK  NI L  G                    K+ DFGL+K        H
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH 199

Query: 253 VSTRVMGTYGYCAPDYAM--TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
                +GT  Y +P+  +  T     KSD+++ G ++ EL +G+                
Sbjct: 200 ---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-------------- 242

Query: 311 WARPMFKDRKNFSQMVDPSLQG-QYPVRGLYQALAI 345
                F    NFSQ++    +G   P++G  + L I
Sbjct: 243 -----FHKANNFSQLISELKRGPDLPIKGKSKELNI 273

Length = 1021

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 42/174 (24%)

Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYE---YMPLGSLDKHLH------DLRPDTRP 188
           E++ LG  +H N++K+        + +L  E   YM     D  L+            RP
Sbjct: 213 EILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRP 264

Query: 189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA------ 242
           L   TR  I       ++Y+H++    +I+RD+K  NI L       L DFG A      
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 243 ----KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                 G  G     S  ++   GYC        ++T   DI+S G++LL++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYC--------EIT---DIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 16/168 (9%)

Query: 127 RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-- 184
           + V G +    E+  L +  H  ++ LI          +V   MP     K+  DL    
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MP-----KYKCDLFTYV 176

Query: 185 -DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA- 242
             + PL     + I       L YLH +    +I+RD+K  NI L+E  +  L DFG A 
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAAC 233

Query: 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
           K+    D         GT    +P+         K+DI+S G+VL E+
Sbjct: 234 KLDAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V    ++  E++ A+K L+   +    E   F  E   L + D    +  + 
Sbjct: 9   IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLH 67

Query: 156 YCAEGDQRL-LVYEYMPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           Y  + +  L LV +Y   G   +L     D  P+     +   M +A  +   L Y+H  
Sbjct: 68  YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH-- 125

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHVSTRVMGTYGYCAPDY-- 268
                  RD+K  N+LL+   H +L+DFG   KM   G  T  S+  +GT  Y +P+   
Sbjct: 126 -------RDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISPEILQ 176

Query: 269 AM---TGQLTFKSDIYSFGVVLLELITG 293
           AM    G+   + D +S GV + E++ G
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 3/111 (2%)

Query: 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
           L  D   LD    +  +   ++G+ +L     +  I+RDL   NILL  G   K+ DFGL
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 260

Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           A+   +     V         + AP+       TF+SD++S+G++L E+ +
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 22/205 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V     +   +V A+K L    +    +   F  E   +  A+ P +V+L  
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           Y  + D+ L +V EYMP G L   + +   P+     +   + +A  A   + ++H    
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---- 165

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT- 271
                RD+K  N+LL++  H KL+DFG   KM   G      T V GT  Y +P+   + 
Sbjct: 166 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAV-GTPDYISPEVLKSQ 218

Query: 272 ---GQLTFKSDIYSFGVVLLELITG 293
              G    + D +S GV L E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 50/194 (25%), Positives = 76/194 (39%), Gaps = 28/194 (14%)

Query: 111 CLE-KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY 169
           C++ K  + V IK     G       + E   L + +HP++++L G           Y  
Sbjct: 111 CIDNKTCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKG--------TFTYNK 156

Query: 170 MPLGSLDKHLHDLR---PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226
                L ++  DL       R +     + I     R +QYLHE     +I+RD+K  NI
Sbjct: 157 FTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENI 213

Query: 227 LLEEGYHPK---LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSF 283
            +    HP    L DFG A   P     +      GT    AP+           DI+S 
Sbjct: 214 FIN---HPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSA 269

Query: 284 GVVLLELITGRKAI 297
           G+VL E+ T   ++
Sbjct: 270 GIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 34/131 (25%), Positives = 59/131 (45%), Gaps = 15/131 (11%)

Query: 167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226
           Y+      +   L D    +  L     +      +RG+++L     +  ++RDL   N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268

Query: 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM--GTY---GYCAPDYAMTGQLTFKSDIY 281
           LL +G   K+ DFGLA+     D  H S  V    T+    + AP+       T  SD++
Sbjct: 269 LLAQGKIVKICDFGLAR-----DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323

Query: 282 SFGVVLLELIT 292
           S+G++L E+ +
Sbjct: 324 SYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 40/261 (15%)

Query: 116 EQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG 173
           E  V +K LD  HR +      +A +M+  S  H +L  + G C  G + ++V E++  G
Sbjct: 44  ELRVVLKVLDPSHRDIALAFFETASLMSQVS--HIHLAFVHGVCVRGSENIMVEEFVEHG 101

Query: 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL-----L 228
            LD  L   +    P+ W  ++ +A   +  L YL +   + +++ ++   NIL     L
Sbjct: 102 PLDVCLRKEKGRV-PVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155

Query: 229 EEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVV 286
            EG  P  KLSD G++    S ++     R+      C P       L+  +D +SFG  
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREER--VERIPWIAPECVPG---GNSLSTAADKWSFGTT 210

Query: 287 LLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIA 346
           LLE+    +   + +   E       +  F ++K+  ++ +PS +         +   + 
Sbjct: 211 LLEICFDGEVPLKERTPSE-------KERFYEKKH--RLPEPSCK---------ELATLI 252

Query: 347 AMCVQEQPNMRPAITDVVMAL 367
           + C+  +P  RP+   ++  L
Sbjct: 253 SQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 50/168 (29%), Positives = 68/168 (40%), Gaps = 38/168 (22%)

Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD--TRPLDWNTRMKIAAGASRG 204
           HPN++        G    ++  +M  GS +  L    P+  +  L  N    I  GA RG
Sbjct: 58  HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRG 113

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHV-------STR 256
           L YLH+      I+R++K S+IL+       LS    L  +  +G K  V       ST 
Sbjct: 114 LNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS 170

Query: 257 VM----------GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           V+            YGY             KSDIYS G+   EL TGR
Sbjct: 171 VLPWLSPELLRQDLYGY-----------NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 12/102 (11%)

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 191

Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT------GRKAIDQ 299
            AP+  +        DI+S G ++ E+I       G   IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 48/183 (26%), Positives = 74/183 (40%), Gaps = 46/183 (25%)

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGP----SGDKTHVS 254
           +RG+++L  +     I+RDL   NILL E    K+ DFGLA+     P     GD   + 
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD-ARLP 238

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP 314
            + M      AP+       T +SD++SFGV+L E+ +               L A   P
Sbjct: 239 LKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS---------------LGASPYP 277

Query: 315 MFKDRKNFSQ-------MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
             +  + F +       M  P    +Y    +Y  +     C    P  RP  +++V  L
Sbjct: 278 GVQIDEEFCRRLKEGTRMRAP----EYATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Query: 368 NYL 370
             L
Sbjct: 331 GDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 43/238 (18%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHP 148
           +F S   +G G FG+V     +    + A+K L   D    + V    AE   L  AD  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
            +VK+     +     L+ E++P G +   L  ++ DT   +  T+  IA      +  +
Sbjct: 62  WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL--MKKDTLS-EEATQFYIAE-TVLAIDAI 117

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---------------KMGPSGD---- 249
           H QL    I+RD+K  N+LL+   H KLSDFGL                   P  D    
Sbjct: 118 H-QLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 250 --------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
                         +  ++   +GT  Y AP+  M        D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +     + T  + T  Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188

Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 12/102 (11%)

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 184

Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 61/238 (25%), Positives = 94/238 (39%), Gaps = 43/238 (18%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHP 148
           +F S   +G G FG+V     +    V A+K L   D    + V    AE   L  AD  
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
            +VK+     +     L+ E++P G +   L  ++ DT   +  T+  IA      +  +
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLT-EEETQFYIAE-TVLAIDSI 117

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT----------------- 251
           H QL    I+RD+K  N+LL+   H KLSDFGL        +T                 
Sbjct: 118 H-QLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 252 ----------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
                            ++   +GT  Y AP+  M        D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 7/93 (7%)

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMG 259
           + G+++L     +  ++RDL   N+L+ EG   K+ DFGLA+  M  S   +  ST +  
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-- 303

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
              + AP+       T  SD++SFG++L E+ T
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 48/179 (26%), Positives = 77/179 (43%), Gaps = 38/179 (21%)

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRVM 258
           ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+ 
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
               + AP+       T +SD++SFGV+L E+ +               L A   P  K 
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVKI 287

Query: 319 RKNF-------SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
            + F       ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 288 DEEFCRRLKEGTRMRAP----DYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 47/216 (21%), Positives = 77/216 (35%), Gaps = 38/216 (17%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           C  +     + K   +    +VA+K+  LD    + ++    E++T     HPN++  + 
Sbjct: 9   CFEDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 156 YCAEGDQRLLVYEYMPLGS----LDKHLHDLRPDTRPLDWNTRMKIA---AGASRGLQYL 208
                 +  +V   M  GS    L  H  +  P+           IA         L Y+
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL---------AIAFILKDVLNALDYI 117

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV--------STRVMGT 260
           H    +  I+R +K S+ILL       LS    +       K           S + +  
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL-- 172

Query: 261 YGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITG 293
             + +P      + G    KSDIYS G+   EL  G
Sbjct: 173 -PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 8e-04
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 49/220 (22%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDH-----RG------------VQGVREFSAEVMT 141
           +G G FG+V    ++   QV A+K L+      R             V G R +   +  
Sbjct: 9   IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW---ITN 65

Query: 142 LGSA--DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA 199
           L  A  D  NL  ++ Y   GD   L      L   +  L    P+     +   M +A 
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL----PEDMARFYLAEMVLAI 115

Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHVSTRVM 258
            +   L Y+H         RD+K  N+LL++  H +L+DFG   ++   G  T  S   +
Sbjct: 116 DSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAV 164

Query: 259 GTYGYCAPDY--AM---TGQLTFKSDIYSFGVVLLELITG 293
           GT  Y +P+   AM    G+   + D +S GV + E++ G
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 37.8 bits (88), Expect = 0.003
 Identities = 35/150 (23%), Positives = 57/150 (38%), Gaps = 17/150 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYC 157
           L  G   +VY   L   ++   +K    R     RE    ++ L  A     V K++   
Sbjct: 6   LKGGLTNRVYL--LGTKDEDYVLKINPSREKGADREREVAILQL-LARKGLPVPKVLASG 62

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV- 216
                  L+ E++   +LD+   + + D          +  A     L  LH QL   V 
Sbjct: 63  ESDGWSYLLMEWIEGETLDEVSEEEKEDIA--------EQLAEL---LAKLH-QLPLLVL 110

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
            + DL   NIL+++G    + D+  A  GP
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 34/213 (15%)

Query: 99  LGEGGFGKVYKGCL------------EKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGS 144
           LG G   ++Y G L             + E  V +K LD  HR +  +  F    M +  
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDIS-LAFFETASM-MRQ 60

Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
             H ++V L G C    + ++V E++  G LD  +H     +  L    + K+A   +  
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASA 117

Query: 205 LQYLHEQLKQPVIYRDLKCSNILL-------EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           L YL +   + +++ ++   NILL       E G   KLSD G+     S  +     R+
Sbjct: 118 LSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS--RQECVERI 172

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
                 C  D   +  L+  +D +SFG  L E+
Sbjct: 173 PWIAPECVED---SKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	426
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.86
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
smart00090	237	RIO RIO-like kinase.	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.49
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.23
KOG3087	229	consensus Serine/threonine protein kinase [General	99.23
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.9
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.81
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.75
PRK09902	216	hypothetical protein; Provisional	98.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.37
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.32
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.32
PLN02876	822	acyl-CoA dehydrogenase	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.08
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.07
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.01
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.92
PRK10593	297	hypothetical protein; Provisional	97.89
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.84
PRK05231	319	homoserine kinase; Provisional	97.75
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.74
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.64
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.61
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.51
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.33
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.27
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.24
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.16
PLN02236	344	choline kinase	97.01
PLN02756	418	S-methyl-5-thioribose kinase	97.0
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.99
PRK12396	409	5-methylribose kinase; Reviewed	96.89
KOG2270	520	consensus Serine/threonine protein kinase involved	96.88
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.85
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.74
COG2334	331	Putative homoserine kinase type II (protein kinase	96.68
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.55
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.54
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.54
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.26
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.12
PRK11768	325	serine/threonine protein kinase; Provisional	96.08
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.92
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.7
PRK06148	1013	hypothetical protein; Provisional	95.61
PTZ00384	383	choline kinase; Provisional	95.43
PTZ00296	442	choline kinase; Provisional	95.34

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-56  Score=428.50  Aligned_cols=291  Identities=56%  Similarity=0.968  Sum_probs=254.5

Q ss_pred             CCCCcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeE
Q 014362           77 SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY  156 (426)
Q Consensus        77 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  156 (426)
                      ..+.|++.++..+|++|...+.||+|+||.||+|.... +..||||++........++|..|+.+|.+++|||+|+++||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            57789999999999999999999999999999999986 48999998876544314569999999999999999999999


Q ss_pred             EeeCC-eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCcee
Q 014362          157 CAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK  235 (426)
Q Consensus       157 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  235 (426)
                      |.+.. ..+||+|||++|+|.++|+.....  +++|..+++||.++|+||+|||..+.+.||||||||+|||||+++.+|
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            99988 599999999999999999874322  899999999999999999999998777899999999999999999999


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      |+|||+|+..+.. .....+...||.+|+|||++..+..+.++|||||||+|+||+||+.|.+...+.....++.|..+.
T Consensus       218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            9999999765431 222221117999999999999999999999999999999999999999876656666688888777


Q ss_pred             hhcccccccccCCccc-CCCCh-HhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          316 FKDRKNFSQMVDPSLQ-GQYPV-RGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      +... .+.+++|+.+. +.++. .....+..++.+|++.+|..||+|.+|++.|..+..
T Consensus       297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            7765 78999999987 66664 678889999999999999999999999999966544

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-53  Score=403.99  Aligned_cols=258  Identities=33%  Similarity=0.506  Sum_probs=216.4

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEE-EEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-eeEEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVYE  168 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e  168 (426)
                      +.+...||.|+||+||+|.|.  |.. ||||++......  ..+.|.+|+.+|.+++|||||+++|+|.++. .+++|||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            444555999999999999999  555 999999865322  2568999999999999999999999999988 7999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC-eEecCCCCCCeeeccCC-ceeEecccccccCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP-VIYRDLKCSNILLEEGY-HPKLSDFGLAKMGP  246 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  246 (426)
                      |+++|+|..+|+..  ....+++..++.++.||++||.|||+.   + ||||||||+||||+.++ ++||+|||+++...
T Consensus       121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~  195 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV  195 (362)
T ss_pred             eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence            99999999999874  357899999999999999999999998   6 99999999999999997 99999999998644


Q ss_pred             CCCCcceeeeecccccccCccccc--cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAM--TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ...  ...+...||+.|||||++.  ...|+.++|||||||++|||+||+.||...........+.              
T Consensus       196 ~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~--------------  259 (362)
T KOG0192|consen  196 ISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVV--------------  259 (362)
T ss_pred             ccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------------
Confidence            321  2233468999999999999  6699999999999999999999999998876522221111              


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                        ....+...|..+...+..|+.+||+.||..||++.+|+..|+.+.....
T Consensus       260 --~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  260 --VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             --hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence              1122333445567789999999999999999999999999999876444

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-53  Score=385.97  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-eeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~e~  169 (426)
                      +.+..+.||+|..|+||+++|+.+++.+|+|.+... .....+++.+|+++++..+||+||.+||+|..+. ..+|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            345566799999999999999999999999999543 3445678999999999999999999999999998 49999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      |++|||+.++..    .+.+++...-+++.+|++||.|||..  .+||||||||+|||++..|.|||||||.++..... 
T Consensus       160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999976    36799999999999999999999963  39999999999999999999999999999864332 


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCc--hhhhcHHHhhhhhhhcccccccccC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD--RKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                         ....++||..|||||.+.+..|+.++||||||++++|+++|+.||.....  ...+.++.             .+++
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-------------~Iv~  296 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-------------AIVD  296 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-------------HHhc
Confidence               34567899999999999999999999999999999999999999976411  11222221             1111


Q ss_pred             CcccCCCCh-HhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPV-RGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      . .....|. .++.++..|+..||++||.+||++.++++.
T Consensus       297 ~-ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  297 E-PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             C-CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1 1112233 377799999999999999999999999853

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-52  Score=400.96  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=220.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .+|...+.||+|||+.||.+++..+|+.||+|++.+..   ....+.+.+|+++.+.|.|||||+++++|++.++.|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            46899999999999999999999999999999998743   345677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |+|+.++|..+++.    .+++++.+++.++.||+.||.|||++   +|||||||..|+||+++.++||+|||||..+..
T Consensus        98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999985    57899999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ....  ....||||.|+|||++....++..+||||+|||||-|+.|++||+...-.+....+.....             
T Consensus       171 ~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y-------------  235 (592)
T KOG0575|consen  171 DGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY-------------  235 (592)
T ss_pred             cccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc-------------
Confidence            3322  3457999999999999999999999999999999999999999998776666555543221             


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                           ..|...+.++.+||..+|+.+|.+||++.+|+. -.++
T Consensus       236 -----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~-h~Ff  272 (592)
T KOG0575|consen  236 -----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD-HPFF  272 (592)
T ss_pred             -----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc-CHhh
Confidence                 123445568899999999999999999999994 3444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-52  Score=384.87  Aligned_cols=209  Identities=31%  Similarity=0.465  Sum_probs=188.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|.+.+.||.|+||+||+|+++.++..||||.+.+..  ....+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            467999999999999999999999999999999998773  445666889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC------CceeEecccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG------YHPKLSDFGL  241 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~------~~~kl~Dfgl  241 (426)
                      |||.||+|..+|+.    .+.+++..++.++.||+.||++||+.   +||||||||.||||+..      -.+||+|||+
T Consensus        89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999987    45799999999999999999999987   99999999999999865      4589999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL  308 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  308 (426)
                      |+....+   ......+|++.|||||++....|+.|+|+||+|+|||+|++|+.||+.....+.+..
T Consensus       162 AR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  162 ARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             hhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence            9976543   233557999999999999999999999999999999999999999997776655543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-52  Score=380.61  Aligned_cols=243  Identities=28%  Similarity=0.383  Sum_probs=211.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..+|++.+.||+|+||+||.++.+++++.+|+|++++...   ...+....|..+|..++||+||+++..|++...+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4579999999999999999999999999999999987643   3467788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      +||+.||.|.-+|.+    .+.+++..+..++.+|+.||.|||+.   +||||||||+|||||..|+++|+||||++..-
T Consensus       104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999986    57799999999999999999999998   99999999999999999999999999998533


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..  ...+..++||+.|||||++.+..|+.++|+||||+++|||++|.+||...+.......+...+             
T Consensus       177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-------------  241 (357)
T KOG0598|consen  177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-------------  241 (357)
T ss_pred             cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------------
Confidence            32  223345799999999999999999999999999999999999999999877555444333221             


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP  358 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  358 (426)
                          ....|...+.++++++.+.|..||++|.
T Consensus       242 ----~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                0112233455889999999999999996

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-52  Score=384.26  Aligned_cols=254  Identities=26%  Similarity=0.345  Sum_probs=210.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-------GVREFSAEVMTLGSADHPNLVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  161 (426)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+....       ....+.+|+++|++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788899999999999999999999999999999865321       2334679999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeEec
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSD  238 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~D  238 (426)
                      ..|+||||+.||.|.+.+-.    .+.+.+...+.++.|++.|+.|||+.   ||+||||||+|||+..+   ..+||+|
T Consensus       250 s~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999998875    56788899999999999999999998   99999999999999766   7899999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccccCCC---CccCchhhHHHHHHHHHhCCCCCCCcCchh-hhcHHHhhhh
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKDRK-ELNLVAWARP  314 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~  314 (426)
                      ||+|+...   ....+...||||.|.|||++.+..+   ..++||||+||+||-+++|.+||....... ....+..++.
T Consensus       323 FGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y  399 (475)
T KOG0615|consen  323 FGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY  399 (475)
T ss_pred             cchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc
Confidence            99999754   3345566899999999999987754   347899999999999999999998654433 2222221111


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .+              ........+.+..+||.+||..||++||++.|+++.
T Consensus       400 ~f--------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  400 AF--------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cc--------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            10              001123456689999999999999999999999964

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-52  Score=369.98  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=215.7

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEee-EEeeCCe-eEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIG-YCAEGDQ-RLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~-~~~~~~~-~~lv~  167 (426)
                      +|++.++||+|+||+||++.+..+|..||.|.+.-..  ....+....|+.+|++|+|||||++++ .|.++.. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4888999999999999999999999999999987443  334566889999999999999999998 4555555 89999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCC-CeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ-PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~-~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||..|+|...++..+...+.+++..+|+++.|++.||..+|+.+++ -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            99999999999999888889999999999999999999999995433 38999999999999999999999999999865


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..  .......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+-......+..        ..+    
T Consensus       180 s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q--------gd~----  245 (375)
T KOG0591|consen  180 SK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ--------GDY----  245 (375)
T ss_pred             ch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc--------CCC----
Confidence            54  3334567999999999999999999999999999999999999999998743222211110        000    


Q ss_pred             CCcccCCCC-hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          327 DPSLQGQYP-VRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       327 ~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                           ...| ..++..+..||..|+..||+.||+...+++.+.
T Consensus       246 -----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  246 -----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                 1123 566778999999999999999999655554443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=7.2e-51  Score=361.91  Aligned_cols=265  Identities=24%  Similarity=0.282  Sum_probs=217.0

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .|+.+.++|+|+||.||+++++.||+.||||++-....  ...+-.++|+.+|++|+|||+|.++++|.....++||+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            57778889999999999999999999999999976543  2334478999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      |+..-| +.|..   ....++...+.+++.|++.|+.|+|++   ++|||||||+||||+.+|.+||||||+|+....  
T Consensus        83 ~dhTvL-~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--  153 (396)
T KOG0593|consen   83 CDHTVL-HELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA--  153 (396)
T ss_pred             cchHHH-HHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence            985433 33433   456799999999999999999999987   999999999999999999999999999997653  


Q ss_pred             CcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh--------hhhhccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR--------PMFKDRK  320 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  320 (426)
                      .....+..+.|.+|.|||.+.+ -.|+..+||||+||++.||++|.+.|.+..+.+++..+....        ..|....
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            2334466788999999999998 589999999999999999999999999998888877665332        2333333


Q ss_pred             ccccccCCcccCC-----CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQGQ-----YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .|..+.-|.....     .....+.-+++|+..||+.||++|++.++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            3333333322221     12233447899999999999999999999884

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-50  Score=382.56  Aligned_cols=257  Identities=30%  Similarity=0.436  Sum_probs=220.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      .+...+.||+|-||.||.|.++. ...||+|.+... ......|.+|+.+|++|+|+|||+++++|..+..+|||||||+
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            35667789999999999999996 347999999865 3445779999999999999999999999999889999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      .|+|.++|+.  ..+..+...+.+.++.|||+||+||+++   ++|||||...||||++++.+||+|||||+... .+..
T Consensus       285 ~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~~Y  358 (468)
T KOG0197|consen  285 KGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG-DDEY  358 (468)
T ss_pred             cCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC-CCce
Confidence            9999999987  3467799999999999999999999998   99999999999999999999999999999433 2233


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                      .......-+..|.|||.+..+.++.+||||||||+||||+| |+.||.+....+.+..                 ++...
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-----------------le~Gy  421 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-----------------LERGY  421 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-----------------HhccC
Confidence            33333334668999999999999999999999999999999 8889888766554433                 34445


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      +-..|..|+.++.+|+..||+.+|++|||++.+...|+.+...
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            5566888999999999999999999999999999999888643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-49  Score=377.82  Aligned_cols=254  Identities=25%  Similarity=0.345  Sum_probs=218.5

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCe
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  162 (426)
                      .....+|..++.||.|+|++|++|+.+.+++.||||++.+.-.   ..++-+..|-.+|..| .||.|++|+-.|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4455689999999999999999999999999999999976532   3345577899999999 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +|+|+||+++|+|.++|+.    -+.+++..++.++.+|+.||+|||+.   |||||||||+|||||++++++|+|||.|
T Consensus       149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            9999999999999999987    37799999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCc---------ce--eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHh
Q 014362          243 KMGPSGDKT---------HV--STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       243 ~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  311 (426)
                      +.+......         ..  ...++||..|.+||++..+..+..+|+|+||||||+|+.|.+||.+.++...+..+..
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~  301 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA  301 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH
Confidence            865432211         11  1458999999999999999999999999999999999999999998887655544432


Q ss_pred             hhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..                  -.+|...+..+.+|+.+.|..||.+|++..+|-+
T Consensus       302 l~------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  302 LD------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             hc------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            21                  1234444468899999999999999999988874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-49  Score=350.24  Aligned_cols=237  Identities=27%  Similarity=0.358  Sum_probs=209.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .+|+..+.||.|+||.|.+++.+.+|..+|+|++.+...   ..++....|..+|+.+.||+++++++.|.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            358888899999999999999999999999999987654   44666889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||++||.|..+|+.    .+.+++..++.+|.||+.||+|||+.   +|++|||||+|||||.+|.+||+|||+|+.+..
T Consensus       124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            99999999999987    46799999999999999999999998   999999999999999999999999999987543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     +...||||.|+|||++...+|+.++|+|||||++|||+.|.+||...++......+....      -       
T Consensus       197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------v-------  258 (355)
T KOG0616|consen  197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------V-------  258 (355)
T ss_pred             c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc------c-------
Confidence            2     345799999999999999999999999999999999999999999887755544443221      1       


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCC
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMR  357 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  357 (426)
                           .+|......+.+|+...|+.|-.+|
T Consensus       259 -----~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 -----KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                 2344455588999999999999999

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=369.51  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=217.2

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC----Cc-ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCC
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR----GV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD  161 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  161 (426)
                      ...++|.+.+.||+|+||+|+.|.+..++..||||++...    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4467899999999999999999999999999999987664    22 23456778999999999 999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEeccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFG  240 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfg  240 (426)
                      .+++||||+.||+|.+++..    ..++.+..+..++.||+.|++|||+.   +|+||||||+|||++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            99999999999999999986    46799999999999999999999998   99999999999999999 999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCC-CC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-LT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+..........+.      ..
T Consensus       167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~------~~  238 (370)
T KOG0583|consen  167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR------KG  238 (370)
T ss_pred             cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh------cC
Confidence            998753  1222334569999999999999987 86 89999999999999999999998754433332211      11


Q ss_pred             ccccccccCCcccCCCChHh-HHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          319 RKNFSQMVDPSLQGQYPVRG-LYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ...            +|... +.++..|+.+||..+|..|+++.+|+ ...+++.
T Consensus       239 ~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  239 EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            111            22222 56889999999999999999999999 7777765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=361.51  Aligned_cols=255  Identities=27%  Similarity=0.435  Sum_probs=207.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC--eeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv~e  168 (426)
                      .+|...+.||+|+||.||++.+..+|...|||.+........+.+.+|+.+|++++|||||+++|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45777788999999999999999999999999987764444777999999999999999999999855444  6899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  247 (426)
                      |+++|+|.+++....   ..|++..+..+++||++||+|||++   +||||||||+||||+. ++.+||+|||+++....
T Consensus        97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            999999999998732   2799999999999999999999987   9999999999999999 79999999999986543


Q ss_pred             -CCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCc-CchhhhcHHHhhhhhhhccccccc
Q 014362          248 -GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQT-KDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       248 -~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                       ...........||+.|||||++..+ ....++|||||||++.||+||++||... ........+.      ..      
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig------~~------  238 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIG------RE------  238 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHh------cc------
Confidence             1222233457899999999999864 3345999999999999999999999864 1111110100      00      


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                          .....+|...+..+.+|+..|+..+|..|||+.+++...
T Consensus       239 ----~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  239 ----DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             ----CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence                011134555667899999999999999999999999643

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-49  Score=368.22  Aligned_cols=266  Identities=24%  Similarity=0.322  Sum_probs=220.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHH--HHHHHHHHhcCC-CCCcceEeeEEeeCC-eeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSAD-HPNLVKLIGYCAEGD-QRL  164 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~E~~~l~~l~-hpniv~~~~~~~~~~-~~~  164 (426)
                      ..++|.+.++||.|+||.||+|+.+.++..||||.++..-.. +++  -.+|+..|++++ |||||++.+++.+++ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            446899999999999999999999999999999999765332 333  457999999999 999999999999988 999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +|||||+ .+|+++++++   ...+++..++.|+.||++||+|+|.+   |+.||||||+|||+.....+||+|||+||.
T Consensus        87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence            9999996 7999999873   68899999999999999999999987   999999999999999888999999999997


Q ss_pred             CCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc-----
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD-----  318 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  318 (426)
                      ......   .+..+.|.+|+|||++.. +-|+.+.||||+|||++|+.+-++.|.+..+.++...+.........     
T Consensus       160 v~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  160 VRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            655433   355688999999998874 57899999999999999999999999999888877666543221111     


Q ss_pred             c--------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          319 R--------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       319 ~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +        -.+++.....+..-.+. .+.++.+|+.+||.+||.+|||+.++++.
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            0        11222222222222333 67789999999999999999999999964

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-47  Score=335.12  Aligned_cols=271  Identities=24%  Similarity=0.335  Sum_probs=220.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .+|...+.||+|.||.||+|++..+|+.||||++......  ......+|+..|+.++|+||+.++++|.+.+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677788899999999999999999999999999865432  23457899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ||+ .+|+..+++   ....++...+..++.++++||+|||+.   .|+||||||.|+|++++|.+||+|||+|+.....
T Consensus        82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            997 699999987   567899999999999999999999987   9999999999999999999999999999987655


Q ss_pred             CCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----hhccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----FKDRKNF  322 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~  322 (426)
                      ....  +..+-|.+|.|||.+.+. .|+..+||||.|||+.||+-|.+-|.+..+.+++..+-.....     +++-..+
T Consensus       155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            4433  333789999999998875 7999999999999999999999999998888777666433211     1111111


Q ss_pred             ccc-----cC-CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          323 SQM-----VD-PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       323 ~~~-----~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ++.     +. +.... .-......+.+|+..+|..||.+|+++.|+++. .++.+
T Consensus       233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~  286 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH-PYFKS  286 (318)
T ss_pred             ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhc
Confidence            111     11 12222 223445567999999999999999999999954 44543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=371.33  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=219.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ..|....+||+|+.|.||.|....+++.||||++........+-+.+|+.+|+.++|+|||.+++.|...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46888899999999999999999999999999998877666677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      +||+|.+.+..     ..+++.++..|++++++||+|||..   +|+|||||.+|||++.+|.+||+|||++........
T Consensus       353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999999865     5599999999999999999999998   999999999999999999999999999986544332


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        ....++|||.|||||++....|++++||||||++++||+-|.+||-..++...+.++.....             +.+
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-------------P~l  489 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-------------PKL  489 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-------------CCc
Confidence              44567999999999999999999999999999999999999999987666555544443211             111


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..+...+..+.+|+.+||+.|+.+||++.|+|+
T Consensus       490 --k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  490 --KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              225556678999999999999999999999995

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.3e-48  Score=367.34  Aligned_cols=249  Identities=23%  Similarity=0.284  Sum_probs=212.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++++.||+|+||.||+|+-+.||..+|+|++++...   ..+..+..|-.+|....+|+||++|..|.+...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999999999999999999988643   457778999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||++||++..+|..    ...|++..+..++.+++.|+..||..   |+|||||||+|+|||..|++||+||||+.-.
T Consensus       219 iMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999976    57899999999999999999999998   9999999999999999999999999998521


Q ss_pred             CC----------------------CCCc----ce-------------------eeeecccccccCccccccCCCCccCch
Q 014362          246 PS----------------------GDKT----HV-------------------STRVMGTYGYCAPDYAMTGQLTFKSDI  280 (426)
Q Consensus       246 ~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv  280 (426)
                      ..                      .+..    ..                   ....+|||-|||||++.+..|+..+|+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            11                      0000    00                   012479999999999999999999999


Q ss_pred             hhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC
Q 014362          281 YSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA  359 (426)
Q Consensus       281 wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  359 (426)
                      ||||||+||||.|-+||....+.+....+...+..+..+.              ......++.+||.+||. ||.+|..
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~--------------~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE--------------EVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC--------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence            9999999999999999999988877765554443332211              11122588999999999 9999976

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-48  Score=363.60  Aligned_cols=267  Identities=23%  Similarity=0.307  Sum_probs=215.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv  166 (426)
                      +.|+.+.+||+|+||.||+|++..+|+.||+|++....  .....-..+|+.+|++|+||||+++.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            45788889999999999999999999999999998654  33455577899999999999999999998876  689999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      +|||+ -+|.-++..   ..-.|++.++..++.||+.||+|+|+.   +|+|||||.+|||||.+|.+||+|||||++..
T Consensus       197 FeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  197 FEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             Eeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            99997 467666654   456799999999999999999999987   99999999999999999999999999999765


Q ss_pred             CCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc----cc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR----KN  321 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~  321 (426)
                      ...... .+..+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+..+.++++.+...-....+.    ..
T Consensus       270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            443332 4455679999999999876 79999999999999999999999999999988888775332211110    00


Q ss_pred             cc--cccCC------cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          322 FS--QMVDP------SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       322 ~~--~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ++  ..+.+      .+++. -...+...++|+..+|..||.+|.|+.++|+.
T Consensus       349 LP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            11  11111      11111 11223467899999999999999999999853

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-47  Score=353.41  Aligned_cols=264  Identities=26%  Similarity=0.366  Sum_probs=217.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..+.|.+...||.|..++||+|+...++..||||++.-.... ..+.+.+|+..++.++||||++++..|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            346799999999999999999999999999999999765443 3688999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC-
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP-  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~-  246 (426)
                      .||.+||+.+++...-.  ..+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+-... 
T Consensus       104 pfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            99999999999987543  4599999999999999999999998   99999999999999999999999999875432 


Q ss_pred             CCCCccee-eeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVS-TRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .+...... ..++||++|||||++..  ..|+.|+|||||||+..||.+|..||....+...+.+-....+...      
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~------  252 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTL------  252 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCc------
Confidence            23222222 56789999999999654  4799999999999999999999999998887665533322211111      


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .-..+..+........+..++..||+.||.+|||++++++
T Consensus       253 --~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 --LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             --ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              1111111222333447889999999999999999999985

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-47  Score=374.25  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=218.9

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCee
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  163 (426)
                      ....+|.+.++||+|+||+|+++..+.+++.+|||.+++...   .+++..+.|..++.... ||++++++..|...+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            345689999999999999999999999999999999998754   45777888999888775 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      |+||||+.||++..+.+     ...+++..+..++..|+.||.|||++   +|||||||.+|||||.+|.+||+|||+++
T Consensus       445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999544333     36799999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .....  ...++.++|||.|||||++.+..|+.++|+|||||+||||+.|..||.+.++.+..+.+..-           
T Consensus       517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-----------  583 (694)
T KOG0694|consen  517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-----------  583 (694)
T ss_pred             ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence            64422  22456789999999999999999999999999999999999999999988876655444321           


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH----HHHHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI----TDVVMALNYL  370 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~L~~l  370 (426)
                             ...+|...+.+.+.|+.++|..+|++|..+    .+.+..-..+
T Consensus       584 -------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFF  627 (694)
T KOG0694|consen  584 -------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFF  627 (694)
T ss_pred             -------CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcc
Confidence                   123566777899999999999999999987    5555543333

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.3e-47  Score=363.89  Aligned_cols=247  Identities=31%  Similarity=0.410  Sum_probs=215.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|.+...||+|+||.||+|+.+.+.+.||+|.+.+...  ...+.+.+|+++++.++|||||.++++|+...++|+|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            468888899999999999999999999999999987644  456779999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+.| +|..+|.+    .+.++++.+..++.+++.||.|||+.   +|+|||+||.|||++.+|.+|+||||+|+.... 
T Consensus        82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-  152 (808)
T ss_pred             hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence            9975 99999987    67899999999999999999999998   999999999999999999999999999996543 


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                       .+...+.+.|||.|||||++.+.+|+..+|+||+|||+|||++|++||....-......+      ..++.        
T Consensus       153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I------~~d~v--------  217 (808)
T KOG0597|consen  153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI------LKDPV--------  217 (808)
T ss_pred             -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH------hcCCC--------
Confidence             455667789999999999999999999999999999999999999999764432222111      11111        


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          .+|...+..+.+|+...|..||..|.+-.+++.
T Consensus       218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                234466678899999999999999999999874

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-46  Score=363.59  Aligned_cols=265  Identities=26%  Similarity=0.381  Sum_probs=208.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC-
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG-  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-  160 (426)
                      ..++|++.+.||.|+||.||+|.+.     .++..||||++..... .....+..|+.++..+ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3467999999999999999999853     3456899999875432 3356788999999999 899999999988764 


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCC-------------------------------------------------------
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPD-------------------------------------------------------  185 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------  185 (426)
                      ..+++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            4588999999999999998752210                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeeccccc
Q 014362          186 ---TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG  262 (426)
Q Consensus       186 ---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~  262 (426)
                         ..++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               23588899999999999999999987   999999999999999999999999999975432222122223356788


Q ss_pred             ccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHH
Q 014362          263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQ  341 (426)
Q Consensus       263 y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (426)
                      |+|||++.+..++.++|||||||++|||++ |..||............      .....          ....+...+..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~------~~~~~----------~~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR------LKDGT----------RMRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH------HhcCC----------CCCCCCCCCHH
Confidence            999999999999999999999999999997 99999765432211100      00000          01112334557


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          342 ALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       342 l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      +.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            8999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-46  Score=365.48  Aligned_cols=249  Identities=26%  Similarity=0.360  Sum_probs=214.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      +-|.+++.||.|+.|.|.+|++..||+.+|||++.+..   ......+.+|+.+|+.+.||||+.+|+.+++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            45888889999999999999999999999999998762   123455889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|.|.++|-.    .+++++.++.++++||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|.+...
T Consensus        92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999986    57899999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCcceeeeecccccccCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      +..   -...||+|.|.|||++.+.+|+ .++||||+|||||.|+||+.||+..+.+..+..+....  +          
T Consensus       165 gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~--f----------  229 (786)
T KOG0588|consen  165 GKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV--F----------  229 (786)
T ss_pred             Ccc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc--c----------
Confidence            322   2345999999999999999986 89999999999999999999999666544443333211  1          


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                            +.|...+.++.+|+.+||..||+.|.|++||++.-
T Consensus       230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                  12445566889999999999999999999999753

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.4e-47  Score=378.98  Aligned_cols=260  Identities=30%  Similarity=0.488  Sum_probs=225.4

Q ss_pred             ccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ......||+|+||+||+|+..     .....||||.+++.... ..++|.+|+++|..|+|||||+++|.|..++.+|+|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            445566999999999999864     33568999999887665 678899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCC------C----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          167 YEYMPLGSLDKHLHDLRP------D----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      +|||..|+|.++|....+      .    ..+|+..+.+.||.|||.||+||.++   .+|||||...|+||.++..|||
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEe
Confidence            999999999999975432      1    23489999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      +|||+++-.-..+......+..-..+|||||.++.++|+.+||||||||+|||+++ |+.||.+....+....+...+- 
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-  723 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-  723 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-
Confidence            99999997666666655545556789999999999999999999999999999998 9999998887766655543221 


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                                      -..|..++.++++|+..||+.+|.+||+++||-.+|+.+..
T Consensus       724 ----------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  724 ----------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             ----------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence                            23577888899999999999999999999999999998754

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-47  Score=353.27  Aligned_cols=248  Identities=29%  Similarity=0.432  Sum_probs=212.4

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .|+....||+|+||.||+|.+..+++.||||++..... ..+.++.+|+.+|..++++||.++|+.|..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            46666779999999999999999999999999986543 45778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      .||++.++|..    ...+++..+.-++++++.||.|||..   +.+|||||+.||||..+|.+||+|||++-.......
T Consensus        94 ~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   94 GGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             cCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999975    45558888899999999999999998   999999999999999999999999999976544332


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                      .  ...++||+.|||||++....|+.++||||||++.+||++|.+|+....+...+.++             +.-..|.+
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------pk~~PP~L  231 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------PKSAPPRL  231 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------cCCCCCcc
Confidence            2  25679999999999999889999999999999999999999999887764333222             12222223


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+    .++..+.+|+..||+.+|+.||++.++++
T Consensus       232 ~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 DG----DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cc----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            22    45557899999999999999999999985

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-46  Score=360.31  Aligned_cols=267  Identities=27%  Similarity=0.438  Sum_probs=215.2

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG  160 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  160 (426)
                      ..++.+..+.+.+...||+|.||+||+|+|.+   .||||.+.....  ...+.|+.|+..|++-+|.||+-+.|+|..+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            36666677778889999999999999999985   499999986543  4678899999999999999999999999987


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      .. .||..+|+|.+|+.+||..   ...++....+.||.||++||.|||..   +|||||||..||+|.++++|||+|||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             ce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence            76 9999999999999999974   46799999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      |+.....-..........|...|||||++..   .+|+..+||||||+++|||+||..||........+-.+.       
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-------  606 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-------  606 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-------
Confidence            9964222111112223457889999999974   479999999999999999999999998333222111111       


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        ..   .+.+.+ ......++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus       607 --rG---~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 --RG---YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             --cc---ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence              00   000000 01223556689999999999999999999999998887765

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4e-45  Score=352.62  Aligned_cols=245  Identities=26%  Similarity=0.349  Sum_probs=205.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|.+.+.||+|+||.||+|++..+++.||||.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56899999999999999999999999999999987542   234566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999876    35689999999999999999999997   999999999999999999999999999976432


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..     ....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.      ....       
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~------~~~~-------  232 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL------AGRL-------  232 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh------cCCc-------
Confidence            21     23579999999999999999999999999999999999999997654332221111      0000       


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                           .+|......+.+|+.+||+.||.+||+     +.+++.
T Consensus       233 -----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        233 -----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                 112223457889999999999999997     677774

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=8.4e-45  Score=342.96  Aligned_cols=247  Identities=23%  Similarity=0.362  Sum_probs=202.9

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc---HHHHHHHHHHHhcCCCCCcceEeeEEee----CCeeEEEEEe
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRLLVYEY  169 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~e~  169 (426)
                      ..||+|++|.||+|.+.  |+.||||.+.......   .+.+.+|+.+|++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            45999999999999984  8899999997653332   5678899999999999999999999877    4568999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.+++..    ...+++...+.++.|++.||.|||+.  .+++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999975    35689999999999999999999973  278899999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                           ....||..|+|||++.+  ..++.++|||||||++|||++|+.||...........+...      .        
T Consensus       178 -----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------~--------  238 (283)
T PHA02988        178 -----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK------N--------  238 (283)
T ss_pred             -----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------C--------
Confidence                 12468899999999876  68999999999999999999999999876543322221100      0        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        .....+..++..+.+|+.+||+.||.+||++.+|++.|+.++.
T Consensus       239 --~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 --NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             --CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence              0111223345678999999999999999999999999998763

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-46  Score=340.08  Aligned_cols=269  Identities=23%  Similarity=0.297  Sum_probs=217.4

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEecc--CCcccHHHHHHHHHHHhcCCCCCcceEeeEEee-----C
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-----G  160 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~  160 (426)
                      .....|...+.||.|+||.|+.|.++.+|+.||||++..  ......++..+|+.+|+.++|+||+.+++.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            345567777889999999999999999999999999973  445567788999999999999999999998865     3


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ...|+|+|+| ..+|...++.    +..|+...+..++.||++||.|+|+.   +|+||||||.|+|++.+..+||+|||
T Consensus        99 ~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            4689999999 4788888875    45699999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      +|+...........+..+-|.+|.|||++.. ..|+.+.||||+|||+.||++|++.|.+.+...++.++....+.....
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            9997644333444566788999999998865 579999999999999999999999999988877777765432221110


Q ss_pred             --------------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 --------------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 --------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                    .++...-...+..-+| .....+++|+.+||..||.+|+|++|+++
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                          0011111111111122 44558899999999999999999999985

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=356.65  Aligned_cols=241  Identities=27%  Similarity=0.448  Sum_probs=205.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      +..||.|+.|.||+|+..  ++.||||+++.-       -..++.-|++|+||||+.|.|+|.....+|||||||..|-|
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            567999999999999998  789999987532       12478889999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      ..+|+.    ..+++......|..+||.||.|||.+   .|||||||.-||||..+..|||+|||.++.....   ...-
T Consensus       200 ~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM  269 (904)
T KOG4721|consen  200 YEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM  269 (904)
T ss_pred             HHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence            999986    57789999999999999999999998   9999999999999999999999999999865433   2223


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      .++||..|||||++.+.+.++|+||||||||||||+||..||...+...    +.|.     -+.       ..+.-..|
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG-----VGs-------NsL~LpvP  333 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG-----VGS-------NSLHLPVP  333 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe-----ccC-------CcccccCc
Confidence            4799999999999999999999999999999999999999997654322    1111     111       12223446


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      ..++..+.-|+++||+..|..||++.+|+..|+...
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            777778899999999999999999999999887553

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.1e-45  Score=328.08  Aligned_cols=266  Identities=24%  Similarity=0.298  Sum_probs=215.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv  166 (426)
                      +.|+.++.|++|+||.||+|+++.+++.||+|+++......  --.-.+|+.+|.+++|||||.+-.+....  +..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            35888889999999999999999999999999998653221  12257899999999999999999887644  568999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||||+ -+|..++...   ..++...++..++.|++.||+|||..   .|+||||||+|+|+...|.+||+|||+|+...
T Consensus       156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            99997 5888888774   36799999999999999999999987   99999999999999999999999999999765


Q ss_pred             CCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc-------
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD-------  318 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  318 (426)
                      ..  ....+..+-|.+|.|||.+.+. .|+.++||||+|||+.||+++++.|.+....++++.+........+       
T Consensus       229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence            44  3345667889999999999876 6999999999999999999999999999888877766432211110       


Q ss_pred             -c-----cccccccCCcccCCCChH-hHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 -R-----KNFSQMVDPSLQGQYPVR-GLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 -~-----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .     ..+.......++..++.. ....-++|+..+|..||.+|.|+++.|+
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence             0     111111222344444444 4567899999999999999999999985

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-45  Score=352.28  Aligned_cols=254  Identities=22%  Similarity=0.312  Sum_probs=209.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....   ......+..|+.++..++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999999999999999997542   234566888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            99999999999975    35689999999999999999999987   999999999999999999999999999975432


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                           ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+......+          .
T Consensus       154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------~  218 (333)
T cd05600         154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----------Q  218 (333)
T ss_pred             -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------c
Confidence                 2234579999999999999999999999999999999999999998765443332222111100          0


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ...........+.++.+|+.+||..+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000012335578899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-44  Score=345.32  Aligned_cols=266  Identities=24%  Similarity=0.396  Sum_probs=207.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC----------------CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK----------------IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVK  152 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~  152 (426)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|.+..... .....+.+|+.++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999998642                345799999876432 33457899999999999999999


Q ss_pred             EeeEEeeCCeeEEEEEecCCCCHHHHhhhhCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeE
Q 014362          153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP---------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI  217 (426)
Q Consensus       153 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii  217 (426)
                      +++++.+....++||||+++|+|.+++.....               ....+++..++.++.||+.||.|||+.   +|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence            99999999999999999999999999865211               123578889999999999999999987   999


Q ss_pred             ecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh--CCC
Q 014362          218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRK  295 (426)
Q Consensus       218 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~  295 (426)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999976543333222333456889999999998999999999999999999987  566


Q ss_pred             CCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          296 AIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ||............   ...+....  ..     .....+..++..+.+|+.+||+.+|.+||++.+|.+.|+
T Consensus       241 p~~~~~~~~~~~~~---~~~~~~~~--~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIENA---GEFFRDQG--RQ-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHHHH---HHHhhhcc--cc-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            77655433222111   11111000  00     001112334567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-45  Score=346.95  Aligned_cols=246  Identities=23%  Similarity=0.285  Sum_probs=206.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+.+++.++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36889999999999999999999999999999986532   233556889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            99999999999875    35689999999999999999999987   999999999999999999999999999975432


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...      .        
T Consensus       154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------~--------  214 (291)
T cd05612         154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------K--------  214 (291)
T ss_pred             C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C--------
Confidence            2     12347999999999999999999999999999999999999999875543322221110      0        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  366 (426)
                          ..++......+.+|+.+||+.||.+||+     +.++++.
T Consensus       215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                0122233457889999999999999995     8888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=345.14  Aligned_cols=261  Identities=26%  Similarity=0.361  Sum_probs=209.8

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------------ccHHHHHHHHHHHhcCCCCC
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------------QGVREFSAEVMTLGSADHPN  149 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpn  149 (426)
                      .+-....++|++.+.||+|.||.|-+|+...+++.||||++.+...              ...+...+|+.+|++++|||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n  169 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN  169 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence            3444566889999999999999999999999999999999975321              12457889999999999999


Q ss_pred             cceEeeEEeeC--CeeEEEEEecCCCCHHHHhhhhCCCCCC-CCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCe
Q 014362          150 LVKLIGYCAEG--DQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI  226 (426)
Q Consensus       150 iv~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI  226 (426)
                      ||+++++..+.  +.+|||+|||..|.+...     ....+ +++.++++++++++.||+|||.+   +||||||||+|+
T Consensus       170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~-----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNL  241 (576)
T KOG0585|consen  170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNL  241 (576)
T ss_pred             eeEEEEeecCcccCceEEEEEeccCCccccC-----CCCcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhhe
Confidence            99999998765  579999999998887432     23455 99999999999999999999998   999999999999


Q ss_pred             eeccCCceeEecccccccCCCCCCc---ceeeeecccccccCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCC
Q 014362          227 LLEEGYHPKLSDFGLAKMGPSGDKT---HVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQ  299 (426)
Q Consensus       227 ll~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~  299 (426)
                      ||+++|++||+|||.+.....+...   ..-...+|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            9999999999999999765332111   1112358999999999988743    35789999999999999999999987


Q ss_pred             cCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          300 TKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ....+..+.+....-.++.                .......+.+||.++|++||+.|.++.+|.....
T Consensus       322 ~~~~~l~~KIvn~pL~fP~----------------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  322 DFELELFDKIVNDPLEFPE----------------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             chHHHHHHHHhcCcccCCC----------------cccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence            7665544444322111111                1133457899999999999999999999976543

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.8e-45  Score=351.21  Aligned_cols=241  Identities=28%  Similarity=0.352  Sum_probs=201.3

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||+|.+..+|+.||||++....   ......+..|+.+++.++||||+++++++...+.+|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            5999999999999999999999999997532   2334567889999999999999999999999999999999999999


Q ss_pred             HHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCccee
Q 014362          175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS  254 (426)
Q Consensus       175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  254 (426)
                      |..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....  ....
T Consensus        82 L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~  152 (323)
T cd05571          82 LFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATM  152 (323)
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcc
Confidence            9998875    45789999999999999999999987   9999999999999999999999999998743221  1122


Q ss_pred             eeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCC
Q 014362          255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY  334 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (426)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      ..            ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~~------------~~~  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EE------------IRF  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc------CC------------CCC
Confidence            345799999999999999999999999999999999999999976543322211110      00            012


Q ss_pred             ChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          335 PVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       335 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                      |......+.+|+.+||+.||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            334456789999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.1e-45  Score=336.41  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=213.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      +.|++++.||.|.-|+||++...+++..+|+|++.+...   ....+...|.+||+.++||.++.+|..|+.+...||||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            468888999999999999999999999999999987643   34566788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |||+||+|..+++.  +....+++..++.++.+|+-||+|||..   |||+|||||+||||.++|++.|+||.|+.....
T Consensus       157 eyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999998876  3567899999999999999999999998   999999999999999999999999998743110


Q ss_pred             ---------------------------------CCCc---------------------ceeeeecccccccCccccccCC
Q 014362          248 ---------------------------------GDKT---------------------HVSTRVMGTYGYCAPDYAMTGQ  273 (426)
Q Consensus       248 ---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~  273 (426)
                                                       ....                     ..+..++||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0000                     0112367999999999999999


Q ss_pred             CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccC
Q 014362          274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQ  353 (426)
Q Consensus       274 ~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  353 (426)
                      .+.++|+|+|||+||||+.|..||.+.+..+.+.-+......+++                ....+..+.+||++.|.+|
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~----------------~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE----------------EPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC----------------CCcchhHHHHHHHHHhccC
Confidence            999999999999999999999999998877665444322211111                1144568899999999999


Q ss_pred             CCCCCC----HHHHH
Q 014362          354 PNMRPA----ITDVV  364 (426)
Q Consensus       354 P~~RPs----~~eil  364 (426)
                      |.+|..    +.||-
T Consensus       376 P~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIK  390 (459)
T ss_pred             hhhhhccccchHHhh
Confidence            999998    77775

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-44  Score=341.32  Aligned_cols=252  Identities=29%  Similarity=0.403  Sum_probs=205.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|+..+.||+|+||.||+|.+..+++.||+|.+.....   .....+.+|+.+++.++|+||+++++++.+.+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            37788899999999999999999999999999875432   223457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|..++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||+++++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999998888652  234689999999999999999999987   9999999999999999999999999999764322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..  . ..           
T Consensus       156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~--~-~~-----------  218 (285)
T cd05631         156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR--R-VK-----------  218 (285)
T ss_pred             Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH--H-hh-----------
Confidence            21   2234789999999999999999999999999999999999999986543221111110  0 00           


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                      .....++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       219 ~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            0011223344567899999999999999997     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-44  Score=355.24  Aligned_cols=260  Identities=26%  Similarity=0.407  Sum_probs=206.1

Q ss_pred             CCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      ++|++.+.||+|+||.||+|.+     ..++..||||++.... ....+.+.+|+.+|..+ +||||++++++|.+....
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688899999999999999975     3456789999987543 23456688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCC-----------------------------------------------------------
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP-----------------------------------------------------------  184 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  184 (426)
                      ++||||+++|+|.+++.....                                                           
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            999999999999999865221                                                           


Q ss_pred             ------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          185 ------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       185 ------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                                  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                        123578999999999999999999987   99999999999999999999999999997544332222


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||.........  ...    ...          ...
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~--~~~----~~~----------~~~  335 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--YKM----IKE----------GYR  335 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH--HHH----HHh----------Ccc
Confidence            2222345678999999999999999999999999999998 88898765432211  111    000          000


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                      ...+...+.++.+|+.+||+.||.+||++.+|++.|+.
T Consensus       336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            11122234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-45  Score=339.27  Aligned_cols=247  Identities=22%  Similarity=0.367  Sum_probs=210.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc---HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .+|++.+.||+|+||+|-+|.....|+.||||.|++.....   .-.+.+|+++|+.|+||||+.+|++|+..+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            46888889999999999999998999999999998765543   445789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||..+|.|++|+..    .+.|++.++..|++||+.|+.|+|..   +++|||||.+|||||.++++||+|||++-....
T Consensus       133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999987    46799999999999999999999987   999999999999999999999999999976543


Q ss_pred             CCCcceeeeecccccccCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .   ..-+.+||++.|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+-......+...           ...
T Consensus       206 ~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-----------aYr  271 (668)
T KOG0611|consen  206 K---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-----------AYR  271 (668)
T ss_pred             c---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc-----------ccc
Confidence            3   233567999999999999999885 8999999999999999999999987643322222211           111


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .|.        .+..+.-||++||..+|++|.|+.+|...
T Consensus       272 EP~--------~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  272 EPE--------TPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             CCC--------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            111        11245669999999999999999999853

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=9.5e-45  Score=355.72  Aligned_cols=262  Identities=25%  Similarity=0.411  Sum_probs=207.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      ++|++.+.||+|+||.||+|.+..+     +..||||.+.... ......+..|+.+++.+ +||||++++++|......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4688999999999999999986543     3579999997543 23345688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCC-----------------------------------------------------------
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP-----------------------------------------------------------  184 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  184 (426)
                      ++||||+++|+|.++++....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999999864210                                                           


Q ss_pred             -------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeee
Q 014362          185 -------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV  257 (426)
Q Consensus       185 -------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  257 (426)
                             ...++++..+++++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++..............
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                   123578899999999999999999987   9999999999999999999999999999754332222222223


Q ss_pred             cccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCCh
Q 014362          258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPV  336 (426)
Q Consensus       258 ~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (426)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||.............      ..          ......+.
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~------~~----------~~~~~~~~  338 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV------KR----------GYQMSRPD  338 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH------Hc----------ccCccCCC
Confidence            45678999999999999999999999999999997 999997644322111100      00          01111122


Q ss_pred             HhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          337 RGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       337 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      ..+.++.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            23457899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-44  Score=363.92  Aligned_cols=254  Identities=22%  Similarity=0.277  Sum_probs=211.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCC-CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .|.+.+.||+|+||.||+|....+ +..||+|.+..........+..|+.+|+.++||||++++++|...+.+||||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            489999999999999999998877 7889999876655555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++|+|.++|........++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999998876444456799999999999999999999987   999999999999999999999999999986543322


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...     .       .    
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-----~-------~----  288 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-----K-------Y----  288 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----C-------C----
Confidence            22334457999999999999999999999999999999999999999765443222211110     0       0    


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+...+..+.+|+.+||+.+|+.||++.+++.
T Consensus       289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             0112234457899999999999999999999874

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-44  Score=346.95  Aligned_cols=265  Identities=23%  Similarity=0.296  Sum_probs=209.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||++.+..++..||+|.+..... .....+.+|+.+|+.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            4689999999999999999999999999999999876432 334678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999999875    35689999999999999999999985  36999999999999999999999999998754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc------
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF------  322 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  322 (426)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.............  ..........      
T Consensus       158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSISP  231 (331)
T ss_pred             ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccCc
Confidence                1223478999999999999999999999999999999999999997554322111110  0000000000      


Q ss_pred             ----------------------ccccC----CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          323 ----------------------SQMVD----PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       323 ----------------------~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                                            ....+    ...........+.++.+|+.+||+.||++||++.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                  00000    000000111345678999999999999999999999965

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.9e-44  Score=339.75  Aligned_cols=267  Identities=19%  Similarity=0.238  Sum_probs=207.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....  ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46999999999999999999999999999999987542  2335668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++++++..+...    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9998877654432    35689999999999999999999987   9999999999999999999999999999864332


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh--------hccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF--------KDRK  320 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~  320 (426)
                      ... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.......        ....
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            211 1223578999999999999899999999999999999999999998765443322221110000        0000


Q ss_pred             ccccccCCcc------cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSL------QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+.....+..      ...+....+..+.+|+.+||+.||.+||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      01111224557899999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.5e-44  Score=344.21  Aligned_cols=259  Identities=25%  Similarity=0.417  Sum_probs=207.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE----EEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|++.+.||+|+||.||+|.+..++.    .||+|.+.... ....+.+..|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468999999999999999999866555    48999987543 23456788999999999999999999999764 5779


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |+||+++|+|.+++..   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999999876   235688999999999999999999987   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.............       ..     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~-------~~-----  227 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KG-----  227 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-------CC-----
Confidence            43322222222335678999999999999999999999999999998 999997654322111111       00     


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                           .....+..+...+.+++.+||..+|.+||++.+|+..|..+...
T Consensus       228 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         228 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                 00011223345788999999999999999999999999888643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4e-44  Score=339.27  Aligned_cols=267  Identities=24%  Similarity=0.310  Sum_probs=207.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            3579999999999999999999999999999999875432 234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ |+|.+++..   ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            997 589888865   234588999999999999999999987   9999999999999999999999999999754322


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh--------hhcc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM--------FKDR  319 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~  319 (426)
                      ..  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......        ....
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         157 TK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             Cc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence            21  1223468999999998875 56899999999999999999999999876655444333211100        0000


Q ss_pred             cccccccCCcccCC----CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQGQ----YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+.....+.....    .......++.+|+.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111111111100    01123457889999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.7e-44  Score=343.46  Aligned_cols=242  Identities=27%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||++.+..+++.||||++....   ......+.+|+.+++.++||||+++++++...+.+++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5999999999999999999999999997542   2345668889999999999999999999999999999999999999


Q ss_pred             HHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCccee
Q 014362          175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS  254 (426)
Q Consensus       175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  254 (426)
                      |..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          82 LFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9988865    35689999999999999999999987   99999999999999999999999999987532211  122


Q ss_pred             eeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCC
Q 014362          255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY  334 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (426)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      ..            ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~------~~------------~~~  214 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------ED------------IKF  214 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc------CC------------ccC
Confidence            345799999999999999999999999999999999999999976543322211110      00            012


Q ss_pred             ChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014362          335 PVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMA  366 (426)
Q Consensus       335 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  366 (426)
                      |......+.+|+.+||+.||.+||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            333455789999999999999997     88998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=345.96  Aligned_cols=239  Identities=26%  Similarity=0.346  Sum_probs=197.6

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||+|+||.||+|.+..+++.||+|.+...   .......+..|+.++..++||||+++++++.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999998753   223456688899999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      .+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ....
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  151 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN  151 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence            999875    35689999999999999999999987   99999999999999999999999999997532221  2223


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...........+      .....            .++
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~------~~~~~------------~~~  213 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI------LQEPL------------RFP  213 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH------HcCCC------------CCC
Confidence            457999999999999999999999999999999999999999765433221111      11100            123


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCH---HHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAI---TDVV  364 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~---~eil  364 (426)
                      ......+.+|+.+||+.||.+||++   .+++
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            3344578899999999999999864   5554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-44  Score=345.20  Aligned_cols=252  Identities=25%  Similarity=0.344  Sum_probs=217.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe-eEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ-RLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  167 (426)
                      ++|.++++||+|+||.++..+++..+..|++|.+.....  ...+....|+.+++++.|||||.+.+.|..++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            578899999999999999999999999999999976433  334567899999999999999999999998888 99999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      +||+||+|.+.+...+  +.-++++.++.++.|++.|+.|||+.   .|+|||||+.||+++.++.|||+|||+|+....
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            9999999999998754  56799999999999999999999976   999999999999999999999999999997655


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..  .....++||+.||.||++.+.+|+.|+|||||||++|||++-+++|...+.......+..                
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~----------------  220 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR----------------  220 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh----------------
Confidence            43  233457899999999999999999999999999999999999999987654332222211                


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       ......|..++.++..+|..||+.+|..||++.+++..
T Consensus       221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             11223456677789999999999999999999999976

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-45  Score=315.75  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=216.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++++.||+|-||.||.|+.+.++-.||+|++.+...   ....++.+|+++-+.|+||||+++|++|.+....||++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            468999999999999999999999999999999976543   34567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||...|+|...|+..  ....+++..+..+..|+|.||.|+|..   +||||||||+|+|++..+.+||+|||-+...+ 
T Consensus       102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999863  246699999999999999999999976   99999999999999999999999999987533 


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                         ......++||..|.+||...+..++..+|+|++|++.||++.|.+||......+....+....              
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--------------  238 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--------------  238 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc--------------
Confidence               223456799999999999999999999999999999999999999998766444333333211              


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                          -.+|...+..+.++|.+|+..+|.+|.+..|++. +.+|
T Consensus       239 ----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~-hpwI  276 (281)
T KOG0580|consen  239 ----LKFPSTISGGAADLISRLLVKNPIERLALTEVMD-HPWI  276 (281)
T ss_pred             ----ccCCcccChhHHHHHHHHhccCccccccHHHHhh-hHHH
Confidence                1234455568899999999999999999999985 3444

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.5e-44  Score=341.12  Aligned_cols=240  Identities=28%  Similarity=0.408  Sum_probs=195.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhc-CCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..+++.||||.+....   ......+..|..++.. .+||||+++++++.....+++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999999999999999987532   2234455666666664 58999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          82 DLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            99998875    35689999999999999999999987   99999999999999999999999999997532222  22


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      .            ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~------------~~~  214 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN------D------------RPH  214 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc------C------------CCC
Confidence            2345799999999999999999999999999999999999999987654332221110      0            011


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHHHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                      +|......+.+|+.+||+.+|.+||++.+.+
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l  245 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDI  245 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence            2333445788999999999999999986444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-44  Score=344.57  Aligned_cols=241  Identities=27%  Similarity=0.358  Sum_probs=200.3

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||++.+..+|..||+|.+....   ......+..|+.+++.++||||++++++|.....+|+||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            5999999999999999999999999997532   2344567789999999999999999999999999999999999999


Q ss_pred             HHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCccee
Q 014362          175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS  254 (426)
Q Consensus       175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  254 (426)
                      |..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        82 L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          82 LFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            9988865    35689999999999999999999987   99999999999999999999999999987432211  112


Q ss_pred             eeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCC
Q 014362          255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY  334 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (426)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      ..            ..+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~------~~------------~~~  214 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EE------------IRF  214 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CC------------CCC
Confidence            235799999999999999999999999999999999999999976543322211110      00            012


Q ss_pred             ChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          335 PVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       335 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                      |...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            333456789999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=351.29  Aligned_cols=272  Identities=27%  Similarity=0.441  Sum_probs=223.9

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCE---E-EEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcce
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---V-VAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVK  152 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~  152 (426)
                      |.....++....+-.+.++||+|+||.||+|.++..+.   . ||||.....   ......+|..|+++++.++|||||+
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            34445555566777788999999999999999875422   3 899998752   3456788999999999999999999


Q ss_pred             EeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC
Q 014362          153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY  232 (426)
Q Consensus       153 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~  232 (426)
                      +||++.....+++|||+|+||+|.++|+.   ....++..+...++.+.|.||+|||+.   ++|||||..+|+|++.++
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence            99999999999999999999999999987   334699999999999999999999997   999999999999999999


Q ss_pred             ceeEecccccccCCCCCCcceee-eecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHH
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVST-RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA  310 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  310 (426)
                      .+||+|||+++....   ..... ..--...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.
T Consensus       300 ~vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~  376 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV  376 (474)
T ss_pred             eEEeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH
Confidence            999999999985431   11111 1134678999999999999999999999999999999 888998877654332221


Q ss_pred             hhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCC
Q 014362          311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYD  376 (426)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  376 (426)
                                      ....+...|...+..+..++.+||..+|+.||+|.+|.+.|+.+......
T Consensus       377 ----------------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  377 ----------------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ----------------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence                            12233334456667888899999999999999999999999999766553

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.3e-44  Score=332.76  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=207.1

Q ss_pred             CCccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.+..... .....+.+|+.+++.++||||+++++++..+...++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            46889999999999999999875   4467899999876533 3345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..   ....+++..++.++.||+.||+|||+.   +++||||||+|||++.++.++|+|||.+....
T Consensus        85 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          85 TEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999875   235689999999999999999999987   99999999999999999999999999876432


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      .... .......++..|+|||++.+..++.++|||||||++|||++ |..||...........+.       ..      
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~------  224 (266)
T cd05064         159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DG------  224 (266)
T ss_pred             ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CC------
Confidence            2111 11112245678999999999999999999999999999875 999997655433221111       00      


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                          .....+..++..+.+++..||+.+|.+||++.+|++.|..+
T Consensus       225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                00112333456789999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-43  Score=342.10  Aligned_cols=245  Identities=29%  Similarity=0.418  Sum_probs=199.4

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHH---hcCCCCCcceEeeEEeeCCeeEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTL---GSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      |++.+.||+|+||.||+|.+..+++.||||.+....   ....+.+..|+.++   +.++||||+++++++.+....|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999999999999999997532   22345566666554   567899999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|..++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999888754     4699999999999999999999987   99999999999999999999999999987432


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...      .       
T Consensus       153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------~-------  217 (324)
T cd05589         153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------E-------  217 (324)
T ss_pred             CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C-------
Confidence            211  1223457999999999999999999999999999999999999999876543322221110      0       


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                           ..+|...+..+.+++.+||+.||.+||     ++.++++
T Consensus       218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                 012233455788999999999999999     5666664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.2e-44  Score=346.69  Aligned_cols=246  Identities=22%  Similarity=0.282  Sum_probs=204.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC-EEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|.+.+.||+|+||.||+|.+..++ ..||+|.+....   ......+..|+.+++.++||||+++++++.+...+++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            46999999999999999999976654 789999986532   23456688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999875    35689999999999999999999987   99999999999999999999999999997543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.      ...       
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------~~~-------  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL------EGI-------  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh------cCC-------
Confidence            21     123579999999999999899999999999999999999999998654432221111      000       


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  366 (426)
                           ..+|......+.+++.+||+.+|.+|+     +++++++.
T Consensus       245 -----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 -----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 012223345678999999999999995     88888753

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.1e-45  Score=333.71  Aligned_cols=263  Identities=25%  Similarity=0.332  Sum_probs=210.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----eeEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRLLV  166 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv  166 (426)
                      .|...+++|.|+||.||+|....+++.||||+.-....    --.+|+.+|+.+.|||||++.-+|....     .+.||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            36677889999999999999999999999999865432    2347999999999999999998885432     34599


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEecccccccC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKMG  245 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~  245 (426)
                      ||||| .+|...++.....+..++...++-+..||++||.|||+.   +|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            99997 799999987655678899999999999999999999997   99999999999999976 99999999999987


Q ss_pred             CCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc-----
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR-----  319 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  319 (426)
                      ..+...   ....-|..|.|||.+.+. .|+.+.||||.||++.||+.|++.|.+....+++..+...-......     
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            666554   223568999999998875 79999999999999999999999999988777766654332211110     


Q ss_pred             ------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 ------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                            ..++++.......-+......++.+|+.++|+.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  1112222111111233455678999999999999999999999984

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.3e-44  Score=355.80  Aligned_cols=267  Identities=21%  Similarity=0.302  Sum_probs=203.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--------  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------  160 (426)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++....    ....+|+.+|+.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4568999999999999999999999999999999885432    2345799999999999999999887432        


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEecc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDF  239 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Df  239 (426)
                      ..+++||||++ ++|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence            24679999997 578777765444567799999999999999999999987   999999999999999664 7999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh--hh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP--MF  316 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~  316 (426)
                      |+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+.....  ..
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99985433221   1234789999999988764 689999999999999999999999987655443322221100  00


Q ss_pred             ---h-ccc-----ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          317 ---K-DRK-----NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       317 ---~-~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         . ...     .+.......+...+|...+.++.+|+.+||+.||.+||++.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence               0 000     0111111112222344455689999999999999999999999843

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-43  Score=334.18  Aligned_cols=259  Identities=31%  Similarity=0.476  Sum_probs=211.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC-----EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            36888899999999999999986554     7899999875433 33456889999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC
Q 014362          165 LVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY  232 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~  232 (426)
                      ++|||+++++|.+++.....            ....+++..++.++.||+.||.|||+.   +++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999999975321            115688999999999999999999987   999999999999999999


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  311 (426)
                      .++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999976443332222334467889999999998999999999999999999998 9999987554332221110


Q ss_pred             hhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                                       ......+..++.++.+|+.+||+.+|.+||++.+|++.|+.
T Consensus       242 -----------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 -----------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -----------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                             00111234456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-44  Score=348.55  Aligned_cols=253  Identities=24%  Similarity=0.295  Sum_probs=204.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|++..+++.||||++....   ......+..|+.++..++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999999999999999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999875    35699999999999999999999987   999999999999999999999999999874322


Q ss_pred             CCCcc------------------------------------eeeeecccccccCccccccCCCCccCchhhHHHHHHHHH
Q 014362          248 GDKTH------------------------------------VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI  291 (426)
Q Consensus       248 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ell  291 (426)
                      .....                                    .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            11000                                    011246999999999999999999999999999999999


Q ss_pred             hCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 014362          292 TGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA---ITDVVM  365 (426)
Q Consensus       292 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~  365 (426)
                      +|..||...........+....      ..        +........+..+.+|+.+|+. +|.+|++   +.++++
T Consensus       234 ~G~~Pf~~~~~~~~~~~i~~~~------~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         234 VGYPPFCSDNPQETYRKIINWK------ET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             cCCCCCCCCCHHHHHHHHHcCC------Cc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999998765433221111000      00        0000011234578899999996 9999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-43  Score=348.29  Aligned_cols=253  Identities=25%  Similarity=0.284  Sum_probs=202.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|.+.+.||+|+||+||+|.+..+++.||||++....   ......+..|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999999999999999997543   2345668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999875    35689999999999999999999987   9999999999999999999999999997532100


Q ss_pred             CC---------------------------------------------cceeeeecccccccCccccccCCCCccCchhhH
Q 014362          249 DK---------------------------------------------THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSF  283 (426)
Q Consensus       249 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl  283 (426)
                      ..                                             .......+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                             000123579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHh--ccccCCCCCCCHH
Q 014362          284 GVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAM--CVQEQPNMRPAIT  361 (426)
Q Consensus       284 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~  361 (426)
                      ||++|||++|..||...........+.....      .        +........+.++.+|+.+  |+..+|..||++.
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~------~--------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVINWEN------T--------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHHcccc------c--------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999999999987554332211110000      0        0000111234577888887  5566666799999


Q ss_pred             HHHH
Q 014362          362 DVVM  365 (426)
Q Consensus       362 eil~  365 (426)
                      +|+.
T Consensus       301 ~~l~  304 (381)
T cd05626         301 DIKA  304 (381)
T ss_pred             HHhc
Confidence            9985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.4e-44  Score=360.14  Aligned_cols=257  Identities=24%  Similarity=0.282  Sum_probs=210.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  161 (426)
                      ..++|++.+.||+|+||+||+|.+..+++.||||.+....  ......+.+|+.++..++|+||+++++.+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3568999999999999999999999999999999987543  234556888999999999999999988775432     


Q ss_pred             ---eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          162 ---QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       162 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                         .+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence               36799999999999999976544556799999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.............      ..
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~------~~  260 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL------AG  260 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh------cC
Confidence            999976443322223344679999999999999999999999999999999999999997654332221111      00


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                            ..     ...+...+..+.+|+.+||+.+|.+||++.+++.
T Consensus       261 ------~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        261 ------RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             ------CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                  00     0123334567899999999999999999999985

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3e-43  Score=344.19  Aligned_cols=255  Identities=24%  Similarity=0.274  Sum_probs=201.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|.+..+++.||||++....   ......+..|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46899999999999999999999999999999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            99999999999875    35799999999999999999999987   999999999999999999999999999875322


Q ss_pred             CCCc---------------------------------ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC
Q 014362          248 GDKT---------------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR  294 (426)
Q Consensus       248 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~  294 (426)
                      ....                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            1100                                 0012357999999999999999999999999999999999999


Q ss_pred             CCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccc--cCCCCCCCHHHHHHH
Q 014362          295 KAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQ--EQPNMRPAITDVVMA  366 (426)
Q Consensus       295 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~eil~~  366 (426)
                      .||...........+.......    .    +.+      .......+.+++.+++.  .++..||++.||++.
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~~----~----~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         234 PPFCSETPQETYKKVMNWKETL----I----FPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCCHHHHHHHHHcCcCcc----c----CCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9998765443322221100000    0    000      01123466777777443  334457899999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-43  Score=339.99  Aligned_cols=241  Identities=28%  Similarity=0.405  Sum_probs=196.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhc-CCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      +.||+|+||.||+|.++.+|..||+|.+....   ......+..|..++.. ++||||+++++++.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            35999999999999999999999999997532   2234556677777765 5899999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      |+|..++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  151 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N  151 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence            999998865    35689999999999999999999987   99999999999999999999999999987422211  1


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+...                  ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------------------~~  213 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------------------TP  213 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------CC
Confidence            223467999999999999999999999999999999999999999765543222111100                  00


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                      .++......+.+|+.+||+.||.+||++.+.+
T Consensus       214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~  245 (316)
T cd05620         214 HYPRWITKESKDILEKLFERDPTRRLGVVGNI  245 (316)
T ss_pred             CCCCCCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence            11223445788999999999999999986433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.1e-43  Score=337.92  Aligned_cols=242  Identities=27%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCC-CcceEeeEEeeCCeeEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHP-NLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~  167 (426)
                      +|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+..|..++..+.|+ +|+.+++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999999999999999987532   23456678899999998765 5888999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            99999999998875    35689999999999999999999987   999999999999999999999999999874322


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      .         
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~------~---------  216 (324)
T cd05587         154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME------H---------  216 (324)
T ss_pred             CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc------C---------
Confidence            11  122345799999999999999999999999999999999999999986654332222110      0         


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                         ...+|...+..+.+++.+||+.+|.+|++.
T Consensus       217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               011233345578899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9e-44  Score=325.90  Aligned_cols=268  Identities=22%  Similarity=0.287  Sum_probs=211.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCC-cceEeeEEeeCC------e
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPN-LVKLIGYCAEGD------Q  162 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~------~  162 (426)
                      .|....+||+|+||+||+|+.+.+|+.||+|++......  .-....+|+.+|+.++|+| |+.+++++....      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            466666799999999999999999999999999765332  2344678999999999999 999999998877      7


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +++|+||++ .+|..++.........++...++.++.||+.||+|||++   +|+||||||.||||++.|.+||+|||+|
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence            899999995 799999987543325688889999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +......  ...+..++|.+|.|||++.+. .|+...||||+|||++||+++++.|.+..+.+++..+-....... ...
T Consensus       168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~-e~~  244 (323)
T KOG0594|consen  168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN-EKD  244 (323)
T ss_pred             HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC-ccC
Confidence            9644332  234556899999999999987 799999999999999999999999998887666555433221111 011


Q ss_pred             ccccc-----CCcccCCC-Ch-------HhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          322 FSQMV-----DPSLQGQY-PV-------RGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       322 ~~~~~-----~~~~~~~~-~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ++...     ........ +.       .......+++.+||+.+|.+|.|+..++..
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111     00111111 11       111378899999999999999999999864

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.1e-44  Score=345.75  Aligned_cols=253  Identities=23%  Similarity=0.268  Sum_probs=205.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|.+.+.||+|+||.||+|.+..+++.||||.+.....   .....+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            468999999999999999999999999999999975422   34556888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999999763   35799999999999999999999997   999999999999999999999999999976433


Q ss_pred             CCCcceeeeecccccccCccccc------cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAM------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      .... ......||+.|+|||++.      ...++.++|||||||++|||++|..||...........+...         
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~---------  224 (330)
T cd05601         155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF---------  224 (330)
T ss_pred             CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence            2221 223347999999999986      456789999999999999999999999765543322211110         


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+.    -......+..+.+|+..||+ +|.+||++.+++.
T Consensus       225 -~~~~~----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 -QRFLK----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             -CCccC----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence             00000    00011234578899999998 9999999999884

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-43  Score=332.60  Aligned_cols=262  Identities=30%  Similarity=0.446  Sum_probs=212.3

Q ss_pred             CCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|.+.+.||.|+||.||++..     ..++..+|+|.+..........+..|+.+++.++||||+++++++.....+++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4688889999999999999985     33456799999987655566779999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhC---------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          166 VYEYMPLGSLDKHLHDLR---------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      ||||+++++|.+++....         .....+++..++.++.||+.||+|||+.   +++||||||+|||+++++.++|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999997532         1223589999999999999999999987   9999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...........+...   
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~---  238 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG---  238 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---
Confidence            99999975433222222223345778999999998999999999999999999998 89999765543322111110   


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                           ...         ..+...+..+.+|+.+||+.+|.+||++.+|+..|+.+..
T Consensus       239 -----~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         239 -----RVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             -----CcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                 000         0112234578999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.7e-44  Score=343.57  Aligned_cols=243  Identities=27%  Similarity=0.351  Sum_probs=200.2

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||++.+..+++.||+|.+....   ......+..|+.++..++||||+++++++.....+|+||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            5999999999999999999999999997532   2334567789999999999999999999999999999999999999


Q ss_pred             HHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCccee
Q 014362          175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS  254 (426)
Q Consensus       175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  254 (426)
                      |..++..    ...+++..++.++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++......  ...
T Consensus        82 L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  153 (325)
T cd05594          82 LFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM  153 (325)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence            9988865    35689999999999999999999972  299999999999999999999999999987432211  112


Q ss_pred             eeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCC
Q 014362          255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY  334 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (426)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||...........+...      .            ..+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------~------------~~~  215 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------E------------IRF  215 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------C------------CCC
Confidence            3357999999999999999999999999999999999999999765543222221110      0            012


Q ss_pred             ChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014362          335 PVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMA  366 (426)
Q Consensus       335 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  366 (426)
                      |......+.+|+.+||+.||.+|+     ++.++++.
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            233455789999999999999996     89998853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.6e-43  Score=335.15  Aligned_cols=267  Identities=23%  Similarity=0.295  Sum_probs=202.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||.|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999999999999999875432 223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ ++|.+++..   ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            996 678777765   245689999999999999999999987   9999999999999999999999999998753222


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchh-hhcHHHhhhhh-----hhcccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK-ELNLVAWARPM-----FKDRKN  321 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-----~~~~~~  321 (426)
                      .  .......||+.|+|||++.+ ..++.++|||||||++|||++|..||....... ....+......     +.....
T Consensus       157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            1  11233468999999998875 458899999999999999999999998654321 11111110000     000000


Q ss_pred             cccccCCcccCCCC---------hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYP---------VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .............+         ......+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000000000         012246789999999999999999999984

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=369.33  Aligned_cols=262  Identities=29%  Similarity=0.438  Sum_probs=219.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC-----EEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      .+.+....||+|+||.||.|......     ..||||.+.+. +.+...+|.+|..+|+.++|||||+++|+|.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            44566778999999999999986433     34999999765 4466788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCC---CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPD---TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      |++|||++|+|..+|++.+..   ...++....+.++.|||+|+.||++.   +.|||||..+|+||+....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999874321   46689999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      |+.....+.+.......-...|||||.+..+.++.++|||||||+|||++| |..||......+.+..+....       
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-------  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-------  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-------
Confidence            994333333333222234568999999999999999999999999999999 888998777655443222111       


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                                +-+.|..++..+.+++..||+.+|++||++..|++.+..+..
T Consensus       922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                      234577788899999999999999999999999999888754

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-43  Score=331.30  Aligned_cols=251  Identities=33%  Similarity=0.508  Sum_probs=199.0

Q ss_pred             ccceeeecCcEEEEEEEEc----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           95 SDCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        95 ~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +.+.||.|+||.||+|.+.    ..+..|+||.+..... .....+.+|+..++.++||||++++|++......++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4567999999999999998    4567899999965433 3477899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.++|...  ....+++..++.++.||+.||.|||+.   +++|++|+++|||++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999873  246799999999999999999999997   99999999999999999999999999998653332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .........+...|+|||.+....++.++||||||+++|||++ |+.||...........+...                
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~----------------  221 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG----------------  221 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT----------------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------
Confidence            2222233457789999999999999999999999999999999 67888766443322222111                


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                       .+...+..++..+.+++..||..+|.+||++.+|++.|
T Consensus       222 -~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 -QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence             11112334455788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-44  Score=347.17  Aligned_cols=254  Identities=25%  Similarity=0.293  Sum_probs=208.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|.+.+.||+|+||+||+|.+..+++.||||++....   ......+..|+.++..++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999999999999999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            99999999999976    25799999999999999999999997   999999999999999999999999999975433


Q ss_pred             CC---------------------------CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCc
Q 014362          248 GD---------------------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT  300 (426)
Q Consensus       248 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~  300 (426)
                      ..                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            22                           001122357999999999999999999999999999999999999999876


Q ss_pred             CchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 014362          301 KDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-ITDVVMA  366 (426)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~  366 (426)
                      ........+....          ..+.    -......+..+.+|+.+||. +|.+||+ +.++++.
T Consensus       234 ~~~~~~~~i~~~~----------~~~~----~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQETYNKIINWK----------ESLR----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHHHHHHHHhccC----------Cccc----CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            5433222111100          0000    00001135578899999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.3e-43  Score=328.78  Aligned_cols=262  Identities=23%  Similarity=0.327  Sum_probs=212.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||.|+||.||+|++..+++.||||.+....   ......+..|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57999999999999999999999999999999876432   233456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++.........+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998876544456689999999999999999999987   999999999999999999999999999875433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ...  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ......    ..      ....
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~----~~------~~~~  225 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQK----IE------QCDY  225 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHH----Hh------cCCC
Confidence            221  1123468899999999998889999999999999999999999996543211 111110    00      0000


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      +   ...+...+..+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       226 ~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         226 P---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             C---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0   0112234457899999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.1e-43  Score=341.11  Aligned_cols=271  Identities=21%  Similarity=0.290  Sum_probs=208.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||++++++|.+...+++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            4689999999999999999999999999999999875422 334668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++......
T Consensus        84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            9999999999875    35689999999999999999999974  37999999999999999999999999998743221


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-hhhc------ccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-MFKD------RKN  321 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~------~~~  321 (426)
                          ......||..|+|||++.+..++.++|||||||++|||++|+.||................. ....      ...
T Consensus       158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence                11234689999999999988999999999999999999999999975443221111100000 0000      000


Q ss_pred             -----------------cccccCCcccC---CC-ChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          322 -----------------FSQMVDPSLQG---QY-PVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       322 -----------------~~~~~~~~~~~---~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                                       ...+.+.....   .. ......++.+|+.+||+.||.+||++.|+++. .+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h-~~~~  303 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH-AFIK  303 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC-HHHh
Confidence                             00000000000   00 01234578899999999999999999999853 3443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-43  Score=342.48  Aligned_cols=266  Identities=23%  Similarity=0.319  Sum_probs=201.5

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----CeeE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQRL  164 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~  164 (426)
                      +|++.+.||+|+||.||+|.+..++..||||.+...  .......+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588899999999999999999999999999998743  223445688999999999999999999988543     2479


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+. ++|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 788888865    35699999999999999999999997   999999999999999999999999999975


Q ss_pred             CCCCCC-cceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh----
Q 014362          245 GPSGDK-THVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK----  317 (426)
Q Consensus       245 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~----  317 (426)
                      ...... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+........    
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            322211 111234579999999999876  6789999999999999999999999977654333222211100000    


Q ss_pred             ----c---ccccccc---cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          318 ----D---RKNFSQM---VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       318 ----~---~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          .   ...+..+   ........+ ......+.+++.+||+.+|++||++.++++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                0   0000000   000000001 1123467899999999999999999999953

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-43  Score=331.86  Aligned_cols=258  Identities=29%  Similarity=0.436  Sum_probs=209.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ++|.+.+.||+|+||.||+|.+..     ++..||||.+...... ....+.+|+.+|+.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            468888899999999999998753     3578999999765444 4567999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          165 LVYEYMPLGSLDKHLHDLR----------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      +||||+++++|.+++....          .....+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence            9999999999999997532          1235588999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........+..  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~--  239 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ--  239 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--
Confidence            9999999875433222222223356788999999999999999999999999999998 9999976554332221110  


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                            .         .....+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus       240 ------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 ------G---------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ------C---------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                  0         001112234457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-43  Score=345.21  Aligned_cols=265  Identities=23%  Similarity=0.298  Sum_probs=213.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-C-----CCcceEeeEEeeCCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-H-----PNLVKLIGYCAEGDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~~~~~~~~~~~  162 (426)
                      +..+|.+.+.||+|+||.|.+|.+..|++.||||++++. ..-..+...|+.+|..|+ |     -|+|+++++|...++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            344889999999999999999999999999999999865 344566778999999987 4     389999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC--CceeEeccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--YHPKLSDFG  240 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfg  240 (426)
                      +|||+|.+. -+|+++|+..  ...+++...++.|+.||+.||.+||..   +|||+||||+||||.+.  ..+||+|||
T Consensus       263 lciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            999999994 7999999873  456799999999999999999999987   99999999999999764  369999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----  315 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----  315 (426)
                      .|......-.     ..+-+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+.+..+......     
T Consensus       337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m  411 (586)
T KOG0667|consen  337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM  411 (586)
T ss_pred             cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9986443321     456788999999999999999999999999999999999999999888877766433211     


Q ss_pred             hhcccccccccCC-----------------------------cccCCCC-----------hHhHHHHHHHHHhccccCCC
Q 014362          316 FKDRKNFSQMVDP-----------------------------SLQGQYP-----------VRGLYQALAIAAMCVQEQPN  355 (426)
Q Consensus       316 ~~~~~~~~~~~~~-----------------------------~~~~~~~-----------~~~~~~l~~li~~cl~~dP~  355 (426)
                      +........+++.                             ......|           ......+.+++.+||.+||.
T Consensus       412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~  491 (586)
T KOG0667|consen  412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA  491 (586)
T ss_pred             HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence            1111111111111                             0000111           23344789999999999999


Q ss_pred             CCCCHHHHHH
Q 014362          356 MRPAITDVVM  365 (426)
Q Consensus       356 ~RPs~~eil~  365 (426)
                      +|+|..++++
T Consensus       492 ~R~tp~qal~  501 (586)
T KOG0667|consen  492 ERITPAQALN  501 (586)
T ss_pred             hcCCHHHHhc
Confidence            9999999985

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.4e-43  Score=347.65  Aligned_cols=263  Identities=23%  Similarity=0.347  Sum_probs=208.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  162 (426)
                      .++|++.+.||.|+||.||+|.+...     +..||||.+..... ...+.+..|+.+|+.+. ||||++++++|.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            46789999999999999999987432     35799999975433 33457899999999996 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCC----------------------------------------------------------
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRP----------------------------------------------------------  184 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  184 (426)
                      .||||||+++|+|.++|+....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999998865211                                                          


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc
Q 014362          185 ----------------------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE  230 (426)
Q Consensus       185 ----------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~  230 (426)
                                                        ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence                                              113578889999999999999999987   9999999999999999


Q ss_pred             CCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHH
Q 014362          231 GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV  309 (426)
Q Consensus       231 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~  309 (426)
                      ++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            99999999999975433222222223457788999999999999999999999999999997 99998754322111000


Q ss_pred             HhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          310 AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                            ....          .....+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       353 ------~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         353 ------IKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ------HhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                  0000          011122334567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=348.45  Aligned_cols=254  Identities=21%  Similarity=0.274  Sum_probs=202.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|.+..+++.||||.+....   ......+..|+.+++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            36899999999999999999999999999999986532   233566888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            99999999999875    35689999999999999999999987   999999999999999999999999999863211


Q ss_pred             CCCc---------------------------------------------ceeeeecccccccCccccccCCCCccCchhh
Q 014362          248 GDKT---------------------------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYS  282 (426)
Q Consensus       248 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwS  282 (426)
                      ....                                             ......+||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                             0001246999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCC---CC
Q 014362          283 FGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMR---PA  359 (426)
Q Consensus       283 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps  359 (426)
                      |||++|||++|..||...........+.....    ...+.          .....+..+.+|+.+||. +|.+|   ++
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----~~~~p----------~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHETYRKIINWRE----TLYFP----------DDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHHHHHHHHccCC----ccCCC----------CCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            99999999999999976554332221110000    00000          011234578899999997 66665   59


Q ss_pred             HHHHHHH
Q 014362          360 ITDVVMA  366 (426)
Q Consensus       360 ~~eil~~  366 (426)
                      +.+++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-43  Score=339.33  Aligned_cols=236  Identities=29%  Similarity=0.422  Sum_probs=195.3

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.++.+++.||||++....   ......+..|..++..+ +||||+++++++.+...+|+||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5999999999999999999999999987532   23455677888888776 6999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          82 DLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             hHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99988875    35689999999999999999999987   99999999999999999999999999987432211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      ....            .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------~~~~------------~  214 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDEV------------V  214 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh------cCCC------------C
Confidence            234579999999999999999999999999999999999999998765433222211      0000            1


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                      .+...+..+.+|+.+||+.||.+||++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            122344578999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-43  Score=334.54  Aligned_cols=240  Identities=30%  Similarity=0.439  Sum_probs=196.1

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhc-CCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..+++.||||.+....   ......+..|..++.. ++||||+++++++.+...+++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999999999999999997542   2234556677777775 58999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05619          82 DLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K  152 (316)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence            99999875    35689999999999999999999987   999999999999999999999999999874322211  2


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+....              +    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------------~----~  214 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--------------P----C  214 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------------C----C
Confidence            234579999999999999999999999999999999999999998655433222221100              0    1


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHH-HHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAIT-DVV  364 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil  364 (426)
                      ++......+.+|+.+||+.+|.+||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            1222345788999999999999999997 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.8e-43  Score=335.84  Aligned_cols=242  Identities=29%  Similarity=0.389  Sum_probs=197.9

Q ss_pred             ceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC----cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           97 CCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +.||+|+||.||+++..   .+++.||||.+....    ......+..|+.+|+.++||||++++++|..+..+|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            56999999999999863   468899999987532    22345578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..    ...+.+..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999875    35688899999999999999999987   99999999999999999999999999987432211


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      ...          
T Consensus       155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~------~~~----------  216 (323)
T cd05584         155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------KGK----------  216 (323)
T ss_pred             --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCC----------
Confidence              11233579999999999999899999999999999999999999998655432221111      100          


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                        ...|......+.+|+.+||+.+|.+||     ++.+++.
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence              012233445788999999999999999     7888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-43  Score=347.30  Aligned_cols=254  Identities=22%  Similarity=0.222  Sum_probs=203.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|++..+++.||||.+....   ......+.+|+.+|+.++||||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36999999999999999999999999999999986532   223466889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999999975    35689999999999999999999987   999999999999999999999999999752210


Q ss_pred             CC-----------------------------------------CcceeeeecccccccCccccccCCCCccCchhhHHHH
Q 014362          248 GD-----------------------------------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVV  286 (426)
Q Consensus       248 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~i  286 (426)
                      ..                                         ........+||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                         0000123479999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC---CHHHH
Q 014362          287 LLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP---AITDV  363 (426)
Q Consensus       287 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ei  363 (426)
                      +|||++|+.||...........+.....          .+    ........+..+.+++.+|+ .+|.+|+   ++.++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~~i~~~~~----------~~----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQLKVINWET----------TL----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHHHHhccCc----------cc----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            9999999999987654433221111000          00    00011123446778888876 5999999   88998


Q ss_pred             HHH
Q 014362          364 VMA  366 (426)
Q Consensus       364 l~~  366 (426)
                      +..
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.1e-43  Score=331.59  Aligned_cols=262  Identities=29%  Similarity=0.443  Sum_probs=213.2

Q ss_pred             CCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|.+.+.||+|+||.||+|.+.     .++..+++|.+........+.+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45888889999999999999864     3456799999877665566779999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc
Q 014362          166 VYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH  233 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~  233 (426)
                      ||||+++++|.+++.....            ....+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            9999999999999975321            224589999999999999999999987   9999999999999999999


Q ss_pred             eeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhh
Q 014362          234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  312 (426)
                      ++|+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||...........+.. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-  240 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-  240 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC-
Confidence            99999999975433322222233457889999999999999999999999999999999 9999876554332211110 


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                             ....         ..+...+..+.+++.+||+.+|.+||++.+|++.|..+..
T Consensus       241 -------~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         241 -------GRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -------CCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                   0000         1122234578899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.2e-43  Score=338.56  Aligned_cols=242  Identities=26%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      +|++.+.||+|+||.||+|.+..+++.||||.+....   ......+..|..++..+ +|++|+.+++++.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999999999999999987542   22344566777887776 5899999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            99999999988865    35689999999999999999999987   999999999999999999999999999874322


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...      .        
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------~--------  217 (323)
T cd05616         154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH------N--------  217 (323)
T ss_pred             CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------C--------
Confidence            11  1223457999999999999999999999999999999999999999876543322222110      0        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                          ..+|...+..+.+|+.+||+.+|.+|++.
T Consensus       218 ----~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 ----VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ----CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                11233345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-43  Score=348.26  Aligned_cols=252  Identities=23%  Similarity=0.253  Sum_probs=200.7

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +|++.+.||+|+||.||+|++..+++.||||.+....   ......+..|+.+++.++||||+++++.+.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999999999999999997542   2335668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            9999999999875    35689999999999999999999987   9999999999999999999999999997532100


Q ss_pred             C---------------------------------------------CcceeeeecccccccCccccccCCCCccCchhhH
Q 014362          249 D---------------------------------------------KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSF  283 (426)
Q Consensus       249 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl  283 (426)
                      .                                             ........+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                             0000123479999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC---H
Q 014362          284 GVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA---I  360 (426)
Q Consensus       284 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~  360 (426)
                      ||++|||++|+.||...........+.....              .+........+.++.+++.+++ .+|.+|++   +
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVINWQT--------------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHccCC--------------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999999987654332211110000              0000001123456788888866 59999997   7


Q ss_pred             HHHHH
Q 014362          361 TDVVM  365 (426)
Q Consensus       361 ~eil~  365 (426)
                      .++++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            77764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-43  Score=339.38  Aligned_cols=242  Identities=30%  Similarity=0.405  Sum_probs=198.6

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..+++.||||++....   ......+..|..++..+ +||||+++++++.+...+|+||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5999999999999999999999999987532   23345677888888765 7999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......  ..
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~  152 (321)
T cd05591          82 DLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT  152 (321)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence            99988875    35689999999999999999999987   99999999999999999999999999987532221  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      ....            .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~------~~~~------------~  214 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL------HDDV------------L  214 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCC------------C
Confidence            234579999999999999999999999999999999999999998765433222111      0000            1


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCC-------CHHHHHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRP-------AITDVVMA  366 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~  366 (426)
                      +|...+.++.+|+.+||+.||.+||       ++.++++.
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            1222345789999999999999999       77777743

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.4e-43  Score=325.29  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .+|.+.+.||.|+||.||+|.+..++..||+|.+... ......+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            4578888999999999999999999999999998754 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||++........
T Consensus        85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            999999998652  235689999999999999999999987   999999999999999999999999999976433221


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      . ......++..|+|||++.+..++.++|||||||++|||++ |..||...........+.                 ..
T Consensus       160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-----------------~~  221 (263)
T cd05052         160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KG  221 (263)
T ss_pred             e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-----------------CC
Confidence            1 1111234668999999999999999999999999999998 999987654322211111                 01


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      .....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11122334456889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.3e-43  Score=330.85  Aligned_cols=248  Identities=24%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||+|+||+||++.+..+++.||+|.+.....   .....+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999999999999999875432   2345677899999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      ..++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988865444456799999999999999999999987   999999999999999999999999999975433221  123


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.............  ....          ..  ...++
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~----------~~--~~~~~  221 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRIL----------ND--SVTYP  221 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--Hhhc----------cc--CCCCc
Confidence            3578999999999999999999999999999999999999997643321111000  0000          00  01223


Q ss_pred             hHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                      ...+..+.+++.+||+.||++||     ++++++.
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            34556789999999999999999     6677774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.8e-43  Score=339.76  Aligned_cols=264  Identities=26%  Similarity=0.381  Sum_probs=207.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC-C
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG-D  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~  161 (426)
                      .++|++.+.||.|+||.||+|.+..     +++.||+|++..... ...+.+..|+.++..+ +||||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3579999999999999999997543     357899999875432 3345678899999999 899999999988644 5


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCC--------------------------------------------------------
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPD--------------------------------------------------------  185 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  185 (426)
                      .++++|||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            688999999999999998642210                                                        


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeeccccccc
Q 014362          186 -TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC  264 (426)
Q Consensus       186 -~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~  264 (426)
                       ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++...............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             13689999999999999999999987   99999999999999999999999999998643322222222345677899


Q ss_pred             CccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHH
Q 014362          265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQAL  343 (426)
Q Consensus       265 aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  343 (426)
                      |||++.+..++.++|||||||++|||++ |..||......+...  .    .....          .....+......+.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~--~----~~~~~----------~~~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC--R----RLKEG----------TRMRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH--H----HHhcc----------CCCCCCccCCHHHH
Confidence            9999999999999999999999999998 999997643322110  0    01000          01111233445789


Q ss_pred             HHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          344 AIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       344 ~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      +++.+||+.+|++||++.+|++.|+.+..
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.2e-43  Score=330.15  Aligned_cols=260  Identities=26%  Similarity=0.444  Sum_probs=206.8

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      ..++|++.+.||+|+||.||+|.+..     ++..||||.+.... .....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45679999999999999999998753     35679999986432 2334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCC------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPD------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      .++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.   +++|+||||+|||+++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence            99999999999999999763321      23467889999999999999999987   9999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........+...   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---  237 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG---  237 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---
Confidence            99999875433222211122345788999999999999999999999999999999 78898765443222111100   


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                           ..         ...+...+..+.+++.+||+.+|.+||++.|+++.|+
T Consensus       238 -----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         238 -----GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -----Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                 00         0112233457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-42  Score=327.20  Aligned_cols=258  Identities=26%  Similarity=0.429  Sum_probs=205.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|++.+.||.|+||.||+|.+..++.    .+++|.+..... ....++..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            468888999999999999999976665    477888754322 234567888889999999999999998864 45788


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ++||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            9999999999999976   235689999999999999999999987   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............++..|+|||++.++.++.++||||||+++|||++ |..||...........+.       .....  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~~--  230 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGERL--  230 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCcC--
Confidence            43332222334467789999999999999999999999999999998 999997654433222211       00000  


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                              ..+..+...+..++.+||..+|.+||++.|+++.|..+..
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 --------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                    0111233467889999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=324.59  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=208.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||.||+|.+...   ...||||.+..... .....+..|+.+++.++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5688999999999999999998643   45799999875433 3345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +|+|+||||+|||+++++.++|+|||+++...
T Consensus        84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999876   234789999999999999999999987   99999999999999999999999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+..       ..     
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-------~~-----  225 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------GY-----  225 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-------CC-----
Confidence            2222222222345678999999998999999999999999999998 9999965443222111110       00     


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                           ....+...+..+.+|+.+||+.+|++||++.+|++.|+.+
T Consensus       226 -----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 -----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 0011223445789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.1e-43  Score=345.88  Aligned_cols=255  Identities=21%  Similarity=0.220  Sum_probs=205.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+....   ......+..|+.+++.++||||+++++++.+...+++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3457999999999999999999999999999999996432   2334557889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            9999999999999865     3588899999999999999999987   9999999999999999999999999999754


Q ss_pred             CCCCCcceeeeecccccccCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ..... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||...........+.....      .
T Consensus       193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------~  265 (370)
T cd05596         193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN------S  265 (370)
T ss_pred             cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------c
Confidence            32211 112335799999999998754    478999999999999999999999987554322211111000      0


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVMA  366 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  366 (426)
                              +.-......+..+.+|+.+||+.+|.+  ||++.+++..
T Consensus       266 --------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 --------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                    000001123568899999999999988  9999999854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7e-43  Score=331.26  Aligned_cols=263  Identities=26%  Similarity=0.393  Sum_probs=211.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  161 (426)
                      ..++|++.+.||+|+||.||+|.+...     ...+|+|.+.... ......+.+|+.++..+ +||||+++++++....
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            345788999999999999999998643     3789999987542 23456688999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE  229 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~  229 (426)
                      .+++||||+++|+|..++....            .....+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence            9999999999999999997532            2345789999999999999999999987   999999999999999


Q ss_pred             cCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcH
Q 014362          230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL  308 (426)
Q Consensus       230 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  308 (426)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            999999999999986543322222222345678999999999999999999999999999998 9999876543332221


Q ss_pred             HHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      +..                 ......+......+.+|+.+||..+|.+||++.+|++.|+.+.
T Consensus       247 ~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         247 LKE-----------------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHc-----------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            110                 0011123334557899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-42  Score=322.63  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHH
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      .||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            59999999999999998899999998865432 33566899999999999999999999999999999999999999999


Q ss_pred             HHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeee
Q 014362          177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR  256 (426)
Q Consensus       177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  256 (426)
                      +++..   ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..............
T Consensus        82 ~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          82 TFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99865   235689999999999999999999987   999999999999999999999999999875332211111111


Q ss_pred             ecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       257 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ..++..|+|||.+.++.++.++||||||+++|||++ |..||...........+..                 ......+
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-----------------~~~~~~~  218 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-----------------GVRLPCP  218 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-----------------CCCCCCc
Confidence            123457999999999999999999999999999998 8888875443221111110                 0111223


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ...+..+.+|+.+||+.+|.+||++.+|++.|.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            334558899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=334.84  Aligned_cols=250  Identities=23%  Similarity=0.326  Sum_probs=218.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      +.+=|.+.+.||+|.|..|-+|++-.+|..||||++.+.....  ...+..|++.|+.++|||||++|++......+|||
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            3456888888999999999999999999999999998875543  45688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-cCCceeEecccccccC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMG  245 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~  245 (426)
                      +|.-++|+|+++|-.   ....+.+..+.+++.||+.|+.|+|..   .+|||||||+||.+- .-|.+||+|||++-.+
T Consensus        96 LELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            999999999999976   457799999999999999999999998   899999999999875 4688999999999765


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..+...   +..||+..|-|||++.+..|+ +++||||||||||.|++|++||...++.+.+-++...+           
T Consensus       170 ~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK-----------  235 (864)
T KOG4717|consen  170 QPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK-----------  235 (864)
T ss_pred             CCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-----------
Confidence            554332   456999999999999999998 78899999999999999999999888776664443221           


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             -..|...+.++.+||..||..||.+|.+.++|+.
T Consensus       236 -------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 -------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                   1346777889999999999999999999999874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.4e-42  Score=333.26  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=196.8

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..+++.||+|++...   .......+..|+.++..+ +||||+++++++.....+++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            599999999999999999999999999754   223445677888888776 7999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~  152 (329)
T cd05618          82 DLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT  152 (329)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence            99888865    35699999999999999999999987   99999999999999999999999999987432211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhh--hcHHHhhhhhhhcccccccccCCccc
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE--LNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+.....         ..  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~--~~  221 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LE--KQ  221 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hc--CC
Confidence            2345799999999999999999999999999999999999999964221110  00011100000         00  01


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPA------ITDVVM  365 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~  365 (426)
                      ..+|......+.+|+.+||+.||.+||+      +.+++.
T Consensus       222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         222 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            1233445567889999999999999998      456653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.9e-43  Score=327.21  Aligned_cols=255  Identities=28%  Similarity=0.447  Sum_probs=212.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ..+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            4568889999999999999999988 889999999877665667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999763  245689999999999999999999987   99999999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                        .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+..                 
T Consensus       159 --~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----------------  219 (261)
T cd05148         159 --YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-----------------  219 (261)
T ss_pred             --ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-----------------
Confidence              11123346778999999998899999999999999999998 8999976553332222110                 


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                      ......+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            01111233445678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1e-42  Score=329.70  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=199.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcC-CCEEEEEEEeccCCc--ccHHHHHHHHHHHhcC---CCCCcceEeeEEe-----e
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV--QGVREFSAEVMTLGSA---DHPNLVKLIGYCA-----E  159 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~-----~  159 (426)
                      .+|++.+.||+|+||.||+|.+.. ++..||||.+.....  .....+.+|+.+++.+   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368999999999999999999854 478899999865432  2234456677766655   7999999999885     2


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ...+++||||++ ++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 6898888753  234589999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|++||...........+....... ..
T Consensus       155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~-~~  230 (290)
T cd07862         155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP-GE  230 (290)
T ss_pred             cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Ch
Confidence            999754322   12234578999999999998899999999999999999999999998766544333322111000 00


Q ss_pred             ccccc-------ccCCcccC---CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQ-------MVDPSLQG---QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+..       .+.+....   .........+.+|+.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000       00000000   011123456789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.7e-42  Score=322.34  Aligned_cols=261  Identities=24%  Similarity=0.358  Sum_probs=213.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....   ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999999889999999886432   233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|..++.........+++..++.++.+++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999976544556789999999999999999999987   999999999999999999999999999875433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ...  ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......    .........           
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-----------  221 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-----------  221 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhh-----------
Confidence            221  122346889999999999889999999999999999999999999654311    111000000           


Q ss_pred             CcccCCCCh-HhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          328 PSLQGQYPV-RGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       328 ~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      .......+. .....+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             cCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            000111122 34557889999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=344.21  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=211.2

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHH
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDK  177 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~  177 (426)
                      +||+|+||+||-|++..+...+|||.+.....+..+.+.+|+.+-+.|+|.|||+++|.+..+..+-|+||-++||||..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            49999999999999999999999999998888888999999999999999999999999999999999999999999999


Q ss_pred             HhhhhCCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccCCCCCCccee
Q 014362          178 HLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVS  254 (426)
Q Consensus       178 ~l~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~  254 (426)
                      +|+.   .-+++  .+...-.+..||++||.|||..   .|||||||-+|||++. .|.+||+|||.++.+..  .+..+
T Consensus       662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T  733 (1226)
T KOG4279|consen  662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT  733 (1226)
T ss_pred             HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence            9986   45667  7889999999999999999987   9999999999999975 68999999999986432  23345


Q ss_pred             eeecccccccCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          255 TRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                      ..+.||..|||||++..+  .|+.++|||||||++.||.||++||.........   .+.-.++            ....
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA---MFkVGmy------------KvHP  798 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA---MFKVGMY------------KVHP  798 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh---hhhhcce------------ecCC
Confidence            567899999999999866  5899999999999999999999999765432211   1111111            1233


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..|...+.++.++|.+|+.+||.+||++.++++
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            567788889999999999999999999999985

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.4e-43  Score=336.84  Aligned_cols=248  Identities=26%  Similarity=0.392  Sum_probs=197.8

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..+++.||||++....   ......+..|..++..+ +||||++++++|.+...+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5999999999999999999999999997532   23345678899999888 7999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          82 DLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            99988865    35799999999999999999999987   99999999999999999999999999987422211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchh--hhcHHHhhhhhhhcccccccccCCccc
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK--ELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.....         ...  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~--~  221 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LEK--Q  221 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------HcC--C
Confidence            234579999999999999999999999999999999999999996432211  000011100000         000  0


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCC------HHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPA------ITDVVM  365 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~  365 (426)
                      ...|...+..+.+++.+||+.||.+||+      +.++++
T Consensus       222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            1123344567899999999999999997      566663

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6e-43  Score=335.91  Aligned_cols=241  Identities=29%  Similarity=0.413  Sum_probs=198.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||+||+|.+..+++.||||++....   ......+..|..++..+ +||||+++++++.+...+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999999999999999997542   23455677888888877 6999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  152 (318)
T cd05570          82 DLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT  152 (318)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence            99988875    35699999999999999999999987   99999999999999999999999999986422211  11


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..      ..            ..
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~------~~------------~~  214 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE------DE------------VR  214 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc------CC------------CC
Confidence            2335799999999999999999999999999999999999999976543322211110      00            01


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAI-----TDVVM  365 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~  365 (426)
                      ++...+..+.+|+.+||+.||.+||++     .+++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            223344578999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=327.68  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +|++.+.||+|+||+||++.+..+++.||||.+.....   .....+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48888999999999999999998999999999975432   223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|..++...  ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888652  235689999999999999999999987   9999999999999999999999999999764322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ..   .....|++.|+|||++.+..++.++|||||||++|||++|..||...........+..  ....           
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--~~~~-----------  219 (285)
T cd05605         156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--RVKE-----------  219 (285)
T ss_pred             Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--Hhhh-----------
Confidence            21   1234789999999999988999999999999999999999999986543221111110  0000           


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMA  366 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  366 (426)
                       ....++...+..+.+|+.+||+.||.+||     ++.++++.
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             01122334455788999999999999999     78888753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.5e-43  Score=343.24  Aligned_cols=255  Identities=21%  Similarity=0.232  Sum_probs=203.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+.+..   ......+.+|+.+++.++||||+++++++.++..+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578999999999999999999999999999999986432   2234557889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            9999999999999865     3588999999999999999999987   9999999999999999999999999999764


Q ss_pred             CCCCCcceeeeecccccccCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ..... .......||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+....      ..
T Consensus       193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~------~~  265 (370)
T cd05621         193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK------NS  265 (370)
T ss_pred             ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------cc
Confidence            32211 1123457999999999987543    7899999999999999999999998655432221111100      00


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVMA  366 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  366 (426)
                              +.-......+..+.+++..||..++.+  ||++.++++.
T Consensus       266 --------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 --------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                    000001123457788999999866544  8999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-42  Score=333.28  Aligned_cols=237  Identities=27%  Similarity=0.332  Sum_probs=192.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHH-HHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||+||+|.+..+|+.||||++.....   .....+..|.. +++.++||||+++++++......++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            59999999999999999999999999975321   22344555544 567899999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            99998875    45689999999999999999999987   99999999999999999999999999987432211  22


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.      ....            .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~~~------------~  214 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL------NKPL------------R  214 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH------cCCC------------C
Confidence            234579999999999999999999999999999999999999997654332221111      0000            1


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAIT  361 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  361 (426)
                      .+...+..+.+++.+||+.+|.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         215 LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1122345788999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-42  Score=324.54  Aligned_cols=255  Identities=23%  Similarity=0.321  Sum_probs=205.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..........+..|+.+++.++||||+++++++.....+++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999999989999999999765545566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++.......
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            999999998865    35689999999999999999999987   99999999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .  ......|++.|+|||.+.   ...++.++|||||||++|||++|..||...........+..           ....
T Consensus       161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~-----------~~~~  227 (267)
T cd06646         161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK-----------SNFQ  227 (267)
T ss_pred             c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec-----------CCCC
Confidence            1  112346889999999874   44578899999999999999999999965433221110000           0000


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .+...  .....+..+.+++.+||+.+|++||++.+|++.
T Consensus       228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence            01110  112334588999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-42  Score=324.38  Aligned_cols=262  Identities=24%  Similarity=0.333  Sum_probs=212.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||.|+||.||+|.+..++..+|||.+....   ......+..|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999999999889999999886532   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++.........+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999999876444456789999999999999999999987   999999999999999999999999999875433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .....   .       +.....
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~-------~~~~~~  225 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---K-------IEQCDY  225 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh---h-------hhcCCC
Confidence            221  1123468999999999998899999999999999999999999996543211 11100   0       000000


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      +.   ..+...+..+.+++.+||+.+|.+||++.+|++.+..+.
T Consensus       226 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         226 PP---LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CC---CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            00   112234557899999999999999999999999988763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9e-43  Score=328.88  Aligned_cols=258  Identities=26%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      +|++.+.||.|+||.||+|.+..+     +..||||.+...... ....+..|+.++..++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            477788899999999999987543     578999999755332 34568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc
Q 014362          166 VYEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH  233 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~  233 (426)
                      ++||+++++|.+++....            .....+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence            999999999999985321            1124588899999999999999999987   9999999999999999999


Q ss_pred             eeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhh
Q 014362          234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  312 (426)
                      +||+|||+++...............+++.|+|||.+.++.++.++|||||||++|||++ |..||...........+...
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~  242 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR  242 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999886443332222233456789999999998899999999999999999998 88888765443222221110


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                                       .....+..++..+.+|+..||+.+|.+||++.+|+..|+.
T Consensus       243 -----------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         243 -----------------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                             0011233455678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-42  Score=322.81  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|++.+.||+|+||.||+|.++. +..+|+|.+.... .....+..|+.+++.++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            458888999999999999998875 5679999886443 33467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++|+|.++++..   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence            999999998752   24589999999999999999999987   999999999999999999999999999875432211


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                       .......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+....          ..    
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~----------~~----  220 (256)
T cd05114         156 -TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF----------RL----  220 (256)
T ss_pred             -eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC----------CC----
Confidence             11122245678999999998899999999999999999999 899997655433222221100          00    


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                         ..+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus       221 ---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 ---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               01122335789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=323.03  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             ccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe-----
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ-----  162 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  162 (426)
                      |.+.+.||+|+||.||+|.+..+   +..||||.+....  ......+..|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56778899999999999998643   4789999987542  2345678999999999999999999998866554     


Q ss_pred             -eEEEEEecCCCCHHHHhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          163 -RLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       163 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                       .++|+||+++|+|..++....  .....+++..++.++.|++.||.|||+.   +++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             789999999999999986532  1234689999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...........+..       
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-------  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-------  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence            99986543322222222345678999999988899999999999999999999 8889876543322211110       


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ..          ....+...+..+.+++.+||+.||.+||++.+|++.|+.+
T Consensus       231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00          0012233455889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=9.3e-43  Score=339.42  Aligned_cols=249  Identities=23%  Similarity=0.339  Sum_probs=196.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .+|+..+.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++|+||+++++++.+...+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            346677889999999999999999999999999865433 3346688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|...        ....+..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999998542        2356778889999999999999987   99999999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                        .......||..|+|||++..     ...+.++|||||||++|||++|+.||................  .        
T Consensus       223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~--------  290 (353)
T PLN00034        223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--M--------  290 (353)
T ss_pred             --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--c--------
Confidence              11223479999999998743     234568999999999999999999997433221111111000  0        


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          ......+.....++.+|+.+||+.+|++||++.||++.
T Consensus       291 ----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        291 ----SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ----cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00011223345578999999999999999999999964

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=306.93  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=216.0

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----e
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----Q  162 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  162 (426)
                      ...++|++.+.||.|||+.||+++.-.++..||+|++.....+..+..++|++..++++||||++++++...+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            34578999999999999999999999999999999998887788888999999999999999999998875443     4


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .||+++|...|||.+.+......+..+++.+++.|+.+|++||.+||+. .++..||||||.|||+.+.+.++|.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            8999999999999999998777777899999999999999999999987 345999999999999999999999999998


Q ss_pred             ccCCCCCCcce-------eeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          243 KMGPSGDKTHV-------STRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       243 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      ......-....       -....-|..|.|||.+.   +...++++|||||||+||+|+.|..||+..-..         
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------  247 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------  247 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence            75332111100       01123578899999886   446789999999999999999999999743211         


Q ss_pred             hhhhhccccc-ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          313 RPMFKDRKNF-SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       313 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                            +.++ -......+.-.-....+..+.+|+.+||+.||.+||++.+++..++.+.
T Consensus       248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                  0110 1111111111112236678999999999999999999999999887663

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-42  Score=327.87  Aligned_cols=261  Identities=30%  Similarity=0.452  Sum_probs=209.0

Q ss_pred             CccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      +|++.+.||+|+||.||+|....     ....+++|.+..... .....+..|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47888899999999999998753     235789998875432 345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 014362          166 VYEYMPLGSLDKHLHDLRP--------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN  225 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N  225 (426)
                      |+||+++++|.+++.....                    ....+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999999865321                    124588999999999999999999987   99999999999


Q ss_pred             eeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchh
Q 014362          226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK  304 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~  304 (426)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999975433222111223356778999999988899999999999999999999 999997654332


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ......                 .......+...+..+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus       238 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 LFNLLK-----------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHh-----------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            221111                 011112233445678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-42  Score=335.93  Aligned_cols=252  Identities=25%  Similarity=0.327  Sum_probs=200.6

Q ss_pred             CccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC----cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      +|++.+.||+|+||.||+++..   .+++.||+|++.+..    ......+..|+.++..+ +||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4888999999999999998864   468899999987532    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            999999999999999875    35689999999999999999999987   99999999999999999999999999997


Q ss_pred             cCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.  ......    
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~~----  226 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILKC----  226 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhcC----
Confidence            54322221 12235799999999998865 47899999999999999999999997543322111111  111110    


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                          +    ..++......+.+++.+||+.||.+||     ++.++++
T Consensus       227 ----~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 ----D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ----C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                1    112233445788999999999999999     6777774

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-42  Score=328.00  Aligned_cols=259  Identities=31%  Similarity=0.446  Sum_probs=207.0

Q ss_pred             CCccccceeeecCcEEEEEEEEc----CCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|++.+.||+|+||.||+|.+.    .++..||+|.+.... ......+.+|+.+++.++||||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45788899999999999999863    346789999997543 2344678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC
Q 014362          166 VYEYMPLGSLDKHLHDLRP-------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY  232 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~  232 (426)
                      ||||+++++|.+++.....             ....+++..++.++.|++.||.|||+.   +++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999863211             123588999999999999999999987   999999999999999999


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  311 (426)
                      .+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...........+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999975433322222233456778999999988899999999999999999998 9999976543222221111


Q ss_pred             hhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                             ..          ....+...+..+.+++.+||+.+|.+||++.+|++.|..
T Consensus       242 -------~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 -------RQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -------CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                   00          001122344578899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.1e-44  Score=313.45  Aligned_cols=255  Identities=23%  Similarity=0.310  Sum_probs=213.2

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc----c----cHHHHHHHHHHHhcC-CCCCcceEeeEEe
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----Q----GVREFSAEVMTLGSA-DHPNLVKLIGYCA  158 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~----~~~~~~~E~~~l~~l-~hpniv~~~~~~~  158 (426)
                      .....|...+.||.|..++|.++.++.+|+.+|+|++.....    +    ..+.-..|+.+|+++ .||+|+.+.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            344567777889999999999999999999999999865322    1    123356799999997 5999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      .+..+++|+|.|+.|.|.++|..    .-.+++.....|++|++.|++|||..   +||||||||+|||+|++.++||+|
T Consensus        94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence            99999999999999999999976    57799999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCcccccc------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      ||+++....+...   ...||||+|+|||.+.-      ..|+..+|+||+|||+|-|+.|.+||......-.+.++...
T Consensus       167 FGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG  243 (411)
T KOG0599|consen  167 FGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG  243 (411)
T ss_pred             cceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence            9999977665543   34699999999998853      36889999999999999999999999877655555555443


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +..+..              ..-...+....+||.+||+.||.+|.|++|++..
T Consensus       244 kyqF~s--------------peWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  244 KYQFRS--------------PEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             ccccCC--------------cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            332221              1122344577899999999999999999999953

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-42  Score=321.71  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=206.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-----ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|.+.+.||.|++|.||+|....+++.||+|.+.....     .....+.+|+.+++.++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            578999999999999999999998899999999865422     234568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||+++..
T Consensus        82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999999999876    35688999999999999999999987   9999999999999999999999999998754


Q ss_pred             CCCCCcce-eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||.............              
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------------  220 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--------------  220 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh--------------
Confidence            32211111 123467889999999999899999999999999999999999997654322211110              


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        ........+......+.+++.+||..+|.+||++.++++.
T Consensus       221 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         221 --TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              0001112233445578999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-42  Score=325.90  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=209.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||.|+||.||+|.+...     +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            35789999999999999999998643     37899999875432 3455688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEe
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS  237 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  237 (426)
                      ++||||+++|+|.+++.....      ....+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            999999999999999975432      123478999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence            9999875433322222233456889999999988899999999999999999998 999997654433222111      


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                       ...          ....|...+..+.+++.+||+.+|.+||++.+|+..|+
T Consensus       236 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 -DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             000          01122333568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=334.68  Aligned_cols=253  Identities=24%  Similarity=0.254  Sum_probs=216.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  164 (426)
                      ....|.+.+.||+|.||.||++..+.+|+.+|+|.+.+....   ....+.+|+.+|+.+. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            446788889999999999999999999999999999876543   3467999999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC----CceeEeccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG----YHPKLSDFG  240 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfg  240 (426)
                      +|||++.||.|.+.+...     .+++..+..++.||+.|+.|||+.   +|+||||||+|+|+...    +.+|++|||
T Consensus       113 lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            999999999999999873     399999999999999999999997   99999999999999643    579999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      ++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+.....      
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------  255 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------  255 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence            9987554   2344567999999999999999999999999999999999999999998776555443332211      


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              .+....-......+.+++..||..||..|+++.++++.
T Consensus       256 --------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 --------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             --------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                    11112223345688999999999999999999999974

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-42  Score=341.53  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=199.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....      ..+.+|+.+|+.++||||++++++|......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            4689999999999999999999999999999997532      3467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +. ++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 788888765    35689999999999999999999987   99999999999999999999999999996432211


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCch-------hhhcHHHhhhhhhhc----
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR-------KELNLVAWARPMFKD----  318 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~----  318 (426)
                       ........||+.|+|||++.+..++.++|||||||++|||++|..||......       .....+.........    
T Consensus       237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~  315 (391)
T PHA03212        237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI  315 (391)
T ss_pred             -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence             11223457999999999999999999999999999999999999887543211       111111100000000    


Q ss_pred             --cccccccc---------CCcccCCC--ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 --RKNFSQMV---------DPSLQGQY--PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 --~~~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ...+...+         .+..+...  ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              00000000         00000000  0123457889999999999999999999995

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.8e-42  Score=337.93  Aligned_cols=262  Identities=20%  Similarity=0.223  Sum_probs=206.4

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      +.++....++|++.+.||+|+||.||+|.++.+++.||+|.+....   ......+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3344455678999999999999999999999999999999986432   2234557889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ...+++||||+++|+|..++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            9999999999999999999865     3588999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      |+++....... ......+||+.|+|||++.+.    .++.++|||||||++|||++|..||...........+..... 
T Consensus       187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-  264 (371)
T cd05622         187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-  264 (371)
T ss_pred             CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-
Confidence            99975432211 122345799999999998754    378999999999999999999999986554322211110000 


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHHHH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVMAL  367 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L  367 (426)
                           . ..+       ..+...+..+.+++..||..++.+  ||++.+|++..
T Consensus       265 -----~-~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         265 -----S-LTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             -----c-ccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                 0 000       001234557889999999844443  78999988654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-42  Score=326.09  Aligned_cols=258  Identities=30%  Similarity=0.465  Sum_probs=208.2

Q ss_pred             CCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|.+...||+|+||.||++...     .++..+|+|.+..........+..|+.+++.++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778889999999999999743     3467899999887666667789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          166 VYEYMPLGSLDKHLHDLRP-----------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      ||||+++++|.+++.....           ....+++..++.++.||+.||+|||+.   +++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence            9999999999999976321           113588999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||................
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            9999999875433222222223345788999999999999999999999999999998 899997654433222111100


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                                       ....+...+..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus       242 -----------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         242 -----------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -----------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                             00112233457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-42  Score=324.90  Aligned_cols=259  Identities=27%  Similarity=0.405  Sum_probs=207.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|.+.+.||+|+||.||+|.+..     ++..||+|.+..... .....+..|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4568999999999999999999986     778999999875432 3345688999999999999999999999998899


Q ss_pred             EEEEEecCCCCHHHHhhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC---ceeEe
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLS  237 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~  237 (426)
                      ++||||+++++|.+++.....   ....+++..++.++.||+.||.|||+.   +++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence            999999999999999976432   123589999999999999999999987   999999999999998754   58999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...........+...    
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~----  237 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG----  237 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC----
Confidence            9999986432221111112234568999999999999999999999999999997 99999765543322211100    


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                                   .....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       238 -------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 -------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                         011123334557889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=331.46  Aligned_cols=256  Identities=21%  Similarity=0.239  Sum_probs=200.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||++.+..+++.||||++.+.   .......+.+|+.++..++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4689999999999999999999999999999999752   2233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999752   35689999999999999999999987   999999999999999999999999999875432


Q ss_pred             CCCcceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ... .......||+.|+|||++..     ..++.++|||||||++|||++|+.||...........+..      ....+
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~------~~~~~  227 (331)
T cd05597         155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HKEHF  227 (331)
T ss_pred             CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc------CCCcc
Confidence            221 11223469999999999863     4578899999999999999999999976543322211110      00000


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCC--CCCCHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPN--MRPAITDVVMA  366 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~eil~~  366 (426)
                       . +.+     .....+..+.+++.+||..++.  .||++.+++..
T Consensus       228 -~-~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 -Q-FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             -c-CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence             0 000     0112445778889887765443  37899998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-43  Score=350.79  Aligned_cols=261  Identities=23%  Similarity=0.242  Sum_probs=212.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEE-ee------C
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYC-AE------G  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~-~~------~  160 (426)
                      ...++++.+.|.+|||+.||.|.+...|..||+|++-..+....+.+.+|+.+|+.|. |+|||.|++.. ..      .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3457888999999999999999999877999999987777788889999999999997 99999999932 11      1


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      -.++|.||||.||.|-+++.....  ..|++.++++|+.|+++|+++||.. +.+|||||||-+||||+.+|..||||||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence            346799999999999999987543  3499999999999999999999998 6789999999999999999999999999


Q ss_pred             ccccCCCCC-Cccee------eeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHH
Q 014362          241 LAKMGPSGD-KTHVS------TRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA  310 (426)
Q Consensus       241 la~~~~~~~-~~~~~------~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~  310 (426)
                      .+.-....- .....      -...-|+.|+|||.+.   +...++|+|||+|||+||-|+....||+.......     
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-----  266 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-----  266 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE-----
Confidence            986321111 00000      0124689999999774   67899999999999999999999999987643222     


Q ss_pred             hhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                                     ++-.+.-.....++..+.+||..||+.+|.+||++-+|+..+-.++.
T Consensus       267 ---------------lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  267 ---------------LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ---------------EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                           22112111124677789999999999999999999999999887754

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.1e-42  Score=326.39  Aligned_cols=265  Identities=25%  Similarity=0.413  Sum_probs=208.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC----------------EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE----------------QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKL  153 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~  153 (426)
                      .+|++.+.||+|+||.||+|.+..++                ..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            57899999999999999999876533                5689999876533 345678899999999999999999


Q ss_pred             eeEEeeCCeeEEEEEecCCCCHHHHhhhhCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCe
Q 014362          154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI  226 (426)
Q Consensus       154 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI  226 (426)
                      ++++......++||||+++++|..++.....       ....+++..++.++.|++.||.|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999999999999999999999999976431       123689999999999999999999987   999999999999


Q ss_pred             eeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCcCchh
Q 014362          227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRK  304 (426)
Q Consensus       227 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~  304 (426)
                      +++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999975443332223334456789999999998899999999999999999998  677886544322


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      .....   ...+...       ........+...+.++.+|+.+||+.+|.+||++.+|++.|.
T Consensus       242 ~~~~~---~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         242 VIENA---GHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHH---Hhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            21111   1111000       000111112334468999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.8e-42  Score=328.86  Aligned_cols=259  Identities=25%  Similarity=0.389  Sum_probs=207.6

Q ss_pred             CCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      ++|.+.+.||+|+||.||+|.+     ..++..||||.+.... ....+.+..|+.+++++ +||||+++++++......
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4689999999999999999985     3346689999987543 23346788999999999 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.++++...  ...+++.+++.++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||+++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999997522  23489999999999999999999987   99999999999999999999999999997


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ...............++..|+|||.+.+..++.++|||||||++|||++ |..||.............      ..    
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~------~~----  259 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI------KE----  259 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH------Hc----
Confidence            5433322112223346788999999999999999999999999999998 999997654332211110      00    


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                            ......+...+..+.+++.+||..+|++||++.+|++.|..+
T Consensus       260 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 ------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                  001111222345789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-42  Score=333.37  Aligned_cols=244  Identities=27%  Similarity=0.387  Sum_probs=195.8

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..+++.||+|++....   ......+..|+.++..+ +||||+.+++++.+...+|+||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999999999999999997542   23455678899998887 6999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          82 DLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99988865    35699999999999999999999997   99999999999999999999999999987422211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||.....................         .  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~--~~~  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------K--PIR  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------C--CCC
Confidence            23457999999999999999999999999999999999999999754322211111111111100         0  011


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAIT  361 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  361 (426)
                      .|...+..+.+++.+||+.||.+||++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            2333445788999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-42  Score=332.62  Aligned_cols=242  Identities=27%  Similarity=0.368  Sum_probs=198.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  167 (426)
                      +|+..+.||+|+||.||+|.+..+++.||||++....   ......+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778889999999999999999999999999987532   233456778888888875 577888999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            99999999998865    35699999999999999999999987   999999999999999999999999999874322


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      ..        
T Consensus       154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~------~~--------  217 (323)
T cd05615         154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME------HN--------  217 (323)
T ss_pred             CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CC--------
Confidence            11  112335699999999999999999999999999999999999999987654322211111      00        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                          ..+|...+..+.+++.+||+.+|.+|++.
T Consensus       218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                01223344578899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.2e-42  Score=321.15  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=206.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||.|+||.||+|.+.. +..||+|.+.... ...+.+..|+.+++.++||||+++++++.+....++||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            3578999999999999999998764 6679999886543 2356789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999999999763  245688999999999999999999987   99999999999999999999999999998643322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .. ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+..       .      ...
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-------~------~~~  223 (261)
T cd05072         158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-------G------YRM  223 (261)
T ss_pred             ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc-------C------CCC
Confidence            11 1122346778999999998899999999999999999998 9999976543322211110       0      000


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                          ..+...+..+.+++.+||..+|++||++.+|++.|+.
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                1112234578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.7e-42  Score=332.38  Aligned_cols=238  Identities=26%  Similarity=0.312  Sum_probs=192.8

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHH-HHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||+||+|.+..+|+.||||++....   ......+..|.. +++.++||||+++++++...+.+++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            5999999999999999999999999987532   223344555554 567899999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          82 ELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            99888865    45789999999999999999999987   99999999999999999999999999987432211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.      ...    .        .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~------~~~----~--------~  214 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL------HKP----L--------V  214 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH------cCC----c--------c
Confidence            234579999999999999999999999999999999999999998655332221111      000    0        0


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAITD  362 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e  362 (426)
                      .+...+..+.+++.+||+.+|.+||++.+
T Consensus       215 ~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 LRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            11123457789999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-42  Score=341.04  Aligned_cols=263  Identities=24%  Similarity=0.381  Sum_probs=207.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  162 (426)
                      .++|.+.+.||+|+||.||+|++.     .++..||||++..... ...+.+..|+.+|..+. ||||+++++++.....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            345778889999999999999964     3456899999975432 33456889999999997 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCC----------------------------------------------------------
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRP----------------------------------------------------------  184 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  184 (426)
                      .++||||+++|+|.++++....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999975321                                                          


Q ss_pred             ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          185 ------------------------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       185 ------------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                                                          ....+++..++.++.||+.||.|||+.   +++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEE
Confidence                                                113477888999999999999999987   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      ++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~  352 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY  352 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence            9999999999999975432221111223357889999999998899999999999999999998 889987654322211


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      ...      .          ...+...|...+..+.+|+.+||..+|..||++.+|++.|+.+.
T Consensus       353 ~~~------~----------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         353 NAI------K----------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH------H----------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            110      0          00111123334568899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.5e-42  Score=322.91  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=206.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCE----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ..+|++.+.||.|+||+||+|.+..++.    .||+|.+..... .....+..|+.++..+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3568889999999999999999876665    489999875433 3456788999999999999999999998754 578


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +++||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++.
T Consensus        85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999999875   235689999999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ..............+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.       ...   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~---  228 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-------KGE---  228 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCC---
Confidence            543222111112235678999999999999999999999999999998 899987554322211111       000   


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                             ....+...+..+.+++.+||+.||+.||++.++++.|..+...
T Consensus       229 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         229 -------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             -------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence                   0011223445788999999999999999999999998877543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.4e-42  Score=321.49  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=201.6

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCE--EEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------Ce
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------DQ  162 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~  162 (426)
                      |.+.+.||+|+||.||+|.+..++.  .||+|.+....  ......+..|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3566789999999999999887665  69999886542  33456788999999999999999999987432      24


Q ss_pred             eEEEEEecCCCCHHHHhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      .++||||+++|+|..++...+  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874321  2235589999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      +++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...........+.       ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-------~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR-------QG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------cC
Confidence            9986543322111122346778999999999999999999999999999999 788997644332211111       00


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ...          ..+...+..+.+++.+||+.+|++||++.+|++.|+.+
T Consensus       231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000          11223345789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.2e-42  Score=326.08  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=207.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .+|++.+.||.|+||.||+|.+..++..||+|.+..........+..|+.+++.++||||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57899999999999999999999889999999998766666677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..     ..+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++....... 
T Consensus       100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-  170 (296)
T cd06654         100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  170 (296)
T ss_pred             CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-
Confidence            99999999864     4588999999999999999999987   99999999999999999999999999987533221 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                       .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.............      ...  .     +. 
T Consensus       171 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~------~~~--~-----~~-  235 (296)
T cd06654         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNG--T-----PE-  235 (296)
T ss_pred             -cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh------cCC--C-----CC-
Confidence             11223468999999999998889999999999999999999999997654322211100      000  0     00 


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+......+.+++.+||..+|++||++.+|+.
T Consensus       236 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         236 -LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence             0112234457889999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.4e-42  Score=360.28  Aligned_cols=260  Identities=20%  Similarity=0.300  Sum_probs=205.4

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee--CC
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GD  161 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~  161 (426)
                      .....++|.+.+.||.|+||+||+|.+..++..||+|.+.....  .....|..|+.+|+.++|||||+++++|.+  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            34456789999999999999999999999999999999875432  345678899999999999999999998854  45


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----CCCeEecCCCCCCeeecc-------
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL----KQPVIYRDLKCSNILLEE-------  230 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----~~~iiH~Dlkp~NIll~~-------  230 (426)
                      .+||||||+++|+|..+|.........+++..++.|+.||+.||.|||+..    ..+||||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            689999999999999999764444567999999999999999999999852    135999999999999964       


Q ss_pred             ----------CCceeEecccccccCCCCCCcceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          231 ----------GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       231 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                                .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||++|..||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      2358999999997543221   1233579999999999864  458899999999999999999999997


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ........  +..    +...   ..     +   .....+..+.+||..||+.+|.+||++.+++.
T Consensus       245 ~~~~~~ql--i~~----lk~~---p~-----l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANNFSQL--ISE----LKRG---PD-----L---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCcHHHH--HHH----HhcC---CC-----C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            65432221  110    0000   00     0   00122457889999999999999999999984

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=319.48  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=206.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            4568999999999999999999765 5789999987643 3356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            99999999987632  35689999999999999999999987   99999999999999999999999999998654221


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      . ........+..|+|||++.+..++.++||||||+++|||++ |+.||...........+..         .       
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------~-------  220 (261)
T cd05068         158 Y-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---------G-------  220 (261)
T ss_pred             c-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------C-------
Confidence            1 11111223457999999999999999999999999999999 9999976543322211110         0       


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                       .....+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       221 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         221 -YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             0001122344578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-42  Score=334.23  Aligned_cols=240  Identities=26%  Similarity=0.323  Sum_probs=193.2

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHH-HHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEV-MTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|++..+++.||+|++.....   .....+..|. .+++.++||||+++++++...+.+++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            59999999999999999999999999875321   2223344444 4567899999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|..++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          82 ELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            99998875    35688899999999999999999987   99999999999999999999999999987432211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.      ...            ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~------------~~  214 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------NKP------------LQ  214 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH------hCC------------cC
Confidence            234579999999999999999999999999999999999999998655433221111      000            01


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHHHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                      .+...+..+.+++.+||+.+|.+||++.+.+
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            1223345788999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.9e-43  Score=340.46  Aligned_cols=253  Identities=23%  Similarity=0.289  Sum_probs=201.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....   ......+..|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999999999999999997532   234566888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            99999999999875    35689999999999999999999987   999999999999999999999999999864322


Q ss_pred             CCCc---------------------------------ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC
Q 014362          248 GDKT---------------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR  294 (426)
Q Consensus       248 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~  294 (426)
                      ....                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            1100                                 0011347999999999999999999999999999999999999


Q ss_pred             CCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 014362          295 KAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA---ITDVVM  365 (426)
Q Consensus       295 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~  365 (426)
                      .||...........+......+        .+.+      ....+..+.+|+.+++ .+|.+|++   +.++++
T Consensus       234 ~Pf~~~~~~~~~~~i~~~~~~~--------~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         234 PPFCSETPQETYRKVMNWKETL--------VFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCCHHHHHHHHHcCCCce--------ecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9998765443322221100000        0000      0113457788888876 49999985   566653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.8e-42  Score=326.91  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=211.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEc-------CCCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE-------KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  160 (426)
                      ..+|.+.+.||+|+||.||+|.+.       ..+..||+|.+.... ....+.+..|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            457889999999999999999753       234579999987542 34456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      ...++||||+++|+|.+++.....            ....+++..++.++.||+.||.|||+.   +++||||||+|||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence            999999999999999999976322            124578899999999999999999987   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  250 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  250 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            9999999999999986543322222223346778999999999899999999999999999998 788886654332222


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .+.       ..          .....+..++..+.+|+.+||+.+|.+||++.+|++.|..+...
T Consensus       251 ~~~-------~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         251 LLK-------EG----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHH-------cC----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            111       00          01112334456889999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-42  Score=326.70  Aligned_cols=265  Identities=23%  Similarity=0.374  Sum_probs=205.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCC--------------CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKI--------------EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIG  155 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~  155 (426)
                      ++|++.+.||+|+||.||++.+..+              ...||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5799999999999999999987543              34599999875432 33456889999999999999999999


Q ss_pred             EEeeCCeeEEEEEecCCCCHHHHhhhhCC--------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCee
Q 014362          156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       156 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl  227 (426)
                      ++......++||||+++++|.+++.....        ....+++..++.++.|++.||.|||+.   +++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence            99999999999999999999999865210        112478899999999999999999987   9999999999999


Q ss_pred             eccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCcCchhh
Q 014362          228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRKE  305 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~~  305 (426)
                      ++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||........
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999975433322222223345778999999999999999999999999999998  6677765543322


Q ss_pred             hcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ......   .+....  .     ......+...+..+.+|+.+||+.+|.+||++.+|++.|.
T Consensus       242 ~~~~~~---~~~~~~--~-----~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IENTGE---FFRNQG--R-----QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHH---hhhhcc--c-----cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            211110   010000  0     0000112223458899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.8e-42  Score=329.53  Aligned_cols=237  Identities=26%  Similarity=0.327  Sum_probs=191.8

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHH-HHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|++..+++.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            59999999999999999999999999875322   22334555554 678899999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      +|...+..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  ..
T Consensus        82 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          82 ELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            99888865    35688999999999999999999987   99999999999999999999999999987432211  12


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.......+      ....            ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~~~------------~~  214 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI------LHKP------------LQ  214 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH------hcCC------------CC
Confidence            23457999999999999999999999999999999999999999765432221111      1000            01


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAIT  361 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~  361 (426)
                      .+......+.+++.+||+.+|.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            2233445788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-43  Score=335.10  Aligned_cols=239  Identities=27%  Similarity=0.344  Sum_probs=195.9

Q ss_pred             ceeeecCcEEEEEEEE---cCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           97 CCLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      +.||+|+||.||+++.   ..+|+.||+|++.....  .....+..|+.+|+.++||||+++++++.+...+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999876   35789999999975432  234457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      +|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            9999999865    35689999999999999999999987   99999999999999999999999999987543221  


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      ....           
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~------~~~~-----------  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL------KAKL-----------  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH------cCCC-----------
Confidence            12234579999999999998899999999999999999999999998654432221111      0000           


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITD  362 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  362 (426)
                       ..|...+..+.+|+.+||+.||.+||++.+
T Consensus       216 -~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 -GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence             122334457889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.9e-42  Score=323.93  Aligned_cols=271  Identities=27%  Similarity=0.420  Sum_probs=206.8

Q ss_pred             CCc-cccceeeecCcEEEEEEEE----cCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--Ce
Q 014362           91 GNF-RSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQ  162 (426)
Q Consensus        91 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~  162 (426)
                      ++| .+.+.||+|+||+||++..    ..++..||+|.+..... .....+.+|+.+|+.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8889999999999988653    35678999999876432 3456788999999999999999999988653  45


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +++||||+++++|.+++..     ..+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence            8899999999999999865     3599999999999999999999987   9999999999999999999999999999


Q ss_pred             ccCCCCCCcc-eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          243 KMGPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       243 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +......... ......++..|+|||++.+..++.++||||||+++|||++|..||....... .......... .....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~-~~~~~  232 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQ-MTVVR  232 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccc-cchhh
Confidence            7644322211 1122345677999999988899999999999999999999999986543211 0011000000 00001


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      +...++.......+...+..+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11112222222234445678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.1e-42  Score=325.41  Aligned_cols=273  Identities=27%  Similarity=0.398  Sum_probs=205.3

Q ss_pred             CCccccceeeecCcEEEEEEEE----cCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~  164 (426)
                      .+|++.+.||+|+||.||+|..    ..++..||+|.+........+.+..|+.+++.++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688889999999999999984    35688999999987666667789999999999999999999998743  34688


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +|+||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            999999999999998752   34689999999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCCcc-eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTH-VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|..|+....... ................+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-MRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-hhhcccccccccchHHHH
Confidence            54332211 1111234456999999998899999999999999999999887764322110 000000000000000000


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      +.+........+...+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            01111111112233456789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.5e-42  Score=316.65  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=207.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|.+.+.||+|+||.||+|.+..+++.|++|.+...  .......+..|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477888999999999999999999999999998753  234466788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999999863  245789999999999999999999987   99999999999999999999999999987543322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      .  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.............      .      .     
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~------~-----  216 (256)
T cd08529         156 N--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII------R------G-----  216 (256)
T ss_pred             c--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------c------C-----
Confidence            1  1233468899999999999999999999999999999999999997655322111110      0      0     


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+......+.+++.+||+.+|++||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            001112234457899999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.3e-42  Score=322.60  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=210.8

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcC----CCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEee-CCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEK----IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  162 (426)
                      ..++|.+.+.||+|+||.||+|.+..    ++..|++|.+.... ......+.+|+.+++.++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34678999999999999999999875    35789999887542 3345668899999999999999999998766 467


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCC----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPD----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      .+++++|+++++|.+++......    ...+++..++.++.||+.||.|||+.   +++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence            88999999999999998764322    15689999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      ||+++...............++..|+|||++.+..++.++||||||+++||+++ |+.||...........+.   .   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~---  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK---D---  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH---c---
Confidence            999975433222212223356778999999998899999999999999999999 999997654432111111   0   


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                       ..          ....+..++..+.+++.+||..+|++||++.+|++.|..+..
T Consensus       235 -~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 -GY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             -CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             00          001122234578999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4e-42  Score=327.95  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=206.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE--EEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||.||+|.+..++.  .+|+|.+.... ......+.+|+.++.++ +||||+++++++.....+++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            568889999999999999999887765  45777766432 23456788999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          167 YEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      |||+++++|.++++....            ....+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence            999999999999975321            123689999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||.............   
T Consensus       164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---  237 (303)
T cd05088         164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---  237 (303)
T ss_pred             EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh---
Confidence            99999998632111   11111234678999999988889999999999999999998 999997554332211110   


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                          .          ......+...+..+.+|+.+||+.+|.+||++.++++.|..+...
T Consensus       238 ----~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         238 ----Q----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             ----c----------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                0          001111222345788999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1e-41  Score=329.22  Aligned_cols=256  Identities=20%  Similarity=0.229  Sum_probs=201.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|.+.+.||+|+||.||++++..+++.||+|.+....   ......+.+|+.++..++|+||+.+++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999986532   223455788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|..++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999762   35689999999999999999999987   999999999999999999999999999975433


Q ss_pred             CCCcceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ... .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||...........+...      ...+
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~------~~~~  227 (331)
T cd05624         155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH------EERF  227 (331)
T ss_pred             CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC------CCcc
Confidence            221 12233579999999999875     56889999999999999999999999765543322111110      0000


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVMA  366 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  366 (426)
                       . +.+     .....+..+.+++.+||..++.+  |+++.+++..
T Consensus       228 -~-~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 -Q-FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -c-CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             0 000     01123457889999999876654  4678887753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.2e-42  Score=327.73  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=209.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  160 (426)
                      .++|.+.+.||+|+||.||+|.+..       +...+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3579999999999999999998743       23569999987542 23456688899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      ...++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||+.   +++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999976432            123589999999999999999999987   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999875432221111122234578999999999899999999999999999998 888886544322221


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .+..                 ......+...+..+.+|+.+||..+|.+||++.+|++.|+.+...
T Consensus       254 ~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 LLKE-----------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHc-----------------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            1110                 011122334456888999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.2e-42  Score=327.49  Aligned_cols=266  Identities=23%  Similarity=0.314  Sum_probs=204.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            579999999999999999999999999999999875432 2334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      ++ ++|..++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            97 488887765   235589999999999999999999987   99999999999999999999999999987533222


Q ss_pred             CcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh--------hhhccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP--------MFKDRK  320 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~  320 (426)
                      .  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+.....        .+....
T Consensus       159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            1  1223467999999998865 4689999999999999999999999987665443333221100        000000


Q ss_pred             ccccccCCcccC----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQG----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+...-.+....    ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000000    001123457889999999999999999999995

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.9e-42  Score=317.38  Aligned_cols=251  Identities=24%  Similarity=0.323  Sum_probs=206.8

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      +|++.+.||.|+||.||++.+..+++.||+|.+... .....+.+..|+.+++.++||||+++++.+.+...+++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            478889999999999999999999999999998643 2344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++...  ....+++..++.++.||+.||.|||+.   +|+|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            999999988653  235689999999999999999999987   99999999999999999999999999997543321 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                       .......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.       . ..         
T Consensus       155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-------~-~~---------  216 (255)
T cd08219         155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-------Q-GS---------  216 (255)
T ss_pred             -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-------c-CC---------
Confidence             12233568999999999998899999999999999999999999997654322111110       0 00         


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ....+...+..+.+|+.+||+.+|.+||++.+|+..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            001122344578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.7e-42  Score=325.93  Aligned_cols=260  Identities=25%  Similarity=0.399  Sum_probs=206.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE--EEEEEEeccC-CcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHR-GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+... .....+.+..|+.++.++ +||||+++++++.....+++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999999877664  4788887643 233456788999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          167 YEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      +||+++++|.+++.....            ....+++..++.++.||+.||+|||+.   +|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999965221            123588999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||...........+.   
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~---  232 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP---  232 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---
Confidence            99999998632111   01111123567999999998899999999999999999997 999997654432211110   


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                                    .......+...+..+.+|+.+||+.+|.+||++.+|++.|..+...
T Consensus       233 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         233 --------------QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             --------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                          0111112233455789999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.9e-42  Score=321.35  Aligned_cols=246  Identities=25%  Similarity=0.376  Sum_probs=196.2

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||+|+||.||++..+.+|+.||+|.+.....   .....+..|+.+++.++||||+++++++.+...+++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            6999999999999999999999999865322   1234456799999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      ..++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++.......   ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~  152 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT  152 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence            9888652  234689999999999999999999987   99999999999999999999999999987543321   123


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ...|+..|+|||++.+..++.++|||||||++|||++|+.||...........+.  ......      .+..     ..
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~------~~~~-----~~  219 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK--RRTLED------EVKF-----EH  219 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH--HHhhcc------cccc-----cc
Confidence            3468999999999999899999999999999999999999997543221111111  111100      0000     01


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...+.++.+|+..||+.||.+||++.|+++
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            123457899999999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.2e-41  Score=325.45  Aligned_cols=268  Identities=23%  Similarity=0.291  Sum_probs=207.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||++++++|.+++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            368999999999999999999999999999999875422 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..    ...+++..+..++.||+.||.|||+.  .+++|+||||+|||++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  153 (308)
T cd06615          81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  153 (308)
T ss_pred             cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence            999999999976    35689999999999999999999973  28999999999999999999999999998643221 


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc--------
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN--------  321 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  321 (426)
                         ......|+..|+|||++.+..++.++||||||+++|+|++|+.||........................        
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence               122347899999999998888999999999999999999999999754422211111100000000000        


Q ss_pred             --------cccccCCcc---cCCCC-hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          322 --------FSQMVDPSL---QGQYP-VRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       322 --------~~~~~~~~~---~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                              .....+...   ....| ......+.+|+.+||..+|++||++.+|++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                    000000000   00011 123457899999999999999999999996543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=347.88  Aligned_cols=265  Identities=25%  Similarity=0.425  Sum_probs=226.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC---EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ....+.++||.|.||.|++|+++..|   ..||||.++.... ....+|+.|+.||-++.||||++|.|+........||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            34567788999999999999998665   5699999987654 4567799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      .|||++|+|+.+|+.   +.+.+++.+...+++.|+.||.||.+.   ++|||||...||||+.+..+|++|||+++...
T Consensus       709 TEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             hhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence            999999999999987   456699999999999999999999988   99999999999999999999999999999765


Q ss_pred             CCCCcceeeeecc--cccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVSTRVMG--TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .+... ..+...|  ..+|.|||.+...+++.+||||||||++||.++ |..||......+..+.+.             
T Consensus       783 dd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------------  848 (996)
T KOG0196|consen  783 DDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------------  848 (996)
T ss_pred             cCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-------------
Confidence            44322 2222223  468999999999999999999999999999987 999998777665544443             


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCCCCC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQN  379 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~  379 (426)
                          ...+-..|..++..|.+|++.||++|-.+||.+.+|+..|+++.+...+-..
T Consensus       849 ----~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  849 ----QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             ----hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence                2333445778888999999999999999999999999999999876554433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=331.23  Aligned_cols=194  Identities=25%  Similarity=0.341  Sum_probs=168.4

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.....      ....|+.+++.++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3456899999999999999999999999999999985433      2346899999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+. ++|..++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            9995 688888765   346799999999999999999999987   999999999999999999999999999974222


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI  297 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~  297 (426)
                      .   .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1   1122357999999999999999999999999999999999966555

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.5e-42  Score=324.89  Aligned_cols=265  Identities=25%  Similarity=0.409  Sum_probs=205.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcC----------------CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEK----------------IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKL  153 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~  153 (426)
                      ++|++.+.||+|+||.||++.+..                ++..||+|.+..... .....+..|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468999999999999999986542                345799999875432 345678999999999999999999


Q ss_pred             eeEEeeCCeeEEEEEecCCCCHHHHhhhhCCC-------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCe
Q 014362          154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD-------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI  226 (426)
Q Consensus       154 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI  226 (426)
                      ++++...+..++||||+++++|.+++......       ...+++..++.++.||+.||.|||+.   +++|+||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999998763221       23478889999999999999999987   999999999999


Q ss_pred             eeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCcCchh
Q 014362          227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRK  304 (426)
Q Consensus       227 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~  304 (426)
                      |++.++.++|+|||+++...............++..|+|||...++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999975433322222222345678999999888899999999999999999998  778886544332


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      .....   ...+....  ....     ...+..++..+.+|+.+||+.+|.+||++.+|++.|+
T Consensus       242 ~~~~~---~~~~~~~~--~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENT---GEFFRDQG--RQVY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHH---HHHHhhcc--cccc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21111   11110000  0000     0112234467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-41  Score=323.04  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=206.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .+.|++.+.||.|+||.||+|.+..++..|++|.+..........+..|+.+++.++||||+++++.+.....+++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            46799999999999999999999999999999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|..++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++...... 
T Consensus        91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-  163 (292)
T cd06644          91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-  163 (292)
T ss_pred             CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence            999999888765   235689999999999999999999987   9999999999999999999999999998643221 


Q ss_pred             CcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                       ........+++.|+|||++.     ...++.++|||||||++|||++|..||.........  ......          
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~----------  230 (292)
T cd06644         164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIAKS----------  230 (292)
T ss_pred             -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--HHHhcC----------
Confidence             11123346889999999885     345788999999999999999999999765432211  110000          


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ..+..  ..+...+..+.+++.+||+.+|++||++.+|++
T Consensus       231 -~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 -EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             00000  112234457889999999999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2e-41  Score=327.33  Aligned_cols=256  Identities=21%  Similarity=0.238  Sum_probs=201.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|.+.+.||+|+||.||++.++.+++.||+|.+.+..   ......+..|+.++..++|+||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            36899999999999999999999999999999986432   223445788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++...   ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999762   35689999999999999999999987   999999999999999999999999999875332


Q ss_pred             CCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      .. ........||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+..      ....+
T Consensus       155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~------~~~~~  227 (332)
T cd05623         155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN------HKERF  227 (332)
T ss_pred             CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC------CCccc
Confidence            21 11223357999999999986     34688999999999999999999999986554332222111      00000


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVMA  366 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  366 (426)
                       . +.     ......+..+.+|+.+||..++.+  |+++.++++.
T Consensus       228 -~-~p-----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 -Q-FP-----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             -c-CC-----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence             0 00     011233557888999988665544  6899998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=311.31  Aligned_cols=252  Identities=21%  Similarity=0.273  Sum_probs=208.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++...||+|.|+.||++.+..+|+.+|+|+++..  .....+.+.+|+.+.+.|+|||||++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45688888899999999999999999999999998643  3346788999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~  244 (426)
                      |+|.|++|..-+-.    ...+++..+-.+++||+.||.|+|..   +|||||+||.|+||-+   .--+||+|||+|..
T Consensus        90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            99999999766654    25678889999999999999999987   9999999999999953   34589999999987


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      +..+.   .....+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.........+.....          
T Consensus       163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y----------  229 (355)
T KOG0033|consen  163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY----------  229 (355)
T ss_pred             eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc----------
Confidence            66332   23446899999999999999999999999999999999999999987554433322221110          


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          .+.+.......+++.+|+++||..||.+|.|+.|.|.
T Consensus       230 ----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 ----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                0111122344568899999999999999999998874

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.5e-42  Score=318.04  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=203.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|++.+.||+|+||.||.|.+.. +..+|||.+.... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            458888999999999999998865 4469999987543 33467899999999999999999999999988999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++|+|.+++...   ...+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999998752   33689999999999999999999987   999999999999999999999999999875433211


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                       .......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+....                
T Consensus       156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------------  218 (256)
T cd05113         156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL----------------  218 (256)
T ss_pred             -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC----------------
Confidence             11112345678999999988889999999999999999999 999997655332221111000                


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                       ....+...+..+.+++.+||+.+|.+||++.+|+..|
T Consensus       219 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         219 -RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence             0011122345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.5e-42  Score=337.03  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=203.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----eeE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRL  164 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~  164 (426)
                      +|++.+.||+|+||.||+|.+..+++.||||.+...  .....+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999989999999998653  2234567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +|+||+. ++|...+..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 677777754    45799999999999999999999987   999999999999999999999999999975


Q ss_pred             CCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh--hhc---
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM--FKD---  318 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~---  318 (426)
                      ...... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......  ...   
T Consensus       153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            432221 122334689999999998874 5799999999999999999999999876654443333211000  000   


Q ss_pred             -cccccccc-----C-Cccc--CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          319 -RKNFSQMV-----D-PSLQ--GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       319 -~~~~~~~~-----~-~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       .......+     . +...  .........++.+|+.+||+.||.+||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             00000000     0 0000  01112235578999999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.3e-41  Score=318.37  Aligned_cols=258  Identities=25%  Similarity=0.426  Sum_probs=207.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCE---EEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|+..+.||+|+||.||+|.+..++.   .+|+|.+.... ....+.+..|+.+++.++||||+++++++.+....++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3468888999999999999999875554   79999987542 3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++++|..++..   ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999875   235689999999999999999999987   9999999999999999999999999999754


Q ss_pred             CCCCCccee-eeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          246 PSGDKTHVS-TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       246 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ......... .....+..|+|||++.+..++.++|||||||++|||++ |..||...........+.       ..    
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-------~~----  226 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-------DG----  226 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-------cC----
Confidence            332211111 11223457999999998899999999999999999998 999997654322221111       00    


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                            .....+...+..+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus       227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  01111223345789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-41  Score=320.67  Aligned_cols=250  Identities=26%  Similarity=0.389  Sum_probs=204.2

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      |++.+.||.|+||.||+|.+..++..+++|.+..........+..|+.+++.++||||+++++++......++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            67778899999999999999999999999999776656677889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      ++|..++..   ...++++..+..++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++......  ..
T Consensus        87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~  158 (282)
T cd06643          87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ  158 (282)
T ss_pred             CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence            999988765   245799999999999999999999997   9999999999999999999999999998753221  11


Q ss_pred             eeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          253 VSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ......|+..|+|||++.     +..++.++|||||||++|||++|+.||...............      .  ....  
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------~--~~~~--  228 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------E--PPTL--  228 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc------C--CCCC--
Confidence            123346899999999884     345788999999999999999999999765432221111100      0  0000  


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                           ..+...+..+.+|+.+||+.+|.+||++.++++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 112233457899999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-41  Score=328.35  Aligned_cols=265  Identities=26%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC-------CEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI-------EQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  160 (426)
                      ..+|.+.+.||+|+||.||+|.+...       +..||+|.+.... ....+.+..|+.+++.+ +||||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            34689999999999999999986432       3478999887542 23456789999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      ...++|+||+++|+|.+++.....            ....+++..++.++.||+.||.|||+.   +++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEE
Confidence            999999999999999999975321            224588999999999999999999987   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  247 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  247 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999999975433222111222334578999999999999999999999999999998 888887654333222


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      .+..                 ......+...+..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus       248 ~~~~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         248 LLKE-----------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHc-----------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1110                 0011122334557889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.4e-41  Score=325.81  Aligned_cols=264  Identities=24%  Similarity=0.374  Sum_probs=209.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD  161 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  161 (426)
                      ++|.+.+.||+|+||.||+|.+..       ....||+|.+.... ......+..|+.+++.+ +||||+++++++.+..
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            568889999999999999998632       34579999987543 23456788999999999 6999999999999988


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE  229 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~  229 (426)
                      .+++||||+++|+|.+++.....            ....+++..+..++.||+.||.|||+.   +++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence            99999999999999999976321            124589999999999999999999987   999999999999999


Q ss_pred             cCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcH
Q 014362          230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL  308 (426)
Q Consensus       230 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  308 (426)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~  248 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL  248 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            999999999999975433221111112234567999999999999999999999999999999 8899976544332222


Q ss_pred             HHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      +..       .          .....+...+..+.+++.+||..+|.+||++.++++.|..+....
T Consensus       249 ~~~-------~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         249 LRE-------G----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHc-------C----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            110       0          001123334457889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=316.99  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=202.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      +|++.+.||+|+||.||+|.++. +..+|+|.+..... ....+.+|+.+++.++||||+++++++......++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            57888899999999999998874 66899999865432 34568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      +++|.+++...   ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-  155 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-  155 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-
Confidence            99999998752   34689999999999999999999987   999999999999999999999999999875432211 


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.       .          ..
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-------~----------~~  218 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-------A----------GY  218 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-------c----------CC
Confidence            11111234567999999999999999999999999999999 899997654332211111       0          01


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      ....+...+..+.+++.+||..+|++||++.+|++.|
T Consensus       219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1112233456889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-41  Score=322.52  Aligned_cols=263  Identities=27%  Similarity=0.414  Sum_probs=207.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45689999999999999999997652     355899998865432 234457889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCC------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRP------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      .++||||+++|+|.+++.....      ....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.++|
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999976321      124457788899999999999999987   9999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...........+.     
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~-----  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM-----  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence            99999975433222222222345778999999999999999999999999999999 788887654332211111     


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                        ....          ...+...+..+.+++.+||+.+|++||++.++++.|....
T Consensus       236 --~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 --DGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --cCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence              0000          0112223457899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-41  Score=319.12  Aligned_cols=257  Identities=25%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE---EEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..|++.+.||+|+||.||+|.+..++.   .||||.+... .......|..|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            458889999999999999999876554   6999998754 233456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999998752   35689999999999999999999987   99999999999999999999999999987543


Q ss_pred             CCCCcceee-eec--ccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          247 SGDKTHVST-RVM--GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       247 ~~~~~~~~~-~~~--gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ......... ...  .+..|+|||++.+..++.++|||||||++|||++ |..||...........+.   .    ..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~----~~--  228 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---Q----DY--  228 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----CC--
Confidence            322111111 111  2457999999999999999999999999999886 999997654332221111   0    00  


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                              ....+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                    0011223345788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=7.6e-42  Score=319.67  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46888888999999999999999999999999987665555567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......  
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--  159 (267)
T cd06645          89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--  159 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence            99999999865    35689999999999999999999987   9999999999999999999999999998754321  


Q ss_pred             cceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          251 THVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ........|+..|+|||++.   ...++.++|||||||++|+|++|..||...............           ....
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-----------~~~~  228 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-----------NFQP  228 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-----------CCCC
Confidence            11123357899999999874   456889999999999999999999998655432222111100           0000


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +....  ....+..+.+++.+||+.+|++||++.+|++
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00100  1123346889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-41  Score=354.44  Aligned_cols=264  Identities=21%  Similarity=0.259  Sum_probs=207.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            689999999999999999999999999999999975322   23456899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          168 EYMPLGSLDKHLHDLRP-------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ||++||+|.+++.....       ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999875321       123456778899999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCC----------------cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchh
Q 014362          241 LAKMGPSGDK----------------THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK  304 (426)
Q Consensus       241 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~  304 (426)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9975421100                011123469999999999999999999999999999999999999997643321


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHh
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-AITDVVMALNYLAS  372 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~  372 (426)
                      ....    .. .         ..+. ........+..+.+++.+||+.||++|| +++++++.|+.+..
T Consensus       239 i~~~----~~-i---------~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYR----DV-I---------LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh----hh-c---------cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1100    00 0         0000 0000112345678999999999999995 56777777877644

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-44  Score=319.39  Aligned_cols=249  Identities=25%  Similarity=0.365  Sum_probs=213.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      |.++.+||+|+||.||+|.++.+|+.+|||.+...  .+.+++..|+.+++++..|+||++||.|.....+|+|||||--
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            67778899999999999999999999999998654  4568899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      |++.+.++-   ..++|++.++..+++..+.||+|||..   .-||||||..||||+.+|.+||+|||+|-.+..  .-.
T Consensus       113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA  184 (502)
T KOG0574|consen  113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA  184 (502)
T ss_pred             CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence            999999986   358899999999999999999999998   789999999999999999999999999965322  223


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                      ....+.|||.|||||++..-.|+.++||||||++..||..|++||....+.....++.             ..-.|.+  
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T~PPPTF--  249 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------TKPPPTF--  249 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------CCCCCCC--
Confidence            3455789999999999999999999999999999999999999998766543221111             1111112  


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ..|...+.++.++++.||-..|++|-++.++++.
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            2266677789999999999999999999988753

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-41  Score=319.62  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=203.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|+..+.||.|+||+||+|.+..+++.||+|.+.....   .....+..|+.+++.++|+||+++++++..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            36777889999999999999999999999999875432   223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|..++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            99999999888753  234699999999999999999999987   9999999999999999999999999998754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ..   .....|+..|+|||++.+..++.++|+||||+++|||++|..||...........+..  .....          
T Consensus       156 ~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~--~~~~~----------  220 (285)
T cd05632         156 ES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR--RVLET----------  220 (285)
T ss_pred             Cc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH--hhhcc----------
Confidence            11   1234789999999999999999999999999999999999999976543222111111  00000          


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                        ...++......+.+|+..||+.+|.+||+     +.+++.
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence              00112233457789999999999999999     666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-41  Score=322.67  Aligned_cols=250  Identities=23%  Similarity=0.330  Sum_probs=208.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .+|++.+.||.|+||.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++++.....+++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46999999999999999999999999999999997765566677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|..++..     ..+++.++..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            99999998864     4589999999999999999999997   999999999999999999999999999875432221


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+...      .  ...      
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~------~--~~~------  234 (296)
T cd06655         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------G--TPE------  234 (296)
T ss_pred             --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------C--Ccc------
Confidence              122346889999999999888999999999999999999999999776543322111100      0  000      


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+...+..+.+++.+||..+|.+||++.+|+.
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             0112234457889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-42  Score=318.17  Aligned_cols=252  Identities=30%  Similarity=0.451  Sum_probs=205.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHH--HHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR--EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      |++.+.||+|+||+||++.+..+++.||+|.+.........  ....|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            67889999999999999999999999999999877544322  3456999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..    ...+++..++.++.||+.||.+||+.   +++|+||||+||++++++.++|+|||++....  ..
T Consensus        81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~  151 (260)
T PF00069_consen   81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN  151 (260)
T ss_dssp             TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred             ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence            99999999983    36689999999999999999999998   99999999999999999999999999987531  11


Q ss_pred             cceeeeecccccccCccccc-cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-hhhcccccccccCC
Q 014362          251 THVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-MFKDRKNFSQMVDP  328 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  328 (426)
                      ........++..|+|||++. +..++.++||||||+++|+|++|..||................. ......        
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  223 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--------  223 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--------
Confidence            22333457899999999998 88999999999999999999999999987633332222221111 000000        


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          .........+.+++.+||+.+|++||++.++++
T Consensus       224 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 ----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ----cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                000011258899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.8e-42  Score=331.25  Aligned_cols=263  Identities=25%  Similarity=0.358  Sum_probs=204.1

Q ss_pred             CCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC-Ce
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG-DQ  162 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~  162 (426)
                      ++|++.+.||+|+||.||+|.+.     .+++.||||.+..... .....+..|+.++..+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            57999999999999999999853     4578999999975432 3456688999999999 689999999988654 46


Q ss_pred             eEEEEEecCCCCHHHHhhhhCC----------------------------------------------------------
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRP----------------------------------------------------------  184 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  184 (426)
                      .++||||+++|+|.+++.....                                                          
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            7899999999999999865221                                                          


Q ss_pred             -----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecc
Q 014362          185 -----DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG  259 (426)
Q Consensus       185 -----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g  259 (426)
                           ....+++..+..++.||+.||.|||+.   +|+||||||.|||++.++.+||+|||++................+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 013478889999999999999999987   999999999999999999999999999975432222111222345


Q ss_pred             cccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHh
Q 014362          260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG  338 (426)
Q Consensus       260 t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (426)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||............      ....          .....+...
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~~----------~~~~~~~~~  307 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR------LKEG----------TRMRAPDYT  307 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH------Hhcc----------CCCCCCCCC
Confidence            678999999999999999999999999999997 89998754322111000      0000          000111123


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       339 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ...+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            3468899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-42  Score=321.33  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=208.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||.|+||.||+|.+..++..||+|.+..........+..|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            35689999999999999999999888999999999876666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|..++...   ...+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            9999999998762   35699999999999999999999987   99999999999999999999999999986533221


Q ss_pred             CcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                        .......|++.|+|||.+.     ...++.++||||||+++|||++|+.||...........+..      .      
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~------  223 (280)
T cd06611         158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK------S------  223 (280)
T ss_pred             --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc------C------
Confidence              1223456899999999875     34577899999999999999999999976543322111110      0      


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       ..+.+  ..+...+..+.+++..||+.+|.+||++.+|++.
T Consensus       224 -~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 -EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             00000  1122344578899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-41  Score=332.70  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----  161 (426)
                      ..++|++.+.||+|+||.||+|.+..++..||||.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999999999999999998653  2234566889999999999999999999986543     


Q ss_pred             -eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          162 -QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       162 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                       .+|+||||+++ +|...+.      ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence             47999999975 5655553      2478899999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHh---------
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW---------  311 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~---------  311 (426)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..........         
T Consensus       169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            99753221   112334789999999999999999999999999999999999999986653322111100         


Q ss_pred             -------hhhhhhcccc-----cccccCCcc---cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          312 -------ARPMFKDRKN-----FSQMVDPSL---QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       312 -------~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                             ..........     +.+......   ...........+.+|+.+||+.||.+||++.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                   0000000000     000000000   000111234568899999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=337.45  Aligned_cols=244  Identities=31%  Similarity=0.425  Sum_probs=207.4

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      |.-++.||.|+||.||-|++..+.+.||||++...+.   ..+.++..|+..|+.++|||++.+.|+|......||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            4445569999999999999999999999999976543   4578899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      | -||-.++|.-   ..+++-+.++..|+.+.+.||+|||++   +.||||||..||||++.|.|||+|||.|.+.... 
T Consensus       108 C-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-  179 (948)
T KOG0577|consen  108 C-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-  179 (948)
T ss_pred             H-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence            9 4788888765   357899999999999999999999998   9999999999999999999999999999764332 


Q ss_pred             CcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                           ..++|||.|||||++.   .+.|+-++|||||||+-.||.-.++|+...+....+.-+....             
T Consensus       180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-------------  241 (948)
T KOG0577|consen  180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------------  241 (948)
T ss_pred             -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------------
Confidence                 3468999999999986   5789999999999999999999999998777655443333211             


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .|.+.   ....+..+++|+..||+.-|.+|||.++++.
T Consensus       242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11111   2445667899999999999999999988774

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-41  Score=315.46  Aligned_cols=248  Identities=28%  Similarity=0.418  Sum_probs=199.1

Q ss_pred             eeeecCcEEEEEEEE--cCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+  ..++..+|+|++.....  ...+.+..|+.+++.+.||||+++++++.. ...++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            489999999999975  45678999999865432  345678999999999999999999998864 5678999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc-
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-  252 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  252 (426)
                      +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||.|||++.++.+||+|||+++......... 
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999865    35689999999999999999999987   99999999999999999999999999997643322211 


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      ......++..|+|||.+....++.++|||||||++|||++ |..||...........+..                 ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~-----------------~~~  216 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES-----------------GER  216 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-----------------CCC
Confidence            1112234678999999988889999999999999999998 9999976544332222211                 011


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ...|...+..+.+|+.+||+.+|++||++.+|.+.|+..
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            122334556889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=314.91  Aligned_cols=250  Identities=31%  Similarity=0.464  Sum_probs=207.0

Q ss_pred             eeeecCcEEEEEEEEcCC---CEEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+...   +..|++|.+....... .+.+..|+..++.++|+||+++++++.....+++||||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            599999999999999865   8899999998654433 678899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhhCCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          174 SLDKHLHDLRPD-----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       174 sL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      +|.+++......     ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999874211     36799999999999999999999987   9999999999999999999999999999865443


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..||...........+..                
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----------------  222 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK----------------  222 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence            32222334567889999999988899999999999999999999 6999987643322211110                


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                       ......+...+..+.+++.+||+.+|.+||++.+++..|
T Consensus       223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence             011122334456889999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=335.69  Aligned_cols=264  Identities=25%  Similarity=0.397  Sum_probs=227.2

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      ++++....+.....+||-|.||.||.|.|+.-.-.||||.++.. ...+.+|..|+.+|+.+.|||+|+++|+|.....+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            56666666677788999999999999999999999999999765 45688999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      |||.|||.+|+|.+||++.  +...++.-..+.++.||..||+||...   ++|||||...|+|+.++..+|++||||++
T Consensus       339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999874  345678888999999999999999976   99999999999999999999999999999


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      +...+..+ .....--..-|.|||.+....++.++|||+|||+|||+.| |-.||.+.+...                 +
T Consensus       414 lMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----------------V  475 (1157)
T KOG4278|consen  414 LMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------------V  475 (1157)
T ss_pred             hhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----------------H
Confidence            76543322 2222233568999999999999999999999999999998 788887755322                 2


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      ..++...++.+.|..|+..+++|++.||+++|.+||++.||-+.++.+-
T Consensus       476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            3344556677778899999999999999999999999999999998764

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-41  Score=322.59  Aligned_cols=259  Identities=27%  Similarity=0.442  Sum_probs=206.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||.|+||.||+|.+..     ++..||+|.+..... .....+..|+.+++.++||||+++++++.+....
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            3578999999999999999998753     578899999875433 3356688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 014362          164 LLVYEYMPLGSLDKHLHDLR------------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN  225 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N  225 (426)
                      ++||||+++|+|.+++....                  .....+++..++.++.||+.||.|||+.   +++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence            99999999999999997532                  1123578899999999999999999987   99999999999


Q ss_pred             eeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchh
Q 014362          226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRK  304 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~  304 (426)
                      ||++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999875433222111222345678999999998999999999999999999998 888887554332


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ....+..       . ..   .      ..+...+.++.+|+.+||+.+|.+||++.||++.|+
T Consensus       241 ~~~~~~~-------~-~~---~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVRD-------G-NV---L------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHhc-------C-CC---C------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            2211110       0 00   0      112234457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.7e-41  Score=314.48  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             eeecCcEEEEEEEEc--CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||+|+||.||+|.+.  ..+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999875  4466799999876533 234568899999999999999999998864 578999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc-ee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VS  254 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~  254 (426)
                      .+++..   ....+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++.......... ..
T Consensus        82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999875   235689999999999999999999987   99999999999999999999999999997543322211 11


Q ss_pred             eeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      ....++..|+|||++.+..++.++||||||+++|||++ |..||...........+..                 .....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----------------~~~~~  218 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ-----------------GKRLD  218 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC-----------------CCCCC
Confidence            11233578999999988889999999999999999996 9999976554322211110                 01112


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      .+..++.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            3344556889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-41  Score=321.19  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=198.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcC---CCCCcceEeeEEee-----CC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSA---DHPNLVKLIGYCAE-----GD  161 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~-----~~  161 (426)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58889999999999999999999999999999875322  2233456677766654   79999999998864     34


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      ..++||||++ ++|..++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            5789999997 5888888653  234589999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-----hh
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-----MF  316 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----~~  316 (426)
                      ++......   ......||..|+|||++.+..++.++|||||||++|||++|++||...........+.....     .+
T Consensus       155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence            97543221   12234689999999999999999999999999999999999999976654433222211100     00


Q ss_pred             hccccc-ccccCCccc---CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 KDRKNF-SQMVDPSLQ---GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 ~~~~~~-~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...... ...+.+...   ..........+.+|+.+||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000 000000000   0011123457889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-41  Score=323.12  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=208.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ..+|++.+.||.|+||.||+|....+++.||+|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36799999999999999999999888999999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            999999999864     4588999999999999999999987   99999999999999999999999999987533221


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++|..||..............      .         ..
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~------~---------~~  232 (297)
T cd06656         170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------N---------GT  232 (297)
T ss_pred             --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc------C---------CC
Confidence              112234688999999999998999999999999999999999999976543221111000      0         00


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+......+.+|+.+||+.+|.+||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000112334456789999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-41  Score=320.09  Aligned_cols=250  Identities=25%  Similarity=0.350  Sum_probs=200.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+..|+.+++.++||||+++++++......++||||+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   81 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM   81 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence            5788889999999999999999999999999986542 334566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|..+        ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++......  
T Consensus        82 ~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--  148 (279)
T cd06619          82 DGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--  148 (279)
T ss_pred             CCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence            99998643        2368889999999999999999987   9999999999999999999999999998754322  


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-cHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-NLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        ......||..|+|||++.+..++.++||||||+++|+|++|+.||......... ............       ..+.
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~  219 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPPV  219 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-------CCCC
Confidence              122357899999999999999999999999999999999999999753321111 001110000000       0000


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +   .....+.++.+++.+||+.+|.+||++.++++.
T Consensus       220 ~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 L---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0   011234578999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-41  Score=316.93  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=206.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC---EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.+..... .....+..|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999886443   4799999875432 3356789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            999999999999975   235689999999999999999999987   99999999999999999999999999997643


Q ss_pred             CCCCcce-eeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          247 SGDKTHV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       247 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ....... .....++..|+|||++.+..++.++|+||||+++||+++ |..||...........+..       ..    
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~-------~~----  226 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEE-------GY----  226 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhC-------CC----
Confidence            3221111 111233568999999998899999999999999999887 9999976554332211110       00    


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                            ....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  0011223345788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.2e-42  Score=319.91  Aligned_cols=254  Identities=26%  Similarity=0.371  Sum_probs=202.8

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC------
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG------  160 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~------  160 (426)
                      .+.+.|++.+.||.|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677899999999999999999999999999999987543 3346788899999988 699999999998753      


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ..+++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+|+||||+||++++++.++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            4689999999999999998763  235689999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      ++.......  .......|++.|+|||++.     ...++.++|||||||++|||++|..||.............     
T Consensus       157 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~-----  229 (272)
T cd06637         157 VSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-----  229 (272)
T ss_pred             Cceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-----
Confidence            987543221  1223457899999999986     3468889999999999999999999997544322111110     


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        . .....        ..+...+..+.+|+.+||..+|.+||++.+|++
T Consensus       230 --~-~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 --R-NPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --c-CCCCC--------CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              0 00000        011223457889999999999999999999974

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.6e-42  Score=345.43  Aligned_cols=268  Identities=20%  Similarity=0.261  Sum_probs=199.0

Q ss_pred             HHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC------CCCcceEeeEEe
Q 014362           85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD------HPNLVKLIGYCA  158 (426)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~~~~~~~  158 (426)
                      ++....++|++.+.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..++      |++++.++++|.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            33445688999999999999999999999999999999996432 22344556777666654      456888999887


Q ss_pred             eC-CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-----
Q 014362          159 EG-DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-----  232 (426)
Q Consensus       159 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-----  232 (426)
                      .. .++|+|||++ +++|.+++..    ...+++..+..++.||+.||.|||+.  .+||||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence            64 5788999988 7888888865    35699999999999999999999972  2999999999999998765     


Q ss_pred             -----------ceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcC
Q 014362          233 -----------HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK  301 (426)
Q Consensus       233 -----------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~  301 (426)
                                 .+||+|||++....     ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       49999999875322     12234589999999999999999999999999999999999999998766


Q ss_pred             chhhhcHHHhhhhhhh-----------------cccccccccCCc----ccCCC---ChHhHHHHHHHHHhccccCCCCC
Q 014362          302 DRKELNLVAWARPMFK-----------------DRKNFSQMVDPS----LQGQY---PVRGLYQALAIAAMCVQEQPNMR  357 (426)
Q Consensus       302 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~----~~~~~---~~~~~~~l~~li~~cl~~dP~~R  357 (426)
                      .......+......+.                 ....+....++.    +....   .......+.+||.+||+.||.+|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            5544433322111000                 000000000000    00000   00113457899999999999999


Q ss_pred             CCHHHHHH
Q 014362          358 PAITDVVM  365 (426)
Q Consensus       358 Ps~~eil~  365 (426)
                      |++.|+++
T Consensus       430 ~ta~e~L~  437 (467)
T PTZ00284        430 LNARQMTT  437 (467)
T ss_pred             CCHHHHhc
Confidence            99999995

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-41  Score=320.68  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=203.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|+..+.||+|+||.||+|.+..+++.||||.+......   ....+..|+.+++.++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367788899999999999999999999999998754322   23457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999988653  234689999999999999999999987   9999999999999999999999999998754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ..   .....||..|+|||++.+..++.++||||||+++|+|++|+.||.............   ....           
T Consensus       156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~-----------  218 (285)
T cd05630         156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVK-----------  218 (285)
T ss_pred             cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhh-----------
Confidence            21   123478999999999999999999999999999999999999997643221110000   0000           


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVMA  366 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  366 (426)
                      .....++......+.+|+..||+.||.+||+     +.++++.
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            0001122334457889999999999999999     8888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=313.97  Aligned_cols=254  Identities=26%  Similarity=0.335  Sum_probs=210.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|++.+.||.|+||.||+|.+..+++.+++|.+........+.+..|+.+++.++||||+++++++.+...++++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57899999999999999999999889999999998765556788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            99999998876   235699999999999999999999987   99999999999999999999999999987543221 


Q ss_pred             cceeeeecccccccCccccccC---CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          251 THVSTRVMGTYGYCAPDYAMTG---QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                       .......++..|+|||.+.+.   .++.++||||||+++|||++|..||..............  .         .+..
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~---------~~~~  223 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--S---------NFPP  223 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--c---------cCCC
Confidence             112334688899999998776   889999999999999999999999976553332211110  0         0000


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +.  ...+...+..+.+++.+||..+|.+||++.+|+.
T Consensus       224 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00  1123344567899999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-43  Score=339.66  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=214.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      .|.++..||.|+||.||+|..+.++...|.|.|.-.......+|.-|++||..+.||+||++++.|...+.+|++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            46666679999999999999999998899999988888888999999999999999999999999988899999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      ||-++..+-.+   +.+|++.++..++.|++.||.|||+.   +|||||||..|||++-+|.++|+|||++-..  ....
T Consensus       113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn--~~t~  184 (1187)
T KOG0579|consen  113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN--KSTR  184 (1187)
T ss_pred             CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc--hhHH
Confidence            99999998874   67899999999999999999999998   9999999999999999999999999998532  1222


Q ss_pred             ceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          252 HVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .....++|||+|||||++.     ..+|++++||||||++|.||..+.+|-...++...+-.+....+        +.++
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSeP--------PTLl  256 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--------PTLL  256 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCC--------Cccc
Confidence            3345679999999999875     45899999999999999999999999877665543322221111        1111


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             .|......+.+|+.+||..+|..||++.++++
T Consensus       257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                   25666778999999999999999999999885

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=317.21  Aligned_cols=258  Identities=26%  Similarity=0.414  Sum_probs=208.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|++.+.||+|+||.||+|.++.++.    .||+|.+..... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            568889999999999999999876654    689998876543 345678899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||+|||+.   +++||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            9999999999999876   234589999999999999999999987   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............++..|+|||.+....++.++||||||+++|||++ |+.||...........+..       ..    
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-------~~----  228 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK-------GE----  228 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC-------CC----
Confidence            43322211112234568999999988899999999999999999999 9999976544322211110       00    


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                            ....+..+...+.+++.+||..+|..||++.++++.|..+..
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  011122234578899999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.5e-41  Score=314.61  Aligned_cols=255  Identities=29%  Similarity=0.419  Sum_probs=204.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+..+ ..||+|.+..... ....+..|+.+++.++||||+++++++.. ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence            35799999999999999999998765 4599999875432 34578899999999999999999998754 567899999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||++++++.++|+|||+++......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999999753  234689999999999999999999987   99999999999999999999999999997543322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |..||...........+..       .         
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------~---------  219 (262)
T cd05071         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------G---------  219 (262)
T ss_pred             cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-------C---------
Confidence            11 1122346778999999988899999999999999999999 8888876543322211110       0         


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                       .....+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       220 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence             00011223455788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-41  Score=315.16  Aligned_cols=250  Identities=24%  Similarity=0.403  Sum_probs=204.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      +|.+...||.|+||.||+|.+..+++.||+|.+......         ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477888999999999999999888999999988654322         23568889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++|+||+++++|..++..    ...+++..+..++.|++.||.|||+.   +++||||+|+||++++++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            9999999999999999975    35689999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCC----cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          243 KMGPSGDK----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       243 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      +.......    ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+.        
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------  225 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG--------  225 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh--------
Confidence            75432111    111123458899999999998899999999999999999999999997654322111000        


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                           ..    .....+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       226 -----~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 -----EN----ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----cc----CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 00    111223334567899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.4e-41  Score=321.07  Aligned_cols=265  Identities=26%  Similarity=0.328  Sum_probs=208.8

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEe-
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCA-  158 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~-  158 (426)
                      +.++.+....++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445566677889999999999999999999999999999999886532 2235678899999998 6999999999874 


Q ss_pred             ----eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          159 ----EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       159 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                          .+..+++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence                34578999999999999998875443456789999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHH
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV  309 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  309 (426)
                      +|+|||+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|+.||............
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            9999999875432211  1223468999999998753     45789999999999999999999999765432211100


Q ss_pred             HhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          310 AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .  .      .......       .+......+.+|+.+||+.+|++||++.||++.
T Consensus       242 ~--~------~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 P--R------NPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             c--c------cCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0  0      0000000       112233468899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-41  Score=331.31  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=202.4

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----  160 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----  160 (426)
                      ...++|++.+.||+|+||.||+|.+..+++.||||.+....  ......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999999999999999987542  23456688899999999999999999988643     


Q ss_pred             -CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          161 -DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       161 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                       ...++||||+++ +|...+.      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             347999999975 6666653      2488899999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh-------
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA-------  312 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-------  312 (426)
                      |+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.............       
T Consensus       164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (355)
T cd07874         164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE  240 (355)
T ss_pred             cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999753322   1123357899999999999999999999999999999999999999876543322111100       


Q ss_pred             ---------hhhhhcccccccc-----cCCcc---cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          313 ---------RPMFKDRKNFSQM-----VDPSL---QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       313 ---------~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                               ............+     .....   ....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                     0000000000000     00000   001112234578899999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.7e-41  Score=313.90  Aligned_cols=254  Identities=29%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.+++.++||||+++++++.. ...++||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence            3578999999999999999998764 56799999876433 34678999999999999999999998854 567899999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||++++++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999998752  235689999999999999999999987   99999999999999999999999999997543322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .. ......++..|+|||++.+..++.++||||||+++|||++ |..||...........+..                 
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-----------------  218 (260)
T cd05070         157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-----------------  218 (260)
T ss_pred             cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------------
Confidence            11 1112245678999999988899999999999999999999 8899976543322211110                 


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                      ......+...+..+.+|+.+||..+|.+||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            00111233345578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.7e-41  Score=313.63  Aligned_cols=250  Identities=27%  Similarity=0.381  Sum_probs=207.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|++.+.||.|+||.||+|.+..++..|++|.+.....  ...+.+|+.+++.++||||+++++++.+...+|+++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999998899999999875532  678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999999865   346789999999999999999999987   999999999999999999999999999875433221


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...........+.             ....+  
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~--  217 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP-------------NKPPP--  217 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc-------------cCCCC--
Confidence              2233458899999999999899999999999999999999999997654332111100             00000  


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....+......+.+++.+||+.+|.+||++.+|++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00112334457899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.6e-41  Score=321.97  Aligned_cols=266  Identities=23%  Similarity=0.310  Sum_probs=204.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            3579999999999999999999999999999999875432 233467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ ++|..++..   ....+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||++......
T Consensus        85 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             ccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            997 688888865   235689999999999999999999987   9999999999999999999999999999753322


Q ss_pred             CCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..  ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...........+........ ...+..++.
T Consensus       158 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  234 (301)
T cd07873         158 TK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILS  234 (301)
T ss_pred             CC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhc
Confidence            11  11233578999999988654 578999999999999999999999987654333222211100000 000011100


Q ss_pred             ---------CcccCC----CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 ---------PSLQGQ----YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ---------~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                               +.....    .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                     100000    11123457889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-41  Score=337.66  Aligned_cols=261  Identities=21%  Similarity=0.236  Sum_probs=199.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...      ...+.+|+.+|+.++|||||++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999999999999999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +. ++|..++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus       242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 788888765   234699999999999999999999987   99999999999999999999999999997643322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCch--------hhhcHHHhhhhhhhcccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR--------KELNLVAWARPMFKDRKN  321 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~  321 (426)
                      .........||+.|+|||++.+..++.++|||||||+||||++|..|+......        .....+........   .
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~---~  391 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD---E  391 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc---c
Confidence            222223457999999999999999999999999999999999988765432211        11111111110000   0


Q ss_pred             ccccc----------------CCcccC-CCC--hHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          322 FSQMV----------------DPSLQG-QYP--VRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       322 ~~~~~----------------~~~~~~-~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +....                .+.... ...  ......+.+|+.+||+.||.+||++.|+++.
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00000                000000 000  0123367899999999999999999999953

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.7e-41  Score=315.58  Aligned_cols=255  Identities=27%  Similarity=0.381  Sum_probs=194.8

Q ss_pred             eeeecCcEEEEEEEEc--CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||+|.+.  .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            4999999999999865  3457799999876433 334568889999999999999999999999899999999999999


Q ss_pred             HHHHhhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          175 LDKHLHDLRP-DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       175 L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      |.+++..... ....+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            9999976432 223567788889999999999999987   999999999999999999999999999975333222222


Q ss_pred             eeeecccccccCccccccC-------CCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          254 STRVMGTYGYCAPDYAMTG-------QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      .....++..|+|||++.+.       .++.++||||||+++|||++ |..||..............     .   .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----~---~~~~~  230 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR-----E---QQLKL  230 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh-----c---ccCCC
Confidence            2234678899999988642       35789999999999999996 9999976544322111100     0   00111


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ..+.+    .......+.+++..|| .+|.+||++.+|++.|.
T Consensus       231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111    1123346788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=311.85  Aligned_cols=248  Identities=27%  Similarity=0.344  Sum_probs=211.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      -++|+.+++||+|+||+|-+++.+.+++.+|||++++.-.   ..+..-..|-++|+..+||++..+...|...+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            3578889999999999999999999999999999987643   3345567799999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||..||.|.-+|..    ...+++..+..+-..|+.||.|||+.   +||+||||.+|+|||.+|++||+|||+++..-
T Consensus       247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999888875    56799999999999999999999997   99999999999999999999999999998533


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .  ....+..+||||.|+|||++....|+.++|+|.+||++|||++|+.||...+-.....++.-..             
T Consensus       320 ~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-------------  384 (516)
T KOG0690|consen  320 K--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-------------  384 (516)
T ss_pred             c--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-------------
Confidence            2  2234556899999999999999999999999999999999999999998766544444333111             


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVV  364 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil  364 (426)
                           -.+|...+.++..|+...|..||.+|.     .+.||.
T Consensus       385 -----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~  422 (516)
T KOG0690|consen  385 -----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM  422 (516)
T ss_pred             -----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence                 124555566889999999999999996     355555

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.5e-41  Score=315.46  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=203.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            34455555679999999999999998899999999987766667789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCC--CHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPL--DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~  245 (426)
                      |+++++|.+++...   ...+  ++..+..++.||+.||.|||+.   +|+||||||+||+++. ++.++|+|||++...
T Consensus        86 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          86 QVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             cCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            99999999999752   2344  8888999999999999999987   9999999999999986 678999999998754


Q ss_pred             CCCCCcceeeeecccccccCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .....  ......|++.|+|||++.+..  ++.++||||||+++|+|++|..||.........   .+......      
T Consensus       160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~------  228 (268)
T cd06624         160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK------  228 (268)
T ss_pred             ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc------
Confidence            32211  122235889999999987643  789999999999999999999999754321111   11000000      


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                            .....+.....++.+++.+||+.+|.+||++.+|+.
T Consensus       229 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 ------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence                  111223344567899999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-41  Score=316.03  Aligned_cols=251  Identities=27%  Similarity=0.435  Sum_probs=198.8

Q ss_pred             eeeecCcEEEEEEEEcCCCE--EEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQ--VVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+..++.  .+++|.+.... ......+..|+.++.++ +||||+++++++......++||||+++|
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            48999999999999987765  46888887432 33456788999999999 7999999999999999999999999999


Q ss_pred             CHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          174 SLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       174 sL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      +|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            99999975321            123588999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      +......   ........+..|+|||++....++.++||||||+++|||++ |..||...........+.       .  
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-------~--  226 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-------Q--  226 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-------C--
Confidence            8632111   11111234567999999988899999999999999999997 999997644322111110       0  


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                              ......+...+..+.+|+.+||..+|.+||++.+++..|..+.
T Consensus       227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         227 --------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             --------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                    0011112233457889999999999999999999999998663

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=312.21  Aligned_cols=250  Identities=28%  Similarity=0.439  Sum_probs=206.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||.|+||.||+|...  |+.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            357888999999999999999876  78899999976543 567799999999999999999999999988999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999998762  223689999999999999999999987   99999999999999999999999999997642211


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .     ...++..|+|||++.+..++.++||||||+++|||++ |..||...........+..                 
T Consensus       157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-----------------  214 (256)
T cd05039         157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-----------------  214 (256)
T ss_pred             c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-----------------
Confidence            1     2245678999999998899999999999999999997 9999976543322111110                 


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                      ......+...+..+.+++.+||..+|.+||++.+++..|+.
T Consensus       215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            00111122345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-41  Score=312.77  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=199.5

Q ss_pred             eeeecCcEEEEEEEEcCCC---EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|+||.||+|.+...+   ..||+|.+..... ...+.+..|+.+++.+.||||+++++++.. ...++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCC
Confidence            5999999999999876554   7899999876543 245678899999999999999999998764 5689999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc-
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-  252 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  252 (426)
                      +|.+++..    ...+++..++.++.|++.||.|||..   +++|+||||+|||++.++.+||+|||+++......... 
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          81 PLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             cHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999976    24689999999999999999999987   99999999999999999999999999997543322211 


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+...       .          .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~-------~----------~  216 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-------E----------R  216 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-------C----------c
Confidence            1111223567999999999999999999999999999998 99999765443222111110       0          0


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ...+...+..+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            112233445788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-41  Score=333.22  Aligned_cols=265  Identities=20%  Similarity=0.221  Sum_probs=201.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEc--CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ...+|.+.+.||.|+||.||++...  .++..||+|.+...     ..+.+|+.+|+.++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            4568999999999999999999764  34678999988643     2356899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||++. ++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++...
T Consensus       165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            99995 688888743    46799999999999999999999987   99999999999999999999999999997544


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh-ccccccc-
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK-DRKNFSQ-  324 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-  324 (426)
                      ............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......+. ....+.. 
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            33322223345799999999999999999999999999999999999999976543221111110000000 0000000 


Q ss_pred             ----------ccCCcccCCCC-------hHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 ----------MVDPSLQGQYP-------VRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ----------~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                                .+....+..+.       ......+.+++.+||+.||.+||++.+++..
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      00000010000       1123467889999999999999999999964

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.3e-41  Score=318.34  Aligned_cols=267  Identities=22%  Similarity=0.270  Sum_probs=203.0

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||.|+||.||+|.+..++..||||.+.....  .....+..|+.+++.++||||+++++++.++..+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            47888999999999999999998999999999865422  2346688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      ++ ++|.+++.... ....+++..++.++.||+.||.|||+.   +++|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 68888886532 235689999999999999999999987   99999999999999999999999999987543221


Q ss_pred             CcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh-h----hhhc---cc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR-P----MFKD---RK  320 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~----~~~~---~~  320 (426)
                        .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||................ .    .+..   ..
T Consensus       156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence              122234678999999988654 57899999999999999999999998655432221110000 0    0000   00


Q ss_pred             ccccccCCc---ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPS---LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+...++..   .........+.++.+++.+||+.||.+||++.+|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000   000011224557889999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.4e-41  Score=316.61  Aligned_cols=251  Identities=29%  Similarity=0.437  Sum_probs=200.9

Q ss_pred             eeeecCcEEEEEEEEcCCC------EEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           98 CLGEGGFGKVYKGCLEKIE------QVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .||+|+||.||+|++....      +.+|||.+.... ......+.+|+.+++.++||||+++++++......++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            5999999999999986544      789999886543 234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-----ceeEeccccc
Q 014362          171 PLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-----HPKLSDFGLA  242 (426)
Q Consensus       171 ~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-----~~kl~Dfgla  242 (426)
                      ++++|.+++.....   ....+++..++.++.||+.||.|||+.   +++|+||||+||+++.++     .++|+|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999975322   224588999999999999999999987   999999999999999877     8999999998


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +...............++..|+|||++.++.++.++|||||||++|||++ |..||...........+..       .  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------~--  229 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-------G--  229 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-------C--
Confidence            75433322222223345788999999999999999999999999999998 9999975543322111110       0  


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                              .....+...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus       230 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 --------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    011122334567899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.9e-41  Score=311.80  Aligned_cols=249  Identities=27%  Similarity=0.403  Sum_probs=202.3

Q ss_pred             eeeecCcEEEEEEEEcC-CC--EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEGGFGKVYKGCLEK-IE--QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||+|++|.||+|.+.. .+  ..||||.+..... ...+.+..|+.+++.++||||+++++++.. ..+++|+||++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            58999999999999865 23  3699999987665 566789999999999999999999999988 8899999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc-c
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-H  252 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  252 (426)
                      +|.+++.....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++........ .
T Consensus        81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            99999976321  5689999999999999999999987   9999999999999999999999999999865432221 1


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||...........+..      ...          .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------~~~----------~  219 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK------EGE----------R  219 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------cCC----------c
Confidence            1123457789999999999999999999999999999999 9999976544332221111      000          0


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ...+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0112233457899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=331.51  Aligned_cols=241  Identities=24%  Similarity=0.340  Sum_probs=190.7

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcC---CCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA---DHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      ||+|+||+||+|++..+++.||||++.....   .....+..|..++..+   .||||+++++++.+...+|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999865322   2233455566666554   699999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      |+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~  151 (330)
T cd05586          81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K  151 (330)
T ss_pred             ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence            999988865    45689999999999999999999987   99999999999999999999999999987532221  1


Q ss_pred             eeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          253 VSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+....      ..+.        
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~--------  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK------VRFP--------  217 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC------CCCC--------
Confidence            12345799999999998765 58999999999999999999999997654433222211100      0000        


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCC----CHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRP----AITDVVM  365 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~  365 (426)
                         .......+.+|+.+||+.+|.+||    ++.++++
T Consensus       218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               011344778999999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-41  Score=317.42  Aligned_cols=239  Identities=23%  Similarity=0.365  Sum_probs=189.8

Q ss_pred             eeeecCcEEEEEEEEcCC------------------------CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceE
Q 014362           98 CLGEGGFGKVYKGCLEKI------------------------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL  153 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  153 (426)
                      .||+|+||.||+|.+..+                        ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            599999999999986321                        24589999876554555678889999999999999999


Q ss_pred             eeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-
Q 014362          154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-  232 (426)
Q Consensus       154 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-  232 (426)
                      ++++.+....++||||+++|+|..++..   ....+++..+..++.||+.||.|||+.   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999998865   245689999999999999999999987   999999999999998643 


Q ss_pred             ------ceeEecccccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHH-hCCCCCCCcCchh
Q 014362          233 ------HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELI-TGRKAIDQTKDRK  304 (426)
Q Consensus       233 ------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~ell-tg~~p~~~~~~~~  304 (426)
                            .+||+|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.......
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                  3799999988643221      12357888999998875 56899999999999999995 7999997654322


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      ......       ....            .+......+.+++.+||+.+|++||++.+|++.|
T Consensus       230 ~~~~~~-------~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KERFYE-------KKHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHH-------hccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            111110       0000            1111223688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=327.76  Aligned_cols=265  Identities=26%  Similarity=0.393  Sum_probs=222.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .....+.++||+|-||.|.++.... +..||||.++...... ..+|.+|+.+|.+|+|||||.++|+|..++.+++|+|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            3456778899999999999998875 6899999998765543 4789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ||++|+|.++|......  .+.......|+.||+.||+||.+.   ++|||||.+.|+|+|.++++||+|||+++-+-.+
T Consensus       616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999999874322  245667788999999999999998   9999999999999999999999999999987778


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh--CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT--GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      +......+.+-..+|||||.+..++++.++|||+||+++||+++  ...||........   +.....++.+....    
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~----  763 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQ----  763 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcc----
Confidence            77777777788899999999999999999999999999999976  6788876654332   22222233322211    


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                         ..-..|..++..+++++.+||..+-.+||+++++...|...
T Consensus       764 ---~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  764 ---VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               11234667788999999999999999999999999888754

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.1e-41  Score=319.17  Aligned_cols=272  Identities=28%  Similarity=0.415  Sum_probs=207.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcC----CCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEee--CCee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEK----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  163 (426)
                      ..|.+.+.||+|+||.||+|.+..    ++..||||.+...... ....+..|+.+++.+.||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            457778899999999999999753    4789999999865443 46779999999999999999999999877  5678


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999999762   33699999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ....... ......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~-~~~~~~~  235 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQG-QMIVTRL  235 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccc-cccHHHH
Confidence            65422211 1111224566799999999889999999999999999999999998653321100 0000000 0000000


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ...+........+..++.++.+|+.+||+.+|.+||++.+|+++|+.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            011111111122233446789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=315.18  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=206.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|++.+.||.|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++.+...+++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999999999999999999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..     ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||+++......
T Consensus        81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            999999999875     3789999999999999999999987   99999999999999999999999999997654321


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        .......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+.             ....+.
T Consensus       153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------------~~~~~~  217 (274)
T cd06609         153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-------------KNNPPS  217 (274)
T ss_pred             --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh-------------hcCCCC
Confidence              12233468889999999998889999999999999999999999997654322111111             000111


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +...   ..+..+.+++.+||..+|++||+++++++
T Consensus       218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1100   13447889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-41  Score=330.39  Aligned_cols=265  Identities=22%  Similarity=0.264  Sum_probs=202.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------  160 (426)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999999999999999987532  23456688899999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ...|+||||++ ++|...+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence            35799999996 46766664      2478899999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh-------
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR-------  313 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-------  313 (426)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....       
T Consensus       172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99754322   11233478999999999999999999999999999999999999998765433322221100       


Q ss_pred             ---------hhhhccccc-----ccccCCcc---cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          314 ---------PMFKDRKNF-----SQMVDPSL---QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       314 ---------~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                               ........+     ........   ...........+.+|+.+||+.||.+|||+.++++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                     000000000     00000000   001111223478899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.6e-41  Score=313.91  Aligned_cols=239  Identities=23%  Similarity=0.363  Sum_probs=190.3

Q ss_pred             eeeecCcEEEEEEEEcCC------------CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           98 CLGEGGFGKVYKGCLEKI------------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .||+|+||.||+|.+...            ...|++|.+..........+.+|+.+++.++||||+++++++......++
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            489999999999986432            33689998876555555678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc-------eeEec
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-------PKLSD  238 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-------~kl~D  238 (426)
                      ||||+++|+|..++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.       ++++|
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          82 VEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999988865   235689999999999999999999987   9999999999999987654       89999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccc-cCCCCccCchhhHHHHHHHHH-hCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELI-TGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      ||++......      ....++..|+|||++. +..++.++|||||||++|||+ +|..||...........       .
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H
Confidence            9998653221      2235788999999887 467899999999999999998 58888765432211100       0


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      ..  . ...         .......+.+|+.+||+.||.+||++.+|++.|
T Consensus       223 ~~--~-~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 EG--Q-CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             hc--C-ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            00  0 000         111234688999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-41  Score=317.40  Aligned_cols=239  Identities=25%  Similarity=0.439  Sum_probs=192.5

Q ss_pred             eeeecCcEEEEEEEEcCCCE-------EEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           98 CLGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .||.|+||.||+|.+...+.       .||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            59999999999999865443       38888887655555677889999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc--------eeEeccccc
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--------PKLSDFGLA  242 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~kl~Dfgla  242 (426)
                      ++|+|..++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.        ++++|||++
T Consensus        82 ~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          82 KFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999998752   34689999999999999999999987   9999999999999987765        599999988


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCC-CCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR-KAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      ......      ....++..|+|||++.+. .++.++||||||+++|||++|. .||............       ... 
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-------~~~-  221 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-------EDR-  221 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------Hcc-
Confidence            643221      224678899999999864 5899999999999999999995 566544332211110       000 


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                                 ...|......+.+|+.+||+.+|++||++.+|++.|
T Consensus       222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         222 -----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             -----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                       112222335789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-41  Score=309.79  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=201.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHH
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      .||.|+||.||+|.+.. ++.||+|.+...... ....+..|+.+++.+.||||+++++++.+....++||||+++++|.
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            59999999999999988 999999998765443 4567899999999999999999999999999999999999999999


Q ss_pred             HHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeee
Q 014362          177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR  256 (426)
Q Consensus       177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  256 (426)
                      +++..   ....+++..++.++.+++.||.|||+.   +++||||+|+|||++.++.++|+|||++..............
T Consensus        81 ~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            99875   234688999999999999999999987   999999999999999999999999999975432211111112


Q ss_pred             ecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       257 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ..++..|+|||.+.++.++.++||||||+++|||++ |..||...........+..                 ......+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-----------------~~~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-----------------GYRMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-----------------CCCCCCC
Confidence            234667999999998899999999999999999999 8888876553322211110                 0011122


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            334558899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-41  Score=318.38  Aligned_cols=264  Identities=24%  Similarity=0.367  Sum_probs=204.2

Q ss_pred             CCccccceeeecCcEEEEEEEE----cCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--Cee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  163 (426)
                      ..|.+.+.||+|+||.||++.+    ..++..||+|.+.... ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478889999999999999985    4568899999987543 33456789999999999999999999998775  568


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999999865   234689999999999999999999987   99999999999999999999999999997


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhh--------hcHHHhhhh
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE--------LNLVAWARP  314 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~--------~~~~~~~~~  314 (426)
                      ........ .......++..|+|||++.+..++.++||||||+++|||+++..|+........        .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            54332211 112234577789999999988999999999999999999998776532111000        000000000


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ..          ........+...+..+.+|+.+||+.+|.+||++.+|++.|+.+
T Consensus       238 ~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VL----------EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HH----------HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00          00011112233556899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.9e-41  Score=316.18  Aligned_cols=266  Identities=25%  Similarity=0.322  Sum_probs=205.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++...||+|+||.||+|.+..+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            468899999999999999999998999999999865432  234567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|..++..    ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999888877653    34689999999999999999999997   9999999999999999999999999999864433


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh-hhhhh-------cc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA-RPMFK-------DR  319 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-------~~  319 (426)
                      ..  ......++..|+|||++.+ ..++.++||||||+++|||++|..||.+....+....+... .....       ..
T Consensus       154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            21  1223467889999999876 45789999999999999999999999876544332222111 00000       00


Q ss_pred             cccccccCCcccCCCC-----hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYP-----VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ........+......+     ...+..+.+|+.+||+.+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000011100001     122457889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.6e-41  Score=312.68  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=204.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||.|+||.||+|.... ++.||+|.+..... ....+.+|+.+++.++||||+++++++.. ...++||||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CCcEEEEEc
Confidence            4578999999999999999998765 67899999875433 35678999999999999999999998754 568999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999988652  245689999999999999999999987   99999999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      . .......++..|+|||++....++.++||||||+++|||++ |+.||...........+.       ..         
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~---------  219 (260)
T cd05067         157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE-------RG---------  219 (260)
T ss_pred             c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH-------cC---------
Confidence            1 11122345778999999998899999999999999999999 999997654332221111       00         


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                       .....+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus       220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         220 -YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence             0001122334578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.2e-41  Score=320.89  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=205.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.+..... .....+..|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            467888899999999999999876665    578888865432 2344688999999999999999999998764 4679


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ++||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence            9999999999999875   234689999999999999999999987   9999999999999999999999999999864


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............++..|+|||++.+..++.++||||||+++|||++ |..||...........+..       ...+  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~~~--  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-------GERL--  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-------CCCC--
Confidence            43222212222345778999999999999999999999999999997 8999976543222211110       0000  


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                              ..+..+...+.+++..||..+|++||++.++++.|..+..
T Consensus       231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                    0112234578899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-40  Score=313.91  Aligned_cols=249  Identities=27%  Similarity=0.397  Sum_probs=207.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ..|+..+.||.|+||.||+|.+..++..||||.+.... ......+..|+.+++.+.||||+++++++.++..+++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777888999999999999999889999999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..     .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            999999998864     4588999999999999999999987   99999999999999999999999999997543322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        .......++..|+|||++.+..++.++|+||||+++|||++|..||...........+                 ...
T Consensus       156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~~  216 (277)
T cd06640         156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------PKN  216 (277)
T ss_pred             --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------hcC
Confidence              1122346888999999999889999999999999999999999999765433211111                 001


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .....+...+..+.+++.+||+.+|.+||++.+++..
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1112334556788999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.7e-41  Score=311.02  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=200.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEe-eCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA-EGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~  169 (426)
                      .+|.+.+.||+|+||.||+|...  +..||+|.+....  ..+.+..|+.+++.++|+||+++++++. .....++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            46888999999999999999876  7789999986543  3467889999999999999999999764 45678999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999998762  234589999999999999999999987   99999999999999999999999999987533221


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                           ....++..|+|||++.+..++.++|||||||++|||++ |+.||...........+.       .          
T Consensus       157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------~----------  214 (256)
T cd05082         157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------K----------  214 (256)
T ss_pred             -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------c----------
Confidence                 12245678999999998899999999999999999998 999987543322111110       0          


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       215 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         215 GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            00111223345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=7.1e-41  Score=317.31  Aligned_cols=264  Identities=28%  Similarity=0.330  Sum_probs=209.0

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEee
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE  159 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  159 (426)
                      +++.++..+.++|.+...||+|+||.||+|....+++.+|+|.+.... .....+..|+.++..+ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            445566667889999999999999999999999999999999986542 2245677899999988 79999999999865


Q ss_pred             C-----CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          160 G-----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       160 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      .     ..+++||||+++++|.++++........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence            4     358999999999999999875444456789999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccC-----CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHH
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV  309 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  309 (426)
                      ||+|||++........  ......|+..|+|||++...     .++.++|||||||++|||++|+.||...........+
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            9999999875432211  11234688999999987643     3689999999999999999999999765432222111


Q ss_pred             HhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          310 AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .  ..      ....+       ..+......+.+|+.+||+.+|++||++.+|++
T Consensus       246 ~--~~------~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 P--RN------PPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             h--cC------CCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0  00      00001       012233447899999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.5e-41  Score=312.61  Aligned_cols=251  Identities=24%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  163 (426)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+....     ......+.+|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999999999999999986432     1234568889999999999999999999865  3578


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++++||+++++|.+++..    ...+++...+.++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||+++
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            899999999999999875    34589999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......++..|+|||++.+..++.++|||||||++|||++|+.||.............            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~------------  222 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA------------  222 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh------------
Confidence            54321111 11122458899999999998889999999999999999999999997543322111100            


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ........+......+.+++ +||..+|++||++.+|++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 ----TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ----cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                00011122333444666777 688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.1e-41  Score=313.75  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=206.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .+|.+.+.||.|+||.||+|.+...   ...||||...... ....+.+..|+.+++.++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4688889999999999999987643   3569999887654 3445678999999999999999999999876 457899


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.++|+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999975   234689999999999999999999987   99999999999999999999999999997543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      .... .......++..|+|||.+....++.++||||||+++|||++ |..||...........+..       ...    
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-------~~~----  226 (270)
T cd05056         159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-------GER----  226 (270)
T ss_pred             cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-------CCc----
Confidence            3211 11122234568999999988899999999999999999996 9999976654332211110       000    


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                            ...+...+..+.+++.+||..+|.+||++.+++..|+.+..
T Consensus       227 ------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         227 ------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  01123344578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1e-40  Score=312.57  Aligned_cols=254  Identities=27%  Similarity=0.368  Sum_probs=191.4

Q ss_pred             eeeecCcEEEEEEEEcC--CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||+|....  ....+|+|.+..... .....+.+|+.+++.++||||+++++.+.....+++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            49999999999997543  345789998765432 334568899999999999999999999999999999999999999


Q ss_pred             HHHHhhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce
Q 014362          175 LDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       175 L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      |.+++...... ....++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999764321 23356788899999999999999987   999999999999999999999999999864322211111


Q ss_pred             eeeecccccccCcccccc-------CCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          254 STRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||...............     .   ....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-----~---~~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-----Q---DIKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-----c---CccC
Confidence            122346778999998743       356889999999999999999 78888765433221111100     0   0011


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      ..+    ..+...+..+.+++..|| .||++||++.+|++.|
T Consensus       231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            111    112234456777888998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-41  Score=311.55  Aligned_cols=256  Identities=28%  Similarity=0.436  Sum_probs=207.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||.|+||.||+|.+.. +..||||.+..... ....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            34679999999999999999999865 57799999875433 35678999999999999999999999998889999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...  ....+++..+..++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||+++.....
T Consensus        82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999762  235689999999999999999999987   9999999999999999999999999998754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .. .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+...         +     
T Consensus       157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~---------~-----  221 (261)
T cd05034         157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG---------Y-----  221 (261)
T ss_pred             hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------C-----
Confidence            11 11112234678999999998899999999999999999999 99999765433222211100         0     


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                         ....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               001112224578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-41  Score=317.33  Aligned_cols=267  Identities=24%  Similarity=0.316  Sum_probs=207.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  ......+..|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            46899999999999999999999999999999987532  2335678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++++.+..++..    ...+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998777655543    35589999999999999999999987   9999999999999999999999999999765433


Q ss_pred             CCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh--------cc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK--------DR  319 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~  319 (426)
                      .. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+...........+.        ..
T Consensus       154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            22 122335688999999999888 889999999999999999999999976554332222111100000        00


Q ss_pred             ccc-----ccccCC-cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNF-----SQMVDP-SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~-----~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+     ....++ .+...++...+..+.+|+.+||..+|++||++++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            000     000000 0011123334678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-40  Score=309.99  Aligned_cols=253  Identities=29%  Similarity=0.427  Sum_probs=202.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|.+...||.|+||.||+|.+..+. .+|+|.+.... ...+.+.+|+.+++.++|||++++++++.. ...++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            46888899999999999999987654 58999886543 234668899999999999999999998864 5688999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999999753  234589999999999999999999987   999999999999999999999999999975433221


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |..||...........+..       .      .   
T Consensus       158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~------~---  220 (260)
T cd05069         158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-------G------Y---  220 (260)
T ss_pred             c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------C------C---
Confidence            1 1112346778999999988899999999999999999999 8999976543322211110       0      0   


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                       ....+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus       221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             001122344578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-41  Score=326.94  Aligned_cols=264  Identities=21%  Similarity=0.290  Sum_probs=200.5

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----  160 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----  160 (426)
                      ...++|++.+.||.|+||.||+|.+..+++.||||.+.....  .....+.+|+.+|+.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            346789999999999999999999999999999999875422  2345677899999999999999999987543     


Q ss_pred             -CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          161 -DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       161 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                       ...|++++++ +++|..++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence             3468999988 7899887753     4699999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh---
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM---  315 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---  315 (426)
                      |+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......   
T Consensus       163 g~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            999754322     223478999999999877 57899999999999999999999999765433322211110000   


Q ss_pred             --hhc-----c----cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          316 --FKD-----R----KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       316 --~~~-----~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        +..     .    ..+.......+. .........+.+|+.+||+.||.+||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              000     0    000000000000 0001123357899999999999999999999953

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.6e-40  Score=308.73  Aligned_cols=251  Identities=23%  Similarity=0.339  Sum_probs=208.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||.|+||.||.++...++..+++|.+....  ......+.+|+.+++.++|+||+++++++.+...++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999999999999999987543  34456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999987632  35689999999999999999999987   99999999999999999999999999997643322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      .  ......|++.|+|||.+.+..++.++||||||+++|||++|..||...........+..        ..+.      
T Consensus       156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------~~~~------  219 (256)
T cd08221         156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------GNYT------  219 (256)
T ss_pred             c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--------CCCC------
Confidence            1  22335689999999999888899999999999999999999999976543322211110        0000      


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence               0112334578899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-40  Score=308.91  Aligned_cols=250  Identities=21%  Similarity=0.311  Sum_probs=203.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee-CCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e  168 (426)
                      +|++.+.||.|++|.||++.+..+++.||+|.+....  ....+.+..|+.+++.++|||++++++.+.. ...+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5889999999999999999999889999999986543  2345668899999999999999999998764 446899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...  ....+++.+++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999998763  235689999999999999999999987   9999999999999999999999999999754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .  .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+      ...      .+  
T Consensus       156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~------~~~------~~--  219 (257)
T cd08223         156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI------IEG------KL--  219 (257)
T ss_pred             C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------Hhc------CC--
Confidence            1  1223456899999999999999999999999999999999999999754432211111      000      00  


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         ...+...+..+.+++.+||+.+|.+||++.++++
T Consensus       220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               0112334457899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.4e-40  Score=310.85  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=201.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--Cee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  163 (426)
                      .+|++.+.||+|+||.||.|.+..++..||||.+....     ......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999999999999999885321     12345788899999999999999999998763  467


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            899999999999999875    24588899999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||.............            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~------------  222 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA------------  222 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh------------
Confidence            54321111 11123468899999999988889999999999999999999999997543322111100            


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ........|......+.+++.+||. +|.+||++++|++
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 ----TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ----cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                0001112344555678889999994 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.8e-41  Score=316.19  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=204.0

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .|+..+.||.|+||.||+|.+..++..||+|.+.... ......+..|+.+++.++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3666777999999999999999889999999987543 234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..     ..+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence            99999988853     4689999999999999999999987   99999999999999999999999999987543321 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                       .......|+..|+|||++.+..++.++||||||+++|||++|..||...........+                 ....
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~~~  217 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-----------------PKNS  217 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-----------------hcCC
Confidence             1112346889999999999989999999999999999999999998754432211100                 0000


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ....+...+..+.+++.+||+.+|.+||++.+|++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            111223345578899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2e-40  Score=310.50  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=192.7

Q ss_pred             eeeecCcEEEEEEEEcCC--CEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           98 CLGEGGFGKVYKGCLEKI--EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      .||+|+||.||+|.....  ...+++|.+.... ......+.+|+.+++.++||||+++++.|.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            499999999999976432  3456777776543 2345678999999999999999999999999999999999999999


Q ss_pred             HHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCccee
Q 014362          175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS  254 (426)
Q Consensus       175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  254 (426)
                      |.+++.........+++..++.++.||+.||.|||+.   +++||||||+|||++.++.++|+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            9999986433345577888899999999999999987   9999999999999999999999999998642222111222


Q ss_pred             eeecccccccCcccccc-------CCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          255 TRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       255 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....++..|+|||++..       ..++.++||||||+++|||++ |..||...........+..      .  ......
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~------~--~~~~~~  230 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK------D--QQVKLF  230 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh------h--cccccC
Confidence            34568899999998753       245789999999999999997 5668865443322221110      0  011122


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ++.+.    ......+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            22222    223456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-40  Score=312.31  Aligned_cols=255  Identities=24%  Similarity=0.385  Sum_probs=201.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc----------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD  161 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  161 (426)
                      +|.+.+.||.|+||.||+|....+++.||+|.+.....          ...+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            47788899999999999999988899999998863211          11346788999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      ..++||||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999999876    25689999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      ++...............|+..|+|||.+....  ++.++|+||||+++|+|++|..||.............      .  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~--  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG------N--  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh------c--
Confidence            97543221111223346889999999987654  8899999999999999999999996443221110000      0  


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ......+.    .......+..+.+++.+||..+|..||++.+|++
T Consensus       227 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 KRSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00000111    1111223458899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.3e-40  Score=309.19  Aligned_cols=258  Identities=29%  Similarity=0.407  Sum_probs=209.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|++.+.||.|+||+||+|.+..++..+|+|.+.... ......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999998889999999987543 23567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..... ...+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999976322 24689999999999999999999987   99999999999999999999999999987544332


Q ss_pred             Cc--ceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          250 KT--HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       250 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..  .......|+..|+|||++... .++.++|+||||+++|+|++|+.||..............  .           .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~--~-----------~  223 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ--N-----------D  223 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc--C-----------C
Confidence            22  122334689999999998877 789999999999999999999999976544322111110  0           0


Q ss_pred             CCcccCCC-ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQY-PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+.+.... ....+..+.+++.+||+.+|++||++.+|++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00111110 1234567899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-40  Score=306.92  Aligned_cols=246  Identities=28%  Similarity=0.423  Sum_probs=198.1

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHH
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      .||+|+||.||+|... ++..||+|.+...... ....+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            5999999999999865 4788999998765432 3346889999999999999999999999999999999999999999


Q ss_pred             HHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeee
Q 014362          177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR  256 (426)
Q Consensus       177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  256 (426)
                      +++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ......
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~  153 (250)
T cd05085          81 SFLRK---KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGL  153 (250)
T ss_pred             HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCC
Confidence            98865   234689999999999999999999987   99999999999999999999999999987432211 111112


Q ss_pred             ecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       257 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ..++..|+|||++.+..++.++||||||+++|+|++ |..||...........+.   .              ......+
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~--------------~~~~~~~  216 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K--------------GYRMSCP  216 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c--------------CCCCCCC
Confidence            244678999999998899999999999999999998 999997654332211111   0              0011122


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ...+..+.+++.+||..+|.+||++.++++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            334568899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-40  Score=310.67  Aligned_cols=251  Identities=25%  Similarity=0.385  Sum_probs=202.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      +|.+.+.||.|+||.||+|... +++.+|+|.+.....      .....+.+|+.+++.++|+||+++++++.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4788899999999999999874 588999999864321      224568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |+||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.++|+|||++...
T Consensus        80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            9999999999999975    34688999999999999999999987   9999999999999999999999999998753


Q ss_pred             CCCC----CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          246 PSGD----KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       246 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ....    .........|+..|+|||++.+..++.++||||||+++|+|++|..||................      . 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------~-  225 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR------G-  225 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc------C-
Confidence            2111    1111223468999999999998899999999999999999999999997654322211111000      0 


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                              .....+......+.+++.+||+.+|.+||++.+++.
T Consensus       226 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         226 --------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    001122334557899999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9.5e-41  Score=312.62  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=205.1

Q ss_pred             CccccceeeecCcEEEEEEEEcC-CCEEEEEEEeccCC----------cccHHHHHHHHHHHhc-CCCCCcceEeeEEee
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRG----------VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAE  159 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~  159 (426)
                      +|++.+.||.|+||.||+|.+.. .++.+|+|.+....          ......+..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788889999999999999987 67899999885321          1234557778887765 799999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ....++||||+++++|.+++.........+++..++.++.|++.||.|||+.  .+++|+||+|+|||++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            9999999999999999999876544556799999999999999999999963  38999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..        
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--------  227 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE--------  227 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--------
Confidence            9997643322   22345689999999999988899999999999999999999999975443221111110        


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                          ....+.    .....+..+.+++.+||+.||.+||++.||..++.
T Consensus       228 ----~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 ----AVYEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----ccCCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                000000    01123457899999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-40  Score=321.21  Aligned_cols=264  Identities=18%  Similarity=0.210  Sum_probs=197.1

Q ss_pred             ccceeeec--CcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           95 SDCCLGEG--GFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        95 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      +...||+|  +|++||++.++.+|+.||+|.+....  ......+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            34569999  78999999999999999999997543  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++|+|.+++....  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++++||+.+........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999986532  34589999999999999999999987   999999999999999999999999986543211110


Q ss_pred             -c----ceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh---c--
Q 014362          251 -T----HVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK---D--  318 (426)
Q Consensus       251 -~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~--  318 (426)
                       .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||............  ......   +  
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~  234 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCcccccccc
Confidence             0    01112356788999999876  46899999999999999999999999754322111000  000000   0  


Q ss_pred             ------------c----cccccc---------cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 ------------R----KNFSQM---------VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ------------~----~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                  .    ..+...         ................+.+|+.+||+.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                        0    000000         0000000112233557889999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.5e-40  Score=309.75  Aligned_cols=255  Identities=22%  Similarity=0.317  Sum_probs=207.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~  167 (426)
                      +|++.+.||.|+||.||+|.+..++..||+|.+.....  ...+.+..|+.+++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            47888999999999999999999999999999875432  335568889999999999999999998754  45689999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||+++++|.+++.........+++..++.++.||+.||.|||..+  ..+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999875555678999999999999999999999221  239999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      .....  ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.       .       
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~-------  224 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-------E-------  224 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh-------c-------
Confidence            43221  1223468999999999998889999999999999999999999998654222111110       0       


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         ......+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       225 ---~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         225 ---GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             ---CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               0011223344568899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-40  Score=315.03  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=204.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++||||+++++++.....+++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3688889999999999999999989999999998654 233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|..++.... ....+++..+..++.||+.||.|||+.  .+|+|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            99999998886521 234789999999999999999999963  38999999999999999999999999998754222 


Q ss_pred             CcceeeeecccccccCccccccC------CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                         ......+++.|+|||.+.+.      .++.++|||||||++|+|++|+.||..............            
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~------------  221 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA------------  221 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH------------
Confidence               11234688899999998554      358899999999999999999999975433221111110            


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       +.. ......+......+.+|+.+||+.+|.+||++.+++..
T Consensus       222 -~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         222 -IVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -Hhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             000 00112233456678999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-40  Score=310.03  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=194.1

Q ss_pred             eeeecCcEEEEEEEEcC---CCEEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEe-eCCeeEEEEEecCC
Q 014362           98 CLGEGGFGKVYKGCLEK---IEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCA-EGDQRLLVYEYMPL  172 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~~  172 (426)
                      .||+|+||.||+|.+..   ....||||.+... .......+..|+.+++.++||||+++++++. .+...++||||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            58999999999998743   3467999998643 2344667889999999999999999999775 45568899999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc-
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-  251 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  251 (426)
                      |+|.+++...   ...+++..+..++.||+.||.|||+.   +++||||||+|||+++++.+||+|||+++........ 
T Consensus        82 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          82 GDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            9999998752   34467888899999999999999987   9999999999999999999999999998753321111 


Q ss_pred             -ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          252 -HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       252 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                       .......++..|+|||++.+..++.++|||||||++|||++| .+||...........+      ... .         
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~------~~~-~---------  219 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL------LQG-R---------  219 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------hcC-C---------
Confidence             111123467789999999888999999999999999999995 5566544322211111      000 0         


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                       ....+...+..+.+++.+||+.+|++||++.+|+..|+.+.
T Consensus       220 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 -RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             00011223347889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.4e-41  Score=317.61  Aligned_cols=266  Identities=25%  Similarity=0.311  Sum_probs=204.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            368889999999999999999998899999999865432  234568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|..+...    ...+++..++.++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            9999998877654    34589999999999999999999987   9999999999999999999999999998754332


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc--------c
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD--------R  319 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~  319 (426)
                      .  .......++..|+|||++.+ ..++.++||||||+++|||++|++||...........+......+..        .
T Consensus       154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            2  12233468899999999875 45788999999999999999999999765433222211111000000        0


Q ss_pred             cccccccCCcccC-----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQG-----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ........+....     ......+..+.+|+.+||+.+|.+||++.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000000010000     011233567899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-41  Score=317.14  Aligned_cols=260  Identities=22%  Similarity=0.326  Sum_probs=208.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+..|+.+++.++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            46888889999999999999999999999999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|..++..    ...+++..+..++.+++.||.|||+.  .+++||||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            999999998865    35689999999999999999999973  389999999999999999999999999986432211


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-----cHHHhhhhhhhccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-----NLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  324 (426)
                          .....|+..|+|||++.+..++.++|||||||++|+|++|..||.........     ............      
T Consensus       159 ----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------  228 (284)
T cd06620         159 ----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------  228 (284)
T ss_pred             ----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence                12347899999999998889999999999999999999999999865432110     011111111100      


Q ss_pred             ccCCcccCCCC-hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          325 MVDPSLQGQYP-VRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       325 ~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                          . ....+ ...+..+.+|+.+||+.||.+||++.||++....+.
T Consensus       229 ----~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         229 ----P-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             ----c-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                0 00111 124457889999999999999999999998765543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.9e-41  Score=315.08  Aligned_cols=260  Identities=26%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEee-
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE-  159 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-  159 (426)
                      +..++....+.|++...||.|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            45555667789999999999999999999999999999999986543 3345688899999888 69999999999853 


Q ss_pred             -----CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          160 -----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       160 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                           ...++++|||+++|+|.+++....  ...+++..++.++.||+.||.|||+.   +|+|+||+|+||++++++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence                 457899999999999999987633  34588999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHH
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV  309 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  309 (426)
                      +|+|||++.......  .......|++.|+|||.+.     ...++.++|||||||++|||++|..||............
T Consensus       161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            999999987432211  1122346899999999876     346888999999999999999999999754432222111


Q ss_pred             HhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          310 AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..             ...+   .......+..+.+|+.+||+.+|.+||++.+|++
T Consensus       239 ~~-------------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         239 PR-------------NPPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hh-------------CCCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00             0000   0011234457899999999999999999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-40  Score=309.07  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=204.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      +|+..+.||+|+||.||+|....++..|++|.+....     ....+.+..|+.+++.++||||+++++++.+...+++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777888999999999999999889999999986543     22456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      +||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999875    34689999999999999999999987   99999999999999999999999999987543


Q ss_pred             CCCCcceeeeecccccccCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ...   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||..............    .   ..    
T Consensus       154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~---~~----  219 (258)
T cd06632         154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR----S---KE----  219 (258)
T ss_pred             ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh----c---cc----
Confidence            322   123356899999999987766 89999999999999999999999976543221111110    0   00    


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                           ....+......+.+++.+||+.+|.+||++.+++.
T Consensus       220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                 01122334457889999999999999999999984

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-40  Score=318.04  Aligned_cols=256  Identities=22%  Similarity=0.284  Sum_probs=204.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||++.+..+++.|++|.+.....   .....+.+|+.+++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            368899999999999999999999999999999876532   33456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            99999999999975    35689999999999999999999987   999999999999999999999999999864211


Q ss_pred             CCCc-------------ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          248 GDKT-------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       248 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      ....             .......|+..|+|||.+.+..++.++||||||+++|||++|..||.+.............. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-  232 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-  232 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-
Confidence            1000             01112457889999999998899999999999999999999999997654322221111000 


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                                ...+..    +...+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       233 ----------~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         233 ----------IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ----------cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                      000000    1123457899999999999999999766555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.1e-41  Score=318.60  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=203.4

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      |.....||.|+||.||++.+..++..||||.+..........+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            44445699999999999999988999999998766555567788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      ++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++.......  .
T Consensus       104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~  173 (292)
T cd06658         104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P  173 (292)
T ss_pred             CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence            999998754     4589999999999999999999987   99999999999999999999999999987533221  1


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                      ......|+..|+|||++.+..++.++||||||+++|||++|+.||...........+.             ..+.+.+..
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~-------------~~~~~~~~~  240 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR-------------DNLPPRVKD  240 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------hcCCCcccc
Confidence            1223468999999999988899999999999999999999999997654332221111             001111111


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        .......+.+++.+||..+|.+||++.++++.
T Consensus       241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              11234467889999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=312.28  Aligned_cols=256  Identities=29%  Similarity=0.384  Sum_probs=205.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~------  161 (426)
                      .+++|++.+.||.|+||.||+|.+..+++.+++|.+..... ....+..|+.+++.+ .||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            46789999999999999999999998899999999876543 346788999999998 6999999999997644      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence            48999999999999999876543456799999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      +.......  .......|+..|+|||++..     ..++.++||||||+++|+|++|..||...........+.      
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------  231 (275)
T cd06608         160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP------  231 (275)
T ss_pred             ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh------
Confidence            87533221  12233468999999998753     346789999999999999999999997543322211110      


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..       ..+.  ...+......+.+|+.+||..||.+||++.+|++
T Consensus       232 ~~-------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RN-------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cc-------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00       0000  1112234567899999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-40  Score=317.90  Aligned_cols=200  Identities=27%  Similarity=0.387  Sum_probs=162.7

Q ss_pred             cceeeecCcEEEEEEEEc--CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeEEEEEecC
Q 014362           96 DCCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMP  171 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~  171 (426)
                      ..+||+|+||.||+|.++  .+++.||+|.+.....  ...+.+|+.+|+.++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            356999999999999975  3678999999875432  3457889999999999999999999854  456889999995


Q ss_pred             CCCHHHHhhhhCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee----ccCCceeEeccccc
Q 014362          172 LGSLDKHLHDLRP-----DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLA  242 (426)
Q Consensus       172 ~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla  242 (426)
                       ++|..++.....     ....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +..+.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             588877753211     223589999999999999999999987   99999999999999    45678999999999


Q ss_pred             ccCCCCCC-cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcC
Q 014362          243 KMGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK  301 (426)
Q Consensus       243 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~  301 (426)
                      +....... ........||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            86433221 1122345789999999998774 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-40  Score=317.11  Aligned_cols=249  Identities=22%  Similarity=0.290  Sum_probs=203.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      |.....||.|+||.||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            44455699999999999999888999999999765555566788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      ++|..++..     ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......  .
T Consensus       103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~  172 (297)
T cd06659         103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P  172 (297)
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence            999987754     4589999999999999999999987   99999999999999999999999999987533221  1


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+...       .      .+..  
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------~------~~~~--  237 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-------P------PPKL--  237 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-------C------CCCc--
Confidence            122357899999999999889999999999999999999999999765433222111100       0      0000  


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ..+......+.+++.+||+.+|.+||++.+|++.
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0111233468899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=8.9e-41  Score=315.32  Aligned_cols=265  Identities=20%  Similarity=0.243  Sum_probs=199.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||.|+||.||+|.+..+|+.||+|.+.....  .....+..|+.+++.++||||+++++++.+...+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            47888999999999999999999999999999865322  2235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      ++ ++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||+++......
T Consensus        81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 578777764   235699999999999999999999987   99999999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCch-hhhcHHHhhh--------hhhhcc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR-KELNLVAWAR--------PMFKDR  319 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~--------~~~~~~  319 (426)
                      .  ......+++.|+|||++.+. .++.++|||||||++|||++|..|+...... .....+....        +.....
T Consensus       154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence            1  11234678999999988765 4789999999999999999999886443322 1111110000        000000


Q ss_pred             cccccc--cCCcc-cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQM--VDPSL-QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~--~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ......  ..... ........+..+.+|+.+||+.||.+|||+++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000  00000 00111234567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-42  Score=319.74  Aligned_cols=251  Identities=29%  Similarity=0.396  Sum_probs=211.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..+.|+.-++||+||||.||-+..+.||+.+|+|.+.+...   ........|..+|.+++.++||.+-.+|+..+.+||
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            34678888999999999999999999999999999876543   234457789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |+..|.||+|.-+|.+..  ...+++..++.++.+|+.||++||..   +||+|||||+|||||+.|+++|+|+|||...
T Consensus       263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEec
Confidence            999999999999998854  36799999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      +.+...   ...+||.+|||||++.+..|+...|+|||||+||||+.|+.||..........-+.  +....        
T Consensus       338 ~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~--------  404 (591)
T KOG0986|consen  338 PEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLE--------  404 (591)
T ss_pred             CCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhc--------
Confidence            554332   22389999999999999999999999999999999999999998765432211111  11111        


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT  361 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  361 (426)
                          ....++...+.++.+|....|+.||.+|....
T Consensus       405 ----~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 ----DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ----chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                12245666777999999999999999997554

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-40  Score=316.93  Aligned_cols=254  Identities=26%  Similarity=0.322  Sum_probs=206.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||.|+||.||+|....+++.||+|.+......   ..+.+..|+.+++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688899999999999999999999999999999765432   4566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+.+++|.+++...  ....+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999998752  245689999999999999999999987   999999999999999999999999999874322


Q ss_pred             CCCc---------------------------ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCc
Q 014362          248 GDKT---------------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQT  300 (426)
Q Consensus       248 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~  300 (426)
                      ....                           .......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                           0111246889999999999989999999999999999999999999765


Q ss_pred             CchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 014362          301 KDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA----ITDVVM  365 (426)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~  365 (426)
                      ........+.      ..          ...-......+..+.+++.+||+.+|++||+    +.+++.
T Consensus       236 ~~~~~~~~~~------~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         236 NRDETFSNIL------KK----------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             chHHHHHHHh------cC----------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            5432221111      00          0000001114568899999999999999999    777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-40  Score=307.15  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=205.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||+|+||.||.+....+++.||+|.+....  ......+..|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            5888999999999999999999899999999987532  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||+|+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999988752  234588999999999999999999987   99999999999999999999999999997543321


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      .  ......|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..      .  .        
T Consensus       156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~------~--~--------  217 (256)
T cd08218         156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR------G--S--------  217 (256)
T ss_pred             h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc------C--C--------
Confidence            1  11234688999999999998999999999999999999999999976543322111110      0  0        


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ....+......+.+++.+||+.+|.+||++.+|++
T Consensus       218 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 -YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             00122334557899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-40  Score=309.33  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=205.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      +|+..+.||+|+||.||+|....+++.||+|.+.....      ...+.+..|+.+++.++||||+++++++.+.+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            47888899999999999999999999999999875321      134678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEeccccccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKM  244 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~  244 (426)
                      |+||+++++|.+++..    ..++++..++.++.||+.||.|||+.   +++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            9999999999999875    35689999999999999999999987   999999999999998775 599999999875


Q ss_pred             CCCCCC--cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          245 GPSGDK--THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       245 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ......  ........|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+...          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------  223 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI----------  223 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----------
Confidence            433211  11122346889999999998889999999999999999999999999654332211111100          


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         .........+......+.+++.+||+.+|.+||++.+++.
T Consensus       224 ---~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 ---ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ---hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence               0001112234445568899999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.1e-40  Score=306.59  Aligned_cols=252  Identities=32%  Similarity=0.484  Sum_probs=204.1

Q ss_pred             ccccceeeecCcEEEEEEEEcCCC----EEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      +++.+.||.|+||.||++.+...+    ..||+|.+...... ....+..|+.++..++||||+++++++.+....+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356678999999999999998766    89999999765443 5678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999987622  12289999999999999999999987   999999999999999999999999999976543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+....             
T Consensus       156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-------------  221 (258)
T smart00219      156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-------------  221 (258)
T ss_pred             cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------
Confidence            322111 12236789999999988899999999999999999998 788887643322221111100             


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                          ....+...+..+.+++.+||..+|.+||++.++++.|
T Consensus       222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                0011222455789999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-40  Score=312.68  Aligned_cols=266  Identities=23%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|.+.+.||.|+||.||+|.+..+|..||+|.+.....  .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            58888999999999999999998899999999876542  3356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      + +++|.+++...   ...+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999998762   36699999999999999999999987   99999999999999999999999999998654332


Q ss_pred             CcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh--------hhhhhccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA--------RPMFKDRK  320 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  320 (426)
                      . .......|+..|+|||.+.+. .++.++||||||+++|||++|.+||...........+...        ++.+....
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            1 112234689999999988654 4689999999999999999998888665443322211110        00000000


Q ss_pred             ccccccCCccc----CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQ----GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....+..+...    ..........+.+++.+||+.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00000000000    0011123468899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-40  Score=314.41  Aligned_cols=245  Identities=26%  Similarity=0.341  Sum_probs=204.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||.|+||.||++.+..+++.||+|.+....   ......+..|+.+++.++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999999999999999986532   234566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +++|+||+|.|||++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            99999999999876    35789999999999999999999987   999999999999999999999999999976433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...........+.      ....       
T Consensus       154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~-------  215 (290)
T cd05580         154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL------EGKV-------  215 (290)
T ss_pred             C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCCc-------
Confidence            2     223468999999999988889999999999999999999999997655322111111      0000       


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                           ..+......+.+++.+||+.+|.+||     ++++++.
T Consensus       216 -----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 -----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 11222345788999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.3e-40  Score=310.30  Aligned_cols=261  Identities=25%  Similarity=0.311  Sum_probs=206.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~  167 (426)
                      ++|...+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+++++.++||||++++++|.+.  ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            468888999999999999999998999999999875433 3456789999999999999999999998653  4689999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++.........+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999998876544556789999999999999999999987   999999999999999999999999999865332


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCc--hhhhcHHHhhhhhhhcccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD--RKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ..    .....++..|+|||.+.+..++.++||||||+++|+|++|..||.....  ........+....     .... 
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~-  227 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-----PNPE-  227 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-----Cchh-
Confidence            21    1234678899999999999999999999999999999999999976532  1111111111110     0000 


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +.....  .....+..+.+++.+||+.+|.+||++.||++.
T Consensus       228 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         228 LKDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            000000  001235678999999999999999999999963

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.5e-40  Score=310.82  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=205.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      .+|+....||.|+||.||+|+.+.     ..+.|++|.+...... ....+..|+.+++.++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            468888999999999999999753     3467999988765443 4567999999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhhhhCCC-----CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPD-----TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      +||||+++|+|.+++......     ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999764311     12689999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..............       
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~-------  233 (275)
T cd05046         162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA-------  233 (275)
T ss_pred             ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-------
Confidence            99864322111 11222356778999999988889999999999999999999 7888865443222111110       


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                       ..        .....+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       234 -~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence             00        000112234457899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.1e-40  Score=306.76  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=202.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .+|++.+.||.|+||.||+|.+.. +..+|+|.+..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            468888999999999999998864 67899998875432 3467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            99999999875   235689999999999999999999987   999999999999999999999999999875432211


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                       .......++..|+|||.+.++.++.++||||||+++|||++ |..||...........+.       ..   ....   
T Consensus       156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~---~~~~---  221 (256)
T cd05112         156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-------AG---FRLY---  221 (256)
T ss_pred             -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-------CC---CCCC---
Confidence             11112235678999999998899999999999999999998 999997654332221111       00   0001   


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                          .+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       222 ----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         222 ----KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                1122345789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-40  Score=308.00  Aligned_cols=237  Identities=26%  Similarity=0.434  Sum_probs=191.5

Q ss_pred             eeeecCcEEEEEEEEcCCC----------EEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           98 CLGEGGFGKVYKGCLEKIE----------QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .||+|+||.||+|.+..++          ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++||
T Consensus         2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            5999999999999998766          45888887654333 6778999999999999999999999988 7789999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-------ceeEeccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-------HPKLSDFG  240 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-------~~kl~Dfg  240 (426)
                      ||+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++       .+||+|||
T Consensus        80 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          80 EYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999999762   23689999999999999999999987   999999999999999887       79999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccC--CCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      ++.....      .....++..|+|||++.+.  .++.++||||||+++|||++ |..||.............       
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------
Confidence            9875432      1223567789999998876  78999999999999999999 577776553221111110       


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      ...            ..+......+.+++.+||..+|.+||++.+|++.|
T Consensus       221 ~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 DQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             cCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            000            00111115788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.5e-40  Score=312.03  Aligned_cols=253  Identities=25%  Similarity=0.332  Sum_probs=198.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHH-HhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMT-LGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||.||+|.+..+|+.||||.+..... .....+..|+.+ ++.++||||+++++++......++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            468899999999999999999999999999999876432 223445556654 667799999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ |+|.+++.........+++..++.++.||+.||.|||+.  .+++||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 788888876544456799999999999999999999974  38999999999999999999999999998753221


Q ss_pred             CCcceeeeecccccccCcccccc----CCCCccCchhhHHHHHHHHHhCCCCCCCcCch-hhhcHHHhhhhhhhcccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR-KELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  323 (426)
                         ...+...|+..|+|||.+.+    ..++.++|+||||+++|+|++|+.||...... ......      ...     
T Consensus       158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~-----  223 (283)
T cd06617         158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV------VEE-----  223 (283)
T ss_pred             ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH------Hhc-----
Confidence               11223468899999998865    45689999999999999999999999643221 111000      000     


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..+.+   .....+..+.+++.+||..+|.+||++.+|++
T Consensus       224 --~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 --PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00000   01123457899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=4.9e-40  Score=312.51  Aligned_cols=265  Identities=24%  Similarity=0.275  Sum_probs=203.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      +|++.+.||.|+||.||+|.+..+++.||||.+......     ....+..|+.+++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478888999999999999999988999999999765332     234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +++|+||+|+|||++.++.++|+|||+++...
T Consensus        81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 89999998752   23699999999999999999999987   99999999999999999999999999997644


Q ss_pred             CCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-----hhhccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-----MFKDRK  320 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~  320 (426)
                      ....  ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||...........+.....     .+....
T Consensus       154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            3221  1122356888999998865 4678999999999999999999888876554332221110000     000000


Q ss_pred             ccccccCCcccCC-----CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQGQ-----YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .............     ........+.+++.+||+.+|.+||++.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0001000000001     11233567899999999999999999999996

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.1e-40  Score=305.04  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|+..+.||.|+||.||+|....+++.+|||.+....  ......+..|+.+++.++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5888899999999999999999999999999987543  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEecccccccCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~  248 (426)
                      +++++|.+++....  ...+++..++.++.+++.||.|||+.   +++|+||+|+||+++.+ +.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997632  35589999999999999999999987   99999999999999865 46899999999764332


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ..   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...........+..        .        
T Consensus       156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--------~--------  216 (256)
T cd08220         156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--------G--------  216 (256)
T ss_pred             cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------c--------
Confidence            21   1234688999999999988899999999999999999999999976543322211110        0        


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .....+...+..+.+++.+||+.+|.+||++.++++
T Consensus       217 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 -TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             001112234557899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.2e-40  Score=306.85  Aligned_cols=255  Identities=24%  Similarity=0.395  Sum_probs=204.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            34679999999999999999998764 5669999887542 335678899999999999999999999887 67899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...  ....+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            99999999999753  245688999999999999999999987   9999999999999999999999999998754332


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .. .......++..|+|||++....++.++|||||||++|+|++ |..||...........+.       ...       
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~-------  220 (260)
T cd05073         156 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGY-------  220 (260)
T ss_pred             Cc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCC-------
Confidence            21 11122345678999999998899999999999999999999 899997654332221111       000       


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                         ....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       221 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               001122334578899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=311.95  Aligned_cols=267  Identities=24%  Similarity=0.324  Sum_probs=200.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||.|+||.||+|..+.+++.||||.+...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            36799999999999999999999988999999998754322 23456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ ++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            997 5899888752   34689999999999999999999987   9999999999999999999999999998743221


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCch-hhhcHHHhhhh-----hhhcccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR-KELNLVAWARP-----MFKDRKN  321 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~-----~~~~~~~  321 (426)
                      ..  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...... .....+.....     .+.....
T Consensus       157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence            11  1122356889999998875 45889999999999999999999999765421 11111110000     0000000


Q ss_pred             ccc--------ccCCcccCCCC-hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQ--------MVDPSLQGQYP-VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~--------~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...        .....+....+ ......+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            000        00000000000 011257789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=326.24  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=212.6

Q ss_pred             ccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..+.+.||+|.||.|++|.|...   -..||||.+...... ...+|.+|+.+|.+|+|||++++||+..+ ....+|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            34456699999999999999743   346999999876554 67889999999999999999999999987 56789999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      .+++|+|.+.|+.  .....|-......++.|||.||.||.+.   ++|||||...|+||-....|||+||||.+.+...
T Consensus       191 LaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999999987  3456788899999999999999999987   9999999999999999999999999999976655


Q ss_pred             CCcceee-eecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          249 DKTHVST-RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       249 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      +....+. ...-...|+|||.+....++.++|||+|||+||||+| |..||-+......+..+.                
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD----------------  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID----------------  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc----------------
Confidence            4443332 2234568999999999999999999999999999999 788998877655443333                


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                       ..-+-..|..|++.+++++..||..+|++||++..|.+.+
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence             2223344778899999999999999999999999997544

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.6e-40  Score=309.55  Aligned_cols=268  Identities=24%  Similarity=0.280  Sum_probs=200.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++++|.+.+.||+|+||.||+|....++..||+|.+...... ....+.+|+.+++.++|+||+++++++......++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999999988999999998754332 2345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+. ++|...+..   ....+++..+..++.||+.||.|||+.   +|+|+||||+|||++.++.++|+|||+++....
T Consensus        83 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9996 677766654   235578889999999999999999987   999999999999999999999999999875332


Q ss_pred             CCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh------hhhccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP------MFKDRK  320 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~------~~~~~~  320 (426)
                      ...  ......+++.|+|||.+.+. .++.++||||||+++|||++|..||.............+...      .+....
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         156 PSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            211  11233578999999998764 578899999999999999999999976543211111111000      000000


Q ss_pred             ccccccCCcccCCCC---------hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQGQYP---------VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..............+         ......+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            000000000000000         012357789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4e-40  Score=312.47  Aligned_cols=266  Identities=24%  Similarity=0.323  Sum_probs=204.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv  166 (426)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.+......  ....+.+|+.+++.++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            4688889999999999999999999999999999754322  234567899999999999999999999877  889999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      +||++ ++|.+++...   ...+++..++.++.||+.||.|||+.   +++|+||||+|||++.++.++|+|||++....
T Consensus        85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            99997 5998888752   34689999999999999999999987   99999999999999999999999999998544


Q ss_pred             CCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh--------hhhh
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR--------PMFK  317 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~  317 (426)
                      ....  ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+....        +.+.
T Consensus       158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            3211  12234678899999988764 46899999999999999999999998665433322211000        0000


Q ss_pred             c-----ccccccccCCcccCCCChH-hHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 D-----RKNFSQMVDPSLQGQYPVR-GLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 ~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .     ...+.......+...++.. ....+.+++.+||+.+|++||++.|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0     0001111111122223332 4567889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.8e-40  Score=305.60  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=204.4

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|.+.+.||.|+||.||+|.+..+++.|++|.+......  ..+.+..|+.+++.++|+||+++++++...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            588889999999999999999888999999998765443  567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999875    34588999999999999999999987   99999999999999999999999999987643322


Q ss_pred             Ccce--eeeecccccccCccccccCC---CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          250 KTHV--STRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       250 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ....  .....++..|+|||++.+..   ++.++||||||+++|+|++|..||.............   . ...      
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~---~-~~~------  223 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV---G-AGH------  223 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH---h-cCC------
Confidence            2111  11246788999999998766   8899999999999999999999997543221111000   0 000      


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .+.+..  .......+.+++.+||+.+|.+||++.+++.
T Consensus       224 --~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 --KPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              000000  1112457789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-40  Score=311.85  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=206.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|.+.+.||.|+||.||+|....++..||+|.+........+.+..|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57899999999999999999998889999999987655555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            99999999865     4588999999999999999999987   999999999999999999999999998865433221


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        ......|++.|+|||.+....++.++||||||+++|+|++|..||...........+..      ...       +. 
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~------~~~-------~~-  234 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------NGT-------PE-  234 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc------CCC-------CC-
Confidence              12234688999999999888899999999999999999999999976543322111100      000       00 


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       ...+......+.+++.+||+.+|.+||++.+++..
T Consensus       235 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 -LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             01122234578899999999999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.9e-40  Score=307.82  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=201.3

Q ss_pred             ccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           93 FRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      |.+.+.||+|+||.||+|.+.   .+++.||||.+....  ....+++.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567778999999999999864   357899999986542  234567889999999999999999999886532      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ..+++++|+++|+|..++....  .....+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            2478899999999998875421  1223578999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |+++...............+++.|++||.+.+..++.++||||||+++|||++ |..||...........+..       
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-------  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-------  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence            99986433222212222345678999999998899999999999999999999 8889876543222111110       


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ....          ..+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0000          01122345789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.5e-40  Score=309.52  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=203.4

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      |...+.||.|++|.||+|.+..++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            45556899999999999999888999999998765545556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      ++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++........  
T Consensus       101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            999998865     4589999999999999999999987   999999999999999999999999998875432211  


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                      ......|++.|+|||.+.+..++.++||||||+++|||++|..||...........+...             ..+... 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-------------~~~~~~-  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-------------LPPKLK-  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-------------CCCCCc-
Confidence            122346899999999998888999999999999999999999999765432222111100             000010 


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .+...+..+.+++.+||+.+|.+||++.++++
T Consensus       237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             -ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence             11123457899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.6e-40  Score=311.16  Aligned_cols=265  Identities=23%  Similarity=0.279  Sum_probs=201.8

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|+..+.||.|+||.||+|.+..+++.||||.+....  ......+..|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888899999999999999999999999999986432  22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +. ++|..++...  ....+++..++.++.||+.||+|||+.   +++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 6888888653  245689999999999999999999987   99999999999999999999999999987543221


Q ss_pred             CcceeeeecccccccCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHH-hhhhhh-----------
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA-WARPMF-----------  316 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~-----------  316 (426)
                      .  ......+++.|+|||++.+.. ++.++||||||+++|||+||+.||............. ......           
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence            1  122335788999999887654 6889999999999999999999997655432221111 000000           


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+.......+. .........+.+++.+||+.||.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000001111100000 001123456789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.5e-40  Score=304.47  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=209.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|++.+.||.|++|.||+|.+..+++.|+||.+..... .....+..|+..+..++||||+++++++.....+++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368888999999999999999999999999999876644 4467799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      +++++|.+++..    ...+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            999999999976    2678999999999999999999998 7   9999999999999999999999999998764332


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ...  .....++..|+|||.+.+..++.++||||||+++|+|++|..||................   .       ... 
T Consensus       154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~-------~~~-  220 (264)
T cd06623         154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D-------GPP-  220 (264)
T ss_pred             CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c-------CCC-
Confidence            221  123468899999999999999999999999999999999999997664311111111111   0       000 


Q ss_pred             cccCCCChH-hHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          329 SLQGQYPVR-GLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       329 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         ...+.. .+..+.+++.+||..+|.+||++.++++.
T Consensus       221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               011222 45688999999999999999999999963

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6e-40  Score=304.64  Aligned_cols=246  Identities=26%  Similarity=0.400  Sum_probs=199.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      .+|++.+.||+|+||.||+|..  +++.||+|.+....  ....+.+|+.+++.++||||+++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4588999999999999999875  47889999986532  346788999999999999999999998764 579999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence            999999999763  234689999999999999999999987   99999999999999999999999999987532211 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                          .....+..|+|||++.+..++.++||||||+++|||++ |+.||...........+..                 .
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-----------------~  213 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-----------------G  213 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-----------------C
Confidence                12234678999999998899999999999999999998 9999976543322111110                 0


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      .....+...+..+.+++.+||+.+|..||++.+|++.|+
T Consensus       214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            011112234457889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.8e-40  Score=307.65  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|+..+.||.|+||.||+|.++.+++.||+|.+..... .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            357788889999999999999999999999999876533 3456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      +++++|.+++...   ...+++..+..++.|++.||.|||+ .   +++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            9999999998763   2678999999999999999999998 6   9999999999999999999999999998643221


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      ..    ....++..|+|||++.+..++.++||||||+++|+|++|..||........ ............       .  
T Consensus       155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~-------~--  220 (265)
T cd06605         155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE-------P--  220 (265)
T ss_pred             Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC-------C--
Confidence            11    115788999999999999999999999999999999999999975431110 011111111000       0  


Q ss_pred             cccCCCChH-hHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVR-GLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ....+.. .+..+.+++.+||..+|.+||++.+++.
T Consensus       221 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         221 --PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              0011111 4557899999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1e-39  Score=311.90  Aligned_cols=247  Identities=30%  Similarity=0.401  Sum_probs=200.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..|...+.||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||++++++|.+....++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            458888999999999999999998899999999864332   33456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||++ |+|.+++..   ....+++..+..++.||+.||.|||+.   +|+||||+|+||+++.++.++|+|||++.....
T Consensus        95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            9997 677776654   235689999999999999999999987   999999999999999999999999999875432


Q ss_pred             CCCcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .      ....+++.|+|||++.   ...++.++||||||+++|||++|..||...........+...     ..     
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-----~~-----  231 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-----DS-----  231 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-----CC-----
Confidence            2      2246888999999874   456889999999999999999999999765433221111100     00     


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         +.   ..+...+..+.+++.+||+.+|.+||++.+|+..
T Consensus       232 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ---PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               00   0122345578999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-39  Score=306.65  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=203.7

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      |+..+.||.|+||.||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++++..+..+++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            6778889999999999999988899999999865432 345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      +++|..++..     ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999998864     4689999999999999999999987   999999999999999999999999999875433211 


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                       ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...........+..        .         ..
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------~---------~~  218 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK--------N---------NP  218 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc--------C---------CC
Confidence             12234688899999999888899999999999999999999999975443221111100        0         00


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11122344578899999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.8e-40  Score=315.36  Aligned_cols=199  Identities=27%  Similarity=0.389  Sum_probs=161.5

Q ss_pred             ceeeecCcEEEEEEEEcC--CCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeEEEEEecCC
Q 014362           97 CCLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMPL  172 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~  172 (426)
                      ..||+|+||.||+|.+..  ++..||+|.+.....  ...+.+|+.+++.++||||+++++++..  ....++||||+. 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence            569999999999999754  568899999875432  3467889999999999999999998853  567899999996 


Q ss_pred             CCHHHHhhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee----ccCCceeEecccccc
Q 014362          173 GSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAK  243 (426)
Q Consensus       173 gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla~  243 (426)
                      ++|.+++....     .....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            57777765321     1223588999999999999999999987   99999999999999    566789999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcC
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK  301 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~  301 (426)
                      ........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            64332211 112335789999999998764 58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-39  Score=306.87  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCC---CCCcceEeeEEeeCCeeEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .|+..+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777888999999999999999899999999987542 344567888999999886   999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++..     ..+++..++.++.|++.||.|||+.   +|+|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            99999999998864     3689999999999999999999987   999999999999999999999999999976543


Q ss_pred             CCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...  ......|+..|+|||.+.++ .++.++||||||+++|+|++|..||...........+.             ...
T Consensus       154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------------~~~  218 (277)
T cd06917         154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-------------KSK  218 (277)
T ss_pred             Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc-------------cCC
Confidence            321  12334689999999988754 57899999999999999999999997654322111000             000


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      .+.+..   ...+..+.+++.+||+.+|.+||++.+++.. .++
T Consensus       219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~-~~~  258 (277)
T cd06917         219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS-KWI  258 (277)
T ss_pred             CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC-hHh
Confidence            111111   1134578899999999999999999999863 444

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.7e-40  Score=306.67  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=205.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +|++.+.||.|+||.||+|.+..++..||+|.+.....   ...+.+.+|+.+++.++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58889999999999999999998999999999975432   346778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+.+++|..++..    ..++++..+..++.||+.||.|||+.   +++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            9999999999875    25789999999999999999999987   9999999999999999999999999998754332


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..............    ...          
T Consensus       154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~----------  216 (258)
T cd05578         154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET----------  216 (258)
T ss_pred             c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc----------
Confidence            2   12234688999999999988899999999999999999999999986653211111110    000          


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCH--HHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI--TDVV  364 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil  364 (426)
                       .....+...+..+.+++.+||+.+|.+||++  .|++
T Consensus       217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence             1112233344688999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-40  Score=314.06  Aligned_cols=270  Identities=21%  Similarity=0.277  Sum_probs=201.4

Q ss_pred             CccccceeeecCcEEEEEEEEcC--CCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRL  164 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~  164 (426)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+....   ......+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47888999999999999999988  78999999998633   33446678899999999999999999999988  8899


Q ss_pred             EEEEecCCCCHHHHhhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc----CCceeEecc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE----GYHPKLSDF  239 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Df  239 (426)
                      +||||++ ++|..++...... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999997 4677766543322 23789999999999999999999987   9999999999999999    899999999


Q ss_pred             cccccCCCCCC-cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-------cHHH
Q 014362          240 GLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-------NLVA  310 (426)
Q Consensus       240 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-------~~~~  310 (426)
                      |+++....... ........+++.|+|||++.+. .++.++||||||+++|+|++|+.||.........       .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99985433221 1122234688999999988764 5889999999999999999999999765432200       0000


Q ss_pred             hhhh----------hhhcccccccccCCcccCCCC---------h--HhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          311 WARP----------MFKDRKNFSQMVDPSLQGQYP---------V--RGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       311 ~~~~----------~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....          .......+....+......++         .  .....+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000          000000000000000001111         1  23457899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-40  Score=317.49  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=216.2

Q ss_pred             ccccceeeecCcEEEEEEEEcC----CCEEEEEEEecc-CCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEK----IEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ....++||.|-||.||.|.+..    ..-.||||..+. ......+.|..|..+++.++||||++++|+|.+. ..||||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            3445679999999999998743    234589998876 4556678899999999999999999999999875 689999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |.++.|.|..+|+.   +...|+......++.||+.||+|||+.   ..|||||...|||+....-+||+|||+++....
T Consensus       470 EL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  470 ELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            99999999999987   456799999999999999999999997   999999999999999999999999999998766


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ......+ ...-+.-|||||.+.-..++.++|||-|||.+||++. |..||.+-...+..                 ..+
T Consensus       544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-----------------~~i  605 (974)
T KOG4257|consen  544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-----------------GHI  605 (974)
T ss_pred             cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------------EEe
Confidence            5544433 3345678999999999999999999999999999987 99999876543322                 222


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ...-+-..|..|+..+..|+.+||..+|.+||.+.+|...|..+..
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            3334445688889999999999999999999999999988887653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-39  Score=355.40  Aligned_cols=263  Identities=29%  Similarity=0.521  Sum_probs=210.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ...|.....||+|+||.||+|.+..++..||||.+......    ...|+.++++++|||||+++++|.+....++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            34577788899999999999999888999999998654322    23468889999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.++++.       ++|..+..++.||+.||+|||..+.++|+||||||+||+++.++.+++. ||........ 
T Consensus       765 ~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        765 IEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             CCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            999999999853       8899999999999999999996656699999999999999999888875 6655432111 


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                           ....||+.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|.+..... .....++++.
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~  908 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPS  908 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCcc
Confidence                 123688999999999999999999999999999999999999954322 122344444333222 2234445555


Q ss_pred             ccCC--CChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          330 LQGQ--YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       330 ~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      +...  .+.....++.+++.+||+.+|++||+|.+|++.|+.+.+
T Consensus       909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            5432  344566788999999999999999999999999998865

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-41  Score=342.12  Aligned_cols=260  Identities=23%  Similarity=0.255  Sum_probs=215.4

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      ..++....++|.+++.||+|+||.|..++++.+++.||+|++.+..   ......|.+|-.+|..-+.+-|+.++-+|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            4556666789999999999999999999999999999999998742   2345679999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ..++|+|||||+||+|..+|..+    ..+++..++.++..|+.||.-||+.   |+|||||||+|||||..|++||+||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999999873    3799999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccc----c-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM----T-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      |.+-..... ........+|||-|++||++.    + +.|+..+|+||+||++|||+.|..||+..........+.....
T Consensus       220 GsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~  298 (1317)
T KOG0612|consen  220 GSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKE  298 (1317)
T ss_pred             hhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhh
Confidence            998654433 233344568999999999986    2 5799999999999999999999999987665555544443322


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC---HHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA---ITDVVM  365 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~  365 (426)
                      .+.    |+..          ...+.++.+||.+.+. +|+.|..   ++++-.
T Consensus       299 ~l~----FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  299 SLS----FPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hcC----CCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            221    1111          2356688899988775 5677877   777753

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-39  Score=316.80  Aligned_cols=265  Identities=23%  Similarity=0.265  Sum_probs=203.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------  160 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+...  .......+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999999999999998643  233455677899999999999999999988643      


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ...|+||||+. ++|.+.+..      .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence            35799999996 588877753      288999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh--------
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA--------  312 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--------  312 (426)
                      +++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+...        
T Consensus       164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9986433211   22346889999999999999999999999999999999999999765432222111100        


Q ss_pred             --------hhhhhcc-----cccccccCC----cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          313 --------RPMFKDR-----KNFSQMVDP----SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       313 --------~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              .......     ..+...+..    ......+......+.+++.+||+.||.+||++.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    0000000     001111111    11111122345578999999999999999999999953

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=317.15  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=206.7

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEecc--CCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCee
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  163 (426)
                      .+....|+++++||+||.+.||++...+ ...||+|++..  .+...+.-|..|+..|.+|. |.+||.+++|-..++.+
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            3345679999999999999999998776 45677766543  34556788999999999995 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      |+||||=+ -+|..+|...   ...++.-.++.+..|++.|+.++|.+   ||||.||||.|+|+-. |.+||+|||+|.
T Consensus       436 YmvmE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             EEEeeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence            99999964 6899999873   23333237889999999999999998   9999999999999985 589999999999


Q ss_pred             cCCCCCCcceeeeecccccccCccccccC-----------CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----------QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      ..............+||+.||+||.+...           +.++++||||||||||+|+.|++||......     +   
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~---  579 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----I---  579 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----H---
Confidence            87776666667778999999999988632           2568999999999999999999999753311     1   


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHH-HHHHHHHhccccCCCCCCCHHHHHH
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLY-QALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             ..+..+.+|.....||..... ++++++..||..||.+||++.++|+
T Consensus       580 -------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                   123455566555555544433 3999999999999999999999985

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-39  Score=299.35  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=209.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||.|+||.||++.+..++..|++|.+.....  .....+..|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            58888999999999999999998999999999976543  4566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++.........+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999987443357799999999999999999999987   99999999999999999999999999997643332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        .......|++.|+|||.+.+..++.++||||||+++|+|++|..||.............      .  .         
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~--~---------  218 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL------K--G---------  218 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh------c--C---------
Confidence              12233478999999999988899999999999999999999999997654322111110      0  0         


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+......+.+++.+||..+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         219 QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            011122234457899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.2e-39  Score=309.94  Aligned_cols=251  Identities=29%  Similarity=0.389  Sum_probs=202.3

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|...+.||+|+||.||+|.+..++..||+|.+.....   .....+..|+.+++.++|||++++++++.+....++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            37778889999999999999998899999999875322   334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ |+|.+.+..   ...++++..+..++.||+.||.|||+.   +|+||||+|+||+++.++.++|+|||++......
T Consensus       106 ~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            997 577777654   245689999999999999999999987   9999999999999999999999999998753321


Q ss_pred             CCcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                            ....|++.|+|||++.   .+.++.++|||||||++|||++|..||...........+...      .      
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~------~------  240 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN------E------  240 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc------c------
Confidence                  2346889999999874   456889999999999999999999999765432222111100      0      


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                          .........+..+.+|+.+||+.+|.+||++.+|++.+..+.
T Consensus       241 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         241 ----SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ----CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence                000011233457899999999999999999999998766544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=309.68  Aligned_cols=271  Identities=27%  Similarity=0.386  Sum_probs=205.8

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc--CCCCCcceEeeEEeeCC----eeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCAEGD----QRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~~~----~~~l  165 (426)
                      ......+||+|.||.||+|.+.  ++.||||++..   +..+.|..|..+.+.  +.|+||++++++-....    .++|
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            3445556999999999999988  69999999964   355678888888765  58999999999876665    8999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHc------CCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ------LKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~------~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      |++|.+.|+|.++|..     ..++|....+++..+++||+|||+.      ++++|+|||||+.||||.+++++.|+||
T Consensus       286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999986     6699999999999999999999975      3678999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCC-CC-----ccCchhhHHHHHHHHHhCCCCCCC-cCchhhhcHHHhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-LT-----FKSDIYSFGVVLLELITGRKAIDQ-TKDRKELNLVAWA  312 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwSlG~il~elltg~~p~~~-~~~~~~~~~~~~~  312 (426)
                      |+|..+..+.........+||.+|||||++.+.. +.     .+.||||+|.|||||++....++. ..+...+..-.. 
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e-  439 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE-  439 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH-
Confidence            9998776555444445579999999999987642 22     478999999999999997655532 111111100000 


Q ss_pred             hhhhhcccccccc----cCCcccCCCCh-----HhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCC
Q 014362          313 RPMFKDRKNFSQM----VDPSLQGQYPV-----RGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYD  376 (426)
Q Consensus       313 ~~~~~~~~~~~~~----~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  376 (426)
                         +.....+.++    +....+..+|.     ..+..+.+.+..||+.||+.|.|+.=+.+++..+......
T Consensus       440 ---vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  440 ---VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             ---hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence               0000111111    11112222222     2344678899999999999999999999999998765543

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=301.65  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--Cee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  163 (426)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+...     .......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4689999999999999999999999999999987532     123456788999999999999999999998764  468


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++|+||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            899999999999999875    34588999999999999999999987   99999999999999999999999999997


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.............            
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------  222 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA------------  222 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH------------
Confidence            54321111 11123468999999999998889999999999999999999999997543322211110            


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ........|......+.+++.+||+ +|..||++.+++.
T Consensus       223 ----~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 ----TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ----cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                0111122344555688999999999 5799999998874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.6e-39  Score=305.26  Aligned_cols=267  Identities=25%  Similarity=0.321  Sum_probs=203.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      +|++.+.||.|++|.||+|.+..+|..||||.+...... ....+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            588899999999999999999999999999998765332 3456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      + ++|.+++.... ....+++..+..++.||+.||.|||+.   +++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-  154 (284)
T cd07836          81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-  154 (284)
T ss_pred             C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence            8 48888876532 235689999999999999999999987   99999999999999999999999999997543221 


Q ss_pred             cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh-hh-------hhcccc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR-PM-------FKDRKN  321 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~-------~~~~~~  321 (426)
                       .......++..|++||++.+. .++.++||||||+++|+|++|..||...........+.... ..       +.....
T Consensus       155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             112234578899999988664 57899999999999999999999998765443322211100 00       000000


Q ss_pred             cccccCC---cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDP---SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +...+..   ..........+..+.+++.+||+.+|.+||++.+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000   0000111223457889999999999999999999984

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.6e-39  Score=297.03  Aligned_cols=250  Identities=28%  Similarity=0.411  Sum_probs=207.7

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      +|++.+.||.|++|.||++.+..++..+++|.+..........+.+|+.+++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            47788899999999999999998899999999987655566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      +++|.+++...   ...+++..+..++.|++.||.|||..   +++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            99999998762   25799999999999999999999987   999999999999999999999999999876443321 


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                        .....++..|+|||++.+..++.++||||||+++|+|++|..||..............        .......     
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~-----  218 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--------NGPPGLR-----  218 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--------cCCCCcC-----
Confidence              2345789999999999988899999999999999999999999976543222211110        0000100     


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .+......+.+++.+||+.+|.+||++.++++
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              01112457899999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-39  Score=301.70  Aligned_cols=250  Identities=24%  Similarity=0.347  Sum_probs=203.4

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|.+.+.||.|+||.||+|.++.+|..||+|.+....  ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788899999999999999999999999999986542  23456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc-eeEecccccccCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-PKLSDFGLAKMGPSG  248 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~  248 (426)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||++++++. +||+|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998753  234589999999999999999999987   9999999999999998864 699999998754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .  .......|++.|+|||++.+..++.++||||||+++|||++|..||............      ..      ..+. 
T Consensus       156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~------~~~~-  220 (257)
T cd08225         156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI------CQ------GYFA-  220 (257)
T ss_pred             c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------hc------ccCC-
Confidence            1  1122346899999999998888999999999999999999999999755432211100      00      0000 


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ..+...+..+.+++.+||+.+|++||++.+|+.
T Consensus       221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                111223457899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.5e-39  Score=307.13  Aligned_cols=267  Identities=20%  Similarity=0.221  Sum_probs=200.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCe-----
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ-----  162 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~-----  162 (426)
                      ++|++.+.||.|+||.||+|.+..+++.||||.+.....  .....+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468899999999999999999999999999999865422  23456888999999995 6999999999877665     


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCC-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEeccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFG  240 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfg  240 (426)
                      .|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.   +|+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 888888653322 35689999999999999999999987   9999999999999998 8899999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      +++.......  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..... ....
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG-TPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC-CCCh
Confidence            9875432211  1122357889999998865 4578999999999999999999999976554332211110000 0000


Q ss_pred             cccccc------------cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQM------------VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+...            ....+. .........+.+||.+||+.+|.+||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000            000000 001124457899999999999999999999884

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.8e-39  Score=304.65  Aligned_cols=254  Identities=27%  Similarity=0.379  Sum_probs=207.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++...||.|+||.||+|.+..++..|++|.+..... ....+..|+.+++.++|+||+++++++......++|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            34567888889999999999999998899999999976544 45678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            99999999999873   24799999999999999999999987   9999999999999999999999999998653322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .  .......++..|+|||++.+..++.++||||||+++|+|++|..||...........+..        .....    
T Consensus       170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~----  235 (286)
T cd06614         170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT--------KGIPP----  235 (286)
T ss_pred             h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------cCCCC----
Confidence            1  112234578899999999888899999999999999999999999976544322211110        00000    


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       .  ..+...+..+.+++.+||+.+|..||++.+|++.
T Consensus       236 -~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 -L--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -C--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             0  0112234578899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.5e-39  Score=298.31  Aligned_cols=252  Identities=25%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLVY  167 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~  167 (426)
                      +|+..+.||+|++|.||+|.+..++..|++|.+.....  ...+.+.+|+.+++.++||||+++++.+.+.  ..+++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47788899999999999999998899999999876543  4567789999999999999999999999988  8899999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999998762    3799999999999999999999987   999999999999999999999999999986544


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ...........++..|+|||.+.+..++.++||||||+++|+|++|..||.........   .+  .          ...
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~--~----------~~~  218 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---LY--K----------IGS  218 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HH--h----------ccc
Confidence            33211123356889999999998888999999999999999999999999765511110   00  0          000


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .......+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            01111223334568899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-39  Score=301.14  Aligned_cols=250  Identities=27%  Similarity=0.377  Sum_probs=208.4

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||.|+||.||++.+..+++.+|+|.+....  ......+..|+.+++.++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5788899999999999999999999999999987543  23355678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|..++.........+++..++.++.|++.||.|||+.   +++|+||+|.||+++.++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999876444456789999999999999999999987   9999999999999999999999999999865443 


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                         ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.                 ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-----------------~~  216 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-----------------RG  216 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------------cC
Confidence               1122468899999999999999999999999999999999999997655322111110                 00


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+.....++.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111122344567899999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2e-39  Score=302.42  Aligned_cols=243  Identities=28%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||.|+||.||+|.+..+++.||+|.+.....   ...+.+..|+.+++.++||||+++++++.++..+++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            6899999999999999999999999975432   3346788999999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      .+++..    ...+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~  150 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW  150 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence            999976    34589999999999999999999987   99999999999999999999999999998654332   122


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ...|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... .....   ..          ........+|
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~----------~~~~~~~~~~  216 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN---DI----------LKGNGKLEFP  216 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH---HH----------hccCCCCCCC
Confidence            3468899999999988889999999999999999999999997655211 11110   00          0001111223


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                      ......+.+++.+||+.+|.+||+     ++|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            333568899999999999999999     777764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-40  Score=316.31  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=200.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----e
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----Q  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~  162 (426)
                      .+++|.+.+.||+|+||.||+|.+..+|+.||||.+.... ......+..|+.+++.++||||+++++++....     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999999999999999986432 234566888999999999999999999876543     5


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++|+||+. ++|..++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            799999996 578777753     5699999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCC-cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          243 KMGPSGDK-THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       243 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      ........ ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+....... ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~-~~~  232 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP-SQE  232 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC-CHH
Confidence            75432211 111123468999999998765 568999999999999999999999997654322221111000000 000


Q ss_pred             ccccccCCc---------ccCCC-----ChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          321 NFSQMVDPS---------LQGQY-----PVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       321 ~~~~~~~~~---------~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .+..+.+..         .....     .......+.+++.+||+.+|.+||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000         00000     01224578999999999999999999999964

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.8e-39  Score=303.65  Aligned_cols=262  Identities=22%  Similarity=0.259  Sum_probs=196.5

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeC--CeeEEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEG--DQRLLVYE  168 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~e  168 (426)
                      |++.+.||+|+||.||+|.+..++..||+|.+..... ........|+.++.++. ||||+++++++.+.  ..+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6678889999999999999998999999999875422 22233457888888885 99999999999987  88999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ ++|.+.+..   ....+++..++.++.||+.||.|||+.   +++||||+|+||+++. +.+||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 578777765   235689999999999999999999987   9999999999999999 99999999999754322


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh--------hhhcc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP--------MFKDR  319 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~  319 (426)
                      ...   ....++..|+|||++.. ..++.++|||||||++|||++|..||...+..+..........        .+...
T Consensus       153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            211   22467899999997654 5578999999999999999999999977654332222111000        00000


Q ss_pred             cccccccCCcccC---CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQG---QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .............   ......+..+.+|+.+||+.+|.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000000   001234568999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.5e-39  Score=307.70  Aligned_cols=268  Identities=25%  Similarity=0.310  Sum_probs=202.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l  165 (426)
                      .++|++.+.||.|+||.||+|.+..+|+.||+|.+.....  .....+.+|+.+++.++|+||+++++++...  +.+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4579999999999999999999999999999999864432  2233466899999999999999999998765  56899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+. ++|.+++...   ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus        86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            999996 5888887652   35689999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----hhcc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----FKDR  319 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~  319 (426)
                      ......  .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...........+......     +...
T Consensus       159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            432211  122346788999998865 46789999999999999999999999876654433322211100     0000


Q ss_pred             cccccccCCcccCC-------CChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          320 KNFSQMVDPSLQGQ-------YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       320 ~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ......-...+...       ........+.+++.+||+.||.+||++.+++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000000000       001135577899999999999999999999953

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=305.26  Aligned_cols=264  Identities=22%  Similarity=0.281  Sum_probs=201.1

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      |++.+.||.|++|.||+|.+..+|..||+|++.....  .....+..|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            6677889999999999999998999999999875432  23456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      + ++|.+++....  ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-  153 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-  153 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence            5 68998886522  24689999999999999999999987   99999999999999999999999999997543221 


Q ss_pred             cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHH-hhhhhhh-------c---
Q 014362          251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA-WARPMFK-------D---  318 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~-~~~~~~~-------~---  318 (426)
                       .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+. .......       .   
T Consensus       154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07835         154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD  232 (283)
T ss_pred             -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence             111223568899999988664 57899999999999999999999997665433221111 0000000       0   


Q ss_pred             -ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 -RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+........ .......+..+.+++.+||+.+|.+||+++++++
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             000000000000 0112233457889999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.4e-39  Score=311.57  Aligned_cols=268  Identities=27%  Similarity=0.339  Sum_probs=202.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC--Cee
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG--DQR  163 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~~  163 (426)
                      ..++|++.+.||.|+||.||+|.+..++..||||.+...  .......+..|+.+++.+ +||||++++++|...  ..+
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            456789999999999999999999988999999988542  223445677899999999 999999999998653  468


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||++ ++|..++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            99999997 589888764     2688999999999999999999987   99999999999999999999999999997


Q ss_pred             cCCCCCCc---ceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc-
Q 014362          244 MGPSGDKT---HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD-  318 (426)
Q Consensus       244 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  318 (426)
                      ........   .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+......... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            54332211   12234568999999998765 46789999999999999999999999765544332222111100000 


Q ss_pred             ------ccccccccC-------CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          319 ------RKNFSQMVD-------PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       319 ------~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                            ......+++       ....... ...+..+.+++.+||+.+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                  000000000       0000011 1145678999999999999999999999963

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.4e-39  Score=306.07  Aligned_cols=244  Identities=23%  Similarity=0.317  Sum_probs=200.5

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHH
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      ..||+|+||.||+|....++..||||.+..........+..|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            45999999999999999999999999987655555667889999999999999999999999999999999999999999


Q ss_pred             HHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeee
Q 014362          177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR  256 (426)
Q Consensus       177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  256 (426)
                      +++..     ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus       106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~  175 (292)
T cd06657         106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS  175 (292)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence            88754     4589999999999999999999987   99999999999999999999999999987543221  11233


Q ss_pred             ecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCCh
Q 014362          257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPV  336 (426)
Q Consensus       257 ~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (426)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+...             +.+.+.  ...
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-------------~~~~~~--~~~  240 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-------------LPPKLK--NLH  240 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-------------CCcccC--Ccc
Confidence            46899999999998888999999999999999999999999765433222211110             000010  011


Q ss_pred             HhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          337 RGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       337 ~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+..+.+++.+||+.+|.+||++.+++.
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            23446789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.6e-39  Score=307.24  Aligned_cols=269  Identities=22%  Similarity=0.298  Sum_probs=199.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      .++|.+.+.||.|+||.||+|.+..+++.||||.+.....  .....+.+|+.+++.++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            4579999999999999999999999999999999864322  22334678999999999999999999987654      


Q ss_pred             --eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          162 --QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       162 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                        ..++||||+. ++|..++..   ....+++..++.++.||+.||.|||+.   +++|+||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence              4599999996 578877764   234689999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCc--ceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          240 GLAKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       240 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |++.........  .......++..|+|||++.+. .++.++||||||+++|||++|..||...........+......+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999754332211  111234578899999988664 47899999999999999999999998765443333322211100


Q ss_pred             h-----ccccccc---c-cCCcccCCC-----ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 K-----DRKNFSQ---M-VDPSLQGQY-----PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 ~-----~~~~~~~---~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .     ....+..   . +........     +......+.+|+.+||..+|.+||++.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0     0000000   0 000000000     0112346778999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=304.16  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=203.1

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLVYE  168 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e  168 (426)
                      |++.+.||.|+||.||+|.+..+++.+|+|.+....  ......+..|+.+++.++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667888999999999999999999999999998653  33456688999999999999999999999888  78999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++ ++|..++..   ....+++..++.++.||+.||+|||+.   +++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            997 488888765   235799999999999999999999987   9999999999999999999999999999865433


Q ss_pred             CCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh-hc-cccccc-
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF-KD-RKNFSQ-  324 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~-  324 (426)
                      .. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....... .. ...+.. 
T Consensus       154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            21 11223457889999998765 467899999999999999999999998766443332222110000 00 000000 


Q ss_pred             ----------ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 ----------MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                .....+...+...++..+.+++.+||+.+|.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                      00000111111113567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4e-39  Score=303.64  Aligned_cols=243  Identities=26%  Similarity=0.346  Sum_probs=190.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHHH---hcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTL---GSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l---~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      .||+|+||.||++.+..+++.+|+|.+......   ....+.+|..++   ...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999999999999999998654321   122334444433   34579999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      +++|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            9999998875    35699999999999999999999987   99999999999999999999999999986432221  


Q ss_pred             ceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          252 HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        .....||..|+|||.+.+ ..++.++|||||||++|||++|..||.......... +..  ...            ..
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~--~~~------------~~  214 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDR--MTL------------TV  214 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHH--Hhh------------cC
Confidence              122468999999998864 568999999999999999999999997543321111 100  000            01


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMA  366 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  366 (426)
                      ....+...+..+.+++.+||+.||.+||     +++++++.
T Consensus       215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1122334456889999999999999999     59988864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.1e-38  Score=298.64  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=196.9

Q ss_pred             HHHHHHhcCCcccccee--eecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc-CCCCCcceEeeEEee
Q 014362           83 FDELAAATGNFRSDCCL--GEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYCAE  159 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~  159 (426)
                      ..+.....++|.+.+.+  |.|+||.||++..+.++..+|+|.+........     |+..... .+||||+++++.|..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~   80 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT   80 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence            34445556778887777  999999999999999999999999875432211     2222222 269999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEec
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSD  238 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~D  238 (426)
                      .+.+++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +++||||||+||+++.++ .++|+|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999999999976    24799999999999999999999987   999999999999999988 999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ||++......      ....|+..|+|||++.+..++.++||||||+++|||++|..||....... .....+.... ..
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~  225 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK  225 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc
Confidence            9998754322      12368999999999999899999999999999999999999997543321 1111111110 00


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-ITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~  365 (426)
                                  ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                        00112234567899999999999999996 688874

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.6e-39  Score=301.34  Aligned_cols=244  Identities=25%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||.|+||.||++.+..+++.|++|.+.....   .....+..|+.+++.++||||+++++.+......|+|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999876533   3456788999999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC-----
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK-----  250 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-----  250 (426)
                      .+++...    ..+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9999762    3689999999999999999999987   999999999999999999999999999875433211     


Q ss_pred             -cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          251 -THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                       ........++..|+|||.+....++.++||||||+++|+|++|..||...........+..      ...         
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~~---------  218 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------GKI---------  218 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------CCc---------
Confidence             1122335688899999999888899999999999999999999999976554332211111      000         


Q ss_pred             ccCCCChH--hHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          330 LQGQYPVR--GLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       330 ~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                         ..+..  .+..+.+++.+||+.+|.+||++..+.+.|
T Consensus       219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence               01111  245789999999999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=295.61  Aligned_cols=248  Identities=30%  Similarity=0.423  Sum_probs=206.8

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|++.+.||.|++|.||+|.+..+++.|++|.+.....  .....+.+|+.+++.++|||++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47888999999999999999998899999999987654  4567799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999999875    25799999999999999999999987   99999999999999999999999999998644332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++|..||.............     ..            
T Consensus       154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~-----~~------------  214 (254)
T cd06627         154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV-----QD------------  214 (254)
T ss_pred             cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh-----cc------------
Confidence            21  233468999999999988888999999999999999999999997654322111100     00            


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+...+..+.+++.+||..+|++||++.+++.
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            001122233457889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.5e-39  Score=309.25  Aligned_cols=264  Identities=21%  Similarity=0.255  Sum_probs=196.7

Q ss_pred             eeeec--CcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           98 CLGEG--GFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        98 ~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .||.|  +||+||+|.+..+|+.||+|++....  ....+.+.+|+.+++.++||||++++++|......++|+||+.++
T Consensus         5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~   84 (328)
T cd08226           5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG   84 (328)
T ss_pred             HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence            36666  99999999999999999999987543  234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc-c
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-H  252 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~  252 (426)
                      +|.+++....  ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++++||+.+......... .
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            9999987642  34589999999999999999999987   9999999999999999999999999865422111100 0


Q ss_pred             ----eeeeecccccccCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc-c------
Q 014362          253 ----VSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD-R------  319 (426)
Q Consensus       253 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~------  319 (426)
                          ......++..|+|||++.+.  .++.++|||||||++|||++|..||..................... .      
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                00112356679999998764  5789999999999999999999999765432211100000000000 0      


Q ss_pred             ----------------------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          320 ----------------------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       320 ----------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                                            ..........+....+..+...+.+|+.+||+.||.+|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                  00001111112222234456789999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-40  Score=319.08  Aligned_cols=241  Identities=25%  Similarity=0.400  Sum_probs=196.6

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEecc----CCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe--eEEEEEecC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDH----RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ--RLLVYEYMP  171 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~lv~e~~~  171 (426)
                      .||+|+|-+||+|.+..+|..||=-.++.    ......++|..|+.+|+.|+||||+++|.++.+...  ..+|+|.+.
T Consensus        47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T  126 (632)
T KOG0584|consen   47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT  126 (632)
T ss_pred             hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence            39999999999999999998888544432    233456889999999999999999999999987665  778999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEecccccccCCCCCC
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~~~~~~~  250 (426)
                      .|+|..|++++    +.++...++.|++||+.||.|||++ .++|||||||.+||+|+.+ |.|||+|+|||....... 
T Consensus       127 SGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-  200 (632)
T KOG0584|consen  127 SGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-  200 (632)
T ss_pred             CCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence            99999999884    5688889999999999999999998 7899999999999999864 899999999998754322 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc-HHHhhhhhhhcccccccccCCc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN-LVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                         ...++|||.|||||... ..|++.+||||||+.++||+|+..||.......... .+.....    +..+..+-|  
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiK----P~sl~kV~d--  270 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIK----PAALSKVKD--  270 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCC----HHHhhccCC--
Confidence               22368999999999664 899999999999999999999999998765443321 1111110    011222222  


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                .++.+||.+||.. ..+||++.|+|.
T Consensus       271 ----------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  271 ----------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence                      3778999999999 999999999995

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3e-39  Score=305.64  Aligned_cols=257  Identities=23%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|.....||+|+||.||++.+..+++.||+|.+..... .....+..|+.++.++. ||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            45566779999999999999999999999999875432 34556888999999986 99999999999998899999999


Q ss_pred             cCCCCHHHHhhhh-CCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          170 MPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       170 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      +. ++|.++.... ......+++..+..++.|++.||+|||+.  .+++||||||+|||++.++.++|+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            86 4555443221 11236799999999999999999999973  38999999999999999999999999998753322


Q ss_pred             CCcceeeeecccccccCccccccC---CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTG---QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ..   .....|++.|+|||++.+.   .++.++|||||||++|||++|+.||......  ...+.   ....       .
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~-------~  226 (288)
T cd06616         162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV--FDQLT---QVVK-------G  226 (288)
T ss_pred             Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH--HHHHh---hhcC-------C
Confidence            11   1233688999999998776   6899999999999999999999999754311  00000   0000       0


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ..+.+....+...+..+.+|+.+||+.+|.+||++.+|+..
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01112222223355688999999999999999999999853

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-39  Score=299.66  Aligned_cols=243  Identities=23%  Similarity=0.288  Sum_probs=191.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHH-HhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMT-LGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      +.||.|+||.||+|.+..+++.||||.+......   ....+..|..+ .....||||+++++++...+.+++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4599999999999999988999999998754322   22334445444 4456899999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      ++|..++..    ...+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.++|+|||+++....     
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            999999875    35689999999999999999999987   999999999999999999999999999875322     


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                       .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...........+...      ...+        ..
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~~~--------~~  214 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSR------RINW--------PE  214 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc------ccCC--------CC
Confidence             12346889999999998888999999999999999999999999765443222111100      0000        00


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ......+..+.+++.+||+.+|++||++.++.+.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            1112344578999999999999999977654443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-41  Score=348.53  Aligned_cols=253  Identities=27%  Similarity=0.369  Sum_probs=209.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .+-+|.-...||.|.||.||.|....+|...|+|.+.-..  ......+.+|..+|..++|||+|++||+-.+.+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            4456777888999999999999999999999999886543  34456688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||||++|+|.+++..    ++..++.....+..|++.|++|||++   |||||||||+||||+.+|.+|++|||.|....
T Consensus      1313 MEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            999999999999975    45678888888999999999999998   99999999999999999999999999998654


Q ss_pred             CCCC--cceeeeecccccccCccccccC---CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-cHHHhhhhhhhccc
Q 014362          247 SGDK--THVSTRVMGTYGYCAPDYAMTG---QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-NLVAWARPMFKDRK  320 (426)
Q Consensus       247 ~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~  320 (426)
                      ....  ...-...+||+.|||||++.+.   ....++||||+||++.||+||+.||...+..... ..+.          
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~---------- 1455 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA---------- 1455 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh----------
Confidence            3311  1112346899999999999864   4668999999999999999999999765533211 1111          


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             ..-...+|...+.+-.+++..||+.||.+|.++.++++
T Consensus      1456 -------~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1456 -------AGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             -------ccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                   11222446667778899999999999999998888774

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.5e-39  Score=304.31  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=200.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++...||.|++|.||+|.++.+++.||+|.+.....  .....+..|+.+++.++||||+++++++.+...+++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            578999999999999999999998999999999865432  234568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~  247 (426)
                      |++ ++|.+++...  ....+++..++.++.||+.||.|||+.   +++|+||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 5787777542  234468889999999999999999987   9999999999999985 56799999999975332


Q ss_pred             CCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh-hh----hhhcccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA-RP----MFKDRKN  321 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~----~~~~~~~  321 (426)
                      .  ........+++.|+|||++.+. .++.++||||||+++|+|+||..||............... ..    .+.....
T Consensus       156 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        156 P--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             C--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            2  1112234678899999988664 5789999999999999999999999765543322111100 00    0000000


Q ss_pred             cccccC--CcccC----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVD--PSLQG----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +.....  +....    ......+..+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000000  00000    011223456889999999999999999999985

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=304.49  Aligned_cols=245  Identities=27%  Similarity=0.374  Sum_probs=208.2

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCe
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  162 (426)
                      .....+|..+.+||+|+||+|.+|..+++.+.+|||++++.-.   .+++--+.|-++|... +-|.+++++.+|..-++
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            3445678999999999999999999999999999999987533   2344455677777766 57899999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +|+||||+.||+|--.+++.    +.+.+..+..+|..|+-||-|||+.   +||+||||.+|||||.+|++||+|||++
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence            99999999999998888873    5678889999999999999999987   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      +....+.  ..+..++|||.|+|||++...+|+.++|+|||||+||||+.|.+||++.++.+....+...          
T Consensus       498 KEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----------  565 (683)
T KOG0696|consen  498 KENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----------  565 (683)
T ss_pred             cccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------
Confidence            8533322  2345689999999999999999999999999999999999999999998876655443321          


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP  358 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  358 (426)
                              ...+|...+.++++++...|...|.+|.
T Consensus       566 --------nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  566 --------NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             --------cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence                    1245666777999999999999999995

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.1e-39  Score=301.91  Aligned_cols=245  Identities=27%  Similarity=0.379  Sum_probs=196.4

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||+|+||+||+|.+..+|+.||+|.+.....   .....+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            6899999999999999999999999875322   2344567899999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      .+++....  ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......   ...
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~  152 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK  152 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence            99987632  24689999999999999999999987   99999999999999999999999999987543211   112


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||...........+..  ....            .....+
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~------------~~~~~~  218 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTLE------------MAVEYP  218 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--cccc------------ccccCC
Confidence            34678899999999888899999999999999999999999976543211111110  0000            011122


Q ss_pred             hHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                      ...+..+.+++.+||+.+|.+||     ++.+++.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            33455789999999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=288.99  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=199.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ...+..||.|+-|.||+++++.+|..+|||.+...+ .+..+++...+.++... .+|+||+.+|+|..+...++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            344556999999999999999999999999997654 35567777788776655 4899999999999999999999998


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      . ..++.+|...   ..++++..+-++...++.||.||...  ++|||||+||+|||+|+.|++||||||++-.+..   
T Consensus       174 s-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd---  244 (391)
T KOG0983|consen  174 S-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD---  244 (391)
T ss_pred             H-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec---
Confidence            4 5666777663   46799999999999999999999986  6999999999999999999999999999864322   


Q ss_pred             cceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-cHHHhhhhhhhccccccccc
Q 014362          251 THVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-NLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....+...|-+.|||||.+.   ...|+.++||||||++++||+||..||.+.+..-.. ..+..             ..
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-------------~e  311 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-------------EE  311 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-------------cC
Confidence            22334568999999999886   447999999999999999999999999886543222 11111             01


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .|.+.+  ....+..+.+|+..||+.|+.+||...++++
T Consensus       312 PP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  312 PPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            112211  1125567899999999999999999999885

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-39  Score=315.09  Aligned_cols=250  Identities=25%  Similarity=0.326  Sum_probs=212.5

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ....+.|.+...||+|.|++|.+|++..++..||||.+.+....  ..+.+.+|+.+++.++|||||+++.+......+|
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY  131 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence            34567899999999999999999999999999999999876433  3455889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+.+|.+.++|..    ...+.+..+..++.|+..|++|||+.   .|||||||++||||+.+.++||+|||++..
T Consensus       132 lV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             EEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence            99999999999999987    35566689999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      +....   .....+|++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||++..-....                 
T Consensus       205 ~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------  264 (596)
T KOG0586|consen  205 FDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------  264 (596)
T ss_pred             ecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------
Confidence            55332   33456999999999999988875 8999999999999999999999875432211                 


Q ss_pred             cccCCcccC--CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 QMVDPSLQG--QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         +..+++  .+|.-...++-+|++++|-.+|.+|+++.+|.+-
T Consensus       265 ---~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  265 ---PRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---chheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence               111222  1233344577899999999999999999998754

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-39  Score=311.17  Aligned_cols=266  Identities=21%  Similarity=0.290  Sum_probs=202.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----Ce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  162 (426)
                      .++|.+.+.||.|+||+||+|.+..++..||||.+...  .......+..|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999999999999998753  223345677899999999999999999988654     34


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++|+||+. ++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            799999995 788887764    35699999999999999999999987   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-hhc--
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-FKD--  318 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--  318 (426)
                      +......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+...... ...  
T Consensus       156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            8643321  12233467899999998865 46899999999999999999999999765432222111110000 000  


Q ss_pred             ----ccccccc-------cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          319 ----RKNFSQM-------VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       319 ----~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          .......       ..+.... .....+..+.+++.+||+.+|.+||++.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                0000000       0000000 112345678999999999999999999999965

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=9.9e-39  Score=303.24  Aligned_cols=257  Identities=16%  Similarity=0.159  Sum_probs=187.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCCcccH-----------HHHHHHHHHHhcCCCCCcceEee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQGV-----------REFSAEVMTLGSADHPNLVKLIG  155 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~~~~  155 (426)
                      .++|.+.+.||+|+||.||+|.+..+   +..+|+|..........           .....++..+..+.|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46799999999999999999999877   66777776443222111           11223344566789999999998


Q ss_pred             EEeeCC----eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC
Q 014362          156 YCAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG  231 (426)
Q Consensus       156 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~  231 (426)
                      ++....    ..+++++++. .++.+.+..    ....++..++.++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            765543    3467788764 466666654    23457888999999999999999987   99999999999999999


Q ss_pred             CceeEecccccccCCCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh
Q 014362          232 YHPKLSDFGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL  306 (426)
Q Consensus       232 ~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~  306 (426)
                      +.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|..||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999754322111     1112346999999999999999999999999999999999999999866322211


Q ss_pred             -cHH--HhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          307 -NLV--AWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       307 -~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                       ...  .+......          ..+   .....+..+.+++..||..+|++||++.+|++.|
T Consensus       243 ~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        243 IHAAKCDFIKRLHE----------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHhHHHHHHHhhh----------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence             111  11111110          000   0112345789999999999999999999999876

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.7e-39  Score=311.71  Aligned_cols=269  Identities=21%  Similarity=0.282  Sum_probs=203.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee----CCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~  163 (426)
                      .++|++.+.||.|+||.||+|....++..||+|.+....  ......+..|+.+|+.++||||+++++++..    ...+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368999999999999999999999999999999987542  2345667889999999999999999998753    3568


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+. ++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            99999995 688888764    35599999999999999999999987   99999999999999999999999999997


Q ss_pred             cCCCCCC--cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh---
Q 014362          244 MGPSGDK--THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK---  317 (426)
Q Consensus       244 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  317 (426)
                      .......  ........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            5432211  111223478999999998865 4689999999999999999999999976554333222211100000   


Q ss_pred             --c--ccccccccCC-cccCCC-----ChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          318 --D--RKNFSQMVDP-SLQGQY-----PVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       318 --~--~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        .  ...+....+. ......     ....+..+.+++.+||+.+|.+||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              0  0000000000 000001     12235678999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.8e-39  Score=310.35  Aligned_cols=267  Identities=23%  Similarity=0.291  Sum_probs=206.4

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----eeE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRL  164 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~  164 (426)
                      +|++.+.||.|+||.||+|.+..+++.||||.+....  ....+.+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999999889999999987643  344567899999999999999999999998775     789


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||++ ++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||.|||++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 588888865    34799999999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCC-cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh-----
Q 014362          245 GPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK-----  317 (426)
Q Consensus       245 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  317 (426)
                      ...... ........++..|+|||++.+. .++.++||||||+++|+|++|..||...........+........     
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            443321 0112334678999999999888 899999999999999999999999987665433322221100000     


Q ss_pred             --cccccccccCC-ccc-----CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          318 --DRKNFSQMVDP-SLQ-----GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       318 --~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        ........+.. ...     .......+..+.+++.+||+.+|.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              00000000000 000     00111235578999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.3e-38  Score=303.29  Aligned_cols=268  Identities=24%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC----
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----  161 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----  161 (426)
                      ...++|++.+.||.|+||.||+|.++.+++.||||.+.....  .....+..|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            455789999999999999999999998899999999975432  23346778999999999999999999987654    


Q ss_pred             ------eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCcee
Q 014362          162 ------QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK  235 (426)
Q Consensus       162 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  235 (426)
                            .+++|+||+++ +|...+..   ....+++..++.++.||+.||.|||+.   +|+|+||||+||++++++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999975 67666654   235689999999999999999999987   999999999999999999999


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      |+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||...........+.....
T Consensus       157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999976443321 11122346788999998865 3578999999999999999999999986554333322221100


Q ss_pred             hhhcccccccc--------cC------CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          315 MFKDRKNFSQM--------VD------PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       315 ~~~~~~~~~~~--------~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .. ....+..+        .+      ...... ....+..+.+++.+||+.+|.+||++.+|+.
T Consensus       236 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SP-CPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CC-Chhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00 00000000        00      000000 1123457899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.9e-38  Score=298.79  Aligned_cols=242  Identities=26%  Similarity=0.347  Sum_probs=190.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHH---HHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEV---MTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~---~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      .||+|+||.||+|.+..+++.||+|.+......   ....+..|.   ..++...||||+.+++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999999988999999998764322   112233343   34455689999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      ||+|..++..    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.......  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988864    35699999999999999999999987   99999999999999999999999999987433221  


Q ss_pred             ceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        .....|+..|+|||++.++ .++.++||||||+++|||++|+.||.............   ....            .
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~------------~  214 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLT------------M  214 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH---Hhhc------------c
Confidence              1234689999999998754 68999999999999999999999997653221111100   0000            0


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                      ....+...+..+.+++.+||..+|.+||     ++.++++
T Consensus       215 ~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1112233456889999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=300.74  Aligned_cols=263  Identities=25%  Similarity=0.293  Sum_probs=204.0

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      |.+.+.||.|++|.||+|.+..+++.+++|.+......  ....+..|+.+++.++||||+++++++.++...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            56778899999999999999988999999998754332  3567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++ +|..++..   ....+++..++.++.||+.||.|||+.   +|+|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            74 88887765   235799999999999999999999987   99999999999999999999999999997654332 


Q ss_pred             cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh--hhhccccccc---
Q 014362          251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP--MFKDRKNFSQ---  324 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---  324 (426)
                       .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+.....  .......+..   
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence             112234678899999998877 789999999999999999999999976654333222211000  0000000000   


Q ss_pred             --------ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 --------MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 --------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                              ...... .......+..+.+++.+||+.+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                    000000 0111234568999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-38  Score=302.95  Aligned_cols=247  Identities=28%  Similarity=0.373  Sum_probs=198.5

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|...+.||.|+||.||+|++..++..+|+|.+...   ......++.+|+.+++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            367777899999999999999988999999998643   22335568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+. |+|.+++..   ....+++..+..++.|++.||.|||+.   +++||||+|+|||++.++.++|+|||++......
T Consensus        96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            996 688777754   235689999999999999999999987   9999999999999999999999999998753321


Q ss_pred             CCcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                            ....|++.|+|||++.   ...++.++|||||||++|+|++|..||.............  ..      ..   
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~------~~---  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--QN------ES---  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh--hc------CC---
Confidence                  2346889999999875   3567889999999999999999999986644322211111  00      00   


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                        +.   ..+......+.+|+.+||+.+|.+||++.+++...
T Consensus       232 --~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 --PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              00   01223445788999999999999999999999653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.3e-39  Score=300.74  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=205.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|.+.+.||.|+||.||+|.+..+++.||+|++....   ......+..|+.+++.+. ||||+++++++.+....++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999999899999999987632   233466888999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999976    34799999999999999999999987   99999999999999999999999999987543


Q ss_pred             CCCCc------------------ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH
Q 014362          247 SGDKT------------------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL  308 (426)
Q Consensus       247 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  308 (426)
                      .....                  .......++..|+|||++....++.++||||||+++|+|++|..||...........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK  233 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            32210                  112234678999999999888899999999999999999999999986653222111


Q ss_pred             HHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 014362          309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI----TDVVM  365 (426)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~  365 (426)
                      ..      .            .....+...+..+.+++.+||+.+|.+||++    .+++.
T Consensus       234 ~~------~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         234 IL------K------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HH------h------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11      0            0111223335578999999999999999999    77653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.2e-38  Score=300.99  Aligned_cols=245  Identities=29%  Similarity=0.419  Sum_probs=197.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      |.....||+|+||.||+|++..++..|++|.+.....   .....+..|+.+++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            6666779999999999999998999999999875322   3345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +. |+|.+++..   ...++++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||++.....  
T Consensus       103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            96 677777754   245689999999999999999999987   999999999999999999999999999864221  


Q ss_pred             CcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                          .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...............        ......
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~  241 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--------DSPTLQ  241 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--------CCCCCC
Confidence                12346899999999984   456889999999999999999999999765443322211100        000000


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              ....+..+.+|+.+||+.+|.+||++.+++..
T Consensus       242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    11223467899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.2e-38  Score=304.63  Aligned_cols=269  Identities=25%  Similarity=0.311  Sum_probs=199.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      .++|++.+.||.|+||.||+|.+..+++.||||.+......  ....+.+|+.+++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            47899999999999999999999999999999998654322  2345678999999999999999999875433      


Q ss_pred             --eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          162 --QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       162 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                        .+++|+||+. ++|...+..   ....+++..++.++.||+.||.|||+.   +|+|+||||+|||+++++.++|+||
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence              4699999996 467666654   245799999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCc---------ceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHH
Q 014362          240 GLAKMGPSGDKT---------HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV  309 (426)
Q Consensus       240 gla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  309 (426)
                      |+++........         ...+...|++.|+|||.+.+. .++.++|||||||++|||++|++||...........+
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999754322111         111234678899999987654 5889999999999999999999999876554433222


Q ss_pred             Hhhhhh-----hhcccccccccCCcccCCCC-------hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          310 AWARPM-----FKDRKNFSQMVDPSLQGQYP-------VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       310 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ......     +..........+.......+       ......+.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            211000     00000000100000000011       112357889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-38  Score=295.73  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=200.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      +|.+.+.||+|+||.||++.+...+..+++|.+...     .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            578889999999999999999877766766665432     122344577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      +||+++++|..++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999999876544556799999999999999999999987   9999999999999986 569999999987543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||............      ..         
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~------~~---------  219 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI------VE---------  219 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH------Hc---------
Confidence            2211  122346888999999998888999999999999999999999999654322111110      00         


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 --GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             --CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence              0011123344568899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.4e-39  Score=310.25  Aligned_cols=267  Identities=22%  Similarity=0.314  Sum_probs=201.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC---------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG---------  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---------  160 (426)
                      .++|.+.+.||.|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            46899999999999999999999999999999999776666677889999999999999999999876543         


Q ss_pred             -----CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCce
Q 014362          161 -----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHP  234 (426)
Q Consensus       161 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~  234 (426)
                           ...++||||++ ++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++. ++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35789999997 588887753     4589999999999999999999987   9999999999999974 5678


Q ss_pred             eEecccccccCCCCCC-cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          235 KLSDFGLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      +|+|||+++....... ........++..|+|||.+.. ..++.++|||||||++|+|++|+.||...............
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999975432111 111122367889999998754 56889999999999999999999999876544333222111


Q ss_pred             hhhhhc--ccc----cccccC-CcccCC-----CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          313 RPMFKD--RKN----FSQMVD-PSLQGQ-----YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       313 ~~~~~~--~~~----~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+....  ...    ...... ......     .......++.+|+.+||+.||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            100000  000    000000 000000     01123457889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=323.28  Aligned_cols=273  Identities=18%  Similarity=0.211  Sum_probs=189.1

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCC-EEEEEEEe--------------cc---CCcccHHHHHHHHHHHhcCCCCC
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQL--------------DH---RGVQGVREFSAEVMTLGSADHPN  149 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~--------------~~---~~~~~~~~~~~E~~~l~~l~hpn  149 (426)
                      ...++|++.+.||+|+||+||++.++... ..+++|.+              .+   ........+.+|+.+|+.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34678999999999999999998765322 22222211              10   11123456789999999999999


Q ss_pred             cceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhC-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       150 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      |+++++++.+.+..|+|++++. ++|..++.... ..........++.++.||+.||.|||+.   +||||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence            9999999999999999999995 57777665421 1122234567788999999999999987   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCC-CCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI-DQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~-~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..++ ..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999986543221 1222357999999999999999999999999999999999987644 3222111111


Q ss_pred             HHHhhhhhhhccccc-------ccccCCc----ccCCCC-----hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          308 LVAWARPMFKDRKNF-------SQMVDPS----LQGQYP-----VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~-------~~~~~~~----~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +.............+       ...++..    .....+     ......+.+++.+||+.||.+||++.|++.
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111100000000000       0000000    000000     012235677899999999999999999985

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=315.66  Aligned_cols=204  Identities=30%  Similarity=0.421  Sum_probs=175.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------CeeEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------DQRLL  165 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l  165 (426)
                      |.....||+|+||.||+|+++.+|+.||||.++... ....+...+|+++|++++|||||+++++-++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            444556999999999999999999999999998643 34567788999999999999999999875543      35689


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--CC--ceeEecccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GY--HPKLSDFGL  241 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~--~~kl~Dfgl  241 (426)
                      |||||.||+|...|.+-. +...|++.+.+.++.+++.||.|||..   +|+||||||.||++-.  +|  .-||+|||.
T Consensus        95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            999999999999998754 456799999999999999999999987   9999999999999943  23  369999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCch
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR  303 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~  303 (426)
                      |+......   ....++||+.|++||.+.. +.|+..+|.|||||++|+++||..||......
T Consensus       171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            99765443   4566899999999999984 88999999999999999999999999755443

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.4e-38  Score=306.11  Aligned_cols=267  Identities=23%  Similarity=0.276  Sum_probs=200.8

Q ss_pred             cCCccc-cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc--------------HHHHHHHHHHHhcCCCCCcceEe
Q 014362           90 TGNFRS-DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--------------VREFSAEVMTLGSADHPNLVKLI  154 (426)
Q Consensus        90 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~~~  154 (426)
                      .++|.. .+.||.|+||.||+|.+..+++.||||.+.......              ...+.+|+.+++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            345654 467999999999999999889999999986542221              12477899999999999999999


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      +++......++||||+. |+|.+++..    ...+++..+..++.||+.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCE
Confidence            99999999999999997 688888864    35689999999999999999999987   99999999999999999999


Q ss_pred             eEecccccccCCCCC------------CcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcC
Q 014362          235 KLSDFGLAKMGPSGD------------KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTK  301 (426)
Q Consensus       235 kl~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~  301 (426)
                      +|+|||++.......            .........+++.|+|||++.+. .++.++|||||||++|||++|..||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999997543110            01111223568899999998764 46899999999999999999999998766


Q ss_pred             chhhhcHHHhhhhh-----hhcccccc------cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          302 DRKELNLVAWARPM-----FKDRKNFS------QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       302 ~~~~~~~~~~~~~~-----~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .......+......     +.......      ........ ......+..+.+++.+||+.+|++||++.+++.
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            54433222111100     00000000      00000000 011123457889999999999999999999995

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.5e-38  Score=300.77  Aligned_cols=257  Identities=20%  Similarity=0.256  Sum_probs=192.4

Q ss_pred             CcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhh
Q 014362          103 GFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH  180 (426)
Q Consensus       103 ~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~  180 (426)
                      ++|.||.++...+++.||||++...  .......+..|+.+++.++||||+++++++......+++|||+++|+|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            4455666666668999999998754  33456779999999999999999999999999999999999999999999997


Q ss_pred             hhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC-----cceee
Q 014362          181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK-----THVST  255 (426)
Q Consensus       181 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-----~~~~~  255 (426)
                      ...  ...+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||.+........     .....
T Consensus        92 ~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~  166 (314)
T cd08216          92 THF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK  166 (314)
T ss_pred             Hhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence            632  34588999999999999999999987   999999999999999999999999998864322111     11112


Q ss_pred             eecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh----hh------cccccc
Q 014362          256 RVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM----FK------DRKNFS  323 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~----~~------~~~~~~  323 (426)
                      ...++..|+|||++..  ..++.++|||||||++|||++|..||.........  .......    +.      ......
T Consensus       167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  244 (314)
T cd08216         167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTYPLYEDSMS  244 (314)
T ss_pred             cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCchhhhcCCcC
Confidence            3457788999999876  35889999999999999999999999765432211  1100000    00      000000


Q ss_pred             c----ccCC----cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 Q----MVDP----SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .    ..++    .............+.+|+.+||+.+|++||++.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0    0000    01111223345678899999999999999999999963

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-38  Score=307.19  Aligned_cols=262  Identities=23%  Similarity=0.301  Sum_probs=197.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      .++|.+...||.|+||.||+|.+..+++.||||.+....  ......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999999889999999987532  223456889999999999999999999986543      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+++|+||+. .+|..++      ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            4689999996 4666554      23589999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh----
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF----  316 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----  316 (426)
                      ++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.......    
T Consensus       164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07879         164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF  238 (342)
T ss_pred             CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            8753221     123467889999999876 468899999999999999999999998755433222221110000    


Q ss_pred             ----hcc--cccccccCCcccCCC---ChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          317 ----KDR--KNFSQMVDPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       317 ----~~~--~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          ...  ......+........   .......+.+|+.+||+.||.+||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000  000000000000000   01234568899999999999999999999843

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=301.91  Aligned_cols=256  Identities=27%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-c------ccHHHHHHHHHHHhcCCCCCcceEeeEEe-eCC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-V------QGVREFSAEVMTLGSADHPNLVKLIGYCA-EGD  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~  161 (426)
                      .++|-++.+||+|||+.||+|.+....+.||||+-.... +      .-.+...+|..+-+.|.||.||++|++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            457888899999999999999998888999999865321 1      12455778999999999999999999985 556


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEec
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSD  238 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~D  238 (426)
                      .+|-|+|||+|.+|+-+|+.    ...+++.++..|+.||+.||.||... +++|||-||||.||||.+   .|.+||+|
T Consensus       542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            78999999999999999987    46799999999999999999999987 779999999999999964   47899999


Q ss_pred             ccccccCCCCCCc-----ceeeeecccccccCccccccC----CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHH
Q 014362          239 FGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTG----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV  309 (426)
Q Consensus       239 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~  309 (426)
                      |||+++.......     ..+....||.+|++||++.-+    +.+.++||||+|||+|..+.|+.||........  .+
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL  694 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL  694 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH
Confidence            9999976554332     234457899999999988644    578999999999999999999999976443221  11


Q ss_pred             HhhhhhhhcccccccccCCcccCCCC--hHhHHHHHHHHHhccccCCCCCCCHHHHH
Q 014362          310 AWARPMFKDRKNFSQMVDPSLQGQYP--VRGLYQALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                      .. ...+..           ....+|  +..+.++.+||++||+..-++|....++.
T Consensus       695 qe-NTIlkA-----------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  695 QE-NTILKA-----------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hh-hchhcc-----------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            11 111111           001111  22345788999999999999998877765

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=296.72  Aligned_cols=263  Identities=27%  Similarity=0.352  Sum_probs=203.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      |+....||.|+||.||+|+...+++.||+|.+....  ......+..|+.+++.++||||+++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566778999999999999999999999999998653  233466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      + ++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||+|+||++++++.++|+|||+++.......
T Consensus        81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 5899999762   25699999999999999999999997   999999999999999999999999999975433221


Q ss_pred             cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh--------hhhhc---
Q 014362          251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR--------PMFKD---  318 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~---  318 (426)
                        ......++..|+|||.+.+. .++.++||||||+++|||++|..||...........+....        .....   
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence              12233567889999998776 88999999999999999999999997655433222111100        00000   


Q ss_pred             -ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 -RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+............+ .....+.+++.+||+.+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             00011111101111111 12457899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-38  Score=295.60  Aligned_cols=264  Identities=25%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      |.+.+.||.|+||.||+|....+++.|+||.+..... .......+|+..++.++ ||||+++++++.++...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677889999999999999998899999999875432 22234557899999999 999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                       +|+|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence             789998887632  34689999999999999999999987   999999999999999999999999999975432211


Q ss_pred             cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh-hhh----hhccccccc
Q 014362          251 THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA-RPM----FKDRKNFSQ  324 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~  324 (426)
                         .....++..|+|||++.+ ..++.++|+||||+++|||++|+.||............... ...    +........
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence               123468889999998754 46789999999999999999999999766543332211100 000    000000000


Q ss_pred             ccCCccc-------CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQ-------GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+.       ..........+.+++.+||+.+|.+||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000       0011112457899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-38  Score=295.26  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=197.8

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcC---CCCCcceEeeEEeeCCe-----
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSA---DHPNLVKLIGYCAEGDQ-----  162 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l---~hpniv~~~~~~~~~~~-----  162 (426)
                      |++.+.||.|+||.||+|.++.+++.||+|.+......  ....+..|+.+++.+   .||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            66788899999999999999988999999999743222  234466677766555   69999999999988776     


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .+++|||+. ++|.+++....  ...+++..++.++.||+.||.|||+.   +++|+||+|+||+++.++.+||+|||++
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            899999997 58888886532  24689999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----hh
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----FK  317 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~  317 (426)
                      ........   .....++..|+|||++.+..++.++|||||||++|||++|.+||......+....+......     +.
T Consensus       155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07838         155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP  231 (287)
T ss_pred             eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence            76433211   12235788999999999999999999999999999999999999865543332222110000     00


Q ss_pred             cccc-cccccCCccc---CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 DRKN-FSQMVDPSLQ---GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 ~~~~-~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .... ....+.....   ..........+.+++.+||+.||.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000 0000000000   0111233467789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.9e-38  Score=303.04  Aligned_cols=267  Identities=22%  Similarity=0.282  Sum_probs=202.1

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEee-CCe
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQ  162 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  162 (426)
                      +..++++|++.+.||.|+||.||+|.+..+++.||||.+...  .....+.+..|+.+++.++||||++++++|.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            345678999999999999999999999999999999988643  22345678899999999999999999999865 557


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++|+||+ +++|..++..     ..+++..+..++.||+.||.|||+.   +|+||||+|.|||+++++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            88999998 5788888754     4588889999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-------
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-------  314 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  314 (426)
                      ......     .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.....       
T Consensus       156 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         156 RIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             cccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            743221     122367889999998766 5789999999999999999999999976543222211111000       


Q ss_pred             -hhhcccccccccCCcccCCCC-----hHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          315 -MFKDRKNFSQMVDPSLQGQYP-----VRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       315 -~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       .........-...-......+     ......+.+++.+||+.+|++||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             000000000000000001111     1234678999999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.3e-38  Score=299.06  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=196.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||.|+||.||+|.+..+++.||||.+..... .....+..|+.++... .||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3568889999999999999999999999999999976432 2344566677766666 4999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+. ++|..++...   ...+++..+..++.||+.||.|||+.  .+|+||||+|+||++++++.+||+|||++.....
T Consensus        94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 5777776552   34799999999999999999999973  3899999999999999999999999999875432


Q ss_pred             CCCcceeeeecccccccCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ...   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||........  ....   ......  .
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~---~~~~~~--~  237 (296)
T cd06618         168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VLTK---ILQEEP--P  237 (296)
T ss_pred             CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HHHH---HhcCCC--C
Confidence            211   12235788999999987554    78999999999999999999999975332111  1110   010000  0


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                           .+.  .......++.+|+.+||+.+|.+||++.++++.
T Consensus       238 -----~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 -----SLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -----CCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 000  011234578999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-38  Score=305.43  Aligned_cols=272  Identities=22%  Similarity=0.275  Sum_probs=204.9

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEe
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCA  158 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  158 (426)
                      ....++....++|.+.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            344566678899999999999999999999999899999999987532  223456788999999999999999999886


Q ss_pred             eC------CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC
Q 014362          159 EG------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY  232 (426)
Q Consensus       159 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~  232 (426)
                      ..      ...+++++++ +++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            43      3467888877 7899887754     4589999999999999999999987   999999999999999999


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  311 (426)
                      .+||+|||+++.....     .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus       158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999998753221     123468899999998876 5688999999999999999999999976543332221111


Q ss_pred             hhhh-----h---hcc--cccccccCCccc---CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          312 ARPM-----F---KDR--KNFSQMVDPSLQ---GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       312 ~~~~-----~---~~~--~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ....     .   ...  ..+...+.....   ..........+.+++.+||+.+|.+||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000     0   000  000000000000   00011234578899999999999999999999954

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=287.22  Aligned_cols=265  Identities=22%  Similarity=0.232  Sum_probs=206.0

Q ss_pred             hcCCcccc-ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc-CCCCCcceEeeEEee----CCe
Q 014362           89 ATGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYCAE----GDQ  162 (426)
Q Consensus        89 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~----~~~  162 (426)
                      ++++|.+. .+||-|-.|.|..+.++.|++.+|+|++...     ....+|+++--. -.|||||.++++|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45566654 5699999999999999999999999998754     345577776544 469999999998754    356


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEecc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDF  239 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Df  239 (426)
                      +.+|||.|+||.|...+.+.  ....+++.++-.|+.||..|+.|||+.   +|.||||||+|+|...   +..+||+||
T Consensus       134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccc
Confidence            78999999999999999884  356799999999999999999999998   9999999999999975   456899999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh----cHHHhhhhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----NLVAWARPM  315 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~----~~~~~~~~~  315 (426)
                      |+|+....   .......+-||.|.|||++...+|+..+|+||+||++|-|++|-+||.........    ..+......
T Consensus       209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~  285 (400)
T KOG0604|consen  209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE  285 (400)
T ss_pred             ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence            99985322   22233458899999999999999999999999999999999999999765432211    111111000


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCCCCCCC
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPP  381 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~~~~  381 (426)
                                    +...--...+....++|+.+|..+|.+|.|+++++. ..++.+....|+.++
T Consensus       286 --------------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~-hpwi~~~~~vp~tpl  336 (400)
T KOG0604|consen  286 --------------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD-HPWINQYEAVPQTPL  336 (400)
T ss_pred             --------------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc-CchhcccccCCCCCc
Confidence                          011112345667899999999999999999999984 345555545454443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=307.58  Aligned_cols=251  Identities=26%  Similarity=0.333  Sum_probs=217.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++..+..||-|+||.|=++..+.....+|+|++++...   ...+.+..|-.+|...+.|+||++|-.|.++...|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            3456677779999999999999887666699999887543   4456688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||-|-||.|...|++    .+.++...+..++..+++|++|||+.   +||+|||||+|+|||.+|-+||.|||+|+...
T Consensus       499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            999999999999987    57799999999999999999999987   99999999999999999999999999999776


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .+..+   ..++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++....+++...-..+          
T Consensus       572 ~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------  638 (732)
T KOG0614|consen  572 SGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------  638 (732)
T ss_pred             cCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------
Confidence            65544   45799999999999999999999999999999999999999999999888777766443333          


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~  366 (426)
                            .+|........+|+++.+..+|.+|..     +.+|-+.
T Consensus       639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  639 ------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                  234445557899999999999999986     6666543

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-38  Score=304.03  Aligned_cols=264  Identities=22%  Similarity=0.262  Sum_probs=200.2

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC----
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----  161 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----  161 (426)
                      ...++|++.+.||.|+||.||+|.+..++..||||.+....  ......+..|+.+++.++||||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            35778999999999999999999999999999999986432  223456889999999999999999999987653    


Q ss_pred             --eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          162 --QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       162 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                        .+++||||+ +++|..++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence              358999999 7899888753     4689999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh---
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM---  315 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---  315 (426)
                      |++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+......   
T Consensus       163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            999754321     123467899999998876 45889999999999999999999999765432221111000000   


Q ss_pred             -hhc------ccccccccCCccc---CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          316 -FKD------RKNFSQMVDPSLQ---GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       316 -~~~------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       +..      ...+...+.....   ..........+.+++.+||+.||.+||++.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             000      0000000000000   0011223446889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-37  Score=294.61  Aligned_cols=252  Identities=26%  Similarity=0.340  Sum_probs=197.5

Q ss_pred             CccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCCc----ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV----QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      +|++.+.||.|+||.||.|...   .+|..||+|.+.....    ...+.+..|+.++..+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788899999999999999874   4688999999875322    2345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++|+||+++++|.+++..    ...+++..+..++.||+.||.|||+.   +++||||+|+|||++.++.+||+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            999999999999999875    35688999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeecccccccCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ....... .......|+..|+|||.+...  .++.++||||||+++|+|++|..||...........+.  .......  
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~--~~~~~~~--  228 (290)
T cd05613         154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKSE--  228 (290)
T ss_pred             ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH--HHhhccC--
Confidence            5432211 112234689999999998753  46889999999999999999999996433221111111  1111000  


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                                ..++......+.+++.+||+.+|.+||     ++.+++.
T Consensus       229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                      012233445788999999999999997     6666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-37  Score=295.07  Aligned_cols=255  Identities=25%  Similarity=0.318  Sum_probs=200.3

Q ss_pred             CccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC----cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      +|++.+.||+|+||.||++.+.   .++..||||.+....    ......+..|+.++..+ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788889999999999999864   357889999987532    12345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||+|.||+++.++.++|+|||+++
T Consensus        81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            999999999999998865    35689999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ....... .......|+..|+|||.+.+..  .+.++||||||+++|||++|..||..........  ..........  
T Consensus       154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~~--  228 (288)
T cd05583         154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILKSK--  228 (288)
T ss_pred             ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHccC--
Confidence            5433221 1122346899999999987665  7889999999999999999999996433221111  1111111110  


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                                ...+......+.+++.+||+.+|++|||+.++.+.|+
T Consensus       229 ----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 ----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             ----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                      1122233457889999999999999999988877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=315.53  Aligned_cols=255  Identities=28%  Similarity=0.420  Sum_probs=216.5

Q ss_pred             cccceeeecCcEEEEEEEEcCCC----EEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .-.++||.|+||+||+|.|-..|    .+||||++.... .....++.+|+.+|.+++|||+++++++|.... +-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34567999999999999995444    468999987643 455678999999999999999999999998765 789999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ||++|+|.++++..   ...+.....+.|..||++||.|||.+   .++||||...||||.+...+||.|||+++.....
T Consensus       778 ~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             hcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999984   56788899999999999999999987   9999999999999999999999999999987766


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........-.+-|||-|.+....|+.++|||||||++||++| |..|+++....+.-+++.                 
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-----------------  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-----------------  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-----------------
Confidence            55544444445678999999999999999999999999999999 899998876654433333                 


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ..-+-..|..+...+.-++.+||..|+..||+++++...+...++
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            222234477788899999999999999999999999988877654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.4e-37  Score=325.07  Aligned_cols=147  Identities=31%  Similarity=0.409  Sum_probs=133.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....   .....+..|+.++..++||||+++++++.....+|||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            3679999999999999999999999999999999975432   2346688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||..   +|+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999875    34688999999999999999999987   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-38  Score=306.29  Aligned_cols=263  Identities=23%  Similarity=0.308  Sum_probs=201.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe----
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ----  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----  162 (426)
                      ..++|++...||.|+||.||+|.+..++..||||.+...  .......+.+|+.+++.++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999999999999998653  22334567789999999999999999998866554    


Q ss_pred             --eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          163 --RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       163 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                        .++|+||+ +++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence              89999998 6799888864     4699999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh--
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK--  317 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  317 (426)
                      ++......     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+........  
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            99754322     123467889999998865 3678999999999999999999999976554332222111100000  


Q ss_pred             --cc------cccccccCCcccCCC---ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 --DR------KNFSQMVDPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 --~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..      ..+...+.......+   ....+..+.+++.+||+.+|.+||++.+|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence              00      000000000000000   1123568899999999999999999999985

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.2e-39  Score=287.08  Aligned_cols=274  Identities=22%  Similarity=0.268  Sum_probs=202.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCC----EEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee-CC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  161 (426)
                      ....|++...||+|+||.||+|..+.++    +.+|||+++-..  ...-....+|+.+++.++||||+.+..+|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3456999999999999999999765543    368999997542  2233567899999999999999999999877 77


Q ss_pred             eeEEEEEecCCCCHHHHhhhhC-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC----CceeE
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG----YHPKL  236 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl  236 (426)
                      .+++++||.+ -+|...|+-.+ .....++...+..|++||+.|+.|||+.   -|+||||||.||||..+    |.|||
T Consensus       102 ~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEe
Confidence            8999999997 47777776543 2335789999999999999999999997   79999999999999877    89999


Q ss_pred             ecccccccCCCCCCcc-eeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhh---------
Q 014362          237 SDFGLAKMGPSGDKTH-VSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE---------  305 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~---------  305 (426)
                      +|||+++.....-... ....++.|.+|.|||.+.+. .|+.+.||||.|||+.||+|-.+.|.+......         
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999766544333 33456789999999999876 699999999999999999999988865432211         


Q ss_pred             hcHHHhhhh-----hhhcccccccccC--CcccCCCChH------------hHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          306 LNLVAWARP-----MFKDRKNFSQMVD--PSLQGQYPVR------------GLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       306 ~~~~~~~~~-----~~~~~~~~~~~~~--~~~~~~~~~~------------~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +..+-....     .+++-.+.++.-+  ..++..+...            -+...++|+..+|+.||.+|.|+++.++-
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            111110000     0000011111100  0011000000            11247899999999999999999998864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-38  Score=326.96  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=192.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEE----------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYC----------  157 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~----------  157 (426)
                      -..+|+....||+||||.||+++++-+|+.||||+|.... ......+.+|+..|++|+|||||+++..+          
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            3456788888999999999999999999999999997653 33456688999999999999999998510          


Q ss_pred             --------------------------------------------------e-----------------------------
Q 014362          158 --------------------------------------------------A-----------------------------  158 (426)
Q Consensus       158 --------------------------------------------------~-----------------------------  158 (426)
                                                                        .                             
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                              0                             


Q ss_pred             -----------------------e-------CCeeEEEEEecCCCCHHHHhhhhCCCCCCC-CHHHHHHHHHHHHHHHHH
Q 014362          159 -----------------------E-------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPL-DWNTRMKIAAGASRGLQY  207 (426)
Q Consensus       159 -----------------------~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~qi~~aL~~  207 (426)
                                             +       ...+||-||||+..+|.+++++.    ... ....+|+++++|+.||.|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N----~~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN----HFNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc----ccchhhHHHHHHHHHHHHHHHH
Confidence                                   0       02358889999988888888762    222 578899999999999999


Q ss_pred             HHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC----------------CCCCcceeeeecccccccCcccccc
Q 014362          208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP----------------SGDKTHVSTRVMGTYGYCAPDYAMT  271 (426)
Q Consensus       208 LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~  271 (426)
                      +|+.   |||||||||.||+||+++.|||+|||+|....                .+......+..+||.-|+|||++.+
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9998   99999999999999999999999999997511                0111223355789999999999876


Q ss_pred             C---CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHh
Q 014362          272 G---QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAM  348 (426)
Q Consensus       272 ~---~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  348 (426)
                      .   .|+.|+|||||||||+||+.   ||...-++.  ..+...+     ...++..      .++.......-..+|++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa--~iL~~LR-----~g~iP~~------~~f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA--SILTNLR-----KGSIPEP------ADFFDPEHPEEASLIRW  853 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHH--HHHHhcc-----cCCCCCC------cccccccchHHHHHHHH
Confidence            5   49999999999999999986   465433222  1111110     0111110      12222333355789999


Q ss_pred             ccccCCCCCCCHHHHHH
Q 014362          349 CVQEQPNMRPAITDVVM  365 (426)
Q Consensus       349 cl~~dP~~RPs~~eil~  365 (426)
                      +++.||.+|||+.|+|.
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999984

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=290.19  Aligned_cols=275  Identities=24%  Similarity=0.288  Sum_probs=207.6

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc--CCCCCcceEeeEEe
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCA  158 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~  158 (426)
                      .++-..+.+..+..+.+.||+|.||.||+|.|+  |+.||||++...   +.+.+.+|.++.+.  |+|+||+.+++.-.
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            444445567788899999999999999999999  889999999754   34567788888765  69999999998754


Q ss_pred             eC----CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----CCCCeEecCCCCCCeeec
Q 014362          159 EG----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ-----LKQPVIYRDLKCSNILLE  229 (426)
Q Consensus       159 ~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~  229 (426)
                      .+    .++|||.+|.+.|||+++|..     ..++....++++..+|.||++||..     .++.|.|||||+.||||.
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            33    368999999999999999976     6799999999999999999999975     367899999999999999


Q ss_pred             cCCceeEecccccccCCCCCCc--ceeeeecccccccCccccccCC----C--CccCchhhHHHHHHHHHhC--------
Q 014362          230 EGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTGQ----L--TFKSDIYSFGVVLLELITG--------  293 (426)
Q Consensus       230 ~~~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwSlG~il~elltg--------  293 (426)
                      .++.+.|+|+|||.........  ......+||.+|||||++....    +  -..+||||||.|+||++..        
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            9999999999999765443211  1223458999999999986542    2  2578999999999999863        


Q ss_pred             --CCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC-CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          294 --RKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG-QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       294 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                        ..||...-+.+...  ...+..     ...+-+.|.+.. ......+..+..|++.||..+|..|.|+--|-+.|.++
T Consensus       431 ey~~Pyyd~Vp~DPs~--eeMrkV-----VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDPSF--EEMRKV-----VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             hhcCCcccCCCCCCCH--HHHhcc-----eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence              34554432221110  000000     001111122222 12345667889999999999999999999999999888


Q ss_pred             Hh
Q 014362          371 AS  372 (426)
Q Consensus       371 ~~  372 (426)
                      ..
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            63

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-37  Score=299.97  Aligned_cols=265  Identities=21%  Similarity=0.242  Sum_probs=196.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCC--CEEEEEEEeccCC--cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC----Ce
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKI--EQVVAIKQLDHRG--VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG----DQ  162 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~----~~  162 (426)
                      +|++.+.||.|+||.||++.+..+  +..||||.+....  ....+.+..|+.+++.+ .||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478889999999999999999887  8899999986432  22345678899999998 599999999875432    45


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .+++++|+. ++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            788899885 688888764    45689999999999999999999987   9999999999999999999999999999


Q ss_pred             ccCCCCCC--cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh---
Q 014362          243 KMGPSGDK--THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF---  316 (426)
Q Consensus       243 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---  316 (426)
                      +.......  ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......   
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            75432211  111223578999999998765 468999999999999999999999997655332221111100000   


Q ss_pred             -----hcc------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 -----KDR------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 -----~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                           ...      ......-...+. .........+.+|+.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                 000      000000000000 001112457899999999999999999999984

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8e-38  Score=259.33  Aligned_cols=264  Identities=22%  Similarity=0.267  Sum_probs=207.9

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +|.-.++||+|+||+||+|+...+++.||+|.++..+  ........+|+-+|+.+.|.|||++++....+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3455567999999999999999999999999987543  23345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      |. ..|..+...   -.+.++.+.+..++.|+++||.|+|++   ++.||||||.|+|++.+|.+||+|||+++.+... 
T Consensus        83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip-  154 (292)
T KOG0662|consen   83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-  154 (292)
T ss_pred             hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence            95 577777765   457799999999999999999999998   9999999999999999999999999999865432 


Q ss_pred             CcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc--
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM--  325 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  325 (426)
                       ....+..+.|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+..+++..+-+......+. .++.+  
T Consensus       155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed-~wps~t~  232 (292)
T KOG0662|consen  155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTED-QWPSMTK  232 (292)
T ss_pred             -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccc-cCCcccc
Confidence             3333445779999999999876 58899999999999999987 677788777777666665543332221 12221  


Q ss_pred             -cCCcccCCCChH---------hHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 -VDPSLQGQYPVR---------GLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 -~~~~~~~~~~~~---------~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       -|-..-..+|..         ....-++|+...|.-+|..|.++++.++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence             111111112221         1124478899999999999999998875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=285.54  Aligned_cols=237  Identities=30%  Similarity=0.374  Sum_probs=196.1

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      ||.|+||.||++.+..+++.+|+|.+......   ....+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999988999999998765332   456788999999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceee
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST  255 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  255 (426)
                      .+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~  151 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN  151 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence            999976    34689999999999999999999987   99999999999999999999999999987543321  1223


Q ss_pred             eecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       256 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ...++..|+|||.+.+...+.++|+||||+++|+|++|..||...........+..      ..            ..++
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------~~------------~~~~  213 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK------DP------------LRFP  213 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc------CC------------CCCC
Confidence            35688999999999888899999999999999999999999976543221111110      00            1122


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITD  362 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~e  362 (426)
                      ...+..+.+++.+||..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            223457889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=290.90  Aligned_cols=272  Identities=19%  Similarity=0.255  Sum_probs=211.9

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC--C----CcceEee
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH--P----NLVKLIG  155 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--p----niv~~~~  155 (426)
                      -+......+++|.+...+|+|+||.|-.+.+..++..||||+++.-. .-.+...-|+.+|.++.+  |    -+|.+.+
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~  158 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRD  158 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeeh
Confidence            33334445889999999999999999999999999999999987532 223445678999998842  3    3788899


Q ss_pred             EEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-----
Q 014362          156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-----  230 (426)
Q Consensus       156 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----  230 (426)
                      ||.-..+.|||+|.+ |.|+.++|..  ++..+++...+..++.|++++++|||+.   +++|-||||+|||+.+     
T Consensus       159 wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  159 WFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEE
Confidence            999999999999998 6799999976  4567899999999999999999999998   9999999999999931     


Q ss_pred             ---------------CCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCC
Q 014362          231 ---------------GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK  295 (426)
Q Consensus       231 ---------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~  295 (426)
                                     +..++|+|||.|+......     +.++.|..|.|||++.+-+++.++||||+||||+||.||..
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                           3458999999998643322     44578999999999999999999999999999999999999


Q ss_pred             CCCCcCchhhhcHHHhhhhhhhcc---c------------ccc---------cccCCc----ccCCCChHhHHHHHHHHH
Q 014362          296 AIDQTKDRKELNLVAWARPMFKDR---K------------NFS---------QMVDPS----LQGQYPVRGLYQALAIAA  347 (426)
Q Consensus       296 p~~~~~~~~~~~~~~~~~~~~~~~---~------------~~~---------~~~~~~----~~~~~~~~~~~~l~~li~  347 (426)
                      .|.+.+..+.+.++......++..   +            .+.         ..+++.    ........+..++.+|+.
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            999988777665554332211110   0            000         000000    000122334457999999


Q ss_pred             hccccCCCCCCCHHHHHH
Q 014362          348 MCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       348 ~cl~~dP~~RPs~~eil~  365 (426)
                      +||..||.+|+|+.|++.
T Consensus       388 ~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHccCccccccHHHHhc
Confidence            999999999999999985

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-37  Score=316.57  Aligned_cols=265  Identities=26%  Similarity=0.418  Sum_probs=214.2

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeE
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGY  156 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~  156 (426)
                      ++....+..+.+.||.|.||.|++|....       ....||||.+..... ...+.+..|+.+|+.+ .||||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            44444555666789999999999998541       145799999876433 4567799999999998 59999999999


Q ss_pred             EeeCCeeEEEEEecCCCCHHHHhhhhC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 014362          157 CAEGDQRLLVYEYMPLGSLDKHLHDLR---PD-------T--RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCS  224 (426)
Q Consensus       157 ~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~  224 (426)
                      |.....+++|+||+..|+|..+|+..+   .-       .  ..++....+.++.||+.||+||++.   ++|||||...
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999889999999999999999998755   00       1  2389999999999999999999997   8999999999


Q ss_pred             CeeeccCCceeEecccccccCCCCCCcceeeeecc--cccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcC
Q 014362          225 NILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG--TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK  301 (426)
Q Consensus       225 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~  301 (426)
                      |||+..+..+||+|||+|+............ -.|  ...|||||.+....|+.++|||||||+||||+| |..||.+..
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999998544433332111 122  446999999999999999999999999999999 788887633


Q ss_pred             chhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          302 DRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ....+                .+.+.+..+...|..+..++.++++.||+.+|++||++.++.+.+...
T Consensus       527 ~~~~l----------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEEL----------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11111                122334455566778888999999999999999999999999999885

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=278.90  Aligned_cols=268  Identities=21%  Similarity=0.317  Sum_probs=205.5

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEe
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCA  158 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  158 (426)
                      .-+|.++-..++.     .||+|+|+.|-.+....+|..||||++.+.......++.+|++++...+ |+||+.+++||+
T Consensus        72 ~g~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE  146 (463)
T KOG0607|consen   72 SGKFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE  146 (463)
T ss_pred             cchHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence            3446666555543     4999999999999999999999999999887777788999999999985 999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc---ee
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PK  235 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~k  235 (426)
                      +...+|||||-|.||+|..+|+.    ...+++.++.++..+|+.||.|||..   ||.||||||+|||-.....   +|
T Consensus       147 dd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  147 DDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             ccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence            99999999999999999999987    46799999999999999999999987   9999999999999976544   79


Q ss_pred             EecccccccCCCC-C----CcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhh
Q 014362          236 LSDFGLAKMGPSG-D----KTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE  305 (426)
Q Consensus       236 l~Dfgla~~~~~~-~----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~  305 (426)
                      |+||.+..-.... +    .+..-...+|+..|||||+..     ...|+.++|.||||||||-|++|.+||.+....+ 
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d-  298 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD-  298 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-
Confidence            9999887421110 0    111112357999999999764     2368999999999999999999999997754321 


Q ss_pred             hcHHHhhhhhhhcccccc-cccCCcccC--CCCh----HhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          306 LNLVAWARPMFKDRKNFS-QMVDPSLQG--QYPV----RGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         .-|.+....  ..-. .++.....+  .+|.    ..+.+..+++...|..+|.+|.++..++.
T Consensus       299 ---CGWdrGe~C--r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  299 ---CGWDRGEVC--RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ---CCccCCCcc--HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence               001100000  0000 011111111  2333    33557788999999999999999998875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=6.5e-37  Score=281.56  Aligned_cols=222  Identities=24%  Similarity=0.258  Sum_probs=180.5

Q ss_pred             cCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhh
Q 014362          102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD  181 (426)
Q Consensus       102 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  181 (426)
                      |.||.||++++..+++.||+|.+....     .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999999999999999997642     233455555566799999999999999999999999999999999875


Q ss_pred             hCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccc
Q 014362          182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY  261 (426)
Q Consensus       182 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~  261 (426)
                          ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......     .....++.
T Consensus        79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~  146 (237)
T cd05576          79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN  146 (237)
T ss_pred             ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence                24589999999999999999999987   9999999999999999999999999987643321     12235677


Q ss_pred             cccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHH
Q 014362          262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQ  341 (426)
Q Consensus       262 ~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (426)
                      .|+|||.+.+..++.++||||+|+++|||++|..|+.......                  .    .......|......
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~----~~~~~~~~~~~~~~  204 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------N----THTTLNIPEWVSEE  204 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------c----cccccCCcccCCHH
Confidence            8999999988889999999999999999999998875322110                  0    00001123334557


Q ss_pred             HHHHHHhccccCCCCCCCHHH
Q 014362          342 ALAIAAMCVQEQPNMRPAITD  362 (426)
Q Consensus       342 l~~li~~cl~~dP~~RPs~~e  362 (426)
                      +.+++.+||+.||.+||++.+
T Consensus       205 ~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCCc
Confidence            899999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-37  Score=305.75  Aligned_cols=260  Identities=27%  Similarity=0.382  Sum_probs=215.6

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEee--
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE--  159 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--  159 (426)
                      ++.+...++-|.+...||.|.+|.||+++.+.+++.+|+|+...... .-.++..|+.+|+.+ .|||++.+||+|.-  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34444556778999999999999999999999999999999876533 346678899999887 69999999999853  


Q ss_pred             ---CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          160 ---GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       160 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                         ++++|||||||.+||..++++...  +..+.|..+..|++.++.||.+||..   .++|||||-.||||+.++.|||
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence               578999999999999999999875  67899999999999999999999987   8999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccC-----CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  311 (426)
                      +|||++..+...  .......+|||.|||||++.-.     .|+..+|+||||++..||.-|.+|+....+...+..+. 
T Consensus       165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-  241 (953)
T KOG0587|consen  165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-  241 (953)
T ss_pred             eeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-
Confidence            999999764432  2333456899999999998643     57889999999999999999999998776544332211 


Q ss_pred             hhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                    -.|...-..|.....++.++|..||..|..+||++.++++
T Consensus       242 --------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  242 --------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                          1112222336677889999999999999999999999884

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=296.97  Aligned_cols=244  Identities=24%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCC
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      +.||.|.||+||-|+++.+|+.||||+|.+-.  ......+.+|+.+|+.+.||.||.+-..|+..+..++|||-+.|--
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            56999999999999999999999999998643  3445778999999999999999999999999999999999996544


Q ss_pred             HHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeEecccccccCCCCCCc
Q 014362          175 LDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       175 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~  251 (426)
                      |.-.|..   ..+.|++.....+..||+.||.|||..   +|+|+||||+||||.+.   -++||||||+|++....   
T Consensus       650 LEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---  720 (888)
T KOG4236|consen  650 LEMILSS---EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---  720 (888)
T ss_pred             HHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh---
Confidence            4444443   467899999999999999999999987   99999999999999654   46999999999975433   


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCccc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      .....++|||.|+|||++.+..|+..-||||.|||+|--++|..||....+..  +.+..+..+++. ..          
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFMyPp-~P----------  787 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFMYPP-NP----------  787 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccccCC-Cc----------
Confidence            23445789999999999999999999999999999999999999997654332  223322222211 11          


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         -.+....+++||...|+..-.+|-+....+.
T Consensus       788 ---W~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  788 ---WSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             ---hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence               1233457899999999999999999887653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=301.09  Aligned_cols=241  Identities=27%  Similarity=0.312  Sum_probs=198.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +..|.....+|.|+|+.|..+.+..+++..++|++.+..    .+..+|+.++... .||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999999999999999999998762    2234566555554 69999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee-ccCCceeEecccccccCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll-~~~~~~kl~Dfgla~~~~~  247 (426)
                      .+.|+.|.+.+..     .+.....+..|+.+|+.|+.|||++   |+|||||||+|||+ ++.++++|+|||.++....
T Consensus       397 ~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  397 LLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            9999988877765     2233377888999999999999997   99999999999999 5889999999999986544


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     ....+-|..|.|||++....|++++||||||++||+|++|+.||.........  ...                
T Consensus       469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei--~~~----------------  525 (612)
T KOG0603|consen  469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI--HTR----------------  525 (612)
T ss_pred             h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH--HHh----------------
Confidence            3     22346789999999999999999999999999999999999999876654111  100                


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       ...+.+....+..+.+|+.+||+.||.+||++.++...
T Consensus       526 -i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  526 -IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             -hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence             01111124455688999999999999999999999854

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=277.11  Aligned_cols=249  Identities=26%  Similarity=0.396  Sum_probs=201.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..+|+++.+||+|+|.+|..++++.|.+.+|+|++++.   ..+.++=.+.|..+.... +||++|.+..+|.....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46799999999999999999999999999999998764   233444456677776654 79999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |.||++||+|--++++    ...++++.+..+...|+.||.|||+.   |||+||||.+|||+|..|++||+|+|+++..
T Consensus       329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999877765    46799999999999999999999998   9999999999999999999999999999854


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCch-hhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR-KELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      -..  ...++.++|||.|+|||++.+..|...+|+|+|||+++||+.|+.||+--... ...+.-.+.         +.-
T Consensus       402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl---------fqv  470 (593)
T KOG0695|consen  402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL---------FQV  470 (593)
T ss_pred             CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH---------HHH
Confidence            322  23346689999999999999999999999999999999999999999743211 011111110         011


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCC
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP  358 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  358 (426)
                      ++..  +..+|...+..+..++...|.+||.+|.
T Consensus       471 ilek--qiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  471 ILEK--QIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             Hhhh--cccccceeehhhHHHHHHhhcCCcHHhc
Confidence            1111  1123445555777899999999999996

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-37  Score=295.21  Aligned_cols=218  Identities=25%  Similarity=0.318  Sum_probs=186.6

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEe
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCA  158 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~  158 (426)
                      .+........-|..++.||-|+||+|.++.-.+|...||+|.+++.+.   ..+..++.|-.||.....+-||+||-.|.
T Consensus       620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ  699 (1034)
T KOG0608|consen  620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ  699 (1034)
T ss_pred             HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence            334444455678888999999999999999999999999999987654   34566889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      +.+.+|+||+|++||++-.+|-+    .+.+.+..++.++.++..|+++.|..   |+|||||||+|||||.+|++||+|
T Consensus       700 DkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTD  772 (1034)
T KOG0608|consen  700 DKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD  772 (1034)
T ss_pred             cCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeee
Confidence            99999999999999999998876    46799999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCC---------CCCcc-------------------------------eeeeecccccccCccccccCCCCccC
Q 014362          239 FGLAKMGPS---------GDKTH-------------------------------VSTRVMGTYGYCAPDYAMTGQLTFKS  278 (426)
Q Consensus       239 fgla~~~~~---------~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  278 (426)
                      |||+.-+.-         ++...                               .....+||+.|+|||++....|+..+
T Consensus       773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c  852 (1034)
T KOG0608|consen  773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC  852 (1034)
T ss_pred             ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence            999852111         00000                               00124699999999999999999999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcCchhhh
Q 014362          279 DIYSFGVVLLELITGRKAIDQTKDRKEL  306 (426)
Q Consensus       279 DvwSlG~il~elltg~~p~~~~~~~~~~  306 (426)
                      |+||.|||||||+.|+.||....+....
T Consensus       853 dwws~gvil~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  853 DWWSVGVILYEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             hhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence            9999999999999999999877665544

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=277.55  Aligned_cols=251  Identities=25%  Similarity=0.307  Sum_probs=195.5

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHh-cCCCCCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLG-SADHPNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      +..||.|+||+|++-.++.+|+..|||+|+.... ...+++..|.+... .-+.||||++||++......|+.||.|+ -
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            3459999999999999999999999999987655 44567888887654 4579999999999999899999999996 5


Q ss_pred             CHHHHh---hhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          174 SLDKHL---HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       174 sL~~~l---~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ||+.+.   +..  ....+++..+-.|+...+.||.||...  ..|||||+||+||||+..|.+||||||++-.+.   .
T Consensus       148 SlDklYk~vy~v--q~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv---~  220 (361)
T KOG1006|consen  148 SLDKLYKRVYSV--QKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV---D  220 (361)
T ss_pred             hHHHHHHHHHHH--HhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH---H
Confidence            665433   332  246699999999999999999999875  589999999999999999999999999986432   1


Q ss_pred             cceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCch-hhhcHHHhhhhhhhcccccccccC
Q 014362          251 THVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR-KELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ....+..+|-..|||||.+..  ..|+.+|||||||++|||+.||..|+...... +++..+...     +   .+. +.
T Consensus       221 SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g-----d---pp~-l~  291 (361)
T KOG1006|consen  221 SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG-----D---PPI-LL  291 (361)
T ss_pred             HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC-----C---CCe-ec
Confidence            223345579999999998863  35999999999999999999999999876542 111111111     0   011 11


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ..   .........+..+|..||.+|-..||.+.++.++
T Consensus       292 ~~---~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FD---KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             Cc---ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            00   0112355688999999999999999999998853

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-37  Score=269.26  Aligned_cols=269  Identities=22%  Similarity=0.331  Sum_probs=203.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee--------C
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--------G  160 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------~  160 (426)
                      +.|.-..+||+|.||.||+|+.+.+|+.||+|++-..+.  .--....+|+.+|..|.|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            346666779999999999999999999999987643221  222346789999999999999999988743        2


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ..+|+||.+|+ -+|.-+|.+   ....++..++.+++.++..||.|+|..   .|+|||+|++|+|++.+|.+||+|||
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            34799999997 467777765   346789999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCc--ceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          241 LAKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       241 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      +++.+......  ...+..+.|.+|.+||.+.+. .|+++.|||..|||+.||.||.+.+.+......+.++......+.
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            99865433221  123345679999999998875 799999999999999999999999999888777776653321111


Q ss_pred             -----cccc---ccccc-CCcccCC--------CChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          318 -----DRKN---FSQMV-DPSLQGQ--------YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       318 -----~~~~---~~~~~-~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                           .-.+   +..+- .|-..+.        .|..-..+..+|+..+|..||.+|+++.+++..
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                 1000   01110 1100110        011112378899999999999999999998854

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=8.4e-35  Score=266.65  Aligned_cols=239  Identities=30%  Similarity=0.390  Sum_probs=194.9

Q ss_pred             CcEEEEEEEEcCCCEEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhh
Q 014362          103 GFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD  181 (426)
Q Consensus       103 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  181 (426)
                      +||.||+|.+..+++.+|+|++....... .+.+..|+..++.++|+||+++++++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999889999999998765544 67899999999999999999999999999999999999999999999876


Q ss_pred             hCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccc
Q 014362          182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY  261 (426)
Q Consensus       182 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~  261 (426)
                      .    ..+++..++.++.+++.+|.|||..   +++|+||+|.||+++.++.++|+|||.+.......   ......++.
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~  150 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP  150 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence            2    2389999999999999999999987   99999999999999999999999999998654332   223356889


Q ss_pred             cccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHH
Q 014362          262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQ  341 (426)
Q Consensus       262 ~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (426)
                      .|++||.+.+..++.++||||||+++|+|++|..||.........  ....   .........         ........
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~--~~~~---~~~~~~~~~---------~~~~~~~~  216 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL--FKKI---GKPKPPFPP---------PEWKISPE  216 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHH---hccCCCCcc---------ccccCCHH
Confidence            999999998888999999999999999999999999763221111  1110   000000000         00003457


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 014362          342 ALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       342 l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +.+++.+||..+|.+||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            889999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.7e-35  Score=299.15  Aligned_cols=264  Identities=20%  Similarity=0.205  Sum_probs=172.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCC----CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeE------Ee
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKI----EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY------CA  158 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~  158 (426)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||||++......  +.+..+  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999988    899999998654321  111111  1222223333332222      24


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRP----------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK  222 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk  222 (426)
                      ....+++|+||+.+++|.+++.....                .........+..++.||+.||.|||+.   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            55678999999999999999875210                001112345678999999999999987   99999999


Q ss_pred             CCCeeecc-CCceeEecccccccCCCCCCcceeeeecccccccCccccccC----------------------CCCccCc
Q 014362          223 CSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG----------------------QLTFKSD  279 (426)
Q Consensus       223 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  279 (426)
                      |+|||++. ++.+||+|||+++...... ........+|+.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 5799999999997543322 1223446789999999966432                      2345679


Q ss_pred             hhhHHHHHHHHHhCCCCCCCcCchhhhcH-HHhhhhhhhcccccccccCCcccCC------CChHhHHHHHHHHHhcccc
Q 014362          280 IYSFGVVLLELITGRKAIDQTKDRKELNL-VAWARPMFKDRKNFSQMVDPSLQGQ------YPVRGLYQALAIAAMCVQE  352 (426)
Q Consensus       280 vwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~  352 (426)
                      ||||||+||||+++..++....  ..... +.....   +...+...+.+....+      ..........+|+.+||+.
T Consensus       362 VwSlGviL~el~~~~~~~~~~~--~~~~~~l~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNL--IQFNRQLKRNDY---DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHH--HHHHHHHHhcCC---cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            9999999999999776654211  10000 000000   0000001111110000      0011122456899999999


Q ss_pred             CCCCCCCHHHHHH
Q 014362          353 QPNMRPAITDVVM  365 (426)
Q Consensus       353 dP~~RPs~~eil~  365 (426)
                      ||.+|||+.++++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999996

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=263.81  Aligned_cols=299  Identities=20%  Similarity=0.307  Sum_probs=242.6

Q ss_pred             cCCCCcccchhhhhhhhhhhcccccccccccCCCCcCCCCCcccccccCCCCcccccccCcCCCCCCCCCCCCCCcCHHH
Q 014362            6 CSGKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDE   85 (426)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (426)
                      |++..+.++.|.+.+.+|+.+..+.+++.|..++++.+++++.+.....-+++.+..                       
T Consensus       140 akp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr~~gid~~~lnl~t-----------------------  196 (448)
T KOG0195|consen  140 AKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSRYTGIDVSSLNLIT-----------------------  196 (448)
T ss_pred             hchHHHHHHHHHHHHhCCCCCcccccccccccccccccccccccccCcchhhhhhhh-----------------------
Confidence            566778888999999999999999999999999999999998877765554443322                       


Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEecc--CCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                                  +|.....|..|+|+|.++  .+++|++..  ......++|.+|...|+.+.||||++++|.|..+.++
T Consensus       197 ------------kl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  197 ------------KLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             ------------hhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence                        378888999999999954  455666554  3445567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEec-CCCCCCeeeccCCceeEe--ccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR-DLKCSNILLEEGYHPKLS--DFG  240 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~-Dlkp~NIll~~~~~~kl~--Dfg  240 (426)
                      .+|..||+.|+|+.+|+..  ..-.++..++.+++.+|++|++|||+.  .+++.| .|.+..|++|++.+++|+  |--
T Consensus       263 v~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             eEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccce
Confidence            9999999999999999973  345678899999999999999999998  356665 799999999999998876  433


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCC---ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT---FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      ++...         ......|.||+||.+...+-+   .++|+|||++++|||.|...||....+.+---          
T Consensus       339 fsfqe---------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------  399 (448)
T KOG0195|consen  339 FSFQE---------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------  399 (448)
T ss_pred             eeeec---------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------
Confidence            33211         112457899999999876543   68999999999999999999998766543221          


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                            .+--+.++..+|...+..+..|+.-|+..||.+||.+..|+-.|+..
T Consensus       400 ------kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  400 ------KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ------hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                  12223456667777788899999999999999999999999888764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-35  Score=248.14  Aligned_cols=205  Identities=24%  Similarity=0.300  Sum_probs=171.2

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhc-CCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ....+..||+|++|.|-+-++..+|...|+|.+...- .+..++...|+.+..+ ..+|++|.+||.+.+....++.||.
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~  126 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL  126 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence            3444556999999999999999999999999997642 3445667778877554 5799999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      |+ .||+.+-......+..+++..+-+|+..|+.||.|||+.  ..+||||+||+|||++..|++|+||||++-.+... 
T Consensus       127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-  202 (282)
T KOG0984|consen  127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-  202 (282)
T ss_pred             hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh-
Confidence            96 688777666555678899999999999999999999997  68999999999999999999999999998643221 


Q ss_pred             CcceeeeecccccccCcccccc----CCCCccCchhhHHHHHHHHHhCCCCCCCcCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMT----GQLTFKSDIYSFGVVLLELITGRKAIDQTKD  302 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlG~il~elltg~~p~~~~~~  302 (426)
                        ...+-..|...|||||.+..    ..|+.++||||||++++||.+++.||+....
T Consensus       203 --iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  203 --IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             --hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence              11222468889999998853    3799999999999999999999999986543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=265.19  Aligned_cols=271  Identities=23%  Similarity=0.359  Sum_probs=220.0

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCC-----EEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeE
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGY  156 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~  156 (426)
                      ..++.....+++....+-+|+||.||.|.|...+     +.|-+|.++.. +...+..+..|-..|..+.|||+.++.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3455556678888899999999999999886432     23556666543 33456778899999999999999999998


Q ss_pred             Eee-CCeeEEEEEecCCCCHHHHhhhhC----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC
Q 014362          157 CAE-GDQRLLVYEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG  231 (426)
Q Consensus       157 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~  231 (426)
                      +.. ....+.++.++.-|+|..+|...+    .....++..+...++.|++.|++|||.+   +|||.||...|.++|+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            754 456788899999999999998432    2335678889999999999999999988   99999999999999999


Q ss_pred             CceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHH
Q 014362          232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA  310 (426)
Q Consensus       232 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~  310 (426)
                      .++||+|=.+++-.-..+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+....+.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9999999999985444444333333445678999999999999999999999999999999 899998877766554433


Q ss_pred             hhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .                 ..+-..|..++.++..++.-||...|++||++++++..|..+..+
T Consensus       513 d-----------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  513 D-----------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             c-----------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence            2                 233344778888999999999999999999999999999887654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-33  Score=281.01  Aligned_cols=262  Identities=19%  Similarity=0.235  Sum_probs=181.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEc----------------CCCEEEEEEEeccCCcccHHH--------------HHHH
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLE----------------KIEQVVAIKQLDHRGVQGVRE--------------FSAE  138 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~E  138 (426)
                      ..++|.+.++||+|+||.||+|.+.                ..++.||||.+........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            3568999999999999999999752                235679999987543322222              3346


Q ss_pred             HHHHhcCCCCCc-----ceEeeEEee--------CCeeEEEEEecCCCCHHHHhhhhCC--------------------C
Q 014362          139 VMTLGSADHPNL-----VKLIGYCAE--------GDQRLLVYEYMPLGSLDKHLHDLRP--------------------D  185 (426)
Q Consensus       139 ~~~l~~l~hpni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~  185 (426)
                      +.++.+++|.++     +.++++|..        ....+|||||+++++|.++|+....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777766554     667777653        3467999999999999999874211                    1


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccC
Q 014362          186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA  265 (426)
Q Consensus       186 ~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a  265 (426)
                      ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            12356788999999999999999987   9999999999999999999999999999754322111 1112245889999


Q ss_pred             ccccccCC--------------------C--CccCchhhHHHHHHHHHhCCC-CCCCcCchhh------hcHHHhhhhhh
Q 014362          266 PDYAMTGQ--------------------L--TFKSDIYSFGVVLLELITGRK-AIDQTKDRKE------LNLVAWARPMF  316 (426)
Q Consensus       266 PE~~~~~~--------------------~--~~~~DvwSlG~il~elltg~~-p~~~~~~~~~------~~~~~~~~~~~  316 (426)
                      ||.+....                    +  ..+.||||+||++|+|++|.. ||........      .....|.  ..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MY  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hh
Confidence            99876432                    1  134799999999999999875 6653221110      0001110  00


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQP---NMRPAITDVVM  365 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~  365 (426)
                      ..         ....-...........+|+.++|..+|   .+|+|+.|+++
T Consensus       457 ~~---------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KG---------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cc---------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00         000001122334578899999999766   68999999985

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-33  Score=263.57  Aligned_cols=146  Identities=23%  Similarity=0.268  Sum_probs=120.6

Q ss_pred             CCCCcCHHHHHHhc-CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-----C---
Q 014362           77 SAKPFTFDELAAAT-GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----H---  147 (426)
Q Consensus        77 ~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----h---  147 (426)
                      ....-++....... ++|.+.++||.|.|++||+|.+..+.+.||+|+.+... .-.+....|+.+|+.++     |   
T Consensus        63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~  141 (590)
T KOG1290|consen   63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGK  141 (590)
T ss_pred             cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence            33444444444445 89999999999999999999999999999999986542 22445678999998873     3   


Q ss_pred             CCcceEeeEEee----CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 014362          148 PNLVKLIGYCAE----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC  223 (426)
Q Consensus       148 pniv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp  223 (426)
                      ..||+|++.|..    +.++|+|+|++ |-+|..+|..  ...+.++...++.|+.||+.||.|||..|  +|||-||||
T Consensus       142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP  216 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP  216 (590)
T ss_pred             ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence            369999999964    46899999999 7788888876  35677999999999999999999999985  999999999


Q ss_pred             CCeee
Q 014362          224 SNILL  228 (426)
Q Consensus       224 ~NIll  228 (426)
                      +|||+
T Consensus       217 ENvLl  221 (590)
T KOG1290|consen  217 ENVLL  221 (590)
T ss_pred             ceeee
Confidence            99999

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-35  Score=284.01  Aligned_cols=254  Identities=24%  Similarity=0.319  Sum_probs=212.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|.+...+|.|+||.||+++++.+++..|+|+++........-+..|+.+++..+|||||.++|.+...+.+|+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45799999999999999999999999999999999987777788889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      |.+|+|.+.-+-    ..++++.++...++..++||+|||+.   +-+|||||-.|||+++.|.+|++|||.+-...  .
T Consensus        94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit--a  164 (829)
T KOG0576|consen   94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT--A  164 (829)
T ss_pred             cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh--h
Confidence            999999887664    67899999999999999999999998   88999999999999999999999999975321  2


Q ss_pred             CcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .......+.||+.|||||+..   .+.|...+|||++|+...|+---++|.....+...+.+...            ..+
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk------------S~~  232 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK------------SGF  232 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc------------cCC
Confidence            223334578999999999764   67899999999999999999988888765555444333331            112


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ++.-.. -+......+.+|++.||..+|.+||+++.++.
T Consensus       233 qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  233 QPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            222111 13445567889999999999999999998764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.1e-34  Score=272.86  Aligned_cols=277  Identities=21%  Similarity=0.221  Sum_probs=218.0

Q ss_pred             CCcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC------CCCcce
Q 014362           79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD------HPNLVK  152 (426)
Q Consensus        79 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~  152 (426)
                      .+|.+.-.+...++|.+....|+|-|++|.+|.+..-|..||||+|.+.... .+.=+.|+++|++|.      --++++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            4556666677788999999999999999999999988999999999876433 344567999999985      347999


Q ss_pred             EeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-
Q 014362          153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-  231 (426)
Q Consensus       153 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-  231 (426)
                      |+-.|...+++|||+|.+ ..+|.++|+.+.. ...|....+..++.|++.||..|-..   +|+|.||||+||||++. 
T Consensus       499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            999999999999999998 4799999988653 45688899999999999999999987   99999999999999976 


Q ss_pred             CceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHh
Q 014362          232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       232 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  311 (426)
                      ..+||||||.|........    +.+..+..|.|||++.+-+|+...|+||.||+||||.||+..|.+.....++.+...
T Consensus       574 ~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            4579999999975433221    223457789999999999999999999999999999999999998887766655543


Q ss_pred             hhhhhhc-----ccccccccC--------------------------C------cccC--CCCh---HhHHHHHHHHHhc
Q 014362          312 ARPMFKD-----RKNFSQMVD--------------------------P------SLQG--QYPV---RGLYQALAIAAMC  349 (426)
Q Consensus       312 ~~~~~~~-----~~~~~~~~~--------------------------~------~~~~--~~~~---~~~~~l~~li~~c  349 (426)
                      ....++.     ..-..+.+|                          |      .+..  .+|.   .....+.+|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            3322221     110111111                          1      0111  1222   3345789999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 014362          350 VQEQPNMRPAITDVVM  365 (426)
Q Consensus       350 l~~dP~~RPs~~eil~  365 (426)
                      |..||++|.+..++|.
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=257.70  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=203.1

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-----eeEEE
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-----QRLLV  166 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~lv  166 (426)
                      +..+.||.|+||.||.+.+..+|+.||+|++..-  +....+.+.+|+.+|..++|.|++..+++..-..     .+|+|
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3445699999999999999999999999998653  2334567899999999999999999988765432     35677


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      .|.|. .+|...+-    ....++.+.++-+..||++||.|||+.   +|.||||||.|+|++.+..+||||||+++...
T Consensus       136 TELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            78774 45555443    467899999999999999999999998   99999999999999999999999999999754


Q ss_pred             CCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh--cc----
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK--DR----  319 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~----  319 (426)
                      .. ....++..+.|..|.|||++++. .|+.+.||||.|||+.||+..+..|....+...+.++........  ..    
T Consensus       208 ~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            43 33445556789999999999976 699999999999999999999999998888888877754321100  00    


Q ss_pred             -cccccccC-----CcccC----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          320 -KNFSQMVD-----PSLQG----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       320 -~~~~~~~~-----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                       +.-..++.     |.+..    .-+.....+.+.+...+|..||+.|.+.++.+..+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence             00000010     00000    11223344678889999999999999999887543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=281.86  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=188.5

Q ss_pred             ccccceeeecCcEE-EEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEec
Q 014362           93 FRSDCCLGEGGFGK-VYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        93 y~~~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      |...+++|.|+.|+ ||+|...  |+.||||.+-..   -..-..+|+..|+.- .|||||++|+.-.+....||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            34445699999886 9999998  789999988543   233467899999887 5999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---C--CceeEecccccccC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---G--YHPKLSDFGLAKMG  245 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~--~~~kl~Dfgla~~~  245 (426)
                      . .+|.+++...............+.+..|++.||++||+.   +||||||||.||||+.   +  ..++|+|||+++..
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            5 799999976311111111145678899999999999998   9999999999999976   2  56899999999876


Q ss_pred             CCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          246 PSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       246 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ..+... .......||-+|+|||++....-+.++|||||||++|+.++| .+||...-.++. +.+       .....+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl-------~~~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL-------TGNYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh-------cCcccee
Confidence            544322 223456799999999999999989999999999999999996 899975443321 111       1111111


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+..       ...+  ++.+||.+|+.++|..||++.+|+.
T Consensus       734 ~L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 HLEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            1110       1111  7889999999999999999999983

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=268.29  Aligned_cols=200  Identities=24%  Similarity=0.329  Sum_probs=174.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------ccHHHHHHHHHHHhcCC---CCCcceEeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSAD---HPNLVKLIGYC  157 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~---hpniv~~~~~~  157 (426)
                      ...+|...+.+|.|+||.|+.|.++.+...|+||.|.+...        ...-.+-.|+.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            34569999999999999999999999999999999876532        11223567999999997   99999999999


Q ss_pred             eeCCeeEEEEEec-CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          158 AEGDQRLLVYEYM-PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       158 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      ++++.+||+||.- +|-+|.+++..    ...+++.++..|+.||+.|+++||+.   +|||||||-+||.++.+|-+||
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence            9999999999986 56788998875    57799999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCC
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQ  299 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~  299 (426)
                      +|||.+-....+    ....++||..|.|||++.+.+| +..-|||++|++||-++....||..
T Consensus       712 idfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  712 IDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999998654332    2345689999999999998887 5778999999999999999999863

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=1.3e-32  Score=236.46  Aligned_cols=261  Identities=16%  Similarity=0.256  Sum_probs=198.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCC--eeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD--QRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~~~l  165 (426)
                      ..++|++.+++|+|-|+.||.|....+++.++||+++.-   ..+.+.+|+.+|..|+ ||||+++++...++.  ...|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            346899999999999999999999888999999999753   3466889999999997 999999999987653  4679


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEeccccccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAKM  244 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~~  244 (426)
                      |+||+.+.+...+.       ..++...+..++.+++.||.|+|+.   ||+|||+||.|+++|.. -.++|+|+|+|..
T Consensus       113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence            99999987776554       3477778899999999999999998   99999999999999964 5699999999987


Q ss_pred             CCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCC-cCchhhhcHHHhhhh--------
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQ-TKDRKELNLVAWARP--------  314 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~-~~~~~~~~~~~~~~~--------  314 (426)
                      ...+....+   .+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||.. .+..+++-.+.....        
T Consensus       183 YHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  183 YHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             cCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            655544332   256778999998875 4689999999999999999999999854 333333322221100        


Q ss_pred             ---hhhcccccccccCCcccC--------CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          315 ---MFKDRKNFSQMVDPSLQG--------QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       315 ---~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         .+.-...+..++....+.        +-..-...++++|+...|..|-.+|||+.|.+.
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence               000001111111111111        111122458899999999999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.2e-32  Score=240.51  Aligned_cols=254  Identities=20%  Similarity=0.271  Sum_probs=191.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEee-EEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIG-YCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~-~~~~~~~~~lv~e  168 (426)
                      +.|.+.+.||.|.||.+-++.++++...+++|.+... ....++|.+|..---.| .|.||+.-|+ .|+..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            5689999999999999999999999999999998754 33467899988664445 4899998775 5777888999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--CCceeEecccccccCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGP  246 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~  246 (426)
                      |++.|+|...+..     ..+.+.....++.|++.||.|+|+.   ++||||||.+||||-.  ...+||||||+.+...
T Consensus       103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999888754     5688999999999999999999987   9999999999999942  3479999999987533


Q ss_pred             CCCCcceeeeecccccccCccccccC-----CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-----QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ..-.     ..-.+..|.+||.....     ...+.+|||.||+++|.++||+.||...... ....+.|....-.....
T Consensus       175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHhcccCcc
Confidence            2211     12346679999976532     3568899999999999999999999843322 22222222211111111


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      .+..+.         ..+..+..+.++-|..+|.+|--+.++.++..
T Consensus       249 ~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  249 LPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             Cchhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            111111         23447888999999999999966666665543

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=3.7e-31  Score=236.57  Aligned_cols=211  Identities=36%  Similarity=0.529  Sum_probs=184.8

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDK  177 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~  177 (426)
                      ||.|++|.||++....+++.+++|.+...... ....+.+|+..++.+.|++|+++++++......++++||+++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999999865433 35678999999999999999999999999899999999999999999


Q ss_pred             HhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccCCCCCCcceeee
Q 014362          178 HLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDKTHVSTR  256 (426)
Q Consensus       178 ~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~  256 (426)
                      ++...   ...+++..++.++.+++.+|.+||+.   +++|+||+|.||+++. ++.++|+|||.+........  ....
T Consensus        81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (215)
T cd00180          81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT  152 (215)
T ss_pred             HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence            98762   14689999999999999999999987   9999999999999999 89999999999976433221  1223


Q ss_pred             ecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCC
Q 014362          257 VMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP  335 (426)
Q Consensus       257 ~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (426)
                      ..+...|++||.+... .++.+.|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4678899999998877 888999999999999999                                             


Q ss_pred             hHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          336 VRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       336 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                256789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=8e-33  Score=248.71  Aligned_cols=262  Identities=23%  Similarity=0.253  Sum_probs=202.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      ..+|..++.+|.|.- .|..|.+.-.+++||+|++...  .....++..+|+..+..+.|+||++++.+|.-..      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            457888888999988 7888889888999999997643  2345677889999999999999999999985443      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      ..|+|||+|. .+|.+.++.      .++-..+..|+.|++.|+.|||+.   +|+||||||+||++..++.+||.|||+
T Consensus        95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence            4689999995 788887763      377788999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh--------
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR--------  313 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------  313 (426)
                      |+..   +.....+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+..-.+....+....        
T Consensus       165 ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  165 ARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            9853   22345566789999999999999999999999999999999999999998665443333322110        


Q ss_pred             -hhhhcc------------cccccccCCcc-cC--CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          314 -PMFKDR------------KNFSQMVDPSL-QG--QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       314 -~~~~~~------------~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .+.+..            .++.+.+...+ ..  +.+......+.+++.+||-.+|++|-++.++|+
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence             000000            11222221111 10  011122336788999999999999999999985

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1e-30  Score=237.18  Aligned_cols=200  Identities=33%  Similarity=0.400  Sum_probs=175.0

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      |++...||.|++|.||+|.+..+++.+|+|.+...... ....+..|+..++.++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56678899999999999999988999999999876554 67789999999999999999999999999899999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT  251 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  251 (426)
                      +++|.+++....   ..+++..++.++.+++.+|.|||+.   +++|+||+|.||+++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-  153 (225)
T smart00221       81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-  153 (225)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence            999999987632   1288999999999999999999987   999999999999999999999999999986543321 


Q ss_pred             ceeeeecccccccCcccc-ccCCCCccCchhhHHHHHHHHHhCCCCCCC
Q 014362          252 HVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELITGRKAIDQ  299 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltg~~p~~~  299 (426)
                      .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122334678899999998 666788899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.7e-30  Score=241.83  Aligned_cols=267  Identities=23%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcC---CCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCe
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  162 (426)
                      ....+.|.++++||.|+|++||+|.+..   ....||+|.+...+  ....+..|+++|..+. +.||+++.+++..+++
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3355679999999999999999999876   68899999997654  3366889999999985 9999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGL  241 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgl  241 (426)
                      ..+|+||++.-...+++..       ++...+..+++.++.||.++|..   |||||||||.|+|.+. .+.-.|+|||+
T Consensus       110 v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechh
Confidence            9999999999888888754       67889999999999999999987   9999999999999985 46678999999


Q ss_pred             cccC-----------------CC--CC-----------------------CcceeeeecccccccCccccccC-CCCccC
Q 014362          242 AKMG-----------------PS--GD-----------------------KTHVSTRVMGTYGYCAPDYAMTG-QLTFKS  278 (426)
Q Consensus       242 a~~~-----------------~~--~~-----------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  278 (426)
                      |...                 ..  +.                       .........||++|.|||++... ..+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            9610                 00  00                       00001124699999999998764 578999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCcCchh--hhcHHHhhh------------h-hhhcccc----------ccccc-CCcc--
Q 014362          279 DIYSFGVVLLELITGRKAIDQTKDRK--ELNLVAWAR------------P-MFKDRKN----------FSQMV-DPSL--  330 (426)
Q Consensus       279 DvwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~------------~-~~~~~~~----------~~~~~-~~~~--  330 (426)
                      ||||.|||+..+++++.||.......  .........            . .+....+          +..+. ....  
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            99999999999999999996543221  111111110            0 0000000          11110 0000  


Q ss_pred             ------cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 ------QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                            ........+..+++|+.+||+.||.+|.++++.|+
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                  01111223347899999999999999999999985

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1.3e-29  Score=271.27  Aligned_cols=196  Identities=16%  Similarity=0.242  Sum_probs=140.5

Q ss_pred             cCCC-CCcceEeeEE-------eeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC
Q 014362          144 SADH-PNLVKLIGYC-------AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP  215 (426)
Q Consensus       144 ~l~h-pniv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~  215 (426)
                      .++| +||+.++++|       .....+++++||+ +++|.++|..   ....+++..++.++.||+.||.|||+.   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4556 6888888877       2334567888988 5799999975   245699999999999999999999987   9


Q ss_pred             eEecCCCCCCeeecc-------------------CCceeEecccccccCCCCCC--------------cceeeeeccccc
Q 014362          216 VIYRDLKCSNILLEE-------------------GYHPKLSDFGLAKMGPSGDK--------------THVSTRVMGTYG  262 (426)
Q Consensus       216 iiH~Dlkp~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~  262 (426)
                      |+||||||+||||+.                   ++.+||+|||+++.......              ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   44566667776653211000              000112468999


Q ss_pred             ccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHH
Q 014362          263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQA  342 (426)
Q Consensus       263 y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  342 (426)
                      |||||++.+..++.++|||||||+||||++|.+|+......  ...+.  ..          .+.+..     .......
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~--~~~~~--~~----------~~~~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT--MSSLR--HR----------VLPPQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH--HHHHH--Hh----------hcChhh-----hhcCHHH
Confidence            99999999999999999999999999999998887532110  00000  00          011100     1112345


Q ss_pred             HHHHHhccccCCCCCCCHHHHHH
Q 014362          343 LAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       343 ~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..++.+||+.+|.+||++.+|++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhh
Confidence            68889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7.2e-28  Score=210.88  Aligned_cols=169  Identities=23%  Similarity=0.206  Sum_probs=127.6

Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      |+|.+++..   ....+++..++.++.||+.||.|||+.   +      ||+|||++.++.+|+  ||+++.....    
T Consensus         1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~----   62 (176)
T smart00750        1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE----   62 (176)
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence            789999975   245699999999999999999999987   4      999999999999999  9998764322    


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                         ...||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........        ..+.. .
T Consensus        63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~--------~~~~~-~  129 (176)
T smart00750       63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPA--------DDPRD-R  129 (176)
T ss_pred             ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhcc--------CCccc-c
Confidence               126899999999999999999999999999999999999999654322111 0011000000        00000 0


Q ss_pred             CCChHhHH--HHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          333 QYPVRGLY--QALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       333 ~~~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ..+.....  .+.+++.+||..+|.+||++.++++.+..+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            11222222  68999999999999999999999998876643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-26  Score=218.07  Aligned_cols=264  Identities=19%  Similarity=0.176  Sum_probs=199.8

Q ss_pred             CccccceeeecCcEEEEEEEEcCCC-EEEEEEEeccCCcccHHHHHHHHHHHhcCCC----CCcceEeeEE-eeCCeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVMTLGSADH----PNLVKLIGYC-AEGDQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~~~~~~-~~~~~~~l  165 (426)
                      +|.+.+.||+|+||.||.+.....+ ..+|+|............+..|..++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999988764 6788888765433322367788888888863    5899999988 47778899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-----CceeEeccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-----YHPKLSDFG  240 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfg  240 (426)
                      ||+.+ |.+|.++.....  ...++..++..++.|++.+|.+||+.   |++||||||+|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99988 889999876532  57799999999999999999999998   99999999999999865     468999999


Q ss_pred             ccc--cCCCCCCc-----ce-eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          241 LAK--MGPSGDKT-----HV-STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       241 la~--~~~~~~~~-----~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      +++  ........     .. .....||..|+++....+...+.+.|+||++.++.|++.|..||...............
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  32111111     01 22356999999999999999999999999999999999999999765543222111111


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      ....        ....     .....+..+..+...+-..+...+|....+...|.......
T Consensus       253 ~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  253 PRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            0000        0000     11222335556666666689999999999999988776544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=5.9e-27  Score=224.88  Aligned_cols=182  Identities=19%  Similarity=0.153  Sum_probs=138.1

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcC-CCEEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCCCcce-Ee
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVK-LI  154 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~-~~  154 (426)
                      +-+......++|.+...||+|+||+||+|.+.. ++..||||++...     .......+.+|+.+|+.++|+||++ ++
T Consensus         9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188          9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            334445667889999999999999999999876 6888899987533     1123456899999999999999985 44


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCCeeeccCCc
Q 014362          155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL-KCSNILLEEGYH  233 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~  233 (426)
                      ++    ...|+||||++|++|.. +..       ..   ...++.+++.||.|||+.   +|+|||| ||+|||++.++.
T Consensus        89 ~~----~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~  150 (365)
T PRK09188         89 AT----GKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE  150 (365)
T ss_pred             Ec----CCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence            32    45799999999999962 211       11   146789999999999997   9999999 999999999999


Q ss_pred             eeEecccccccCCCCCCcce------eeeecccccccCccccccCC------CCccCchh
Q 014362          234 PKLSDFGLAKMGPSGDKTHV------STRVMGTYGYCAPDYAMTGQ------LTFKSDIY  281 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~------~~~~~Dvw  281 (426)
                      +||+|||+|+..........      -+...+++.|+|||++....      .+..+|-|
T Consensus       151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999999986543321111      13457889999999886432      23446666

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-25  Score=199.85  Aligned_cols=206  Identities=22%  Similarity=0.299  Sum_probs=176.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..-+|+++++||.|+||..+.|+..-++++||||.-...+  ...++..|+...+.|. .++|..+|-|...+.+..||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            4457999999999999999999999999999999865543  3356778888888875 799999999999998999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-----CceeEeccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-----YHPKLSDFGLA  242 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-----~~~kl~Dfgla  242 (426)
                      |.+ |.||++++.-   .+..++..++..+|.|++.-++|+|++   .+|+|||||+|+||...     ..+.|+|||+|
T Consensus       104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            998 7899988765   367899999999999999999999997   99999999999999753     35899999999


Q ss_pred             ccCCCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCch
Q 014362          243 KMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR  303 (426)
Q Consensus       243 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~  303 (426)
                      +........     .......||.+||+--...+...+.+.|+-|||-++++.+-|..||.+....
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            865544322     2223467999999999999999999999999999999999999999987643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=3.2e-24  Score=204.40  Aligned_cols=258  Identities=31%  Similarity=0.445  Sum_probs=198.7

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCC-CcceEeeEEeeCCeeEEEEE
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---GVREFSAEVMTLGSADHP-NLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~lv~e  168 (426)
                      |.+...||.|+||.||.+.+.   ..+++|.+......   ....+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            677888999999999999988   67899998765433   367799999999999988 79999999987777899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEecccccccCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGPS  247 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~  247 (426)
                      ++.++++..++...... ..+.......++.|++.++.|+|..   +++|||+||+||+++..+ .++++|||+++....
T Consensus        79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~  154 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD  154 (384)
T ss_pred             cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence            99999999766542111 3689999999999999999999998   899999999999999988 799999999975433


Q ss_pred             CCCcc----eeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCch----hhhcHHHhhhhhh
Q 014362          248 GDKTH----VSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR----KELNLVAWARPMF  316 (426)
Q Consensus       248 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~----~~~~~~~~~~~~~  316 (426)
                      .....    ......||..|+|||.+.+   ..++...|+||+|++++++++|..||......    .....+...    
T Consensus       155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----  230 (384)
T COG0515         155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----  230 (384)
T ss_pred             CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----
Confidence            32221    2345689999999999987   57889999999999999999999997665431    111111100    


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        ...   ..........+......+.+++..|+..+|..|.+..+....
T Consensus       231 --~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 --PTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --CCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000   000011111112223467889999999999999999987764

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-25  Score=191.61  Aligned_cols=265  Identities=20%  Similarity=0.227  Sum_probs=199.2

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC-CCcceEeeEEeeCCeeEEE
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv  166 (426)
                      ...+.|.++++||.|+||.+|.|....+|..||||.-....  ...++..|..+.+.|++ ..|..+..++.+..+..+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            34678999999999999999999999999999999875432  23557788888888875 6788888888888899999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeEecccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~  243 (426)
                      |+.+ |.||.+++.-   ....++..+++.++.|++.-++|+|..   +.|||||||+|+|..-+   ..+.|+|||+|+
T Consensus        90 MdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            9998 7899988765   346799999999999999999999987   99999999999999643   468999999998


Q ss_pred             cCCCCCC-----cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          244 MGPSGDK-----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       244 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ...+...     ........||.+|.+--...+-..+.+.|+-|+|.+|....-|..||.+.........-...    .+
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI----~E  238 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI----SE  238 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH----HH
Confidence            6443221     12224568999999988877888899999999999999999999999987643322111110    00


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      . ... ..-..+...+|.    ++.-.+.-|=..--++-|...-+-+.+..+.
T Consensus       239 k-K~s-~~ie~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf  285 (341)
T KOG1163|consen  239 K-KMS-TPIEVLCKGFPA----EFAMYLNYCRGLGFEEKPDYMYLRQLFRILF  285 (341)
T ss_pred             h-hcC-CCHHHHhCCCcH----HHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence            0 000 000112222333    4555666777777778888777776665553

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=3.7e-26  Score=233.23  Aligned_cols=253  Identities=22%  Similarity=0.249  Sum_probs=190.9

Q ss_pred             ccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--Cccc----HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQG----VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        95 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ....+|.|++|.|+..........++.|.+...  ....    ...+..|+.+-..+.|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            456699999998888877665665666654311  1111    1225667778888999999988887777666666699


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ||++ +|..++..    ...+....+..++.|++.|+.|||+.   ||.|||||++|++++.+|.+||+|||.+..+..+
T Consensus       402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9998 99988865    34688889999999999999999998   9999999999999999999999999999866555


Q ss_pred             CCc--ceeeeecccccccCccccccCCCCc-cCchhhHHHHHHHHHhCCCCCCCcCchhhhc-HHHhhhhhhhccccccc
Q 014362          249 DKT--HVSTRVMGTYGYCAPDYAMTGQLTF-KSDIYSFGVVLLELITGRKAIDQTKDRKELN-LVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       249 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  324 (426)
                      ...  ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+... .....     .   ...
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~-----~---~~~  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS-----D---QRN  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc-----c---ccc
Confidence            444  5556789999999999999999984 6799999999999999999997655443321 00000     0   000


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...  -........+...+.++.++|+.+|.+|.++++|++
T Consensus       546 ~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  546 IFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            000  000011223446788999999999999999999995

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=1.1e-23  Score=188.70  Aligned_cols=172  Identities=12%  Similarity=0.110  Sum_probs=134.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHH---H------HHHHHHHHhcCCCCCcceEeeEEee
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR---E------FSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~------~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      ..++|++.+.||.|+||.||.+..  ++..+|||.+.........   .      +.+|+..+.++.||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            568999999999999999999655  3668999999754333222   2      5789999999999999999988664


Q ss_pred             C--------CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC
Q 014362          160 G--------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG  231 (426)
Q Consensus       160 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~  231 (426)
                      .        ...+|||||++|.+|.++..        ++.    ....+|+.+|..||..   +++|||++|+||+++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            3        34789999999999977631        222    2456999999999987   99999999999999998


Q ss_pred             CceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh
Q 014362          232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT  292 (426)
Q Consensus       232 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt  292 (426)
                      | ++|+|||...........              ..++....|+.++|+||||+++..+..
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            8 999999987643211100              114556667889999999999886653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=4.1e-23  Score=182.51  Aligned_cols=138  Identities=14%  Similarity=0.091  Sum_probs=107.2

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--c-------HH-----------------HHHHHHHHHhcCCCCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--G-------VR-----------------EFSAEVMTLGSADHPN  149 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~hpn  149 (426)
                      ...||+|+||.||+|.+. +|+.||||++......  .       ..                 ....|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            356999999999999987 7999999999754211  0       11                 1234899999998877


Q ss_pred             cceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCCCeEecCCCCCCeee
Q 014362          150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL-HEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       150 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiH~Dlkp~NIll  228 (426)
                      +.....+...  ..+|||||++|+++...+..    ...+++..+..++.|++.+|.|| |+.   +|+||||||+|||+
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            6443332222  24899999998877544322    35689999999999999999999 676   99999999999999


Q ss_pred             ccCCceeEeccccccc
Q 014362          229 EEGYHPKLSDFGLAKM  244 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~  244 (426)
                      + ++.++|+|||+|..
T Consensus       152 ~-~~~v~LiDFG~a~~  166 (190)
T cd05147         152 H-DGKLYIIDVSQSVE  166 (190)
T ss_pred             E-CCcEEEEEcccccc
Confidence            8 47899999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.9e-24  Score=209.20  Aligned_cols=225  Identities=26%  Similarity=0.320  Sum_probs=181.7

Q ss_pred             eeecCcEEEEEEEE---cCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           99 LGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        99 lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      +|.|+||.|++++-   ...|..+|+|.+.+....  .......|..++...+ ||.+|.+...+.....++++++|..|
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            78999999998643   345778999988765332  1124556777888887 99999999999999999999999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      |.|...+..    ...+++.....+...++-|++++|..   +|+|||+|++||+++.+|.+++.|||+++........ 
T Consensus        82 g~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   82 GDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             chhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999887765    46678888888999999999999998   9999999999999999999999999999864332221 


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG  332 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (426)
                           +||..|||||++.  ....++|.||||++++||+||..||..    +....+..                  ..-
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~------------------~~~  204 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK------------------AEL  204 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh------------------hcc
Confidence                 8999999999987  678899999999999999999999986    11111111                  011


Q ss_pred             CCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          333 QYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       333 ~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                      ..|......+.+++..++..+|..|...
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2355666678889999999999999765

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=4.9e-22  Score=176.13  Aligned_cols=138  Identities=17%  Similarity=0.147  Sum_probs=109.7

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc--------------------------HHHHHHHHHHHhcCCCCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--------------------------VREFSAEVMTLGSADHPN  149 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~hpn  149 (426)
                      ...||+|+||.||+|.+. +|+.||||++.......                          ...+..|...+..+.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            456999999999999987 79999999987642110                          112357889999999998


Q ss_pred             cceEeeEEeeCCeeEEEEEecCCCCHHHH-hhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCee
Q 014362          150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKH-LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       150 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIl  227 (426)
                      |.....+...  ..+|||||++|+++... +..     ..++...+..++.|++.+|.+||+ .   +|+||||||+|||
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence            7544443332  24899999998865433 332     457888999999999999999998 6   9999999999999


Q ss_pred             eccCCceeEecccccccC
Q 014362          228 LEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~~~  245 (426)
                      ++ ++.++|+|||++...
T Consensus       151 l~-~~~~~liDFG~a~~~  167 (190)
T cd05145         151 YH-DGKPYIIDVSQAVEL  167 (190)
T ss_pred             EE-CCCEEEEEcccceec
Confidence            99 789999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=5.6e-22  Score=182.85  Aligned_cols=234  Identities=18%  Similarity=0.230  Sum_probs=151.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCC-----------CCcceEee---
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADH-----------PNLVKLIG---  155 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~h-----------pniv~~~~---  155 (426)
                      +.....||.|+++.||.+++..|++.+|+|++....   ....+.+.+|......+.+           ..++++--   
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            455677999999999999999999999999975432   2346667777655555433           12222211   


Q ss_pred             -----EEeeC---C-----eeEEEEEecCCCCHHHHhhh---hCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 014362          156 -----YCAEG---D-----QRLLVYEYMPLGSLDKHLHD---LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR  219 (426)
Q Consensus       156 -----~~~~~---~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~  219 (426)
                           ++...   .     ..+++|+-+ -++|..++.-   .......+.......+..|+++.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                 11111   1     236778877 4688776542   221222344556677889999999999998   99999


Q ss_pred             CCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccC--------CCCccCchhhHHHHHHHHH
Q 014362          220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG--------QLTFKSDIYSFGVVLLELI  291 (426)
Q Consensus       220 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlG~il~ell  291 (426)
                      ||+|+|++++.+|.+.|+||+.......    .... ...+..|.+||.....        .++.+.|.|+||+++|.|.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999998764221    1111 2456789999976432        4788999999999999999


Q ss_pred             hCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCC
Q 014362          292 TGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMR  357 (426)
Q Consensus       292 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  357 (426)
                      +|..||...........                     .-..+. ..+..+..||..+|+.+|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999986543221110                     111333 455678899999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=5.2e-23  Score=210.90  Aligned_cols=248  Identities=21%  Similarity=0.200  Sum_probs=179.1

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHH--HhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMT--LGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|...+.||.+.|=+|.+|++.. |. |+||++-+... -..+.|.++++-  ...++|||.+++.-+-.....-|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            67777889999999999999875 54 88999876653 334444443333  556789999999888777777888888


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC--
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP--  246 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~--  246 (426)
                      |.. -+|++.|..    ...+...+.+.|+.|++.||.-+|..   +|+|||||.+||||+.-.-+.|+||..-+..-  
T Consensus       102 yvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            884 477776643    56678889999999999999999988   99999999999999999899999998776322  


Q ss_pred             CCCCcce---eeeecccccccCccccccC----------C-CCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHh
Q 014362          247 SGDKTHV---STRVMGTYGYCAPDYAMTG----------Q-LTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       247 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~-~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~  311 (426)
                      .+.....   ......-.+|+|||.+...          . .+++.||||+||+++||++ |++||....      +..+
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aY  247 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAY  247 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhH
Confidence            2211111   1111223479999988642          1 5789999999999999998 678885321      2222


Q ss_pred             hhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ....    ....+.+-..+.       ...+++|+..|++.||..|.++++.|+.
T Consensus       248 r~~~----~~~~e~~Le~Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  248 RSGN----ADDPEQLLEKIE-------DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             hccC----ccCHHHHHHhCc-------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1110    000111111111       1156889999999999999999999986

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.3e-21  Score=171.68  Aligned_cols=188  Identities=20%  Similarity=0.161  Sum_probs=139.7

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc----cHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEE
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ----GVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .+...|++|+||+||.+..  .+..++.+.+.....-    ....+.+|+.+|++|. |++|++++++    ...+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3456799999999997765  3777887777654331    1225789999999995 5889999886    34689999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCC-CCCCeeeccCCceeEecccccccCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL-KCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl-kp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |+.|.+|...+..           ....++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|||++.....
T Consensus        79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            9999998654321           1135788999999999998   9999999 79999999999999999999985443


Q ss_pred             CCCc---ce--------eeeecccccccCccccccC-CCC-ccCchhhHHHHHHHHHhCCCCCCCcC
Q 014362          248 GDKT---HV--------STRVMGTYGYCAPDYAMTG-QLT-FKSDIYSFGVVLLELITGRKAIDQTK  301 (426)
Q Consensus       248 ~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DvwSlG~il~elltg~~p~~~~~  301 (426)
                      ....   ..        .....+++.|++|+...-- ..+ ...++++.|.-+|.++|+..+.....
T Consensus       145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            3210   00        0112367888888754321 233 66789999999999999998875543

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=8e-22  Score=192.94  Aligned_cols=218  Identities=28%  Similarity=0.420  Sum_probs=164.3

Q ss_pred             HhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCe-EecC
Q 014362          142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV-IYRD  220 (426)
Q Consensus       142 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i-iH~D  220 (426)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+..   ....+++.....+.++|+.||.|||+.   +| .|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeee
Confidence            4578999999999999999999999999999999999986   467799999999999999999999986   44 9999


Q ss_pred             CCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCC-------CCccCchhhHHHHHHHHHhC
Q 014362          221 LKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-------LTFKSDIYSFGVVLLELITG  293 (426)
Q Consensus       221 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlG~il~elltg  293 (426)
                      |++.|.++|....+||+|||+.................-..-|.|||.+....       .+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            99999999999999999999987653211111111122345699999887641       46789999999999999999


Q ss_pred             CCCCCCcCchhhh-cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          294 RKAIDQTKDRKEL-NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       294 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ..||......... ..+.....      .....+.|.+....  .....+..++..||..+|..||++..|-..+..+..
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9999874433221 12221111      01111222221111  333378999999999999999999999988876654


Q ss_pred             C
Q 014362          373 Q  373 (426)
Q Consensus       373 ~  373 (426)
                      .
T Consensus       227 ~  227 (484)
T KOG1023|consen  227 G  227 (484)
T ss_pred             c
Confidence            3

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=8.2e-23  Score=196.32  Aligned_cols=173  Identities=22%  Similarity=0.375  Sum_probs=129.0

Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +||.|++|.-.+|.++|...+ .....++.....++.|++.|+.|   .   +.+|+|+||.||+...+..+||.|||+.
T Consensus       331 lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578899999999999997533 34567888999999999999999   4   8999999999999999999999999998


Q ss_pred             ccCCCCC----CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          243 KMGPSGD----KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       243 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      .......    .....+...||..||+||.+.+..|+.++||||||+||+||++ -..+++........           
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~-----------  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDI-----------  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhh-----------
Confidence            7544333    1223455689999999999999999999999999999999998 33333221111000           


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHH
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITD  362 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  362 (426)
                          -...+++....++|     .-..|+.+++.+.|.+||++.+
T Consensus       473 ----r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  473 ----RDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             ----hcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence                01112222222222     3357999999999999994433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.86  E-value=2.4e-22  Score=205.81  Aligned_cols=213  Identities=23%  Similarity=0.317  Sum_probs=154.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ...+|+.++.|..|+||.||..+++.+.+++|+ .+++.+..     .+-  +|.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee-----------------
Confidence            446899999999999999999999999999999 45443221     110  23333344443                 


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                          |+-...++.    .++++...        +.+++|||+.   +|+|||+||+|.||+.-|++|++|||+++.....
T Consensus       136 ----gDc~tllk~----~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 ----GDCATLLKN----IGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             ----chhhhhccc----CCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                333444443    23344332        6899999987   9999999999999999999999999999753211


Q ss_pred             CC-------------cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          249 DK-------------THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       249 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      ..             ......++||+.|.|||++....|+..+|+|++|+|+||.+.|..||.+..+.+.+..+......
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~  276 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  276 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcc
Confidence            10             01123468999999999999999999999999999999999999999998776655433322111


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                      +      .+-         ......++.+++.+.|+.+|..|--.
T Consensus       277 w------pE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  277 W------PEE---------DEALPPEAQDLIEQLLRQNPLCRLGT  306 (1205)
T ss_pred             c------ccc---------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence            1      111         22233488999999999999999533

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6e-21  Score=170.38  Aligned_cols=135  Identities=21%  Similarity=0.239  Sum_probs=107.7

Q ss_pred             ccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-----CCCCcceEeeEEeeCC---e-eEE
Q 014362           95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLVKLIGYCAEGD---Q-RLL  165 (426)
Q Consensus        95 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~---~-~~l  165 (426)
                      -...||+|+||.||.  +..++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   . +.+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            345699999999995  6665555 69998765555567799999999999     5799999999998874   3 337


Q ss_pred             EEEe--cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHH-HHHHHcCCCCeEecCCCCCCeeecc----CCceeEec
Q 014362          166 VYEY--MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL-QYLHEQLKQPVIYRDLKCSNILLEE----GYHPKLSD  238 (426)
Q Consensus       166 v~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~~~~iiH~Dlkp~NIll~~----~~~~kl~D  238 (426)
                      |+||  +++|+|.+++.+     ..+++.  ..++.+++.++ .|||+.   +|+||||||+|||++.    ++.++|+|
T Consensus        83 I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            8999  567999999965     235555  35678888777 999998   9999999999999974    34799999


Q ss_pred             cccc
Q 014362          239 FGLA  242 (426)
Q Consensus       239 fgla  242 (426)
                      |+.+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.2e-20  Score=196.78  Aligned_cols=203  Identities=20%  Similarity=0.220  Sum_probs=159.6

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC---CCCcceEeeEEe
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCA  158 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~  158 (426)
                      ...+.+.-...|.+.+.||+|+||+||.|.... |+.||+|+-.......   |.--..++.+|+   -+-|..+..++.
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~  764 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV  764 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc
Confidence            334455556778999999999999999999988 9999999977654432   111122222333   244666666666


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-------C
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-------G  231 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------~  231 (426)
                      -.+..+||+||.+.|||.+++.    ..+.++|..++.++.|++..++.||..   +|||+||||+|+||..       .
T Consensus       765 ~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  765 FQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             cCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcc
Confidence            6777889999999999999987    467899999999999999999999998   9999999999999942       3


Q ss_pred             CceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCC
Q 014362          232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK  295 (426)
Q Consensus       232 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~  295 (426)
                      ..++|+|||.+--...--........++|-.+--+|...|..+++.+|.|.|+.+++-||.|+.
T Consensus       838 ~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            4589999998852211111123345688999999999999999999999999999999999964

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=6.5e-20  Score=167.57  Aligned_cols=143  Identities=15%  Similarity=0.106  Sum_probs=112.3

Q ss_pred             cCCccccceeeecCcEEEEEEE-EcCCCEEEEEEEeccCCcc------------------------cHHHHHHHHHHHhc
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQLDHRGVQ------------------------GVREFSAEVMTLGS  144 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~  144 (426)
                      ...|.+.+.||+|+||.||+|. +..+|+.||||.+......                        ....+..|+..+..
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3458899999999999999998 6678999999998754210                        01235679999999


Q ss_pred             CCCC--CcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC-eEecCC
Q 014362          145 ADHP--NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP-VIYRDL  221 (426)
Q Consensus       145 l~hp--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-iiH~Dl  221 (426)
                      +.+.  .+..++++    ...++||||++|++|...+..    ...+....+..++.||+.+|.+||..   + |+||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Di  175 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDL  175 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCC
Confidence            8753  33444443    235899999999888665422    23466667789999999999999988   8 999999


Q ss_pred             CCCCeeeccCCceeEeccccccc
Q 014362          222 KCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       222 kp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ||+||+++ ++.++|+|||.+..
T Consensus       176 kp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      176 SEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             ChhhEEEE-CCCEEEEEChhhhc
Confidence            99999999 88999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.5e-19  Score=167.66  Aligned_cols=198  Identities=21%  Similarity=0.232  Sum_probs=141.3

Q ss_pred             CCCCcceEeeEEee---------------------------CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHH
Q 014362          146 DHPNLVKLIGYCAE---------------------------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA  198 (426)
Q Consensus       146 ~hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  198 (426)
                      +|||||.+.++|.+                           +..+|+||..++ -+|..++..     ...+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence            69999999987744                           234689998885 689998875     345666778899


Q ss_pred             HHHHHHHHHHHHcCCCCeEecCCCCCCeee--ccCC--ceeEecccccccCCCCC----CcceeeeecccccccCccccc
Q 014362          199 AGASRGLQYLHEQLKQPVIYRDLKCSNILL--EEGY--HPKLSDFGLAKMGPSGD----KTHVSTRVMGTYGYCAPDYAM  270 (426)
Q Consensus       199 ~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll--~~~~--~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~  270 (426)
                      .|+++|+.|||.+   +|.|||||++||||  |+++  .+.|+|||++--.....    .....-...|....||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999988   99999999999999  3333  46889999875321100    001111235788899999886


Q ss_pred             cCC------CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHH
Q 014362          271 TGQ------LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALA  344 (426)
Q Consensus       271 ~~~------~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  344 (426)
                      ..+      --.++|.|+.|.+.||+++...||...... .++...           ..+-    .-...|..++..+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----------Yqe~----qLPalp~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----------YQES----QLPALPSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----------hhhh----hCCCCcccCChHHHH
Confidence            432      125899999999999999999999873321 111111           1111    111234556668899


Q ss_pred             HHHhccccCCCCCCCHHHHHHHHH
Q 014362          345 IAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       345 li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ++...|+.||.+||+..-....|+
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            999999999999998776655544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.8e-19  Score=158.72  Aligned_cols=134  Identities=21%  Similarity=0.257  Sum_probs=112.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +.||+|++|.||+|.+.  |..|++|+.......        ....+..|+.++..+.|++|.....++.+....++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEeeC--CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            46999999999999884  677999986543221        12347789999999999998877777777778899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      |++|++|.+++...       .. .+..++.+++.+|.+||+.   +++|+|++|.|||++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999988641       11 7889999999999999987   999999999999999 78899999998863

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=8.9e-19  Score=156.45  Aligned_cols=129  Identities=22%  Similarity=0.282  Sum_probs=105.3

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ||+|+||.||+|.+.  +..|++|........        ....+..|+.++..+.|+++.....++......++||||+
T Consensus         2 ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         2 IAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            899999999999864  678999986543211        1345778999999999887665555555666789999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +|++|.+.+...    ..       .++.+++.+|.+||+.   +++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887541    10       7899999999999987   999999999999999 78999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=1.9e-18  Score=154.24  Aligned_cols=143  Identities=16%  Similarity=0.061  Sum_probs=110.4

Q ss_pred             HHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc----------------------cHHHHHHHHHHH
Q 014362           85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ----------------------GVREFSAEVMTL  142 (426)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~E~~~l  142 (426)
                      ++......|.+.+.||.|+||.||+|.+. +|+.||||++......                      ....+..|+.++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            34444445888899999999999999875 6999999987643210                      011256788888


Q ss_pred             hcCCCCC--cceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecC
Q 014362          143 GSADHPN--LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRD  220 (426)
Q Consensus       143 ~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~D  220 (426)
                      ..+.|++  ++.+++.    ...++||||++|++|......          .....++.+++.++.++|..   +|+|||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D  150 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD  150 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence            8887774  4444432    345899999999998765321          24567889999999999987   999999


Q ss_pred             CCCCCeeeccCCceeEecccccccC
Q 014362          221 LKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       221 lkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |||+||++++++.++|+|||++...
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccC
Confidence            9999999999999999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=1.8e-18  Score=177.13  Aligned_cols=144  Identities=20%  Similarity=0.235  Sum_probs=114.4

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--Cc------ccHHHHHHHHHHHhcCCCCCcceEe
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GV------QGVREFSAEVMTLGSADHPNLVKLI  154 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~------~~~~~~~~E~~~l~~l~hpniv~~~  154 (426)
                      +.........|...+.||+|+||+||+|.+....  +++|+....  ..      .....+..|+.++..++|++++...
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            3333344455677889999999999999887533  444432211  11      1234578899999999999999888


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      .++.+....++||||++|++|.+++.            ....++.+++.+|.|||+.   +++||||||+|||+ .++.+
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcE
Confidence            77777778899999999999998875            3467899999999999987   99999999999999 57799


Q ss_pred             eEeccccccc
Q 014362          235 KLSDFGLAKM  244 (426)
Q Consensus       235 kl~Dfgla~~  244 (426)
                      +|+|||+++.
T Consensus       467 ~liDFGla~~  476 (535)
T PRK09605        467 YLIDFGLGKY  476 (535)
T ss_pred             EEEeCccccc
Confidence            9999999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=3.7e-19  Score=182.03  Aligned_cols=256  Identities=23%  Similarity=0.279  Sum_probs=191.3

Q ss_pred             CCccccceeeecCcEEEEEEEEc-CCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE-KIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..|.+.+.||+|+|+.|-..... .....+|+|.+....  .........|..+-..+. |+|++.+++...+....+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45777777999999999988764 334567777776543  222334455777766776 99999999999999999999


Q ss_pred             EEecCCCCHHHHh-hhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCCeEecCCCCCCeeeccCC-ceeEecccccc
Q 014362          167 YEYMPLGSLDKHL-HDLRPDTRPLDWNTRMKIAAGASRGLQYLH-EQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~  243 (426)
                      ++|..|+++...+ ..   .....+...+-.++.|+..++.|+| ..   ++.|+||||+|.+++..+ .++++|||+|.
T Consensus       100 ~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999998877 32   2225666778889999999999999 65   999999999999999999 99999999998


Q ss_pred             cCCC-CCCcceeeeecc-cccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          244 MGPS-GDKTHVSTRVMG-TYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       244 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      .... ..........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+......... ...|...    ..
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~----~~  248 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN----KG  248 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc----cc
Confidence            6655 333344445678 9999999998885 4568899999999999999999999765543311 0010000    00


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .        ..............+++.+++..+|..|.+.+++..
T Consensus       249 ~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 R--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             c--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence            0        001111222336678889999999999999998763

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.71  E-value=7e-17  Score=142.68  Aligned_cols=134  Identities=19%  Similarity=0.180  Sum_probs=96.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHH----------------------HHHHHHHhcCCCC--C
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREF----------------------SAEVMTLGSADHP--N  149 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~hp--n  149 (426)
                      .+.||+|+||+||+|.+. +++.||||++......  ....+                      ..|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            456999999999999887 6899999998753221  11111                      2455555555433  2


Q ss_pred             cceEeeEEeeCCeeEEEEEecCCCCHHH-HhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCee
Q 014362          150 LVKLIGYCAEGDQRLLVYEYMPLGSLDK-HLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       150 iv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIl  227 (426)
                      +.+.+++    ...++||||++++++.. .+....     .. ..+..++.+++.++.++|. .   +|+|+||||+||+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil  147 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL  147 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence            4444433    24689999999854421 222210     11 5678899999999999998 6   9999999999999


Q ss_pred             eccCCceeEeccccccc
Q 014362          228 LEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~~  244 (426)
                      ++ ++.++|+|||.+..
T Consensus       148 i~-~~~~~liDfg~a~~  163 (187)
T cd05119         148 VD-DGKVYIIDVPQAVE  163 (187)
T ss_pred             EE-CCcEEEEECccccc
Confidence            99 88999999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.2e-16  Score=135.29  Aligned_cols=134  Identities=20%  Similarity=0.138  Sum_probs=113.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC--CCcceEeeEEeeCCeeEEEEEecCCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH--PNLVKLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      .+.||.|.++.||++....  ..+++|.......  ...+..|+..+..++|  ++++++++++...+..+++|||++++
T Consensus         3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4569999999999999864  6799999865533  4678899999999976  58999999888888899999999987


Q ss_pred             CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          174 SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       174 sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      .+..+           +......++.+++.+|.+||.....+++|+||+|.||+++..+.++++|||++..
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            76432           4556678899999999999986445799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=2.5e-16  Score=144.28  Aligned_cols=134  Identities=19%  Similarity=0.154  Sum_probs=103.6

Q ss_pred             ceee-ecCcEEEEEEEEcCCCEEEEEEEeccCCc-------------ccHHHHHHHHHHHhcCCCCCc--ceEeeEEeeC
Q 014362           97 CCLG-EGGFGKVYKGCLEKIEQVVAIKQLDHRGV-------------QGVREFSAEVMTLGSADHPNL--VKLIGYCAEG  160 (426)
Q Consensus        97 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpni--v~~~~~~~~~  160 (426)
                      ..|| .|+.|+||.+...  +..++||.+.....             .....+.+|+.++..+.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3487 7889999998775  67899998854221             123457889999999998875  6666664332


Q ss_pred             C----eeEEEEEecCC-CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCcee
Q 014362          161 D----QRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK  235 (426)
Q Consensus       161 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  235 (426)
                      .    ..++|||+++| .+|.+++..     ..++..    .+.+|+.+|.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    22599999997 689888754     345544    357899999999987   999999999999999988999


Q ss_pred             Eeccccccc
Q 014362          236 LSDFGLAKM  244 (426)
Q Consensus       236 l~Dfgla~~  244 (426)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999999864

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1.2e-15  Score=138.77  Aligned_cols=204  Identities=24%  Similarity=0.355  Sum_probs=144.7

Q ss_pred             HHHhcCCCCCcceEeeEEeeC-----CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCC
Q 014362          140 MTLGSADHPNLVKLIGYCAEG-----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ  214 (426)
Q Consensus       140 ~~l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  214 (426)
                      ..|-.+-|.|||+++.|+.+.     ....++.|||..|+|..+|++.+.....+......+|+.||+.||.|||+. .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            345566799999999987654     346899999999999999998777778888889999999999999999997 78


Q ss_pred             CeEecCCCCCCeeeccCCceeEecccccccCC--CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh
Q 014362          215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP--SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT  292 (426)
Q Consensus       215 ~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt  292 (426)
                      +|+|+++..+-|++..+|-+|+.----.....  ............+-++|.|||+-.....+.++|||+||+...||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999988886211110000  0001111122356789999998777778899999999999999998


Q ss_pred             CCCCCCCcCchhhh-cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          293 GRKAIDQTKDRKEL-NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       293 g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +..--......... ..+..  .       +.. +...+           -+.++..|++..|..||+|.+++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~--~-------i~~-len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIAN--V-------IIG-LENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeehhhhhhh--h-------eee-ccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            76542222111100 00000  0       000 00111           134777899999999999999764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=3.5e-15  Score=146.63  Aligned_cols=254  Identities=24%  Similarity=0.284  Sum_probs=185.2

Q ss_pred             Cccccceeee--cCcEEEEEEEE--cCCCEEEEEEEecc--CCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeE
Q 014362           92 NFRSDCCLGE--GGFGKVYKGCL--EKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        92 ~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  164 (426)
                      .|.+...+|.  |.+|.||.+..  ..++..+|+|.-..  ........=.+|+.....+ .|+|.++.+..+...+.++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4666777999  99999999998  77889999998433  2223333334566655566 4999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHH----HHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEecc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDF  239 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Df  239 (426)
                      +-+|++. .+|..+.+.   ....++...++..+.+...    ||.++|+.   +++|-|+||.||++..+ ...+++||
T Consensus       195 iqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            9999994 788877765   2344788888899999999    99999987   99999999999999999 88999999


Q ss_pred             cccccCCCCCCcce---eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          240 GLAKMGPSGDKTHV---STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       240 gla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |+............   .....|...|++||. .++.++..+|+|++|.++.+..++..+........      |.    
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~----  336 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS----  336 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc----
Confidence            99986554432221   123367888999995 56788999999999999999999877664431100      00    


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                          .+....   +..++-......+...+..+++.+|..|++.+.+. .|..+.
T Consensus       337 ----~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~  383 (524)
T KOG0601|consen  337 ----QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIH  383 (524)
T ss_pred             ----cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh-cccccc
Confidence                000100   11111122233556689999999999999877765 455444

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=1.8e-13  Score=135.93  Aligned_cols=170  Identities=15%  Similarity=0.179  Sum_probs=132.4

Q ss_pred             EEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCC
Q 014362          109 KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP  188 (426)
Q Consensus       109 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~  188 (426)
                      .|..+.++.+|.|..+...+........+-+..|+.++||||++++..++.....|||+|.+.  .|..++..       
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence            577778899999999887665445567788899999999999999999999999999999984  67777766       


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccc
Q 014362          189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY  268 (426)
Q Consensus       189 l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~  268 (426)
                      +....+..-+.||+.||.|||..  .+++|++|.-..|+|+..|..||++|-++........  ......--..|..|+.
T Consensus       101 l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  101 LGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE  176 (690)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence            33567777899999999999975  4899999999999999999999999998864322111  0011111224666765


Q ss_pred             cccCCCCccCchhhHHHHHHHHHhC
Q 014362          269 AMTGQLTFKSDIYSFGVVLLELITG  293 (426)
Q Consensus       269 ~~~~~~~~~~DvwSlG~il~elltg  293 (426)
                      +....  -..|.|-||++++|++.|
T Consensus       177 ~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  177 IDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cCccc--cchhhhhHHHHHHHHhCc
Confidence            43222  456999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=5.6e-14  Score=139.66  Aligned_cols=140  Identities=19%  Similarity=0.139  Sum_probs=95.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccH------------------------------H----------HHH
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV------------------------------R----------EFS  136 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------~----------~~~  136 (426)
                      +.||.|++|.||+|+.+. |+.||||+....-....                              +          +|.
T Consensus       123 ~plasaSigQVh~A~l~~-G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD-GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEecC-CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            579999999999999864 89999999865321100                              0          133


Q ss_pred             HHHHHHhcC----CCCCcceEeeEE-eeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 014362          137 AEVMTLGSA----DHPNLVKLIGYC-AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR-GLQYLHE  210 (426)
Q Consensus       137 ~E~~~l~~l----~hpniv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~-aL~~LH~  210 (426)
                      .|+..+..+    +|.+-+.+-..+ ......+|||||++|++|.+.....   ...++   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHh
Confidence            444444443    232223322222 2234578999999999998876531   11122   3446666665 4677887


Q ss_pred             cCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       211 ~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      .   |++|+|++|.||+++.++.++|+|||++....
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            6   99999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.49  E-value=2.8e-14  Score=143.50  Aligned_cols=145  Identities=14%  Similarity=0.083  Sum_probs=93.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------------------------------cH----H---
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------------------------------GV----R---  133 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------------------~~----~---  133 (426)
                      ..|+. +.||.|++|.||+|+++.+|+.||||++.+.-..                              ..    +   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45776 7899999999999999988999999999754110                              00    1   


Q ss_pred             ---HHHHHHHHHhcC----CCCCcceEeeEEee-CCeeEEEEEecCCCCHHHHh--hhhCCCCCCCCHHHHHHHHHHHHH
Q 014362          134 ---EFSAEVMTLGSA----DHPNLVKLIGYCAE-GDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASR  203 (426)
Q Consensus       134 ---~~~~E~~~l~~l----~hpniv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~qi~~  203 (426)
                         ++..|+..+.++    .+.+.+.+-.++.+ ....+|||||++|+.|.++-  .........+....+..++.|++ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-  277 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-  277 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence               123333333333    23333333333322 34567999999999997742  22100111234444444555543 


Q ss_pred             HHHHHHHcCCCCeEecCCCCCCeeeccCC----ceeEecccccccCC
Q 014362          204 GLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGP  246 (426)
Q Consensus       204 aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Dfgla~~~~  246 (426)
                            ..   |++|+|+||.||+++.++    .+++.|||++....
T Consensus       278 ------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        278 ------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  23   999999999999999888    99999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.44  E-value=2.7e-14  Score=147.47  Aligned_cols=253  Identities=19%  Similarity=0.203  Sum_probs=182.7

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      ....+.+.+.+-+-.|+++.++.+.-..+|...++|.......   ...+....+-.++-..+||.++...--+.-....
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            3445667777889999999999998888887677666543221   1223333333344345567777665555566778


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      +|+++|+.+++|...|+.    ....+..-+..+...+.++++|||+.   .++|+|++|.|+|...++..+++|||+..
T Consensus       880 ~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             chhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence            999999999999999986    24567777788888999999999986   69999999999999999999999998433


Q ss_pred             cCCCC-----------------------------CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC
Q 014362          244 MGPSG-----------------------------DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR  294 (426)
Q Consensus       244 ~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~  294 (426)
                      .....                             +.........||+.|.+||.+.+......+|+|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            21100                             0001122356999999999999999999999999999999999999


Q ss_pred             CCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHH
Q 014362          295 KAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT  361 (426)
Q Consensus       295 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  361 (426)
                      +||..........-+......+               ...+.....++.+++...+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f~ni~~~~~~~---------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPW---------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhhhccccCCCCC---------------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            9998766544331111110000               012334455778899999999999998776

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=4.5e-13  Score=116.20  Aligned_cols=129  Identities=18%  Similarity=0.117  Sum_probs=95.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcc-eEeeEEeeCCeeEEEEEecCCCCH
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      +.|+.|.++.||++...  +..|++|....... ....+..|+.+++.+.+.+++ +++.+..  ...++||||++|.++
T Consensus         4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            45889999999999876  77899999765432 123467889998888665554 4444432  345799999999887


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ...  .       .   ....++.+++.+|+.||...  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            532  0       0   11345778999999999872  12259999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=5.2e-13  Score=131.43  Aligned_cols=262  Identities=19%  Similarity=0.198  Sum_probs=182.2

Q ss_pred             CCCCCcCHHH-HHHhcCCccccceeeecCcEEEEEEEEc-CCCEEEEEEEeccCCcccHHHH--HHHHHHHhcC-CCCCc
Q 014362           76 KSAKPFTFDE-LAAATGNFRSDCCLGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGVQGVREF--SAEVMTLGSA-DHPNL  150 (426)
Q Consensus        76 ~~~~~~~~~~-~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~~--~~E~~~l~~l-~hpni  150 (426)
                      ...+.+.-.+ ......+|..+..||.|.|+.|+....+ .++..|++|.+.+.-.....++  ..|+.+...+ .|.++
T Consensus       249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence            3444555555 4556678999999999999999998765 5678899998876543333322  2345444444 48888


Q ss_pred             ceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc
Q 014362          151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE  230 (426)
Q Consensus       151 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~  230 (426)
                      +.++..+....+.|+-.|||.++++...+.    ....+++...+.+..|++.++.++|+.   .++|+|+||.||++..
T Consensus       329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~  401 (524)
T KOG0601|consen  329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISN  401 (524)
T ss_pred             CCCCCCccccccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeecc
Confidence            887777766677789999999998876652    245688889999999999999999987   9999999999999988


Q ss_pred             C-CceeEecccccccCCCCCCcceeeeeccccccc--CccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc
Q 014362          231 G-YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC--APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN  307 (426)
Q Consensus       231 ~-~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  307 (426)
                      + +..++.|||++..+....     ....+.-+++  +|+......+..+.|++|||..+.|.+++...-.......   
T Consensus       402 ~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---  473 (524)
T KOG0601|consen  402 DGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---  473 (524)
T ss_pred             chhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce---
Confidence            6 778999999986321111     1122333444  5555556678899999999999999999865432211100   


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                                      . +........+... ..+..+...+...++..||.+.++....+.+
T Consensus       474 ----------------~-i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  474 ----------------T-IRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ----------------e-eecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                            0 0000000111122 4667788889999999999998887655444

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.36  E-value=1.7e-11  Score=107.67  Aligned_cols=135  Identities=16%  Similarity=0.117  Sum_probs=97.8

Q ss_pred             ceeeecCcEEEEEEEEcC------CCEEEEEEEeccCCc----------------------ccHHHHH----HHHHHHhc
Q 014362           97 CCLGEGGFGKVYKGCLEK------IEQVVAIKQLDHRGV----------------------QGVREFS----AEVMTLGS  144 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~----------------------~~~~~~~----~E~~~l~~  144 (426)
                      ..||.|--+.||.|....      .+..+|||+.+....                      .....+.    +|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            459999999999998653      357899999752110                      0112233    78888888


Q ss_pred             CCC--CCcceEeeEEeeCCeeEEEEEecCCCCHH-HHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHH-HHcCCCCeEecC
Q 014362          145 ADH--PNLVKLIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL-HEQLKQPVIYRD  220 (426)
Q Consensus       145 l~h--pniv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~~~~iiH~D  220 (426)
                      +..  -++..++++    ...+|||||+.+..+. ..+.+     ..++......+..+++.+|..| |..   ++||+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            753  456666654    4578999999764332 22332     2355566778889999999999 776   999999


Q ss_pred             CCCCCeeeccCCceeEeccccccc
Q 014362          221 LKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       221 lkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      |++.|||+++ +.+.|+|||.+..
T Consensus       151 Ls~~NIL~~~-~~v~iIDF~qav~  173 (197)
T cd05146         151 LSEYNMLWHD-GKVWFIDVSQSVE  173 (197)
T ss_pred             CCHHHEEEEC-CcEEEEECCCcee
Confidence            9999999974 6899999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=3.9e-11  Score=108.62  Aligned_cols=142  Identities=16%  Similarity=0.182  Sum_probs=109.0

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCC--CCcceEeeEEeeCC---eeEEEEEec
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADH--PNLVKLIGYCAEGD---QRLLVYEYM  170 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~---~~~lv~e~~  170 (426)
                      ..|+.|.++.||++.... |..+++|....... .....+..|+.+++.+.+  .++.+++.+.....   ..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            358999999999998754 67899999765432 234568899999999875  44677777766542   568999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--------------------------------------  212 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------  212 (426)
                      +|.++...+..     ..++......++.+++++|..||+..                                      
T Consensus        83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            99888665421     34677778888888888888888531                                      


Q ss_pred             ---------------CCCeEecCCCCCCeeecc--CCceeEeccccccc
Q 014362          213 ---------------KQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKM  244 (426)
Q Consensus       213 ---------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~  244 (426)
                                     ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           245799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=2.9e-10  Score=110.12  Aligned_cols=171  Identities=17%  Similarity=0.176  Sum_probs=130.9

Q ss_pred             cEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEe----eCCeeEEEEEecCC-CCHHHH
Q 014362          104 FGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA----EGDQRLLVYEYMPL-GSLDKH  178 (426)
Q Consensus       104 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~lv~e~~~~-gsL~~~  178 (426)
                      -.+.|++....+|..|++|+++-...........-+++++++.|+|||++.++|.    .+..++||++|+++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            3579999999999999999994433333333445688899999999999998876    34568999999985 577776


Q ss_pred             hhhhC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          179 LHDLR-----------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       179 l~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      -..-.           ..+..+++..+|.++.|+..||.++|+.   |+..+-|.|.+||++.+.+++|+..|+......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            54311           1335578899999999999999999998   999999999999999998999998887754332


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA  296 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p  296 (426)
                      ..              .  |.+..   -.+-|.=.||.+++.|.||..-
T Consensus       446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            21              0  11111   2467889999999999999643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.2e-10  Score=99.00  Aligned_cols=130  Identities=23%  Similarity=0.276  Sum_probs=97.8

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--cc------HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QG------VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .+++|+-+.+|.+.+.  |..+++|.-.+..-  ..      ...-.+|+.++..++--.|.-.+=+..+.+...|+|||
T Consensus         3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            4789999999999876  55566665332211  11      23356788898888655555555555667778899999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ++|..|.+.+...           ...++..+-..+.-||..   +|+|+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998988888652           245677777888889987   999999999999998775 99999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.23  E-value=1.8e-10  Score=97.66  Aligned_cols=143  Identities=18%  Similarity=0.178  Sum_probs=104.3

Q ss_pred             ccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        95 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ....|-+|+-+.|+++.+.  |+...||.--....        -..++...|+..|.+++--.|.-..-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4456889999999999988  77777776322111        1234567799998887655554444456666777899


Q ss_pred             EEecCC-CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC---ceeEeccccc
Q 014362          167 YEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLA  242 (426)
Q Consensus       167 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgla  242 (426)
                      |||++| .++.+++.....  ..........++..|-+.+.-||..   +|||+||..+||+|..++   .+.|+|||++
T Consensus        89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence            999987 478888876432  2222233367899999999999987   999999999999997654   3589999998


Q ss_pred             cc
Q 014362          243 KM  244 (426)
Q Consensus       243 ~~  244 (426)
                      ..
T Consensus       164 ~~  165 (229)
T KOG3087|consen  164 SV  165 (229)
T ss_pred             hc
Confidence            64

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=4.2e-09  Score=99.81  Aligned_cols=265  Identities=17%  Similarity=0.198  Sum_probs=160.8

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeE------Eee-CCeeEEEEE
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY------CAE-GDQRLLVYE  168 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~------~~~-~~~~~lv~e  168 (426)
                      ...||+|+-+.+|..-.-  + -.+.|++.........+...|+  ..--.||-+-.=+.|      ..+ +...-++|.
T Consensus        16 gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            455999999999964322  1 2345777665444333222222  222345533221111      111 222567888


Q ss_pred             ecCCCC-HHHHhh--hhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          169 YMPLGS-LDKHLH--DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      .+.+.. +..++.  ..+.+-....|..+++.++.++.+.+-||..   |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            877642 222221  1223445578999999999999999999998   8899999999999999999999975443322


Q ss_pred             CCCCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhC-CCCCCCcCchhhh----c-HHHhhhh
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKEL----N-LVAWARP  314 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~----~-~~~~~~~  314 (426)
                      ..+   ....-.+|...|.+||.-.     +..-+...|.|.||+++++|+.| ++||.+.......    . .+.... 
T Consensus       168 ~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~-  243 (637)
T COG4248         168 ANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR-  243 (637)
T ss_pred             cCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce-
Confidence            111   1222347899999999654     33557889999999999999997 9999764321110    0 111111 


Q ss_pred             hhhcccccccccCCcccCCCCh-HhHHHHHHHHHhccccC--CCCCCCHHHHHHHHHHHHhCC
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPV-RGLYQALAIAAMCVQEQ--PNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~d--P~~RPs~~eil~~L~~l~~~~  374 (426)
                       +.....-..-+.+.- ...|- -.+..+..|..+|+...  +.-||+++..+..|..+..+.
T Consensus       244 -f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         244 -FAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             -eeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence             110000000001111 11222 22346777889998654  568999999999999887543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.04  E-value=5.7e-09  Score=96.85  Aligned_cols=138  Identities=14%  Similarity=0.068  Sum_probs=97.9

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cH----------HHHHHHHHHHhcCCCCC--cceEeeEEee-----C
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GV----------REFSAEVMTLGSADHPN--LVKLIGYCAE-----G  160 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~----------~~~~~E~~~l~~l~hpn--iv~~~~~~~~-----~  160 (426)
                      +-.-....|++..+.  |+.|.||........ ..          ..+.+|+..+..+..-+  .+.+++++..     .
T Consensus        30 v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         30 FRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            333334456676654  788999987543311 11          13678888887774332  3344445443     2


Q ss_pred             CeeEEEEEecCCC-CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-------CC
Q 014362          161 DQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-------GY  232 (426)
Q Consensus       161 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-------~~  232 (426)
                      ..-+||+|++++. +|.+++....  ....+......++.+++..+.-||..   ||+|+||++.|||++.       ++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            3468999999876 8988886432  23456677889999999999999998   9999999999999985       46


Q ss_pred             ceeEecccccc
Q 014362          233 HPKLSDFGLAK  243 (426)
Q Consensus       233 ~~kl~Dfgla~  243 (426)
                      .+.|+||+.++
T Consensus       183 ~~~LIDl~r~~  193 (268)
T PRK15123        183 KLSVIDLHRAQ  193 (268)
T ss_pred             eEEEEECCccc
Confidence            78999999875

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=6.9e-09  Score=90.86  Aligned_cols=124  Identities=23%  Similarity=0.235  Sum_probs=79.7

Q ss_pred             EEEEEEEcCCCEEEEEEEeccCCc-------------c-------------cHHHHHHHHHHHhcCCCC--CcceEeeEE
Q 014362          106 KVYKGCLEKIEQVVAIKQLDHRGV-------------Q-------------GVREFSAEVMTLGSADHP--NLVKLIGYC  157 (426)
Q Consensus       106 ~V~~~~~~~~~~~vaiK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~hp--niv~~~~~~  157 (426)
                      .||.|.... |..+|||+......             .             ......+|+..|..+..-  ++..++++.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            489988754 88999999753210             0             012356799999999765  456666442


Q ss_pred             eeCCeeEEEEEecC--CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHH-HHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          158 AEGDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY-LHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       158 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                          ..+|||||++  |..+.. |..     ..++......++.+++..+.. +|..   ||+|+||.+.|||++++ .+
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKD-----VDLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHH-----CGGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred             ----CCEEEEEecCCCccchhh-HHh-----ccccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence                3569999998  555544 333     111133456677888886666 4665   99999999999999988 99


Q ss_pred             eEeccccccc
Q 014362          235 KLSDFGLAKM  244 (426)
Q Consensus       235 kl~Dfgla~~  244 (426)
                      .|+|||.+..
T Consensus       146 ~iIDf~qav~  155 (188)
T PF01163_consen  146 YIIDFGQAVD  155 (188)
T ss_dssp             EE--GTTEEE
T ss_pred             EEEecCccee
Confidence            9999998864

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.90  E-value=9.7e-09  Score=92.71  Aligned_cols=140  Identities=20%  Similarity=0.110  Sum_probs=97.4

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc----------------------ccHHHHHHHHHHHh
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----------------------QGVREFSAEVMTLG  143 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~E~~~l~  143 (426)
                      +.....-+.+...||-|--+.||.|.... |..+|||.-+....                      -......+|+++|.
T Consensus        86 l~~r~~ve~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~  164 (304)
T COG0478          86 LVKRGIVEAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ  164 (304)
T ss_pred             HHHcChHHhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence            33333446677889999999999998874 88999997542110                      01233567999999


Q ss_pred             cCCCC--CcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 014362          144 SADHP--NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL  221 (426)
Q Consensus       144 ~l~hp--niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl  221 (426)
                      .|...  .|...+++    +...+||||++|-.|...-         ++....-.++..|+.-+.-+-..   ||||+|+
T Consensus       165 ~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDl  228 (304)
T COG0478         165 RLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDL  228 (304)
T ss_pred             HhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence            98654  56666654    5667999999986664321         12233334444455544444444   9999999


Q ss_pred             CCCCeeeccCCceeEeccccc
Q 014362          222 KCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       222 kp~NIll~~~~~~kl~Dfgla  242 (426)
                      ++-||+++++|.+.++||--+
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~  249 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQA  249 (304)
T ss_pred             chheEEEecCCCEEEEeCccc
Confidence            999999999999999999644

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=1.4e-09  Score=108.92  Aligned_cols=151  Identities=15%  Similarity=0.223  Sum_probs=102.8

Q ss_pred             HHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcce-------eeeecccccccCcccccc
Q 014362          199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-------STRVMGTYGYCAPDYAMT  271 (426)
Q Consensus       199 ~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  271 (426)
                      .+++.||.|+|..  .++||++|.|++|.++.++..||+.|+++...........       ..-..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3445899999986  6899999999999999999999999998864333111110       011234567999999999


Q ss_pred             CCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhcc
Q 014362          272 GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCV  350 (426)
Q Consensus       272 ~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  350 (426)
                      ...+.++|+||+|+++|-+.. |+.-+............              ...+..-.-.+....+.++++=+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHh
Confidence            888999999999999999994 55444433221111110              011111111122344557888889999


Q ss_pred             ccCCCCCCCHHHHHH
Q 014362          351 QEQPNMRPAITDVVM  365 (426)
Q Consensus       351 ~~dP~~RPs~~eil~  365 (426)
                      ..++..||++.++..
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999997777653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.75  E-value=1.3e-07  Score=84.68  Aligned_cols=105  Identities=21%  Similarity=0.217  Sum_probs=81.4

Q ss_pred             HHHHHHHHHHhcCCC--CCcceEeeEEeeC----CeeEEEEEecCCC-CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHH
Q 014362          133 REFSAEVMTLGSADH--PNLVKLIGYCAEG----DQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL  205 (426)
Q Consensus       133 ~~~~~E~~~l~~l~h--pniv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  205 (426)
                      ....+|...+..|..  -.+...+++....    ...+||+|++++. +|.+++...    ..++......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            456778877766643  2345556665542    2358999999874 799988763    2266677889999999999


Q ss_pred             HHHHHcCCCCeEecCCCCCCeeeccCC---ceeEeccccccc
Q 014362          206 QYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLAKM  244 (426)
Q Consensus       206 ~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgla~~  244 (426)
                      .-||..   ||+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999998   999999999999999887   799999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.74  E-value=1.8e-07  Score=82.54  Aligned_cols=137  Identities=14%  Similarity=0.105  Sum_probs=101.3

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCC------cccHHHHHHHHHHHhcCCCC--CcceEeeEEe-e----CCeeEE
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRG------VQGVREFSAEVMTLGSADHP--NLVKLIGYCA-E----GDQRLL  165 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~-~----~~~~~l  165 (426)
                      -|+||.+.|++-...  |+.+-+|.-...-      +.....|.+|+..|..|..-  .+.++. ++. .    ...-+|
T Consensus        26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            567999999997766  4578889865221      22456799999998887532  244444 332 1    123579


Q ss_pred             EEEecCC-CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc--eeEeccccc
Q 014362          166 VYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--PKLSDFGLA  242 (426)
Q Consensus       166 v~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla  242 (426)
                      |+|-+.| -+|.+++.+.  .-.+.+......++.+|+.++.-||..   |+.|+|+.+.|||++.++.  ++++||--+
T Consensus       103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            9998754 5888887652  123467777889999999999999998   9999999999999986667  899999766


Q ss_pred             c
Q 014362          243 K  243 (426)
Q Consensus       243 ~  243 (426)
                      +
T Consensus       178 r  178 (216)
T PRK09902        178 R  178 (216)
T ss_pred             c
Confidence            5

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=1.5e-07  Score=94.65  Aligned_cols=142  Identities=16%  Similarity=0.113  Sum_probs=88.0

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc------------------------------HHH----------HH
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG------------------------------VRE----------FS  136 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~~~----------~~  136 (426)
                      ..|+.++-|.||+|+++. |+.||||+.++.-...                              +++          +.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            569999999999999987 9999999975431100                              111          22


Q ss_pred             HHHHHHhcC----C-CCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 014362          137 AEVMTLGSA----D-HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ  211 (426)
Q Consensus       137 ~E~~~l~~l----~-hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  211 (426)
                      .|..-+.++    + .|+|.--.=+.+-.....|+|||++|-.+.+...-.   ...++...+.....++.--.-+-|  
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f~~q~~~d--  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAFLRQLLRD--  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHHHHHHHhc--
Confidence            233333332    1 232211111122234568999999998888774321   133443333332222222222223  


Q ss_pred             CCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       212 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                         |++|.|..|.||+++.+|.+.+.|||+......
T Consensus       285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               999999999999999999999999999865433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.59  E-value=6.4e-09  Score=103.34  Aligned_cols=186  Identities=18%  Similarity=0.097  Sum_probs=136.3

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC-cceEeeEEeeCCeeEEEEEecC
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      |....-+++|+++++++.+...+...+ .+.+...     ....-++++|.+++||| .+..++-+...+..+++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            333445889999999998776644333 5555332     34556889999999999 7777777877888999999998


Q ss_pred             CC-CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          172 LG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       172 ~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++ +.......   ....+...+...+.+.-+++|+|||+.   .-+|+|    ||+..+ +..+..||+....+.... 
T Consensus       318 ~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  318 TGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             CCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc-
Confidence            77 22211111   123344445566777778899999976   458888    777766 578999999987544332 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                        ......+|+.|+|||+...+.+....|+|++|+-..+|.-|-+|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              2344679999999999999999999999999998888888877654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.59  E-value=8.8e-07  Score=80.45  Aligned_cols=140  Identities=16%  Similarity=0.166  Sum_probs=85.4

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC--cceEeeEEeeCCeeEEEEEecCCCC
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      ..||.|..+.||+.  .  +..+++|......  ......+|.++++.+..-.  +.+++++........+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~--~--~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH--K--TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe--c--CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            35899999999983  1  4457788876532  2345788999998886433  4667888777778889999999863


Q ss_pred             -HHHH---------------------hhhhCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHHcC-CCCeEecC
Q 014362          175 -LDKH---------------------LHDLRPDTRPLDWNTRMKIAA----------GASR-GLQYLHEQL-KQPVIYRD  220 (426)
Q Consensus       175 -L~~~---------------------l~~~~~~~~~l~~~~~~~i~~----------qi~~-aL~~LH~~~-~~~iiH~D  220 (426)
                       +...                     ||........+... ...+..          .+.. ...+|.... ...++|+|
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence             2111                     11110011111100 000100          0111 122222221 33578999


Q ss_pred             CCCCCeeeccCCceeEeccccccc
Q 014362          221 LKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       221 lkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +.|.||++++++ +.|+||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=1.9e-06  Score=76.47  Aligned_cols=137  Identities=12%  Similarity=0.074  Sum_probs=88.8

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHH---------HHHHHHhcCC---CCCcceEeeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---------AEVMTLGSAD---HPNLVKLIGY  156 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~E~~~l~~l~---hpniv~~~~~  156 (426)
                      ..++|...+.+-......|.+-...  |+.+++|..........+.|.         +++..+..++   --..+.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4567888777777776666665554  788999988765433333222         2333333332   2222232222


Q ss_pred             E-----eeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC
Q 014362          157 C-----AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG  231 (426)
Q Consensus       157 ~-----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~  231 (426)
                      .     .-....+|||||++|..|.+...        +++    .++..|++++.-||..   |++|+|+.|.|++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence            2     12234568999999988765431        222    2456677889999998   99999999999999965


Q ss_pred             CceeEecccccc
Q 014362          232 YHPKLSDFGLAK  243 (426)
Q Consensus       232 ~~~kl~Dfgla~  243 (426)
                       .++++||+..+
T Consensus       172 -~i~iID~~~k~  182 (229)
T PF06176_consen  172 -GIRIIDTQGKR  182 (229)
T ss_pred             -cEEEEECcccc
Confidence             49999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=3.3e-06  Score=76.78  Aligned_cols=143  Identities=20%  Similarity=0.205  Sum_probs=83.3

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--CcceEeeEEee---CCeeEEEEEecC
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP--NLVKLIGYCAE---GDQRLLVYEYMP  171 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~~~~---~~~~~lv~e~~~  171 (426)
                      +.|+.|..+.||+..... + .+++|.....  .....+..|..+++.+...  .+..++.+...   ....+++|++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             ccCCCCCeeeEEEEEECC-c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            468999999999998875 4 7889987654  4456677888888777433  34566654432   334689999999


Q ss_pred             CCCHHH----------------Hhh---hhCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHH
Q 014362          172 LGSLDK----------------HLH---DLRPDTRPLDWNT---------RMKI------------AAGASR-GLQYLHE  210 (426)
Q Consensus       172 ~gsL~~----------------~l~---~~~~~~~~l~~~~---------~~~i------------~~qi~~-aL~~LH~  210 (426)
                      |..+..                .+.   .......++....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988777                111   1101111111110         0000            111222 3334443


Q ss_pred             c----CCCCeEecCCCCCCeeec-cCCceeEecccccc
Q 014362          211 Q----LKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAK  243 (426)
Q Consensus       211 ~----~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~  243 (426)
                      .    ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            2    234699999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.37  E-value=2.1e-06  Score=86.23  Aligned_cols=138  Identities=17%  Similarity=0.101  Sum_probs=88.9

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc---------------------------HH----------HHHHHH
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---------------------------VR----------EFSAEV  139 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------------------~~----------~~~~E~  139 (426)
                      ..||.-+.|.||+|+.+. |+.||||+-++.-...                           .+          +|..|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            459999999999999998 9999999865321100                           01          123333


Q ss_pred             HH----HhcCCCCC------cceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014362          140 MT----LGSADHPN------LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH  209 (426)
Q Consensus       140 ~~----l~~l~hpn------iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  209 (426)
                      +-    .+.+.|-+      |.++|-.+.  ....|+||||+|..+.+.-.-   ....++...+..-+.++..-+-+-|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHhc
Confidence            22    22234444      444443332  356899999999887765432   1244555544444444333333333


Q ss_pred             HcCCCCeEecCCCCCCeeecc----CCceeEecccccccC
Q 014362          210 EQLKQPVIYRDLKCSNILLEE----GYHPKLSDFGLAKMG  245 (426)
Q Consensus       210 ~~~~~~iiH~Dlkp~NIll~~----~~~~kl~Dfgla~~~  245 (426)
                           |.+|+|-.|.||+++.    ++.+.+.|||+....
T Consensus       321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence                 8999999999999984    668999999998653

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=4.9e-06  Score=70.72  Aligned_cols=129  Identities=19%  Similarity=0.113  Sum_probs=89.0

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcce-EeeEEeeCCeeEEEEEecCC
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK-LIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~~~~~lv~e~~~~  172 (426)
                      ++.+.||+|++|.||+|.|.  |..+|+|+-...+.  ...+..|+++|..+.--++.+ +|.+..    .++.|||+.|
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G   96 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence            44566999999999999998  66899998765443  367889999999988766655 443332    3356999998


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC-CCCeeeccCCceeEeccccccc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK-CSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk-p~NIll~~~~~~kl~Dfgla~~  244 (426)
                      -.|.+.-..       .+...    ...++++---|-..   ||-|+.|. |...+|..++.+.|+||.-|+.
T Consensus        97 ~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          97 RPLGKLEIG-------GDRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cchhhhhhc-------ccHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            888765432       12233    33444443334444   99999887 5555555555899999998874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.32  E-value=6.7e-06  Score=75.69  Aligned_cols=140  Identities=19%  Similarity=0.166  Sum_probs=84.2

Q ss_pred             eeecCc-EEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEEecCCCCHH
Q 014362           99 LGEGGF-GKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus        99 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      |..|.+ ..||+....  +..+.||......   ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 789998654  4578888875443   345667888887774 344667788777766789999999988776


Q ss_pred             HHh-------------------hhhCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHHc----
Q 014362          177 KHL-------------------HDLRPDTRPLDWN--TRMKIAA--------------------GASRGLQYLHEQ----  211 (426)
Q Consensus       177 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------qi~~aL~~LH~~----  211 (426)
                      ...                   +.......++...  .......                    .+...+..|-..    
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   1111111111100  0000000                    011112222111    


Q ss_pred             CCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       212 ~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            12458999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.32  E-value=8.5e-06  Score=73.20  Aligned_cols=152  Identities=20%  Similarity=0.173  Sum_probs=99.5

Q ss_pred             CcCHHHHHHhcCCccccceee---ecCcEEEEEEEEcCCCEEEEEEEeccCCcc-------------------cHHH---
Q 014362           80 PFTFDELAAATGNFRSDCCLG---EGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-------------------GVRE---  134 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~---  134 (426)
                      ..+...+.....+..+....|   .|--+.||+|... .+..+|||++......                   ..++   
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            455666666666666665555   5556689998764 3889999998643211                   0111   


Q ss_pred             --HHHHHHHHhcCC--CCCcceEeeEEeeCCeeEEEEEecCCC-CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 014362          135 --FSAEVMTLGSAD--HPNLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH  209 (426)
Q Consensus       135 --~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  209 (426)
                        ..+|+.-|+++.  +-.+.+-+++.    ...|||||+... .-.-.|.+     .++...++..+..++++.+.-|-
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHH
Confidence              234666666653  34444555443    356999998532 22222322     23334467778888888888887


Q ss_pred             HcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       210 ~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ..  .++||+||+.-|||+. ++.+.|+|||-|..
T Consensus       184 ~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         184 KE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             Hh--cCcccccchhhheEEE-CCeEEEEECccccc
Confidence            62  3999999999999999 78999999998753

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.9e-05  Score=85.39  Aligned_cols=150  Identities=15%  Similarity=0.221  Sum_probs=91.8

Q ss_pred             cceeeecCcEEEEEEEEcCCC--EEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCCc--ceEeeEEeeC---CeeEEE
Q 014362           96 DCCLGEGGFGKVYKGCLEKIE--QVVAIKQLDHRGV-QGVREFSAEVMTLGSAD-HPNL--VKLIGYCAEG---DQRLLV  166 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~-hpni--v~~~~~~~~~---~~~~lv  166 (426)
                      ...|+.|.+..+|+......+  ..+++|+...... .....+.+|+.+|+.+. |++|  .+++.+|.+.   ...|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            456889999999998765432  4677777654322 23356889999999985 6654  7788887764   357899


Q ss_pred             EEecCCCCHHH--------------------H---hhhhCCC-------CCCCC--HHHHHHHH---------------H
Q 014362          167 YEYMPLGSLDK--------------------H---LHDLRPD-------TRPLD--WNTRMKIA---------------A  199 (426)
Q Consensus       167 ~e~~~~gsL~~--------------------~---l~~~~~~-------~~~l~--~~~~~~i~---------------~  199 (426)
                      |||++|..+.+                    .   ||.....       ..+..  ..++..+.               -
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998764321                    1   1111100       01111  11121111               1


Q ss_pred             HHHHHHHHHHHcCC--------CCeEecCCCCCCeeeccC-Cc-eeEecccccccC
Q 014362          200 GASRGLQYLHEQLK--------QPVIYRDLKCSNILLEEG-YH-PKLSDFGLAKMG  245 (426)
Q Consensus       200 qi~~aL~~LH~~~~--------~~iiH~Dlkp~NIll~~~-~~-~kl~Dfgla~~~  245 (426)
                      .+...+.+|.....        ..+||+|+++.|||++.+ +. +-|.||.++...
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            12334566644322        359999999999999853 33 568899988653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=1.2e-05  Score=70.77  Aligned_cols=104  Identities=25%  Similarity=0.249  Sum_probs=80.7

Q ss_pred             HHHHHHHhcCCC-CCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCC
Q 014362          136 SAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ  214 (426)
Q Consensus       136 ~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~  214 (426)
                      ..|..+++.+.+ +++++++|+|-    .++|.||...+++...-... ..-...+|..+.+||.++++.+.+|+.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            358888888876 69999999994    35789999877664210000 0123478999999999999999999986444


Q ss_pred             CeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       215 ~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      .+.-.|++++|+-++++|.+|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            577789999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.08  E-value=9e-05  Score=65.53  Aligned_cols=130  Identities=18%  Similarity=0.221  Sum_probs=88.8

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCC----------------cccHHHHHHHHHHHhcCC------CCCcceEe
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG----------------VQGVREFSAEVMTLGSAD------HPNLVKLI  154 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~~~  154 (426)
                      ..||+|+.-.||.  +.. +....||+.....                ....++..+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            4599999999997  332 4457788887654                122455666666555544      78899999


Q ss_pred             eEEeeCCeeEEEEEecC------CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          155 GYCAEGDQRLLVYEYMP------LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~~~------~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      |+.+++...-+|+|.+.      .-||.+++..     ..++. .....+.   .-..||-..   .|+.+||+|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEEE
Confidence            99999999999999863      2357777754     34555 3333443   444566655   89999999999999


Q ss_pred             ccC--C--ceeEec-ccc
Q 014362          229 EEG--Y--HPKLSD-FGL  241 (426)
Q Consensus       229 ~~~--~--~~kl~D-fgl  241 (426)
                      ...  +  .+.|+| ||.
T Consensus       152 ~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EecCCCceEEEEEeCCCC
Confidence            643  2  466665 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.07  E-value=2.6e-05  Score=71.33  Aligned_cols=73  Identities=11%  Similarity=0.080  Sum_probs=44.9

Q ss_pred             ceeeecCcE-EEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC---CcceEeeEEeeC---CeeEEEEEe
Q 014362           97 CCLGEGGFG-KVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP---NLVKLIGYCAEG---DQRLLVYEY  169 (426)
Q Consensus        97 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~~~---~~~~lv~e~  169 (426)
                      ..|+.|+.. .||+.     +..+++|.....  .....+..|+.+|..+...   .+..+++.....   ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            347777766 58875     234677765432  2245688899988877531   344444443332   234789999


Q ss_pred             cCCCCHH
Q 014362          170 MPLGSLD  176 (426)
Q Consensus       170 ~~~gsL~  176 (426)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=7.8e-05  Score=65.49  Aligned_cols=137  Identities=27%  Similarity=0.394  Sum_probs=95.0

Q ss_pred             CCCCCCCcCHHHHHHhcCCccccceeeecCc-EEEEEEEEcCCCEEEEEEEecc---CCc------------------cc
Q 014362           74 SGKSAKPFTFDELAAATGNFRSDCCLGEGGF-GKVYKGCLEKIEQVVAIKQLDH---RGV------------------QG  131 (426)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~~------------------~~  131 (426)
                      .+..-.+|+.     -+.+++.+..||.|.- |.||++...  |+.+|+|.+..   ...                  ..
T Consensus        25 ~gPKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y   97 (207)
T PF13095_consen   25 PGPKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHY   97 (207)
T ss_pred             CCCCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhh
Confidence            4455666766     2278888999999999 999999988  78999999432   110                  11


Q ss_pred             HHHHHHHHHHHhcC---CCCCc--ceEeeEEeeC------------------CeeEEEEEecCCCCHHHHhhhhCCCCCC
Q 014362          132 VREFSAEVMTLGSA---DHPNL--VKLIGYCAEG------------------DQRLLVYEYMPLGSLDKHLHDLRPDTRP  188 (426)
Q Consensus       132 ~~~~~~E~~~l~~l---~hpni--v~~~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~  188 (426)
                      ...|..|.+...+|   .+.++  |+.+||..-.                  ....||.||++...             .
T Consensus        98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~  164 (207)
T PF13095_consen   98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------P  164 (207)
T ss_pred             cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------c
Confidence            23477787776665   45566  8888887221                  12357888776432             1


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       189 l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +.    ..-+.+|.+-|..+|..   +|+-+|+++.|..     .-+|+|||.+
T Consensus       165 ~~----~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  165 LQ----IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             cc----hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            22    22355666778889987   9999999999986     4589999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.01  E-value=5.8e-05  Score=80.62  Aligned_cols=195  Identities=19%  Similarity=0.192  Sum_probs=135.7

Q ss_pred             HHHHHHHHhcCCCCCcceEeeEEeeCCee----EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 014362          135 FSAEVMTLGSADHPNLVKLIGYCAEGDQR----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE  210 (426)
Q Consensus       135 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  210 (426)
                      ...|+..+....|+|++.++.|.......    .+..+++..-++...+..    -..++....+.+..++..||.|+|+
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence            44577778889999999999887554332    244578887788777765    4678889999999999999999998


Q ss_pred             cCCCCeEecCCCCC---CeeeccCCceeEe--cccccccCCCCCCcceeeeecccccccCccccccCCCCc--cCchhhH
Q 014362          211 QLKQPVIYRDLKCS---NILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF--KSDIYSF  283 (426)
Q Consensus       211 ~~~~~iiH~Dlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DvwSl  283 (426)
                      .   ...|.-|...   +...+..+.+.++  ||+.++.........   ...-+..|.+||......+..  ..|+|.+
T Consensus       305 ~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 L---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             h---ccceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence            7   5566555544   5555666777777  998887544332221   123455688888777665554  4799999


Q ss_pred             HHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHH
Q 014362          284 GVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV  363 (426)
Q Consensus       284 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei  363 (426)
                      |..+..+..|..+-......                   ..+++.        .....+.+....|+..++++|+++.++
T Consensus       379 gll~~~~~~~~~i~~~~~~~-------------------~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSAVP-------------------VSLLDV--------LSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHhhhhhcCcccccccch-------------------hhhhcc--------ccchhhhhhhhhhcchhhhhccchhhh
Confidence            99999999986654322111                   111111        001145678889999999999999999


Q ss_pred             HHH
Q 014362          364 VMA  366 (426)
Q Consensus       364 l~~  366 (426)
                      +..
T Consensus       432 l~~  434 (1351)
T KOG1035|consen  432 LTH  434 (1351)
T ss_pred             hhc
Confidence            853

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.92  E-value=0.00022  Score=69.90  Aligned_cols=76  Identities=16%  Similarity=0.111  Sum_probs=53.2

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccC-----C--cccHHHHHHHHHHHhcCC---CCCcceEeeEEeeCCeeEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----G--VQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~--~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv  166 (426)
                      +.||.|.+..||++.....++.|+||.-...     .  .....++..|.+.|..+.   ..++.+++.+  +....++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            3589999999999998754468999985421     1  123456777888887753   3457777776  33557899


Q ss_pred             EEecCCCC
Q 014362          167 YEYMPLGS  174 (426)
Q Consensus       167 ~e~~~~gs  174 (426)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PRK10593 hypothetical protein; Provisional

Probab=97.89  E-value=0.00028  Score=66.96  Aligned_cols=76  Identities=11%  Similarity=0.033  Sum_probs=54.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC---CCcceEeeEEeeC---CeeEEEEEe
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH---PNLVKLIGYCAEG---DQRLLVYEY  169 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~---~~~~lv~e~  169 (426)
                      ...||.|..+.||.....+ + .+.+|..+..  .....+..|...|+.+.-   ..+.++++++...   +..+||||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3459999999999986543 3 4666774331  123578889999988753   4678888877543   568999999


Q ss_pred             cCCCCH
Q 014362          170 MPLGSL  175 (426)
Q Consensus       170 ~~~gsL  175 (426)
                      ++|+++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.84  E-value=0.00026  Score=65.68  Aligned_cols=139  Identities=15%  Similarity=0.032  Sum_probs=78.8

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcc-eEeeEEeeCCeeEEEEEecCCCCHHH
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLGSLDK  177 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~gsL~~  177 (426)
                      +..|-.+.+|+...  .+..+++|..........-....|..+++.+....++ +++....    -++|+||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            45677788998863  3667888876543222112356788888888644343 3444332    368999999876532


Q ss_pred             --------------H---hhhhCCCCCCCCHHH-HHHHHHHH---------HHHHHHHHHc-----CCCCeEecCCCCCC
Q 014362          178 --------------H---LHDLRPDTRPLDWNT-RMKIAAGA---------SRGLQYLHEQ-----LKQPVIYRDLKCSN  225 (426)
Q Consensus       178 --------------~---l~~~~~~~~~l~~~~-~~~i~~qi---------~~aL~~LH~~-----~~~~iiH~Dlkp~N  225 (426)
                                    .   ||.......+++... ...+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence                          1   122111122222221 11211111         1112222111     12358999999999


Q ss_pred             eeeccCCceeEeccccccc
Q 014362          226 ILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~  244 (426)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=97.75  E-value=0.00084  Score=64.36  Aligned_cols=158  Identities=18%  Similarity=0.143  Sum_probs=81.3

Q ss_pred             CHHHHHHhcCCccc-----cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-----CCCCcc
Q 014362           82 TFDELAAATGNFRS-----DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLV  151 (426)
Q Consensus        82 ~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv  151 (426)
                      +.+++......|.+     .+.|+.|....+|+..... | .+++|++....   ...+..|+.++..|     ..|.++
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcce
Confidence            34444444444544     2446677778899987543 3 68899876222   22333344444443     233333


Q ss_pred             eEe-e--EEeeCCeeEEEEEecCCCCHH-----------HHh---hhhCCC-------CCCCCH-HHHHH----------
Q 014362          152 KLI-G--YCAEGDQRLLVYEYMPLGSLD-----------KHL---HDLRPD-------TRPLDW-NTRMK----------  196 (426)
Q Consensus       152 ~~~-~--~~~~~~~~~lv~e~~~~gsL~-----------~~l---~~~~~~-------~~~l~~-~~~~~----------  196 (426)
                      .-. |  +....+..+++++|++|..+.           ..|   |.....       ...+.+ .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            211 0  122345678999999987431           111   111100       011111 11111          


Q ss_pred             --HHHH-HHHHHHHHHHc----CCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          197 --IAAG-ASRGLQYLHEQ----LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       197 --i~~q-i~~aL~~LH~~----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                        ...+ +...+..+...    ...++||+|+.|.|||++.+...-|+||+.+..
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              1111 11122233211    245899999999999999765568999998753

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.74  E-value=0.00069  Score=61.81  Aligned_cols=74  Identities=16%  Similarity=0.148  Sum_probs=46.5

Q ss_pred             ceeeecCcEEEEEEEEcC-CCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC-cceEeeEEeeCCeeEEEEEecCCCC
Q 014362           97 CCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      +.|..|-...+|+..... .+..|++|+....... .-....|+.+++.+...+ .+++++.+.    -.+||||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            346677788999986543 2467889977643222 123346888888775433 344544432    237999999876


Q ss_pred             H
Q 014362          175 L  175 (426)
Q Consensus       175 L  175 (426)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.64  E-value=0.00051  Score=65.54  Aligned_cols=144  Identities=17%  Similarity=0.147  Sum_probs=79.7

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--CcceEeeE------EeeCCeeEEEE
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP--NLVKLIGY------CAEGDQRLLVY  167 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~------~~~~~~~~lv~  167 (426)
                      ...++.|....+|+....  +..+++|+......  ...+..|+.++..|...  .+.+++..      ....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            345667777889987643  33577888754321  23445566666555321  13333331      12235678999


Q ss_pred             EecCCCCHH-----------HH---hhhhCCC---CC-----CCCHHHHH------------HHHHHHHHHHHHHHH---
Q 014362          168 EYMPLGSLD-----------KH---LHDLRPD---TR-----PLDWNTRM------------KIAAGASRGLQYLHE---  210 (426)
Q Consensus       168 e~~~~gsL~-----------~~---l~~~~~~---~~-----~l~~~~~~------------~i~~qi~~aL~~LH~---  210 (426)
                      +|++|..+.           ..   +|.....   ..     .-.|....            .....+...+.++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999885432           11   1211110   00     00111100            011123345555542   


Q ss_pred             -cCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          211 -QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       211 -~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                       ....++||+|+.+.||+++.++.+.|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             124689999999999999988777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.61  E-value=0.001  Score=62.98  Aligned_cols=143  Identities=17%  Similarity=0.142  Sum_probs=82.9

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC--cceEeeE------EeeCCeeEEEE
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGY------CAEGDQRLLVY  167 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~------~~~~~~~~lv~  167 (426)
                      ...|..|....+|+....  +..+++|+....   ....+..|+.++..+.+.+  +.+++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            345777777899987654  346888987642   2345666777777664322  4444331      12344568999


Q ss_pred             EecCCCCHHH--------------HhhhhCCC-C------CCCCHHHHH----------HHHHHHHHHHHHHHH----cC
Q 014362          168 EYMPLGSLDK--------------HLHDLRPD-T------RPLDWNTRM----------KIAAGASRGLQYLHE----QL  212 (426)
Q Consensus       168 e~~~~gsL~~--------------~l~~~~~~-~------~~l~~~~~~----------~i~~qi~~aL~~LH~----~~  212 (426)
                      +|++|..+..              .||..... .      ....|....          .....+..++.++..    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999876521              11111100 0      111111110          011123334445443    11


Q ss_pred             CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       213 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ..+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            3479999999999999998777899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.51  E-value=1.4e-05  Score=87.01  Aligned_cols=162  Identities=15%  Similarity=0.023  Sum_probs=121.0

Q ss_pred             HHHHHHHHhcCCCCCcceEeeEEee--CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 014362          135 FSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL  212 (426)
Q Consensus       135 ~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  212 (426)
                      ...|...++...|+++...+.-...  ....+.+++|+.+|.+...|-.......+++..-+.....+.+.+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4445555666789988877654432  33567899999999999988765545556666555555555577777777663


Q ss_pred             --CCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHH
Q 014362          213 --KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL  290 (426)
Q Consensus       213 --~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~el  290 (426)
                        ..-.+|++||+.|.+|..+..+|+.++|+.+....  .........+++.|++|++...-.++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              22368999999999999999999999999983222  12223345788899999998888899999999999999999


Q ss_pred             HhCCCCCC
Q 014362          291 ITGRKAID  298 (426)
Q Consensus       291 ltg~~p~~  298 (426)
                      ..|..+|-
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            98887763

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.33  E-value=0.00018  Score=67.17  Aligned_cols=136  Identities=15%  Similarity=0.051  Sum_probs=90.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-----------------cc-----HHHHHHHHHHHhcCC-
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----------------QG-----VREFSAEVMTLGSAD-  146 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------~~-----~~~~~~E~~~l~~l~-  146 (426)
                      ..-+.++++||-|--+.||.+.+.. |...++|.-+....                 ..     .-...+|+..|+.|. 
T Consensus        91 ~~v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e  169 (465)
T KOG2268|consen   91 GSVESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE  169 (465)
T ss_pred             chhhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence            3457889999999999999998765 77888886431100                 00     112456787787774 


Q ss_pred             CC-CcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 014362          147 HP-NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN  225 (426)
Q Consensus       147 hp-niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N  225 (426)
                      |- -|.+.+++    +..++|||++.|-.|...-+-       .+...   +...+..-+.-|..+   |+||+|..--|
T Consensus       170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la~~---GlIHgDFNEFN  232 (465)
T KOG2268|consen  170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLANH---GLIHGDFNEFN  232 (465)
T ss_pred             cCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHHHc---Cceecccchhe
Confidence            32 24444443    456899999998887654321       12222   233333334445544   99999999999


Q ss_pred             eeeccCCceeEecccccc
Q 014362          226 ILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~  243 (426)
                      |++++++.++++||--+.
T Consensus       233 imv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             eEEecCCCEEEeechHhh
Confidence            999999999999996543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.27  E-value=0.0024  Score=60.72  Aligned_cols=141  Identities=22%  Similarity=0.250  Sum_probs=81.0

Q ss_pred             eeeecCcEEEEEEEEcC------CCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCc-ceEeeEEeeCCeeEEEEEec
Q 014362           98 CLGEGGFGKVYKGCLEK------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~  170 (426)
                      .|..|-...||+.....      .++.+++|+..... ........|+.++..+....+ .++++++..    .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence            35556667899887643      25788899976543 222345678877777753333 345555542    3689999


Q ss_pred             CCCCHHHH-----------------hhhhCCCC--C---CCC--HHHHHH--------------------------HHHH
Q 014362          171 PLGSLDKH-----------------LHDLRPDT--R---PLD--WNTRMK--------------------------IAAG  200 (426)
Q Consensus       171 ~~gsL~~~-----------------l~~~~~~~--~---~l~--~~~~~~--------------------------i~~q  200 (426)
                      +|.++...                 ||......  .   ..+  +.....                          +...
T Consensus        80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (302)
T cd05156          80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED  159 (302)
T ss_pred             CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence            88766431                 11111110  0   111  111111                          1122


Q ss_pred             HHHHHHHHHH------cCCCCeEecCCCCCCeeeccC----CceeEecccccc
Q 014362          201 ASRGLQYLHE------QLKQPVIYRDLKCSNILLEEG----YHPKLSDFGLAK  243 (426)
Q Consensus       201 i~~aL~~LH~------~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~  243 (426)
                      +...+.+|-.      ..+..++|+|+.+.|||++++    +.+.|+||..|.
T Consensus       160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            2223334432      124578999999999999984    789999998875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.24  E-value=0.0034  Score=59.54  Aligned_cols=128  Identities=17%  Similarity=0.224  Sum_probs=79.1

Q ss_pred             EEEEEEEcCCCEEEEEEEecc--CCcccHHHHHHHHHHHhcCCC--CCcceEeeEEeeCC--eeEEEEEecCCCCHHHHh
Q 014362          106 KVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSADH--PNLVKLIGYCAEGD--QRLLVYEYMPLGSLDKHL  179 (426)
Q Consensus       106 ~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~--~~~lv~e~~~~gsL~~~l  179 (426)
                      .+|.....  ++.+++. ...  ..........+|+.+++.+.-  .-+...++.|.+..  ..+.||+|++|..+...+
T Consensus        40 ~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~  116 (321)
T COG3173          40 DTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL  116 (321)
T ss_pred             ceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence            45554443  6778887 331  223345556778888877642  23455677777665  668999999985433222


Q ss_pred             hhhCCCCCCCCHHHHHHHHH-HHHHHHHHHHHc-----------------------------------------------
Q 014362          180 HDLRPDTRPLDWNTRMKIAA-GASRGLQYLHEQ-----------------------------------------------  211 (426)
Q Consensus       180 ~~~~~~~~~l~~~~~~~i~~-qi~~aL~~LH~~-----------------------------------------------  211 (426)
                      ..     ....    .+++. .++..|.-||+.                                               
T Consensus       117 ~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         117 PP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             Cc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            11     0000    11222 444444444432                                               


Q ss_pred             ---C-----CCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          212 ---L-----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       212 ---~-----~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                         .     ...++|+|+.+.||+++.++.+=|.||+++...
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence               1     345899999999999999988999999998754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.16  E-value=0.008  Score=57.88  Aligned_cols=73  Identities=14%  Similarity=0.155  Sum_probs=47.4

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEecc-------CCcccHHHHHHHHHHHhcCC--CC-CcceEeeEEeeCCeeEEEE
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDH-------RGVQGVREFSAEVMTLGSAD--HP-NLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-niv~~~~~~~~~~~~~lv~  167 (426)
                      .||.|....||++.....++.|+||+-..       .-.-...+..-|...|+...  -| .+.++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            37999999999999865446899998432       11223445556777776653  34 34445543  445567999


Q ss_pred             EecCC
Q 014362          168 EYMPL  172 (426)
Q Consensus       168 e~~~~  172 (426)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.01  E-value=0.0096  Score=57.71  Aligned_cols=140  Identities=17%  Similarity=0.200  Sum_probs=80.8

Q ss_pred             eeecCcEEEEEEEEcC----CCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcc-eEeeEEeeCCeeEEEEEecCCC
Q 014362           99 LGEGGFGKVYKGCLEK----IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLG  173 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~g  173 (426)
                      |-.|-.-.+|+..+..    .++.|++|+........+. -..|..+++.+..-++. ++++.+..+    .|.+|+++.
T Consensus        44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~  118 (344)
T PLN02236         44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR  118 (344)
T ss_pred             cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence            4446677899987532    2467889988765433333 36688888877544444 456665432    589999876


Q ss_pred             CHHHH-----------------hhhhCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHHHH-----cC
Q 014362          174 SLDKH-----------------LHDLRPDTR--PLDWNTRMKIAAGA-----------------SRGLQYLHE-----QL  212 (426)
Q Consensus       174 sL~~~-----------------l~~~~~~~~--~l~~~~~~~i~~qi-----------------~~aL~~LH~-----~~  212 (426)
                      +|...                 +|.......  ...+..+..+..++                 ...+..|..     ..
T Consensus       119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~  198 (344)
T PLN02236        119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ  198 (344)
T ss_pred             CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence            76421                 122111111  12233333333221                 111222221     11


Q ss_pred             CCCeEecCCCCCCeeecc-CCceeEecccccc
Q 014362          213 KQPVIYRDLKCSNILLEE-GYHPKLSDFGLAK  243 (426)
Q Consensus       213 ~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~  243 (426)
                      ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            336899999999999986 4679999998875

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.00  E-value=0.013  Score=57.59  Aligned_cols=73  Identities=16%  Similarity=0.114  Sum_probs=49.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccC----Cc---ccHHHHHHHHHHHhcCC---CCCcceEeeEEeeCCeeEE
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR----GV---QGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~---~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~l  165 (426)
                      .+.||.|....||+....  +..++||+-...    +.   ....+-..|+..|+.+.   ..++.+++.++.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            345899999999998764  456889986521    11   12344445566666553   3478888888874  4678


Q ss_pred             EEEecCC
Q 014362          166 VYEYMPL  172 (426)
Q Consensus       166 v~e~~~~  172 (426)
                      +|||+++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999976

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.99  E-value=0.0078  Score=56.58  Aligned_cols=73  Identities=18%  Similarity=0.224  Sum_probs=46.6

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC---CCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      ...|+-|....+|+..  .+++.+.||.-..   .....|..|.+-|+.|.   --.+.+++++....+..+||+||++.
T Consensus        22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            3458888899999876  5578899998762   23356778888877773   44577888888777778999999986


Q ss_pred             C
Q 014362          173 G  173 (426)
Q Consensus       173 g  173 (426)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.89  E-value=0.0056  Score=59.69  Aligned_cols=74  Identities=18%  Similarity=0.158  Sum_probs=48.7

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEecc---C--C-cccHHHHHHHHHHHhcCC--CC-CcceEeeEEeeCCeeEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDH---R--G-VQGVREFSAEVMTLGSAD--HP-NLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~--~-~~~~~~~~~E~~~l~~l~--hp-niv~~~~~~~~~~~~~lv~  167 (426)
                      ..||.|....||++.+...++.|+||+-..   .  + +-...+..-|.+.|+.+.  -| .+.++|.+  +.....+||
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM  112 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM  112 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence            458999999999999854356799998432   1  1 223555666777777653  34 45556543  444567899


Q ss_pred             EecCC
Q 014362          168 EYMPL  172 (426)
Q Consensus       168 e~~~~  172 (426)
                      |+++.
T Consensus       113 EdL~~  117 (409)
T PRK12396        113 EDLSD  117 (409)
T ss_pred             HhCcc
Confidence            99854

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.88  E-value=0.0094  Score=56.90  Aligned_cols=138  Identities=17%  Similarity=0.188  Sum_probs=91.1

Q ss_pred             ccceeeecCcEEEEEEEEcCCCEEEEEEEeccC------------------------Ccc-cHHH-HHHHHHHHhcCCCC
Q 014362           95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR------------------------GVQ-GVRE-FSAEVMTLGSADHP  148 (426)
Q Consensus        95 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------~~~-~~~~-~~~E~~~l~~l~hp  148 (426)
                      +..+|..|--..||.|.... |..+|||+++-.                        ++. .++- ...|++-|.+++.-
T Consensus       148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            44568888889999987665 788999997421                        000 0111 23466667666543


Q ss_pred             CcceEeeEEeeCCeeEEEEEecCC-CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCee
Q 014362          149 NLVKLIGYCAEGDQRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       149 niv~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl  227 (426)
                      .|.-.--+..  ....|||+|+-. |--.-.|+     ...++...+..+-.+++.-|.-|...|  ++||.||.--|+|
T Consensus       227 GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~L  297 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLL  297 (520)
T ss_pred             CCCCCCceee--ecceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhhe
Confidence            3321111111  134699999842 22222333     355777788888899999999888764  8999999999999


Q ss_pred             eccCCceeEecccccc
Q 014362          228 LEEGYHPKLSDFGLAK  243 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~  243 (426)
                      +-+ |.+.|+|.+-+.
T Consensus       298 yhd-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  298 YHD-GKLYIIDVSQSV  312 (520)
T ss_pred             EEC-CEEEEEEccccc
Confidence            975 588999987664

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.85  E-value=0.011  Score=55.37  Aligned_cols=31  Identities=29%  Similarity=0.389  Sum_probs=25.7

Q ss_pred             CCeEecCCCCCCeeeccCCc-eeEeccccccc
Q 014362          214 QPVIYRDLKCSNILLEEGYH-PKLSDFGLAKM  244 (426)
Q Consensus       214 ~~iiH~Dlkp~NIll~~~~~-~kl~Dfgla~~  244 (426)
                      ..++|+|+.|.|||+++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.74  E-value=0.023  Score=54.19  Aligned_cols=29  Identities=24%  Similarity=0.335  Sum_probs=25.7

Q ss_pred             CCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       214 ~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999998 678999998765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.68  E-value=0.045  Score=52.44  Aligned_cols=140  Identities=23%  Similarity=0.301  Sum_probs=80.7

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC---CCC---cceEee----EEeeCCeeEEEEE
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPN---LVKLIG----YCAEGDQRLLVYE  168 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpn---iv~~~~----~~~~~~~~~lv~e  168 (426)
                      |.. .-..||+..... |. +++|+....  ....++..|+..|..|.   .+=   |...-|    ....+...+-|++
T Consensus        34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            444 456788887664 43 488888765  33455666777776653   221   222222    2222247788999


Q ss_pred             ecCCCCHHH---------------Hhhh----hC----CCCCCCCHH-------------HHHHHHHHHHHHHHHHHHc-
Q 014362          169 YMPLGSLDK---------------HLHD----LR----PDTRPLDWN-------------TRMKIAAGASRGLQYLHEQ-  211 (426)
Q Consensus       169 ~~~~gsL~~---------------~l~~----~~----~~~~~l~~~-------------~~~~i~~qi~~aL~~LH~~-  211 (426)
                      |++|..+..               .||.    +.    .......|.             .......++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999888772               1111    10    011122332             0111333444444444433 


Q ss_pred             ---CCCC---eEecCCCCCCeeeccCCc-eeEecccccc
Q 014362          212 ---LKQP---VIYRDLKCSNILLEEGYH-PKLSDFGLAK  243 (426)
Q Consensus       212 ---~~~~---iiH~Dlkp~NIll~~~~~-~kl~Dfgla~  243 (426)
                         .+..   +||+|+.|.|||++.+.. +.++|||-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               2334   999999999999998874 8899999875

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.55  E-value=0.03  Score=53.38  Aligned_cols=32  Identities=19%  Similarity=0.241  Sum_probs=28.7

Q ss_pred             CCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       213 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ..++||+|+.+.|||++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999998999999998864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.54  E-value=0.011  Score=52.49  Aligned_cols=137  Identities=12%  Similarity=0.041  Sum_probs=85.2

Q ss_pred             EEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHH
Q 014362          118 VVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK  196 (426)
Q Consensus       118 ~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~  196 (426)
                      +..+|++..-... ...-|..++.++.++.  .|+++..-  ....+-+|+|+|--.             ....    ..
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~-------------~i~~----~N  145 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI-------------KINF----SN  145 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-------------ccch----hH
Confidence            4556776654444 3445677888888763  46776632  334566999998421             1111    11


Q ss_pred             HHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCc
Q 014362          197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF  276 (426)
Q Consensus       197 i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  276 (426)
                      ++..=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+..-.              .+..|.--|   ....+.
T Consensus       146 ~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~  207 (308)
T PF07387_consen  146 FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQ  207 (308)
T ss_pred             HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccCh
Confidence            111113667888965 46899999999999999999999999875421              011122211   234466


Q ss_pred             cCchhhHHHHHHHHHhC
Q 014362          277 KSDIYSFGVVLLELITG  293 (426)
Q Consensus       277 ~~DvwSlG~il~elltg  293 (426)
                      ++.+-+|=.-+++++..
T Consensus       208 ~aE~~~fv~s~l~~v~~  224 (308)
T PF07387_consen  208 EAEVKVFVKSCLKLVEK  224 (308)
T ss_pred             HHHHHHHHHHHHHHHHH
Confidence            77777777777777664

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.54  E-value=0.023  Score=54.73  Aligned_cols=140  Identities=19%  Similarity=0.240  Sum_probs=77.5

Q ss_pred             eeecCcEEEEEEEEcCC---CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcc-eEeeEEeeCCeeEEEEEecCCCC
Q 014362           99 LGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      |..|=...+|+......   +..|.+|+........ -.-..|..+++.+..-++. ++++++..+    +|.+|+++.+
T Consensus        22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~~   96 (330)
T PLN02421         22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINART   96 (330)
T ss_pred             eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCCC
Confidence            43455667888865432   2378899886543322 2235688888887655554 456555322    5899998766


Q ss_pred             HHH--------------Hh---hhhCCC-C-CCCCHHHHHHHHHHH----------------------HHHHHHHHHc--
Q 014362          175 LDK--------------HL---HDLRPD-T-RPLDWNTRMKIAAGA----------------------SRGLQYLHEQ--  211 (426)
Q Consensus       175 L~~--------------~l---~~~~~~-~-~~l~~~~~~~i~~qi----------------------~~aL~~LH~~--  211 (426)
                      |..              .|   |..... . .+-.+..+..+..++                      ..-+..+...  
T Consensus        97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~  176 (330)
T PLN02421         97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD  176 (330)
T ss_pred             CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence            521              11   111101 1 111233333332221                      1112222111  


Q ss_pred             ---CCCCeEecCCCCCCeeecc-CCceeEecccccc
Q 014362          212 ---LKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAK  243 (426)
Q Consensus       212 ---~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~  243 (426)
                         .+.-.+|.|+.+.|||+++ ++.++++||..|.
T Consensus       177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence               0123799999999999975 5789999998875

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.26  E-value=0.0065  Score=60.27  Aligned_cols=48  Identities=21%  Similarity=0.276  Sum_probs=38.1

Q ss_pred             HHHHHHHHHHhcCCCCCcceEeeEEeeC-CeeEEEEEecCCCCHHHHhhh
Q 014362          133 REFSAEVMTLGSADHPNLVKLIGYCAEG-DQRLLVYEYMPLGSLDKHLHD  181 (426)
Q Consensus       133 ~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~  181 (426)
                      .++.....+++.+.|+|+..++++.... ....+|+|++ +.||++.+..
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            4566678889999999999999887543 3467889998 6899988865

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.12  E-value=0.018  Score=54.91  Aligned_cols=72  Identities=18%  Similarity=0.176  Sum_probs=56.6

Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      .+.|++|++- |++|. .       .....+.++..|+++.+..+.-+...  -..-|||+.-.||||+ +|++-|+||-
T Consensus       299 ~y~yl~~kdh-gt~is-~-------ik~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-I-------IKADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             eEEEEEEecC-Cceee-e-------eecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence            4556777774 44442 1       13356789999999998888888764  4789999999999999 8999999999


Q ss_pred             cccc
Q 014362          241 LAKM  244 (426)
Q Consensus       241 la~~  244 (426)
                      +++.
T Consensus       367 lsRl  370 (488)
T COG5072         367 LSRL  370 (488)
T ss_pred             eeec
Confidence            9985

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.08  E-value=0.34  Score=46.59  Aligned_cols=71  Identities=13%  Similarity=-0.015  Sum_probs=41.6

Q ss_pred             cCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--Ccce---Eee--EEeeCCeeEEEEEecCCCC
Q 014362          102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP--NLVK---LIG--YCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus       102 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~---~~~--~~~~~~~~~lv~e~~~~gs  174 (426)
                      +.-..||+..... +..+++|+..... .....+..|+..+..|...  .++.   .-|  +...+...+.|+++++|..
T Consensus        36 s~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            4556799886543 5678899875332 2345566777776655321  1222   112  1233456788999998764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.92  E-value=0.017  Score=51.66  Aligned_cols=29  Identities=34%  Similarity=0.359  Sum_probs=20.8

Q ss_pred             CeEecCCCCCCeee-ccCCceeEecccccc
Q 014362          215 PVIYRDLKCSNILL-EEGYHPKLSDFGLAK  243 (426)
Q Consensus       215 ~iiH~Dlkp~NIll-~~~~~~kl~Dfgla~  243 (426)
                      .++|.||.|.|||+ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            57999999999999 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.70  E-value=0.038  Score=53.56  Aligned_cols=61  Identities=18%  Similarity=0.057  Sum_probs=45.0

Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE  230 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~  230 (426)
                      ..|+-+|+.|.++..++..     ...++....+++.--++||--+--.  .+.+|.|+.|.||++.-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence            4567778889899888865     4456666777777777776554433  27999999999999954

>PRK06148 hypothetical protein; Provisional

Probab=95.61  E-value=0.18  Score=56.08  Aligned_cols=32  Identities=34%  Similarity=0.327  Sum_probs=26.7

Q ss_pred             CCCeEecCCCCCCeeeccCC--cee-Eeccccccc
Q 014362          213 KQPVIYRDLKCSNILLEEGY--HPK-LSDFGLAKM  244 (426)
Q Consensus       213 ~~~iiH~Dlkp~NIll~~~~--~~k-l~Dfgla~~  244 (426)
                      +.++||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            55899999999999999875  454 999998753

>PTZ00384 choline kinase; Provisional

Probab=95.43  E-value=0.2  Score=49.20  Aligned_cols=74  Identities=16%  Similarity=0.184  Sum_probs=44.4

Q ss_pred             eeeecCcEEEEEEEEcCCC-E-----EEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcce-EeeEEeeCCeeEEEEEec
Q 014362           98 CLGEGGFGKVYKGCLEKIE-Q-----VVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK-LIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~-~-----~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~-~~~~~~~~~~~~lv~e~~  170 (426)
                      .|..|=...+|++...... .     .|.++...... ...-.-..|+.+++.+...++.+ +++.+..    ++|.||+
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI  131 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV  131 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence            4545777889998764321 1     24444433222 21222356888888887655554 5555542    5899999


Q ss_pred             CCCCHH
Q 014362          171 PLGSLD  176 (426)
Q Consensus       171 ~~gsL~  176 (426)
                      +|.+|.
T Consensus       132 eGr~l~  137 (383)
T PTZ00384        132 EGNTMG  137 (383)
T ss_pred             ccccCC
Confidence            987764

>PTZ00296 choline kinase; Provisional

Probab=95.34  E-value=0.18  Score=50.54  Aligned_cols=74  Identities=9%  Similarity=0.028  Sum_probs=45.7

Q ss_pred             ceeeecCcEEEEEEEEcCC--------CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcc-eEeeEEeeCCeeEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKI--------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVY  167 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~  167 (426)
                      +.|..|=.-.+|+......        ++.|.+++........+ .-..|..+++.+...+|. ++++.+.    -+.|.
T Consensus       111 ~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I~  185 (442)
T PTZ00296        111 NQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRIE  185 (442)
T ss_pred             EEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEEE
Confidence            4455555667888875421        46788888866543333 345677777776554444 3555543    24689


Q ss_pred             EecCCCCH
Q 014362          168 EYMPLGSL  175 (426)
Q Consensus       168 e~~~~gsL  175 (426)
                      +|++|.+|
T Consensus       186 efi~g~~l  193 (442)
T PTZ00296        186 EWLYGDPL  193 (442)
T ss_pred             EeeCCccC
Confidence            99988744

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	426
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-55
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-55
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-53
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-52
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-45
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-44
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-43
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-41
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-21
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-21
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		8e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		9e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-20
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-20
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		9e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-19
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-19
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-19
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-18
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-17
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-17
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		5e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-16
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-16
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		7e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		8e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-15
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		6e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		8e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		9e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-14
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-13
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-13
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-10
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-10
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-10
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-10
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-10
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-10
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-10
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		7e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-07
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		7e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		8e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		7e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		9e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3soa_A	444	Full-Length Human Camkii Length = 444		1e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  213 bits (541), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 121/294 (41%), Positives = 178/294 (60%), Gaps = 8/294 (2%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSA 137
           K F+  EL  A+ NF +   LG GGFGKVYKG L     +VA+K+L     QG   +F  
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGELQFQT 84
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMK 196
           EV  +  A H NL++L G+C    +RLLVY YM  GS+   L + RP+++ PLDW  R +
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQR 143
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
           IA G++RGL YLH+     +I+RD+K +NILL+E +   + DFGLAK+    D  HV   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXA 202
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK--DRKELNLVAWARP 314
           V GT G+ AP+Y  TG+ + K+D++ +GV+LLELITG++A D  +  +  ++ L+ W + 
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
           + K++K    +VD  LQG Y    + Q + +A +C Q  P  RP +++VV  L 
Sbjct: 263 LLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  211 bits (536), Expect = 8e-55,   Method: Compositional matrix adjust.
 Identities = 120/294 (40%), Positives = 177/294 (60%), Gaps = 8/294 (2%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSA 137
           K F+  EL  A+ NF +   LG GGFGKVYKG L     +VA+K+L     QG   +F  
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLAD-GXLVAVKRLKEERTQGGELQFQT 76
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMK 196
           EV  +  A H NL++L G+C    +RLLVY YM  GS+   L + RP+++ PLDW  R +
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQR 135
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
           IA G++RGL YLH+     +I+RD+K +NILL+E +   + DFGLAK+    D  HV   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVXXA 194
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK--DRKELNLVAWARP 314
           V G  G+ AP+Y  TG+ + K+D++ +GV+LLELITG++A D  +  +  ++ L+ W + 
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
           + K++K    +VD  LQG Y    + Q + +A +C Q  P  RP +++VV  L 
Sbjct: 255 LLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 117/285 (41%), Positives = 168/285 (58%), Gaps = 5/285 (1%)
Query: 85  ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS 144
           +L  AT NF     +G G FGKVYKG L    +V A+K+      QG+ EF  E+ TL  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEFETEIETLSF 91
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
             HP+LV LIG+C E ++ +L+Y+YM  G+L +HL+     T  + W  R++I  GA+RG
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L YLH    + +I+RD+K  NILL+E + PK++DFG++K G   D+TH+   V GT GY 
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
            P+Y + G+LT KSD+YSFGVVL E++  R AI Q+  R+ +NL  WA     +     Q
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQ 267
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
           +VDP+L  +     L +    A  C+      RP++ DV+  L Y
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  201 bits (512), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 116/285 (40%), Positives = 167/285 (58%), Gaps = 5/285 (1%)
Query: 85  ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS 144
           +L  AT NF     +G G FGKVYKG L    +V A+K+      QG+ EF  E+ TL  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV-ALKRRTPESSQGIEEFETEIETLSF 91
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
             HP+LV LIG+C E ++ +L+Y+YM  G+L +HL+     T  + W  R++I  GA+RG
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L YLH    + +I+RD+K  NILL+E + PK++DFG++K G    +TH+   V GT GY 
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
            P+Y + G+LT KSD+YSFGVVL E++  R AI Q+  R+ +NL  WA     +     Q
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-HNNGQLEQ 267
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
           +VDP+L  +     L +    A  C+      RP++ DV+  L Y
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 115/295 (38%), Positives = 165/295 (55%), Gaps = 24/295 (8%)
Query: 81  FTFDELAAATGNFRSDCC------LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQ 130
           F+F EL   T NF           +GEGGFG VYKG +      VA+K+L    D    +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 72
Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
             ++F  E+  +    H NLV+L+G+ ++GD   LVY YMP GSL   L  L   T PL 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLS 131
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
           W+ R KIA GA+ G+ +LHE      I+RD+K +NILL+E +  K+SDFGLA+      +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           T + +R++GT  Y AP+ A+ G++T KSDIYSFGVVLLE+ITG  A+D+   R+   L+ 
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLD 245
Query: 311 WARPMFKDRKNFSQMVDPSLQ--GQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
               +  + K     +D  +       V  +Y   ++A+ C+ E+ N RP I  V
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKV 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 115/295 (38%), Positives = 164/295 (55%), Gaps = 24/295 (8%)
Query: 81  FTFDELAAATGNFRSDCC------LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQ 130
           F+F EL   T NF           +GEGGFG VYKG +      VA+K+L    D    +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 72
Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
             ++F  E+  +    H NLV+L+G+ ++GD   LVY YMP GSL   L  L   T PL 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLS 131
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
           W+ R KIA GA+ G+ +LHE      I+RD+K +NILL+E +  K+SDFGLA+      +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           T +  R++GT  Y AP+ A+ G++T KSDIYSFGVVLLE+ITG  A+D+   R+   L+ 
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLD 245
Query: 311 WARPMFKDRKNFSQMVDPSLQ--GQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
               +  + K     +D  +       V  +Y   ++A+ C+ E+ N RP I  V
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  174 bits (440), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 114/295 (38%), Positives = 163/295 (55%), Gaps = 24/295 (8%)
Query: 81  FTFDELAAATGNFRSDCC------LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQ 130
           F+F EL   T NF           +GEGGFG VYKG +      VA+K+L    D    +
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 66
Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
             ++F  E+  +    H NLV+L+G+ ++GD   LVY YMP GSL   L  L   T PL 
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLS 125
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
           W+ R KIA GA+ G+ +LHE      I+RD+K +NILL+E +  K+SDFGLA+      +
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
             +  R++GT  Y AP+ A+ G++T KSDIYSFGVVLLE+ITG  A+D+   R+   L+ 
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLD 239
Query: 311 WARPMFKDRKNFSQMVDPSLQ--GQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
               +  + K     +D  +       V  +Y   ++A+ C+ E+ N RP I  V
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKV 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 112/300 (37%), Positives = 161/300 (53%), Gaps = 34/300 (11%)
Query: 81  FTFDELAAATGNFRSDCC------LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQ 130
           F+F EL   T NF            GEGGFG VYKG +      VA+K+L    D    +
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITTEE 63
Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
             ++F  E+       H NLV+L+G+ ++GD   LVY Y P GSL   L  L   T PL 
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLS 122
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
           W+ R KIA GA+ G+ +LHE      I+RD+K +NILL+E +  K+SDFGLA+      +
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
               +R++GT  Y AP+ A+ G++T KSDIYSFGVVLLE+ITG  A+D+ ++ + L  + 
Sbjct: 180 XVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 238
Query: 311 WARPM-------FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
                       + D+K  +     S++  Y         ++A+ C+ E+ N RP I  V
Sbjct: 239 EEIEDEEKTIEDYIDKKX-NDADSTSVEAXY---------SVASQCLHEKKNKRPDIKKV 288

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 114/215 (53%), Gaps = 25/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL---DHRG----VQGVREFSAEVMTLGSADHPNLV 151
           +G+GGFG V+KG L K + VVAIK L   D  G    ++  +EF  EV  + + +HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           KL G      +  +V E++P G L    H L     P+ W+ ++++    + G++Y+  Q
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 212 LKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
              P+++RDL+  NI L+          K++DFGL++        H  + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 267 DY--AMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299
           +   A     T K+D YSF ++L  ++TG    D+
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 99  LGEGGFGKVYKG-----CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+         E+ + +VA+K L        ++F  E   L    H ++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
            G C EG   L+V+EYM  G L++ L    PD +           PL     + +A+  +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+ YL        ++RDL   N L+ +G   K+ DFG+++   S D   V  R M    
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN 321
           +  P+  +  + T +SD++SFGVVL E+ T G++   Q  + + ++ +   R + + R  
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA- 284
Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
                 P            +  AI   C Q +P  R +I DV   L  LA
Sbjct: 285 ----CPP------------EVYAIMRGCWQREPQQRHSIKDVHARLQALA 318

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 99  LGEGGFGKVYKG-----CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+         E+ + +VA+K L        ++F  E   L    H ++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
            G C EG   L+V+EYM  G L++ L    PD +           PL     + +A+  +
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+ YL        ++RDL   N L+ +G   K+ DFG+++   S D   V  R M    
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN 321
           +  P+  +  + T +SD++SFGVVL E+ T G++   Q  + + ++ +   R + + R  
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA- 255
Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
                 P            +  AI   C Q +P  R +I DV   L  LA
Sbjct: 256 ----CPP------------EVYAIMRGCWQREPQQRHSIKDVHARLQALA 289

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 37/290 (12%)
Query: 99  LGEGGFGKVYKG-----CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+         E+ + +VA+K L        ++F  E   L    H ++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
            G C EG   L+V+EYM  G L++ L    PD +           PL     + +A+  +
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            G+ YL        ++RDL   N L+ +G   K+ DFG+++   S D   V  R M    
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN 321
           +  P+  +  + T +SD++SFGVVL E+ T G++   Q  + + ++ +   R + + R  
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRA- 261
Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
                 P            +  AI   C Q +P  R +I DV   L  LA
Sbjct: 262 ----CPP------------EVYAIMRGCWQREPQQRHSIKDVHARLQALA 295

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 25/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL---DHRG----VQGVREFSAEVMTLGSADHPNLV 151
           +G+GGFG V+KG L K + VVAIK L   D  G    ++  +EF  EV  + + +HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           KL G      +  +V E++P G L    H L     P+ W+ ++++    + G++Y+  Q
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 212 LKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
              P+++RDL+  NI L+          K++DF L++        H  + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 267 DY--AMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299
           +   A     T K+D YSF ++L  ++TG    D+
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 113/215 (52%), Gaps = 25/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL---DHRG----VQGVREFSAEVMTLGSADHPNLV 151
           +G+GGFG V+KG L K + VVAIK L   D  G    ++  +EF  EV  + + +HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           KL G      +  +V E++P G L    H L     P+ W+ ++++    + G++Y+  Q
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 212 LKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
              P+++RDL+  NI L+          K++DFG ++        H  + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 267 DY--AMTGQLTFKSDIYSFGVVLLELITGRKAIDQ 299
           +   A     T K+D YSF ++L  ++TG    D+
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 128/288 (44%), Gaps = 35/288 (12%)
Query: 99  LGEGGFGKV-----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV     Y  C E+ + +VA+K L        ++F  E   L +  H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---------RPLDWNTRMKIAAGASRG 204
            G C EGD  ++V+EYM  G L+K L    PD            L  +  + IA   + G
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           + YL     Q  ++RDL   N L+ E    K+ DFG+++   S D   V    M    + 
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M  + T +SD++S GVVL E+ T G++   Q  + + +  +   R + + R    
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQ 257
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           ++ +  L                  C Q +P+MR  I  +   L  LA
Sbjct: 258 EVYELMLG-----------------CWQREPHMRKNIKGIHTLLQNLA 288

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 125/282 (44%), Gaps = 22/282 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V++      +  V I        + V EF  EV  +    HPN+V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V EY+  GSL + LH      + LD   R+ +A   ++G+ YLH +   P+++
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDLK  N+L+++ Y  K+ DFGL+++  S      S    GT  + AP+         KS
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRLKAS--XFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK-DRKNFSQMVDPSLQGQYPVR 337
           D+YSFGV+L EL T ++        + +  V      FK  R    + ++P         
Sbjct: 221 DVYSFGVILWELATLQQPWGNLNPAQVVAAVG-----FKCKRLEIPRNLNP--------- 266
Query: 338 GLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQN 379
              Q  AI   C   +P  RP+   ++  L  L      P N
Sbjct: 267 ---QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 129/283 (45%), Gaps = 24/283 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V++      +  V I        + V EF  EV  +    HPN+V  +G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V EY+  GSL + LH      + LD   R+ +A   ++G+ YLH +   P+++
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR-VMGTYGYCAPDYAMTGQLTFK 277
           R+LK  N+L+++ Y  K+ DFGL+++  S   T +S++   GT  + AP+         K
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKAS---TFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK-DRKNFSQMVDPSLQGQYPV 336
           SD+YSFGV+L EL T ++        + +  V      FK  R    + ++P        
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-----FKCKRLEIPRNLNP-------- 266
Query: 337 RGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQN 379
               Q  AI   C   +P  RP+   ++  L  L      P N
Sbjct: 267 ----QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 54/302 (17%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 129
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 130 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 186
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 228
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALNYLA 371
             QGQ  V  L + L                  I   C     N RP+  D+ + ++ + 
Sbjct: 229 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 288
Query: 372 SQ 373
            Q
Sbjct: 289 DQ 290

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/302 (29%), Positives = 132/302 (43%), Gaps = 54/302 (17%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 162
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 219
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 261
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALNYLA 371
             QGQ  V  L + L                  I   C     N RP+  D+ + ++ + 
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
Query: 372 SQ 373
            Q
Sbjct: 322 DQ 323

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
             R    LG G FG V+KG      E I+  V IK + D  G Q  +  +  ++ +GS D
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           H ++V+L+G C  G    LV +Y+PLGSL  H+   R    P   L+W  ++      ++
Sbjct: 92  HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AK 144
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL E     +++R+L   N+LL+     +++DFG+A + P  DK  + +       +
Sbjct: 145 GMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 201
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            A +    G+ T +SD++S+GV + EL+T
Sbjct: 202 MALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPES 188
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 230
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 18/209 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
             R    LG G FG V+KG      E I+  V IK + D  G Q  +  +  ++ +GS D
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           H ++V+L+G C  G    LV +Y+PLGSL  H+   R    P   L+W  ++      ++
Sbjct: 74  HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AK 126
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL E     +++R+L   N+LL+     +++DFG+A + P  DK  + +       +
Sbjct: 127 GMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            A +    G+ T +SD++S+GV + EL+T
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K          + P       F +M+  
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----------SPP-----AEFMRMIGN 233
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 136
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 137 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 193
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K          + P       F +M+  
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----------SPP-----AEFMRMIGN 235
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 236 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 292

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 20  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH         +    + IA   +RG+ YLH    + +
Sbjct: 77  STK-PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSI 129
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+      +  
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 222

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 138
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 139 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 195
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K          + P       F +M+  
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----------SPP-----AEFMRMIGN 237
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 238 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 294

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 130
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 131 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 187
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K          + P       F +M+  
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----------SPP-----AEFMRMIGN 229
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 230 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 188
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 230
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 88/297 (29%), Positives = 132/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 188
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K          + P       F +M+  
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----------SPP-----AEFMRMIGN 230
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 231 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 135
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 136 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 192
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 234
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 235 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 291

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 137
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 138 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 194
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 236
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 237 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 293

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 149
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 150 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 206
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 248
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 133/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ E++P GSL ++L  H  R D   L     ++  +   +G++YL  
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K          + P       F +M+  
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT---YIEKSK----------SPP-----AEFMRMIGN 233
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEYLG- 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 191
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 233
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 234 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 290

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 130/297 (43%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 149
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+RDL   NIL+E     K+ DFGL K+ P  DK     +  G     + AP+ 
Sbjct: 150 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKVKEPGESPIFWYAPES 206
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 248
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 249 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 131/297 (44%), Gaps = 54/297 (18%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           G C    +R   L+ EY+P GSL  +L  H  R D   L     ++  +   +G++YL  
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG- 132
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT--YGYCAPDY 268
              +  I+R+L   NIL+E     K+ DFGL K+ P  DK +   +  G     + AP+ 
Sbjct: 133 --TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPES 189
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               + +  SD++SFGVVL EL T    I+++K                    F +M+  
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT---YIEKSKSPP---------------AEFMRMIGN 231
Query: 329 SLQGQYPVRGLYQAL-----------------AIAAMCVQEQPNMRPAITDVVMALN 368
             QGQ  V  L + L                  I   C     N RP+  D+ + ++
Sbjct: 232 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 288

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 35/214 (16%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH-------RGVQGVREFSAEVMTLGSADHPNL 150
            +G GGFGKVY+     I   VA+K   H       + ++ VR+   E        HPN+
Sbjct: 14  IIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQ---EAKLFAMLKHPNI 68
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLH 209
           + L G C +     LV E+   G L++ L   R P    ++W  ++      +RG+ YLH
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLH 122
Query: 210 EQLKQPVIYRDLKCSNILLEEGYH--------PKLSDFGLAKMGPSGDKTHVSTRV--MG 259
           ++   P+I+RDLK SNIL+ +            K++DFGLA+      + H +T++   G
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRTTKMSAAG 176
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            Y + AP+       +  SD++S+GV+L EL+TG
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH         +    + IA   +RG+ YLH    + +
Sbjct: 89  STK-PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQ 273
           I+RDLK +NI L E    K+ DFGLA        +H   ++ G+  + AP+      +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/213 (31%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 32  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
            +   Q  +V ++    SL  HLH         +    + IA   +RG+ YLH    + +
Sbjct: 89  -STAPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQ 273
           I+RDLK +NI L E    K+ DFGLA        +H   ++ G+  + AP+      +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 130/291 (44%), Gaps = 38/291 (13%)
Query: 99  LGEGGFGKVYKG-CL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+   C      K + +VA+K L    +   ++F  E   L +  H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RP------LDWNTRMKIAAGA 201
            G C +GD  ++V+EYM  G L+K L    PD       +P      L  +  + IA+  
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
           + G+ YL     Q  ++RDL   N L+      K+ DFG+++   S D   V    M   
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRK 320
            +  P+  M  + T +SD++SFGV+L E+ T G++   Q  + + +  +   R + + R 
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV 259
Query: 321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
              ++ D  L                  C Q +P  R  I ++   L+ L 
Sbjct: 260 CPKEVYDVMLG-----------------CWQREPQQRLNIKEIYKILHALG 293

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 192 DVWAFGVLLWEIAT 205

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 130
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
            +   Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 73  -STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 19/221 (8%)
Query: 98  CLGEGGFGKVYKGCL----EKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
            LG G FG VYKG      E ++  VAIK L+   G +   EF  E + + S DHP+LV+
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLH 209
           L+G C     +L V + MP G L +++H+ + +      L+W  ++      ++G+ YL 
Sbjct: 82  LLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 134
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E+    +++RDL   N+L++   H K++DFGLA++    +K + +        + A +  
Sbjct: 135 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 191
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
              + T +SD++S+GV + EL+T G K  D    R+  +L+
Sbjct: 192 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 43  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 100 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 152
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 153
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
                 +V EYMP G+L  +L +  R +   +     + +A   S  ++YL    K+  I
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAV---VLLYMATQISSAMEYLE---KKNFI 152
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E +  K++DFGL+++  +GD             + AP+       + K
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 278 SDIYSFGVVLLELIT 292
           SD+++FGV+L E+ T
Sbjct: 212 SDVWAFGVLLWEIAT 226

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 21  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 78  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 130
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 18  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 75  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 127
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 220

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 118/221 (53%), Gaps = 19/221 (8%)
Query: 98  CLGEGGFGKVYKGCL----EKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
            LG G FG VYKG      E ++  VAIK L+   G +   EF  E + + S DHP+LV+
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLH 209
           L+G C     +L V + MP G L +++H+ + +      L+W  ++      ++G+ YL 
Sbjct: 105 LLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 157
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E+    +++RDL   N+L++   H K++DFGLA++    +K + +        + A +  
Sbjct: 158 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 214
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
              + T +SD++S+GV + EL+T G K  D    R+  +L+
Sbjct: 215 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 195 DVWAFGVLLWEIAT 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + ++VVAIK +D       + +   E+  L   D P + K  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +  +  ++ EY+  GS    L  L P   PLD      I     +GL YLH + K   I
Sbjct: 90  LKDTKLWIIMEYLGGGSA---LDLLEPG--PLDETQIATILREILKGLDYLHSEKK---I 141
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK 199
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G     +    K L L+    P             P+L+G Y  P
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 246
Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++   +A      C+ ++P+ RP   +++
Sbjct: 247 LKEFVEA------CLNKEPSFRPTAKELL 269

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + ++VVAIK +D       + +   E+  L   D P + K  G  
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +  +  ++ EY+  GS    L  L P   PLD      I     +GL YLH + K   I
Sbjct: 95  LKDTKLWIIMEYLGGGS---ALDLLEPG--PLDETQIATILREILKGLDYLHSEKK---I 146
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 147 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 204
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G     +    K L L+    P             P+L+G Y  P
Sbjct: 205 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 251
Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++   +A      C+ ++P+ RP   +++
Sbjct: 252 LKEFVEA------CLNKEPSFRPTAKELL 274

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 81  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 135
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 195 DVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + ++VVAIK +D       + +   E+  L   D P + K  G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +  +  ++ EY+  GS    L  L P   PLD      I     +GL YLH + K   I
Sbjct: 75  LKDTKLWIIMEYLGGGS---ALDLLEPG--PLDETQIATILREILKGLDYLHSEKK---I 126
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 184
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G     +    K L L+    P             P+L+G Y  P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 231
Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++   +A      C+ ++P+ RP   +++
Sbjct: 232 LKEFVEA------CLNKEPSFRPTAKELL 254

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 196 DVWAFGVLLWEIAT 209

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + ++VVAIK +D       + +   E+  L   D P + K  G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +  +  ++ EY+  GS    L  L P   PLD      I     +GL YLH + K   I
Sbjct: 75  LKDTKLWIIMEYLGGGS---ALDLLEPG--PLDETQIATILREILKGLDYLHSEKK---I 126
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK 184
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G     +    K L L+    P             P+L+G Y  P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 231
Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++   +A      C+ ++P+ RP   +++
Sbjct: 232 LKEFVEA------CLNKEPSFRPTAKELL 254

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 93  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 147
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 207 DVWAFGVLLWEIAT 220

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 196 DVWAFGVLLWEIAT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 82  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 136
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 196 DVWAFGVLLWEIAT 209

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 192 DVWAFGVLLWEIAT 205

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 101 STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 153
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA        +H   ++ G+  + AP+         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 36  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 93  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 145
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA        +H   ++ G+  + AP+         
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 238

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 84  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 138
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 198 DVWAFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H N++  +GY
Sbjct: 16  IGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +  Q  +V ++    SL  HLH +      +     + IA   ++G+ YLH +    +
Sbjct: 73  STK-PQLAIVTQWCEGSSLYHHLHIIETKFEMIK---LIDIARQTAQGMDYLHAK---SI 125
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQ 273
           I+RDLK +NI L E    K+ DFGLA        +H   ++ G+  + AP+         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            +F+SD+Y+FG+VL EL+TG+       +R ++
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 85  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 199 DVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 78  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 132
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 192 DVWAFGVLLWEIAT 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 80  REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 194 DVWAFGVLLWEIAT 207

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+VYKG     ++VVAIK +D       + +   E+  L   D P + +  G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +  +  ++ EY+  GS    L  L+P   PL+      I     +GL YLH + K   I
Sbjct: 87  LKSTKLWIIMEYLGGGSA---LDLLKPG--PLEETYIATILREILKGLDYLHSERK---I 138
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+        FK
Sbjct: 139 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK 196
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY--P 335
           +DI+S G+  +EL  G          + L L+    P             P+L+GQ+  P
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQHSKP 243
Query: 336 VRGLYQALAIAAMCVQEQPNMRPAITDVV 364
            +   +A      C+ + P  RP   +++
Sbjct: 244 FKEFVEA------CLNKDPRFRPTAKELL 266

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 102/211 (48%), Gaps = 11/211 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG VYKG       V  +K +D    Q  + F  EV  L    H N++  +GY  
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQ-FQAFRNEVAVLRKTRHVNILLFMGYMT 102
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + D   +V ++    SL KHLH      +       + IA   ++G+ YLH +    +I+
Sbjct: 103 K-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---LIDIARQTAQGMDYLHAK---NIIH 155
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLT 275
           RD+K +NI L EG   K+ DFGLA +      +    +  G+  + AP+          +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           F+SD+YS+G+VL EL+TG        +R ++
Sbjct: 216 FQSDVYSYGIVLYELMTGELPYSHINNRDQI 246

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + ++    + +A   S  ++YL    K+  I+
Sbjct: 326 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLE---KKNFIH 380
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           R+L   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 440 DVWAFGVLLWEIAT 453

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 131/284 (46%), Gaps = 38/284 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V K      +  VAIKQ++    +  + F  E+  L   +HPN+VKL G C 
Sbjct: 16  VGRGAFGVVCKAKWRAKD--VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR---MKIAAGASRGLQYLHEQLKQP 215
             +   LV EY   GSL   LH       PL + T    M      S+G+ YLH    + 
Sbjct: 72  --NPVCLVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 216 VIYRDLKCSNILLEEG-YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           +I+RDLK  N+LL  G    K+ DFG A       +TH+ T   G+  + AP+       
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNY 180
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY 334
           + K D++S+G++L E+IT RK  D+              P F+          P L    
Sbjct: 181 SEKCDVFSWGIILWEVITRRKPFDEI-----------GGPAFRIMWAVHNGTRPPL---- 225
Query: 335 PVRGLYQAL-AIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
            ++ L + + ++   C  + P+ RP++ ++V  + +L   +Y P
Sbjct: 226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL--MRYFP 266

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 101/194 (52%), Gaps = 7/194 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +    HPNLV+L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +   + + +     + +A   S  ++YL    K+  I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           R+L   N L+ E +  K++DFGL+++  +GD             + AP+     + + KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 279 DIYSFGVVLLELIT 292
           D+++FGV+L E+ T
Sbjct: 401 DVWAFGVLLWEIAT 414

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 131/284 (46%), Gaps = 38/284 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V K      +  VAIKQ++    +  + F  E+  L   +HPN+VKL G C 
Sbjct: 17  VGRGAFGVVCKAKWRAKD--VAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 72
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR---MKIAAGASRGLQYLHEQLKQP 215
             +   LV EY   GSL   LH       PL + T    M      S+G+ YLH    + 
Sbjct: 73  --NPVCLVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 216 VIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           +I+RDLK  N+LL  G    K+ DFG A       +TH+ T   G+  + AP+       
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWMAPEVFEGSNY 181
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY 334
           + K D++S+G++L E+IT RK  D+              P F+          P L    
Sbjct: 182 SEKCDVFSWGIILWEVITRRKPFDEI-----------GGPAFRIMWAVHNGTRPPL---- 226
Query: 335 PVRGLYQAL-AIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
            ++ L + + ++   C  + P+ RP++ ++V  + +L   +Y P
Sbjct: 227 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL--MRYFP 267

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 47/293 (16%)
Query: 98  CLGEGGFGKVYKGCLEKIE-----QVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLV 151
            LGEG FGKV K     ++       VA+K L ++     +R+  +E   L   +HP+++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--------------------PDTRPLDW 191
           KL G C++    LL+ EY   GSL   L + R                    PD R L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
              +  A   S+G+QYL E     +++RDL   NIL+ EG   K+SDFGL++     D  
Sbjct: 150 GDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310
              ++      + A +       T +SD++SFGV+L E++T G          +  NL+ 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
               M +      +M    LQ                 C +++P+ RP   D+
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQ-----------------CWKQEPDKRPVFADI 302

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 47/293 (16%)
Query: 98  CLGEGGFGKVYKGCLEKIE-----QVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLV 151
            LGEG FGKV K     ++       VA+K L ++     +R+  +E   L   +HP+++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--------------------PDTRPLDW 191
           KL G C++    LL+ EY   GSL   L + R                    PD R L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
              +  A   S+G+QYL E     +++RDL   NIL+ EG   K+SDFGL++     D  
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310
              ++      + A +       T +SD++SFGV+L E++T G          +  NL+ 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
               M +      +M    LQ                 C +++P+ RP   D+
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQ-----------------CWKQEPDKRPVFADI 302

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 125/293 (42%), Gaps = 47/293 (16%)
Query: 98  CLGEGGFGKVYKGCLEKIE-----QVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLV 151
            LGEG FGKV K     ++       VA+K L ++     +R+  +E   L   +HP+++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR--------------------PDTRPLDW 191
           KL G C++    LL+ EY   GSL   L + R                    PD R L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
              +  A   S+G+QYL E     +++RDL   NIL+ EG   K+SDFGL++     D  
Sbjct: 150 GDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVA 310
              ++      + A +       T +SD++SFGV+L E++T G          +  NL+ 
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLK 266
Query: 311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
               M +      +M    LQ                 C +++P+ RP   D+
Sbjct: 267 TGHRMERPDNCSEEMYRLMLQ-----------------CWKQEPDKRPVFADI 302

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 31/296 (10%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSA 137
           DE   A         LG+G FG VY+G  + +     E  VAIK ++       R EF  
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDW 191
           E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+        P   
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
           +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ +     D  
Sbjct: 123 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
               + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +++     
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 239
Query: 312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
              +     N   M+                L +  MC Q  P MRP+  +++ ++
Sbjct: 240 EGGLLDKPDNCPDML----------------LELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 129/306 (42%), Gaps = 31/306 (10%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG 128
           S  +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++   
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 129 VQGVR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR 187
               R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+  
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 188 ------PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
                 P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301
            +     D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q  
Sbjct: 179 TRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 238
Query: 302 DRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT 361
             +++        +     N   M+                  +  MC Q  P MRP+  
Sbjct: 239 SNEQVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFL 282
Query: 362 DVVMAL 367
           +++ ++
Sbjct: 283 EIISSI 288

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K +D +  + + ++  E+  L S DHPN+VKL+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   ++ E+   G++D  + +L    RPL  +    +       L YLH+     +I+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIH 158
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ-- 273
           RDLK  NIL       KL+DFG+     S   T    R    +GT  + AP+  M     
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 274 ---LTFKSDIYSFGVVLLEL 290
                +K+D++S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 99  LGEGGFGKVYK----GCLE-KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           +GEG FG+V++    G L  +   +VA+K L       ++ +F  E   +   D+PN+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--------------------RPLDWN 192
           L+G CA G    L++EYM  G L++ L  + P T                     PL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
            ++ IA   + G+ YL E   +  ++RDL   N L+ E    K++DFGL++   S D   
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                     +  P+     + T +SD++++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/196 (32%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LGEG +G VYK   ++  Q+VAIKQ+       ++E   E+  +   D P++VK  G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V EY   GS+      +R   + L  +    I     +GL+YLH   K   I+
Sbjct: 95  KNTDLWIVMEYCGAGSVSD---IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IH 148
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  NILL    H KL+DFG+A  G   D       V+GT  + AP+          +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 279 DIYSFGVVLLELITGR 294
           DI+S G+  +E+  G+
Sbjct: 207 DIWSLGITAIEMAEGK 222

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K +D +  + + ++  E+  L S DHPN+VKL+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   ++ E+   G++D  + +L    RPL  +    +       L YLH+     +I+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIH 158
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ-- 273
           RDLK  NIL       KL+DFG+     S   T    R    +GT  + AP+  M     
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV-----SAKNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 274 ---LTFKSDIYSFGVVLLEL 290
                +K+D++S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 19/200 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K +D +  + + ++  E+  L S DHPN+VKL+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   ++ E+   G++D  + +L    RPL  +    +       L YLH+     +I+
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIH 158
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQ-- 273
           RDLK  NIL       KL+DFG+     S   T    R    +GT  + AP+  M     
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGV-----SAKNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 274 ---LTFKSDIYSFGVVLLEL 290
                +K+D++S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/303 (24%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  F  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 2   AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 61
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--- 187
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+     
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 188 ---PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 238
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 239 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 282
Query: 365 MAL 367
            ++
Sbjct: 283 SSI 285

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 99/219 (45%), Gaps = 14/219 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DH 147
           +F     LG+G FGKV+    +K  Q  AIK L    V     V     E   L  A +H
Sbjct: 19  DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 78
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P L  +       +    V EY+  G L  H+          D +     AA    GLQ+
Sbjct: 79  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 134
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + ++YRDLK  NILL++  H K++DFG+ K    GD    +    GT  Y AP+
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAPE 189
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
             +  +     D +SFGV+L E++ G+      +D +EL
Sbjct: 190 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 227

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +    +VA+KQL H G    R+F  E+  L +     +VK  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 155 GYC-AEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G     G Q L LV EY+P G L   L   R     LD +  +  ++   +G++YL  + 
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 134
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG--TYGYCAPDYAM 270
               ++RDL   NIL+E   H K++DFGLAK+ P  DK +   R  G     + AP+   
Sbjct: 135 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLS 190
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
               + +SD++SFGVVL EL T
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/306 (23%), Positives = 129/306 (42%), Gaps = 31/306 (10%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRG 128
           S  +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++   
Sbjct: 2   SFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 61
Query: 129 VQGVR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR 187
               R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+  
Sbjct: 62  SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEME 121
Query: 188 ------PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
                 P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301
            +     D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q  
Sbjct: 179 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 238
Query: 302 DRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT 361
             +++        +     N   M+                  +  MC Q  P MRP+  
Sbjct: 239 SNEQVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFL 282
Query: 362 DVVMAL 367
           +++ ++
Sbjct: 283 EIISSI 288

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +    +VA+KQL H G    R+F  E+  L +     +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 155 GYC-AEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G     G Q L LV EY+P G L   L   R     LD +  +  ++   +G++YL  + 
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 147
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG---TYGYCAPDYA 269
               ++RDL   NIL+E   H K++DFGLAK+ P  DK +   R  G    + Y AP+  
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWY-APESL 202
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
                + +SD++SFGVVL EL T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V    Y    +    +VA+KQL H G    R+F  E+  L +     +VK  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 155 GYC-AEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G     G Q L LV EY+P G L   L   R     LD +  +  ++   +G++YL  + 
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 135
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG--TYGYCAPDYAM 270
               ++RDL   NIL+E   H K++DFGLAK+ P  DK +   R  G     + AP+   
Sbjct: 136 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESLS 191
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
               + +SD++SFGVVL EL T
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKLI 154
           LG+G FGKV+    +K  Q  AIK L    V     V     E   L  A +HP L  + 
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                 +    V EY+  G L  H+          D +     AA    GLQ+LH    +
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH---SK 137
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            ++YRDLK  NILL++  H K++DFG+ K    GD    +    GT  Y AP+  +  + 
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPEILLGQKY 195
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
               D +SFGV+L E++ G+      +D +EL
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 226

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 10/212 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V AIK L   G      F  E   +    H  LV+L    +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKV-AIKTLKP-GTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E +   +V EYM  GSL   L D   + R L     + +AA  + G+ Y+    +   I+
Sbjct: 75  E-EPIYIVTEYMNKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 128
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL+ +NIL+  G   K++DFGLA++    + T           + AP+ A+ G+ T KS
Sbjct: 129 RDLRSANILVGNGLICKIADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 279 DIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
           D++SFG++L EL+T GR       +R+ L  V
Sbjct: 188 DVWSFGILLTELVTKGRVPYPGMNNREVLEQV 219

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 77  NPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--- 187
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+     
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 188 ---PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 240
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 241 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 284
Query: 365 MAL 367
            ++
Sbjct: 285 SSI 287

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 77  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 130 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 33  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 92
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--- 187
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+     
Sbjct: 93  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 152
Query: 188 ---PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 153 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 209
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 210 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 269
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 270 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 313
Query: 365 MAL 367
            ++
Sbjct: 314 SSI 316

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 86  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 138
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 139 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 4   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 63
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--- 187
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+     
Sbjct: 64  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 188 ---PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 124 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 180
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 240
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 241 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 284
Query: 365 MAL 367
            ++
Sbjct: 285 SSI 287

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 128/303 (42%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR--- 187
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+     
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 130
Query: 188 ---PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 248 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 291
Query: 365 MAL 367
            ++
Sbjct: 292 SSI 294

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 76  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 114/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 79  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 31/296 (10%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSA 137
           DE   A         LG+G FG VY+G  + +     E  VAIK ++       R EF  
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDW 191
           E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+        P   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
           +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ +     D  
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
               + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +++     
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 241
Query: 312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
              +     N   M+                  +  MC Q  P MRP+  +++ ++
Sbjct: 242 EGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 82  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 134
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 135 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 78  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 101 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 153
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 154 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 79  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 132 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 125/296 (42%), Gaps = 31/296 (10%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSA 137
           DE   A         LG+G FG VY+G  + +     E  VAIK ++       R EF  
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 138 EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDW 191
           E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP+        P   
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
           +  +++A   + G+ YL+       ++RDL   N  + E +  K+ DFG+ +     D  
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW 311
               + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +++     
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 241
Query: 312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
              +     N   M+                L +  MC Q  P MRP+  +++ ++
Sbjct: 242 EGGLLDKPDNCPDML----------------LELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 70  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 122
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 123 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++RDL   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 242
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  PNMRP   ++V
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGLA++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 99/202 (49%), Gaps = 15/202 (7%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL- 153
           LG+G FG V    Y    +    +VA+KQL H G    R+F  E+  L +     +VK  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 154 -IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            + Y     +  LV EY+P G L   L   R     LD +  +  ++   +G++YL  + 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGSRR 131
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG--TYGYCAPDYAM 270
               ++RDL   NIL+E   H K++DFGLAK+ P  DK     R  G     + AP+   
Sbjct: 132 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPESLS 187
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
               + +SD++SFGVVL EL T
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 131
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 132 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      + 
Sbjct: 73  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AE 125
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 126 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 148
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 149 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 205
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 1   AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 60
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---- 186
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP      
Sbjct: 61  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 120
Query: 187 --RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 121 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 177
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 178 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 237
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 238 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 281
Query: 365 MAL 367
            ++
Sbjct: 282 SSI 284

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 158
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 159 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 31/303 (10%)
Query: 77  SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG 131
           +A  +  DE   A         LG+G FG VY+G  + +     E  VAIK ++      
Sbjct: 11  AADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 132 VR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---- 186
            R EF  E   +   +  ++V+L+G  ++G   L++ E M  G L  +L  LRP      
Sbjct: 71  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 187 --RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
              P   +  +++A   + G+ YL+       ++RDL   N ++ E +  K+ DFG+ + 
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
               D      + +    + +P+    G  T  SD++SFGVVL E+ T  +   Q    +
Sbjct: 188 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247
Query: 305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
           ++        +     N   M+                  +  MC Q  P MRP+  +++
Sbjct: 248 QVLRFVMEGGLLDKPDNCPDML----------------FELMRMCWQYNPKMRPSFLEII 291
Query: 365 MAL 367
            ++
Sbjct: 292 SSI 294

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 22/229 (9%)
Query: 80  PFTFDELAAATGNFRSDC---------CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHR 127
           PFTF++   A   F  +           +G G FG+V  G L+   K E  VAIK L   
Sbjct: 13  PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 72
Query: 128 GVQGVR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT 186
             +  R +F +E   +G  DHPN++ L G   +    +++ E+M  GSLD     LR + 
Sbjct: 73  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF---LRQND 129
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
                   + +  G + G++YL +      ++RDL   NIL+      K+SDFGL++   
Sbjct: 130 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 186
Query: 247 SGDKTHVSTRVMG---TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                   T  +G      + AP+     + T  SD++S+G+V+ E+++
Sbjct: 187 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    L  G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 83  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    L  G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 92  NFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM 140
           +F+    LG G FG+V           Y   + K E VV +KQ++H         + E +
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT--------NDERL 58
Query: 141 TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG 200
            L    HP ++++ G   +  Q  ++ +Y+  G L   L   +    P+        AA 
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV----AKFYAAE 114
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
               L+YLH    + +IYRDLK  NILL++  H K++DFG AK  P      V+  + GT
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGT 166
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+   T       D +SFG+++ E++ G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V EYM  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL ++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    L  G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFG AK+  + +K + +        +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 80  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFG AK+  + +K + +        +
Sbjct: 133 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 78  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFG AK+  + +K + +        +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 113/216 (52%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L++ + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 78  NPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFG AK+  + +K + +        +
Sbjct: 131 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++RDL   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 239
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  P MRP   ++V
Sbjct: 240 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAI +L +    +  +E   E   + S D
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 110 NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 162
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFGLAK+  + +K + +        +
Sbjct: 163 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 76  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFG AK+  + +K + +        +
Sbjct: 129 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 9/221 (4%)
Query: 72  NNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG 131
           + + K  KP+  DE        +    LG G FG+V+ G      +V A+K L  +G   
Sbjct: 2   SQTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMS 59
Query: 132 VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
              F AE   +    H  LV+L     + +   ++ EYM  GSL   L    P    L  
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTI 116
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
           N  + +AA  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T
Sbjct: 117 NKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT 173
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                      + AP+    G  T KSD++SFG++L E++T
Sbjct: 174 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 213

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 11/224 (4%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHP 148
           +F+    LG+G F  VY+         VAIK +D + +     V+    EV       HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           ++++L  Y  + +   LV E    G ++++L   +   +P   N           G+ YL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYL---KNRVKPFSENEARHFMHQIITGMLYL 128
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H      +++RDL  SN+LL    + K++DFGLA       + H +  + GT  Y +P+ 
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA 312
           A       +SD++S G +   L+ GR   D    +  LN V  A
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 112/216 (51%), Gaps = 19/216 (8%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
            F+    LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASR 203
           +P++ +L+G C     +L+  + MP G L  ++ + + +      L+W  ++      ++
Sbjct: 83  NPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+ YL ++    +++RDL   N+L++   H K++DFG AK+  + +K + +        +
Sbjct: 136 GMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID 298
            A +  +    T +SD++S+GV + EL+T G K  D
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 89
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 145
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 146 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 198
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 64
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T +S    GT  Y
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDY 173
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + +AA  + G+ Y+  
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 381 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 437
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++RDL   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 242
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  P MRP   ++V
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 80
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 81  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 136
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 137 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 189
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G+G FG+V+KG   + +QVVAIK +D       + +   E+  L   D   + K  G  
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +G +  ++ EY+  GS    L  LR    P D      +     +GL YLH + K   I
Sbjct: 91  LKGSKLWIIMEYLGGGS---ALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKK---I 142
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K +N+LL E    KL+DFG+A  G   D        +GT  + AP+         K
Sbjct: 143 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 200
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP--MFKD-RKNFSQMVDPSLQGQY 334
           +DI+S G+  +EL  G          + L L+    P  +  D  K+F + +D       
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFID------- 253
Query: 335 PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
                         C+ + P+ RP   +++
Sbjct: 254 -------------ACLNKDPSFRPTAKELL 270

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 121/274 (44%), Gaps = 25/274 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     ++V AIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV+E+M  G L  +   LR         T + +      G+ YL E     VI+
Sbjct: 73  EQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIH 126
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L   +    
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLASTH---- 232
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
           +YQ   I   C +E+P  RPA + ++  L  +A+
Sbjct: 233 VYQ---IMNHCWKERPEDRPAFSRLLRQLAAIAA 263

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + +AA  + G+ Y+  
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 354
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 9/220 (4%)
Query: 73  NSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV 132
            + K  KP+  DE        +    LG G FG+V+ G      +V A+K L  +G    
Sbjct: 1   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSP 58
Query: 133 REFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN 192
             F AE   +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N
Sbjct: 59  DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTIN 115
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
             + +AA  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T 
Sbjct: 116 KLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT- 171
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                     + AP+    G  T KSD++SFG++L E++T
Sbjct: 172 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + +AA  + G+ Y+  
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 354
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR 133
           S K  KP+  D       + + +  LG G FG+V+     K  +V A+K +   G   V 
Sbjct: 165 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKP-GSMSVE 222
Query: 134 EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNT 193
            F AE   + +  H  LVKL     + +   ++ E+M  GSL   L       +PL    
Sbjct: 223 AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--K 279
Query: 194 RMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253
            +  +A  + G+ ++ ++     I+RDL+ +NIL+      K++DFGLA++G        
Sbjct: 280 LIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVGAKF----- 331
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                    + AP+    G  T KSD++SFG++L+E++T
Sbjct: 332 ------PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 9/219 (4%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR 133
           + K  KP+  DE        +    LG G FG+V+ G      +V A+K L  +G     
Sbjct: 2   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPD 59
Query: 134 EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNT 193
            F AE   +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N 
Sbjct: 60  AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINK 116
Query: 194 RMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253
            + +AA  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T  
Sbjct: 117 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-A 172
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                    + AP+    G  T KSD++SFG++L E++T
Sbjct: 173 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 9/219 (4%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR 133
           + K  KP+  DE        +    LG G FG+V+ G      +V A+K L  +G     
Sbjct: 1   TQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPD 58
Query: 134 EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNT 193
            F AE   +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N 
Sbjct: 59  AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINK 115
Query: 194 RMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253
            + +AA  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T  
Sbjct: 116 LLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-A 171
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                    + AP+    G  T KSD++SFG++L E++T
Sbjct: 172 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + +AA  + G+ Y+  
Sbjct: 67  QLYAVVSE-EPIXIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 121
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 122 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAAL 178
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 218

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 98  CLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
            +G G FG+VYKG L+    K E  VAIK L     +  R +F  E   +G   H N+++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G  ++    +++ EYM  G+LDK L +   +   L     ++   G + G++YL    
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLR---GIAAGMKYLA--- 164
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPDYA 269
               ++RDL   NIL+      K+SDFGL+++    P    T    ++     + AP+  
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAI 222
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
              + T  SD++SFG+V+ E++T
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 80  PFTFDELAAATGNFRSDC---------CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHR 127
           PFTF++   A   F  +           +G G FG+V  G L+   K E  VAIK L   
Sbjct: 9   PFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG 68
Query: 128 GV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRP 184
              +  R+F +E   +G  DHPN++ L G   +    +++ EYM  GSLD  L  +D R 
Sbjct: 69  YTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRF 128
Query: 185 DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM 244
               L     + +  G   G++YL +      ++RDL   NIL+      K+SDFG++++
Sbjct: 129 TVIQL-----VGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRV 180
Query: 245 GPSGDKTHVSTRVMGT-YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                +   +TR       + AP+     + T  SD++S+G+V+ E+++
Sbjct: 181 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 9/220 (4%)
Query: 73  NSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV 132
            + K  KP+  DE        +    LG G FG+V+ G      +V A+K L  +G    
Sbjct: 5   QTQKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLK-QGSMSP 62
Query: 133 REFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN 192
             F AE   +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N
Sbjct: 63  DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTIN 119
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
             + +AA  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T 
Sbjct: 120 KLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 175
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                     + AP+    G  T KSD++SFG++L E++T
Sbjct: 176 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     ++V AIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV+E+M  G L  +   LR         T + +      G+ YL E     VI+
Sbjct: 76  EQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L   +    
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLASTH---- 235
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           +YQ   I   C +E+P  RPA + ++  L  +A
Sbjct: 236 VYQ---IMNHCWRERPEDRPAFSRLLRQLAEIA 265

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     ++V AIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV+E+M  G L  +   LR         T + +      G+ YL E     VI+
Sbjct: 73  EQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L   +    
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLASTH---- 232
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           +YQ   I   C +E+P  RPA + ++  L  +A
Sbjct: 233 VYQ---IMNHCWKERPEDRPAFSRLLRQLAEIA 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     ++V AIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV+E+M  G L  +   LR         T + +      G+ YL E     VI+
Sbjct: 71  EQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L   +    
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLASTH---- 230
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           +YQ   I   C +E+P  RPA + ++  L  +A
Sbjct: 231 VYQ---IMNHCWKERPEDRPAFSRLLRQLAEIA 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 66
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 122
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 175
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 111/242 (45%), Gaps = 34/242 (14%)
Query: 73  NSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHR 127
           N  K AK     E++ +   F  +  LGE  FGKVYKG L      +  Q VAIK L  +
Sbjct: 13  NQHKQAK---LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK 67
Query: 128 GVQGVRE-FSAEVMTLGSADHPNLVKLIG-------------YCAEGDQRLLVYEYMP-- 171
               +RE F  E M      HPN+V L+G             YC+ GD    +    P  
Sbjct: 68  AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHS 127
Query: 172 -LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE 230
            +GS D    D R     L+    + + A  + G++YL       V+++DL   N+L+ +
Sbjct: 128 DVGSTD----DDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYD 180
Query: 231 GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
             + K+SD GL +   + D   +    +    + AP+  M G+ +  SDI+S+GVVL E+
Sbjct: 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240
Query: 291 IT 292
            +
Sbjct: 241 FS 242

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++R+L   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 243
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  PNMRP   ++V
Sbjct: 244 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + +AA  + G+ Y+  
Sbjct: 243 QLYAVVSE-EPIYIVGEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 298 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 354
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + +AA  + G+ Y+  
Sbjct: 70  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 124
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 125 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 181
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 182 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 221

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++R+L   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 242
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  PNMRP   ++V
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 68
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 124
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 177
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 68
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 124
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 177
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V E M  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V E M  GSLD  L  HD +     L     + +  G + G+
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 131
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 132 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 64
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDY 173
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           +L     +  ++RDL   N +L+E +  K++DFGLA+  +    D  H  T       + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 256
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 257 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 297

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G      +V A+K L  +G      F AE
Sbjct: 2   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 59
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 60  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 116
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 117 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAK 172
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 206

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++RDL   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 241
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  P MRP   ++V
Sbjct: 242 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G      +V A+K L  +G      F AE
Sbjct: 3   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 60
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 61  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 117
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 118 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAK 173
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H    + VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 120 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G      +V A+K L  +G      F AE
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 58
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 115
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAK 171
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 24/280 (8%)
Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C +       ++VA+K L    G Q    +  E+  L +  H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 154 IGYCA-EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C  +G++ L LV EY+PLGSL  +L         +     +  A     G+ YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH-- 134
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM----GTYGYCAPD 267
             Q  I+R+L   N+LL+     K+ DFGLAK  P G   H   RV         + AP+
Sbjct: 135 -SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAPE 190
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                +  + SD++SFGV L EL+T   +  Q+   K L L+  A+      +  +++++
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLR-LTELLE 248
Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
              +   P +   +   +   C + + + RP   +++  L
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 68
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 124
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDY 177
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G      +V A+K L  +G      F AE
Sbjct: 10  KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 67
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 68  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 124
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 125 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAK 180
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G      +V A+K L  +G      F AE
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 58
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 115
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXT-AREGAK 171
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 37/281 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+    +  ++RDL   N ++   +  K+ DFG+ +     D      + +    + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E                  + + A   ++   N  Q++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN-EQVL 242
Query: 327 DPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
              + G Y   P     +   +  MC Q  P MRP   ++V
Sbjct: 243 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/280 (28%), Positives = 129/280 (46%), Gaps = 24/280 (8%)
Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C +       ++VA+K L    G Q    +  E+  L +  H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 154 IGYCA-EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C  +G++ L LV EY+PLGSL  +L         +     +  A     G+ YLH  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH-- 134
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM----GTYGYCAPD 267
             Q  I+R+L   N+LL+     K+ DFGLAK  P G   H   RV         + AP+
Sbjct: 135 -AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAPE 190
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                +  + SD++SFGV L EL+T   +  Q+   K L L+  A+      +  +++++
Sbjct: 191 CLKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLR-LTELLE 248
Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
              +   P +   +   +   C + + + RP   +++  L
Sbjct: 249 RGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 9/219 (4%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR 133
           S K  KP+  D       + + +  LG G FG+V+     K  +V A+K +   G   V 
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKP-GSMSVE 228
Query: 134 EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNT 193
            F AE   + +  H  LVKL     + +   ++ E+M  GSL   L       +PL    
Sbjct: 229 AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--K 285
Query: 194 RMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV 253
            +  +A  + G+ ++ ++     I+RDL+ +NIL+      K++DFGLA++    + T  
Sbjct: 286 LIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-A 341
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                    + AP+    G  T KSD++SFG++L+E++T
Sbjct: 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G      +V A+K L  +G      F AE
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 58
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 115
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAK 171
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADH 147
           N   D  +G G FG+V  G L+   K E  VAIK L     +  R +F  E   +G  DH
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+++L G   +    ++V E M  GSLD  L  HD +     L     + +  G + G+
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL-----VGMLRGIASGM 160
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYC 264
           +YL +      ++RDL   NIL+      K+SDFGL+++     +   +TR       + 
Sbjct: 161 KYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT 292
           +P+     + T  SD++S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV    Y    +   + VA+K L    G   + +   E+  L +  H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 154 IGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C E  G+   L+ E++P GSL ++L     +   ++   ++K A    +G+ YL  +
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST---RVMGTYGYCAPDY 268
                ++RDL   N+L+E  +  K+ DFGL K     DK   +    R    + Y AP+ 
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
            M  +    SD++SFGV L EL+T
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 25/291 (8%)
Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C +       ++VA+K L    G Q    +  E+  L +  H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 154 IGYCAE-GDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C + G   L LV EY+PLGSL  +L         +     +  A     G+ YLH  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH-- 151
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM----GTYGYCAPD 267
             Q  I+RDL   N+LL+     K+ DFGLAK  P G   H   RV         + AP+
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEXYRVREDGDSPVFWYAPE 207
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                +  + SD++SFGV L EL+T   +  Q+   K L L+  A+      +  +++++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMTVLR-LTELLE 265
Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQ 378
              +   P +   +   +   C + + + RP   +++  L     +KY  Q
Sbjct: 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK-TVHEKYQGQ 315

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV    Y    +   + VA+K L    G   + +   E+  L +  H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 154 IGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C E  G+   L+ E++P GSL ++L     +   ++   ++K A    +G+ YL  +
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST---RVMGTYGYCAPDY 268
                ++RDL   N+L+E  +  K+ DFGL K     DK   +    R    + Y AP+ 
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
            M  +    SD++SFGV L EL+T
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 66
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 122
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H    + VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDY 175
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 62
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 118
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 119 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 171
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 172 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 29/216 (13%)
Query: 99  LGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVK 152
           LGE  FGKVYKG L      +  Q VAIK L  +    +RE F  E M      HPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 153 LIG-------------YCAEGDQRLLVYEYMP---LGSLDKHLHDLRPDTRPLDWNTRMK 196
           L+G             YC+ GD    +    P   +GS D    D R     L+    + 
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD----DDRTVKSALEPPDFVH 132
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR 256
           + A  + G++YL       V+++DL   N+L+ +  + K+SD GL +   + D   +   
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            +    + AP+  M G+ +  SDI+S+GVVL E+ +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 89
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 145
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +  +     GT  Y
Sbjct: 146 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDY 198
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + ++A  + G+ Y+  
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSL---LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE- 128
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 129 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT-ARQGAKFPIKWTAPEAAL 185
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 225

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     ++V AIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKV-AIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV+E+M  G L  +   LR         T + +      G+ YL E     VI+
Sbjct: 93  EQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L   +    
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLASTH---- 252
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           +YQ   I   C +E+P  RPA + ++  L  +A
Sbjct: 253 VYQ---IMNHCWKERPEDRPAFSRLLRQLAEIA 282

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           +L     +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 255
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 256 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 67
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 123
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 124 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 176
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 177 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVIEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 148
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           +L     +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 256
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 257 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 297

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +T + L     + ++A  + G+ Y+  
Sbjct: 74  QLYAVVSE-EPIYIVTEYMNKGSL---LDFLKGETGKYLRLPQLVDMSAQIASGMAYVE- 128
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 129 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 185
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 186 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 225

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 145
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           +L     +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + 
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 253
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 254 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G+++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 207
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 314
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 315 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 355

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 65
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 121
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K+++FG +   PS  +T     + GT  Y
Sbjct: 122 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDY 174
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 152
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           +L     +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + 
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 260
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 261 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 301

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 119/273 (43%), Gaps = 25/273 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     ++V AIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV E+M  G L  +   LR         T + +      G+ YL E     VI+
Sbjct: 74  EQAPICLVTEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L   +    
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLASTH---- 233
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
           +YQ   I   C +E+P  RPA + ++  L  +A
Sbjct: 234 VYQ---IMNHCWRERPEDRPAFSRLLRQLAEIA 263

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 131/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 147
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           +L     +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 255
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 256 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 60
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 116
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H    + VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y
Sbjct: 117 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDY 169
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVIEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 68  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 122
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 123 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 179
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 180 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 219

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 65
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 121
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +  +     GT  Y
Sbjct: 122 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDY 174
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 98  CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKL 153
            +G G FG+V +G L+   K E  VAIK L     +   REF +E   +G  +HPN+++L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            G        +++ E+M  G+LD     LR +         + +  G + G++YL E   
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSF---LRLNDGQFTVIQLVGMLRGIASGMRYLAE--- 136
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG---TYGYCAPDYAM 270
              ++RDL   NIL+      K+SDFGL++           T  +G      + AP+   
Sbjct: 137 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
             + T  SD +S+G+V+ E+++
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMS 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 66  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 120
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 121 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 177
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 217

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 66
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGA 201
              HPN+++L GY  +  +  L+ EY PLG++ + L  L    + R   + T +      
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ 120
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
           +  L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +  +     GT 
Sbjct: 121 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 173
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
            Y  P+         K D++S GV+  E + G+   +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 68
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY P G + K L  L       D           + 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELAN 124
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 177
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
           +GEG FG+V K  ++K  +    AIK++ ++      R+F+ E+  L     HPN++ L+
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
           G C       L  EY P G+L   L   R  +T P           L     +  AA  +
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RG+ YL ++     I+RDL   NIL+ E Y  K++DFGL++    G + +V  + MG   
Sbjct: 143 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 194
Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + A +       T  SD++S+GV+L E+++
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
           +GEG FG+V K  ++K  +    AIK++ ++      R+F+ E+  L     HPN++ L+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
           G C       L  EY P G+L   L   R  +T P           L     +  AA  +
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RG+ YL ++     I+RDL   NIL+ E Y  K++DFGL++    G + +V  + MG   
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 204
Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + A +       T  SD++S+GV+L E+++
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FG+  K    +  +V+ +K+L     +  R F  EV  +   +HPN++K IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           + D+RL  + EY+  G+L   +  +  D++   W+ R+  A   + G+ YLH      +I
Sbjct: 78  K-DKRLNFITEYIKGGTLRGIIKSM--DSQ-YPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKM------GPSG-------DKTHVSTRVMGTYGYC 264
           +RDL   N L+ E  +  ++DFGLA++       P G       D+    T V+G   + 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGNPYWM 189
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELI 291
           AP+         K D++SFG+VL E+I
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 66
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 122
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K+++FG +   PS  +T     + GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDY 175
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 110/220 (50%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVCEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 64
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 120
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +      + GT  Y
Sbjct: 121 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGTLDY 173
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 254
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 255 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 295

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 98  CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKL 153
            +G G FG+V +G L+   K E  VAIK L     +   REF +E   +G  +HPN+++L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            G        +++ E+M  G+LD     LR +         + +  G + G++YL E   
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSF---LRLNDGQFTVIQLVGMLRGIASGMRYLAE--- 134
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP--SGDKTHVSTRVMG---TYGYCAPDY 268
              ++RDL   NIL+      K+SDFGL++     S D T+ S+  +G      + AP+ 
Sbjct: 135 MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS--LGGKIPIRWTAPEA 192
Query: 269 AMTGQLTFKSDIYSFGVVLLELIT 292
               + T  SD +S+G+V+ E+++
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K ++ +  + + ++  E+  L + DHP +VKL+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
              +  ++ E+ P G++D  + +L R  T P       +I     + L+ L+    + +I
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEALNFLHSKRII 139
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-- 275
           +RDLK  N+L+      +L+DFG++       +   S   +GT  + AP+  M   +   
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDT 197
Query: 276 ---FKSDIYSFGVVLLEL 290
              +K+DI+S G+ L+E+
Sbjct: 198 PYDYKADIWSLGITLIEM 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  D       + + +  LG G FG+V+     K  +V A+K +   G   V  F AE
Sbjct: 3   KPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKP-GSMSVEAFLAE 60
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              + +  H  LVKL     + +   ++ E+M  GSL   L       +PL     +  +
Sbjct: 61  ANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFS 117
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ ++     I+RDL+ +NIL+      K++DFGLA++    + T       
Sbjct: 118 AQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAK 173
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L+E++T
Sbjct: 174 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 25/288 (8%)
Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C +       ++VA+K L    G Q    +  E+  L +  H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 154 IGYCA-EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C  +G++ + LV EY+PLGSL  +L         +     +  A     G+ YLH  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH-- 129
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM----GTYGYCAPD 267
             Q  I+R L   N+LL+     K+ DFGLAK  P G   H   RV         + AP+
Sbjct: 130 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAPE 185
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                +  + SD++SFGV L EL+T   + +Q+   K   L+   +      +  +++++
Sbjct: 186 CLKECKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLR-LTELLE 243
Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
              +   P R   +   +   C + + + RP   ++V  L   A +KY
Sbjct: 244 RGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ-TAQEKY 290

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 20/227 (8%)
Query: 80  PFTFDELAAATGNFRSDC---------CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHR 127
           P T+++   A   F  +           +G G FG+V  G L+   K E  VAIK L   
Sbjct: 2   PHTYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG 61
Query: 128 GVQGVR-EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT 186
             +  R +F  E   +G  DHPN++ L G   +    ++V EYM  GSLD     L+ + 
Sbjct: 62  YTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF---LKKND 118
Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
                   + +  G S G++YL +      ++RDL   NIL+      K+SDFGL+++  
Sbjct: 119 GQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 175
Query: 247 SGDKTHVSTRVMGT-YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
              +   +TR       + AP+     + T  SD++S+G+V+ E+++
Sbjct: 176 DDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 102/198 (51%), Gaps = 15/198 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K ++ +  + + ++  E+  L + DHP +VKL+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
              +  ++ E+ P G++D  + +L R  T P       +I     + L+ L+    + +I
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQVVCRQMLEALNFLHSKRII 131
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-- 275
           +RDLK  N+L+      +L+DFG++       +   S   +GT  + AP+  M   +   
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDT 189
Query: 276 ---FKSDIYSFGVVLLEL 290
              +K+DI+S G+ L+E+
Sbjct: 190 PYDYKADIWSLGITLIEM 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G FG VY     + + ++A+K     QL+  GV+   +   EV       HPN+++L
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHPNILRL 77
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            GY  +  +  L+ EY PLG++ + L  L   +R  +  T   I   A+  L Y H    
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELAN-ALSYCH---S 130
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           + VI+RD+K  N+LL      K++DFG +   PS  +T     + GT  Y  P+      
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRM 186
Query: 274 LTFKSDIYSFGVVLLELITG 293
              K D++S GV+  E + G
Sbjct: 187 HDEKVDLWSLGVLCYEFLVG 206

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL  +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 66
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 122
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H    + VI+RD+K  N+LL      K++DFG +   PS  +  +     GT  Y
Sbjct: 123 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDY 175
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKL 153
            +G G + KV    L+K +++ A+K +    V   + +     E      A +HP LV L
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 154 IGYCAEGDQRLL-VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
              C + + RL  V EY+  G L  H+       R L        +A  S  L YLHE+ 
Sbjct: 87  HS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER- 140
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAMT 271
              +IYRDLK  N+LL+   H KL+D+G+ K G   GD T   +   GT  Y AP+    
Sbjct: 141 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRG 195
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAID 298
               F  D ++ GV++ E++ GR   D
Sbjct: 196 EDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 23/287 (8%)
Query: 99  LGEGGFGKVYKGCLEKIE----QVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C +       ++VA+K L +  G Q    +  E+  L +  H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 154 IGYCA-EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C  +G++ + LV EY+PLGSL  +L         +     +  A     G+ YLH  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH-- 128
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG---TYGYCAPDY 268
             Q  I+R L   N+LL+     K+ DFGLAK  P G + +   R  G    + Y AP+ 
Sbjct: 129 -AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWY-APEC 185
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
               +  + SD++SFGV L EL+T   + +Q+   K   L+   +      +  +++++ 
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLR-LTELLER 243
Query: 329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
             +   P R   +   +   C + + + RP   ++V  L   A +KY
Sbjct: 244 GERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ-TAQEKY 289

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +  +     GT  Y
Sbjct: 120 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGA 201
              HPN+++L GY  +  +  L+ EY PLG++ + L  L    + R   + T +      
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL------ 117
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
           +  L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +  +     GT 
Sbjct: 118 ANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTL 170
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
            Y  P+         K D++S GV+  E + G+   +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 24/230 (10%)
Query: 78  AKPFTFDELAAATGNFRSDC---------CLGEGGFGKVYKGCLEKIEQ---VVAIKQLD 125
           A+P T++E   A  +F  +           +G G  G+V  G L    Q    VAIK L 
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 126 HRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDL 182
               +   R+F +E   +G  DHPN+++L G    G   ++V EYM  GSLD  L  HD 
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 183 RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
           +     L     + +  G   G++YL +      ++RDL   N+L++     K+SDFGL+
Sbjct: 147 QFTIMQL-----VGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 243 K-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
           + +    D  + +T       + AP+       +  SD++SFGVV+ E++
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 47/286 (16%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G    I     E  VA+K ++       R EF  E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------PLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L+V E M  G L  +L  LRP+        P      +++AA  + G+ 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG---- 262
           YL+    +  ++RDL   N ++   +  K+ DFG+ +     D    +    G  G    
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETAYYRKGGKGLLPV 196
Query: 263 -YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN 321
            + AP+    G  T  SD++SFGVVL E                  + + A   ++   N
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWE------------------ITSLAEQPYQGLSN 238
Query: 322 FSQMVDPSLQGQY---PVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
             Q++   + G Y   P     +   +  MC Q  P MRP   ++V
Sbjct: 239 -EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/194 (30%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L  +G      F AE   +    H  LV+L     
Sbjct: 16  LGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + +   ++ EYM  GSL   L    P    L  N  + +AA  + G+ ++ E+     I+
Sbjct: 74  Q-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL+ +NIL+ +    K++DFGLA++    + T           + AP+    G  T KS
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 279 DIYSFGVVLLELIT 292
           D++SFG++L E++T
Sbjct: 187 DVWSFGILLTEIVT 200

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 99  LGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FG V +G L++     ++  V   +LD+   + + EF +E   +    HPN+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 154 IGYCAEGDQR-----LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGLQ 206
           +G C E   +     +++  +M  G L  +L   R +T P  +   T +K     + G++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL     +  ++RDL   N +L +     ++DFGL+K   SGD             + A 
Sbjct: 162 YLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
           +       T KSD+++FGV + E+ T
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKL 153
            +G G + KV    L+K +++ A+K +    V   + +     E      A +HP LV L
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 154 IGYCAEGDQRLL-VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
              C + + RL  V EY+  G L  H+       R L        +A  S  L YLHE+ 
Sbjct: 72  HS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER- 125
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAMT 271
              +IYRDLK  N+LL+   H KL+D+G+ K G   GD T   +   GT  Y AP+    
Sbjct: 126 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRG 180
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAID 298
               F  D ++ GV++ E++ GR   D
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 109/232 (46%), Gaps = 28/232 (12%)
Query: 78  AKPFTFDELAAATGNFRSDC---------CLGEGGFGKVYKGCLEKIEQ---VVAIKQLD 125
           A+P T++E   A  +F  +           +G G  G+V  G L    Q    VAIK L 
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 126 HRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDL 182
               +   R+F +E   +G  DHPN+++L G    G   ++V EYM  GSLD  L  HD 
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG 146
Query: 183 RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
           +     L     + +  G   G++YL +      ++RDL   N+L++     K+SDFGL+
Sbjct: 147 QFTIMQL-----VGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 243 KM---GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
           ++    P    T    ++     + AP+       +  SD++SFGVV+ E++
Sbjct: 199 RVLEDDPDAAXTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    +  + ++A+K     QL+  GV+   +   EV    
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 63
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 119
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H    + VI+RD+K  N+LL      K++DFG +   PS  +  +     GT  Y
Sbjct: 120 ALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDY 172
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 68
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY P G + K L  L       D           + 
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK----FDEQRTATYITELAN 124
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +      + GT  Y
Sbjct: 125 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRX----XLXGTLDY 177
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 255
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 256 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
           +G G FG+V+ G L     +VA+K         ++ +F  E   L    HPN+V+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
               Q+  +Y  M L      L  LR +   L   T +++   A+ G++YL  +     I
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E    K+SDFG+++    G              + AP+    G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 278 SDIYSFGVVLLELIT 292
           SD++SFG++L E  +
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 17/207 (8%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKL 153
            +G G + KV    L+K +++ A+K +    V   + +     E      A +HP LV L
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 154 IGYCAEGDQRLL-VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
              C + + RL  V EY+  G L  H+       R L        +A  S  L YLHE+ 
Sbjct: 76  HS-CFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER- 129
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYAMT 271
              +IYRDLK  N+LL+   H KL+D+G+ K G   GD T   +   GT  Y AP+    
Sbjct: 130 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SXFCGTPNYIAPEILRG 184
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAID 298
               F  D ++ GV++ E++ GR   D
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
           +GEG FG+V K  ++K  +    AIK++ ++      R+F+ E+  L     HPN++ L+
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-DTRP-----------LDWNTRMKIAAGAS 202
           G C       L  EY P G+L   L   R  +T P           L     +  AA  +
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RG+ YL ++     I+R+L   NIL+ E Y  K++DFGL++    G + +V  + MG   
Sbjct: 150 RGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRLP 201
Query: 263 --YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + A +       T  SD++S+GV+L E+++
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  G L   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVMEYMSKGCL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 12/227 (5%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-EVMTLGSAD 146
           +++  F+    LG G +  VYKG  +     VA+K++     +G    +  E+  +    
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRG 204
           H N+V+L       ++  LV+E+M    L K++        P  L+ N          +G
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L + HE     +++RDLK  N+L+ +    KL DFGLA+    G   +  +  + T  Y 
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYR 175
Query: 265 APDYAMTGQLTFKS--DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           APD  M G  T+ +  DI+S G +L E+ITG+     T D ++L L+
Sbjct: 176 APDVLM-GSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL---- 153
           LG GGFG V +   +   + VAIKQ         RE +  E+  +   +HPN+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 154 --IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
             +   A  D  LL  EY   G L K+L+    +   L       + +  S  L+YLHE 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 212 LKQPVIYRDLKCSNILLEEGYH---PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
               +I+RDLK  NI+L+ G      K+ D G AK     D+  + T  +GT  Y AP+ 
Sbjct: 141 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPEL 194
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG 293
               + T   D +SFG +  E ITG
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL---- 153
           LG GGFG V +   +   + VAIKQ         RE +  E+  +   +HPN+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 154 --IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
             +   A  D  LL  EY   G L K+L+    +   L       + +  S  L+YLHE 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 212 LKQPVIYRDLKCSNILLEEGYH---PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
               +I+RDLK  NI+L+ G      K+ D G AK     D+  + T  +GT  Y AP+ 
Sbjct: 142 R---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVGTLQYLAPEL 195
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG 293
               + T   D +SFG +  E ITG
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLG 143
           A  +F     LG+G FG VY    ++ + ++A+K     QL+  GV+   +   EV    
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQS 66
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
              HPN+++L GY  +  +  L+ EY PLG++ + L  L       D           + 
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELAN 122
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L Y H +    VI+RD+K  N+LL      K++DFG +   PS  +  +     GT  Y
Sbjct: 123 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDY 175
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
             P+         K D++S GV+  E + G+   +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 254
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 255 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 41/288 (14%)
Query: 98  CLGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLV 151
            +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 152 KLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQ 206
            L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMK 165
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYC 264
           YL  +     ++RDL   N +L+E +  K++DFGLA+          H  T       + 
Sbjct: 166 YLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           A +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+    
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR---- 273
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
                LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 274 ----LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 314

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 146
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 253
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 254 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 294

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  G L   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 77  QLYAVVSE-EPIYIVTEYMSKGCL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 131
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGLA++    + T           + AP+ A+
Sbjct: 132 --RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAAL 188
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 189 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLI 154
           +G G FG+V  G L+   K E  VAIK L      +  R+F +E   +G  DHPN++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G   +    +++ EYM  GSLD  L  +D R     L     + +  G   G++YL +  
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL-----VGMLRGIGSGMKYLSD-- 134
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               ++RDL   NIL+      K+SDFG++++     +   +TR       + AP+    
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
            + T  SD++S+G+V+ E+++
Sbjct: 194 RKFTSASDVWSYGIVMWEVMS 214

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 98  CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKL 153
            +G G FG+V  G L+   K +  VAIK L     +  R +F  E   +G  DHPN+V L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G    G   ++V E+M  G+LD  L  HD +     L     + +  G + G++YL + 
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL-----VGMLRGIAAGMRYLAD- 163
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG--YCAPDYA 269
                ++RDL   NIL+      K+SDFGL+++    D   V T   G     + AP+  
Sbjct: 164 --MGYVHRDLAARNILVNSNLVCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAPEAI 220
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
              + T  SD++S+G+V+ E+++
Sbjct: 221 QYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 140
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L  +     ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 141 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 247
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 248 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 143
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 250
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 251 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 291

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 73  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 121
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DHPNLVKL 153
            +G G + KV    L+K +++ A++ +    V   + +     E      A +HP LV L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 154 IGYCAEGDQRLL-VYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHE 210
              C + + RL  V EY+  G L  H+   R  P+     ++  + +A      L YLHE
Sbjct: 119 HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHE 171
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTYGYCAPDYA 269
           +    +IYRDLK  N+LL+   H KL+D+G+ K G   GD T   +   GT  Y AP+  
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 225
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAID 298
                 F  D ++ GV++ E++ GR   D
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G      +V AIK L   G      F  E   +    H  LV
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKP-GNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHE 210
           +L    +E +   +V EYM  GSL   L  L+ +  + L     + +AA  + G+ Y+  
Sbjct: 244 QLYAVVSE-EPIYIVTEYMSKGSL---LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE- 298
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +   ++RDL+ +NIL+ E    K++DFGL ++    + T           + AP+ A+
Sbjct: 299 --RMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT-ARQGAKFPIKWTAPEAAL 355
Query: 271 TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            G+ T KSD++SFG++L EL T GR       +R+ L+ V
Sbjct: 356 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 395

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 167
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L  +     ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 168 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 274
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 275 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 315

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 30/280 (10%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADH 147
            NFR +  +G G F +VY+         VA+K++   D    +   +   E+  L   +H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           PN++K      E ++  +V E    G L + +   +   R +   T  K        L++
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           +H +    V++RD+K +N+ +      KL D GL +   S  KT  +  ++GT  Y +P+
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE 206
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                   FKSDI+S G +L E                  + A   P + D+ N   +  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKMNLYSLCK 248
Query: 328 PSLQGQYPV----RGLYQALAIAAMCVQEQPNMRPAITDV 363
              Q  YP         +   +  MC+   P  RP +T V
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 145
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 146 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 252
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 253 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 293

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 130/287 (45%), Gaps = 41/287 (14%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           +G G FG VY G L     +KI    A+K L+    +  V +F  E + +    HPN++ 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIH--CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG----ASRGLQY 207
           L+G C   +   L+V  YM  G       DLR   R    N  +K   G     ++G++Y
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHG-------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKY 148
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCA 265
           L     +  ++RDL   N +L+E +  K++DFGLA+          H  T       + A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
            +   T + T KSD++SFGV+L EL+T  +      D    ++  +   + + R+     
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVY---LLQGRR----- 255
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
               LQ +Y    LY+ +     C   +  MRP+ +++V  ++ + S
Sbjct: 256 ---LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKLIGYC 157
           +G G FG+V+ G L     +VA+K         ++ +F  E   L    HPN+V+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
               Q+  +Y  M L      L  LR +   L   T +++   A+ G++YL  +     I
Sbjct: 182 T---QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E    K+SDFG+++    G              + AP+    G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 278 SDIYSFGVVLLELIT 292
           SD++SFG++L E  +
Sbjct: 296 SDVWSFGILLWETFS 310

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 95  SDCCLGEGGFGKVYKGCLEKIEQV-----VAIKQLDH-RGVQGVREFSAEVMTLGSADHP 148
           SD  +G+G FG VY G  E I+Q       AIK L     +Q V  F  E + +   +HP
Sbjct: 25  SDRVIGKGHFGVVYHG--EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 149 NLVKLIGYC--AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           N++ LIG     EG   +L+  YM  G L   L  +R   R       +      +RG++
Sbjct: 83  NVLALIGIMLPPEGLPHVLL-PYMCHGDL---LQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----MGPSGDKTHVSTRVMGTYG 262
           YL EQ     ++RDL   N +L+E +  K++DFGLA+          + H   R+     
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL--PVK 193
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + A +   T + T KSD++SFGV+L EL+T
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 123
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 99  LGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLI 154
           +G G FG+V  G L+   K E  VAIK L      +  R+F +E   +G  DHPN++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G   +    +++ EYM  GSLD     LR +         + +  G   G++YL +    
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAF---LRKNDGRFTVIQLVGMLRGIGSGMKYLSD---M 129
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMTGQ 273
             ++RDL   NIL+      K+SDFG++++     +   +TR       + AP+     +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 274 LTFKSDIYSFGVVLLELIT 292
            T  SD++S+G+V+ E+++
Sbjct: 190 FTSASDVWSYGIVMWEVMS 208

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 98  CLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKL 153
            +G G FG+V  G L+   K E  VAIK L     +  R +F +E   +G  DHPN++ L
Sbjct: 14  VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 73
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            G   +    +++ E+M  GSLD     LR +         + +  G + G++YL +   
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDSF---LRQNDGQFTVIQLVGMLRGIAAGMKYLAD--- 127
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG---TYGYCAPDYAM 270
              ++R L   NIL+      K+SDFGL++           T  +G      + AP+   
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 271 TGQLTFKSDIYSFGVVLLELIT 292
             + T  SD++S+G+V+ E+++
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 107/232 (46%), Gaps = 25/232 (10%)
Query: 99  LGEGGFGKVYKGCLEK----IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V+   +E+    +E+V+     D   V  + +  AE+  L S DHPN++K+ 
Sbjct: 30  LGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNIIKIF 86
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
               +     +V E    G L + +   +   + L      ++       L Y H    Q
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQ 143
Query: 215 PVIYRDLKCSNILLEEG--YHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            V+++DLK  NIL ++   + P K+ DFGLA++  S +    ST   GT  Y AP+    
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPE-VFK 199
Query: 272 GQLTFKSDIYSFGVVLLELITG--------RKAIDQTKDRKELNLVAWARPM 315
             +TFK DI+S GVV+  L+TG         + + Q    KE N     RP+
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL 251

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 132/305 (43%), Gaps = 29/305 (9%)
Query: 71  SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
           S++  +S        L    G F     +G G +G+VYKG   K  Q+ AIK +D  G +
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 131 GVREFSAEVMTLGS-ADHPNLVKLIGYCAE------GDQRLLVYEYMPLGSLDKHLHDLR 183
              E   E+  L   + H N+    G   +       DQ  LV E+   GS+   + + +
Sbjct: 64  E-EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
            +T   +W     I     RGL +LH+     VI+RD+K  N+LL E    KL DFG++ 
Sbjct: 123 GNTLKEEWIAY--ICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 244 MGPSGDKTHVSTR--VMGTYGYCAPDYAMTGQ-----LTFKSDIYSFGVVLLELITGRKA 296
                D+T V  R   +GT  + AP+     +       FKSD++S G+  +E+  G   
Sbjct: 178 ---QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
Query: 297 IDQTKDRKELNLVAW-ARPMFKDR---KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQE 352
           +      + L L+     P  K +   K F   ++  L   +  R   + L +    +++
Sbjct: 234 LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL-MKHPFIRD 292
Query: 353 QPNMR 357
           QPN R
Sbjct: 293 QPNER 297

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 15/225 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD 146
             R    LG G FG VYKG      E ++  VAIK L ++   +  +E   E   +    
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW-NTRMKIAAGASRGL 205
            P + +L+G C     +L V + MP G L  H+ + R      D  N  M+IA    +G+
Sbjct: 78  SPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIA----KGM 132
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
            YL +     +++RDL   N+L++   H K++DFGLA++    +  + +        + A
Sbjct: 133 SYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
            +  +  + T +SD++S+GV + EL+T G K  D    R+  +L+
Sbjct: 190 LESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 20/200 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L   G   V+ F  E   + +  H  LV+L     
Sbjct: 21  LGAGQFGEVWMGYYNNSTKV-AVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 159 EGDQRLLVYEYMPLGSLDKHLHD------LRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             +   ++ EYM  GSL   L        L P          +  +A  + G+ Y+    
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL--------IDFSAQIAEGMAYIE--- 127
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
           ++  I+RDL+ +N+L+ E    K++DFGLA++    + T           + AP+    G
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFG 186
Query: 273 QLTFKSDIYSFGVVLLELIT 292
             T KSD++SFG++L E++T
Sbjct: 187 CFTIKSDVWSFGILLYEIVT 206

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 18/200 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G FG VY     + + ++A+K     QL+  GV+   +   EV       HPN+++L
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHPNILRL 77
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            GY  +  +  L+ EY PLG++ + L  L   +R  +  T   I   A+  L Y H    
Sbjct: 78  YGYFHDATRVYLILEYAPLGTVYRELQKL---SRFDEQRTATYITELAN-ALSYCH---S 130
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           + VI+RD+K  N+LL      K++DFG +   PS  +      + GT  Y  P+      
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPEMIEGRM 186
Query: 274 LTFKSDIYSFGVVLLELITG 293
              K D++S GV+  E + G
Sbjct: 187 HDEKVDLWSLGVLCYEFLVG 206

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 98  CLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVM---TLGSADHPN 149
            LG+G FGKV+   ++KI      Q+ A+K L  +    VR+     M    L   +HP 
Sbjct: 31  VLGQGSFGKVF--LVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVEVNHPF 87
Query: 150 LVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           +VKL  Y  + + +L L+ +++  G L      L  +    + + +  +A  A   L +L
Sbjct: 88  IVKL-HYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELAL-ALDHL 142
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H      +IYRDLK  NILL+E  H KL+DFGL+K     +K   S    GT  Y AP+ 
Sbjct: 143 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 197
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
                 T  +D +SFGV++ E++TG     Q KDRKE
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKE 233

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 98  CLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVM---TLGSADHPN 149
            LG+G FGKV+   ++KI      Q+ A+K L  +    VR+     M    L   +HP 
Sbjct: 32  VLGQGSFGKVF--LVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVEVNHPF 88
Query: 150 LVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           +VKL  Y  + + +L L+ +++  G L      L  +    + + +  +A  A   L +L
Sbjct: 89  IVKL-HYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELAL-ALDHL 143
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H      +IYRDLK  NILL+E  H KL+DFGL+K   S D    +    GT  Y AP+ 
Sbjct: 144 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEV 198
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
                 T  +D +SFGV++ E++TG     Q KDRKE
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKE 234

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/217 (34%), Positives = 109/217 (50%), Gaps = 23/217 (10%)
Query: 98  CLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVM---TLGSADHPN 149
            LG+G FGKV+   ++KI      Q+ A+K L  +    VR+     M    L   +HP 
Sbjct: 31  VLGQGSFGKVF--LVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVEVNHPF 87
Query: 150 LVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           +VKL  Y  + + +L L+ +++  G L      L  +    + + +  +A  A   L +L
Sbjct: 88  IVKL-HYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLAELAL-ALDHL 142
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H      +IYRDLK  NILL+E  H KL+DFGL+K   S D    +    GT  Y AP+ 
Sbjct: 143 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEV 197
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
                 T  +D +SFGV++ E++TG     Q KDRKE
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKE 233

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L  +G      F AE   +    H  LV+L     
Sbjct: 17  LGAGQFGEVWMGYYNGHTKV-AVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + +   ++ EYM  GSL   L    P    L  N  + +AA  + G+ ++ E+     I+
Sbjct: 75  Q-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 128
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           R+L+ +NIL+ +    K++DFGLA++    + T           + AP+    G  T KS
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 279 DIYSFGVVLLELIT 292
           D++SFG++L E++T
Sbjct: 188 DVWSFGILLTEIVT 201

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 9/214 (4%)
Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  D         +    LG G  G+V+ G      +V A+K L  +G      F AE
Sbjct: 1   KPWWEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAE 58
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMA 115
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    + T       
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAK 171
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               + AP+    G  T KSD++SFG++L E++T
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG  G+V        E+ VA+K +D  R V        E+      +H N+VK  G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            EG+ + L  EY   G L D+   D+    PD +        +       G+ YLH    
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ--------RFFHQLMAGVVYLH---G 122
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+     +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 274 LTFKS-DIYSFGVVLLELITGRKAIDQTKD 302
              +  D++S G+VL  ++ G    DQ  D
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSD 212

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 91/199 (45%), Gaps = 21/199 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G FG VY     +  +VVAIK++ + G Q     ++   EV  L    HPN ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV EY  LGS    L       +PL       +  GA +GL YLH      
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT--- 271
           +I+RD+K  NILL E    KL DFG A  M P       +   +GT  + AP+  +    
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDE 188
Query: 272 GQLTFKSDIYSFGVVLLEL 290
           GQ   K D++S G+  +EL
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 146
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 95  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 146
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 206 KFSSKSDVWSFGVLMWEAFS 225

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 92/199 (46%), Gaps = 21/199 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G FG VY     +  +VVAIK++ + G Q     ++   EV  L    HPN ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV EY  LGS    L   +   +PL       +  GA +GL YLH      
Sbjct: 122 CYLREHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHN 174
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT--- 271
           +I+RD+K  NILL E    KL DFG A  M P       +   +GT  + AP+  +    
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDE 227
Query: 272 GQLTFKSDIYSFGVVLLEL 290
           GQ   K D++S G+  +EL
Sbjct: 228 GQYDGKVDVWSLGITCIEL 246

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 136
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFS 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 46/224 (20%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE--VMTLGSADHPNLVKLIGY 156
           +G G +G VYKG L+  E+ VA+K       Q    F  E  +  +   +H N+ + I  
Sbjct: 21  IGRGRYGAVYKGSLD--ERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIV- 74
Query: 157 CAEGDQR---------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
              GD+R         LLV EY P GSL K+L          DW +  ++A   +RGL Y
Sbjct: 75  ---GDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 208 LHEQL------KQPVIYRDLKCSNILLEEGYHPKLSDFGLA------KMGPSGDKTHVST 255
           LH +L      K  + +RDL   N+L++      +SDFGL+      ++   G++ + + 
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 256 RVMGTYGYCAPDYAMTGQLTFKS--------DIYSFGVVLLELI 291
             +GT  Y AP+  + G +  +         D+Y+ G++  E+ 
Sbjct: 187 SEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 124
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 184 KFSSKSDVWSFGVLMWEAFS 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFS 205

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 163 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 271
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 272 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 308

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 93  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 144
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 204 KFSSKSDVWSFGVLMWEAFS 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 14/213 (6%)
Query: 95  SDCCLGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLV 151
           +D  LG G FG V +G   + K +  VAIK L     +    E   E   +   D+P +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           +LIG C + +  +LV E    G L K L   R +  P+  +   ++    S G++YL E+
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI-PV--SNVAELLHQVSMGMKYLEEK 129
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYA 269
                ++RDL   N+LL   ++ K+SDFGL+K     D ++ + R  G +   + AP+  
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK 301
              + + +SD++S+GV + E ++ G+K   + K
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 157 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 265
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 266 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 302

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 157 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 265
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 266 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 302

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 130
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+     
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 183 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 291
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 292 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 328

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD----- 146
            FR    LG+GGFG+V   C  ++     +        + +++   E M L         
Sbjct: 185 TFRQYRVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 147 HPNLVKLIGYCAEG-DQRLLVYEYMPLGSLDKHLHDL----RPDTRPLDWNTRMKIAAGA 201
           +   V  + Y  E  D   LV   M  G L  H++ +     P+ R + +      AA  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEI 295
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
             GL+ LH   ++ ++YRDLK  NILL++  H ++SD GLA   P G    +  RV GT 
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 349
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           GY AP+     + TF  D ++ G +L E+I G+    Q K +
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDH-RGVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 279
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 280 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 316

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 173 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 281
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 282 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 318

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/227 (32%), Positives = 112/227 (49%), Gaps = 23/227 (10%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGVQGVREFSAEVM-- 140
           A   +F     LG+G FGKV+   + K+ +     + A+K L  +    VR+     M  
Sbjct: 25  ADPSHFELLKVLGQGSFGKVF--LVRKVTRPDSGHLYAMKVLK-KATLKVRDRVRTKMER 81
Query: 141 -TLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
             L   +HP +VKL  Y  + + +L L+ +++  G L      L  +    + + +  +A
Sbjct: 82  DILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTEEDVKFYLA 137
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
             A  GL +LH      +IYRDLK  NILL+E  H KL+DFGL+K     +K   S    
Sbjct: 138 ELA-LGLDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FC 191
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
           GT  Y AP+       +  +D +S+GV++ E++TG     Q KDRKE
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF-QGKDRKE 237

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD----- 146
            FR    LG+GGFG+V   C  ++     +        + +++   E M L         
Sbjct: 185 TFRQYRVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV 241
Query: 147 HPNLVKLIGYCAEG-DQRLLVYEYMPLGSLDKHLHDL----RPDTRPLDWNTRMKIAAGA 201
           +   V  + Y  E  D   LV   M  G L  H++ +     P+ R + +      AA  
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEI 295
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
             GL+ LH   ++ ++YRDLK  NILL++  H ++SD GLA   P G    +  RV GT 
Sbjct: 296 CCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTV 349
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           GY AP+     + TF  D ++ G +L E+I G+    Q K +
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 264
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 265 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 301

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 264
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 265 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 301

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 12/198 (6%)
Query: 98  CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 77  IGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 129
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           +  ++RD+   N+L+      KL DFGL++          S   +    + AP+     +
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI-KWMAPESINFRR 188
Query: 274 LTFKSDIYSFGVVLLELI 291
            T  SD++ FGV + E++
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 279
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 280 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 316

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 457 IGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
           +  ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 279
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 280 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 316

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 148 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 256
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 257 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 293

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 157 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 265
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 266 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 302

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 117/285 (41%), Gaps = 31/285 (10%)
Query: 92  NFRSDCCLGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREFSAEVMTLGS-- 144
           N +    LG G FGKV +     L K + V  VA+K L        +E     + + S  
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH-----DL-RPDTRPLDWNTRMKIA 198
             H N+V L+G C  G   L++ EY   G L   L      DL + D RPL+    +  +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           +  ++G+ +L  +     I+RD+   N+LL  G+  K+ DFGLA+   +     V     
Sbjct: 167 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
               + AP+       T +SD++S+G++L E+ +             L L  +  P    
Sbjct: 224 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY--PGILV 268
Query: 319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
              F ++V    Q   P        +I   C   +P  RP    +
Sbjct: 269 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL  + 
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 135
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               I+RDL   N+LL      K+ DFGL +  P  D  +V        + +CAP+   T
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 174 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 282
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 283 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 319

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           LG GG   VY      +   VAIK +        + ++ F  EV       H N+V +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              E D   LV EY+   +L +++        PL  +T +        G+++ H+     
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---R 131
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           +++RD+K  NIL++     K+ DFG+AK       T  +  V+GT  Y +P+ A  G+ T
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQA-KGEAT 189
Query: 276 FK-SDIYSFGVVLLELITGR 294
            + +DIYS G+VL E++ G 
Sbjct: 190 DECTDIYSIGIVLYEMLVGE 209

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 37/286 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L      Q   +F  E + +   +H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----LDWNTRMKIAAGASRGLQY 207
            IG   +   R ++ E M  G L   L + RP  RP     L     + +A   + G QY
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 208 LHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L E      I+RD+   N LL     G   K+ DFG+A+              M    + 
Sbjct: 197 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
            P+  M G  T K+D +SFGV+L E+ + G        +++ L  V     M        
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-------- 305
Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
              DP      PV        I   C Q QP  RP    ++  + Y
Sbjct: 306 ---DPPKNCPGPV------YRIMTQCWQHQPEDRPNFAIILERIEY 342

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 31/278 (11%)
Query: 99  LGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLV 151
           LG G FGKV +     L K + V  VA+K L        +E     + + S    H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLH-----DL-RPDTRPLDWNTRMKIAAGASRGL 205
            L+G C  G   L++ EY   G L   L      DL + D RPL+    +  ++  ++G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
            +L  +     I+RD+   N+LL  G+  K+ DFGLA+   +     V         + A
Sbjct: 166 AFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMA 222
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
           P+       T +SD++S+G++L E+ +             L L  +  P       F ++
Sbjct: 223 PESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY--PGILVNSKFYKL 267
Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           V    Q   P        +I   C   +P  RP    +
Sbjct: 268 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 96  DCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           D  LG G FG V KG  +         V I + +        E  AE   +   D+P +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           ++IG C E +  +LV E   LG L+K+L       R +     +++    S G++YL E 
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 488
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYA 269
                ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+  
Sbjct: 489 ---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
              + + KSD++SFGV++ E  +
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 16/205 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           LG G FGKV  G  E     VA+K L+    R +  V +   E+  L    HP+++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +      +V EY+  G L     D       LD     ++      G+ Y H  +   
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--- 136
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           V++RDLK  N+LL+   + K++DFGL+ M   G+    S    G+  Y AP+  ++G+L 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE-VISGRLY 192
Query: 276 F--KSDIYSFGVVLLELITGRKAID 298
              + DI+S GV+L  L+ G    D
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL  +  
Sbjct: 77  IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 131
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
              ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 132 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 457 IGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
           +  ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 79  IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 131
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
           +  ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 190 RFTSASDVWMFGVCMWEIL 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 99  LGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +         V I + +        E  AE   +   D+P +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E    
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 130
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYAMTG 272
             ++RDL   N+LL   ++ K+SDFGL+K     D+     +  G +   + AP+     
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFGV++ E  +
Sbjct: 190 KFSSKSDVWSFGVLMWEAFS 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 96  DCCLGEGGFGKVYKGCLE----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           D  LG G FG V KG  +         V I + +        E  AE   +   D+P +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           ++IG C E +  +LV E   LG L+K+L       R +     +++    S G++YL E 
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES 489
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY--GYCAPDYA 269
                ++RDL   N+LL   ++ K+SDFGL+K     D+ +   +  G +   + AP+  
Sbjct: 490 ---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
              + + KSD++SFGV++ E  +
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 74  IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
           +  ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 185 RFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL  +  
Sbjct: 82  IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
              ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 193 RFTSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL  +  
Sbjct: 105 IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 159
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
              ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 160 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 216 RFTSASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 80  IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 132
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
           +  ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 191 RFTSASDVWMFGVCMWEIL 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL     
Sbjct: 77  IGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 129
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
           +  ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 99  LGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLV 151
           LG G FGKV +     L K + V  VA+K L        +E     + + S    H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA--AGASRGLQYLH 209
            L+G C  G   L++ EY   G L   L+ LR  +R L+ +    IA    ++R L +  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDL---LNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 210 EQLKQPV--------IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            Q+ Q +        I+RD+   N+LL  G+  K+ DFGLA+   +     V        
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN 321
            + AP+       T +SD++S+G++L E+ +             L L  +  P       
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY--PGILVNSK 275
Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           F ++V    Q   P        +I   C   +P  RP    +
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL  + 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               I+RDL   N+LL      K+ DFGL +  P  D  +V        + +CAP+   T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL  + 
Sbjct: 80  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 135
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               I+RDL   N+LL      K+ DFGL +  P  D  +V        + +CAP+   T
Sbjct: 136 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL  + 
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               I+RDL   N+LL      K+ DFGL +  P  D  +V        + +CAP+   T
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E+I G          + L L+A
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 16/220 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F     LG+G FGKV     +  E++ AIK L    V     V     E   L   D P
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 149 NLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             +  +  C +   RL  V EY+  G L  H+  +     P      +  AA  S GL +
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISIGLFF 135
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTR-VMGTYGYCAP 266
           LH   K+ +IYRDLK  N++L+   H K++DFG+ K         V+TR   GT  Y AP
Sbjct: 136 LH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDYIAP 189
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           +           D +++GV+L E++ G+   D  +D  EL
Sbjct: 190 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDEL 228

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 98  CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E      V+  M L +L +    L+     LD  + +  A   S  L YL  +  
Sbjct: 77  IGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR- 131
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYCAPDYAMTG 272
              ++RD+   N+L+      KL DFGL++     D T+  +++      + AP+     
Sbjct: 132 --FVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 273 QLTFKSDIYSFGVVLLELI 291
           + T  SD++ FGV + E++
Sbjct: 188 RFTSASDVWMFGVCMWEIL 206

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL    
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
            +  I+RDL   N+LL      K+ DFGL +  P  D  +V        + +CAP+   T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG+V+ G      +V A+K L   G   V+ F  E   + +  H  LV+L     
Sbjct: 20  LGAGQFGEVWMGYYNNSTKV-AVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 159 EGDQRLLVYEYMPLGSLDKHLHD------LRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           + +   ++ E+M  GSL   L        L P          +  +A  + G+ Y+    
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKL--------IDFSAQIAEGMAYIE--- 126
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
           ++  I+RDL+ +N+L+ E    K++DFGLA++    + T           + AP+    G
Sbjct: 127 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFG 185
Query: 273 QLTFKSDIYSFGVVLLELIT 292
             T KS+++SFG++L E++T
Sbjct: 186 CFTIKSNVWSFGILLYEIVT 205

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E+I G          + L L+A
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 138/300 (46%), Gaps = 35/300 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGS 144
           +F     +G GGFG+VY GC +    ++ A+K LD + +   QG     +  +M   + +
Sbjct: 189 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGAS 202
            D P +V +       D+   + + M  G L  HL  H +  +      + R   AA   
Sbjct: 248 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRF-YAAEII 301
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            GL+++H +    V+YRDLK +NILL+E  H ++SD GLA    S  K H S   +GT+G
Sbjct: 302 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 354
Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQ--TKDRKELNLVAWARPMFKDR 319
           Y AP+    G      +D +S G +L +L+ G     Q  TKD+ E++ +     + +  
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELP 413
Query: 320 KNFSQMVDPSLQG--QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
            +FS  +   L+G  Q  V      L   A  V+E P  R     +V        QKY P
Sbjct: 414 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL------QKYPP 467

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E+I G          + L L+A
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 89/300 (29%), Positives = 138/300 (46%), Gaps = 35/300 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGS 144
           +F     +G GGFG+VY GC +    ++ A+K LD + +   QG     +  +M   + +
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGAS 202
            D P +V +       D+   + + M  G L  HL  H +  +      + R   AA   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRF-YAAEII 302
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            GL+++H +    V+YRDLK +NILL+E  H ++SD GLA    S  K H S   +GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 355
Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQ--TKDRKELNLVAWARPMFKDR 319
           Y AP+    G      +D +S G +L +L+ G     Q  TKD+ E++ +     + +  
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELP 414
Query: 320 KNFSQMVDPSLQG--QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
            +FS  +   L+G  Q  V      L   A  V+E P  R     +V        QKY P
Sbjct: 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFL------QKYPP 468

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 140
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E+I G          + L L+A
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGY 156
            +G G    V        ++ VAIK+++    Q  + E   E+  +    HPN+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 157 CAEGDQRLLVYEYMPLGS-LDKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
               D+  LV + +  GS LD   H +      +  LD +T   I      GL+YLH   
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTR--VMGTYGYCAPDYA 269
           K   I+RD+K  NILL E    +++DFG+ A +   GD T    R   +GT  + AP+  
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 270 -MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
                  FK+DI+SFG+  +EL TG     +    K L L     P             P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-------------P 245
Query: 329 SLQGQYPVRGLYQALA-----IAAMCVQEQPNMRPAITDVV 364
           SL+     + + +        + ++C+Q+ P  RP   +++
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL  + 
Sbjct: 86  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               I+RDL   N+LL      K+ DFGL +  P  D   V        + +CAP+   T
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 99  LGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S DH NL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G       ++ V E  PLGSL   L  LR         T  + A   + G+ YL  + 
Sbjct: 76  LYGVVLTPPMKM-VTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT-YGYCAPDYAMT 271
               I+RDL   N+LL      K+ DFGL +  P  D   V        + +CAP+   T
Sbjct: 132 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              +  SD + FGV L E+ T
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT 209

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 113/228 (49%), Gaps = 26/228 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGS 144
           +F     +G GGFG+VY GC +    ++ A+K LD + +   QG     +  +M   + +
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGAS 202
            D P +V +       D+   + + M  G L  HL  H +  +      + R   AA   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRF-YAAEII 302
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            GL+++H +    V+YRDLK +NILL+E  H ++SD GLA    S  K H S   +GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 355
Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQ--TKDRKELN 307
           Y AP+    G      +D +S G +L +L+ G     Q  TKD+ E++
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 113/228 (49%), Gaps = 26/228 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV---QG-VREFSAEVMT--LGS 144
           +F     +G GGFG+VY GC +    ++ A+K LD + +   QG     +  +M   + +
Sbjct: 190 DFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGAS 202
            D P +V +       D+   + + M  G L  HL  H +  +      + R   AA   
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRF-YAAEII 302
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            GL+++H +    V+YRDLK +NILL+E  H ++SD GLA    S  K H S   +GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 355
Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQ--TKDRKELN 307
           Y AP+    G      +D +S G +L +L+ G     Q  TKD+ E++
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 403

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +C + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 152
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 153 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 116/282 (41%), Gaps = 35/282 (12%)
Query: 99  LGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLV 151
           LG G FGKV +     L K + V  VA+K L        +E     + + S    H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG--ASRGLQYLH 209
            L+G C  G   L++ EY   G L   L+ LR  +R L+ +    IA    ++R L +  
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDL---LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 210 EQLKQPV--------IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            Q+ Q +        I+RD+   N+LL  G+  K+ DFGLA+   +     V        
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN 321
            + AP+       T +SD++S+G++L E+ +             L L  +  P       
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY--PGILVNSK 275
Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           F ++V    Q   P        +I   C   +P  RP    +
Sbjct: 276 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 29/220 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGVRE--FSAEVMTLGSADHPNLV 151
           LG G FGKV       I +      VA+K L  +     RE   S   M      H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLDWN 192
            L+G C       L++EY   G L  +L   R                    D   L + 
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
             +  A   ++G+++L     +  ++RDL   N+L+  G   K+ DFGLA+   S     
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           V         + AP+    G  T KSD++S+G++L E+ +
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 106/226 (46%), Gaps = 13/226 (5%)
Query: 98  CLGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
            LG G FG+V+K C E    + +A K +  RG++   E   E+  +   DH NL++L   
Sbjct: 96  ILGGGRFGQVHK-CEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
               +  +LV EY+  G L   + D   +   LD    MK       G++++H+     +
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMY---I 208
Query: 217 IYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           ++ DLK  NIL    +    K+ DFGLA+     +K  V+    GT  + AP+      +
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNYDFV 265
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK 320
           +F +D++S GV+   L++G        D + LN +   R   +D +
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGY 156
            +G G    V        ++ VAIK+++    Q  + E   E+  +    HPN+V     
Sbjct: 17  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 157 CAEGDQRLLVYEYMPLGS-LDKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
               D+  LV + +  GS LD   H +      +  LD +T   I      GL+YLH   
Sbjct: 77  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 133
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTR--VMGTYGYCAPDYA 269
           K   I+RD+K  NILL E    +++DFG+ A +   GD T    R   +GT  + AP+  
Sbjct: 134 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 270 -MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
                  FK+DI+SFG+  +EL TG     +    K L L     P             P
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP-------------P 240
Query: 329 SLQGQYPVRGLYQALA-----IAAMCVQEQPNMRPAITDVV 364
           SL+     + + +        + ++C+Q+ P  RP   +++
Sbjct: 241 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GVQGV-REFSAEVMTLGSADHPNLVKL 153
           LGEG F  VYK   +   Q+VAIK+  L HR     G+ R    E+  L    HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +          LV+++M    L+  + D      P      M +     +GL+YLH+   
Sbjct: 78  LDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTL---QGLEYLHQHW- 132
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +++RDLK +N+LL+E    KL+DFGLAK   S ++ +    V  T  Y AP+     +
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGAR 188
Query: 274 LT-FKSDIYSFGVVLLELI 291
           +     D+++ G +L EL+
Sbjct: 189 MYGVGVDMWAVGCILAELL 207

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 95/226 (42%), Gaps = 21/226 (9%)
Query: 73  NSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV 132
           N G S+ P       A   +F     +G+G FGKV     +  E   A+K L  + +   
Sbjct: 26  NLGPSSNP------HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK 79
Query: 133 RE----FSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP 188
           +E     S   + L +  HP LV L       D+   V +Y+  G L  HL   R    P
Sbjct: 80  KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP 139
Query: 189 LDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS 247
                R +  AA  +  L YLH      ++YRDLK  NILL+   H  L+DFGL K    
Sbjct: 140 -----RARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191
Query: 248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            + T  ++   GT  Y AP+           D +  G VL E++ G
Sbjct: 192 HNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 14/221 (6%)
Query: 95  SDCCLGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLV 151
           +D  LG G FG V +G   + K +  VAIK L     +    E   E   +   D+P +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           +LIG C + +  +LV E    G L K L   R +   +  +   ++    S G++YL E+
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEK 455
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG--YCAPDYA 269
                ++R+L   N+LL   ++ K+SDFGL+K     D ++ + R  G +   + AP+  
Sbjct: 456 ---NFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECI 511
Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLV 309
              + + +SD++S+GV + E ++ G+K   + K  + +  +
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 126/286 (44%), Gaps = 33/286 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +GEG +G V K   +   ++VAIK+     D + V+ +     E+  L    H NLV L+
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQLRHENLVNLL 90
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
             C +  +  LV+E++    LD    DL      LD+    K       G+ + H     
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILD----DLELFPNGLDYQVVQKYLFQIINGIGFCH---SH 143
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
            +I+RD+K  NIL+ +    KL DFG A+ +   G+   V    + T  Y AP+  + G 
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPE-LLVGD 199
Query: 274 LTF--KSDIYSFGVVLLELITGRKAIDQTKDRKEL--------NLVAWARPMFKDRKNFS 323
           + +    D+++ G ++ E+  G        D  +L        NL+   + +F     F+
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 324 QMVDPSLQGQYPVRGLYQALA-----IAAMCVQEQPNMRPAITDVV 364
            +  P ++ + P+   Y  L+     +A  C+   P+ RP   +++
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +   D          +IAA     LQ L       VI+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTETCMD--------EGQIAAVCRECLQALEFLHSNQVIH 140
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           R++K  NILL      KL+DFG  A++ P   K    + ++GT  + AP+         K
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGPK 197
Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
            DI+S G++ +E+I G          + L L+A
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 230

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 102 GGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD 161
           G FG V+K  L  + + VA+K    +  Q  +    EV +L    H N+++ IG    G 
Sbjct: 35  GRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 162 Q----RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL----- 212
                  L+  +   GSL   L         + WN    IA   +RGL YLHE +     
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKD 146
Query: 213 --KQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPD 267
             K  + +RD+K  N+LL+      ++DFGLA   + G S   TH     +GT  Y AP+
Sbjct: 147 GHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ---VGTRRYMAPE 203
Query: 268 YAMTGQLTF------KSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
             + G + F      + D+Y+ G+VL EL +   A D   D   L
Sbjct: 204 -VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 102 GGFGKVYKGCLEKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           G FG V+K  L  +   VA+K     D +  Q  RE    + +     H NL++ I    
Sbjct: 26  GRFGCVWKAQL--MNDFVAVKIFPLQDKQSWQSERE----IFSTPGMKHENLLQFIAAEK 79
Query: 159 EGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-- 212
            G     +  L+  +   GSL  +L         + WN    +A   SRGL YLHE +  
Sbjct: 80  RGSNLEVELWLITAFHDKGSLTDYL-----KGNIITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 213 ------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
                 K  + +RD K  N+LL+      L+DFGLA     G     +   +GT  Y AP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 267 DYAMTGQLTF------KSDIYSFGVVLLELITGRKAIDQTKD 302
           +  + G + F      + D+Y+ G+VL EL++  KA D   D
Sbjct: 195 E-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVD 235

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 93  FRSDC-----CLGEGGFGKVYKGCLEKIE-----QVVAIKQLDH----RGVQGVREFSAE 138
            R +C      LG+GG+GKV++  + K+      ++ A+K L      R  +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              L    HP +V LI     G +  L+ EY+  G L   L   R      D  T     
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMED--TACFYL 127
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRV 257
           A  S  L +LH++    +IYRDLK  NI+L    H KL+DFGL K     G  TH     
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---F 181
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT  Y AP+  M        D +S G ++ +++TG
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 96/215 (44%), Gaps = 25/215 (11%)
Query: 93  FRSDC-----CLGEGGFGKVYKGCLEKIE-----QVVAIKQLDH----RGVQGVREFSAE 138
            R +C      LG+GG+GKV++  + K+      ++ A+K L      R  +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              L    HP +V LI     G +  L+ EY+  G L   L   R      D  T     
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMED--TACFYL 127
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  S  L +LH++    +IYRDLK  NI+L    H KL+DFGL K   S     V+    
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHXFC 182
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           GT  Y AP+  M        D +S G ++ +++TG
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          +K  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDXXK 207
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 112/288 (38%), Gaps = 31/288 (10%)
Query: 92  NFRSDCCLGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREFSAEVMTLGS-- 144
           N +    LG G FGKV +     L K + V  VA+K L        +E     + + S  
Sbjct: 47  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG-ASR 203
             H N+V L+G C  G   L++ EY   G L   L   RP      +N         +SR
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 204 GLQYLHEQLKQPV--------IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
            L +   Q+ Q +        I+RD+   N+LL  G+  K+ DFGLA+   +     V  
Sbjct: 167 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM 315
                  + AP+       T +SD++S+G++L E+ +             L L  +  P 
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-------------LGLNPY--PG 271
Query: 316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
                 F ++V    Q   P        +I   C   +P  RP    +
Sbjct: 272 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 97  CCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKL 153
           C LG+G FG+V K C ++I +Q  A+K ++    +         EV  L   DHPN++KL
Sbjct: 28  CMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                +     +V E    G     L D     +    +   +I      G+ Y+H   K
Sbjct: 87  FEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGITYMH---K 139
Query: 214 QPVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +++RDLK  NILLE        K+ DFGL+        T +  R+ GT  Y AP+  +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPE-VL 195
Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
            G    K D++S GV+L  L++G
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                  +  SD+++ G ++ +L+ G
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLI 154
            LG GG  +V+     ++ + VA+K L     R       F  E     + +HP +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 155 GY----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                    G    +V EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 79  ATGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYA 269
                +I+RD+K +NI++      K+ DFG+A+ +  SG+    +  V+GT  Y +P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +  +SD+YS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 71  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 125
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 126 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 70  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 124
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 125 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 15/226 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V K    +   ++  ++L H  ++  +R +   E+  L   + P 
Sbjct: 17  DFERISELGAGNGGVVTK-VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L +     + +      K++    RGL YL 
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLR 131
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y AP+  
Sbjct: 132 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMAPERL 185
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM 315
                + +SDI+S G+ L+EL  GR  I    D KEL  + + RP+
Sbjct: 186 QGTHYSVQSDIWSMGLSLVELAVGRYPI-PPPDAKELEAI-FGRPV 229

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/298 (24%), Positives = 116/298 (38%), Gaps = 44/298 (14%)
Query: 92  NFRSDCCLGEGGFGKVYKGC---LEKIEQV--VAIKQLDHRGVQGVREFSAEVMTLGS-- 144
           N +    LG G FGKV +     L K + V  VA+K L        +E     + + S  
Sbjct: 32  NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 91
Query: 145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH---------DLRP----------D 185
             H N+V L+G C  G   L++ EY   G L   L           L P          D
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 186 TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
            RPL+    +  ++  ++G+ +L     +  I+RD+   N+LL  G+  K+ DFGLA+  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 208
Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
            +     V         + AP+       T +SD++S+G++L E+ +             
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS------------- 255
Query: 306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           L L  +  P       F ++V    Q   P        +I   C   +P  RP    +
Sbjct: 256 LGLNPY--PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 68  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 122
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 123 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 69  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 123
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLI 154
            LG GG  +V+     ++ + VA+K L     R       F  E     + +HP +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 155 ----GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                    G    +V EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYA 269
                +I+RD+K +NI++      K+ DFG+A+ +  SG+    +  V+GT  Y +P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +  +SD+YS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 13/211 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DH 147
           NF     LG+G FGKV    +++   + A+K L    +     V     E   L  A +H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P L +L       D+   V E++  G L  H+      +R  D       AA     L +
Sbjct: 84  PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMF 139
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH++    +IYRDLK  N+LL+   H KL+DFG+ K G     T  +    GT  Y AP+
Sbjct: 140 LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPE 194
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
                      D ++ GV+L E++ G    +
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    +    ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM---KIAAGASRGLQYLHEQLKQP 215
            GD+  +V E++  G+L             +  +TRM   +IAA     LQ L     Q 
Sbjct: 219 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLQALSVLHAQG 267
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           VI+RD+K  +ILL      KLSDFG         +      ++GT  + AP+        
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYG 325
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
            + DI+S G++++E++ G          K + ++   R     R      V PSL+G
Sbjct: 326 PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKVSPSLKG 379

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 75  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 129
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 130 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    +++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 148
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 149 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 150 TYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 148
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 149 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 155 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 13/234 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    +    ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR        +IAA     LQ L     Q VI+
Sbjct: 97  VGDELWVVMEFLEGGALT----DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIH 148
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+         + 
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           DI+S G++++E++ G          K + ++   R     R      V PSL+G
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKVSPSLKG 257

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 13/234 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    +    ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR        +IAA     LQ L     Q VI+
Sbjct: 88  VGDELWVVMEFLEGGALT----DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIH 139
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+         + 
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           DI+S G++++E++ G          K + ++   R     R      V PSL+G
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKVSPSLKG 248

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 147
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 148 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 13/234 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    +    ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR        +IAA     LQ L     Q VI+
Sbjct: 92  VGDELWVVMEFLEGGALT----DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIH 143
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+         + 
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           DI+S G++++E++ G          K + ++   R     R      V PSL+G
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKVSPSLKG 252

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 13/234 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    +    ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR        +IAA     LQ L     Q VI+
Sbjct: 99  VGDELWVVMEFLEGGALT----DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIH 150
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+         + 
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           DI+S G++++E++ G          K + ++   R     R      V PSL+G
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKVSPSLKG 259

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 150
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 151 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 13/214 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-EVMTLGSADHPNLVKLIGYC 157
           LGEG +  VYKG  +  + +VA+K++     +G    +  EV  L    H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                  LV+EY     LDK L     D    ++ +          RGL Y H   +Q V
Sbjct: 70  HTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQLT 275
           ++RDLK  N+L+ E    KL+DFGLA+      KT+ +  V  T  Y  PD  + +   +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYS 179
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            + D++  G +  E+ TGR     +   ++L+ +
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 144
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 145 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 152 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      ++              +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 209 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLI 154
            LG GG  +V+     ++ + VA+K L     R       F  E     + +HP +V + 
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 155 ----GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                    G    +V EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 96  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 151
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYA 269
                +I+RD+K +NI++      K+ DFG+A+ +  SG+    +  V+GT  Y +P+ A
Sbjct: 152 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +  +SD+YS G VL E++TG
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 144
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 145 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLI 154
            LG GG  +V+     +  + VA+K L     R       F  E     + +HP +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 155 ----GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                    G    +V EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYA 269
                +I+RD+K +NIL+      K+ DFG+A+ +  SG+    +  V+GT  Y +P+ A
Sbjct: 135 N---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +  +SD+YS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 13/234 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V    +    ++VA+K++D R  Q       EV+ +    H N+V++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR        +IAA     LQ L     Q VI+
Sbjct: 142 VGDELWVVMEFLEGGALT----DIVTHTR----MNEEQIAAVCLAVLQALSVLHAQGVIH 193
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  +ILL      KLSDFG         +      ++GT  + AP+         + 
Sbjct: 194 RDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           DI+S G++++E++ G          K + ++   R     R      V PSL+G
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRLKNLHKVSPSLKG 302

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          +K  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 196
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          +K  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 200
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          +K  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 199
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          +K  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTL 142
           A  GN++    LGEG FGKV         Q VA+K ++ +      +QG      E+  L
Sbjct: 11  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 68
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
               HP+++KL       D+ ++V EY         L D       +      +      
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYA-----GNELFDYIVQRDKMSEQEARRFFQQII 123
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             ++Y H   +  +++RDLK  N+LL+E  + K++DFGL+ +   G+    S    G+  
Sbjct: 124 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 177
Query: 263 YCAPDYAMTGQLTF--KSDIYSFGVVLLELITGRKAID 298
           Y AP+  ++G+L    + D++S GV+L  ++  R   D
Sbjct: 178 YAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTL 142
           A  GN++    LGEG FGKV         Q VA+K ++ +      +QG      E+  L
Sbjct: 10  AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 67
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
               HP+++KL       D+ ++V EY         L D       +      +      
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYA-----GNELFDYIVQRDKMSEQEARRFFQQII 122
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             ++Y H   +  +++RDLK  N+LL+E  + K++DFGL+ +   G+    S    G+  
Sbjct: 123 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 176
Query: 263 YCAPDYAMTGQLTF--KSDIYSFGVVLLELITGRKAID 298
           Y AP+  ++G+L    + D++S GV+L  ++  R   D
Sbjct: 177 YAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 102/228 (44%), Gaps = 23/228 (10%)
Query: 78  AKPFTFDELAAAT-GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVR 133
           + P  FDE       +F     +G+G FGKV        +++ A+K ++ +       VR
Sbjct: 1   SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 134 EFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD---LRPDTRPLD 190
               E+  +   +HP LV L     + +   +V + +  G L  HL      + +T  L 
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL- 119
Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
                         L YL     Q +I+RD+K  NILL+E  H  ++DF +A M P   +
Sbjct: 120 ------FICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--E 168
Query: 251 THVSTRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRK 295
           T ++T + GT  Y AP+   + +    +F  D +S GV   EL+ GR+
Sbjct: 169 TQITT-MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTL 142
           A  GN++    LGEG FGKV         Q VA+K ++ +      +QG      E+  L
Sbjct: 1   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 58
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
               HP+++KL       D+ ++V EY         L D       +      +      
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYA-----GNELFDYIVQRDKMSEQEARRFFQQII 113
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             ++Y H   +  +++RDLK  N+LL+E  + K++DFGL+ +   G+    S    G+  
Sbjct: 114 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 167
Query: 263 YCAPDYAMTGQLTF--KSDIYSFGVVLLELITGRKAID 298
           Y AP+  ++G+L    + D++S GV+L  ++  R   D
Sbjct: 168 YAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 36/273 (13%)
Query: 99  LGEGGFGK--VYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +GEG FGK  + K   +  + V+    +     +   E   EV  L +  HPN+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHD----LRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             E     +V +Y   G L K ++     L  + + LDW  ++ +A      L+++H++ 
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVHDR- 144
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +++RD+K  NI L +    +L DFG+A++  S     ++   +GT  Y +P+     
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENK 200
Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP-SLQ 331
               KSDI++ G VL EL T + A +    +   NLV          K  S    P SL 
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVL---------KIISGSFPPVSLH 248
Query: 332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
             Y +R L   L       +  P  RP++  ++
Sbjct: 249 YSYDLRSLVSQL------FKRNPRDRPSVNSIL 275

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 16/221 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 69  DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 183
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYCAPDY 268
           E+ K  +++RD+K SNIL+      KL DFG+     SG     ++   +GT  Y +P+ 
Sbjct: 184 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPER 236
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
                 + +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 237 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELM 276

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       +++        VA+K L     +  + +  +E+ M      H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 248
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++  Y   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 21/218 (9%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTL 142
           A  GN++    LGEG FGKV         Q VA+K ++ +      +QG      E+  L
Sbjct: 5   AHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYL 62
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
               HP+++KL       D+ ++V EY         L D       +      +      
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYA-----GNELFDYIVQRDKMSEQEARRFFQQII 117
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             ++Y H   +  +++RDLK  N+LL+E  + K++DFGL+ +   G+    S    G+  
Sbjct: 118 SAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPN 171
Query: 263 YCAPDYAMTGQLTF--KSDIYSFGVVLLELITGRKAID 298
           Y AP+  ++G+L    + D++S GV+L  ++  R   D
Sbjct: 172 YAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK   +   ++VA+K++    +  G+    +RE S     L    HPN+V 
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKELHHPNIVS 83
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA-GASRGLQYLHEQ 211
           LI          LV+E+M     +K L  +  + +    ++++KI      RG+ + H+ 
Sbjct: 84  LIDVIHSERCLTLVFEFM-----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM- 270
               +++RDLK  N+L+      KL+DFGLA+    G      T  + T  Y APD  M 
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           + + +   DI+S G +  E+ITG+       D  +L
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK   +   ++VA+K++    +  G+    +RE S     L    HPN+V 
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKELHHPNIVS 83
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA-GASRGLQYLHEQ 211
           LI          LV+E+M     +K L  +  + +    ++++KI      RG+ + H+ 
Sbjct: 84  LIDVIHSERCLTLVFEFM-----EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM- 270
               +++RDLK  N+L+      KL+DFGLA+    G      T  + T  Y APD  M 
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           + + +   DI+S G +  E+ITG+       D  +L
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +GEG  G V     +   + VA+K++D R  Q       EV+ +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V E++  G+L     D+   TR ++      +     R L YLH    Q VI+
Sbjct: 113 VGDELWVVMEFLEGGALT----DIVTHTR-MNEEQIATVCLSVLRALSYLH---NQGVIH 164
Query: 219 RDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RD+K  +ILL      KLSDFG  A++     K      ++GT  + AP+         +
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK---RKXLVGTPYWMAPEVISRLPYGTE 221
Query: 278 SDIYSFGVVLLELITG 293
            DI+S G++++E+I G
Sbjct: 222 VDIWSLGIMVIEMIDG 237

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F            +  AIK L+ R +     V   + E   +   DHP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 149 NLVKLIGYCAEGDQRLLV-YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             VKL  +  + D++L     Y   G L K++  +       D        A     L+Y
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEY 145
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+
Sbjct: 146 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     SD+++ G ++ +L+ G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLI 154
            LG GG  +V+     +  + VA+K L     R       F  E     + +HP +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 155 ----GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                    G    +V EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYA 269
                +I+RD+K +NI++      K+ DFG+A+ +  SG+    +  V+GT  Y +P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +  +SD+YS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLI 154
            LG GG  +V+     +  + VA+K L     R       F  E     + +HP +V + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 155 ----GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                    G    +V EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 79  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYA 269
                +I+RD+K +NI++      K+ DFG+A+ +  SG+    +  V+GT  Y +P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +  +SD+YS G VL E++TG
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQV--VAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V          +K  +V  VA+K L     +  + +  +E+ M      H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 192
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 122/274 (44%), Gaps = 33/274 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   K +  VA+K +   G     EF  E  T+    HP LVK  G C+
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V EY+  G L   L+ LR   + L+ +  +++      G+ +L        I+
Sbjct: 74  KEYPIYIVTEYISNGCL---LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
           RDL   N L++     K+SDFG+ +     D  +VS+  +GT     + AP+     + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSS--VGTKFPVKWSAPEVFHYFKYS 183
Query: 276 FKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQY 334
            KSD+++FG+++ E+ + G+   D   + + +  V+    +++          P L    
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR----------PHLASD- 232
Query: 335 PVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
               +YQ   I   C  E P  RP    ++ ++ 
Sbjct: 233 ---TIYQ---IMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V      +     A+K LD + V  ++E      E   L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY P G +  HL  +   + P   + R   AA    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 152
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+++++  + K++DFGLAK         V  R     GT
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGT 201
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 34  DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 148
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 202
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
                + +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELM 241

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQL-DHRGVQGVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       I++        VA+K L D    + + +  +E+ M      H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++  Y   G+L ++L   RP      ++              +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +RG++YL     Q  I+RDL   N+L+ E    K++DFGLA+   + D    +T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       T +SD++SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     +G G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EYMP G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + K++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 97  CCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKL 153
           C LG+G FG+V K C ++I +Q  A+K ++    +         EV  L   DHPN++KL
Sbjct: 28  CMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                +     +V E    G L     D     +    +   +I      G+ Y+H   K
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---K 139
Query: 214 QPVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +++RDLK  NILLE        K+ DFGL+        T +  R+ GT  Y AP+  +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPE-VL 195
Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
            G    K D++S GV+L  L++G
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     +G G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EYMP G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + K++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K Y+      ++V A K +    +       + S E+    S D+P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  I     +G+QYLH 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR---YFMRQTI-----QGVQYLHN 160
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                VI+RDLK  N+ L +    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 161 NR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT---LCGTPNYIAPEVL 214
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ DI+S G +L  L+ G+   + +
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       +++        VA+K L     +  + +  +E+ M      H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP      +N              +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 97  CCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKL 153
           C LG+G FG+V K C ++I +Q  A+K ++    +         EV  L   DHPN++KL
Sbjct: 28  CMLGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                +     +V E    G L     D     +    +   +I      G+ Y+H   K
Sbjct: 87  FEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMH---K 139
Query: 214 QPVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             +++RDLK  NILLE        K+ DFGL+        T +  R+ GT  Y AP+  +
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPE-VL 195
Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
            G    K D++S GV+L  L++G
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K Y+      ++V A K +    +       + S E+    S D+P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  I     +G+QYLH 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR---YFMRQTI-----QGVQYLHN 160
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                VI+RDLK  N+ L +    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 161 NR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVL 214
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ DI+S G +L  L+ G+   + +
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
                + +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI-PPPDAKELELM 214

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
                + +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI-PPPDAKELELM 214

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
                + +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI-PPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 14/220 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
                + +SDI+S G+ L+E+  GR  I    D KEL L+
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI-PPPDAKELELM 214

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 72  NNSGKS---AKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK-----Q 123
           N+SG      + FT D       +F     LG+G FG VY    +K   +VA+K     Q
Sbjct: 8   NSSGTPDILTRHFTID-------DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQ 60
Query: 124 LDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
           ++  GV+   +   E+       HPN+++L  Y  +  +  L+ EY P G L K L    
Sbjct: 61  IEKEGVE--HQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQ--- 115
Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
             +   D      I    +  L Y H    + VI+RD+K  N+LL      K++DFG + 
Sbjct: 116 -KSCTFDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSV 171
Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             PS  +      + GT  Y  P+         K D++  GV+  EL+ G
Sbjct: 172 HAPSLRR----KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K Y+      ++V A K +    +       + S E+    S D+P++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  I     +G+QYLH 
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR---YFMRQTI-----QGVQYLHN 160
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                VI+RDLK  N+ L +    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 161 NR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVL 214
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ DI+S G +L  L+ G+   + +
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 245

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHP 148
           GN+R    +G+G F KV         + VA+K +D   +    +++   EV  +   +HP
Sbjct: 15  GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+VKL           LV EY   G +  +L       R  +   R K     S  +QY 
Sbjct: 75  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVS-AVQYC 130
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H++    +++RDLK  N+LL+   + K++DFG +     G+K        G+  Y AP+ 
Sbjct: 131 HQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPEL 184
Query: 269 AMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
               +    + D++S GV+L  L++G    D
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHP 148
           GN+R    +G+G F KV         + VA+K +D   +    +++   EV  +   +HP
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+VKL           LV EY   G +  +L       R  +   R K     S  +QY 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVS-AVQYC 129
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H++    +++RDLK  N+LL+   + K++DFG +     G+K        G+  Y AP+ 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPEL 183
Query: 269 AMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
               +    + D++S GV+L  L++G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVK 152
           LGEG FG+VY+G       EKI   VA+K          +E F +E + + + DHP++VK
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKIN--VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           LIG   E +   ++ E  P G L  +L   +   + L   T +  +    + + YL E +
Sbjct: 74  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYL-ESI 128
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
               ++RD+   NIL+      KL DFGL++     D    S   +    + +P+     
Sbjct: 129 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINFR 185
Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + T  SD++ F V + E+++
Sbjct: 186 RFTTASDVWMFAVCMWEILS 205

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 24/219 (10%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL---------DHRGVQGVREFSA 137
           + AT  +     +G G +G VYK         VA+K +             +  VRE  A
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV-A 63
Query: 138 EVMTLGSADHPNLVKLIGYCAEG--DQRL---LVYEYMPLGSLDKHLHDLRPDTRPLDWN 192
            +  L + +HPN+V+L+  CA    D+ +   LV+E++    L  +L    P   P +  
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAE-- 120
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
           T   +     RGL +LH      +++RDLK  NIL+  G   KL+DFGLA++        
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQM 174
Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
             T V+ T  Y AP+  +        D++S G +  E+ 
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K Y+      ++V A K +    +       + S E+    S D+P++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  I     +G+QYLH 
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEAR---YFMRQTI-----QGVQYLHN 144
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                VI+RDLK  N+ L +    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 145 NR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKDLCGTPNYIAPEVL 198
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ DI+S G +L  L+ G+   + +
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPPFETS 229

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 98  CLGEGGFGKVY------KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
            LG GGFG+V+       G L   +++   +    +G QG      E   L    H   +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV-HSRFI 247
Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
             + Y  E    L LV   M  G +  H++++  D         +   A    GL++LH+
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPD 267
           +    +IYRDLK  N+LL++  + ++SD GLA   K G +  K +      GT G+ AP+
Sbjct: 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPE 359
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR---KAIDQTKDRKELN 307
             +  +  F  D ++ GV L E+I  R   +A  +  + KEL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 98  CLGEGGFGKVY------KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
            LG GGFG+V+       G L   +++   +    +G QG      E   L    H   +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV-HSRFI 247
Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
             + Y  E    L LV   M  G +  H++++  D         +   A    GL++LH+
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPD 267
           +    +IYRDLK  N+LL++  + ++SD GLA   K G +  K +      GT G+ AP+
Sbjct: 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPE 359
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR---KAIDQTKDRKELN 307
             +  +  F  D ++ GV L E+I  R   +A  +  + KEL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHP 148
           GN+R    +G+G F KV         + VA+K +D   +    +++   EV  +   +HP
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+VKL           LV EY   G +  +L       R  +   R K     S  +QY 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVS-AVQYC 129
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H++    +++RDLK  N+LL+   + K++DFG +     G+K        G+  Y AP+ 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPEL 183
Query: 269 AMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
               +    + D++S GV+L  L++G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTL 142
           AT  +     +G G +G VYK         VA+K +      +   +  VRE  A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREV-ALLRRL 60
Query: 143 GSADHPNLVKLIGYCAEG--DQRL---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
            + +HPN+V+L+  CA    D+ +   LV+E++    L  +L    P   P +  T   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAE--TIKDL 117
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                RGL +LH      +++RDLK  NIL+  G   KL+DFGLA++            V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPV 171
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
           + T  Y AP+  +        D++S G +  E+ 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 98  CLGEGGFGKVY------KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
            LG GGFG+V+       G L   +++   +    +G QG      E   L    H   +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV-HSRFI 247
Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
             + Y  E    L LV   M  G +  H++++  D         +   A    GL++LH+
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPD 267
           +    +IYRDLK  N+LL++  + ++SD GLA   K G +  K +      GT G+ AP+
Sbjct: 308 R---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPE 359
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR---KAIDQTKDRKELN 307
             +  +  F  D ++ GV L E+I  R   +A  +  + KEL 
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 152
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 201
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQ-GVREFSAEV-MTLGSADHPN 149
           LGEG FG+V       +++        VA+K L     +  + +  +E+ M      H N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MKI 197
           ++ L+G C +     ++ EY   G+L ++L    P      +N              +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL     +  I+RDL   N+L+ E    K++DFGLA+     D  H+    
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 258 MGTYG-----YCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             T G     + AP+       T +SD++SFGV+L E+ T
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 152
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 201
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 34/277 (12%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVK 152
           LGEG FG+VY+G       EKI   VA+K          +E F +E + + + DHP++VK
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKIN--VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           LIG   E +   ++ E  P G L  +L   +   + L   T +  +    + + YL E +
Sbjct: 90  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYL-ESI 144
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
               ++RD+   NIL+      KL DFGL++     D    S   +    + +P+     
Sbjct: 145 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINFR 201
Query: 273 QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
           + T  SD++ F V + E+++ G++     +++  + ++        DR     +  P L 
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----DRLPKPDLCPPVLY 256
Query: 332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
                        +   C    P+ RP  T++V +L+
Sbjct: 257 ------------TLMTRCWDYDPSDRPRFTELVCSLS 281

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK----QLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LGEG FGKV      K +Q VA+K    QL  +    +R    E+  L    HP+++KL 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKLY 75
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                    ++V EY         L D   + + +  +   +        ++Y H   + 
Sbjct: 76  DVITTPTDIVMVIEYA-----GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH---RH 127
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +++RDLK  N+LL++  + K++DFGL+ +   G+    S    G+  Y AP+  + G+L
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKL 183
Query: 275 TF--KSDIYSFGVVLLELITGRKAID 298
               + D++S G+VL  ++ GR   D
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADH 147
            GN+R    +G+G F KV         + VA+K +D   +    +++   EV  +   +H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           PN+VKL           LV EY   G +  +L       R  +   R K     S  +QY
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVS-AVQY 128
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC-AP 266
            H++    +++RDLK  N+LL+   + K++DFG +     G+K            +C AP
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLD---------AFCGAP 176
Query: 267 DYAMTGQLTFKS------DIYSFGVVLLELITGRKAID 298
            YA       K       D++S GV+L  L++G    D
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 25/222 (11%)
Query: 99  LGEGGFGKVY------KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG GGFG+V+       G L   +++   +    +G QG      E   L    H   + 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV-HSRFIV 248
Query: 153 LIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            + Y  E    L LV   M  G +  H++++  D         +   A    GL++LH++
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVMGTYGYCAPDY 268
               +IYRDLK  N+LL++  + ++SD GLA   K G +  K +      GT G+ AP+ 
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-----GTPGFMAPEL 360
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR---KAIDQTKDRKELN 307
            +  +  F  D ++ GV L E+I  R   +A  +  + KEL 
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 34/277 (12%)
Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVK 152
           LGEG FG+VY+G       EKI   VA+K          +E F +E + + + DHP++VK
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKIN--VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           LIG   E +   ++ E  P G L  +L   +   + L   T +  +    + + YL E +
Sbjct: 78  LIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVL---TLVLYSLQICKAMAYL-ESI 132
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
               ++RD+   NIL+      KL DFGL++     D    S   +    + +P+     
Sbjct: 133 N--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINFR 189
Query: 273 QLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
           + T  SD++ F V + E+++ G++     +++  + ++        DR     +  P L 
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-----DRLPKPDLCPPVLY 244
Query: 332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
                        +   C    P+ RP  T++V +L+
Sbjct: 245 ------------TLMTRCWDYDPSDRPRFTELVCSLS 269

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQ 96
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 97  AVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 152
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 201
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 153
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 154 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 202
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 89
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 146
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK       T    
Sbjct: 147 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 198
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            + GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 199 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V      +     A+K LD + V  ++E      E   L 
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY P G +  HL  +   + P   + R   AA    
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 152
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+++++  + +++DFGLAK         V  R     GT
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGT 201
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 153
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 154 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 202
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSAD 146
            G++     LG G FGKV  G  +     VA+K L+    R +  V +   E+  L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           HP+++KL    +      +V EY+  G L  ++       R  +   R ++       + 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEAR-RLFQQILSAVD 125
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           Y H  +   V++RDLK  N+LL+   + K++DFGL+ M   G+    S    G+  Y AP
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAP 179
Query: 267 DYAMTGQLTF--KSDIYSFGVVLLELITGRKAID 298
           +  ++G+L    + DI+S GV+L  L+ G    D
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 30  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 89
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 145
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 146 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 194
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 195 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 31/218 (14%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 23  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 74
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 75  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 131
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK       T    
Sbjct: 132 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---- 183
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            + GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 184 -LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 153
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 154 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 202
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 97
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY P G +  HL  +   + P   + R   AA    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 153
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+++++  + K++DFG AK         V  R     GT
Sbjct: 154 TFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGT 202
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 47/268 (17%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 62
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDT---RPLDWNTRMKIAAGA 201
           +HPN+VKL+      ++  LV+E++   S+D K   D    T    PL  +   ++    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            +GL + H      V++RDLK  N+L+      KL+DFGLA+      +T+    V  T 
Sbjct: 117 -QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 170
Query: 262 GYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVA 310
            Y AP+  +  +  +   DI+S G +  E++T R       +  +L          + V 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 311 WA--------RPMFKD--RKNFSQMVDP 328
           W         +P F    R++FS++V P
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPP 258

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     +G G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + K++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G FG VY    ++ + ++A+K     QL+  GV+   +   E+       HPN++++
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILRM 80
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
             Y  +  +  L+ E+ P G L K   +L+   R  D           +  L Y HE+  
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYK---ELQKHGR-FDEQRSATFMEELADALHYCHER-- 134
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTG 272
             VI+RD+K  N+L+      K++DFG +   PS     +  R M GT  Y  P+     
Sbjct: 135 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEGK 188
Query: 273 QLTFKSDIYSFGVVLLELITGRKAID 298
               K D++  GV+  E + G    D
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTL 142
           AT  +     +G G +G VYK         VA+K +      +   +  VRE  A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREV-ALLRRL 60
Query: 143 GSADHPNLVKLIGYCAEG--DQRL---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
            + +HPN+V+L+  CA    D+ +   LV+E++    L  +L    P   P +  T   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAE--TIKDL 117
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                RGL +LH      +++RDLK  NIL+  G   KL+DFGLA++            V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPV 171
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
           + T  Y AP+  +        D++S G +  E+ 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 58  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 117
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +   + P   + R   AA    
Sbjct: 118 AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 173
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT
Sbjct: 174 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 222
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 47/268 (17%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 60
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDT---RPLDWNTRMKIAAGA 201
           +HPN+VKL+      ++  LV+E++   S+D K   D    T    PL  +   ++    
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            +GL + H      V++RDLK  N+L+      KL+DFGLA+      +T+    V  T 
Sbjct: 115 -QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 168
Query: 262 GYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVA 310
            Y AP+  +  +  +   DI+S G +  E++T R       +  +L          + V 
Sbjct: 169 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 228
Query: 311 WA--------RPMFKD--RKNFSQMVDP 328
           W         +P F    R++FS++V P
Sbjct: 229 WPGVTSMPDYKPSFPKWARQDFSKVVPP 256

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G FG VY    ++ + ++A+K     QL+  GV+   +   E+       HPN++++
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILRM 79
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
             Y  +  +  L+ E+ P G L K   +L+   R  D           +  L Y HE+  
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYK---ELQKHGR-FDEQRSATFMEELADALHYCHER-- 133
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTG 272
             VI+RD+K  N+L+      K++DFG +   PS     +  R M GT  Y  P+     
Sbjct: 134 -KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEGK 187
Query: 273 QLTFKSDIYSFGVVLLELITGRKAID 298
               K D++  GV+  E + G    D
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
            +F     LG+G FG+V K       +  AIK++ H   + +    +EVM L S +H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYV 64
Query: 151 VKLIGYCAEGDQRLLV---------------YEYMPLGSLDKHLHDLRPDT-RPLDWNTR 194
           V+   Y A  ++R  V                EY   G+L   +H    +  R   W   
Sbjct: 65  VRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----------- 243
            +I       L Y+H Q    +I+RDLK  NI ++E  + K+ DFGLAK           
Sbjct: 123 RQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 244 ----MGPSGDKTHVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELI----TGR 294
               +  S D     T  +GT  Y A +    TG    K D+YS G++  E+I    TG 
Sbjct: 176 DSQNLPGSSDNL---TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 295 KAIDQTKDRKELNL 308
           + ++  K  + +++
Sbjct: 233 ERVNILKKLRSVSI 246

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 13/211 (6%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHP 148
           GN+R    +G+G F KV         + VA++ +D   +    +++   EV  +   +HP
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+VKL           LV EY   G +  +L       R  +   R K     S  +QY 
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVS-AVQYC 129
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H++    +++RDLK  N+LL+   + K++DFG +     G+K        G+  Y AP+ 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPEL 183
Query: 269 AMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
               +    + D++S GV+L  L++G    D
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 13/212 (6%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADH 147
            GN+R    +G+G F KV         + VA++ +D   +    +++   EV  +   +H
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           PN+VKL           LV EY   G +  +L       R  +   R K     S  +QY
Sbjct: 73  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAHGRMKEKEARAKFRQIVS-AVQY 128
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
            H++    +++RDLK  N+LL+   + K++DFG +     G+K        G+  Y AP+
Sbjct: 129 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPE 182
Query: 268 YAMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
                +    + D++S GV+L  L++G    D
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 89  ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTL 142
           AT  +     +G G +G VYK         VA+K +      +   +  VRE  A +  L
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREV-ALLRRL 60
Query: 143 GSADHPNLVKLIGYCAEG--DQRL---LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
            + +HPN+V+L+  CA    D+ +   LV+E++    L  +L    P   P +  T   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAE--TIKDL 117
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                RGL +LH      +++RDLK  NIL+  G   KL+DFGLA++            V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPV 171
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
           + T  Y AP+  +        D++S G +  E+ 
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 47/268 (17%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 62
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDT---RPLDWNTRMKIAAGA 201
           +HPN+VKL+      ++  LV+E++   S+D K   D    T    PL  +   ++    
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            +GL + H      V++RDLK  N+L+      KL+DFGLA+      +T+    V  T 
Sbjct: 117 -QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 170
Query: 262 GYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVA 310
            Y AP+  +  +  +   DI+S G +  E++T R       +  +L          + V 
Sbjct: 171 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 230
Query: 311 WA--------RPMFKD--RKNFSQMVDP 328
           W         +P F    R++FS++V P
Sbjct: 231 WPGVTSMPDYKPSFPKWARQDFSKVVPP 258

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 89
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 146
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 147 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 194
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E   L 
Sbjct: 30  TAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ 89
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY+P G +  HL  +     P   + R   AA    
Sbjct: 90  AVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARF-YAAQIVL 145
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
             +YLH      +IYRDLK  N+L+++  + +++DFG AK          +  + GT  Y
Sbjct: 146 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEY 197
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 198 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     ++T  S        +  P+  M  + + KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 279 DIYSFGVVLLELIT 292
           DI++FGV++ E+ +
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY P G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+++++  + K++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLI 154
            LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L 
Sbjct: 17  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 76
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
                 D+   V EY   G L  HL   R  T       R +   A     L+YLH    
Sbjct: 77  YAFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLH---S 128
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           + V+YRD+K  N++L++  H K++DFGL K G S   T       GT  Y AP+      
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDND 186
Query: 274 LTFKSDIYSFGVVLLELITGR 294
                D +  GVV+ E++ GR
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGR 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 125/291 (42%), Gaps = 45/291 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA----------EVMTLGSADHP 148
           LG G +G+V   C +K+  V        R ++ +R+ S           EV  L   DHP
Sbjct: 45  LGSGAYGEVLL-CRDKVTHV-------ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           N++KL  +  +     LV E    G L D+ +H  R     +D    +K       G+ Y
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH--RMKFNEVDAAVIIKQVLS---GVTY 151
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LH   K  +++RDLK  N+LLE        K+ DFGL+ +  +  K       +GT  Y 
Sbjct: 152 LH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYI 205
Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK--DRKNF 322
           AP+  +  +   K D++S GV+L  L+ G        D++ L  V   +  F   + KN 
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV 264
Query: 323 S--------QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMR-PAITDVV 364
           S        QM+    Q +   +   +   I  MC +++  +  P++ + +
Sbjct: 265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI 315

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 123/268 (45%), Gaps = 47/268 (17%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 61
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDT---RPLDWNTRMKIAAGA 201
           +HPN+VKL+      ++  LV+E++   S+D K   D    T    PL  +   ++    
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            +GL + H      V++RDLK  N+L+      KL+DFGLA+      +T+    V  T 
Sbjct: 116 -QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TL 169
Query: 262 GYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVA 310
            Y AP+  +  +  +   DI+S G +  E++T R       +  +L          + V 
Sbjct: 170 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 229
Query: 311 WA--------RPMFKD--RKNFSQMVDP 328
           W         +P F    R++FS++V P
Sbjct: 230 WPGVTSMPDYKPSFPKWARQDFSKVVPP 257

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 86/199 (43%), Gaps = 12/199 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                D+   V EY   G L  HL   R  T       R   A   S  L+YLH    + 
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVS-ALEYLH---SRD 125
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           V+YRD+K  N++L++  H K++DFGL K G S   T       GT  Y AP+        
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDNDYG 183
Query: 276 FKSDIYSFGVVLLELITGR 294
              D +  GVV+ E++ GR
Sbjct: 184 RAVDWWGLGVVMYEMMCGR 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 155
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 156 PVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 66
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 120
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 121 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 162
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 163 PVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 222
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 223 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 262

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 25/217 (11%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHP 148
           GN+R    +G+G F KV         + VA+K +D   +    +++   EV      +HP
Sbjct: 14  GNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+VKL           LV EY   G +  +L       R  +   R K     S  +QY 
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYL---VAHGRXKEKEARAKFRQIVS-AVQYC 129
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC-APD 267
           H++    +++RDLK  N+LL+   + K++DFG +     G+K            +C AP 
Sbjct: 130 HQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLD---------AFCGAPP 177
Query: 268 YAMTGQLTFKS------DIYSFGVVLLELITGRKAID 298
           YA       K       D++S GV+L  L++G    D
Sbjct: 178 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQ 214
                D+   V EY   G L  HL   R  T       R +   A     L+YLH    +
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLH---SR 124
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            V+YRD+K  N++L++  H K++DFGL K G S   T  +    GT  Y AP+       
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 182
Query: 275 TFKSDIYSFGVVLLELITGR 294
               D +  GVV+ E++ GR
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
           RDL   N L+ +    K+SDFGL++     D  + S+R  G+     +  P+  M  + +
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSR--GSKFPVRWSPPEVLMYSKFS 184
Query: 276 FKSDIYSFGVVLLELIT 292
            KSDI++FGV++ E+ +
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 16  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 75
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQ 214
                D+   V EY   G L  HL   R  T       R +   A     L+YLH    +
Sbjct: 76  AFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLH---SR 127
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            V+YRD+K  N++L++  H K++DFGL K G S   T  +    GT  Y AP+       
Sbjct: 128 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 185
Query: 275 TFKSDIYSFGVVLLELITGR 294
               D +  GVV+ E++ GR
Sbjct: 186 GRAVDWWGLGVVMYEMMCGR 205

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV +     +        VA+K L        RE   +E+  L    +H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRP---------LDWNTRMKI 197
            L+G C  G   L++ EY   G L   L   R       T P         LD    +  
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           +   ++G+ +L  +     I+RDL   NILL  G   K+ DFGLA+   +     V    
Sbjct: 167 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       TF+SD++S+G+ L EL                +L +   P   
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL---------------FSLGSSPYPGMP 268
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
               F +M+    +   P     +   I   C    P  RP    +V
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV +     +        VA+K L        RE   +E+  L    +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRP---------LDWNTRMKI 197
            L+G C  G   L++ EY   G L   L   R       T P         LD    +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           +   ++G+ +L  +     I+RDL   NILL  G   K+ DFGLA+   +     V    
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       TF+SD++S+G+ L EL                +L +   P   
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL---------------FSLGSSPYPGMP 275
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
               F +M+    +   P     +   I   C    P  RP    +V
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQ 214
                D+   V EY   G L  HL   R  T       R +   A     L+YLH    +
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLH---SR 124
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            V+YRD+K  N++L++  H K++DFGL K G S   T  +    GT  Y AP+       
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLEDNDY 182
Query: 275 TFKSDIYSFGVVLLELITGR 294
               D +  GVV+ E++ GR
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSA---EVMTL 142
           A  +  ++    LG+G FG+V   C +KI  Q  A+K +  R V+   +  +   EV  L
Sbjct: 22  AIFSDRYKGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLL 80
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
              DHPN++KL  +  +     LV E    G L   +   R     +D     +I     
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVD---AARIIRQVL 136
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
            G+ Y+H   K  +++RDLK  N+LLE   +  + ++ DFGL+    +  K       +G
Sbjct: 137 SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK---IG 190
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           T  Y AP+  + G    K D++S GV+L  L++G
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 118/275 (42%), Gaps = 61/275 (22%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 58
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           +HPN+VKL+      ++  LV+E         H+H         D  T M  +A     L
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFE---------HVHQ--------DLKTFMDASALTGIPL 101
Query: 206 ----QYLHEQLK-------QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
                YL + L+         V++RDLK  N+L+      KL+DFGLA+    G      
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA--FGVPVRTY 159
Query: 255 TRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL------- 306
           T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L       
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219
Query: 307 ---NLVAWA--------RPMFKD--RKNFSQMVDP 328
              + V W         +P F    R++FS++V P
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSAD 146
            G++     LG G FGKV  G  +     VA+K L+    R +  V +   E+  L    
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           HP+++KL    +      +V EY+  G L  ++       R  +   R ++       + 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK---HGRVEEMEAR-RLFQQILSAVD 125
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           Y H  +   V++RDLK  N+LL+   + K++DFGL+ M   G+    S    G+  Y AP
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAP 179
Query: 267 DYAMTGQLTF--KSDIYSFGVVLLELITGRKAID 298
           +  ++G+L    + DI+S GV+L  L+ G    D
Sbjct: 180 E-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 114 -------------QGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 155
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 156 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 66
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 67  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 120
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 121 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 162
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 163 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 222
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 223 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 262

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 118/264 (44%), Gaps = 39/264 (14%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           +HPN+VKL+      ++  LV+E+     L + L D   D   L       I +   + L
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKDFM-DASALTGIPLPLIKSYLFQLL 113
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           Q L       V++RDLK  N+L+      KL+DFGLA+      +T+    V  T  Y A
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 171
Query: 266 PDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVAWA-- 312
           P+  +  +  +   DI+S G +  E++T R       +  +L          + V W   
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 313 ------RPMFKD--RKNFSQMVDP 328
                 +P F    R++FS++V P
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQ 214
                D+   V EY   G L  HL   R  T       R +   A     L+YLH    +
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLH---SR 124
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            V+YRD+K  N++L++  H K++DFGL K G S   T       GT  Y AP+       
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDNDY 182
Query: 275 TFKSDIYSFGVVLLELITGR 294
               D +  GVV+ E++ GR
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQLD-HRGVQG-----VREFS 136
           D L  A   +     +GEG +GKV+K   L+   + VA+K++    G +G     +RE  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 137 AEVMTLGSADHPNLVKLIGYCA----EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDW 191
           A +  L + +HPN+V+L   C     + + +L LV+E++    L  +L  +     P + 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE- 120
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
            T   +     RGL +LH      V++RDLK  NIL+      KL+DFGLA++       
Sbjct: 121 -TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQ 173
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
              T V+ T  Y AP+  +        D++S G +  E+   +     + D  +L
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV +     +        VA+K L        RE   +E+  L    +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRP---------LDWNTRMKI 197
            L+G C  G   L++ EY   G L   L   R       T P         LD    +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           +   ++G+ +L  +     I+RDL   NILL  G   K+ DFGLA+   +     V    
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       TF+SD++S+G+ L EL                +L +   P   
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL---------------FSLGSSPYPGMP 252
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
               F +M+    +   P     +   I   C    P  RP    +V
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +     P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQ 214
                D+   V EY   G L  HL   R  T       R +   A     L+YLH    +
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLH---SR 124
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            V+YRD+K  N++L++  H K++DFGL K G S   T       GT  Y AP+       
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDNDY 182
Query: 275 TFKSDIYSFGVVLLELITGR 294
               D +  GVV+ E++ GR
Sbjct: 183 GRAVDWWGLGVVMYEMMCGR 202

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +     P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADH 147
            GN+R    +G+G F KV         + VA+K +D   +    +++   EV  +   +H
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASRGL 205
           PN+VKL           LV EY   G +  +L  H    +        R K     S  +
Sbjct: 66  PNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-----EARAKFRQIVS-AV 119
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           QY H++    +++RDLK  N+LL+   + K++DFG +     G+K        G+  Y A
Sbjct: 120 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAA 173
Query: 266 PDYAMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
           P+     +    + D++S GV+L  L++G    D
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 89
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+P G +  HL  +     P   + R 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEP---HARF 146
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 147 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 194
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG----SADHPNLVKLI 154
           +G G +G V K   +   Q++A+K++  R     +E    +M L     S+D P +V+  
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 155 GYCAEGDQRLLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G         +  E M        K+++ +  D  P +     KI     + L +L E L
Sbjct: 88  GALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE--ILGKITLATVKALNHLKENL 145
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY---- 268
           K  +I+RD+K SNILL+   + KL DFG++  G   D     TR  G   Y AP+     
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMAPERIDPS 200
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
           A       +SD++S G+ L EL TGR
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 63
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 117
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 118 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 159
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 160 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 219
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 220 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 259

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 127
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     + T  S        +  P+  M  + + KS
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 279 DIYSFGVVLLELIT 292
           DI++FGV++ E+ +
Sbjct: 187 DIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 123
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     + T  S        +  P+  M  + + KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 279 DIYSFGVVLLELIT 292
           DI++FGV++ E+ +
Sbjct: 183 DIWAFGVLMWEIYS 196

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 58
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 112
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 113 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 154
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 155
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 156 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 58
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 112
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 113 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 154
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 60
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 114
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 115 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 156
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 157 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 256

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 155
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 156 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     + T  S        +  P+  M  + + KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 279 DIYSFGVVLLELIT 292
           DI++FGV++ E+ +
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 91/215 (42%), Gaps = 24/215 (11%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV +     +        VA+K L        RE   +E+  L    +H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRP---------LDWNTRMKI 197
            L+G C  G   L++ EY   G L   L   R       T P         LD    +  
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           +   ++G+ +L  +     I+RDL   NILL  G   K+ DFGLA+   +     V    
Sbjct: 169 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + AP+       TF+SD++S+G+ L EL +
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G+G FG V    Y+G        VA+K + +      + F AE   +    H NLV+L+
Sbjct: 29  IGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 80
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQL 212
           G   E    L +V EYM  GSL  +L   R   R  L  +  +K +      ++YL    
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 134
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMT 271
               ++RDL   N+L+ E    K+SDFGL K   S  D   +  +      + AP+    
Sbjct: 135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALRE 188
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
            + + KSD++SFG++L E+ +
Sbjct: 189 KKFSTKSDVWSFGILLWEIYS 209

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 21/225 (9%)
Query: 78  AKPFTFDELAAA--TGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVRE 134
           A P  F + + A  +  ++    LG+G FG+V   C +KI  Q  A+K +  R V+   +
Sbjct: 34  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTD 92
Query: 135 FSA---EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
             +   EV  L   DHPN++KL  +  +     LV E    G     L D     +    
Sbjct: 93  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSE 148
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSG 248
               +I      G+ Y+H   K  +++RDLK  N+LLE   +  + ++ DFGL+    + 
Sbjct: 149 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 205
Query: 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            K       +GT  Y AP+  + G    K D++S GV+L  L++G
Sbjct: 206 KKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     + T  S        +  P+  M  + + KS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 279 DIYSFGVVLLELIT 292
           DI++FGV++ E+ +
Sbjct: 203 DIWAFGVLMWEIYS 216

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY P G +  HL  +     P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+++++  + K++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 108/287 (37%), Gaps = 39/287 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV +     +        VA+K L        RE   +E+  L    +H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRP---------LDWNTRMKI 197
            L+G C  G   L++ EY   G L   L   R       T P         LD    +  
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           +   ++G+ +L  +     I+RDL   NILL  G   K+ DFGLA+   +     V    
Sbjct: 174 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       TF+SD++S+G+ L EL                +L +   P   
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL---------------FSLGSSPYPGMP 275
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
               F +M+    +   P     +   I   C    P  RP    +V
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L ++ HP L  L  
Sbjct: 159 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 218
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                D+   V EY   G L  HL       R    +      A     L YLH +  + 
Sbjct: 219 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE--KN 272
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           V+YRDLK  N++L++  H K++DFGL K G     T  +    GT  Y AP+        
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYG 330
Query: 276 FKSDIYSFGVVLLELITGR 294
              D +  GVV+ E++ GR
Sbjct: 331 RAVDWWGLGVVMYEMMCGR 349

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 104/225 (46%), Gaps = 21/225 (9%)
Query: 78  AKPFTFDELAAA--TGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVRE 134
           A P  F + + A  +  ++    LG+G FG+V   C +KI  Q  A+K +  R V+   +
Sbjct: 35  ATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTD 93
Query: 135 FSA---EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
             +   EV  L   DHPN++KL  +  +     LV E    G     L D     +    
Sbjct: 94  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSE 149
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSG 248
               +I      G+ Y+H   K  +++RDLK  N+LLE   +  + ++ DFGL+    + 
Sbjct: 150 VDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 206
Query: 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            K       +GT  Y AP+  + G    K D++S GV+L  L++G
Sbjct: 207 KKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 9/194 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R   +       +++       ++YL     +  ++
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLE---SKQFLH 134
Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     + T  S        +  P+  M  + + KS
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 279 DIYSFGVVLLELIT 292
           DI++FGV++ E+ +
Sbjct: 194 DIWAFGVLMWEIYS 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G+G FG V    Y+G        VA+K + +      + F AE   +    H NLV+L+
Sbjct: 14  IGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 65
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQL 212
           G   E    L +V EYM  GSL  +L   R   R  L  +  +K +      ++YL    
Sbjct: 66  GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 119
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMT 271
               ++RDL   N+L+ E    K+SDFGL K   S  D   +  +      + AP+    
Sbjct: 120 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALRE 173
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
            + + KSD++SFG++L E+ +
Sbjct: 174 KKFSTKSDVWSFGILLWEIYS 194

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 85/199 (42%), Gaps = 11/199 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L ++ HP L  L  
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                D+   V EY   G L  HL       R    +      A     L YLH +  + 
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE--KN 269
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           V+YRDLK  N++L++  H K++DFGL K G     T  +    GT  Y AP+        
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLEDNDYG 327
Query: 276 FKSDIYSFGVVLLELITGR 294
              D +  GVV+ E++ GR
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           +F+    +G GGFG+V+K       +   IK++ +   +  RE  A    L   DH N+V
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA----LAKLDHVNIV 67
Query: 152 KLIG------YCAEGDQR----------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
              G      Y  E   +           +  E+   G+L++ +   R +   LD    +
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLAL 125
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
           ++    ++G+ Y+H +    +I RDLK SNI L +    K+ DFGL     +  K     
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RX 179
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
           R  GT  Y +P+   +     + D+Y+ G++L EL+
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
            +F     LG+G FG+V K       +  AIK++ H   + +    +EVM L S +H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYV 64
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKH--------------LHDLRPDT-----RPLDW 191
           V+   Y A  ++R  V    P+ ++ K               L+DL         R   W
Sbjct: 65  VRY--YAAWLERRNFV---KPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW 119
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDK 250
               +I       L Y+H Q    +I+RDLK  NI ++E  + K+ DFGLAK +  S D 
Sbjct: 120 RLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 251 THVS-----------TRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELI----TGR 294
             +            T  +GT  Y A +    TG    K D+YS G++  E+I    TG 
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
Query: 295 KAIDQTKDRKELNL 308
           + ++  K  + +++
Sbjct: 233 ERVNILKKLRSVSI 246

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY P G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+++++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQLD-HRGVQG-----VREFS 136
           D L  A   +     +GEG +GKV+K   L+   + VA+K++    G +G     +RE  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 137 AEVMTLGSADHPNLVKLIGYCA----EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDW 191
           A +  L + +HPN+V+L   C     + + +L LV+E++    L  +L  +     P + 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE- 120
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
            T   +     RGL +LH      V++RDLK  NIL+      KL+DFGLA++       
Sbjct: 121 -TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQ 173
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
              T V+ T  Y AP+  +        D++S G +  E+   +     + D  +L
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 26  DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 140
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 141 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 194
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAI 297
                + +SDI+S G+ L+E+  GR  I
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 93/201 (46%), Gaps = 27/201 (13%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G+G FG V    Y+G        VA+K + +      + F AE   +    H NLV+L+
Sbjct: 20  IGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 71
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQL 212
           G   E    L +V EYM  GSL  +L   R   R  L  +  +K +      ++YL    
Sbjct: 72  GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 125
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMT 271
               ++RDL   N+L+ E    K+SDFGL K   S  D   +  +      + AP+    
Sbjct: 126 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALRE 179
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
              + KSD++SFG++L E+ +
Sbjct: 180 AAFSTKSDVWSFGILLWEIYS 200

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 99  LGEGGFGKV----YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G+G FG V    Y+G        VA+K + +      + F AE   +    H NLV+L+
Sbjct: 201 IGKGEFGDVMLGDYRG------NKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 252
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQL 212
           G   E    L +V EYM  GSL  +L   R   R  L  +  +K +      ++YL    
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 306
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMT 271
               ++RDL   N+L+ E    K+SDFGL K   S  D   +  +      + AP+    
Sbjct: 307 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALRE 360
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
            + + KSD++SFG++L E+ +
Sbjct: 361 KKFSTKSDVWSFGILLWEIYS 381

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 25/218 (11%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADH 147
            GN+R    +G+G F KV         + VAIK +D   +    +++   EV  +   +H
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           PN+VKL           L+ EY   G +  +L       R  +   R K     S  +QY
Sbjct: 74  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVS-AVQY 129
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC-AP 266
            H++    +++RDLK  N+LL+   + K++DFG +     G K            +C AP
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD---------AFCGAP 177
Query: 267 DYAMTGQLTFKS------DIYSFGVVLLELITGRKAID 298
            YA       K       D++S GV+L  L++G    D
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 21/213 (9%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLG 143
            A    F     LG G FG+V     ++     A+K LD + V  +++      E     
Sbjct: 38  TAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQ 97
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           + + P LVKL     +     +V EY P G +  HL  +   + P   + R   AA    
Sbjct: 98  AVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEP---HARF-YAAQIVL 153
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GT 260
             +YLH      +IYRDLK  N+L+++  + K++DFG AK         V  R     GT
Sbjct: 154 TFEYLHSL---DLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGT 202
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
             Y AP+  ++       D ++ GV++ E+  G
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 92/228 (40%), Gaps = 12/228 (5%)
Query: 86  LAAATGN-FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMT 141
           +A  T N F     LG+G FGKV     +   +  A+K L    +    E +    E   
Sbjct: 3   MARVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRV 62
Query: 142 LGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201
           L ++ HP L  L       D+   V EY   G L  HL       R    +      A  
Sbjct: 63  LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEI 118
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
              L YLH +  + V+YRDLK  N++L++  H K++DFGL K G     T       GT 
Sbjct: 119 VSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTP 174
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            Y AP+           D +  GVV+ E++ GR         K   L+
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 222

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 43/266 (16%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASR 203
           +HPN+VKL+      ++  LV+E++    L K +    L     PL  +   ++     +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLL----Q 114
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           GL + H      V++RDLK  N+L+      KL+DFGLA+      +T+    V  T  Y
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 264 CAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVAWA 312
            AP+  +  +  +   DI+S G +  E++T R       +  +L          + V W 
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 229
Query: 313 --------RPMFKD--RKNFSQMVDP 328
                   +P F    R++FS++V P
Sbjct: 230 GVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 81  FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSA-- 137
           F     A  +  ++    LG+G FG+V   C +KI  Q  A+K +  R V+   +  +  
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTDKESLL 80
Query: 138 -EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK 196
            EV  L   DHPN++KL  +  +     LV E    G L   +   R     +D     +
Sbjct: 81  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVD---AAR 136
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHV 253
           I      G+ Y+H   K  +++RDLK  N+LLE   +  + ++ DFGL+    +  K   
Sbjct: 137 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 193
Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
               +GT  Y AP+  + G    K D++S GV+L  L++G
Sbjct: 194 K---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 58
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 112
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 113 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 157 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 62
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 116
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 117 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 161 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 258

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 61
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 115
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 116 -------------QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 159
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 160 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 257

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 61
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 115
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 116 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 160 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 257

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQLD-HRGVQG-----VREFS 136
           D L  A   +     +GEG +GKV+K   L+   + VA+K++    G +G     +RE  
Sbjct: 4   DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV- 62
Query: 137 AEVMTLGSADHPNLVKLIGYCA----EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDW 191
           A +  L + +HPN+V+L   C     + + +L LV+E++    L  +L  +     P + 
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTE- 120
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT 251
            T   +     RGL +LH      V++RDLK  NIL+      KL+DFGLA++       
Sbjct: 121 -TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQ 173
Query: 252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
              T V+ T  Y AP+  +        D++S G +  E+   +     + D  +L
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 228

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 13/208 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 7   DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 121
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D   ++   +GT  Y +P+  
Sbjct: 122 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 175
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAI 297
                + +SDI+S G+ L+E+  GR  I
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 61
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 115
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 116 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 160 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 217
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 218 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 257

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 158 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 100/230 (43%), Gaps = 43/230 (18%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           +F+    +G GGFG+V+K       +   I+++ +   +  RE  A    L   DH N+V
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKA----LAKLDHVNIV 68
Query: 152 KLIGYCAEG--------DQRLLVYEYMP----------------------LGSLDKHLHD 181
              G C +G        D  L   +Y P                       G+L++ +  
Sbjct: 69  HYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
            R +   LD    +++    ++G+ Y+H +    +I+RDLK SNI L +    K+ DFGL
Sbjct: 128 RRGE--KLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGL 182
Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
                +  K    TR  GT  Y +P+   +     + D+Y+ G++L EL+
Sbjct: 183 VTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 60
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 114
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 115 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 159 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 256

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 13/212 (6%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADH 147
            GN+R    +G+G F KV         + VAIK +D   +    +++   EV  +   +H
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH 70
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           PN+VKL           L+ EY   G +  +L       R  +   R K     S  +QY
Sbjct: 71  PNIVKLFEVIETEKTLYLIMEYASGGEVFDYL---VAHGRMKEKEARSKFRQIVS-AVQY 126
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
            H++    +++RDLK  N+LL+   + K++DFG +     G K        G+  Y AP+
Sbjct: 127 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPE 180
Query: 268 YAMTGQLTF-KSDIYSFGVVLLELITGRKAID 298
                +    + D++S GV+L  L++G    D
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 158 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 87/214 (40%), Gaps = 11/214 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L ++ HP L  L  
Sbjct: 18  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 77
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                D+   V EY   G L  HL       R    +      A     L YLH +  + 
Sbjct: 78  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE--KN 131
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           V+YRDLK  N++L++  H K++DFGL K G     T       GT  Y AP+        
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDNDYG 189
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
              D +  GVV+ E++ GR         K   L+
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 223

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 99  LGEGGFGKVY-----KGCLEKIEQVVAIKQLD-------HRGVQGVRE-FSAEVMTLGSA 145
           LG G +G+V       G  EK  +V+   Q D       ++ ++   E    E+  L S 
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           DHPN++KL     +     LV E+   G L + +     +    D      I      G+
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----INRHKFDECDAANIMKQILSGI 159
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            YLH   K  +++RD+K  NILLE      + K+ DFGL+       K +     +GT  
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLGTAY 213
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y AP+  +  +   K D++S GV++  L+ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 63
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 117
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 118 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 162 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 219
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 220 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 259

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 87/214 (40%), Gaps = 11/214 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L ++ HP L  L  
Sbjct: 16  LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 75
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                D+   V EY   G L  HL       R    +      A     L YLH +  + 
Sbjct: 76  SFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE--KN 129
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           V+YRDLK  N++L++  H K++DFGL K G     T       GT  Y AP+        
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDNDYG 187
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
              D +  GVV+ E++ GR         K   L+
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 221

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 158 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 58
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 112
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 113 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 157 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 62
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL------ 116
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 117 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 161 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 258

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 62
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 116
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 117 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 161 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 218
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 219 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 258

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 89
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P L KL     +     +V EY P G +  HL  +   + P   + R 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF 146
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+++++  + K++DFG AK         V  
Sbjct: 147 -YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKG 194
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 121/266 (45%), Gaps = 43/266 (16%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 60
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHL--HDLRPDTRPLDWNTRMKIAAGASR 203
           +HPN+VKL+      ++  LV+E++    L K +    L     PL  +   ++     +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLL----Q 115
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           GL + H      V++RDLK  N+L+      KL+DFGLA+      +T+    V  T  Y
Sbjct: 116 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 264 CAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVAWA 312
            AP+  +  +  +   DI+S G +  E++T R       +  +L          + V W 
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 230
Query: 313 --------RPMFKD--RKNFSQMVDP 328
                   +P F    R++FS++V P
Sbjct: 231 GVTSMPDYKPSFPKWARQDFSKVVPP 256

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 72/280 (25%), Positives = 118/280 (42%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 60
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 114
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+      
Sbjct: 115 -------------QGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
           +T+    V  T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 159 RTYXHEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 216
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 217 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 256

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 89
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P L KL     +     +V EY P G +  HL  +   + P   + R 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEP---HARF 146
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+++++  + K++DFG AK         V  
Sbjct: 147 -YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKG 194
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVR-EFSAEVMTLGSADHPN 149
           +F     LG G  G V+K    K   +V  ++L H  ++  +R +   E+  L   + P 
Sbjct: 10  DFEKISELGAGNGGVVFK-VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR 124
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           E  K  +++RD+K SNIL+      KL DFG++  G   D+  ++   +GT  Y +P+  
Sbjct: 125 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVGTRSYMSPERL 178
Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
                + +SDI+S G+ L+E+  GR
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 97  CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
             LG+G +G VY G     +  +AIK++  R  +  +    E+       H N+V+ +G 
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHD----LRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            +E     +  E +P GSL   L      L+ + + + + T+  +      GL+YLH+  
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHD-- 140
Query: 213 KQPVIYRDLKCSNILLEEGYHP--KLSDFG----LAKMGPSGDKTHVSTRVMGTYGYCAP 266
              +++RD+K  N+L+   Y    K+SDFG    LA + P       +    GT  Y AP
Sbjct: 141 -NQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP------CTETFTGTLQYMAP 192
Query: 267 DYAMTGQLTF--KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           +    G   +   +DI+S G  ++E+ TG+    +     E     +   MFK       
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL---GEPQAAMFKVGMFK------- 242
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM 365
            V P +    P     +A A    C +  P+ R    D+++
Sbjct: 243 -VHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 278

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 132 VREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLLVYEYMPLGSLDKHLHDLRPDTRPL 189
           + +   E+  L   DHPN+VKL+    +   D   +V+E +  G + +      P  +PL
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-----VPTLKPL 134
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
             +          +G++YLH    Q +I+RD+K SN+L+ E  H K++DFG++      D
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKS---DIYSFGVVLLELITGR 294
               +T  +GT  + AP+     +  F     D+++ GV L   + G+
Sbjct: 192 ALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 21/225 (9%)
Query: 78  AKPFTFDELAAA--TGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVRE 134
           A P  F + + A  +  ++    LG+G FG+V   C +KI  Q  A+K +  R V+   +
Sbjct: 11  ATPGXFVQHSTAIFSDRYKGQRVLGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTD 69
Query: 135 FSA---EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
             +   EV  L   DHPN+ KL  +  +     LV E    G L   +   R     +D 
Sbjct: 70  KESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVD- 127
Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSG 248
               +I      G+ Y H   K  +++RDLK  N+LLE   +  + ++ DFGL+    + 
Sbjct: 128 --AARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            K       +GT  Y AP+  + G    K D++S GV+L  L++G
Sbjct: 183 KKXKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G  G+V+K    K   V+A+KQ+   G   +  R      + L S D P +V+  G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                   +  E M  G+  + L   +    P+      K+     + L YL E  K  V
Sbjct: 93  FITNTDVFIAMELM--GTCAEKLK--KRMQGPIPERILGKMTVAIVKALYYLKE--KHGV 146
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGL--------AKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           I+RD+K SNILL+E    KL DFG+        AK   +G   +++   +       PDY
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
            +      ++D++S G+ L+EL TG+
Sbjct: 207 DI------RADVWSLGISLVELATGQ 226

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 120
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 176
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YLH      +IYRDLK  N+L+++  + +++DFG AK       T     + GT  Y AP
Sbjct: 177 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAP 228
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +  ++       D ++ GV++ E+  G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 118/264 (44%), Gaps = 39/264 (14%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+K++    +  GV    +RE S     L   
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS----LLKEL 62
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           +HPN+VKL+      ++  LV+E++     D+ L     D   L       I +   + L
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-----DQDLKKFM-DASALTGIPLPLIKSYLFQLL 116
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           Q L       V++RDLK  N+L+      KL+DFGLA+      +T+    V  T  Y A
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 266 PDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL----------NLVAWA-- 312
           P+  +  +  +   DI+S G +  E++T R       +  +L          + V W   
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 313 ------RPMFKD--RKNFSQMVDP 328
                 +P F    R++FS++V P
Sbjct: 235 TSMPDYKPSFPKWARQDFSKVVPP 258

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 99  LGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G FG V +  L++     ++  V + + D      + EF  E   +   DHP++ KL
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGL 205
           +G       +      +++  +M  G L   L   R    P  L   T ++     + G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           +YL     +  I+RDL   N +L E     ++DFGL++   SGD             + A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELIT 292
            +       T  SD+++FGV + E++T
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 35  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 86
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 142
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YLH      +IYRDLK  N+L++E  + +++DFG AK          +  + GT  Y AP
Sbjct: 143 YLHSL---DLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 194
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +  ++       D ++ GV++ E+  G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP--------LDWNTRMKIAAGAS 202
            L+G C + G   +++ E+   G+L  +L   R +  P        L     +  +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRVMG 259
           +G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+  
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLAR-DIYKDPDYVRKGDARL-- 208
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD 318
              + AP+       T +SD++SFGV+L E+ + G       K  +E           + 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFX---------RR 259
Query: 319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
            K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 260 LKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 304

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 105/240 (43%), Gaps = 20/240 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVV-AIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLI 154
           LG G +G+V   C +K+     AIK +    V       A   EV  L   DHPN++KL 
Sbjct: 12  LGSGAYGEVLL-CKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +     LV E    G L   +  LR     +D    MK       G  YLH   K 
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMKQVLS---GTTYLH---KH 123
Query: 215 PVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            +++RDLK  N+LLE        K+ DFGL+     G K       +GT  Y AP+  + 
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTAYYIAPE-VLR 179
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
            +   K D++S GV+L  L+ G        D++ L  V   +  F D  +++Q+ D + Q
Sbjct: 180 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSF-DPPDWTQVSDEAKQ 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 38  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 89
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P L KL     +     +V EY P G +  HL  +     P   + R 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEP---HARF 146
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+++++  + K++DFG AK         V  
Sbjct: 147 -YAAQIVLTFEYLHSL---DLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKG 194
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKI-------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           LG+G F K++KG   ++       E  V +K LD         F      +    H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
              G C  GD+ +LV E++  GSLD +   L+ +   ++   ++++A   +  + +L E 
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTY---LKKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 212 LKQPVIYRDLKCSNILL------EEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
               +I+ ++   NILL      + G  P  KLSD G++      D   +  R+      
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI--LQERIPWVPPE 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
           C  +      L   +D +SFG  L E+ + G K +     +++L         ++DR   
Sbjct: 188 CIEN---PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-------YEDRH-- 235
Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQ 378
                     Q P     +   +   C+  +P+ RP+   ++  LN L +    P+
Sbjct: 236 ----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+ ++    +  GV    +RE S     L   
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREIS----LLKEL 59
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 113
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 114 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 155
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 156 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 215
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 216 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 255

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 116/280 (41%), Gaps = 71/280 (25%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSA 145
           NF+    +GEG +G VYK   +   +VVA+ ++    +  GV    +RE S     L   
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREIS----LLKEL 58
Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYM----------------PLGSLDKHLHDLRPDTRPL 189
           +HPN+VKL+      ++  LV+E++                PL  +  +L  L       
Sbjct: 59  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL------ 112
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                        +GL + H      V++RDLK  N+L+      KL+DFGLA+    G 
Sbjct: 113 -------------QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA--FGV 154
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-- 306
                T  + T  Y AP+  +  +  +   DI+S G +  E++T R       +  +L  
Sbjct: 155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214
Query: 307 --------NLVAWA--------RPMFKD--RKNFSQMVDP 328
                   + V W         +P F    R++FS++V P
Sbjct: 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPP 254

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQV---VAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           +GEG  G V   CL + +     VA+K +D R  Q       EV+ +    H N+V++  
Sbjct: 53  IGEGSTGIV---CLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
               G++  ++ E++  G+L   +  +R     L+      +     + L YLH    Q 
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH---AQG 161
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           VI+RD+K  +ILL      KLSDFG  A++     K      ++GT  + AP+       
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK---RKXLVGTPYWMAPEVISRSLY 218
Query: 275 TFKSDIYSFGVVLLELITG 293
             + DI+S G++++E++ G
Sbjct: 219 ATEVDIWSLGIMVIEMVDG 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 128/280 (45%), Gaps = 35/280 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ-LDHRGVQGVREFSA-EVMTLGSADHPNLVKLIGY 156
           +GEG +G V+K       Q+VAIK+ L+      +++ +  E+  L    HPNLV L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                +  LV+EY     L    H+L    R +  +    I     + + + H   K   
Sbjct: 71  FRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNC 123
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSG-DKTHVSTRVMGTYGYCAPDYAMTGQ 273
           I+RD+K  NIL+ +    KL DFG A++  GPS      V+TR      Y +P+  + G 
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE-LLVGD 177
Query: 274 LTF--KSDIYSFGVVLLELIT------GRKAIDQTK-DRKEL-NLVAWARPMFKDRKNFS 323
             +    D+++ G V  EL++      G+  +DQ    RK L +L+   + +F   + FS
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 324 --QMVDPS----LQGQYPVRGLYQALAIAAMCVQEQPNMR 357
             ++ DP     L+ ++P    Y AL +   C+   P  R
Sbjct: 238 GVKIPDPEDMEPLELKFPNIS-YPALGLLKGCLHMDPTER 276

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K ++      ++V A K +    +       + S E+    S  H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  +      G QYLH 
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR---YYLRQIVL-----GCQYLH- 156
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             +  VI+RDLK  N+ L E    K+ DFGLA K+   G++  V   + GT  Y AP+  
Sbjct: 157 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVL 211
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ D++S G ++  L+ G+   + +
Sbjct: 212 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 242

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YLH      +IYRDLK  N+L+++  + +++DFG AK          +  + GT  Y AP
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLXGTPEYLAP 207
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +  ++       D ++ GV++ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 14/212 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +  +++ A+K L    V     V     E   L     P  +  + 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            C +   RL  V EY+  G L  H+  +     P      +  AA  + GL +L  +   
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAEIAIGLFFLQSK--- 461
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +IYRDLK  N++L+   H K++DFG+ K       T  +    GT  Y AP+       
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPY 519
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
               D ++FGV+L E++ G+    + +D  EL
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPF-EGEDEDEL 550

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 16/220 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F     LG+G FGKV     +  +++ A+K L    V     V     E   L     P
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 149 NLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
             +  +  C +   RL  V EY+  G L  H+  +     P      +  AA  + GL +
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP----HAVFYAAEIAIGLFF 136
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAP 266
           L     + +IYRDLK  N++L+   H K++DFG+ K         V+T+   GT  Y AP
Sbjct: 137 LQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIAP 190
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           +           D ++FGV+L E++ G+    + +D  EL
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDEL 229

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 31/207 (14%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YLH      +IYRDLK  N+L+++  + +++DFG AK          +  + GT  Y AP
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLAGTPEYLAP 207
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +  ++       D ++ GV++ E+  G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K ++      ++V A K +    +       + S E+    S  H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  +      G QYLH 
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR---YYLRQIVL-----GCQYLH- 158
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             +  VI+RDLK  N+ L E    K+ DFGLA K+   G++  V   + GT  Y AP+  
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVL 213
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ D++S G ++  L+ G+   + +
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 244

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 42/281 (14%)
Query: 97  CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
             LG+G +G VY G     +  +AIK++  R  +  +    E+       H N+V+ +G 
Sbjct: 14  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHD----LRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            +E     +  E +P GSL   L      L+ + + + + T+  +      GL+YLH+  
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHD-- 126
Query: 213 KQPVIYRDLKCSNILLEEGYHP--KLSDFG----LAKMGPSGDKTHVSTRVMGTYGYCAP 266
              +++RD+K  N+L+   Y    K+SDFG    LA + P       +    GT  Y AP
Sbjct: 127 -NQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINP------CTETFTGTLQYMAP 178
Query: 267 DYAMTGQLTF--KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           +    G   +   +DI+S G  ++E+ TG+    +     E     +   MFK       
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL---GEPQAAMFKVGMFK------- 228
Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM 365
            V P +    P     +A A    C +  P+ R    D+++
Sbjct: 229 -VHPEI----PESMSAEAKAFILKCFEPDPDKRACANDLLV 264

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNL 150
           +FR    LG G F +V     ++ +++VAIK +  + ++G       E+  L    HPN+
Sbjct: 21  DFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-----DKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           V L      G    L+ + +  G L     +K  +  R  +R         +       +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---------LIFQVLDAV 129
Query: 206 QYLHEQLKQPVIYRDLKCSNIL---LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           +YLH+     +++RDLK  N+L   L+E     +SDFGL+KM   G    V +   GT G
Sbjct: 130 KYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y AP+       +   D +S GV+   L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 38/291 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP----------LDWNTRMKIAAG 200
            L+G C + G   +++ E+   G+L  +L   R +  P          L     +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
            ++G+++L     +  I+RDL   NILL E    K+ DFGLA+                 
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDR 319
             + AP+       T +SD++SFGV+L E+ + G       K  +E           +  
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------RRL 264
Query: 320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
           K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 265 KEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 308

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 87  AAATGNFRSDCCLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREF 135
            A    F     LG G FG+V           Y   +   ++VV +KQ++H         
Sbjct: 37  TAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHT-------- 88
Query: 136 SAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
             E   L + + P LVKL     +     +V EY+  G +  HL  +   + P   + R 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF 145
Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA      +YLH      +IYRDLK  N+L+++  + +++DFG AK         V  
Sbjct: 146 -YAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKG 193
Query: 256 RVM---GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           R     GT  Y AP+  ++       D ++ GV++ E+  G
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKI-------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           LG+G F K++KG   ++       E  V +K LD         F      +    H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
              G C  GD+ +LV E++  GSLD +   L+ +   ++   ++++A   +  + +L E 
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTY---LKKNKNCINILWKLEVAKQLAWAMHFLEEN 132
Query: 212 LKQPVIYRDLKCSNILL------EEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
               +I+ ++   NILL      + G  P  KLSD G++      D   +  R+      
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI--LQERIPWVPPE 187
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
           C  +      L   +D +SFG  L E+ + G K +     +++L         ++DR   
Sbjct: 188 CIEN---PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF-------YEDRH-- 235
Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQ 378
                     Q P     +   +   C+  +P+ RP+   ++  LN L +    P+
Sbjct: 236 ----------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 26/215 (12%)
Query: 91  GNF-RSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADH 147
           G F + D  +G G F  VYKG   E   +V   +  D +  +  R+ F  E   L    H
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQH 84
Query: 148 PNLVKLIGY---CAEGDQ-RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           PN+V+         +G +  +LV E    G+L  +L   +          ++K+     R
Sbjct: 85  PNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV--------XKIKVLRSWCR 136
Query: 204 ----GLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
               GLQ+LH +   P+I+RDLKC NI +       K+ D GLA +     +   +  V+
Sbjct: 137 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVI 191
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           GT  + AP+     +     D+Y+FG   LE  T 
Sbjct: 192 GTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATS 225

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K ++      ++V A K +    +       + S E+    S  H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  +      G QYLH 
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR---YYLRQIVL-----GCQYLH- 132
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             +  VI+RDLK  N+ L E    K+ DFGLA K+   G++  V   + GT  Y AP+  
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEVL 187
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ D++S G ++  L+ G+   + +
Sbjct: 188 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 49  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 100
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 156
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 157 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 205
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 206 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNL 150
           +FR    LG G F +V     ++ +++VAIK +    ++G       E+  L    HPN+
Sbjct: 21  DFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-----DKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           V L      G    L+ + +  G L     +K  +  R  +R         +       +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---------LIFQVLDAV 129
Query: 206 QYLHEQLKQPVIYRDLKCSNIL---LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           +YLH+     +++RDLK  N+L   L+E     +SDFGL+KM   G    V +   GT G
Sbjct: 130 KYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y AP+       +   D +S GV+   L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGV----QGVREFSAEVMTL 142
           NF     LG G +GKV+   + KI      ++ A+K L    +    +       E   L
Sbjct: 55  NFELLKVLGTGAYGKVF--LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 143 GSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG- 200
                   +  + Y  + + +L L+ +Y+  G L  HL       R       ++I  G 
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQIYVGE 167
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
               L++LH   K  +IYRD+K  NILL+   H  L+DFGL+K   + D+T  +    GT
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA-DETERAYDFCGT 223
Query: 261 YGYCAPDYAMTGQLTFKS--DIYSFGVVLLELITG 293
             Y APD    G        D +S GV++ EL+TG
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 105/240 (43%), Gaps = 20/240 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVV-AIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLI 154
           LG G +G+V   C +K+     AIK +    V       A   EV  L   DHPN++KL 
Sbjct: 29  LGSGAYGEVLL-CKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +     LV E    G L   +  LR     +D    MK       G  YLH   K 
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEI-ILRQKFSEVDAAVIMKQVLS---GTTYLH---KH 140
Query: 215 PVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            +++RDLK  N+LLE        K+ DFGL+     G K       +GT  Y AP+  + 
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTAYYIAPE-VLR 196
Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
            +   K D++S GV+L  L+ G        D++ L  V   +  F D  +++Q+ D + Q
Sbjct: 197 KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSF-DPPDWTQVSDEAKQ 255

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNL 150
           +FR    LG G F +V     ++ +++VAIK +    ++G       E+  L    HPN+
Sbjct: 21  DFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-----DKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           V L      G    L+ + +  G L     +K  +  R  +R         +       +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---------LIFQVLDAV 129
Query: 206 QYLHEQLKQPVIYRDLKCSNIL---LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           +YLH+     +++RDLK  N+L   L+E     +SDFGL+KM   G    V +   GT G
Sbjct: 130 KYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y AP+       +   D +S GV+   L+ G
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 39/292 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP-----------LDWNTRMKIAA 199
            L+G C + G   +++ E+   G+L  +L   R +  P           L     +  + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
             ++G+++L     +  I+RDL   NILL E    K+ DFGLA+                
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD 318
              + AP+       T +SD++SFGV+L E+ + G       K  +E           + 
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------RR 263
Query: 319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
            K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 264 LKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 308

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +     P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 125/292 (42%), Gaps = 42/292 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP--------LDWNTRMKIAAGAS 202
            L+G C + G   +++ E+   G+L  +L   R +  P        L     +  +   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRVMG 259
           +G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+  
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDARL-- 208
Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD 318
              + AP+       T +SD++SFGV+L E+ + G       K  +E           + 
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------RR 259
Query: 319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
            K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 260 LKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 304

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +     P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +     P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 26/222 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNL 150
           +FR    LG G F +V     ++ +++VAIK +    ++G       E+  L    HPN+
Sbjct: 21  DFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-----DKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           V L      G    L+ + +  G L     +K  +  R  +R         +       +
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---------LIFQVLDAV 129
Query: 206 QYLHEQLKQPVIYRDLKCSNIL---LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           +YLH+     +++RDLK  N+L   L+E     +SDFGL+KM   G    V +   GT G
Sbjct: 130 KYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPG 183
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
           Y AP+       +   D +S GV+   L+ G        D K
Sbjct: 184 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK 225

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLI 154
            LG G FG+V     ++     A+K LD + V  +++      E   L + + P LVKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
               +     +V EY+  G +  HL  +     P   + R   AA      +YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARF-YAAQIVLTFEYLHSL--- 160
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGYCAPDYAMT 271
            +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y AP+  ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILS 212
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+               
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK 317
               + AP+       T +SD++SFGV+L E+ + G       K  +E           +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------R 262
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 263 RLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 308

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 31/207 (14%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 43  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 94
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +     P   + R   AA      +
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARF-YAAQIVLTFE 150
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YLH      +IYRDLK  N+L+++  + +++DFG AK          +  + GT  Y AP
Sbjct: 151 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 202
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +  ++       D ++ GV++ E+  G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K ++      ++V A K +    +       + S E+    S  H ++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  +      G QYLH 
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR---YYLRQIVL-----GCQYLH- 138
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             +  VI+RDLK  N+ L E    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 139 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVL 193
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ D++S G ++  L+ G+   + +
Sbjct: 194 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 224

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+               
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK 317
               + AP+       T +SD++SFGV+L E+ + G       K  +E           +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------R 253
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 254 RLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 299

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+++++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 205 LAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 69  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 120
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +     P   + R   AA      +
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEP---HARF-YAAQIVLTFE 176
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 177 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 225
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ E+  G
Sbjct: 226 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K ++      ++V A K +    +       + S E+    S  H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  +      G QYLH 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR---YYLRQIVL-----GCQYLH- 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             +  VI+RDLK  N+ L E    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 135 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVL 189
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ D++S G ++  L+ G+   + +
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGF K ++      ++V A K +    +       + S E+    S  H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +  + D   +V E     SL + LH  R     P+ R   +  R  +      G QYLH 
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEAR---YYLRQIVL-----GCQYLH- 134
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             +  VI+RDLK  N+ L E    K+ DFGLA K+   G++      + GT  Y AP+  
Sbjct: 135 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT---LCGTPNYIAPEVL 189
Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQT 300
                +F+ D++S G ++  L+ G+   + +
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+               
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK 317
               + AP+       T +SD++SFGV+L E+ + G       K  +E           +
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------R 253
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 254 RLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 299

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 37/210 (17%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGY 263
           YLH      +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEY 204
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  ++       D ++ GV++ ++  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 90/202 (44%), Gaps = 21/202 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLI 154
            LG G FG+V     ++     A+K LD + V  +++      E   L + + P LVKL 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
               +     +V EY+  G +  HL  +   + P   + R   AA      +YLH     
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFEYLHSL--- 160
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM---GTYGYCAPDYAMT 271
            +IYRDLK  N+L+++  + +++DFG AK         V  R     GT  Y AP   ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPAIILS 212
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                  D ++ GV++ E+  G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---ST 255
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDA 212
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARP 314
           R+     + AP+       T +SD++SFGV+L E+ + G       K  +E         
Sbjct: 213 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------- 263
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             +  K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 264 --RRLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 310

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---ST 255
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDA 210
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARP 314
           R+     + AP+       T +SD++SFGV+L E+ + G       K  +E         
Sbjct: 211 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------- 261
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             +  K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 262 --RRLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 308

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 120/293 (40%), Gaps = 40/293 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+               
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFK 317
               + AP+       T +SD++SFGV+L E+ + G       K  +E           +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---------R 262
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 263 RLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 308

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS---T 255
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDA 201
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARP 314
           R+     + AP+       T +SD++SFGV+L E+ + G       K  +E         
Sbjct: 202 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------- 252
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             +  K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 253 --RRLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 299

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---ST 255
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     
Sbjct: 192 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDA 247
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARP 314
           R+     + AP+       T +SD++SFGV+L E+ + G       K  +E         
Sbjct: 248 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------- 298
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             +  K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 299 --RRLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 345

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 46/296 (15%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-----VAIKQLDHRGVQGV-REFSAEV-MTLGSADHPNLV 151
           LG G FG+V +     I++      VA+K L         R   +E+ + +    H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS---T 255
              ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDA 201
Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARP 314
           R+     + AP+       T +SD++SFGV+L E+ + G       K  +E         
Sbjct: 202 RL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC------- 252
Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             +  K  ++M  P     Y    +YQ +     C   +P+ RP  +++V  L  L
Sbjct: 253 --RRLKEGTRMRAPD----YTTPEMYQTMLD---CWHGEPSQRPTFSELVEHLGNL 299

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 143 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 135 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 141 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 132 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 133 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 133 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 135 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 137 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T   T  + T 
Sbjct: 155 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+L+      K+ DFGLA++  P  D T   T  + T 
Sbjct: 155 RGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 115/248 (46%), Gaps = 30/248 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL----- 153
           LG GG G V+       ++ VAIK++     Q V+    E+  +   DH N+VK+     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 154 ---------IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
                    +G   E +   +V EYM     +  L ++      L+ + R+       RG
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARL-FMYQLLRG 132
Query: 205 LQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK-MGPS-GDKTHVSTRVMGTY 261
           L+Y+H      V++RDLK +N+ +  E    K+ DFGLA+ M P    K H+S  ++ T 
Sbjct: 133 LKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TK 188
Query: 262 GYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF--KD 318
            Y +P   ++    T   D+++ G +  E++TG+       + +++ L+  + P+   +D
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 319 RKNFSQMV 326
           R+    ++
Sbjct: 249 RQELLSVI 256

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 40/224 (17%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD---HRGVQGVREFSAEVMTLGS-ADHPNLVKLI 154
           LG+G +G V+K    +  +VVA+K++           R F  E+M L   + H N+V L+
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGLQYLHE 210
                 + R   LV++YM          DL    R   L+   +  +     + ++YLH 
Sbjct: 76  NVLRADNDRDVYLVFDYMET--------DLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS-------------------GDKT 251
                +++RD+K SNILL    H K++DFGL++   +                    D  
Sbjct: 128 G---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 252 HVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLELITGR 294
            + T  + T  Y AP+  + + + T   D++S G +L E++ G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 113/248 (45%), Gaps = 38/248 (15%)
Query: 66  NLKDDSNNSGK-SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL 124
           +L D S  SG  S  PF      A         C+G+G +G+V++G  +   + VA+K  
Sbjct: 13  DLLDHSCTSGSGSGLPFLVQRTVARQITLLE--CVGKGRYGEVWRGSWQG--ENVAVKIF 68
Query: 125 DHRGVQG-VREFSAEVMTLGSADHPNLVKLIGYCAE-------GDQRLLVYEYMPLGSLD 176
             R  +   RE   E+       H N+   +G+ A          Q  L+  Y  +GSL 
Sbjct: 69  SSRDEKSWFRE--TELYNTVMLRHENI---LGFIASDMTSRHSSTQLWLITHYHEMGSLY 123
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-----KQPVIYRDLKCSNILLEEG 231
            +L     DT        ++I    + GL +LH ++     K  + +RDLK  NIL+++ 
Sbjct: 124 DYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 178
Query: 232 YHPKLSDFGLAKM-GPSGDKTHV--STRVMGTYGYCAPDYA-MTGQL-TFKS----DIYS 282
               ++D GLA M   S ++  V  + RV GT  Y AP+    T Q+  F S    DI++
Sbjct: 179 GQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWA 237
Query: 283 FGVVLLEL 290
           FG+VL E+
Sbjct: 238 FGLVLWEV 245

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 45/214 (21%)
Query: 98  CLGEGGFGKV-----------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
            LG G FG+V           Y   +   ++VV +KQ++H           E   L + +
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT--------LNEKRILQAVN 99
Query: 147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
            P LVKL     +     +V EY+  G +  HL  +   + P   + R   AA      +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARF-YAAQIVLTFE 155
Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG-TYGYC- 264
           YLH      +IYRDLK  N+L+++  + +++DFG AK            RV G T+  C 
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK------------RVKGRTWXLCG 200
Query: 265 -----APDYAMTGQLTFKSDIYSFGVVLLELITG 293
                AP+  ++       D ++ GV++ E+  G
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
           C+G+G +G+V++G      + VA+K    R  Q   RE   E+       H N++  I  
Sbjct: 15  CVGKGRYGEVWRGLWHG--ESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIAS 70
Query: 157 CA----EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
                    Q  L+  Y   GSL   L   R    P   +  +++A  A+ GL +LH ++
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQ--RQTLEP---HLALRLAVSAACGLAHLHVEI 125
Query: 213 -----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHV--STRVMGTYGYC 264
                K  + +RD K  N+L++      ++D GLA M   G D   +  + RV GT  Y 
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYM 184
Query: 265 APDYAMTGQL---TFKS----DIYSFGVVLLELITGRKAI 297
           AP+  +  Q+    F+S    DI++FG+VL E+   R+ I
Sbjct: 185 APE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 121/282 (42%), Gaps = 47/282 (16%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC- 157
           L E   G+++KG  +  + VV + ++     +  R+F+ E   L    HPN++ ++G C 
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 158 -AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                   L+  +MP GSL   LH+       +D +  +K A   +RG+ +LH    +P+
Sbjct: 78  SPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL--EPL 133
Query: 217 IYRD-LKCSNILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM--- 270
           I R  L   +++++E    ++S  D   +   P           M    + AP+      
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWVAPEALQKKP 184
Query: 271 --TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
             T + +  +D++SF V+L EL+T           +E+         F D  N    +  
Sbjct: 185 EDTNRRS--ADMWSFAVLLWELVT-----------REVP--------FADLSNMEIGMKV 223
Query: 329 SLQGQYPV--RGLYQALA-IAAMCVQEQPNMRPAITDVVMAL 367
           +L+G  P    G+   ++ +  +C+ E P  RP    +V  L
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSADHPNLVKLIGY 156
           +G G +G+  K   +   +++  K+LD+  +    +    +EV  L    HPN+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 157 CAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK- 213
             +     L  V EY   G L   +     + + LD    +++    +  L+  H +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 214 -QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RDLK +N+ L+   + KL DFGLA++      T  +   +GT  Y +P+     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 273 QLTFKSDIYSFGVVLLEL 290
               KSDI+S G +L EL
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T      + T 
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG-PSGDKTHVSTRVMGTY 261
           RGL+Y+H      V++RDLK SN+LL      K+ DFGLA++  P  D T      + T 
Sbjct: 140 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
            Y AP+  +  +   KS DI+S G +L E+++ R
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSADHPNLVKLIGY 156
           +G G +G+  K   +   +++  K+LD+  +    +    +EV  L    HPN+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 157 CAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK- 213
             +     L  V EY   G L   +     + + LD    +++    +  L+  H +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 214 -QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RDLK +N+ L+   + KL DFGLA++      T  +   +GT  Y +P+     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 273 QLTFKSDIYSFGVVLLEL 290
               KSDI+S G +L EL
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
           C+G+G +G+V++G  +   + VA+K    R  +   RE   E+       H N+   +G+
Sbjct: 15  CVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENI---LGF 67
Query: 157 CAE-------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
            A          Q  L+  Y  +GSL  +L     DT        ++I    + GL +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLH 122
Query: 210 EQL-----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-GPSGDKTHV--STRVMGTY 261
            ++     K  + +RDLK  NIL+++     ++D GLA M   S ++  V  + RV GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTK 181
Query: 262 GYCAPDYA-MTGQL-TFKS----DIYSFGVVLLEL 290
            Y AP+    T Q+  F S    DI++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 104/254 (40%), Gaps = 49/254 (19%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
            +F     LG+G FG+V K       +  AIK++ H   + +    +EV  L S +H  +
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVXLLASLNHQYV 64
Query: 151 VKLIGYCAEGDQRLLV---------------YEYMPLGSLDKHLHDLRPDT-RPLDWNTR 194
           V+   Y A  ++R  V                EY    +L   +H    +  R   W   
Sbjct: 65  VRY--YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLF 122
Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK----------- 243
            +I       L Y+H Q    +I+R+LK  NI ++E  + K+ DFGLAK           
Sbjct: 123 RQIL----EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 244 ----MGPSGDKTHVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELI----TGR 294
               +  S D     T  +GT  Y A +    TG    K D YS G++  E I    TG 
Sbjct: 176 DSQNLPGSSDNL---TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGX 232
Query: 295 KAIDQTKDRKELNL 308
           + ++  K  + +++
Sbjct: 233 ERVNILKKLRSVSI 246

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLI 154
            +G G FG+V     +  ++V A+K L    +    +   F  E   +  A+ P +V+L 
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 140
Query: 155 GYCAEGDQRLL--VYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            +CA  D + L  V EYMP G L   + +   P+     +   + +A  A   +  +H  
Sbjct: 141 -FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH-- 197
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                  RD+K  N+LL++  H KL+DFG   KM  +G   H  T V GT  Y +P+   
Sbjct: 198 -------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVHCDTAV-GTPDYISPEVLK 248
Query: 271 T----GQLTFKSDIYSFGVVLLELITG 293
           +    G    + D +S GV L E++ G
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 35/215 (16%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
           C+G+G +G+V++G  +   + VA+K    R  +   RE   E+       H N+   +G+
Sbjct: 15  CVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENI---LGF 67
Query: 157 CAE-------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
            A          Q  L+  Y  +GSL  +L     DT        ++I    + GL +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLH 122
Query: 210 EQL-----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-GPSGDKTHV--STRVMGTY 261
            ++     K  + +RDLK  NIL+++     ++D GLA M   S ++  V  + RV GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTK 181
Query: 262 GYCAPDYA-MTGQL-TFKS----DIYSFGVVLLEL 290
            Y AP+    T Q+  F S    DI++FG+VL E+
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 15/220 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVK---- 152
           +G G +G V         Q VAIK++ +    V   +    E+  L    H N++     
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L      G+ + +   Y+ L  ++  LH +   ++PL             RGL+Y+H   
Sbjct: 123 LRPTVPYGEFKSV---YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ 179
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPDYAM 270
              VI+RDLK SN+L+ E    K+ DFG+A+       +  +  T  + T  Y AP+  +
Sbjct: 180 ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 236
Query: 271 T-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           +  + T   D++S G +  E++  R+         +L L+
Sbjct: 237 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 276

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----W 192
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 17/222 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVK--- 152
            +G G +G V         Q VAIK++ +    V   +    E+  L    H N++    
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 153 -LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L      G+ + +   Y+ L  ++  LH +   ++PL             RGL+Y+H  
Sbjct: 121 ILRPTVPYGEFKSV---YVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-- 175
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHVSTRVMGTYGYCAPDY 268
               VI+RDLK SN+L+ E    K+ DFG+A+     P+ +  +  T  + T  Y AP+ 
Sbjct: 176 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPA-EHQYFMTEYVATRWYRAPEL 233
Query: 269 AMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            ++  + T   D++S G +  E++  R+         +L L+
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI 275

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----W 192
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----W 198
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----W 194
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----W 194
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----W 194
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----W 189
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 79/178 (44%), Gaps = 12/178 (6%)
Query: 74  SGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR 133
           SG+    F    +       R    L EGGF  VY+       +  A+K+L     +  R
Sbjct: 11  SGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR 70
Query: 134 EFSAEVMTLGS-ADHPNLVKLIGYCAEGDQR-------LLVYEYMPLGSLDKHLHDLRPD 185
               EV  +   + HPN+V+     + G +         L+   +  G L + L  +  +
Sbjct: 71  AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM--E 128
Query: 186 TR-PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
           +R PL  +T +KI     R +Q++H Q K P+I+RDLK  N+LL      KL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----W 193
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 146 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 197
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 245

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 192
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSA--EVMTLGSADHPNLVK 152
           +GEG +G V+K    +  ++VA+K++    D  GV      SA  E+  L    H N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALREICLLKELKHKNIVR 65
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L        +  LV+E+     L K+      D   LD            +GL + H + 
Sbjct: 66  LHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RDLK  N+L+      KL+DFGLA+    G      +  + T  Y  PD     
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLADFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 273 QLTFKS-DIYSFGVVLLELITGRKAI 297
           +L   S D++S G +  EL    + +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 135 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 186
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 234

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 199
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 199
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 207
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 255

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 147 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 198
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 246

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 148 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 199
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 247

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 189
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 189
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 141 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 192
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 240

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 138 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 189
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 237

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----W 210
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 194
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 206
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 254

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 193
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 193
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 155 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 206
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 254

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 142 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 193
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 241

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 207
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 255

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 159 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 210
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 258

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 184
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 183
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 133 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 184
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 134 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 185
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 233

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 183
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 183
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSADHPNLVKLIGY 156
           +G G +G+  K   +   +++  K+LD+  +    +    +EV  L    HPN+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 157 CAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK- 213
             +     L  V EY   G L   +     + + LD    +++    +  L+  H +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 214 -QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RDLK +N+ L+   + KL DFGLA++    +    +   +GT  Y +P+     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQMNRM 191
Query: 273 QLTFKSDIYSFGVVLLEL 290
               KSDI+S G +L EL
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSA-EVMTLGSADHPNLVKLIGY 156
           +GEG +G VYK       +  A+K++   +  +G+   +  E+  L    H N+VKL   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQP 215
                + +LV+E+     LD+ L  L       L+  T          G+ Y H++    
Sbjct: 69  IHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQL 274
           V++RDLK  N+L+      K++DFGLA+    G      T  + T  Y APD  M + + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 275 TFKSDIYSFGVVLLELITG 293
           +   DI+S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLI 154
            +G G FG+V     +   +V A+K L    +    +   F  E   +  A+ P +V+L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            Y  + D+ L +V EYMP G L   + +   P+     +   + +A  A   + ++H   
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--- 191
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
                 RD+K  N+LL++  H KL+DFG   KM   G      T V GT  Y +P+   +
Sbjct: 192 ------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAV-GTPDYISPEVLKS 243
Query: 272 ----GQLTFKSDIYSFGVVLLELITG 293
               G    + D +S GV L E++ G
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLI 154
            +G G FG+V     +   +V A+K L    +    +   F  E   +  A+ P +V+L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            Y  + D+ L +V EYMP G L   + +   P+     +   + +A  A   + ++H   
Sbjct: 141 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--- 196
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
                 RD+K  N+LL++  H KL+DFG   KM   G      T V GT  Y +P+   +
Sbjct: 197 ------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAV-GTPDYISPEVLKS 248
Query: 272 ----GQLTFKSDIYSFGVVLLELITG 293
               G    + D +S GV L E++ G
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 11/197 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V++          A K +             E+ T+    HP LV L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + ++ +++YE+M  G L + + D   +   +  +  ++      +GL ++HE      ++
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 172
Query: 219 RDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
            DLK  NI+   +     KL DFGL           V+T   GT  + AP+ A    + +
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 229
Query: 277 KSDIYSFGVVLLELITG 293
            +D++S GV+   L++G
Sbjct: 230 YTDMWSVGVLSYILLSG 246

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSA-EVMTLGSADHPNLVKLIGY 156
           +GEG +G VYK       +  A+K++   +  +G+   +  E+  L    H N+VKL   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQP 215
                + +LV+E+     LD+ L  L       L+  T          G+ Y H++    
Sbjct: 69  IHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQL 274
           V++RDLK  N+L+      K++DFGLA+    G      T  + T  Y APD  M + + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 275 TFKSDIYSFGVVLLELITG 293
           +   DI+S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSA-EVMTLGSADHPNLVKLIGY 156
           +GEG +G VYK       +  A+K++   +  +G+   +  E+  L    H N+VKL   
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRP-LDWNTRMKIAAGASRGLQYLHEQLKQP 215
                + +LV+E+     LD+ L  L       L+  T          G+ Y H++    
Sbjct: 69  IHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---R 120
Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-TGQL 274
           V++RDLK  N+L+      K++DFGLA+    G      T  + T  Y APD  M + + 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 275 TFKSDIYSFGVVLLELITG 293
           +   DI+S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+         V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 107/244 (43%), Gaps = 36/244 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM----TLGSADHPNLVKLI 154
           LG G +G V K       Q++A+K++  R     +E    +M    ++ + D P  V   
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 116
Query: 155 G-YCAEGDQRLLVYEYMPL--GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           G    EGD    V+  M L   SLDK    +    + +  +   KIA    + L++LH +
Sbjct: 117 GALFREGD----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 172
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           L   VI+RD+K SN+L+      K+ DFG++  G   D     T   G   Y AP+  + 
Sbjct: 173 LS--VIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKTIDAGCKPYMAPE-RIN 226
Query: 272 GQL-----TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
            +L     + KSDI+S G+ ++EL   R   D           +W  P F+  K   +  
Sbjct: 227 PELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTP-FQQLKQVVEEP 274
Query: 327 DPSL 330
            P L
Sbjct: 275 SPQL 278

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY- 156
           +G+G FG+V++G     E  VA+K    R  +   RE  AE+       H N++  I   
Sbjct: 12  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 67
Query: 157 ---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                   Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH ++ 
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 122
Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
               K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y AP
Sbjct: 123 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 267 DYA-----MTGQLTFK-SDIYSFGVVLLEL 290
           +       M    +FK +DIY+ G+V  E+
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+         V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 86/197 (43%), Gaps = 11/197 (5%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V++          A K +             E+ T+    HP LV L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + ++ +++YE+M  G L + + D   +   +  +  ++      +GL ++HE      ++
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 278
Query: 219 RDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
            DLK  NI+   +     KL DFGL           V+T   GT  + AP+ A    + +
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGY 335
Query: 277 KSDIYSFGVVLLELITG 293
            +D++S GV+   L++G
Sbjct: 336 YTDMWSVGVLSYILLSG 352

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 18/232 (7%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADH 147
           + +F+    LGEG +G V     +   ++VAIK+++   + +  +R    E+  L    H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            N++ +               Y+    +   LH +   T+ L  +          R ++ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKV 127
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---------GPSGDKTHVSTRVM 258
           LH      VI+RDLK SN+L+      K+ DFGLA++          P+G ++ + T  +
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TEXV 183
Query: 259 GTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            T  Y AP+  +T  + +   D++S G +L EL   R        R +L L+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 101/232 (43%), Gaps = 18/232 (7%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADH 147
           + +F+    LGEG +G V     +   ++VAIK+++   + +  +R    E+  L    H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            N++ +               Y+    +   LH +   T+ L  +          R ++ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKV 127
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---------GPSGDKTHVSTRVM 258
           LH      VI+RDLK SN+L+      K+ DFGLA++          P+G ++ + T  +
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-TEYV 183
Query: 259 GTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            T  Y AP+  +T  + +   D++S G +L EL   R        R +L L+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+         V+TR      
Sbjct: 156 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----W 207
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 255

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLI 154
            +G G FG+V     +   +V A+K L    +    +   F  E   +  A+ P +V+L 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            Y  + D+ L +V EYMP G L   + +   P+     +   + +A  A   + ++H   
Sbjct: 141 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--- 196
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
                 RD+K  N+LL++  H KL+DFG   KM   G      T V GT  Y +P+   +
Sbjct: 197 ------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAV-GTPDYISPEVLKS 248
Query: 272 ----GQLTFKSDIYSFGVVLLELITG 293
               G    + D +S GV L E++ G
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY- 156
           +G+G FG+V++G     E  VA+K    R  +   RE  AE+       H N++  I   
Sbjct: 11  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 66
Query: 157 ---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                   Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH ++ 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 121
Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
               K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 267 DYA-----MTGQLTFK-SDIYSFGVVLLEL 290
           +       M    +FK +DIY+ G+V  E+
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+         V+TR      
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----W 183
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 52/293 (17%)
Query: 88  AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS------AEVMT 141
           A    +R    LG+GGFG V+ G        VAIK +    V G    S       EV  
Sbjct: 28  AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVAL 87
Query: 142 L----GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
           L        HP +++L+ +    +  +LV E  PL + D  L D   +  PL        
Sbjct: 88  LWKVGAGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQD--LFDYITEKGPLGEGPSRCF 144
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNIL--LEEGYHPKLSDFGLAKMGPSGDKTH--V 253
                  +Q+ H    + V++RD+K  NIL  L  G   KL DFG      SG   H   
Sbjct: 145 FGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCA-KLIDFG------SGALLHDEP 194
Query: 254 STRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA 312
            T   GT  Y  P++    Q     + ++S G++L +++ G    ++ ++  E  L    
Sbjct: 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL---- 250
Query: 313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM 365
                   +F   V P               A+   C+  +P+ RP++ ++++
Sbjct: 251 --------HFPAHVSP------------DCCALIRRCLAPKPSSRPSLEEILL 283

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY- 156
           +G+G FG+V++G     E  VA+K    R  +   RE  AE+       H N++  I   
Sbjct: 14  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 69
Query: 157 ---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                   Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH ++ 
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 124
Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
               K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y AP
Sbjct: 125 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 267 DYA-----MTGQLTFK-SDIYSFGVVLLEL 290
           +       M    +FK +DIY+ G+V  E+
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY- 156
           +G+G FG+V++G     E  VA+K    R  +   RE  AE+       H N++  I   
Sbjct: 17  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 72
Query: 157 ---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                   Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH ++ 
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 127
Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
               K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y AP
Sbjct: 128 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 267 DYA-----MTGQLTFK-SDIYSFGVVLLEL 290
           +       M    +FK +DIY+ G+V  E+
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLV 151
           F     LG G F +V     +   ++ A+K +  + ++G       E+  L    H N+V
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L       +   LV + +  G L   + +    T   D +T ++    A   + YLH  
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK-DASTLIRQVLDA---VYYLH-- 137
Query: 212 LKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
            +  +++RDLK  N+L    +E     +SDFGL+KM   GD   V +   GT GY AP+ 
Sbjct: 138 -RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGTPGYVAPEV 193
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG 293
                 +   D +S GV+   L+ G
Sbjct: 194 LAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+         V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ D+GLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+        +V+TR      
Sbjct: 165 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 216
Query: 263 YCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +         DI+S G ++ EL+TGR     T    +L  +
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQI 264

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 105/247 (42%), Gaps = 33/247 (13%)
Query: 66  NLKD---DSNNSGK-SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAI 121
            LKD   D   SG  S  P       A T   +    +G+G FG+V++G     E  VA+
Sbjct: 2   TLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQES--IGKGRFGEVWRGKWRGEE--VAV 57
Query: 122 KQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY----CAEGDQRLLVYEYMPLGSLD 176
           K    R  +   RE  AE+       H N++  I           Q  LV +Y   GSL 
Sbjct: 58  KIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLF 115
Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-----KQPVIYRDLKCSNILLEEG 231
            +L+        +     +K+A   + GL +LH ++     K  + +RDLK  NIL+++ 
Sbjct: 116 DYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 170
Query: 232 YHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAPDYA-----MTGQLTFK-SDIYSF 283
               ++D GLA    S   T        +GT  Y AP+       M    +FK +DIY+ 
Sbjct: 171 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 230
Query: 284 GVVLLEL 290
           G+V  E+
Sbjct: 231 GLVFWEI 237

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DFGL +        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 109/252 (43%), Gaps = 36/252 (14%)
Query: 67  LKDDSNNSG-----------KSAKPFT--FDELAAATGNFRSDCCLGEGGFGKVYKGCLE 113
           L D+ NNS            + AKPFT    ++     +F     +G G FG+V    L+
Sbjct: 37  LYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLK 96
Query: 114 KIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEY 169
             ++V A+K L+   +    E   F  E   L + D    +  + Y  + D  L LV +Y
Sbjct: 97  NADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYLVMDY 155
Query: 170 MPLG---SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI 226
              G   +L     D  P+     +   M IA  +   L Y+H         RD+K  NI
Sbjct: 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNI 206
Query: 227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY--AMT---GQLTFKSDIY 281
           L++   H +L+DFG + +    D T  S+  +GT  Y +P+   AM    G+   + D +
Sbjct: 207 LMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265
Query: 282 SFGVVLLELITG 293
           S GV + E++ G
Sbjct: 266 SLGVCMYEMLYG 277

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV-REFSAEVMTLGSADHPNLVKLIGYC 157
           LGEG F    K   +K  Q  A+K +  R      +E +A  +  G   HPN+VKL    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHEVF 75
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +     LV E +  G L + +   +  +         K+ +  S    ++H+     V+
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS----HMHDV---GVV 128
Query: 218 YRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           +RDLK  N+L     +    K+ DFG A++ P  D   + T    T  Y AP+       
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAPELLNQNGY 186
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKDR 303
               D++S GV+L  +++G+    Q+ DR
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPF-QSHDR 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY- 156
           +G+G FG+V++G     E  VA+K    R  +   RE  AE+       H N++  I   
Sbjct: 50  IGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105
Query: 157 ---CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                   Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH ++ 
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIV 160
Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
               K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 267 DYA-----MTGQLTFK-SDIYSFGVVLLEL 290
           +       M    +FK +DIY+ G+V  E+
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           LGEG   +V + C+  I  Q  A+K ++ + G    R F    M      H N+++LI +
Sbjct: 21  LGEGAHARV-QTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             E D+  LV+E M  GS+  H+H  R     L+ +  ++  A A   L +LH    + +
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASA---LDFLH---NKGI 132
Query: 217 IYRDLKCSNILLEEGYHP------KLSDFGLAK-MGPSGDKTHVSTRVM----GTYGYCA 265
            +RDLK  NIL E   HP      K+ DFGL   +  +GD + +ST  +    G+  Y A
Sbjct: 133 AHRDLKPENILCE---HPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 266 PDY--AMTGQLTF---KSDIYSFGVVLLELITG 293
           P+   A + + +    + D++S GV+L  L++G
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 20/199 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSA--EVMTLGSADHPNLVK 152
           +GEG +G V+K    +  ++VA+K++    D  GV      SA  E+  L    H N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS----SALREICLLKELKHKNIVR 65
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L        +  LV+E+     L K+      D   LD            +GL + H + 
Sbjct: 66  LHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              V++RDLK  N+L+      KL++FGLA+    G      +  + T  Y  PD     
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 273 QLTFKS-DIYSFGVVLLEL 290
           +L   S D++S G +  EL
Sbjct: 177 KLYSTSIDMWSAGCIFAEL 195

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-VMTL 142
           +E+  AT   R    LG G FG+V++   ++     A+K++       +  F AE +M  
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMAC 139
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD--LRPDTRPLDWNTRMKIAAG 200
                P +V L G   EG    +  E +  GSL + + +    P+ R L +  +      
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQ------ 193
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAK-MGPSGDKTHVST--R 256
           A  GL+YLH +    +++ D+K  N+LL  +G H  L DFG A  + P G    + T   
Sbjct: 194 ALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           + GT  + AP+  +      K D++S   ++L ++ G
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNL 150
           +F    CLG GGFG V++   +  +   AIK++     +  RE    EV  L   +HP +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 151 VKLIGYCAEGD--QRLL-----VYEYMPLGSLDK-HLHDL---RPDTRPLDWNTRMKIAA 199
           V+      E +  ++L      VY Y+ +    K +L D    R      + +  + I  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRV- 257
             +  +++LH    + +++RDLK SNI        K+ DFGL   M    ++  V T + 
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 258 --------MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELI 291
                   +GT  Y +P+       + K DI+S G++L EL+
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 36/213 (16%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRG-------VQGVREFSAEVMTL 142
           G +    C+  GG G +Y      +  + V +K L H G           R+F AEV+  
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-- 137
Query: 143 GSADHPNLVKLIGYCAEGDQR-----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
               HP++V++  +    D+       +V EY+   SL +      P    + +   +  
Sbjct: 138 ----HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILP 193
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A      L YLH      ++Y DLK  NI+L E    KL D G         + +    +
Sbjct: 194 A------LSYLH---SIGLVYNDLKPENIMLTE-EQLKLIDLGAVS------RINSFGYL 237
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLEL 290
            GT G+ AP+   TG  T  +DIY+ G  L  L
Sbjct: 238 YGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 19/188 (10%)
Query: 114 KIEQVVAIKQLDHRGVQGVREFSA-EVMTLGS-ADHPNLVKLIGYCAEGDQRLLVYEYMP 171
           KI +V A ++L    ++ VRE +  E   L   A HP+++ LI          LV++ M 
Sbjct: 125 KIMEVTA-ERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG 231
            G L  +L     +   L       I       + +LH      +++RDLK  NILL++ 
Sbjct: 184 KGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN 236
Query: 232 YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ------LTFKSDIYSFGV 285
              +LSDFG +     G+K      + GT GY AP+               + D+++ GV
Sbjct: 237 MQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293
Query: 286 VLLELITG 293
           +L  L+ G
Sbjct: 294 ILFTLLAG 301

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 18/232 (7%)
Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADH 147
           + +F+    LGEG +G V     +   ++VAIK+++   + +  +R    E+  L    H
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            N++ +               Y+    +   LH +   T+ L  +          R ++ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVKV 127
Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM---------GPSGDKTHVSTRVM 258
           LH      VI+RDLK SN+L+      K+ DFGLA++          P+G ++ +    +
Sbjct: 128 LH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM-VEFV 183
Query: 259 GTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            T  Y AP+  +T  + +   D++S G +L EL   R        R +L L+
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHP 148
            + S   +G G +G V     ++  + VAIK+L  R  Q     +    E++ L    H 
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 149 NLVKLIGYCAEGDQRLLVYEY---MPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGASRG 204
           N++ L+            Y++   MP    D + +  L+     + +     +     +G
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKG 138
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L+Y+H      V++RDLK  N+ + E    K+ DFGLA+   +    +V TR      Y 
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 190
Query: 265 APDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
           AP+  ++     ++ DI+S G ++ E++TG+
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 84  DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-VMTL 142
           +E+  AT   R    LG G FG+V++   ++     A+K++       +  F AE +M  
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMAC 120
Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD--LRPDTRPLDWNTRMKIAAG 200
                P +V L G   EG    +  E +  GSL + + +    P+ R L +  +      
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQ------ 174
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAK-MGPSGDKTHVST--R 256
           A  GL+YLH +    +++ D+K  N+LL  +G H  L DFG A  + P G    + T   
Sbjct: 175 ALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 257 VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           + GT  + AP+  +      K D++S   ++L ++ G
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 78  AKPFT--FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE- 134
           AKPFT    E+     +F     +G G FG+V    ++  E++ A+K L+   +    E 
Sbjct: 75  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 134
Query: 135 --FSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG---SLDKHLHDLRPDTRPL 189
             F  E   L + D   +  L     + +   LV +Y   G   +L     D  P+    
Sbjct: 135 ACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR 194
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
            +   M +A  +   L Y+H         RD+K  N+LL+   H +L+DFG + +  + D
Sbjct: 195 FYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDD 244
Query: 250 KTHVSTRVMGTYGYCAPDY--AM---TGQLTFKSDIYSFGVVLLELITG 293
            T  S+  +GT  Y +P+   AM    G+   + D +S GV + E++ G
Sbjct: 245 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 293

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLVK 152
           LG G F  V K   +   +  A K +  R +   R      E   EV  L    HPN++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L          +L+ E +  G L     D   +   L  +   +       G+ YLH   
Sbjct: 73  LHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLH--- 125
Query: 213 KQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
            + + + DLK  NI+L +   P    KL DFG+A    +G++      + GT  + AP+ 
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEI 182
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG 293
                L  ++D++S GV+   L++G
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+  FGLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLVK 152
           LG G F  V K   +   +  A K +  R +   R      E   EV  L    HPN++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L          +L+ E +  G L     D   +   L  +   +       G+ YLH   
Sbjct: 80  LHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLH--- 132
Query: 213 KQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
            + + + DLK  NI+L +   P    KL DFG+A    +G++      + GT  + AP+ 
Sbjct: 133 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEI 189
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG 293
                L  ++D++S GV+   L++G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G     L D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPAFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAIK +  R   +   RE         E+  L   +HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 129
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 183
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITG 293
           AP+  +   T       D +S GV+L   ++G
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 23/229 (10%)
Query: 78  AKPFT--FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE- 134
           AKPFT    E+     +F     +G G FG+V    ++  E++ A+K L+   +    E 
Sbjct: 59  AKPFTQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAET 118
Query: 135 --FSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG---SLDKHLHDLRPDTRPL 189
             F  E   L + D   +  L     + +   LV +Y   G   +L     D  P+    
Sbjct: 119 ACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMAR 178
Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
            +   M +A  +   L Y+H         RD+K  N+LL+   H +L+DFG + +  + D
Sbjct: 179 FYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFG-SCLKMNDD 228
Query: 250 KTHVSTRVMGTYGYCAPDY--AM---TGQLTFKSDIYSFGVVLLELITG 293
            T  S+  +GT  Y +P+   AM    G+   + D +S GV + E++ G
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 277

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAIK +  R   +   RE         E+  L   +HP +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 77  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 128
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 129 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 182
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITG 293
           AP+  +   T       D +S GV+L   ++G
Sbjct: 183 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAIK +  R   +   RE         E+  L   +HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 129
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 183
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITG 293
           AP+  +   T       D +S GV+L   ++G
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAIK +  R   +   RE         E+  L   +HP +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 78  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 129
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 183
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITG 293
           AP+  +   T       D +S GV+L   ++G
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 29/222 (13%)
Query: 99  LGEGGFGKV------YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LGEGGF  V      + G    +++++  +Q D    Q  RE  A++  L   +HPN+++
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ--RE--ADMHRL--FNHPNILR 90
Query: 153 LIGYC----AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           L+ YC        +  L+  +   G+L   +  L+     L  +  + +  G  RGL+ +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG---LAKMGPSGDKTHVSTRVMG----TY 261
           H    +   +RDLK +NILL +   P L D G    A +   G +  ++ +       T 
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 262 GYCAPD-YAMTGQLTF--KSDIYSFGVVLLELITGRKAIDQT 300
            Y AP+ +++        ++D++S G VL  ++ G    D  
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ DF LA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 20/205 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLVK 152
           LG G F  V K   +   +  A K +  R +   R      E   EV  L    HPN++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L          +L+ E +  G L     D   +   L  +   +       G+ YLH   
Sbjct: 94  LHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLH--- 146
Query: 213 KQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
            + + + DLK  NI+L +   P    KL DFG+A    +G++      + GT  + AP+ 
Sbjct: 147 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPEI 203
Query: 269 AMTGQLTFKSDIYSFGVVLLELITG 293
                L  ++D++S GV+   L++G
Sbjct: 204 VNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 97/237 (40%), Gaps = 32/237 (13%)
Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPN 149
           +R    +G G +G V      +    VAIK+L +R  Q     +    E+  L    H N
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 150 LVKLIGYCAEG---DQRLLVYEYMP-----LGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201
           ++ L+         D     Y  MP     LG L KH          L  +    +    
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--------EKLGEDRIQFLVYQM 137
Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
            +GL+Y+H      +I+RDLK  N+ + E    K+ DFGLA+   S     V TR     
Sbjct: 138 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR----- 189
Query: 262 GYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR---KAIDQTKDRKELNLVAWARP 314
            Y AP+  +   + T   DI+S G ++ E+ITG+   K  D     KE+  V    P
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYC 157
           LGEG + KV      +  +  A+K ++ +          EV TL     + N+++LI + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR--MKIAAGASRGLQYLHEQLKQP 215
            +  +  LV+E +  GS+  H+   +       +N R   ++    +  L +LH    + 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQKQK------HFNEREASRVVRDVAAALDFLH---TKG 131
Query: 216 VIYRDLKCSNILLE--EGYHP-KLSDFGLAK-MGPSGDKTHVSTRVM----GTYGYCAPD 267
           + +RDLK  NIL E  E   P K+ DF L   M  +   T ++T  +    G+  Y AP+
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 268 Y--AMTGQLTF---KSDIYSFGVVLLELITG 293
                T Q TF   + D++S GVVL  +++G
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 105/244 (43%), Gaps = 36/244 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM----TLGSADHPNLVKLI 154
           LG G +G V K       Q++A+K++  R     +E    +M    ++ + D P  V   
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 155 G-YCAEGDQRLLVYEYMPL--GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           G    EGD    V+  M L   SLDK    +    + +  +   KIA    + L++LH +
Sbjct: 73  GALFREGD----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           L   VI+RD+K SN+L+      K+ DFG++          +     G   Y AP+  + 
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPE-RIN 182
Query: 272 GQL-----TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
            +L     + KSDI+S G+ ++EL   R   D           +W  P F+  K   +  
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTP-FQQLKQVVEEP 230
Query: 327 DPSL 330
            P L
Sbjct: 231 SPQL 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAIK +  R   +   RE         E+  L   +HP +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 84  IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 135
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 136 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 189
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           AP+  +   T       D +S GV+L   ++G     + + +  L
Sbjct: 190 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ D GLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAI+ +  R   +   RE         E+  L   +HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 203 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 254
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 255 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 308
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           AP+  +   T       D +S GV+L   ++G     + + +  L
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 99  LGEGGFGKVYKGC------LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C      LE   +++  K+L  R  Q   +   E        HPN+V+
Sbjct: 37  LGKGAFS-VVRRCVHKTTGLEFAAKIINTKKLSARDFQ---KLEREARICRKLQHPNIVR 92
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L     E     LV++ +  G       +L  D    ++ +     A AS  +Q + E +
Sbjct: 93  LHDSIQEESFHYLVFDLVTGG-------ELFEDIVAREFYSE----ADASHCIQQILESI 141
Query: 213 ----KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
                  +++R+LK  N+LL    +G   KL+DFGLA      +  H      GT GY +
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLS 198
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
           P+       +   DI++ GV+L  L+ G
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVRE------FSAEVMTLGSADHPNL 150
           LG G  G+V      K  + VAI+ +  R   +   RE         E+  L   +HP +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHD--LRPDTRPLDWNTRMKIAAGASRGLQY 207
           +K+  +  + +   +V E M  G L DK + +  L+  T  L +  +M +A      +QY
Sbjct: 217 IKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLA------VQY 268
Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T + GT  Y 
Sbjct: 269 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCGTPTYL 322
Query: 265 APDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           AP+  +   T       D +S GV+L   ++G     + + +  L
Sbjct: 323 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 367

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G     L D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ D GLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 82/206 (39%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  + K C EK   +  A K +  R  +  R      E   EV  L    HPN++
Sbjct: 20  LGSGQFA-IVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D       L              G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 212 LKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
             + + + DLK  NI+L +      H KL DFGLA     G +      + GT  + AP+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV---REFSAEVMTLGSADHPNLVKLIG 155
           +G G +G V      ++ Q VA+K+L  R  Q +   R    E+  L    H N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 156 YCAEGDQRLLVYE-YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                       E Y+    +   L+++       D + +  +     RGL+Y+H     
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH---SA 150
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SN+ + E    ++ DFGLA+        +V+TR      Y AP+  M   +
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPE-IMLNWM 204
Query: 275 TFKS--DIYSFGVVLLELITGRKA------IDQTKDRKEL 306
            +    DI+S G ++ EL+ G+        IDQ K   E+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV 244

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 9/108 (8%)
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           RGL+Y+H      +I+RDLK SN+ + E    K+ D GLA+        +V+TR      
Sbjct: 136 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----W 187
Query: 263 YCAPDYAMTGQLTFKS-DIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
           Y AP+  +      ++ DI+S G ++ EL+TGR     T    +L L+
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 235

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G     L D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHP 148
            + S   +G G +G V     ++  + VAIK+L  R  Q     +    E++ L    H 
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSEIFAKRAYRELLLLKHMQHE 101
Query: 149 NLVKLIGYCAEGDQRLLVYEY---MPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGASRG 204
           N++ L+            Y++   MP    D + +  +      + +     +     +G
Sbjct: 102 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKG 156
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           L+Y+H      V++RDLK  N+ + E    K+ DFGLA+   +    +V TR      Y 
Sbjct: 157 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYR 208
Query: 265 APDYAMTGQLTFKS-DIYSFGVVLLELITGR 294
           AP+  ++     ++ DI+S G ++ E++TG+
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G     L D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 33/275 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC- 157
           L E   G+++KG  +  + VV + ++     +  R+F+ E   L    HPN++ ++G C 
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 158 -AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                   L+  + P GSL   LH+       +D +  +K A   +RG  +LH    +P+
Sbjct: 78  SPPAPHPTLITHWXPYGSLYNVLHEG--TNFVVDQSQAVKFALDXARGXAFLHTL--EPL 133
Query: 217 IYRD-LKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           I R  L   ++ ++E    ++S   +     S  + +    V        P+        
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRS-- 191
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP 335
             +D +SF V+L EL+T           +E+         F D  N       +L+G  P
Sbjct: 192 --ADXWSFAVLLWELVT-----------REVP--------FADLSNXEIGXKVALEGLRP 230
Query: 336 V--RGLYQALA-IAAMCVQEQPNMRPAITDVVMAL 367
               G+   ++ +  +C  E P  RP    +V  L
Sbjct: 231 TIPPGISPHVSKLXKICXNEDPAKRPKFDXIVPIL 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 99  LGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G F  V +       LE   +++  K+L  R  Q +     E        HPN+V+L
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVRL 70
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                E     LV++ +  G       +L  D    ++ +     A AS  +Q + E + 
Sbjct: 71  HDSIQEESFHYLVFDLVTGG-------ELFEDIVAREFYSE----ADASHCIQQILESIA 119
Query: 213 ---KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
                 +++R+LK  N+LL    +G   KL+DFGLA      +  H      GT GY +P
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 176
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +       +   DI++ GV+L  L+ G
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVREFSAEV-MTLGSADHPNLVKLIGY 156
           +G G +  V K C+ K   +  A+K +D    +  R+ + E+ + L    HPN++ L   
Sbjct: 30  IGVGSYS-VCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 157 CAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +G    +V E M  G L DK L       R         +    ++ ++YLH    Q 
Sbjct: 85  YDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-----AVLFTITKTVEYLH---AQG 136
Query: 216 VIYRDLKCSNIL-LEEGYHP---KLSDFGLAK---------MGPSGDKTHVSTRVMGTYG 262
           V++RDLK SNIL ++E  +P   ++ DFG AK         M P      V+  V+   G
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y A             DI+S GV+L  ++TG
Sbjct: 197 YDA-----------ACDIWSLGVLLYTMLTG 216

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 99  LGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G F  V +       LE   +++  K+L  R  Q +     E        HPN+V+L
Sbjct: 13  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVRL 69
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                E     LV++ +  G       +L  D    ++ +     A AS  +Q + E + 
Sbjct: 70  HDSIQEESFHYLVFDLVTGG-------ELFEDIVAREFYSE----ADASHCIQQILESIA 118
Query: 213 ---KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
                 +++R+LK  N+LL    +G   KL+DFGLA      +  H      GT GY +P
Sbjct: 119 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 175
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +       +   DI++ GV+L  L+ G
Sbjct: 176 EVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGKFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G     L D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           LGEG   +V + C+  I  Q  A+K ++ + G    R F    M      H N+++LI +
Sbjct: 21  LGEGAHARV-QTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             E D+  LV+E M  GS+  H+H  R     L+ +  ++  A A   L +LH    + +
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASA---LDFLH---NKGI 132
Query: 217 IYRDLKCSNILLEEGYHP------KLSDFGLAK-MGPSGDKTHVSTRVM----GTYGYCA 265
            +RDLK  NIL E   HP      K+ DF L   +  +GD + +ST  +    G+  Y A
Sbjct: 133 AHRDLKPENILCE---HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 266 PDY--AMTGQLTF---KSDIYSFGVVLLELITG 293
           P+   A + + +    + D++S GV+L  L++G
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 23/213 (10%)
Query: 97  CCLGEGGFGKVY--KGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVK 152
           C +G G +G VY  K    K ++  A+KQ++  G+      SA  E+  L    HPN++ 
Sbjct: 27  CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVIS 82
Query: 153 LIG-YCAEGDQRL-LVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASRGLQ 206
           L   + +  D+++ L+++Y    L  + K     + + +P+     M   +      G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 207 YLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVST-RVMGTY 261
           YLH      V++RDLK +NIL+     E    K++D G A++  S  K       V+ T+
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 262 GYCAPDYAMTGQLTFKS-DIYSFGVVLLELITG 293
            Y AP+  +  +   K+ DI++ G +  EL+T 
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)
Query: 99  LGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G F  V +       LE   +++  K+L  R  Q +     E        HPN+V+L
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVRL 70
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
                E     LV++ +  G       +L  D    ++ +     A AS  +Q + E + 
Sbjct: 71  HDSIQEESFHYLVFDLVTGG-------ELFEDIVAREFYSE----ADASHCIQQILESIA 119
Query: 213 ---KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
                 +++R+LK  N+LL    +G   KL+DFGLA      +  H      GT GY +P
Sbjct: 120 YCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSP 176
Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITG 293
           +       +   DI++ GV+L  L+ G
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQG--VREFSAEVM 140
           A +   +R    LGEG +G+VYK       + VAIK++    +  GV G  +RE S    
Sbjct: 30  ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS---- 85
Query: 141 TLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG 200
            L    H N+++L        +  L++EY     L K++ D  PD         M++   
Sbjct: 86  LLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYM-DKNPD-------VSMRVIKS 136
Query: 201 ----ASRGLQYLHEQLKQPVIYRDLKCSNILL-----EEGYHPKLSDFGLAKMGPSGDKT 251
                  G+ + H +     ++RDLK  N+LL      E    K+ DFGLA+    G   
Sbjct: 137 FLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPI 191
Query: 252 HVSTRVMGTYGYCAPDYAM-TGQLTFKSDIYSFGVVLLE------LITGRKAIDQ 299
              T  + T  Y  P+  + +   +   DI+S   +  E      L  G   IDQ
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 18  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 77  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 18  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 77  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +G+G FG+V+K    K  Q VA+K++     +     +A  E+  L    H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 157 C---AEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQL 212
           C   A    R     Y+     +  L  L  +       +   ++      GL Y+H   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 142
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHVSTRVMGTYGYCAPDYA 269
           +  +++RD+K +N+L+      KL+DFGLA+   +  +        RV+ T  Y  P+  
Sbjct: 143 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPE-L 200
Query: 270 MTGQLTF--KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           + G+  +    D++  G ++ E+ T    +    ++ +L L++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGVFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 27/210 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G +G+V+ G     E+V              RE   E+       H N++  I    
Sbjct: 45  IGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADI 101
Query: 159 EGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-- 212
           +G     Q  L+ +Y   GSL  +L      +  LD  + +K+A  +  GL +LH ++  
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 213 ---KQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHV--STRVMGTYGYCAP 266
              K  + +RDLK  NIL+++     ++D GLA K     ++  +  +TRV GT  Y  P
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYMPP 215
Query: 267 DYAMTG------QLTFKSDIYSFGVVLLEL 290
           +           Q    +D+YSFG++L E+
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 97/238 (40%), Gaps = 34/238 (14%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVM------TLGS 144
           N+     LG G    V + C+ K   +  A+K +D   V G   FSAE +      TL  
Sbjct: 18  NYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREATLKE 73
Query: 145 AD-------HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
            D       HPN+++L           LV++ M  G L  +L     +   L      KI
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKI 129
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                  +  LH   K  +++RDLK  NILL++  + KL+DFG +     G+K      V
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 183
Query: 258 MGTYGYCAPDYAMTGQ------LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            GT  Y AP+               + D++S GV++  L+ G       K    L ++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV---REFSAEVMTLGSADHPNLVKLIG 155
           +G G +G V      ++ Q VA+K+L  R  Q +   R    E+  L    H N++ L+ 
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLD 86
Query: 156 YCAEGDQRLLVYE-YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                       E Y+    +   L+++       D + +  +     RGL+Y+H     
Sbjct: 87  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---SA 142
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SN+ + E    ++ DFGLA+        +V+TR      Y AP+  +    
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMH 197
Query: 275 TFKS-DIYSFGVVLLELITGRKA------IDQTKDRKEL 306
             ++ DI+S G ++ EL+ G+        IDQ K   E+
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV 236

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 21/219 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV---REFSAEVMTLGSADHPNLVKLIG 155
           +G G +G V      ++ Q VA+K+L  R  Q +   R    E+  L    H N++ L+ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 156 YCAEGDQRLLVYE-YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
                       E Y+    +   L+++       D + +  +     RGL+Y+H     
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---SA 150
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SN+ + E    ++ DFGLA+        +V+TR      Y AP+  +    
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMH 205
Query: 275 TFKS-DIYSFGVVLLELITGRKA------IDQTKDRKEL 306
             ++ DI+S G ++ EL+ G+        IDQ K   E+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEV 244

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 96/238 (40%), Gaps = 34/238 (14%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVM------TLGS 144
           N+     LG G    V + C+ K   +  A+K +D   V G   FSAE +      TL  
Sbjct: 5   NYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREATLKE 60
Query: 145 AD-------HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
            D       HPN+++L           LV++ M  G L     D   +   L      KI
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKI 116
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                  +  LH   K  +++RDLK  NILL++  + KL+DFG +     G+K      V
Sbjct: 117 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EV 170
Query: 258 MGTYGYCAPDYAMTGQ------LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            GT  Y AP+               + D++S GV++  L+ G       K    L ++
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 228

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 97/238 (40%), Gaps = 34/238 (14%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVM------TLGS 144
           N+     LG G    V + C+ K   +  A+K +D   V G   FSAE +      TL  
Sbjct: 18  NYEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIID---VTGGGSFSAEEVQELREATLKE 73
Query: 145 AD-------HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI 197
            D       HPN+++L           LV++ M  G L  +L     +   L      KI
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKI 129
Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
                  +  LH   K  +++RDLK  NILL++  + KL+DFG +     G+K      V
Sbjct: 130 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SV 183
Query: 258 MGTYGYCAPDYAMTGQ------LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            GT  Y AP+               + D++S GV++  L+ G       K    L ++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 33/191 (17%)
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK------- 196
           S DHPN+++   YC+E   R L   Y+ L   + +L DL       D N +++       
Sbjct: 83  SDDHPNVIRY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-------------EGYHPKLSDFGLAK 243
           +    + G+ +LH  LK  +I+RDLK  NIL+              E     +SDFGL K
Sbjct: 138 LLRQIASGVAHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 244 MGPSGDKTHVS--TRVMGTYGYCAPDY---AMTGQLTFKSDIYSFGVVLLELITGRKAID 298
              SG            GT G+ AP+    +   +LT   DI+S G V   +++  K   
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 299 QTKDRKELNLV 309
             K  +E N++
Sbjct: 255 GDKYSRESNII 265

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 84/191 (43%), Gaps = 33/191 (17%)
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK------- 196
           S DHPN+++   YC+E   R L   Y+ L   + +L DL       D N +++       
Sbjct: 83  SDDHPNVIRY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 137
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-------------EGYHPKLSDFGLAK 243
           +    + G+ +LH  LK  +I+RDLK  NIL+              E     +SDFGL K
Sbjct: 138 LLRQIASGVAHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 244 MGPSGDKTHVS--TRVMGTYGYCAPDY---AMTGQLTFKSDIYSFGVVLLELITGRKAID 298
              SG            GT G+ AP+    +   +LT   DI+S G V   +++  K   
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF 254
Query: 299 QTKDRKELNLV 309
             K  +E N++
Sbjct: 255 GDKYSRESNII 265

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +G+G FG+V+K    K  Q VA+K++     +     +A  E+  L    H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 157 C---AEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQL 212
           C   A    R     Y+     +  L  L  +       +   ++      GL Y+H   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 142
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHVSTRVMGTYGYCAPDYA 269
           +  +++RD+K +N+L+      KL+DFGLA+   +  +        RV+ T  Y  P+  
Sbjct: 143 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPE-L 200
Query: 270 MTGQLTF--KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           + G+  +    D++  G ++ E+ T    +    ++ +L L++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  V K C EK   +  A K +  R  +  R      +   EV  L    HPN++
Sbjct: 19  LGSGQFA-VVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D   +   L      +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILIGELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 212 LKQPVIYRDLKCSNILLEEGYHPK----LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
               + + DLK  NI+L +   PK    + DFGLA     G++      + GT  + AP+
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 187
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)
Query: 99  LGEGGFGKVYKGCLEKI------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C++K        +++  K+L  R  Q + E  A +  L    HPN+V+
Sbjct: 39  LGKGAFS-VVRRCVKKTPTQEYAAKIINTKKLSARDHQKL-EREARICRL--LKHPNIVR 94
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L    +E     LV++ +  G       +L  D    ++ +    +    + L+ ++   
Sbjct: 95  LHDSISEEGFHYLVFDLVTGG-------ELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 213 KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
           +  +++RDLK  N+LL    +G   KL+DFGLA +   G++        GT GY +P+  
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQ-QAWFGFAGTPGYLSPEVL 205
Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
                    DI++ GV+L  L+ G
Sbjct: 206 RKDPYGKPVDIWACGVILYILLVG 229

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 99  LGEGGFGKVYKGCL------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C+      E   +++  K+L  R  Q + E  A +  L    HPN+V+
Sbjct: 12  LGKGAFS-VVRRCMKIPTGQEYAAKIINTKKLSARDHQKL-EREARICRL--LKHPNIVR 67
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L    +E     LV++ +  G       +L  D    ++ +     A AS  +Q + E +
Sbjct: 68  LHDSISEEGFHYLVFDLVTGG-------ELFEDIVAREYYSE----ADASHCIQQILESV 116
Query: 213 KQ----PVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
                  +++RDLK  N+LL    +G   KL+DFGLA +   GD+        GT GY +
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLS 174
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
           P+           D+++ GV+L  L+ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 85/195 (43%), Gaps = 37/195 (18%)
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK------- 196
           S DHPN+++   YC+E   R L   Y+ L   + +L DL       D N +++       
Sbjct: 65  SDDHPNVIRY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-------------EGYHPKLSDFGLAK 243
           +    + G+ +LH  LK  +I+RDLK  NIL+              E     +SDFGL K
Sbjct: 120 LLRQIASGVAHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 244 MGPSGDKTHVS--TRVMGTYGYCAPDYAMTG-------QLTFKSDIYSFGVVLLELITGR 294
              SG  +  +      GT G+ AP+            +LT   DI+S G V   +++  
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 295 KAIDQTKDRKELNLV 309
           K     K  +E N++
Sbjct: 237 KHPFGDKYSRESNII 251

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 30/209 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G+G FG+VY G   +    VAI+ +D        ++ F  EVM      H N+V  +G 
Sbjct: 41  IGKGRFGQVYHG---RWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
           C       ++       +L   + D +     LD N   +IA    +G+ YLH    + +
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKM------GPSGDKTHVSTRVMGTYGYCAPDY-- 268
           +++DLK  N+  + G    ++DFGL  +      G   DK  +     G   + AP+   
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEIIR 207
Query: 269 -----AMTGQLTFK--SDIYSFGVVLLEL 290
                    +L F   SD+++ G +  EL
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +G+G FG+V+K    K  Q VA+K++     +     +A  E+  L    H N+V LI  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 157 C---AEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQL 212
           C   A    R     Y+     +  L  L  +       +   ++      GL Y+H   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 142
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHVSTRVMGTYGYCAPDYA 269
           +  +++RD+K +N+L+      KL+DFGLA+   +  +        RV+ T  Y  P+  
Sbjct: 143 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPE-L 200
Query: 270 MTGQLTF--KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           + G+  +    D++  G ++ E+ T    +    ++ +L L++
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 27/212 (12%)
Query: 95  SDC-CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           ++C  +G G FG V++  L + ++ VAIK++    +Q  R  + E+  +    HPN+V L
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDL 97
Query: 154 IGYC-AEGDQR-----LLVYEYMP--LGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRG 204
             +  + GD++      LV EY+P  +    +H   L+  T P+     +K+      R 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPM---LLIKLYMYQLLRS 153
Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           L Y+H      + +RD+K  N+LL+      KL DFG AK+  +G+     + +   Y Y
Sbjct: 154 LAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSXICSRY-Y 207
Query: 264 CAPDYAM-TGQLTFKSDIYSFGVVLLELITGR 294
            AP+        T   DI+S G V+ EL+ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 16/223 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--EVMTLGSADHPNLVKLIGY 156
           +G+G FG+V+K    K  Q VA+K++     +     +A  E+  L    H N+V LI  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 157 C---AEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQL 212
           C   A    R     Y+     +  L  L  +       +   ++      GL Y+H   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH--- 141
Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK---MGPSGDKTHVSTRVMGTYGYCAPDYA 269
           +  +++RD+K +N+L+      KL+DFGLA+   +  +        RV+ T  Y  P+  
Sbjct: 142 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPPE-L 199
Query: 270 MTGQLTF--KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           + G+  +    D++  G ++ E+ T    +    ++ +L L++
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 14/209 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G F +V+        ++ A+K +             E+  L    H N+V L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 LV + +  G L   + +    T     +  + I    S  ++YLHE     +++
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEK---DASLVIQQVLS-AVKYLHEN---GIVH 129
Query: 219 RDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           RDLK  N+L    EE     ++DFGL+KM  +G    + +   GT GY AP+       +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYS 185
Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRK 304
              D +S GV+   L+ G     +  + K
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESK 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +E+ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVI--QMELDHERMSYLLYQMLVGIKHLH---SA 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y AP+  +    
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGY 202
Query: 275 TFKSDIYSFGVVLLELITG 293
               DI+S GV++ E+I G
Sbjct: 203 KENVDIWSVGVIMGEMIKG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 99  LGEGGFGKVYKGCL------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C+      E   +++  K+L  R  Q + E  A +  L    HPN+V+
Sbjct: 12  LGKGAFS-VVRRCMKIPTGQEYAAKIINTKKLSARDHQKL-EREARICRL--LKHPNIVR 67
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L    +E     LV++ +  G       +L  D    ++ +     A AS  +Q + E +
Sbjct: 68  LHDSISEEGFHYLVFDLVTGG-------ELFEDIVAREYYSE----ADASHCIQQILESV 116
Query: 213 KQ----PVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
                  +++RDLK  N+LL    +G   KL+DFGLA +   GD+        GT GY +
Sbjct: 117 NHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLS 174
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
           P+           D+++ GV+L  L+ G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-VMTLGSADHPNLVKLIGYC 157
           LG G FG+V++   ++     A+K++       +  F  E ++       P +V L G  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            EG    +  E +  GSL + +  +   P+ R L +  +      A  GL+YLH    + 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLEYLH---TRR 184
Query: 216 VIYRDLKCSNILLE-EGYHPKLSDFGLAK-MGPSGDKTHVST--RVMGTYGYCAPDYAMT 271
           +++ D+K  N+LL  +G    L DFG A  + P G    + T   + GT  + AP+  M 
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                K DI+S   ++L ++ G
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG       ++  ++VA+K ++ RG +       E++   S  HPN+V+      
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 +V EY   G L + + +     R  +   R       S G+ Y H      V +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLIS-GVSYAH---AMQVAH 138
Query: 219 RDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTR-VMGTYGYCAPDYAMTGQLT 275
           RDLK  N LL+    P  K++DFG +K        H   +  +GT  Y AP+  +  +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSK----ASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 276 FK-SDIYSFGVVLLELITGRKAIDQTKDRK 304
            K +D++S GV L  ++ G    +  ++ K
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPK 224

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG       ++  ++VA+K ++ RG +       E++   S  HPN+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 +V EY   G L + + +     R  +   R       S G+ Y H      V +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLIS-GVSYCH---AMQVCH 138
Query: 219 RDLKCSNILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           RDLK  N LL+    P+L   DFG +K   S          +GT  Y AP+  +  +   
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 277 K-SDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           K +D++S GV L  ++ G    +  ++ K  
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 16/208 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G +G+V     +      A K++    V+ V  F  E+  + S DHPN+++L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 159 EGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           +     LV E    G L ++ +H      R    +   +I       + Y H   K  V 
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVA 128
Query: 218 YRDLKCSNILL--EEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
           +RDLK  N L   +    P KL DFGLA     G    + T+V GT  Y +P   + G  
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKV-GTPYYVSPQ-VLEGLY 184
Query: 275 TFKSDIYSFGVVLLELITGRKAIDQTKD 302
             + D +S GV++  L+ G        D
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTD 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 33/221 (14%)
Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSA-- 145
            ++R    L +G F K+     EK  +  A+K+ +   ++  R+F+    + +++ S   
Sbjct: 31  NDYRIIRTLNQGKFNKI--ILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 146 DHPNLVKLIG-----YC--AEG-----DQRLLVYEYMPLGSL---DKHLHDLRPDTRPLD 190
           D  N +++I      YC   EG     D+  ++YEYM   S+   D++   L  +     
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 191 WNTRMK-IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
               +K I         Y+H +  + + +RD+K SNIL+++    KLSDFG ++     D
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--D 204
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVL 287
           K    +R  GTY +  P++  + + ++   K DI+S G+ L
Sbjct: 205 KKIKGSR--GTYEFMPPEF-FSNESSYNGAKVDIWSLGICL 242

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 46/214 (21%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVREFSAEV-MTLGSADHPNLVKLIGY 156
           +G G + +  K C+ K   +  A+K +D    +  R+ S E+ + L    HPN++ L   
Sbjct: 35  IGVGSYSEC-KRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 157 CAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +G    LV E M  G L DK L       R   +     +     + ++YLH    Q 
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLH---SQG 141
Query: 216 VIYRDLKCSNIL-LEEGYHP---KLSDFGLAK---------MGPSGDKTHVSTRVMGTYG 262
           V++RDLK SNIL ++E  +P   ++ DFG AK         M P      V+  V+   G
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 263 Y---CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y   C              DI+S G++L  ++ G
Sbjct: 202 YDEGC--------------DIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 46/214 (21%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVREFSAEV-MTLGSADHPNLVKLIGY 156
           +G G + +  K C+ K   +  A+K +D    +  R+ S E+ + L    HPN++ L   
Sbjct: 35  IGVGSYSEC-KRCVHKATNMEYAVKVID----KSKRDPSEEIEILLRYGQHPNIITLKDV 89
Query: 157 CAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +G    LV E M  G L DK L       R   +     +     + ++YLH Q    
Sbjct: 90  YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKTVEYLHSQ---G 141
Query: 216 VIYRDLKCSNIL-LEEGYHP---KLSDFGLAK---------MGPSGDKTHVSTRVMGTYG 262
           V++RDLK SNIL ++E  +P   ++ DFG AK         M P      V+  V+   G
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 263 Y---CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y   C              DI+S G++L  ++ G
Sbjct: 202 YDEGC--------------DIWSLGILLYTMLAG 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 16/209 (7%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            +G G +G+V     +      A K++    V+ V  F  E+  + S DHPN+++L    
Sbjct: 33  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 92
Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
            +     LV E    G L ++ +H      R    +   +I       + Y H   K  V
Sbjct: 93  EDNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNV 144
Query: 217 IYRDLKCSNILL--EEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
            +RDLK  N L   +    P KL DFGLA     G    + T+V GT  Y +P   + G 
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKV-GTPYYVSPQ-VLEGL 200
Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKD 302
              + D +S GV++  L+ G        D
Sbjct: 201 YGPECDEWSAGVMMYVLLCGYPPFSAPTD 229

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++ +VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 194
Query: 270 MTGQ-LTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 168
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+      KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 169 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 220
Query: 268 YAM-TGQLTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 174
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+      KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 226
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 176
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+      KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 177 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 228
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 83/195 (42%), Gaps = 37/195 (18%)
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK------- 196
           S DHPN+++   YC+E   R L   Y+ L   + +L DL       D N +++       
Sbjct: 65  SDDHPNVIRY--YCSETTDRFL---YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-------------EGYHPKLSDFGLAK 243
           +    + G+ +LH  LK  +I+RDLK  NIL+              E     +SDFGL K
Sbjct: 120 LLRQIASGVAHLH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 244 MGPSGDKTHVS--TRVMGTYGYCAPDYAMTG-------QLTFKSDIYSFGVVLLELITGR 294
              SG            GT G+ AP+            +LT   DI+S G V   +++  
Sbjct: 177 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 295 KAIDQTKDRKELNLV 309
           K     K  +E N++
Sbjct: 237 KHPFGDKYSRESNII 251

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 13/199 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +E+ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVI--QMELDHERMSYLLYQMLVGIKHLH---SA 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y AP+  +    
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-YRAPEVILGMGY 202
Query: 275 TFKSDIYSFGVVLLELITG 293
               DI+S GV++ E+I G
Sbjct: 203 KENVDIWSVGVIMGEMIKG 221

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 178
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+      KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 179 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 230
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 219
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+      KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 220 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 271
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 145
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+ +    KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 146 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 197
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 98/234 (41%), Gaps = 32/234 (13%)
Query: 88  AATGNFRSDCCLGEGGFGKVY----KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG 143
           A +  F  +  LG G    VY    KG  +     V  K +D + V+       E+  L 
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR------TEIGVLL 103
Query: 144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGAS 202
              HPN++KL        +  LV E +  G L D+ +       R      +  + A A 
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVA- 162
Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVM 258
               YLHE     +++RDLK  N+L      P    K++DFGL+K+    +   +   V 
Sbjct: 163 ----YLHEN---GIVHRDLKPENLLYATP-APDAPLKIADFGLSKIV---EHQVLMKTVC 211
Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI-----DQTKDRKELN 307
           GT GYCAP+         + D++S G++   L+ G +       DQ   R+ LN
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 99  LGEGGFGKVYKGCL------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C+      E   +++  K+L  R  Q + E  A +  L    HPN+V+
Sbjct: 30  LGKGAFS-VVRRCVKVLAGQEYAAKIINTKKLSARDHQKL-EREARICRL--LKHPNIVR 85
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L    +E     L+++ +  G       +L  D    ++ +     A AS  +Q + E +
Sbjct: 86  LHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSE----ADASHCIQQILEAV 134
Query: 213 ----KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
               +  V++RDLK  N+LL    +G   KL+DFGLA +   G++        GT GY +
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLS 192
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
           P+           D+++ GV+L  L+ G
Sbjct: 193 PEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 153
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+ +    KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 154 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 205
Query: 268 YAM-TGQLTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 14/211 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG       ++  ++VA+K ++ RG +       E++   S  HPN+V+      
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVIL 84
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 +V EY   G L + + +     R  +   R       S G+ Y H      V +
Sbjct: 85  TPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLIS-GVSYCH---AMQVCH 137
Query: 219 RDLKCSNILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           RDLK  N LL+    P+L   DFG +K   S          +GT  Y AP+  +  +   
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 277 K-SDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           K +D++S GV L  ++ G    +  ++ K  
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 225

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-VMTLGSADHPNLVKLIGYC 157
           +G G FG+V++   ++     A+K++       +  F  E ++       P +V L G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            EG    +  E +  GSL + +  +   P+ R L +  +      A  GL+YLH    + 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLEYLH---TRR 170
Query: 216 VIYRDLKCSNILLE-EGYHPKLSDFGLAK-MGPSGDKTHVST--RVMGTYGYCAPDYAMT 271
           +++ D+K  N+LL  +G    L DFG A  + P G    + T   + GT  + AP+  M 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                K DI+S   ++L ++ G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 174
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+      KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 175 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 228
Query: 270 MTGQ-LTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 93/238 (39%), Gaps = 25/238 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  + K C EK   +  A K +  R  +  R      E   EV  L    H N++
Sbjct: 20  LGSGQFA-IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D       L              G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 212 LKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
             + + + DLK  NI+L +      H KL DFGLA     G +      + GT  + AP+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKA-IDQTKDRKELNLVAWARPMFKDRKNFSQ 324
                 L  ++D++S GV+   L++G    +  TK     N+ A +     D + FSQ
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF--DEEFFSQ 244

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 152
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+      KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 153 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 206
Query: 270 M-TGQLTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE-VMTLGSADHPNLVKLIGYC 157
           +G G FG+V++   ++     A+K++       +  F  E ++       P +V L G  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 135
Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            EG    +  E +  GSL + +  +   P+ R L +  +      A  GL+YLH    + 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLEYLH---TRR 186
Query: 216 VIYRDLKCSNILLE-EGYHPKLSDFGLAK-MGPSGDKTHVST--RVMGTYGYCAPDYAMT 271
           +++ D+K  N+LL  +G    L DFG A  + P G    + T   + GT  + AP+  M 
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                K DI+S   ++L ++ G
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+ +    KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 192
Query: 268 YAM-TGQLTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  + K C EK   +  A K +  R  +  R      E   EV  L    H N++
Sbjct: 20  LGSGQFA-IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D       L              G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 212 LKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
             + + + DLK  NI+L +      H KL DFGLA     G +      + GT  + AP+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  + K C EK   +  A K +  R  +  R      E   EV  L    H N++
Sbjct: 20  LGSGQFA-IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D       L              G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 212 LKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
             + + + DLK  NI+L +      H KL DFGLA     G +      + GT  + AP+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 148
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 149 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 202
Query: 270 M-TGQLTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +QG    + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+ +    KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 192
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 152
Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+      KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 153 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 206
Query: 270 MTGQ-LTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  + K C EK   +  A K +  R  +  R      E   EV  L    H N++
Sbjct: 20  LGSGQFA-IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D       L              G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 212 LKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
             + + + DLK  NI+L +      H KL DFGLA     G +      + GT  + AP+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +QG    + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDK--THVSTRVMGTYGYCAPD 267
                + +RD+K  N+LL+ +    KL DFG AK    G+   +++ +R      Y AP+
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 192
Query: 268 YAMTGQ-LTFKSDIYSFGVVLLELITGR 294
                   T   D++S G VL EL+ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 159
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 160 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 213
Query: 270 M-TGQLTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +QG    + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 194
Query: 270 MTGQ-LTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRV 257
            ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDARL 262
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       T +SD++SFGV+L E+ +               L A   P  K
Sbjct: 263 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVK 305
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             + F + +    + + P     +       C   +P+ RP  +++V  L  L
Sbjct: 306 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRV 257
            ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDARL 264
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       T +SD++SFGV+L E+ +               L A   P  K
Sbjct: 265 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVK 307
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             + F + +    + + P     +       C   +P+ RP  +++V  L  L
Sbjct: 308 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 109/271 (40%), Gaps = 35/271 (12%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG----SADHPNLVKLI 154
           LG G +G V K       Q+ A+K++  R     +E    +  L     + D P  V   
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISXRTVDCPFTVTFY 99
Query: 155 G-YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           G    EGD  + +   +   SLDK    +    + +  +   KIA    + L++LH +L 
Sbjct: 100 GALFREGD--VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             VI+RD+K SN+L+      K  DFG++          +     G   Y AP+  +  +
Sbjct: 158 --VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA---GCKPYXAPE-RINPE 211
Query: 274 L-----TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
           L     + KSDI+S G+  +EL   R   D           +W  P F+  K   +   P
Sbjct: 212 LNQKGYSVKSDIWSLGITXIELAILRFPYD-----------SWGTP-FQQLKQVVEEPSP 259
Query: 329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPA 359
            L      +   + +   + C+++    RP 
Sbjct: 260 QLPAD---KFSAEFVDFTSQCLKKNSKERPT 287

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +++ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKXVNHKNIISLLN 90
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVI--QMELDHERMSYLLYQMLXGIKHLHSA--- 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y AP+  +    
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 275 TFKSDIYSFGVVLLELI------TGRKAIDQ 299
               DI+S G ++ E++       GR  IDQ
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRV 257
            ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDARL 255
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       T +SD++SFGV+L E+                +L A   P  K
Sbjct: 256 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEI---------------FSLGASPYPGVK 298
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             + F + +    + + P     +       C   +P+ RP  +++V  L  L
Sbjct: 299 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +++ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 90
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMDANLXQVI--QMELDHERMSYLLYQMLXGIKHLHSA--- 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y AP+  +    
Sbjct: 146 GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 275 TFKSDIYSFGVVLLELI------TGRKAIDQ 299
               DI+S G ++ E++       GR  IDQ
Sbjct: 203 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPNL 150
           FR    +G G FG++Y G   +  + VAIK   +  +  Q + E     +  G    PN 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPN- 67
Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYLH 209
           V+  G   EGD  +LV +      L   L DL    +R L   T + +A      ++++H
Sbjct: 68  VRWFG--VEGDYNVLVMDL-----LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPK---LSDFGLA-KMGPSGDKTHVSTR----VMGTY 261
               +  ++RD+K  N L+  G       + DFGLA K   +    H+  R    + GT 
Sbjct: 121 S---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            Y + +  +  + + + D+ S G VL+  + G
Sbjct: 178 RYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 141
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 142 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 195
Query: 270 M-TGQLTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 196 FGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 194
Query: 270 M-TGQLTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 141 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 194
Query: 270 M-TGQLTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 24/173 (13%)
Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV---STRV 257
            ++G+++L     +  I+RDL   NILL E    K+ DFGLA+     D  +V     R+
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPDYVRKGDARL 257
Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       T +SD++SFGV+L E+ +               L A   P  K
Sbjct: 258 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVK 300
Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
             + F + +    + + P     +       C   +P+ RP  +++V  L  L
Sbjct: 301 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 16/205 (7%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           +F  D   G  G  ++ +  L K  ++VA+K ++ RG         E++   S  HPN+V
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTK--ELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIV 79
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           +            ++ EY   G L + + +     R  +   R       S G+ Y H  
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNA---GRFSEDEARFFFQQLLS-GVSYCH-- 133
Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
               + +RDLK  N LL+    P+L   DFG +K   S          +GT  Y AP+  
Sbjct: 134 -SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVL 189
Query: 270 MTGQLTFK-SDIYSFGVVLLELITG 293
           +  +   K +D++S GV L  ++ G
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL-IGYC 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L   + 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 158 AEGDQRLLVY-----EYMPLGSLDKHLHDLRP-DTRPLDWNTRMKI-AAGASRGLQYLHE 210
           + G+++  VY     +Y+P        H  R   T P+ +   +K+      R L Y+H 
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 144
Query: 211 QLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                + +RD+K  N+LL+ +    KL DFG AK    G+    +   + +  Y AP+  
Sbjct: 145 ---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRYYRAPELI 198
Query: 270 MTGQ-LTFKSDIYSFGVVLLELITGR 294
                 T   D++S G VL EL+ G+
Sbjct: 199 FGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 19/211 (9%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +++ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLXQVI--QMELDHERMSYLLYQMLXGIKHLHSA--- 138
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y AP+  +    
Sbjct: 139 GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 275 TFKSDIYSFGVVLLELI------TGRKAIDQ 299
               DI+S G ++ E++       GR  IDQ
Sbjct: 196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 22/182 (12%)
Query: 188 PLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGP 246
           P+     +  +   +RG+++L     +  I+RDL   NILL E    K+ DFGLA+ +  
Sbjct: 195 PITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 247 SGDKTHVS-TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
           + D      TR+     + AP+       + KSD++S+GV+L E+ +             
Sbjct: 252 NPDYVRKGDTRL--PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS------------- 296
Query: 306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM 365
             L     P  +  ++F   +   ++ + P     +   I   C    P  RP   ++V 
Sbjct: 297 --LGGSPYPGVQMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVE 354
Query: 366 AL 367
            L
Sbjct: 355 KL 356

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 22/206 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVR------EFSAEVMTLGSADHPNLV 151
           LG G F  + K C EK   +  A K +  R  +  R      E   EV  L    H N++
Sbjct: 20  LGSGQFA-IVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            L          +L+ E +  G L     D       L              G+ YLH  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLH-- 132
Query: 212 LKQPVIYRDLKCSNILLEEGY----HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
             + + + DLK  NI+L +      H KL DFGLA     G +      + GT  + AP+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPE 188
Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 L  ++D++S GV+   L++G
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 34/225 (15%)
Query: 87  AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------------QGVRE 134
           A   G +     LGEG +GKV        ++V+  + L  R V             G   
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKV--------KEVLDSETLCRRAVKILKKKKLRRIPNGEAN 52
Query: 135 FSAEVMTLGSADHPNLVKLIG--YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWN 192
              E+  L    H N+++L+   Y  E  +  +V EY   G   + + D  P+ R     
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKR-FPVC 109
Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGP-SGDK 250
                      GL+YLH Q    ++++D+K  N+LL  G   K+S  G+A+ + P + D 
Sbjct: 110 QAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 251 THVSTRVMGTYGYCAPDYA--MTGQLTFKSDIYSFGVVLLELITG 293
           T  +++  G+  +  P+ A  +     FK DI+S GV L  + TG
Sbjct: 167 TCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 38/76 (50%), Gaps = 1/76 (1%)
Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RD+K  NIL+       L DFG+A        T +   V GT  Y AP+       T++
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 278 SDIYSFGVVLLELITG 293
           +DIY+   VL E +TG
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 16/201 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADH-PNLVKLIG 155
           LG G F  V +   +   Q  A K L    RG     E   E+  L  A   P ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                 + +L+ EY   G +      L      +  N  +++      G+ YLH+     
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILEGVYYLHQN---N 151
Query: 216 VIYRDLKCSNILLEEGY---HPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           +++ DLK  NILL   Y     K+ DFG++ K+G + +       +MGT  Y AP+    
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR----EIMGTPEYLAPEILNY 207
Query: 272 GQLTFKSDIYSFGVVLLELIT 292
             +T  +D+++ G++   L+T
Sbjct: 208 DPITTATDMWNIGIIAYMLLT 228

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +E+ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN 90
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVI--QMELDHERMSYLLYQMLVGIKHLH---SA 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y AP+  +    
Sbjct: 146 GIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 275 TFKSDIYSFGVVLLELITG 293
               DI+S G ++ E+I G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 99  LGEGGFGKVYKGCL------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +G+G F  V + C+      E   +++  K+L  R  Q + E  A +  L    H N+V+
Sbjct: 12  IGKGAFS-VVRRCVKLCTGHEYAAKIINTKKLSARDHQKL-EREARICRL--LKHSNIVR 67
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L    +E     LV++ +  G       +L  D    ++ +     A AS  +Q + E +
Sbjct: 68  LHDSISEEGFHYLVFDLVTGG-------ELFEDIVAREYYSE----ADASHCIQQILEAV 116
Query: 213 ----KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
               +  V++RDLK  N+LL    +G   KL+DFGLA +   GD+        GT GY +
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLS 174
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
           P+           DI++ GV+L  L+ G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVTRY-Y 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 30/208 (14%)
Query: 99  LGEGGFGKVYKGCL------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C+      E    ++  K+L  R  Q + E  A +  L    HPN+V+
Sbjct: 19  LGKGAFS-VVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-EREARICRL--LKHPNIVR 74
Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L    +E     L+++ +  G       +L  D    ++ +     A AS  +Q + E +
Sbjct: 75  LHDSISEEGHHYLIFDLVTGG-------ELFEDIVAREYYSE----ADASHCIQQILEAV 123
Query: 213 ----KQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
               +  V++R+LK  N+LL    +G   KL+DFGLA +   G++        GT GY +
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQ-QAWFGFAGTPGYLS 181
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITG 293
           P+           D+++ GV+L  L+ G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    ++  V+  Y Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRY-Y 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G  G V       +E+ VAIK+L  R  Q     +    E++ +   +H N++ L+ 
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN 90
Query: 156 -YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
            +  +         Y+ +  +D +L  +      LD      +      G+++LH     
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVI--QMELDHERMSYLLYQMLCGIKHLHSA--- 145
Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL 274
            +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y AP+  +    
Sbjct: 146 GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 275 TFKSDIYSFGVVLLELITG 293
               DI+S G ++ E+I G
Sbjct: 203 KENVDIWSVGCIMGEMIKG 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 26/223 (11%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSADHPN 149
           N+     +G G +G VY    +  E+ VAIK+++     +   +    E+  L       
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +++L       D       Y+ L   D  L  L      L       I      G  ++H
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS--------------- 254
           E     +I+RDLK +N LL +    K+ DFGLA+   S   T++                
Sbjct: 147 ES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 255 -----TRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELI 291
                T  + T  Y AP+  +  +   KS DI+S G +  EL+
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 139 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 192
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 137 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 190
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 99  LGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN---- 149
           LGEG FGKV + C++     +   V  +K +D R  +  R     +  L + D PN    
Sbjct: 22  LGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTD-PNSTFR 78
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQYL 208
            V+++ +        +V+E + L + D     ++ +   P   +   K+A    + + +L
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDF----IKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 209 HEQLKQPVIYRDLKCSNILL-----EEGYHPKLS--------------DFGLAKMGPSGD 249
           H      + + DLK  NIL       E Y+PK+               DFG A       
Sbjct: 135 H---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
            T VSTR      Y AP+  +    +   D++S G +L+E   G   +  T D KE
Sbjct: 192 STLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYYLGF-TVFPTHDSKE 241

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 132 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 176 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 229
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    +   V+  Y Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRY-Y 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 132 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        DI+S G ++ E++       GR  IDQ
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 23/218 (10%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLVKL 153
           +G+G F  V +    +  Q  A+K +D          S E +   ++      HP++V+L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLH 209
           +   +      +V+E+M    L   +   R D     +     +A+   R     L+Y H
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVK-RADA---GFVYSEAVASHYMRQILEALRYCH 147
Query: 210 EQLKQPVIYRDLKCSNILL--EEGYHP-KLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCA 265
           +     +I+RD+K  N+LL  +E   P KL DFG+A ++G SG    V+   +GT  + A
Sbjct: 148 D---NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG---LVAGGRVGTPHFMA 201
Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           P+           D++  GV+L  L++G      TK+R
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +     + T  + T  Y
Sbjct: 136 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYY 189
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV 309
            AP+  +        DI+S G ++ EL+ G      T    + N V
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 235

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 14/211 (6%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG       ++  ++VA+K ++ RG +       E++   S  HPN+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 +V EY   G L + + +     R  +   R       S G+ Y H      V +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLIS-GVSYCH---AMQVCH 138
Query: 219 RDLKCSNILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           RDLK  N LL+    P+L    FG +K   S          +GT  Y AP+  +  +   
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 277 K-SDIYSFGVVLLELITGRKAIDQTKDRKEL 306
           K +D++S GV L  ++ G    +  ++ K  
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +     + T  + T  Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ EL+ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 16/212 (7%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG       ++  ++VA+K ++ RG +       E++   S  HPN+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVRFKEVIL 85
Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 +V EY   G L + + +     R  +   R       S G+ Y H      V +
Sbjct: 86  TPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLIS-GVSYCH---AMQVCH 138
Query: 219 RDLKCSNILLEEGYHPKLS--DFGLAKMGPSGDKTHVSTR-VMGTYGYCAPDYAMTGQLT 275
           RDLK  N LL+    P+L    FG +K        H   +  +GT  Y AP+  +  +  
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSK----SSVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 276 FK-SDIYSFGVVLLELITGRKAIDQTKDRKEL 306
            K +D++S GV L  ++ G    +  ++ K  
Sbjct: 195 GKVADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 32/231 (13%)
Query: 79  KPFTFDELAAATGNFRSDCC----LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----- 129
           K    + LAA  G +         LG G FG V+    ++  + V +K +    V     
Sbjct: 8   KAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCW 67
Query: 130 ---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLG-----SLDKHLHD 181
                + + + E+  L   +H N++K++          LV E    G      +D+H   
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-- 125
Query: 182 LRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL 241
            R D     +  R  ++A     + YL  +LK  +I+RD+K  NI++ E +  KL DFG 
Sbjct: 126 -RLDEPLASYIFRQLVSA-----VGYL--RLKD-IIHRDIKDENIVIAEDFTIKLIDFGS 176
Query: 242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS-DIYSFGVVLLELI 291
           A     G   +      GT  YCAP+  M         +++S GV L  L+
Sbjct: 177 AAYLERGKLFYT---FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 74/337 (21%), Positives = 134/337 (39%), Gaps = 58/337 (17%)
Query: 60  MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDC-CLGEGGFGKVYKGCLEKIEQV 118
           MD  +L   DD   S  +      +E  +  G   S    +G GG  KV++   EK +Q+
Sbjct: 30  MDSPDLGTDDDDKASSSA------NECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQI 82
Query: 119 VAIK--QLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGYCAEGDQRLLVYEYMPLGS 174
            AIK   L+    Q +  +  E+  L      +  +++L  Y    DQ   +Y  M  G+
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQ--YIYMVMECGN 139
Query: 175 LD-----KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE 229
           +D     K    + P  R   W             L+ +H   +  +++ DLK +N L+ 
Sbjct: 140 IDLNSWLKKKKSIDPWERKSYWKNM----------LEAVHTIHQHGIVHSDLKPANFLIV 189
Query: 230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY-----------AMTGQLTFKS 278
           +G   KL DFG+A        + V    +GT  Y  P+                +++ KS
Sbjct: 190 DGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 248
Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++S G +L  +  G+    Q      +N ++              ++DP+ + ++P   
Sbjct: 249 DVWSLGCILYYMTYGKTPFQQI-----INQIS----------KLHAIIDPNHEIEFPDIP 293
Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
                 +   C++  P  R +I + ++A  Y+  Q +
Sbjct: 294 EKDLQDVLKCCLKRDPKQRISIPE-LLAHPYVQIQTH 329

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 40/211 (18%)
Query: 99  LGEGGFGKVYKGCLEKIEQV-VAIKQLDHRGVQGVREFSAEV-MTLGSADHPNLVKLIGY 156
           +G G +  V K C+ K      A+K +D    +  R+ + E+ + L    HPN++ L   
Sbjct: 30  IGVGSYS-VCKRCIHKATNXEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 157 CAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
             +G    +V E    G L DK L       R         +    ++ ++YLH    Q 
Sbjct: 85  YDDGKYVYVVTELXKGGELLDKILRQKFFSEREAS-----AVLFTITKTVEYLH---AQG 136
Query: 216 VIYRDLKCSNIL-LEEGYHP---KLSDFGLAKM---------GPSGDKTHVSTRVMGTYG 262
           V++RDLK SNIL ++E  +P   ++ DFG AK           P      V+  V+   G
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQG 196
Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           Y A             DI+S GV+L   +TG
Sbjct: 197 YDA-----------ACDIWSLGVLLYTXLTG 216

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 73/333 (21%), Positives = 137/333 (41%), Gaps = 50/333 (15%)
Query: 60  MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDC-CLGEGGFGKVYKGCLEKIEQV 118
           MD  +L   DD   S  +      +E  +  G   S    +G GG  KV++   EK +Q+
Sbjct: 30  MDSPDLGTDDDDKASSSA------NECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQI 82
Query: 119 VAIK--QLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGYCAEGDQRLLVYEYMPLGS 174
            AIK   L+    Q +  +  E+  L      +  +++L  Y    DQ   +Y  M  G+
Sbjct: 83  YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQ--YIYMVMECGN 139
Query: 175 LDKHLHDLRPDTRPLD-WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH 233
           +D  L+      + +D W  +    +     L+ +H   +  +++ DLK +N L+ +G  
Sbjct: 140 ID--LNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGML 193
Query: 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY-----------AMTGQLTFKSDIYS 282
            KL DFG+A        + V    +GT  Y  P+                +++ KSD++S
Sbjct: 194 -KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS 252
Query: 283 FGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQA 342
            G +L  +  G+    Q      +N ++              ++DP+ + ++P       
Sbjct: 253 LGCILYYMTYGKTPFQQI-----INQIS----------KLHAIIDPNHEIEFPDIPEKDL 297
Query: 343 LAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
             +   C++  P  R +I + ++A  Y+  Q +
Sbjct: 298 QDVLKCCLKRDPKQRISIPE-LLAHPYVQIQTH 329

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    +   V+  Y Y
Sbjct: 140 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRY-Y 193
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            AP+  +        DI+S G ++ E+I G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 143 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 196
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        D++S G ++ E++       GR  IDQ
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y
Sbjct: 132 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 185
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        D++S G ++ E++       GR  IDQ
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +G    +   V+  Y Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMEPEVVTRY-Y 191
Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELI------TGRKAIDQ 299
            AP+  +        D++S G ++ E++       GR  IDQ
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 30/215 (13%)
Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDH----RGVQ-GVREFSAEVMTLGSADHPNLVK 152
            LG+G    V++G  +K   + AIK  ++    R V   +REF      L   +H N+VK
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV----LKKLNHKNIVK 71
Query: 153 LIGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           L     E   R  +L+ E+ P GSL   L +   +   L  +  + +      G+ +L E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 211 QLKQPVIYRDLKCSNILL---EEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
                +++R++K  NI+    E+G    KL+DFG A+     D+  VS  + GT  Y  P
Sbjct: 131 ---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVS--LYGTEEYLHP 184
Query: 267 DYAMTGQLT--------FKSDIYSFGVVLLELITG 293
           D      L            D++S GV      TG
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 98/241 (40%), Gaps = 31/241 (12%)
Query: 75  GKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQL-----DHRG 128
           G++A      EL A    +     +  G +G V  G   E I   VAIK++     D R 
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIP--VAIKRVFNTVSDGRT 63
Query: 129 VQGV------REFSAEVMTLGSADHPNLVKL----IGYCAEGDQRLLVYEYMPLGSLDKH 178
           V  +      +    E+  L    HPN++ L    + +      +L +   +    L + 
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 179 LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD 238
           +HD R    P      M        GL  LHE     V++RDL   NILL +     + D
Sbjct: 124 IHDQRIVISPQHIQYFMY---HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177
Query: 239 FGLAKMGPS-GDKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKA 296
           F LA+   +  +KTH  T       Y AP+  M  +  T   D++S G V+ E+   RKA
Sbjct: 178 FNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKA 232
Query: 297 I 297
           +
Sbjct: 233 L 233

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 119/282 (42%), Gaps = 42/282 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPN--LVKLI 154
           +G GG  KV++   EK +Q+ AIK   L+    Q +  +  E+  L      +  +++L 
Sbjct: 17  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD-WNTRMKIAAGASRGLQYLHEQLK 213
            Y    DQ   +Y  M  G++D  L+      + +D W  +    +     L+ +H   +
Sbjct: 76  DYEI-TDQ--YIYMVMECGNID--LNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQ 126
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY----- 268
             +++ DLK +N L+ +G   KL DFG+A        + V    +GT  Y  P+      
Sbjct: 127 HGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 269 ------AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
                     +++ KSD++S G +L  +  G+    Q      +N ++            
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQIS----------KL 230
Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
             ++DP+ + ++P         +   C++  P  R +I +++
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/231 (22%), Positives = 86/231 (37%), Gaps = 29/231 (12%)
Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH--RGVQGVREFSAEVMTLGSADHPN 149
           N+     +G G +G VY    +   + VAIK+++     +   +    E+  L       
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +++L       D       Y+ L   D  L  L      L       I      G +++H
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH 148
Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS--------------- 254
           E     +I+RDLK +N LL +    K+ DFGLA+   S    H+                
Sbjct: 149 ES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPH 205
Query: 255 --------TRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKA 296
                   T  + T  Y AP+  +  +  T   DI+S G +  EL+   K+
Sbjct: 206 NKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 98/241 (40%), Gaps = 31/241 (12%)
Query: 75  GKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGC-LEKIEQVVAIKQL-----DHRG 128
           G++A      EL A    +     +  G +G V  G   E I   VAIK++     D R 
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIP--VAIKRVFNTVSDGRT 63
Query: 129 VQGV------REFSAEVMTLGSADHPNLVKL----IGYCAEGDQRLLVYEYMPLGSLDKH 178
           V  +      +    E+  L    HPN++ L    + +      +L +   +    L + 
Sbjct: 64  VNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQV 123
Query: 179 LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD 238
           +HD R    P      M        GL  LHE     V++RDL   NILL +     + D
Sbjct: 124 IHDQRIVISPQHIQYFMY---HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177
Query: 239 FGLAKMGPS-GDKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKA 296
           F LA+   +  +KTH  T       Y AP+  M  +  T   D++S G V+ E+   RKA
Sbjct: 178 FNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKA 232
Query: 297 I 297
           +
Sbjct: 233 L 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 124/293 (42%), Gaps = 43/293 (14%)
Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHPN--LVKLI 154
           +G GG  KV++   EK +Q+ AIK   L+    Q +  +  E+  L      +  +++L 
Sbjct: 20  IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD-WNTRMKIAAGASRGLQYLHEQLK 213
            Y    DQ   +Y  M  G++D  L+      + +D W  +    +     L+ +H   +
Sbjct: 79  DY-EITDQ--YIYMVMECGNID--LNSWLKKKKSIDPWERK----SYWKNMLEAVHTIHQ 129
Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY----- 268
             +++ DLK +N L+ +G   KL DFG+A        + V    +GT  Y  P+      
Sbjct: 130 HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 269 ------AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
                     +++ KSD++S G +L  +  G+    Q      +N ++            
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-----INQIS----------KL 233
Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
             ++DP+ + ++P         +   C++  P  R +I + ++A  Y+  Q +
Sbjct: 234 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE-LLAHPYVQIQTH 285

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	426
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-179
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-174
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-65
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-55
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-52
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-42
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-35
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-35
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-35
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-34
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-33
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-29
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-27
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-26
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-20
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-20
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-18
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-18
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-17
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-17
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-16
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-15
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	3e-13
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-12
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-12
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-12
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-10
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  512 bits (1320), Expect = 0.0
 Identities = 113/309 (36%), Positives = 166/309 (53%), Gaps = 20/309 (6%)

Query: 74  SGKSAKPFTFDELAAATGNFRSDCC------LGEGGFGKVYKGCLEKIEQVVAIKQL--- 124
           S      F+F EL   T NF           +GEGGFG VYKG +      VA+K+L   
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAM 65

Query: 125 -DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
            D    +  ++F  E+  +    H NLV+L+G+ ++GD   LVY YMP GSL   L    
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-L 124

Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
             T PL W+ R KIA GA+ G+ +LHE      I+RD+K +NILL+E +  K+SDFGLA+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR 181

Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
                 +T +++R++GT  Y AP+  + G++T KSDIYSFGVVLLE+ITG  A+D+   R
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--R 238

Query: 304 KELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           +   L+     +  + K     +D  +        +    ++A+ C+ E+ N RP I  V
Sbjct: 239 EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

Query: 364 VMALNYLAS 372
              L  + +
Sbjct: 298 QQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  502 bits (1294), Expect = e-179
 Identities = 120/299 (40%), Positives = 171/299 (57%), Gaps = 5/299 (1%)

Query: 71  SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
           S      +      +L  AT NF     +G G FGKVYKG L      VA+K+      Q
Sbjct: 19  SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQ 77

Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
           G+ EF  E+ TL    HP+LV LIG+C E ++ +L+Y+YM  G+L +HL+     T  + 
Sbjct: 78  GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMS 137

Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK 250
           W  R++I  GA+RGL YLH +    +I+RD+K  NILL+E + PK++DFG++K G   D+
Sbjct: 138 WEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ 194

Query: 251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA 310
           TH+ST V GT GY  P+Y + G+LT KSD+YSFGVVL E++  R AI Q+  R+ +NL  
Sbjct: 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAE 254

Query: 311 WARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY 369
           WA     +     Q+VDP+L  +     L +    A  C+      RP++ DV+  L Y
Sbjct: 255 WAVESHNNG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  487 bits (1257), Expect = e-174
 Identities = 122/306 (39%), Positives = 179/306 (58%), Gaps = 6/306 (1%)

Query: 65  LNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL 124
           +  ++D        K F+  EL  A+ NF +   LG GGFGKVYKG L     +VA+K+L
Sbjct: 4   VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRL 62

Query: 125 DHRGVQGV-REFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
                QG   +F  EV  +  A H NL++L G+C    +RLLVY YM  GS+   L +  
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122

Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
               PLDW  R +IA G++RGL YLH+     +I+RD+K +NILL+E +   + DFGLAK
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
           +    D THV+T V GT G+ AP+Y  TG+ + K+D++ +GV+LLELITG++A D  +  
Sbjct: 183 LMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241

Query: 304 KE--LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT 361
            +  + L+ W + + K++K    +VD  LQG Y    + Q + +A +C Q  P  RP ++
Sbjct: 242 NDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS 300

Query: 362 DVVMAL 367
           +VV  L
Sbjct: 301 EVVRML 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  268 bits (686), Expect = 2e-87
 Identities = 74/330 (22%), Positives = 118/330 (35%), Gaps = 32/330 (9%)

Query: 65  LNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL 124
           +      ++SG        + L   +   +       G FG V+K  L    + VA+K  
Sbjct: 1   MGHHHHHHSSGV---DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIF 55

Query: 125 DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLLVYEYMPLGSLDKHLH 180
             +  Q   +   EV +L    H N+++ IG    G        L+  +   GSL   L 
Sbjct: 56  PIQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114

Query: 181 DLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-------KQPVIYRDLKCSNILLEEGYH 233
                   + WN    IA   +RGL YLHE +       K  + +RD+K  N+LL+    
Sbjct: 115 A-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169

Query: 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----QLTFKSDIYSFGVVLL 288
             ++DFGLA    +G     +   +GT  Y AP+              + D+Y+ G+VL 
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229

Query: 289 ELITGRKAIDQTKDRKELNLVA--WARPMFKDRKNF--SQMVDPSLQGQYPVRGLYQALA 344
           EL +   A D   D   L         P  +D +     +   P L+  +        L 
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

Query: 345 -IAAMCVQEQPNMRPAITDVVMALNYLASQ 373
                C       R +   V   +  +   
Sbjct: 290 ETIEECWDHDAEARLSAGCVGERITQMQRL 319

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  212 bits (541), Expect = 1e-65
 Identities = 68/337 (20%), Positives = 119/337 (35%), Gaps = 40/337 (11%)

Query: 81  FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVM 140
               E +    N +    +G G +G VYKG L+  E+ VA+K       Q        + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINE-KNIY 59

Query: 141 TLGSADHPNLVKLIGYCAEGD-----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM 195
            +   +H N+ + I            + LLV EY P GSL K+L          DW +  
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSC 114

Query: 196 KIAAGASRGLQYLHEQL------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM----- 244
           ++A   +RGL YLH +L      K  + +RDL   N+L++      +SDFGL+       
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 245 -GPSGDKTHVSTRVMGTYGYCAPDYAM-------TGQLTFKSDIYSFGVVLLELITGRKA 296
               G++ + +   +GT  Y AP+                + D+Y+ G++  E+      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 297 IDQTKDRKELNL----VAWARPMFKDRKNF--SQMVDPSLQGQYPV--RGLYQALAIAAM 348
           +   +   E  +         P F+D +     +   P     +      +         
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 349 CVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSS 385
           C  +    R         +  L       ++    + 
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  206 bits (526), Expect = 1e-63
 Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 33/292 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG V++         VA+K L  +      V EF  EV  +    HPN+V  +G 
Sbjct: 45  IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
             +     +V EY+  GSL + LH        LD   R+ +A   ++G+ YLH +   P+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++R+LK  N+L+++ Y  K+ DFGL+++  S   +  S    GT  + AP+         
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218

Query: 277 KSDIYSFGVVLLELITGR---KAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ 333
           KSD+YSFGV+L EL T +     ++  +       V  A      R    + ++P +   
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQ-------VVAAVGFKCKRLEIPRNLNPQVA-- 269

Query: 334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSS 385
                     AI   C   +P  RP+   ++  L  L         PP+RS 
Sbjct: 270 ----------AIIEGCWTNEPWKRPSFATIMDLLRPLIKS---AVPPPNRSD 308

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  201 bits (513), Expect = 1e-61
 Identities = 78/294 (26%), Positives = 126/294 (42%), Gaps = 35/294 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V K       + VAIKQ++    +  + F  E+  L   +HPN+VKL G C 
Sbjct: 16  VGRGAFGVVCKAKWRA--KDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   LV EY   GSL   LH   P          M      S+G+ YLH    + +I+
Sbjct: 72  --NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 219 RDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           RDLK  N+LL   G   K+ DFG A      D     T   G+  + AP+       + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183

Query: 278 SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM--FKD-RKNFSQMVDPSLQGQY 334
            D++S+G++L E+IT RK  D      E+   A+          R    + +   ++   
Sbjct: 184 CDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 234

Query: 335 PVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKS 388
                    ++   C  + P+ RP++ ++V  + +L  + +   + P +   + 
Sbjct: 235 ---------SLMTRCWSKDPSQRPSMEEIVKIMTHLM-RYFPGADEPLQYPCQH 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  199 bits (509), Expect = 2e-61
 Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 53/293 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-------VREFSAEVMTLGSADHPNLV 151
           +G+GGFG V+KG L K + VVAIK L     +G        +EF  EV  + + +HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           KL G         +V E++P G L   L D      P+ W+ ++++    + G++Y+   
Sbjct: 87  KLYGLMHN--PPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ-N 140

Query: 212 LKQPVIYRDLKCSNILLEEG-----YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
              P+++RDL+  NI L+          K++DFGL++        H  + ++G + + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMAP 195

Query: 267 DYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS 323
           +  +  +    T K+D YSF ++L  ++TG                    P F +  ++ 
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGE------------------GP-FDE-YSYG 234

Query: 324 QMVDPSLQGQYPVR-----GLYQALA-IAAMCVQEQPNMRPAITDVVMALNYL 370
           ++   ++  +  +R          L  +  +C    P  RP  + +V  L+ L
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  193 bits (492), Expect = 1e-58
 Identities = 66/306 (21%), Positives = 111/306 (36%), Gaps = 33/306 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FG+  K    +  +V+ +K+L     +  R F  EV  +   +HPN++K IG   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +  +   + EY+  G+L   +  +        W+ R+  A   + G+ YLH      +I+
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKM------------GPSGDKTHVSTRVMGTYGYCAP 266
           RDL   N L+ E  +  ++DFGLA++                        V+G   + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +         K D++SFG+VL E+I    A      R     +     +    +      
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---DRYCPPNC 248

Query: 327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSR 386
            PS               I   C    P  RP+   +   L  L            +  +
Sbjct: 249 PPSF------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296

Query: 387 KSPSCL 392
                 
Sbjct: 297 LDRGFW 302

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (489), Expect = 1e-58
 Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 43/286 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
           L E   G+++KG  +     + +K L  R       R+F+ E   L    HPN++ ++G 
Sbjct: 18  LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 157 CAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           C          +  +MP GSL   LH+       +D +  +K A   +RG+ +LH  L+ 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH-TLEP 132

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ- 273
            +    L   +++++E    ++S   +         +  S   M    + AP+ A+  + 
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKKP 184

Query: 274 ---LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
                  +D++SF V+L EL+T                     P F D  N    +  +L
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREV------------------P-FADLSNMEIGMKVAL 225

Query: 331 QGQYPV--RGLYQALA-IAAMCVQEQPNMRPAITDVVMALNYLASQ 373
           +G  P    G+   ++ +  +C+ E P  RP    +V  L  +  +
Sbjct: 226 EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  190 bits (484), Expect = 5e-58
 Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 45/285 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G GGFGKVY+         VA+K      D    Q +     E        HPN++ L 
Sbjct: 15  IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C +     LV E+   G L++ L       + +  +  +  A   +RG+ YLH++   
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 215 PVIYRDLKCSNILLEEGYHP--------KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           P+I+RDLK SNIL+ +            K++DFGLA+      +T   +   G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WHRTTKMSAA-GAYAWMAP 183

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +       +  SD++S+GV+L EL+TG                    P F+     +   
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEV------------------P-FRGIDGLAVAY 224

Query: 327 DPSLQGQYPV--RGLYQALA-IAAMCVQEQPNMRPAITDVVMALN 368
             ++            +  A +   C    P+ RP+ T+++  L 
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  186 bits (474), Expect = 6e-56
 Identities = 61/310 (19%), Positives = 107/310 (34%), Gaps = 56/310 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIGY 156
           +G+G FG+VY G        VAI+ +D        ++ F  EVM      H N+V  +G 
Sbjct: 41  IGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
           C       ++       +L   + D +     LD N   +IA    +G+ YLH    + +
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAP------- 266
           +++DLK  N+  + G    ++DFGL  +     +G +        G   + AP       
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 267 --DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL--VAWA-----RPMFK 317
                     +  SD+++ G +  EL             K      + W      +P   
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------KTQPAEAIIWQMGTGMKPNLS 264

Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
                   +   +              I   C   +   RP  T ++  L  L  +    
Sbjct: 265 QIG-----MGKEIS------------DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307

Query: 378 QNPP--SRSS 385
            +P    +S+
Sbjct: 308 SHPGHFWKSA 317

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  184 bits (470), Expect = 1e-55
 Identities = 66/201 (32%), Positives = 98/201 (48%), Gaps = 15/201 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G FG VYKG        VA+K L       Q ++ F  EV  L    H N++  +GY
Sbjct: 32  IGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                Q  +V ++    SL  HLH         +    + IA   +RG+ YLH    + +
Sbjct: 89  STA-PQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP---DYAMTGQ 273
           I+RDLK +NI L E    K+ DFGLA        +H   ++ G+  + AP       +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 274 LTFKSDIYSFGVVLLELITGR 294
            +F+SD+Y+FG+VL EL+TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (458), Expect = 3e-53
 Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 41/304 (13%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
            +G+G +G+V+ G      + VA+K           RE   E+       H N++  I  
Sbjct: 44  QIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAA 99

Query: 157 CAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             +G     Q  L+ +Y   GSL  +L         LD  + +K+A  +  GL +LH ++
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 213 -----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCA 265
                K  + +RDLK  NIL+++     ++D GLA    S            +GT  Y  
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 266 P---DYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
           P   D ++          +D+YSFG++L E+     +    ++ +    + +   +    
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ----LPY-HDLVPSD 269

Query: 320 KNFSQMVD--------PSLQGQYPVRGLYQALA-IAAMCVQEQPNMRPAITDVVMALNYL 370
            ++  M +        PS   ++      + +  +   C    P  R     V   L  +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329

Query: 371 ASQK 374
           +  +
Sbjct: 330 SESQ 333

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  173 bits (440), Expect = 4e-51
 Identities = 66/300 (22%), Positives = 119/300 (39%), Gaps = 41/300 (13%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
           C+G+G +G+V++G  +   + VA+K    R  +   RE   E+       H N++  I  
Sbjct: 15  CVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS 70

Query: 157 CAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
                    Q  L+  Y  +GSL  +L         LD  + ++I    + GL +LH ++
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 213 -----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV--STRVMGTYGYCA 265
                K  + +RDLK  NIL+++     ++D GLA M           +   +GT  Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 266 P------DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
           P                + DI++FG+VL E+     +    +D K      +   +  + 
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK----PPFYD-VVPND 240

Query: 320 KNFSQMVD--------PSLQGQYPVRGLYQALA-IAAMCVQEQPNMRPAITDVVMALNYL 370
            +F  M          P++  ++       +LA +   C  + P+ R     +   L  +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  172 bits (438), Expect = 2e-50
 Identities = 68/304 (22%), Positives = 122/304 (40%), Gaps = 41/304 (13%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLIGY 156
            +G+G FG+V++G      + VA+K    R  +   RE  AE+       H N++  I  
Sbjct: 49  SIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAA 104

Query: 157 CAEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-- 210
             + +    Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH   
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 211 ---QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCA 265
              Q K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 266 P---DYAMTGQL---TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
           P   D ++  +      ++DIY+ G+V  E+          +D +    + +   +    
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ----LPYYD-LVPSD 274

Query: 320 KNFSQMVD--------PSLQGQYPVRGLYQALA-IAAMCVQEQPNMRPAITDVVMALNYL 370
            +  +M          P++  ++      + +A I   C       R     +   L+ L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334

Query: 371 ASQK 374
           + Q+
Sbjct: 335 SQQE 338

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  151 bits (384), Expect = 1e-42
 Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V         +    +VA+KQL H G    R+F  E+  L +     +VK  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G      ++   LV EY+P G L   L   R     LD +  +  ++   +G++YL    
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYSSQICKGMEYLGS-- 145

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPD 267
            +  ++RDL   NIL+E   H K++DFGLAK+ P     +V        G     + AP+
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                  + +SD++SFGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (381), Expect = 9e-42
 Identities = 55/195 (28%), Positives = 91/195 (46%), Gaps = 7/195 (3%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G G FG+V+ G L     +VA+K   +        +F  E   L    HPN+V+LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            +     +V E +  G        LR +   L   T +++   A+ G++YL     +  I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTF---LRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL   N L+ E    K+SDFG+++    G              + AP+    G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 278 SDIYSFGVVLLELIT 292
           SD++SFG++L E  +
Sbjct: 296 SDVWSFGILLWETFS 310

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  148 bits (375), Expect = 1e-41
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V         +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G C    +R   L+ EY+P GSL  +L   +     +D    ++  +   +G++YL    
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT-- 132

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPD 267
            +  I+RDL   NIL+E     K+ DFGL K+ P   +           G     + AP+
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                + +  SD++SFGVVL EL T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  149 bits (377), Expect = 1e-41
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 21/205 (10%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG V         +   +VVA+K+L H   + +R+F  E+  L S  H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 155 GYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           G C    +R   L+ EY+P GSL  +L   +     +D    ++  +   +G++YL    
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGT-- 163

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPD 267
            +  I+RDL   NIL+E     K+ DFGL K+ P   + +         G     + AP+
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
                + +  SD++SFGVVL EL T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  148 bits (377), Expect = 2e-41
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D+P++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G C       L+ + MP G L  ++ + + +   +     +      ++G+ YL ++  
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR-- 136

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +++RDL   N+L++   H K++DFGLAK+  + +K + +        + A +  +   
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            T +SD++S+GV + EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  145 bits (369), Expect = 1e-40
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV         +   + VA+K L    G   + +   E+  L +  H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C E       L+ E++P GSL ++L     +   ++   ++K A    +G+ YL  +
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLGSR 145

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAP 266
                ++RDL   N+L+E  +  K+ DFGL K   +  + +               + AP
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
           +  M  +    SD++SFGV L EL+T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  145 bits (367), Expect = 2e-40
 Identities = 69/221 (31%), Positives = 99/221 (44%), Gaps = 25/221 (11%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV   C     +   ++VA+K L    G Q    +  E+  L +  H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 154 IGYCAEGDQR--LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
            G C +       LV EY+PLGSL  +L         L     +  A     G+ YLH Q
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAP 266
                I+RDL   N+LL+     K+ DFGLAK  P G + +     +   G     + AP
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL 306
           +     +  + SD++SFGV L EL+T    +        EL
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  145 bits (367), Expect = 4e-40
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG V+KG      E I+  V IK + D  G Q  +  +  ++ +GS DH ++V+L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G C  G    LV +Y+PLGSL  H+   R     L     +      ++G+ YL E   
Sbjct: 81  LGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLEEH-- 134

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +++R+L   N+LL+     +++DFG+A + P  DK  + +       + A +    G+
Sbjct: 135 -GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            T +SD++S+GV + EL+T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (371), Expect = 2e-39
 Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 7/195 (3%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG G +G+VY+G  +K    VA+K L       V EF  E   +    HPNLV+L+G C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
                  ++ E+M  G+L  +L +     + +     + +A   S  ++YL +   +  I
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEK---KNFI 340

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +R+L   N L+ E +  K++DFGL+++  +GD             + AP+     + + K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 278 SDIYSFGVVLLELIT 292
           SD+++FGV+L E+ T
Sbjct: 400 SDVWAFGVLLWEIAT 414

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  142 bits (360), Expect = 4e-39
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG G FG VYKG      EK++  VAIK+L +    +  +E   E   + S D+P++ +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +G C       L+ + MP G L  ++ + + +   +     +      ++G+ YL ++  
Sbjct: 83  LGIC-LTSTVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLEDR-- 136

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +++RDL   N+L++   H K++DFGLAK+  + +K + +        + A +  +   
Sbjct: 137 -RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            T +SD++S+GV + EL+T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (349), Expect = 7e-38
 Identities = 62/207 (29%), Positives = 90/207 (43%), Gaps = 19/207 (9%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL---DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG V +G           VA+K L        + + +F  EV  + S DH NL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L G         +V E  PLGSL   L   +         T  + A   + G+ YL  + 
Sbjct: 86  LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESK- 140

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYA 269
               I+RDL   N+LL      K+ DFGL +  P  D  +V          + +CAP+  
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196

Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRK 295
            T   +  SD + FGV L E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  138 bits (351), Expect = 7e-38
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G  + +     E  VAIK + +   ++   EF  E   +   +  ++V+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RPLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L++ E M  G L  +L  LRP         P   +  +++A   + G+ 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV------MGT 260
           YL+       ++RDL   N ++ E +  K+ DFG+ +     D      +       M  
Sbjct: 153 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               +P+    G  T  SD++SFGVVL E+ T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (348), Expect = 9e-38
 Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 19/210 (9%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHPNL 150
            + D  +G G F  VYKG   +    VA  +           + F  E   L    HPN+
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 151 VKLIGYC---AEGDQRLLVY-EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           V+         +G + +++  E M  G+L           + +             +GLQ
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTL----KTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 207 YLHEQLKQPVIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           +LH +   P+I+RDLKC NI +    G   K+ D GLA +     +   +  V+GT  + 
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLK----RASFAKAVIGTPEFM 197

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           AP+     +     D+Y+FG+ +LE+ T  
Sbjct: 198 APEM-YEEKYDESVDVYAFGMCMLEMATSE 226

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  137 bits (347), Expect = 3e-37
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 31/216 (14%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+      +     + +VA+K L        ++F  E   L    H ++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR-----------PLDWNTRMKIAAGAS 202
            G C EG   L+V+EYM  G L++ L    PD +           PL     + +A+  +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV----- 257
            G+ YL   L    ++RDL   N L+ +G   K+ DFG+++   S D   V  R      
Sbjct: 169 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 258 -MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            M       P+  +  + T +SD++SFGVVL E+ T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (342), Expect = 5e-37
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 24/208 (11%)

Query: 99  LGEGGFGKVYKGCL--EKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG    +K+ + VA+K L  +        E  AE   +   D+P +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL E+   
Sbjct: 85  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYL-EESN- 137

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPDY 268
             ++RDL   N+LL   ++ K+SDFGL+K   + +  + +              + AP+ 
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191

Query: 269 AMTGQLTFKSDIYSFGVVLLELIT-GRK 295
               + + KSD++SFGV++ E  + G+K
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  135 bits (341), Expect = 9e-37
 Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 31/206 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G +G+VY+G  +K    VA+K L       V EF  E   +    HPNLV+L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
                 ++ E+M  G+L  +L +       +     + +A   S  ++YL E+     I+
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYL-EKKN--FIH 134

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY------------CAP 266
           RDL   N L+ E +  K++DFGL+             R+M    Y             AP
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYTAHAGAKFPIKWTAP 181

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
           +     + + KSD+++FGV+L E+ T
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIAT 207

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (340), Expect = 9e-37
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)

Query: 99  LGEGGFGKVYKGCL--EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           LG G FG V +G     K +  VAIK L          E   E   +   D+P +V+LIG
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            C + +  +LV E    G L K L         +  +   ++    S G++YL E+    
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 130

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPDYA 269
            ++RDL   N+LL   ++ K+SDFGL+K   + D  + +              + AP+  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185

Query: 270 MTGQLTFKSDIYSFGVVLLELIT-GRK 295
              + + +SD++S+GV + E ++ G+K
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 1e-36
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G  G+V  G L    + +  VAIK L      +  R+F +E   +G  DHPN+++L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G    G   ++V EYM  GSLD     LR           + +  G   G++YL +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTF---LRTHDGQFTIMQLVGMLRGVGAGMRYLSD---L 170

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             ++RDL   N+L++     K+SDFGL++ +    D  + +T       + AP+      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            +  SD++SFGVV+ E++  G +
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGER 253

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  135 bits (341), Expect = 1e-36
 Identities = 58/276 (21%), Positives = 100/276 (36%), Gaps = 35/276 (12%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQ--LDHRGVQGVREFSAEVMTLGS-ADH 147
           +F+    LG G +G+V+K    K + ++ A+K+     RG +      AEV +      H
Sbjct: 58  SFQRLSRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P  V+L     EG    L  E     SL +H          L               L +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAH 172

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH Q    +++ D+K +NI L      KL DFGL     +     V     G   Y AP+
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE 226

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
             + G     +D++S G+ +LE+                        +    + + Q+  
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACN-------------------MELPHGGEGWQQLRQ 266

Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
             L  ++      +  ++  M ++  P +R     +
Sbjct: 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (340), Expect = 1e-36
 Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 32/217 (14%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FGKV+      +     + +VA+K L    +   ++F  E   L +  H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------------PLDWNTRMKIAAGA 201
            G C +GD  ++V+EYM  G L+K L    PD               L  +  + IA+  
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV---- 257
           + G+ YL        ++RDL   N L+      K+ DFG+++   S D   V        
Sbjct: 143 ASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 258 --MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             M       P+  M  + T +SD++SFGV+L E+ T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  134 bits (340), Expect = 2e-36
 Identities = 66/328 (20%), Positives = 115/328 (35%), Gaps = 36/328 (10%)

Query: 71  SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
            ++SG+    F    +     ++     LGEGGF  V            A+K++     Q
Sbjct: 9   HHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ 68

Query: 131 GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR----LLVYEYMPLGSLDKHLHDLRPDT 186
              E   E       +HPN+++L+ YC           L+  +   G+L   +  L+   
Sbjct: 69  DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
             L  +  + +  G  RGL+ +H    +   +RDLK +NILL +   P L D G      
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185

Query: 247 SGDKTHVSTRVM-------GTYGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
              +       +        T  Y AP          +  ++D++S G VL  ++ G   
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

Query: 297 IDQTKDRKE-LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPN 355
            D    + + + L    +         S            +  L     + +M     P+
Sbjct: 246 YDMVFQKGDSVALAVQNQLSIPQSPRHSS----------ALWQL-----LNSMM-TVDPH 289

Query: 356 MRPAITDVVMALNYLASQKYDPQNPPSR 383
            RP I  ++  L  L  Q   P    ++
Sbjct: 290 QRPHIPLLLSQLEAL--QPPAPGQHTTQ 315

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  134 bits (339), Expect = 2e-36
 Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LGE  FGKVYKG L         Q VAIK L D        EF  E M      HPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTR------------PLDWNTRMKIAAG 200
           L+G   +     +++ Y   G L + L    P +              L+    + + A 
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV- 257
            + G++YL       V+++DL   N+L+ +  + K+SD GL +   + D  K   ++ + 
Sbjct: 137 IAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193

Query: 258 ---MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
              M      AP+  M G+ +  SDI+S+GVVL E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (346), Expect = 4e-36
 Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG+G FG+V+ G        VAIK L   G      F  E   +    H  LV+L    
Sbjct: 191 KLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           +E +   +V EYM  GSL   L       + L     + +AA  + G+ Y+        +
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYV 302

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL+ +NIL+ E    K++DFGLA++    ++            + AP+ A+ G+ T K
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

Query: 278 SDIYSFGVVLLELIT 292
           SD++SFG++L EL T
Sbjct: 362 SDVWSFGILLTELTT 376

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  134 bits (339), Expect = 4e-36
 Identities = 72/324 (22%), Positives = 123/324 (37%), Gaps = 59/324 (18%)

Query: 99  LGEGGFGKVYKGCL-----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +     +     VA+K L +    Q   +F  E + +   +H N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---RPLDWNTRMKIAAGASRGLQYLH 209
            IG   +   R ++ E M  G L   L + RP       L     + +A   + G QYL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156

Query: 210 EQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           E+     I+RD+   N LL     G   K+ DFG+A+              M    +  P
Sbjct: 157 EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT----------GRKAIDQTKDRKELNLVAWARPMF 316
           +  M G  T K+D +SFGV+L E+ +           ++ ++       ++      P  
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-----PPKN 269

Query: 317 -KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
                                  +Y+   I   C Q QP  RP    ++  + Y      
Sbjct: 270 CPGP-------------------VYR---IMTQCWQHQPEDRPNFAIILERIEYCT---- 303

Query: 376 DPQNPPSRSSRKSPSCLGVNKDDD 399
             Q+P   ++        + ++++
Sbjct: 304 --QDPDVINTALPIEYGPLVEEEE 325

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  134 bits (339), Expect = 4e-36
 Identities = 82/317 (25%), Positives = 133/317 (41%), Gaps = 57/317 (17%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           +G G FG+VYKG L     K E  VAIK L      +   +F  E   +G   H N+++L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            G  ++    +++ EYM  G+LDK    LR           + +  G + G++YL     
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLRGIAAGMKYLAN--- 165

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG------YCAPD 267
              ++RDL   NIL+      K+SDFGL+++     +   +T      G      + AP+
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
                + T  SD++SFG+V+ E++T G                   RP + +  N    V
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGE------------------RP-YWELSN--HEV 259

Query: 327 DPSLQGQY----PV---RGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA---SQKYD 376
             ++   +    P+     +YQ   +   C Q++   RP   D+V  L+ L         
Sbjct: 260 MKAINDGFRLPTPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316

Query: 377 PQNPPSRSSRKSPSCLG 393
             +   R S + PS  G
Sbjct: 317 LADFDPRVSIRLPSTSG 333

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  132 bits (335), Expect = 7e-36
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G FG VY G L   +  +   A+K L     +  V +F  E + +    HPN++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92

Query: 155 GYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           G C   +   L+V  YM  G L   + +   +         +      ++G++YL     
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGMKYLAS--- 146

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG------TYGYCAPD 267
           +  ++RDL   N +L+E +  K++DFGLA+     +   V  +              A +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
              T + T KSD++SFGV+L EL+T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (338), Expect = 1e-35
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G G FG+V  G L    K E  VAIK L      +  R+F  E   +G  DHPN+++L 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G   +    ++V EYM  GSLD     LR           + +  G + G++YL +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSF---LRKHDAQFTVIQLVGMLRGIASGMKYLSD---M 166

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             ++RDL   NIL+      K+SDFGL + +    +  + +        + +P+     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            T  SD++S+G+VL E+++ G +
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGER 249

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  132 bits (333), Expect = 2e-35
 Identities = 72/311 (23%), Positives = 123/311 (39%), Gaps = 30/311 (9%)

Query: 60  MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVV 119
           MD ++  ++       +  K    D       NFR +  +G G F +VY+         V
Sbjct: 1   MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60

Query: 120 AIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLD 176
           A+K++    +   +  +    E+  L   +HPN++K      E ++  +V E    G L 
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120

Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL 236
           + +   +   R +   T  K        L+++H +    V++RD+K +N+ +      KL
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKL 177

Query: 237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKA 296
            D GL +   S   T   + V GT  Y +P+        FKSDI+S G +L E+   +  
Sbjct: 178 GDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ-- 233

Query: 297 IDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYP--VRGLY-QAL-AIAAMCVQE 352
                            P + D+ N   +     Q  YP      Y + L  +  MC+  
Sbjct: 234 ----------------SPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 277

Query: 353 QPNMRPAITDV 363
            P  RP +T V
Sbjct: 278 DPEKRPDVTYV 288

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  131 bits (331), Expect = 2e-35
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           LGEG FG+VY+G     +  +  VA+K       +    +F +E + + + DHP++VKLI
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G   E +   ++ E  P G L  +L   +   + L     +  +    + + YL E +  
Sbjct: 80  GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYL-ESIN- 133

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY----------- 263
             ++RD+   NIL+      KL DFGL+             R +    Y           
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRLPIK 179

Query: 264 -CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRK 295
             +P+     + T  SD++ F V + E+++ G++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  133 bits (336), Expect = 2e-35
 Identities = 72/324 (22%), Positives = 123/324 (37%), Gaps = 59/324 (18%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG G FG+VY+G +  +        VA+K L +    Q   +F  E + +   +H N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT---RPLDWNTRMKIAAGASRGLQYLH 209
            IG   +   R ++ E M  G L   L + RP       L     + +A   + G QYL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197

Query: 210 EQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           E+     I+RD+   N LL     G   K+ DFG+A+              M    +  P
Sbjct: 198 EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT----------GRKAIDQTKDRKELNLVAWARPMF 316
           +  M G  T K+D +SFGV+L E+ +           ++ ++       ++      P  
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD-----PPKN 310

Query: 317 -KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
                                  +Y+   I   C Q QP  RP    ++  + Y      
Sbjct: 311 CPGP-------------------VYR---IMTQCWQHQPEDRPNFAIILERIEYCT---- 344

Query: 376 DPQNPPSRSSRKSPSCLGVNKDDD 399
             Q+P   ++        + ++++
Sbjct: 345 --QDPDVINTALPIEYGPLVEEEE 366

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 2e-35
 Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 32/292 (10%)

Query: 21  KNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKP 80
            +    + +    ++   PR     +           L     + NL     N+      
Sbjct: 12  HHHGRRRASVAAGILV--PRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69

Query: 81  FTFDELAAATGNF---RSDCC------LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHR 127
               EL  A  +     S         +G G FG VY G L   +  +   A+K L    
Sbjct: 70  ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129

Query: 128 GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDT 186
            +  V +F  E + +    HPN++ L+G C   +   L+V  YM  G L   + +   + 
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 188

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
                   +      ++G+++L  +     ++RDL   N +L+E +  K++DFGLA+   
Sbjct: 189 --PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243

Query: 247 SGDKTHVSTRVMG------TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             +   V  +              A +   T + T KSD++SFGV+L EL+T
Sbjct: 244 DKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (333), Expect = 3e-35
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 28/213 (13%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LG+G FG V +  L   +     VA+K L  D      + EF  E   +   DHP++ KL
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 154 IGYCAEGDQR------LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGL 205
           +G       +      +++  +M  G L   L   R    P  L   T ++     + G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV----MG 259
           +YL        I+RDL   N +L E     ++DFGL++   SGD  +   ++++    + 
Sbjct: 151 EYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                A +       T  SD+++FGV + E++T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  130 bits (328), Expect = 3e-35
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     +  VAIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 16  IGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV E+M  G L  +L   R         T + +      G+ YL E+    VI+
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYL-EEAC--VIH 127

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGD-KTHVSTRV----MGTYGYCAPDYAMTGQ 273
           RDL   N L+ E    K+SDFG+ +        +   T+            +P+     +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPEVFSFSR 181

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            + KSD++SFGV++ E+ + G+ 
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (329), Expect = 4e-35
 Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 29/214 (13%)

Query: 99  LGEGGFGKVYKGCL-------EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           LG+G F K++KG         +  E  V +K LD         F      +    H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
              G C  GD+ +LV E++  GSLD +L   +     ++   ++++A   +  + +L E+
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFL-EE 131

Query: 212 LKQPVIYRDLKCSNILLEEGYHP--------KLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
               +I+ ++   NILL              KLSD G++      D        +     
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV----- 184

Query: 264 CAPDYAMTGQL-TFKSDIYSFGVVLLELIT-GRK 295
             P+     +     +D +SFG  L E+ + G K
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  135 bits (341), Expect = 4e-35
 Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 9/195 (4%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG+G FG+V+ G        VAIK L   G      F  E   +    H  LV+L    
Sbjct: 274 KLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           +E +   +V EYM  GSL   L       + L     + +AA  + G+ Y+        +
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFK 277
           +RDL+ +NIL+ E    K++DFGLA++    ++            + AP+ A+ G+ T K
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

Query: 278 SDIYSFGVVLLELIT 292
           SD++SFG++L EL T
Sbjct: 445 SDVWSFGILLTELTT 459

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  131 bits (331), Expect = 4e-35
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           LGEG FG V +G L   +     VA+K +  D+   + + EF +E   +    HPN+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 154 IGYCAEGDQR-----LLVYEYMPLGSLDKHLHDLRPDTRP--LDWNTRMKIAAGASRGLQ 206
           +G C E   +     +++  +M  G L  +L   R +T P  +   T +K     + G++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV----MGT 260
           YL        ++RDL   N +L +     ++DFGL+K   SGD  +     ++    +  
Sbjct: 162 YL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
               A +       T KSD+++FGV + E+ T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (343), Expect = 4e-35
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 99  LGEGGFGKVYKGCL--EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           LG G FG V +G     K +  VAIK L          E   E   +   D+P +V+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            C + +  +LV E    G L K L   R +   +  +   ++    S G++YL E+    
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL-EEKN-- 456

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTG 272
            ++R+L   N+LL   ++ K+SDFGL+K   + D  + +           + AP+     
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECINFR 514

Query: 273 QLTFKSDIYSFGVVLLELIT-GRK 295
           + + +SD++S+GV + E ++ G+K
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  129 bits (327), Expect = 5e-35
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G  +  +  VA+K +   G     EF  E  T+    HP LVK  G C+
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     +V EY+  G L  +L         L+ +  +++      G+ +L E  +   I+
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL-ESHQ--FIH 127

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
           RDL   N L++     K+SDFG+ +              +GT     + AP+     + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHYFKYS 183

Query: 276 FKSDIYSFGVVLLELIT-GRK 295
            KSD+++FG+++ E+ + G+ 
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (329), Expect = 6e-35
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +G+G FG VY G      +     AIK L     +Q V  F  E + +   +HPN++ LI
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 155 GYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           G     +    ++  YM  G L + +   + +         +      +RG++YL  + K
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGLQVARGMEYL-AEQK 144

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG------TYGYCAPD 267
              ++RDL   N +L+E +  K++DFGLA+     +   V            T    A +
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198

Query: 268 YAMTGQLTFKSDIYSFGVVLLELIT 292
              T + T KSD++SFGV+L EL+T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (336), Expect = 7e-35
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 11/196 (5%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG G FG+V+          VA+K +   G   V  F AE   + +  H  LVKL    
Sbjct: 195 KLGAGQFGEVWMATY-NKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            + +   ++ E+M  GSL   L     +         +  +A  + G+ ++ ++     I
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD-KTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           +RDL+ +NIL+      K++DFGLA++    +       +      + AP+    G  T 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAPEAINFGSFTI 364

Query: 277 KSDIYSFGVVLLELIT 292
           KSD++SFG++L+E++T
Sbjct: 365 KSDVWSFGILLMEIVT 380

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  129 bits (327), Expect = 8e-35
 Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 15/197 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G     +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 32  LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R           +++       ++YL E  +   ++
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYL-ESKQ--FLH 143

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT---YGYCAPDYAMTGQLT 275
           RDL   N L+ +    K+SDFGL++     +     T  +G+     +  P+  M  + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLMYSKFS 199

Query: 276 FKSDIYSFGVVLLELIT 292
            KSDI++FGV++ E+ +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (325), Expect = 2e-34
 Identities = 59/214 (27%), Positives = 88/214 (41%), Gaps = 37/214 (17%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +GEG FG V++G     E     VAIK   +        +F  E +T+   DHP++VKLI
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G     +   ++ E   LG L   L   +     LD  + +  A   S  L YL  +   
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLESK--- 135

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY----------- 263
             ++RD+   N+L+      KL DFGL+             R M    Y           
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKGKLPIK 182

Query: 264 -CAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRK 295
             AP+     + T  SD++ FGV + E++  G K
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (337), Expect = 4e-34
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVKLI 154
           +GEG FG V++G     E     VAIK   +        +F  E +T+   DHP++VKLI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G     +   ++ E   LG L   L   +     LD  + +  A   S  L YL  +   
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESK--- 510

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG-----YCAPDYA 269
             ++RD+   N+L+      KL DFGL++                + G     + AP+  
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGKLPIKWMAPESI 564

Query: 270 MTGQLTFKSDIYSFGVVLLELIT 292
              + T  SD++ FGV + E++ 
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  131 bits (331), Expect = 4e-34
 Identities = 56/200 (28%), Positives = 89/200 (44%), Gaps = 23/200 (11%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            +G+G FG V  G        VA+K +  +     + F AE   +    H NLV+L+G  
Sbjct: 200 TIGKGEFGDVMLGDYRG--NKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 158 AEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
            E    L +V EYM  GSL  +L         L  +  +K +      ++YL        
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV----MGTYGYCAPDYAMTG 272
           ++RDL   N+L+ E    K+SDFGL K       T  + ++           AP+     
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 361

Query: 273 QLTFKSDIYSFGVVLLELIT 292
           + + KSD++SFG++L E+ +
Sbjct: 362 KFSTKSDVWSFGILLWEIYS 381

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (320), Expect = 8e-34
 Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 11/196 (5%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG G FG+V+ G        VA+K L  +G      F AE   +    H  LV+L    
Sbjct: 20  RLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            + +   ++ EYM  GSL   L    P    L  N  + +AA  + G+ ++ E+     I
Sbjct: 78  TQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI-EERN--YI 131

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD-KTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           +RDL+ +NIL+ +    K++DFGLA++    +       +      + AP+    G  T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 189

Query: 277 KSDIYSFGVVLLELIT 292
           KSD++SFG++L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (323), Expect = 1e-33
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 41/226 (18%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +GEG FG+V++     +       +VA+K L +        +F  E   +   D+PN+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--------------------RPLDWN 192
           L+G CA G    L++EYM  G L++ L  + P T                     PL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--K 250
            ++ IA   + G+ YL  + K   ++RDL   N L+ E    K++DFGL++   S D  K
Sbjct: 175 EQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231

Query: 251 THVSTRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
              +  +    M       P+     + T +SD++++GVVL E+ +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (320), Expect = 2e-33
 Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 38/218 (17%)

Query: 99  LGEGGFGKVYKGCLEK--IEQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADHPNLVK 152
           +GEG FG+V K  ++K  +    AIK++ ++      R+F+   EV+  LG   HPN++ 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG--HHPNIIN 90

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRMKIAAG 200
           L+G C       L  EY P G+L   L   R                 L     +  AA 
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVSTRV- 257
            +RG+ YL  Q +   I+RDL   NIL+ E Y  K++DFGL++     +        R+ 
Sbjct: 151 VARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204

Query: 258 ---MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
              M      A +       T  SD++S+GV+L E+++
Sbjct: 205 VRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (317), Expect = 2e-33
 Identities = 68/311 (21%), Positives = 124/311 (39%), Gaps = 55/311 (17%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
           +F+    +G GGFG+V+K    +I+ +   IK++ +   +  RE    V  L   DH N+
Sbjct: 12  DFKEIELIGSGGFGQVFK-AKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNI 66

Query: 151 VKLIGYCAEGDQRL----------------LVYEYMPLGSLDKHLHDLRPDTRPLDWNTR 194
           V   G     D                   +  E+   G+L++ +   R     LD    
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLA 124

Query: 195 MKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS 254
           +++    ++G+ Y+H +    +I RDLK SNI L +    K+ DFGL     +  K    
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP 314
           TR  GT  Y +P+   +     + D+Y+ G++L EL+                       
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------------------CDT 220

Query: 315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK 374
            F+  K F+ + D  +   +      +   +    + ++P  RP  +++   L  L   K
Sbjct: 221 AFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI---LRTLTVWK 273

Query: 375 YDPQNPPSRSS 385
             P+     ++
Sbjct: 274 KSPEKNERHTA 284

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (316), Expect = 3e-33
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 24/203 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G FG V  G     +  VA+K +        + F AE   +    H NLV+L+G   
Sbjct: 29  IGKGEFGDVMLGDYRGNK--VAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 159 EGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           E    L +V EYM  GSL  +L         L  +  +K +      ++YL E      +
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 139

Query: 218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV----MGTYGYCAPDYAMTGQ 273
           +RDL   N+L+ E    K+SDFGL K       T  + ++           AP+     +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190

Query: 274 LTFKSDIYSFGVVLLELIT-GRK 295
            + KSD++SFG++L E+ + GR 
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  124 bits (314), Expect = 5e-33
 Identities = 60/275 (21%), Positives = 111/275 (40%), Gaps = 33/275 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIG- 155
           +G G +G+  K   +   +++  K+LD+  +     +   +EV  L    HPN+V+    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ--L 212
                +  L +V EY   G L   +     + + LD    +++    +  L+  H +   
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
              V++RDLK +N+ L+   + KL DFGLA+ +          T V GT  Y +P+    
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYYMSPEQMNR 190

Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
                KSDI+S G +L EL                       P F    +  ++     +
Sbjct: 191 MSYNEKSDIWSLGCLLYELCAL-------------------MPPFTA-FSQKELAGKIRE 230

Query: 332 GQY-PVRGLY--QALAIAAMCVQEQPNMRPAITDV 363
           G++  +   Y  +   I    +  +   RP++ ++
Sbjct: 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (315), Expect = 1e-32
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 40/223 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-------EQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADH 147
           LGEG FG+V       I          VA+K L D    + + +     E+M  +G   H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 100

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRM 195
            N++ L+G C +     ++ EY   G+L ++L   RP                + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHV 253
                 +RG++YL    K   I+RDL   N+L+ E    K++DFGLA+   + D  K   
Sbjct: 161 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 254 STRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + R+    M      AP+       T +SD++SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (317), Expect = 1e-32
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 99  LGEGGFGKVYKGCLEKIE-------QVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADH 147
           LGEG FG+V       I+         VA+K L D    + + +     E+M  +G   H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 146

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRM 195
            N++ L+G C +     ++ EY   G+L ++L   RP                + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHV 253
                 +RG++YL    K   I+RDL   N+L+ E    K++DFGLA+   + D  K   
Sbjct: 207 SCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 254 STRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + R+    M      AP+       T +SD++SFGV++ E+ T
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  123 bits (311), Expect = 2e-32
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 11/199 (5%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKLIG 155
           LG GG   VY      +   VAIK +        + ++ F  EV       H N+V +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              E D   LV EY+   +L +++        PL  +T +        G+++ H+     
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---R 131

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           +++RD+K  NIL++     K+ DFG+AK       T  +  V+GT  Y +P+ A      
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATD 190

Query: 276 FKSDIYSFGVVLLELITGR 294
             +DIYS G+VL E++ G 
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (313), Expect = 2e-32
 Identities = 66/332 (19%), Positives = 128/332 (38%), Gaps = 42/332 (12%)

Query: 98  CLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLI 154
            +GEG FGK         + +   IK+++   +  +   E   EV  L +  HPN+V+  
Sbjct: 31  KIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
               E     +V +Y   G L K ++  +        +  +         L+++H++   
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRK-- 145

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
            +++RD+K  NI L +    +L DFG+A+ +  + +       + GT  Y +P+      
Sbjct: 146 -ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI-GTPYYLSPEICENKP 201

Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ 333
              KSDI++ G VL EL T                    +  F+   +   +V   + G 
Sbjct: 202 YNNKSDIWALGCVLYELCTL-------------------KHAFEA-GSMKNLVLKIISGS 241

Query: 334 Y-PVRGLY-QAL-AIAAMCVQEQPNMRPAITD------VVMALNYLASQKYDPQNPPSRS 384
           + PV   Y   L ++ +   +  P  RP++        +   +    S +   +    ++
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKT 301

Query: 385 SRKSPSCLGVNKDDDHGKNARSASNREEVKSS 416
             K  S     K    G+N+ S    +++   
Sbjct: 302 FSKFGSQPIPAKRPASGQNSISVMPAQKITKP 333

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (311), Expect = 3e-32
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 16/201 (7%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            +G G FG+V++   ++     A+K++     +       E++       P +V L G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
            EG    +  E +  GS    L  L      L  +  +     A  GL+YLH    + ++
Sbjct: 120 REGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHT---RRIL 172

Query: 218 YRDLKCSNILL-EEGYHPKLSDFGLAK-MGPSGDKTHVSTR--VMGTYGYCAPDYAMTGQ 273
           + D+K  N+LL  +G    L DFG A  + P G    + T   + GT  + AP+  M   
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 274 LTFKSDIYSFGVVLLELITGR 294
              K DI+S   ++L ++ G 
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  127 bits (320), Expect = 6e-32
 Identities = 53/212 (25%), Positives = 79/212 (37%), Gaps = 26/212 (12%)

Query: 91  GNFRSDCCLGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHP 148
           G +    C+  GG G +Y         + V +K L H G    +    AE   L    HP
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 149 NLVKLIGYCAEGDQRL-----LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           ++V++  +    D+       +V EY+   SL +         + L     +        
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILP 193

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYG 262
            L YLH      ++Y DLK  NI+L E    KL D G    +   G        + GT G
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGTPG 242

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           + AP+       T  +DIY+ G  L  L    
Sbjct: 243 FQAPEIV-RTGPTVATDIYTVGRTLAALTLDL 273

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  121 bits (307), Expect = 1e-31
 Identities = 61/223 (27%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAE--VM-TLGSADHPN 149
           LG G FGKV +     +        VA+K L     +       +E  V+  LG  +H N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG--NHMN 88

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--------------RPLDWNTRM 195
           +V L+G C  G   L++ EY   G L   L   R                   LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             +   ++G+ +L        I+RDL   NILL  G   K+ DFGLA+   +     V  
Sbjct: 149 SFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 256 ------RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                 + M      AP+       TF+SD++S+G+ L EL +
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (309), Expect = 1e-31
 Identities = 63/273 (23%), Positives = 108/273 (39%), Gaps = 21/273 (7%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREF-SAEVMTLGSADHPNLV 151
           F     LG G  G V+K   +    V+A K +       +R     E+  L   + P +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
              G      +  +  E+M  GSLD     +      +      K++    +GL YL E+
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
            K  +++RD+K SNIL+      KL DFG++ ++  S   + V     GT  Y +P+   
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQ 203

Query: 271 TGQLTFKSDIYSFGVVLLELITGR-----KAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
               + +SDI+S G+ L+E+  GR         + +      +   A       +   + 
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP 358
           ++       P   +++ L      V E P   P
Sbjct: 264 LNKFGMDSRPPMAIFELL---DYIVNEPPPKLP 293

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (307), Expect = 1e-31
 Identities = 69/226 (30%), Positives = 104/226 (46%), Gaps = 41/226 (18%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LGEG FGKV K     +        VA+K L ++     +R+  +E   L   +HP+++K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------------------DTRPLDWN 192
           L G C++    LL+ EY   GSL   L + R                     D R L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--K 250
             +  A   S+G+QYL  ++K  +++RDL   NIL+ EG   K+SDFGL++     D   
Sbjct: 151 DLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 251 THVSTRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                R+    M      A +       T +SD++SFGV+L E++T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  121 bits (306), Expect = 1e-31
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 35/223 (15%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG+G FG+V K       +  AIK++ H   + +    +EVM L S +H  +V+     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 158 AEGDQRL-------------LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
            E    +             +  EY   G+L   +H           +   ++       
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEA 128

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-------------GPSGDKT 251
           L Y+H Q    +I+RDLK  NI ++E  + K+ DFGLAK                 G   
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185

Query: 252 HVSTRVMGTYGYCAPD-YAMTGQLTFKSDIYSFGVVLLELITG 293
           ++++ + GT  Y A +    TG    K D+YS G++  E+I  
Sbjct: 186 NLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  122 bits (309), Expect = 2e-31
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 40/223 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-------EQVVAIKQL-DHRGVQGVREFS--AEVMT-LGSADH 147
           LGEG FG+V       +          VA+K L      + + +     E+M  +G   H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--KH 134

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------M 195
            N++ L+G C +     ++ EY   G+L ++L   RP      +N              +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHV 253
             A   +RG++YL    K   I+RDL   N+L+ E    K++DFGLA+     D  K   
Sbjct: 195 SCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 254 STRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           + R+    M      AP+       T +SD++SFGV+L E+ T
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (306), Expect = 2e-31
 Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 36/219 (16%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAE--VMT-LGSADHPN 149
           LG G FGKV +     +        VA+K L             +E  +M+ LG   H N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHEN 111

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR----------MKIAA 199
           +V L+G C  G   L++ EY   G L   L                         +  ++
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST---- 255
             ++G+ +L        I+RD+   N+LL  G+  K+ DFGLA+   +     V      
Sbjct: 172 QVAQGMAFL-ASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 256 --RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             + M      AP+       T +SD++S+G++L E+ +
Sbjct: 229 PVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  120 bits (303), Expect = 3e-31
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGY 156
           CLG GGFG V++   +  +   AIK++     +  RE    EV  L   +HP +V+    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 157 CAEGD---------QRLLVY---EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
             E +          ++ +Y   +     +L K   + R      + +  + I    +  
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM----------GPSGDKTHVS 254
           +++LH +    +++RDLK SNI        K+ DFGL                       
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 255 TRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
           T  +GT  Y +P+       + K DI+S G++L EL+ 
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  120 bits (302), Expect = 3e-31
 Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 13/202 (6%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            LG+G +G VY G     +  +AIK++  R  +  +    E+       H N+V+ +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI 217
           +E     +  E +P GSL   L   +      +  T          GL+YLH+     ++
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIV 144

Query: 218 YRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP---DYAMTG 272
           +RD+K  N+L+    G   K+SDFG +K     +    +    GT  Y AP   D    G
Sbjct: 145 HRDIKGDNVLINTYSG-VLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG 201

Query: 273 QLTFKSDIYSFGVVLLELITGR 294
                +DI+S G  ++E+ TG+
Sbjct: 202 -YGKAADIWSLGCTIIEMATGK 222

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (303), Expect = 4e-31
 Identities = 52/207 (25%), Positives = 78/207 (37%), Gaps = 11/207 (5%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVRE-FSAEVMTLGSADH 147
           G +R    +G GG G VY+      E++VA+K +          R     E  T G    
Sbjct: 34  GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P++V +  +     Q  +    +    L   L        PL     + I       L  
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDA 149

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
            H        +RD+K  NIL+       L DFG+A        T +    +GT  Y AP+
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPE 205

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGR 294
                  T+++DIY+   VL E +TG 
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGS 232

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  119 bits (300), Expect = 5e-31
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 20/212 (9%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADH 147
                 LG G +G V K       Q++A+K++          + + +     +++ + D 
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLD---ISMRTVDC 65

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P  V   G         +  E M   SLDK    +    + +  +   KIA    + L++
Sbjct: 66  PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP 266
           LH +L   VI+RD+K SN+L+      K+ DFG+   +     K        G   Y AP
Sbjct: 125 LHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGCKPYMAP 178

Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
                       + KSDI+S G+ ++EL   R
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  119 bits (301), Expect = 6e-31
 Identities = 48/242 (19%), Positives = 92/242 (38%), Gaps = 25/242 (10%)

Query: 68  KDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR 127
              S+      +   F  ++     +     +G GG  KV++  L + +Q+ AIK ++  
Sbjct: 5   HHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLE 63

Query: 128 GV--QGVREFSAEVMTLGSADHPNL--VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR 183
               Q +  +  E+  L      +   ++L  Y        +V E      L+  L    
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-- 120

Query: 184 PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
              + +D   R          +  +H+     +++ DLK +N L+ +G   KL DFG+A 
Sbjct: 121 --KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIAN 174

Query: 244 MGPSGDKTHVSTRVMGTYGYCAP-----------DYAMTGQLTFKSDIYSFGVVLLELIT 292
                  + V    +GT  Y  P           +     +++ KSD++S G +L  +  
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234

Query: 293 GR 294
           G+
Sbjct: 235 GK 236

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  119 bits (301), Expect = 1e-30
 Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 35/229 (15%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA------------- 137
            ++R    L +G F K+     EK  +  A+K+ +   ++  R+F+              
Sbjct: 31  NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 138 ----EVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPL 189
               E+  +    +   +   G     D+  ++YEYM   S+ K            T  +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 190 DWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD 249
                  I         Y+H +    + +RD+K SNIL+++    KLSDFG ++      
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206

Query: 250 -KTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVLLELITGR 294
            K        GTY +  P+   + + ++   K DI+S G+ L  +    
Sbjct: 207 IKG-----SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  118 bits (298), Expect = 2e-30
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 39/222 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADHPN 149
           LG G FG+V +     I      + VA+K L +       R      +++  +G   H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92

Query: 150 LVKLIGYCAEGDQ-RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------------MK 196
           +V L+G C +     +++ E+   G+L  +L   R +  P                  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 197 IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD--KTHVS 254
            +   ++G+++L    K   I+RDL   NILL E    K+ DFGLA+             
Sbjct: 153 YSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 255 TRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
            R+    M      AP+       T +SD++SFGV+L E+ +
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  118 bits (298), Expect = 2e-30
 Identities = 46/212 (21%), Positives = 85/212 (40%), Gaps = 25/212 (11%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNL--VKL 153
            +G GG  KV++  L + +Q+ AIK ++      Q +  +  E+  L      +   ++L
Sbjct: 16  QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
             Y        +V E      L+  L       + +D   R          +  +H+   
Sbjct: 75  YDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 128

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------- 266
             +++ DLK +N L+ +G   KL DFG+A        + V    +GT  Y  P       
Sbjct: 129 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
               +     +++ KSD++S G +L  +  G+
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  118 bits (298), Expect = 3e-30
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 45/228 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFS--AEVM-TLGSADHPN 149
           LG G FGKV       I        VA+K L +              ++M  LG   H N
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG--SHEN 110

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLD 190
           +V L+G C       L++EY   G L  +L   R                    D   L 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 191 WNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD- 249
           +   +  A   ++G+++L E      ++RDL   N+L+  G   K+ DFGLA+   S   
Sbjct: 171 FEDLLCFAYQVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 250 -KTHVSTRV----MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
                + R+    M      AP+    G  T KSD++S+G++L E+ +
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (296), Expect = 5e-30
 Identities = 71/308 (23%), Positives = 112/308 (36%), Gaps = 43/308 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYC 157
           L EGGF  VY+       +  A+K+L     +  R    EV  +   + HPN+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 158 AEGDQR-------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           + G +         L+   +  G L + L  +      L  +T +KI     R +Q++H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMHR 154

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---KMGPSGDKTHVSTRVM-------GT 260
           Q K P+I+RDLK  N+LL      KL DFG A      P    +     ++        T
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 261 YGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
             Y  P   D      +  K DI++ G +L  L   +   +     + +N     +    
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----GKYSIP 269

Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP 377
                                L     I AM +Q  P  R +I +VV  L  +A+ +   
Sbjct: 270 PHDTQYT----------VFHSL-----IRAM-LQVNPEERLSIAEVVHQLQEIAAARNVN 313

Query: 378 QNPPSRSS 385
              P    
Sbjct: 314 PKSPITEL 321

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  117 bits (294), Expect = 6e-30
 Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 13/203 (6%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLV 151
           F     +G+G FG+V+KG   + ++VVAIK +D    +  + +   E+  L   D P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           K  G   +  +  ++ EY+  GS    L  L P   PLD      I     +GL YLH +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSA---LDLLEP--GPLDETQIATILREILKGLDYLHSE 138

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
            K   I+RD+K +N+LL E    KL+DFG+  ++  +  K +     +GT  + AP+   
Sbjct: 139 KK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIK 192

Query: 271 TGQLTFKSDIYSFGVVLLELITG 293
                 K+DI+S G+  +EL  G
Sbjct: 193 QSAYDSKADIWSLGITAIELARG 215

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  116 bits (292), Expect = 9e-30
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 21/210 (10%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +     LG+G FGKVYK   ++   + A K ++ +  + + ++  E+  L + DHP +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           L+G      +  ++ E+ P G++D     +     R L       +       L +LH +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVD----AIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDK--THVSTRVMGTYGYCAP-- 266
                I+RDLK  N+L+      +L+DFG+ AK   +  K  + +     GT  + AP  
Sbjct: 137 RI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188

Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITG 293
              +        +K+DI+S G+ L+E+   
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 1e-29
 Identities = 42/334 (12%), Positives = 93/334 (27%), Gaps = 73/334 (21%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDH----------------------RGVQGVREFS 136
           LG+       +   ++  +   +                           RG++  ++  
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 137 AEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVYEY--MP-----LGSLDKHLHDLRPDT 186
             +  +   D    P   K+I    +     ++  +   P     L +  + L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
           + L  + R+++     R L  LH      +++  L+  +I+L++     L+ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 247 SGDKTHVSTRVMGTYGYCAPDY----------AMTGQLTFKSDIYSFGVVLLELITGRKA 296
            G     S       G+  P+                +TF  D ++ G+ +  +      
Sbjct: 261 DGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 297 IDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM 356
                       +  +  +F+  KN  Q          PVR L     +     +     
Sbjct: 317 NTDD------AALGGSEWIFRSCKNIPQ----------PVRAL-----LEGFL-RYPKED 354

Query: 357 RPAITDVVMALNYLASQKYDPQNPPSRSSRKSPS 390
           R      +    Y   +       P   +   P+
Sbjct: 355 RLLPLQAMETPEYEQLRTELSAALPLYQTDGEPT 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  119 bits (300), Expect = 2e-29
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 18/216 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG+GGFG+V    +    ++ A K+L+ + +   +G      E   L   +   +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
           Y  E    L LV   M  G L  H++ +     P     R    AA    GL+ LH +  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCGLEDLHRER- 306

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             ++YRDLK  NILL++  H ++SD GLA   P G       RV GT GY AP+     +
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNER 361

Query: 274 LTFKSDIYSFGVVLLELITGR---KAIDQTKDRKEL 306
            TF  D ++ G +L E+I G+   +   +   R+E+
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (295), Expect = 2e-29
 Identities = 45/212 (21%), Positives = 84/212 (39%), Gaps = 25/212 (11%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNL--VKL 153
            +G GG  KV++  L + +Q+ AIK ++      Q +  +  E+  L      +   ++L
Sbjct: 63  QIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
             Y        +V E      L+  L       + +D   R          +  +H+   
Sbjct: 122 YDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG- 175

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------- 266
             +++ DLK +N L+ +G   KL DFG+A        + V    +G   Y  P       
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
               +     +++ KSD++S G +L  +  G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  116 bits (292), Expect = 3e-29
 Identities = 34/214 (15%), Positives = 70/214 (32%), Gaps = 20/214 (9%)

Query: 98  CLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
            LGEG F +VY+         K +Q   +K             +  +  L  +     +K
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQ 211
                   +  +LV E    G+L   ++  +    + +     +  A      ++ +H+ 
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191

Query: 212 LKQPVIYRDLKCSNILLEEGYHP-----------KLSDFGLAKMGPSGDKTHVSTRVMGT 260
               +I+ D+K  N +L  G+              L D G +       K  + T    T
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
            G+   +        ++ D +     +  ++ G 
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  116 bits (292), Expect = 3e-29
 Identities = 30/291 (10%), Positives = 59/291 (20%), Gaps = 49/291 (16%)

Query: 77  SAKPFTFD-ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---V 132
                T D  L+      +    L  G    V+     +  +  A+K            +
Sbjct: 47  QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 133 REFSAEVMTLGSADHPNLVKLIGYC--------------------------AEGDQRLLV 166
                           +  +                                     LL+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 167 YEYMP--LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCS 224
                  L  L   L  +              + A   R    L  +    +++      
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPD 223

Query: 225 NILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM--TGQLTFKSDIYS 282
           N+ +       L D         G +   S+       Y   ++    T   T   + + 
Sbjct: 224 NLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQ 278

Query: 283 FGVVLLELITGR-------KAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
            G+ +  +             I  +  R  L +       F         V
Sbjct: 279 LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV 329

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (287), Expect = 3e-29
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 16/200 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FG VY    ++ + ++A+K L    ++      +   EV       HPN+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
           Y  +  +  L+ EY PLG++ + L   +  ++  +  T        +  L Y H    + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTA-TYITELANALSYCH---SKR 129

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG-DKTHVSTRVMGTYGYCAPDYAMTGQL 274
           VI+RD+K  N+LL      K++DFG +   PS          + GT  Y  P+       
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMH 184

Query: 275 TFKSDIYSFGVVLLELITGR 294
             K D++S GV+  E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  115 bits (289), Expect = 3e-29
 Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 14/206 (6%)

Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN 149
              F     LGEG +G VYK   ++  Q+VAIKQ+       ++E   E+  +   D P+
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDL-RPDTRPLDWNTRMKIAAGASRGLQYL 208
           +VK  G   +     +V EY   GS+     D+ R   + L  +    I     +GL+YL
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVS----DIIRLRNKTLTEDEIATILQSTLKGLEYL 141

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPD 267
           H   K   I+RD+K  NILL    H KL+DFG+  ++  +  K +    V+GT  + AP+
Sbjct: 142 HFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPE 195

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                     +DI+S G+  +E+  G
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEG 221

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (289), Expect = 4e-29
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEV-MTLGSADHPN 149
           + +    +G G +G V K   +   Q++A+K++      +  ++   ++ + + S+D P 
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYL 208
           +V+  G         +  E M   S DK    +       +      KI     + L +L
Sbjct: 83  IVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAP- 266
            E LK  +I+RD+K SNILL+   + KL DFG+  ++  S  K    TR  G   Y AP 
Sbjct: 142 KENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAGCRPYMAPE 195

Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
                A       +SD++S G+ L EL TGR
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  114 bits (288), Expect = 4e-29
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 12/212 (5%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPNL 150
           ++     +G G    V        ++ VAIK+++  +    + E   E+  +    HPN+
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSL----DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           V         D+  LV + +  GS+       +      +  LD +T   I      GL+
Sbjct: 76  VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTR--VMGTYGY 263
           YLH+  +   I+RD+K  NILL E    +++DFG+ A +   GD T    R   +GT  +
Sbjct: 136 YLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 264 CAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
            AP+     +   FK+DI+SFG+  +EL TG 
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  114 bits (287), Expect = 5e-29
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDH---RGVQGVREFSAEVMTLGSADHPNLVKL-- 153
           LG GG  +V+     +  + VA+K L     R       F  E     + +HP +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 154 IGYCAEGDQRLLVY---EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
            G  AE     L Y   EY+   +L   +H       P+     +++ A A + L + H+
Sbjct: 80  TG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 134

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST-RVMGTYGYCAPDYA 269
                +I+RD+K +NI++      K+ DFG+A+       +   T  V+GT  Y +P+ A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
               +  +SD+YS G VL E++TG 
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  113 bits (286), Expect = 6e-29
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 12/202 (5%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +     +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
            +     GD+  +V EY+  GSL     D+      +D      +     + L++LH   
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVV-TETCMDEGQIAAVCRECLQALEFLH--- 133

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
              VI+RD+K  NILL      KL+DFG  A++ P   K    T V GT  + AP+    
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEVVTR 190

Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                K DI+S G++ +E+I G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (285), Expect = 7e-29
 Identities = 50/199 (25%), Positives = 88/199 (44%), Gaps = 14/199 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FG VY    ++ + ++A+K L    ++      +   E+       HPN++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
           Y  +  +  L+ E+ P G L K L   +   R  +  +   +   A   L Y H   ++ 
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELAD-ALHYCH---ERK 134

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           VI+RD+K  N+L+      K++DFG +   PS  +        GT  Y  P+        
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPS-LRRRTMC---GTLDYLPPEMIEGKTHD 190

Query: 276 FKSDIYSFGVVLLELITGR 294
            K D++  GV+  E + G 
Sbjct: 191 EKVDLWCAGVLCYEFLVGM 209

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  117 bits (294), Expect = 9e-29
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 15/216 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG GGFG+V+   ++   ++ A K+L+ + +   +G +    E   L       +V L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
           Y  E    L LV   M  G +  H++++  D        R     A    GL++LH++  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLEHLHQR-- 308

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +IYRDLK  N+LL++  + ++SD GLA    +G          GT G+ AP+  +  +
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEE 365

Query: 274 LTFKSDIYSFGVVLLELITGR---KAIDQTKDRKEL 306
             F  D ++ GV L E+I  R   +A  +  + KEL
Sbjct: 366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  113 bits (284), Expect = 2e-28
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 12/202 (5%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
             S   +GEG  G V     +   + VA+K +D R  Q       EV+ +    H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           +      G++  ++ E++  G+L     D+      L+      +     + L YLH   
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQV-RLNEEQIATVCEAVLQALAYLH--- 158

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            Q VI+RD+K  +ILL      KLSDFG  A++     K    + V GT  + AP+    
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISR 215

Query: 272 GQLTFKSDIYSFGVVLLELITG 293
                + DI+S G++++E++ G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  112 bits (282), Expect = 2e-28
 Identities = 50/302 (16%), Positives = 93/302 (30%), Gaps = 66/302 (21%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSA--EVMTLGS-ADH 147
            F     +G G FG V+K C+++++  + AIK+        V E +A  EV        H
Sbjct: 12  EFHELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            ++V+     AE D  L+  EY   GSL   + +               +     RGL+Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 208 LHEQLKQPVIYRDLKCSNILL-------------------EEGYHPKLSDFGLAKMGPSG 248
           +H      +++ D+K SNI +                         K+ D G      S 
Sbjct: 131 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI-SS 186

Query: 249 DKTHVST-------RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK 301
            +             +   Y +             K+DI++  + ++             
Sbjct: 187 PQVEEGDSRFLANEVLQENYTH-----------LPKADIFALALTVVCAAGAEPLPRN-- 233

Query: 302 DRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT 361
                          + R+       P +          +   +  + +   P  RP+  
Sbjct: 234 ----------GDQWHEIRQGRL----PRIPQVLS----QEFTELLKVMIHPDPERRPSAM 275

Query: 362 DV 363
            +
Sbjct: 276 AL 277

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (284), Expect = 4e-28
 Identities = 26/239 (10%), Positives = 65/239 (27%), Gaps = 52/239 (21%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE------------------------ 134
           LG+       +   ++  +   +                                     
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 135 ----FSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLVYEYM--PLGSLDKHLHDLRPDT 186
               F      +       ++++     +     R  +Y  M   L +  + L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
           + L  + R+++     R L  LH      +++  L+  +I+L++     L+ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGR 294
              +         + G+  P+                 +TF  D ++ G+V+  +    
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  111 bits (280), Expect = 5e-28
 Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 20/234 (8%)

Query: 71  SNNSGKSAKPFTFDE--LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDH-R 127
           S +SGK     T       A   +  +   +G G  G+V+K    K   V+A+KQ+    
Sbjct: 3   SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62

Query: 128 GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT 186
             +  +    ++  +  + D P +V+  G         +  E M     +K     +   
Sbjct: 63  NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEK---LKKRMQ 118

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMG 245
            P+      K+     + L YL E+    VI+RD+K SNILL+E    KL DFG+  ++ 
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176

Query: 246 PSGDKTHVSTRVMGTYGYCAP-----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
               K     R  G   Y AP               ++D++S G+ L+EL TG+
Sbjct: 177 DDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (281), Expect = 1e-27
 Identities = 44/219 (20%), Positives = 75/219 (34%), Gaps = 22/219 (10%)

Query: 90  TGNFRSDCCLGEG--GFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSA 145
            G +     +G+G      V     +   + V +++  L+    + V     E+      
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA---GAS 202
           +HPN+V         ++  +V  +M  GS    +     D           IA    G  
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG-LAKMGPSGDKTHV----STRV 257
           + L Y+H       ++R +K S+IL+       LS       M   G +  V        
Sbjct: 139 KALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 258 MGTYGYCAPDYAMTGQL--TFKSDIYSFGVVLLELITGR 294
           +    + +P+           KSDIYS G+   EL  G 
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (284), Expect = 3e-27
 Identities = 67/215 (31%), Positives = 92/215 (42%), Gaps = 17/215 (7%)

Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHP 148
            G +     LG GGFG V +   +   + VAIKQ         RE +  E+  +   +HP
Sbjct: 13  CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72

Query: 149 NLVKLI------GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
           N+V            A  D  LL  EY   G L K+L+    +   L       + +  S
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDIS 131

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP---KLSDFGLAKMGPSGDKTHVSTRVMG 259
             L+YLHE     +I+RDLK  NI+L+ G      K+ D G AK    G+       V G
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-G 185

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           T  Y AP+     + T   D +SFG +  E ITG 
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  111 bits (280), Expect = 3e-27
 Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 33/260 (12%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL-GSADHPNL 150
           +F     LG G  G +    +    + VA+K++             EV  L  S +HPN+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECFSFADR---EVQLLRESDEHPNV 80

Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           ++      +   + +  E     +L +++   + D   L       +    + GL +LH 
Sbjct: 81  IRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPI-TLLQQTTSGLAHLHS 136

Query: 211 QLKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAKMGPSGDKT-HVSTRVMGTYGYC 264
                +++RDLK  NIL+            +SDFGL K    G  +    + V GT G+ 
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 265 AP---DYAMTGQLTFKSDIYSFGVVLLELITG---------RKAIDQTKDRKELNLVAWA 312
           AP           T+  DI+S G V   +I+          ++  +       L+ +   
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253

Query: 313 RPMFKDRKNF-SQM--VDPS 329
           +      +    +M  +DP 
Sbjct: 254 KHEDVIARELIEKMIAMDPQ 273

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  109 bits (274), Expect = 4e-27
 Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 22/211 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LG+G    V++G  +K   + AIK  ++       +    E   L   +H N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 158 AEGDQRL--LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            E   R   L+ E+ P GSL   L +   +   L  +  + +      G+ +L E     
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 216 VIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD---- 267
           +++R++K  NI+   G       KL+DFG A+     ++    +   GT  Y  PD    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GTEEYLHPDMYER 189

Query: 268 ----YAMTGQLTFKSDIYSFGVVLLELITGR 294
                    +     D++S GV      TG 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (283), Expect = 4e-27
 Identities = 75/303 (24%), Positives = 121/303 (39%), Gaps = 37/303 (12%)

Query: 15  DEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNS 74
              I++   +L K+     L    P ++      + +V      S        +  +   
Sbjct: 126 KSAIEHVQGHLVKKQVPPDLF--QPYIEEICQNLRGDVFQKFIESDKFTRF-CQWKNVEL 182

Query: 75  GKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QG 131
                   F               +G GGFG+VY        ++ A+K LD + +   QG
Sbjct: 183 NIHLTMNDFSVHRI----------IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG 232

Query: 132 VREFSAE---VMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTR 187
                 E   +  + + D P +V +  Y      +L  + + M  G L  HL      + 
Sbjct: 233 ETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE 291

Query: 188 PLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
                  M+  AA    GL+++H    + V+YRDLK +NILL+E  H ++SD GLA    
Sbjct: 292 A-----DMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343

Query: 247 SGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRK--AIDQTKDR 303
              K H    V GT+GY AP+    G      +D +S G +L +L+ G       +TKD+
Sbjct: 344 -KKKPH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399

Query: 304 KEL 306
            E+
Sbjct: 400 HEI 402

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (274), Expect = 5e-27
 Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 32/241 (13%)

Query: 71  SNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ 130
           S++  +S        L    G F     +G G +G+VYKG   K  Q+ AIK +D  G  
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62

Query: 131 GVREFSAEVMTLGSA-DHPNLVKLIG-----YCAEGDQRL-LVYEYMPLGSLDKHLHDLR 183
              E   E+  L     H N+    G          D +L LV E+   GS+   + + +
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 184 PDTRPLDWNTRMKIAA---GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG 240
            +T   +W     IA       RGL +LH   +  VI+RD+K  N+LL E    KL DFG
Sbjct: 123 GNTLKEEW-----IAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174

Query: 241 LAKMGPSGDKTHVSTR---VMGTYGYCAPDYAMTGQLT-----FKSDIYSFGVVLLELIT 292
           +     S        R    +GT  + AP+     +       FKSD++S G+  +E+  
Sbjct: 175 V-----SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229

Query: 293 G 293
           G
Sbjct: 230 G 230

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (273), Expect = 9e-27
 Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 27/211 (12%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPN 149
           F     +G G FG VY     +  +VVAIK++ + G Q     ++   EV  L    HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAA---GASRGLQ 206
            ++  G         LV EY    + D     L    +PL     ++IAA   GA +GL 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD----LLEVHKKPLQ---EVEIAAVTHGALQGLA 168

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL-AKMGPSGDKTHVSTRVMGTYGYCA 265
           YLH       I+RD+K  NILL E    KL DFG  + M P+   +      +GT  + A
Sbjct: 169 YLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--NS-----FVGTPYWMA 218

Query: 266 PDYAMTGQLT---FKSDIYSFGVVLLELITG 293
           P+  +         K D++S G+  +EL   
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  106 bits (268), Expect = 2e-26
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 15/209 (7%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE-FSAEVMTLGSADH 147
            +F+    LG+G F  VY+         VAIK +D + +   G+ +    EV       H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD-WNTRMKIAAGASRGLQ 206
           P++++L  Y  + +   LV E    G ++++L +     +P      R  +    + G+ 
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIIT-GML 126

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCA 265
           YLH      +++RDL  SN+LL    + K++DFGLA ++    +K +      GT  Y +
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYIS 180

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           P+ A       +SD++S G +   L+ GR
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  108 bits (272), Expect = 2e-26
 Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 22/211 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LG+G    V++G  +K   + AIK  ++       +    E   L   +H N+VKL    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 158 AEGDQRL--LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
            E   R   L+ E+ P GSL   L +   +   L  +  + +      G+ +L E     
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132

Query: 216 VIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD---- 267
           +++R++K  NI+   G       KL+DFG A+     D     +   GT  Y  PD    
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYLHPDMYER 189

Query: 268 ----YAMTGQLTFKSDIYSFGVVLLELITGR 294
                    +     D++S GV      TG 
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (267), Expect = 2e-26
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 14/208 (6%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE-FSAEVMTLGSADH 147
             +     LG+GGF K ++      ++V A K +    +     RE  S E+    S  H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            ++V   G+  + D   +V E     SL +     +  T P     R  +      G QY
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIVL-GCQY 130

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAP 266
           LH      VI+RDLK  N+ L E    K+ DFGLA K+   G++  V     GT  Y AP
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAP 184

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
           +       +F+ D++S G ++  L+ G+
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  106 bits (267), Expect = 5e-26
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 14/208 (6%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVRE-FSAEVMTLGSADH 147
             +     LG+GGF K ++      ++V A K +    +     RE  S E+    S  H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            ++V   G+  + D   +V E     SL +     +  T P     R  +      G QY
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE---ARYYLRQIVL-GCQY 156

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKTHVSTRVMGTYGYCAP 266
           LH      VI+RDLK  N+ L E    K+ DFGLA K+   G++  V     GT  Y AP
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAP 210

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
           +       +F+ D++S G ++  L+ G+
Sbjct: 211 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  101 bits (254), Expect = 3e-24
 Identities = 71/245 (28%), Positives = 104/245 (42%), Gaps = 36/245 (14%)

Query: 61  DVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY---KGCLEKIEQ 117
            +K + +        + A P  F+ L            LG+G FGKV+   K       Q
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLK----------VLGQGSFGKVFLVKKISGSDARQ 53

Query: 118 VVAIKQLDHRGVQGVREFSAEVMT----LGSADHPNLVKLIGYCAEGDQRL-LVYEYMPL 172
           + A+K L    +                L   +HP +VKL  Y  + + +L L+ +++  
Sbjct: 54  LYAMKVLKKATL--KVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRG 110

Query: 173 GSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EE 230
           G L   L      T        +K   A  +  L +LH      +IYRDLK  NILL EE
Sbjct: 111 GDLFTRLSKEVMFTEE-----DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE 162

Query: 231 GYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 289
           G H KL+DFGL+K     +K         GT  Y AP+       T  +D +SFGV++ E
Sbjct: 163 G-HIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218

Query: 290 LITGR 294
           ++TG 
Sbjct: 219 MLTGT 223

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (251), Expect = 6e-24
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 14/202 (6%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLI 154
            LGEG F  V         +  AIK L+ R +     V   + E   +   DHP  VKL 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQL 212
            +  + D++L     Y   G L K++          D  T  +   A     L+YLH + 
Sbjct: 97  -FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFD-ETCTRFYTAEIVSALEYLHGK- 149

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+     
Sbjct: 150 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 273 QLTFKSDIYSFGVVLLELITGR 294
                SD+++ G ++ +L+ G 
Sbjct: 208 SACKSSDLWALGCIIYQLVAGL 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  101 bits (253), Expect = 1e-23
 Identities = 73/301 (24%), Positives = 111/301 (36%), Gaps = 27/301 (8%)

Query: 9   KSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNA---------NLKKEEVSNDGQLS 59
              + +  E    N  + +      +I  T  V++               + +       
Sbjct: 58  AQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAE 117

Query: 60  MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVV 119
           MD ++ +  D+S                     F     LG+G FGKV     +   +  
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAKPKHRVTMN-EFEYLKLLGKGTFGKVILVKEKATGRYY 176

Query: 120 AIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSL 175
           A+K L    +    E +    E   L ++ HP L  L  Y  +   RL  V EY   G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL 235

Query: 176 DKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP 234
             HL   R  +       R +   A     L YLH +    V+YRDLK  N++L++  H 
Sbjct: 236 FFHLSRERVFSED-----RARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI 288

Query: 235 KLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           K++DFGL K G     T    +   GT  Y AP+           D +  GVV+ E++ G
Sbjct: 289 KITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345

Query: 294 R 294
           R
Sbjct: 346 R 346

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 33/301 (10%)

Query: 8   GKSNKKLDEEIDNKNKNLNKQADKKQLIADTPRVDSNANLKKEEVSNDGQLSMDVKNLNL 67
           G  +      +D   +NL  Q+ K     D+    + A  K+   + D    M VK+   
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEA--KEVWSNADLTERMPVKSKRT 59

Query: 68  KDDSNNSGKSAKPFTFDELAAATGNFRSD------CCLGEGGFGKVYKGCLEKI-EQVVA 120
              + +      PF    + A  G   S         LG G FG+V+K C E      +A
Sbjct: 60  SALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLA 118

Query: 121 IKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLH 180
            K +  RG++   E   E+  +   DH NL++L       +  +LV EY+  G     L 
Sbjct: 119 AKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE----LF 174

Query: 181 DLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQLKQPVIYRDLKCSNILL--EEGY 232
           D     R +D +  +         +    G++++H   +  +++ DLK  NIL    +  
Sbjct: 175 D-----RIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAK 226

Query: 233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT 292
             K+ DFGLA+     +K  V     GT  + AP+      ++F +D++S GV+   L++
Sbjct: 227 QIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283

Query: 293 G 293
           G
Sbjct: 284 G 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 66/241 (27%), Positives = 98/241 (40%), Gaps = 40/241 (16%)

Query: 68  KDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVY---KGCLEKIEQVVAIKQL 124
           +   N   +  +P  F+ L            LG+GG+GKV+   K       ++ A+K L
Sbjct: 4   ETSVNRGPEKIRPECFELLR----------VLGKGGYGKVFQVRKVTGANTGKIFAMKVL 53

Query: 125 -------DHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL-LVYEYMPLGSLD 176
                  + +     +   AE   L    HP +V LI Y  +   +L L+ EY+  G L 
Sbjct: 54  KKAMIVRNAKDTAHTK---AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELF 109

Query: 177 KHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHP 234
             L                    A  S  L +LH++    +IYRDLK  NI+L  +G H 
Sbjct: 110 MQLEREGIFMED-----TACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG-HV 160

Query: 235 KLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
           KL+DFGL K           T    GT  Y AP+  M        D +S G ++ +++TG
Sbjct: 161 KLTDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

Query: 294 R 294
            
Sbjct: 218 A 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 99.1 bits (247), Expect = 7e-23
 Identities = 51/223 (22%), Positives = 88/223 (39%), Gaps = 38/223 (17%)

Query: 99  LGEGGFGKV-YKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG-SADHPNLVKLIGY 156
           LG G  G V ++G  +   + VA+K++             E+  L  S DHPN+++    
Sbjct: 23  LGYGSSGTVVFQGSFQG--RPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77

Query: 157 CAEGDQRLLVYEYMPLGSLDKHL---HDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                   +  E     +L   +   +    + +       + +    + G+ +LH    
Sbjct: 78  ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-- 134

Query: 214 QPVIYRDLKCSNILL-------------EEGYHPKLSDFGLAKM---GPSGDKTHVSTRV 257
             +I+RDLK  NIL+              E     +SDFGL K    G S  +T+++   
Sbjct: 135 -KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 258 MGTYGYCAP-------DYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT G+ AP       +     +LT   DI+S G V   +++ 
Sbjct: 194 -GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 37/212 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLI 154
           LG+G FG+V   C +KI  Q  A+K +  R V+          EV  L   DHPN++KL 
Sbjct: 34  LGKGSFGEVIL-CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GL 205
            +  +     LV E    G L              D            AA   R    G+
Sbjct: 93  EFFEDKGYFYLVGEVYTGGEL-------------FDEIISRKRFSEVDAARIIRQVLSGI 139

Query: 206 QYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
            Y+H+     +++RDLK  N+LL    +  + ++ DFGL+    +  K       +GT  
Sbjct: 140 TYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAY 193

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           Y AP+  + G    K D++S GV+L  L++G 
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 61/235 (25%), Positives = 92/235 (39%), Gaps = 34/235 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE--FSAEVMTLGSADHPNLVKLIGY 156
           LG G +G+V     +      AIK +    V          EV  L   DHPN++KL  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQY 207
             +     LV E    G L              D            AA   +    G+ Y
Sbjct: 105 FEDKRNYYLVMECYKGGEL-------------FDEIIHRMKFNEVDAAVIIKQVLSGVTY 151

Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYC 264
           LH+     +++RDLK  N+LL   E+    K+ DFGL+ +  +  K       +GT  Y 
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYI 205

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
           AP+  +  +   K D++S GV+L  L+ G        D++ L  V   +  F   
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.3 bits (237), Expect = 5e-22
 Identities = 47/264 (17%), Positives = 84/264 (31%), Gaps = 72/264 (27%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIK----------------------QLDHRGV------ 129
           C+G GGFG V++   +  +   AIK                      +L+H G+      
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 130 ------------------------------QGVREFSAEVMTLGSADHPNLVKLIGYCAE 159
                                           +   S ++  +      N V  +   + 
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR 219
                +  +     +L K   + R      +    + I    +  +++LH +    +++R
Sbjct: 133 KVYLYIQMQLCRKENL-KDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHR 188

Query: 220 DLKCSNILLEEGYHPKLSDFGLAKM----------GPSGDKTHVSTRVMGTYGYCAPDYA 269
           DLK SNI        K+ DFGL                       T  +GT  Y +P+  
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248

Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
                + K DI+S G++L EL+  
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYS 272

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 64/202 (31%), Positives = 89/202 (44%), Gaps = 18/202 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIG 155
           LG+G FGKV     +   +  A+K L    +    E +    E   L +  HP L  L  
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
           Y  +   RL  V EY   G L  HL   R  T       R +   A     L+YLH +  
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALEYLHSR-- 124

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTG 272
             V+YRD+K  N++L++  H K++DFGL K G S   T    +   GT  Y AP+     
Sbjct: 125 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPEVLEDN 180

Query: 273 QLTFKSDIYSFGVVLLELITGR 294
                 D +  GVV+ E++ GR
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 33/218 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G V+K    +  ++VA+K+  LD    GV    +RE       L    H N+V+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC----LLKELKHKNIVR 65

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L        +  LV+E+     L K+          LD            +GL + H + 
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAM 270
              V++RDLK  N+L+      KL++FGLA+    P    +     V+ T  Y  PD   
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLF 174

Query: 271 TGQLTFKS--DIYSFGVVLLELITGRKA-------IDQ 299
            G   + +  D++S G +  EL    +         DQ
Sbjct: 175 -GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 21/208 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           +G G F +V    +++  QV A+K ++   +     V  F  E   L + D   + +L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQLK 213
           +  + +  L LV EY   G L   L   +   R P +   R  +A      +  +H   +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLS--KFGERIPAEM-ARFYLAEIVM-AIDSVH---R 180

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------- 266
              ++RD+K  NILL+   H +L+DFG      +         V GT  Y +P       
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVG 239

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGR 294
               TG    + D ++ GV   E+  G+
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 20/204 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           +G+G FGKV        +++ A+K ++ +       VR    E+  +   +HP LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
           Y  + ++ + +V + +  G L  HL               +K+        L YL     
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-----EETVKLFICELVMALDYLQ---N 133

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
           Q +I+RD+K  NILL+E  H  ++DF +A M P   +    T + GT  Y AP+   + +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSRK 190

Query: 274 L---TFKSDIYSFGVVLLELITGR 294
               +F  D +S GV   EL+ GR
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGR 214

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 46/304 (15%), Positives = 89/304 (29%), Gaps = 54/304 (17%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADH 147
           G +R     G     + ++     +++ VA+  +D +GV     ++E  +  + L   D 
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P + +++         L+V E++  GSL +                 ++     +     
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADA 144

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
            H      V       S + +        S  G   +                       
Sbjct: 145 AHRA---GVALSIDHPSRVRV--------SIDGDVVLA--------------YPATMPDA 179

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
                    + DI   G  L  L+  R  + +   R  L            R    Q ++
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIE 224

Query: 328 PSLQGQYPVRGLYQAL-AIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSR 386
           P+       R +   + A+AA  VQ    +R A T + +     A         P   + 
Sbjct: 225 PADID----RDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAP 280

Query: 387 KSPS 390
            S +
Sbjct: 281 VSAA 284

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.6 bits (231), Expect = 3e-21
 Identities = 76/326 (23%), Positives = 125/326 (38%), Gaps = 63/326 (19%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGVQGVREFSA--EVMTLGSADHPNLVK 152
           +GEG +G V+K       Q+VAIK+     D   +    +  A  E+  L    HPNLV 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI----KKIALREIRMLKQLKHPNLVN 66

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           L+       +  LV+EY         H  D     R +  +    I     + + + H  
Sbjct: 67  LLEVFRRKRRLHLVFEYC---DHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTR-------VMGTY 261
            K   I+RD+K  NIL+ +    KL DFG A++  GPS      V+TR       ++G  
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELIT------GRKAIDQ-TKDRKEL---NLVAW 311
            Y  P            D+++ G V  EL++      G+  +DQ    RK L        
Sbjct: 179 QYGPP-----------VDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQ 227

Query: 312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLY-----QALAIAAMCVQEQPNMRPAITDVVMA 366
              +F   + FS +  P  +   P+   +      AL +   C+   P  R         
Sbjct: 228 --QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ---L 282

Query: 367 LN--YLASQKYDPQNPPSRSSRKSPS 390
           L+  Y  + + + ++      + + +
Sbjct: 283 LHHPYFENIR-EIEDLAKEHDKPAEN 307

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 93.0 bits (231), Expect = 3e-21
 Identities = 51/245 (20%), Positives = 81/245 (33%), Gaps = 54/245 (22%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           +G+G +G V    +E     + AIK     ++     + V     EV  +    HPN+ +
Sbjct: 34  IGQGSYGVVRV-AIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 153 LIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR--- 203
           L     +     LV E    G L             +     +                 
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 204 ---------------------------GLQYLHEQLKQPVIYRDLKCSNILLE--EGYHP 234
                                       L YLH    Q + +RD+K  N L    + +  
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEI 209

Query: 235 KLSDFGLAKM---GPSGDKTHVSTRVMGTYGYCAPD--YAMTGQLTFKSDIYSFGVVLLE 289
           KL DFGL+K      +G+   ++T+  GT  + AP+           K D +S GV+L  
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 290 LITGR 294
           L+ G 
Sbjct: 269 LLMGA 273

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 55/260 (21%), Positives = 97/260 (37%), Gaps = 31/260 (11%)

Query: 48  KKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRS----DCCLGEGG 103
           ++    ++    +  K     +  N      K +    +     +          LG G 
Sbjct: 110 RRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGA 169

Query: 104 FGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ 162
           FG V++   E+      A K +             E+ T+    HP LV L     + ++
Sbjct: 170 FGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE 228

Query: 163 RLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQLKQP 215
            +++YE+M  G L +          +  D + +M    A    R    GL ++HE     
Sbjct: 229 MVMIYEFMSGGELFE----------KVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275

Query: 216 VIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
            ++ DLK  NI+   +     KL DFGL           V     GT  + AP+ A    
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKP 332

Query: 274 LTFKSDIYSFGVVLLELITG 293
           + + +D++S GV+   L++G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 92.6 bits (231), Expect = 3e-21
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 34/212 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR-GV--QGVREFSAEVMTLGSADHPNLVKL 153
           LG G +  VYKG  +     VA+K+  LD   G     +RE S     +    H N+V+L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELKHENIVRL 68

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAGASRGLQYLHEQ 211
                  ++  LV+E+M    L K++         R L+ N          +GL + HE 
Sbjct: 69  YDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYA 269
               +++RDLK  N+L+ +    KL DFGLA+    P    +     V+ T  Y APD  
Sbjct: 128 K---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPD-- 178

Query: 270 MTGQLTFKS-------DIYSFGVVLLELITGR 294
               +   S       DI+S G +L E+ITG+
Sbjct: 179 ----VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 54/221 (24%), Positives = 83/221 (37%), Gaps = 45/221 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-------------EVMTLGSA 145
           LG G +G+V     +      AIK +        R                 E+  L S 
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAG 200
           DHPN++KL     +     LV E+   G L              +            AA 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-------------FEQIINRHKFDECDAAN 150

Query: 201 ASR----GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHV 253
             +    G+ YLH+     +++RD+K  NILL       + K+ DFGL+       K   
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR- 206

Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
               +GT  Y AP+  +  +   K D++S GV++  L+ G 
Sbjct: 207 --DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 37/211 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK   +   ++VA+K+  LD    G+    +RE S     L    HPN+V 
Sbjct: 29  VGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGIPSTAIREIS----LLKELHHPNIVS 83

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           LI          LV+E+M    L K L + +     L  +          RG+ + H+  
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQHR 139

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAM 270
              +++RDLK  N+L+      KL+DFGLA+    P    TH    V+ T  Y APD   
Sbjct: 140 ---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRAPD--- 189

Query: 271 TGQLTFKS-------DIYSFGVVLLELITGR 294
              +   S       DI+S G +  E+ITG+
Sbjct: 190 ---VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           LG+G FGKV+    +K  Q  AIK L    V  + +     M        + +HP L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
                +  + L  V EY+  G L  H+              R    AA    GLQ+LH +
Sbjct: 84  F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQFLHSK 137

Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
               ++YRDLK  NILL ++G H K++DFG+ K    GD     T    GT  Y AP+  
Sbjct: 138 ---GIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEIL 190

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
           +  +     D +SFGV+L E++ G+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.5 bits (228), Expect = 5e-21
 Identities = 51/201 (25%), Positives = 77/201 (38%), Gaps = 32/201 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G +G+V     +      A K++    V+ V  F  E+  + S DHPN+++L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYLH 209
           +     LV E    G L              +            AA   +     + Y H
Sbjct: 77  DNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDAARIMKDVLSAVAYCH 123

Query: 210 EQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           +     V +RDLK  N L          KL DFGLA     G    + T+V GT  Y +P
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYVSP 177

Query: 267 DYAMTGQLTFKSDIYSFGVVL 287
              + G    + D +S GV++
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMM 197

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 25/204 (12%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LG G FG V++ C+EK   +V   K ++            E+  +    HP L+ L    
Sbjct: 59  LGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQ 211
            +  + +L+ E++  G L     D     R    + +M         R    GL+++HE 
Sbjct: 118 EDKYEMVLILEFLSGGEL----FD-----RIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 212 LKQPVIYRDLKCSNILLE--EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
               +++ D+K  NI+ E  +    K+ DFGLA      +   V      T  + AP+  
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIV 222

Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               + F +D+++ GV+   L++G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.0 bits (227), Expect = 6e-21
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 37/211 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G VYK       +  A+K+  L+    G+    +RE S     L    H N+VK
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREIS----ILKELKHSNIVK 64

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L        + +LV+E++    L K L         L+  T          G+ Y H++ 
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAM 270
              V++RDLK  N+L+      K++DFGLA+    P    TH    ++ T  Y APD   
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPD--- 170

Query: 271 TGQLTFKS-------DIYSFGVVLLELITGR 294
              +   S       DI+S G +  E++ G 
Sbjct: 171 ---VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.0 bits (229), Expect = 8e-21
 Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 41/283 (14%)

Query: 42  DSNANLKKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGE 101
              A     +  + G+  + VK+     +     +      F+ L            LG 
Sbjct: 15  SGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----------VLGT 64

Query: 102 GGFGKVY---KGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT----LGSADH-PNLVKL 153
           G +GKV+   K       ++ A+K L    +    + +    T    L      P LV L
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
             Y  + + +L L+ +Y+  G L  HL      T        ++I        L++LH+ 
Sbjct: 125 H-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH-----EVQIYVGEIVLALEHLHKL 178

Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK--MGPSGDKTHVSTRVMGTYGYCAPDY 268
               +IYRD+K  NILL   G H  L+DFGL+K  +    ++ +      GT  Y APD 
Sbjct: 179 ---GIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAY--DFC-GTIEYMAPDI 231

Query: 269 AMTGQL--TFKSDIYSFGVVLLELITGR---KAIDQTKDRKEL 306
              G        D +S GV++ EL+TG        +   + E+
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 274

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 8e-21
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 19/206 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE---FSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V    L+  ++V A+K L+   +    E   F  E   L + D   +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTR-PLDWNTRMKIAAGASRGLQYLHEQLK 213
           Y  + D  L LV +Y   G L   L   + + R P +   R  +A      +  +H   +
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLS--KFEDRLPEEM-ARFYLAEMVI-AIDSVH---Q 193

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
              ++RD+K  NIL++   H +L+DFG             S  V GT  Y +P+     +
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAME 252

Query: 274 LTFKS-----DIYSFGVVLLELITGR 294
                     D +S GV + E++ G 
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGE 278

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 62/252 (24%), Positives = 102/252 (40%), Gaps = 29/252 (11%)

Query: 48  KKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKV 107
           K  E  +  +     K   LK     S  +A+   FD +            LG G FG+V
Sbjct: 8   KGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRV 57

Query: 108 YKGCLEKIEQVVAIKQLDHRGVQGVREFS---AEVMTLGSADHPNLVKLIGYCAEGDQRL 164
                ++     A+K LD + V  +++      E   L + + P LVKL     +     
Sbjct: 58  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117

Query: 165 LVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK 222
           +V EY+  G +  HL  +    +        R   AA      +YLH      +IYRDLK
Sbjct: 118 MVMEYVAGGEMFSHLRRIGRFSEPH-----ARF-YAAQIVLTFEYLHSL---DLIYRDLK 168

Query: 223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYS 282
             N+L+++  + +++DFG AK       T     + GT    AP+  ++       D ++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWWA 223

Query: 283 FGVVLLELITGR 294
            GV++ E+  G 
Sbjct: 224 LGVLIYEMAAGY 235

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 91.9 bits (229), Expect = 1e-20
 Identities = 64/205 (31%), Positives = 90/205 (43%), Gaps = 23/205 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           +G+G FGKV     +  E   A+K L  + +   +E    +M+     L +  HP LV L
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE-KHIMSERNVLLKNVKHPFLVGL 104

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
             +  +   +L  V +Y+  G L  HL   R    P     R +  AA  +  L YLH  
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHSL 158

Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
               ++YRDLK  NILL  +G H  L+DFGL K     + T   T    GT  Y AP+  
Sbjct: 159 ---NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVL 211

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
                    D +  G VL E++ G 
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 61/211 (28%), Positives = 93/211 (44%), Gaps = 36/211 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FG+V K C ++I +Q  A+K ++    +         EV  L   DHPN++KL  
Sbjct: 30  LGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-----AAGASR----GLQ 206
              +     +V E    G L              D   + K      AA   +    G+ 
Sbjct: 89  ILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 207 YLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           Y+H+     +++RDLK  NILL   E+    K+ DFGL+       K       +GT  Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYY 189

Query: 264 CAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
            AP+  + G    K D++S GV+L  L++G 
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 35/210 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR-GV--QGVREFSAEVMTLGSADHPNLVKL 153
           LGEG +  VYKG  +  + +VA+K+  L+H  G     +RE S     L    H N+V L
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHANIVTL 65

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
                      LV+EY+    L ++L D       ++ +          RGL Y H Q  
Sbjct: 66  HDIIHTEKSLTLVFEYLDK-DLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQK- 120

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
             V++RDLK  N+L+ E    KL+DFGLA+    P+    +    V+ T  Y  PD    
Sbjct: 121 --VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPD---- 170

Query: 272 GQLTFKS-------DIYSFGVVLLELITGR 294
             +   S       D++  G +  E+ TGR
Sbjct: 171 --ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 59/204 (28%), Positives = 86/204 (42%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LG G FG V+            IK ++    Q   E   AE+  L S DHPN++K+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLHEQL 212
            +     +V E    G L ++ +          +        A   +     L Y H Q 
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSE-----GYVAELMKQMMNALAYFHSQ- 143

Query: 213 KQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
              V+++DLK  NIL          K+ DFGLA++  S +    +    GT  Y AP+  
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALYMAPE-V 197

Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               +TFK DI+S GVV+  L+TG
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTG 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 69/253 (27%), Positives = 110/253 (43%), Gaps = 28/253 (11%)

Query: 50  EEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYK 109
           E +   G +   ++      ++  SGK++             +F     +G G + KV  
Sbjct: 18  ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------DFDLLRVIGRGSYAKVLL 70

Query: 110 GCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKLIGYCAEGDQRL 164
             L+K +++ A++ +    V    E    V T       +++HP LV L   C + + RL
Sbjct: 71  VRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRL 128

Query: 165 -LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLKQPVIYRDLK 222
             V EY+  G L  H+   R            +  +A  S  L YLHE+    +IYRDLK
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHER---GIIYRDLK 180

Query: 223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAMTGQLTFKSDIY 281
             N+LL+   H KL+D+G+ K G     T   T    GT  Y AP+        F  D +
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEILRGEDYGFSVDWW 237

Query: 282 SFGVVLLELITGR 294
           + GV++ E++ GR
Sbjct: 238 ALGVLMFEMMAGR 250

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 36/204 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIG 155
           LG+G FG+V K C ++I +Q  A+K ++    +         EV  L   DHPN++KL  
Sbjct: 30  LGKGSFGEVLK-CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQ 206
              +     +V E    G L              D   +        AA   +    G+ 
Sbjct: 89  ILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAARIIKQVFSGIT 135

Query: 207 YLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           Y+H+     +++RDLK  NILL   E+    K+ DFGL+       K     R+ GT  Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI-GTAYY 189

Query: 264 CAPDYAMTGQLTFKSDIYSFGVVL 287
            AP+  + G    K D++S GV+L
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 44/217 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLVK 152
           LGEG +G+VYK       + VAIK+  L+H   GV    +RE S     L    H N+++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKELQHRNIIE 97

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS------RGLQ 206
           L        +  L++EY          +DL+   + +D N  + +    S       G+ 
Sbjct: 98  LKSVIHHNHRLHLIFEYAE--------NDLK---KYMDKNPDVSMRVIKSFLYQLINGVN 146

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHP-----KLSDFGLAKM--GPSGDKTHVSTRVMG 259
           + H +     ++RDLK  N+LL           K+ DFGLA+    P    TH    ++ 
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII- 199

Query: 260 TYGYCAPDYAMTGQLTFKS--DIYSFGVVLLELITGR 294
           T  Y  P+  + G   + +  DI+S   +  E++   
Sbjct: 200 TLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKT 235

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D +      E    E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQYLH 209
            EG+ + L  EY   G L D+           ++ +  M     A R       G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD-AQRFFHQLMAGVVYLH 122

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--- 266
                 + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
              ++    +     D++S G+VL  ++ G 
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 58/208 (27%), Positives = 82/208 (39%), Gaps = 21/208 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ-LDHRGVQGVREFSAEVMTLGSADHPNLVKLI--- 154
            G+G FG V  G  +     VAIK+ +        RE    +  L    HPN+V+L    
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88

Query: 155 ---GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
              G     D  L +V EY+P  +L +   +                     R +  LH 
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147

Query: 211 QLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKM-GPSGDKTH-VSTRVMGTYGYCAPD 267
                V +RD+K  N+L+ E     KL DFG AK   PS      + +R    Y Y AP+
Sbjct: 148 PSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR----Y-YRAPE 201

Query: 268 YAMTGQL-TFKSDIYSFGVVLLELITGR 294
                Q  T   DI+S G +  E++ G 
Sbjct: 202 LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 58/219 (26%), Positives = 88/219 (40%), Gaps = 45/219 (20%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA--------EVMTLGSADHPN 149
           LG G  G+V     E+   + VAI+ +  R         A        E+  L   +HP 
Sbjct: 143 LGSGACGEVKL-AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW---NTRM--KIAAGASR- 203
           ++K+  +  + +   +V E M  G L              D    N R+           
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQ 247

Query: 204 ---GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +QYLHE     +I+RDLK  N+LL   EE    K++DFG +K+   G+ + + T  
Sbjct: 248 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 302

Query: 258 MGTYGYCAP---DYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT  Y AP       T       D +S GV+L   ++G
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 23/205 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           +G G + KV    L+K +++ A+K +    V    E    V T       +++HP LV L
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGL 75

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
              C + + RL  V EY+  G L  H+   R            +  +A  S  L YLHE+
Sbjct: 76  H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLHER 129

Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
               +IYRDLK  N+LL  EG H KL+D+G+ K G     T   T    GT  Y AP+  
Sbjct: 130 ---GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPEIL 182

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
                 F  D ++ GV++ E++ GR
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 22/208 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA----EVMTLGSADHPNLVKL- 153
           LGEG +GKV +    +     A+K L  + ++ +    A    E+  L    H N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 154 -IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK----IAAGASRGLQYL 208
            + Y  E  +  +V EY   G  +  + D  P+ R             I      GL+YL
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID-----GLEYL 125

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H    Q ++++D+K  N+LL  G   K+S  G+A+               G+  +  P+ 
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 269 AMTGQL--TFKSDIYSFGVVLLELITGR 294
           A        FK DI+S GV L  + TG 
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.8 bits (221), Expect = 5e-20
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHR--GVQGV-----REFSAEVMTLGSADHPN 149
           +G G +G VYK         VA+K   + +   G  G+     RE +  +  L + +HPN
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLEAFEHPN 75

Query: 150 LVKLI----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGAS 202
           +V+L+        + + ++ LV+E++          DLR   D  P        I     
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVD--------QDLRTYLDKAPPPGLPAETIKDLMR 127

Query: 203 ---RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-GPSGDKTHVSTRVM 258
              RGL +LH      +++RDLK  NIL+  G   KL+DFGLA++       T     V+
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VVV 181

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
            T  Y AP+  +        D++S G +  E+   +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 23/205 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           LG+G FGKV     +  +++ A+K L    V    +     M            P L +L
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQL 86

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
              C +   RL  V EY+  G L  H+  +     P          AA  + GL +L  +
Sbjct: 87  H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQSK 140

Query: 212 LKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYA 269
               +IYRDLK  N++L  EG H K++DFG+ K       T   T+   GT  Y AP+  
Sbjct: 141 ---GIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEII 193

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
                    D ++FGV+L E++ G+
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 48/202 (23%), Positives = 80/202 (39%), Gaps = 34/202 (16%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LG G F +V+    +++  ++ A+K +             E+  L    H N+V L    
Sbjct: 17  LGSGAFSEVFL-VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYL 208
                  LV + +  G L              D          K A+   +     ++YL
Sbjct: 76  ESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 209 HEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           HE     +++RDLK  N+L    EE     ++DFGL+KM    ++  + +   GT GY A
Sbjct: 123 HEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVA 175

Query: 266 PDYAMTGQLTFKSDIYSFGVVL 287
           P+       +   D +S GV+ 
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGY 156
           LGEG   +V   C+  I  Q  A+K ++ +          EV  L     H N+++LI +
Sbjct: 21  LGEGAHARVQT-CINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             E D+  LV+E M  GS+  H+H  R     +   +     ++  A A   L +LH   
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-----VQDVASA---LDFLHN-- 129

Query: 213 KQPVIYRDLKCSNILLEEGYHP---KLSDFGLAK-MGPSGDKTHVSTRVM----GTYGYC 264
            + + +RDLK  NIL E        K+ DF L   +  +GD + +ST  +    G+  Y 
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 265 AP---DYAMTGQLTF--KSDIYSFGVVL 287
           AP   +        +  + D++S GV+L
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.2 bits (222), Expect = 7e-20
 Identities = 61/204 (29%), Positives = 91/204 (44%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           LG+G FGKV    +++   + A+K L    +    +     MT       + +HP L +L
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
              C +   RL  V E++  G L  H+   R          R +  AA     L +LH++
Sbjct: 90  F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMFLHDK 143

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAM 270
               +IYRDLK  N+LL+   H KL+DFG+ K G     T   T    GT  Y AP+   
Sbjct: 144 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPEILQ 197

Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
                   D ++ GV+L E++ G 
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGH 221

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 91.2 bits (226), Expect = 7e-20
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT-----LGSADHPNLVKL 153
           LG+G FGKV     +  +++ A+K L  + V    +     M            P L +L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKIL-KKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407

Query: 154 IGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQ 211
              C +   RL  V EY+  G L  H+  +     P          AA  + GL +L  +
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQSK 461

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM-GTYGYCAPDYAM 270
               +IYRDLK  N++L+   H K++DFG+ K       T   T+   GT  Y AP+   
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPEIIA 515

Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
                   D ++FGV+L E++ G+
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 89.5 bits (222), Expect = 9e-20
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 43/225 (19%)

Query: 96  DCCLGEGGFGKVYKGCLEKIE--QVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLV 151
            C +G G +G VYK   +  +  +  A+KQ++  G+     RE    +  L    HPN++
Sbjct: 26  GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVI 81

Query: 152 KLIGYCAE-GDQRL-LVYEYMPLGSLD-KHLHDLRPDTRPLDWNTRMKIAAGAS------ 202
            L        D+++ L+++Y      D  H+      ++      ++      S      
Sbjct: 82  SLQKVFLSHADRKVWLLFDYA---EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKM--GPSGDKTHVSTR 256
            G+ YLH      V++RDLK +NIL+          K++D G A++   P      +   
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 257 VMGTYGYCAPD-------YAMTGQLTFKSDIYSFGVVLLELITGR 294
           V+ T+ Y AP+       Y      T   DI++ G +  EL+T  
Sbjct: 196 VV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.8 bits (221), Expect = 9e-20
 Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 55/291 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL----DHRGV--QGVREFSAEVMTLGSADHPNLVK 152
           +GEG +G V K   +   ++VAIK+     D + V    +RE       L    H NLV 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIK----LLKQLRHENLVN 88

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L+  C +  +  LV+E++   ++   L         LD+    K       G+ + H   
Sbjct: 89  LLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKYLFQIINGIGFCH--- 141

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTR-------VMGTYG 262
              +I+RD+K  NIL+ +    KL DFG A+    P       V+TR       ++G   
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGR------KAIDQ-TKDRKEL---NLVAWA 312
           Y               D+++ G ++ E+  G         IDQ       L         
Sbjct: 202 YGKA-----------VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ- 249

Query: 313 RPMFKDRKNFSQMVDPSLQGQYPVRGLY-----QALAIAAMCVQEQPNMRP 358
             +F     F+ +  P ++ + P+   Y       + +A  C+   P+ RP
Sbjct: 250 -ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGYC 157
           LGEG +G+V        E+ VA+K +D +      E    E+      +H N+VK  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 158 AEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQYLH 209
            EG+ + L  EY   G L D+           ++ +  M     A R       G+ YLH
Sbjct: 75  REGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPD-AQRFFHQLMAGVVYLH 122

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--- 266
                 + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP   
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179

Query: 267 ---DYAMTGQLTFKSDIYSFGVVLLELITGR 294
              ++    +     D++S G+VL  ++ G 
Sbjct: 180 KRREFH--AE---PVDVWSCGIVLTAMLAGE 205

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 35/212 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQ--GVREFSA--EVMTLGSADHPNLVK 152
           LGEG F  VYK   +   Q+VAIK+  L HR     G+   +A  E+  L    HPN++ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN-RTALREIKLLQELSHPNIIG 76

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L+          LV+++M    L+  + D       L  +          +GL+YLH+  
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW 132

Query: 213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTH-VSTRVMGTYGYCAPDYA 269
              +++RDLK +N+LL+E    KL+DFGLAK    P+   TH V TR      Y AP+  
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRAPE-- 182

Query: 270 MTGQLTFKS-------DIYSFGVVLLELITGR 294
               L F +       D+++ G +L EL+   
Sbjct: 183 ----LLFGARMYGVGVDMWAVGCILAELLLRV 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 39/204 (19%), Positives = 82/204 (40%), Gaps = 26/204 (12%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LG G FG V++ C+E   ++    K +  +G         E+  L  A H N++ L    
Sbjct: 13  LGRGEFGIVHR-CVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM--KIAAGASR----GLQYLHEQ 211
              ++ ++++E++    +     +     R       +  +            LQ+LH  
Sbjct: 71  ESMEELVMIFEFISGLDI----FE-----RINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 212 LKQPVIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
               + + D++  NI+         K+ +FG A+    GD   +   +     Y AP+  
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVH 175

Query: 270 MTGQLTFKSDIYSFGVVLLELITG 293
               ++  +D++S G ++  L++G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 33/211 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY-C 157
           +G G FG VY+  L    ++VAIK++    +Q  R  + E+  +   DH N+V+L  +  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 158 AEGDQRL-----LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK-----IAAGASRGLQY 207
           + G+++      LV +Y+P  ++ +         + L     +K     +     R L Y
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLF----RSLAY 171

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK-TH-VSTRVMGTYGYC 264
           +H      + +RD+K  N+LL+      KL DFG AK    G+     + +R    Y Y 
Sbjct: 172 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223

Query: 265 APDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
           AP+        T   D++S G VL EL+ G+
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 55/215 (25%), Positives = 84/215 (39%), Gaps = 46/215 (21%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLD--------HRGVQGVRE-FSAEVMTLGS-ADH 147
           LG G    V + C+ K   +  A+K +D           VQ +RE    EV  L   + H
Sbjct: 25  LGRGVSSVVRR-CIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGAS 202
           PN+++L           LV++ M  G L              D+ T       K      
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSEKETRKIM 130

Query: 203 R----GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           R     +  LH+     +++RDLK  NILL++  + KL+DFG +     G+K        
Sbjct: 131 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVC- 184

Query: 259 GTYGYCAP------DYAMTGQLTFKSDIYSFGVVL 287
           GT  Y AP                + D++S GV++
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 34/214 (15%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQ--LDHR--GV--QGVREFSAEVMTLGSADHPNLV 151
           +GEG +GKV+K    K   + VA+K+  +     G+    +RE +  +  L + +HPN+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 77

Query: 152 KLI----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRP--DTRPLDWNTRMKIAAGAS-- 202
           +L         + + +L LV+E++          DL    D  P        I       
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVD--------QDLTTYLDKVPEPGVPTETIKDMMFQL 129

Query: 203 -RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM-GPSGDKTHVSTRVMGT 260
            RGL +LH      V++RDLK  NIL+      KL+DFGLA++       T     V+ T
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV-T 182

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
             Y AP+  +        D++S G +  E+   +
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 51/217 (23%)

Query: 99  LGEGGFGKVY----KG--------CLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD 146
           LG G FG+V+    +          L+K E VV +KQ++H           E + L    
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEH-----TN---DERLMLSIVT 64

Query: 147 HPNLVKLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASR 203
           HP ++++     +  Q++ ++ +Y+  G L   L   +  P+        +   A     
Sbjct: 65  HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV-----AKFYAAEVCL- 117

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L+YLH +    +IYRDLK  NILL++  H K++DFG AK  P    T     + GT  Y
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDY 169

Query: 264 CAP------DYAMTGQLTFKSDIYSFGVVLLELITGR 294
            AP       Y  +       D +SFG+++ E++ G 
Sbjct: 170 IAPEVVSTKPYNKS------IDWWSFGILIYEMLAGY 200

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 56/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
           LG G F  V K C EK      A K +  R  +  R          EV  L    HPN++
Sbjct: 20  LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
            L          +L+ E +  G L       + L +              + A    +  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------------EEATSFIKQI 124

Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
             G+ YLH +    + + DLK  NI+L        H KL DFGLA     G +      +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---I 178

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT  + AP+      L  ++D++S GV+   L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 41/207 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C+ K      A K     +L  R  Q +     E        HPN+V+
Sbjct: 14  LGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNIVR 69

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR---- 203
           L     E     LV++ +  G L              +            A+   +    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILE 116

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
            + Y H      +++R+LK  N+LL    +G   KL+DFGLA      +  H      GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFA-GT 170

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVL 287
            GY +P+       +   DI++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 20/205 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           +G G FG+V     +   +V A+K L    +        F  E   +  A+ P +V+L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 156 YCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKI-AAGASRGLQYLHEQLK 213
           Y  + D+ L +V EYMP G L   + +              +   A     L  +H    
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP------EKWARFYTAEVVLALDAIH---S 186

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP----DYA 269
              I+RD+K  N+LL++  H KL+DFG              T V GT  Y +P       
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
             G    + D +S GV L E++ G 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGD 270

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 54/216 (25%), Positives = 87/216 (40%), Gaps = 42/216 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
           LG G F  V K C +K   +  A K +  R +   R   +      EV  L    HPN++
Sbjct: 13  LGSGQFAIVRK-CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
            L          +L+ E +  G L       + L +                A    +  
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------------DEATQFLKQI 117

Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILLEEGYHP----KLSDFGLAKMGPSGDKTHVSTRV 257
             G+ YLH +    + + DLK  NI+L +   P    KL DFG+A    +G++      +
Sbjct: 118 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---I 171

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT  + AP+      L  ++D++S GV+   L++G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 49/217 (22%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVKL 153
           +G+G F KV         + VAIK     QL+   +Q +     EV  +   +HPN+VKL
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK----------IAAGASR 203
                      L+ EY   G +  +L            + RMK          I +    
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKEARSKFRQIVSA--- 126

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            +QY H   ++ +++RDLK  N+LL+   + K++DFG +     G K        G   Y
Sbjct: 127 -VQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPY 179

Query: 264 CAP------DYAMTGQLTFKSDIYSFGVVLLELITGR 294
            AP       Y   G    + D++S GV+L  L++G 
Sbjct: 180 AAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGS 211

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 63/317 (19%), Positives = 109/317 (34%), Gaps = 59/317 (18%)

Query: 4   FRCSGKSNKKLDEEIDNKNKNLNK----QADKKQLIADTPRVDSNANLKKEEVSNDGQLS 59
              S   + K ++E     + +        ++++    + R D + +      +N    +
Sbjct: 5   HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQS------ANLLAEA 58

Query: 60  MDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRS----DCCLGEGGFGKVYKGCLEKI 115
             + +   K   N   +S  P       AA   F         +G G    V + C+ + 
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR-CVHRA 117

Query: 116 -EQVVAIKQLDHRGVQGVREFSA--------EVMTLGS-ADHPNLVKLIGYCAEGDQRLL 165
                A+K ++    +   E           E   L   A HP+++ LI          L
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL 177

Query: 166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYLHEQLKQPV 216
           V++ M  G L              D+ T       K      R     + +LH      +
Sbjct: 178 VFDLMRKGEL-------------FDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NI 221

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP------DYAM 270
           ++RDLK  NILL++    +LSDFG +     G+K        GT GY AP          
Sbjct: 222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPEILKCSMDET 278

Query: 271 TGQLTFKSDIYSFGVVL 287
                 + D+++ GV+L
Sbjct: 279 HPGYGKEVDLWACGVIL 295

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 57/213 (26%), Positives = 81/213 (38%), Gaps = 45/213 (21%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA--------EVMTLGSADHPN 149
           LG G  G+V     E+   + VAIK +  R         A        E+  L   +HP 
Sbjct: 18  LGSGACGEVKL-AFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW---NTRM--KIAAGASR- 203
           ++K+  +  + +   +V E M  G L              D    N R+           
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQ 122

Query: 204 ---GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
               +QYLHE     +I+RDLK  N+LL   EE    K++DFG +K+          T  
Sbjct: 123 MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RTLC 177

Query: 258 MGTYGYCAP---DYAMTGQLTFKSDIYSFGVVL 287
            GT  Y AP       T       D +S GV+L
Sbjct: 178 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
           LG G F  V K C EK      A K +  R  +  R   +      EV  L    H N++
Sbjct: 20  LGSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
            L          +L+ E +  G L       + L +              + A    +  
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------------EEATSFIKQI 124

Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
             G+ YLH +    + + DLK  NI+L        H KL DFGLA     G +      +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---I 178

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT  + AP+      L  ++D++S GV+   L++G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 85.0 bits (211), Expect = 1e-18
 Identities = 54/216 (25%), Positives = 83/216 (38%), Gaps = 42/216 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA------EVMTLGSADHPNLV 151
           LG G F  V K C EK      A K +  R  +  R   +      EV  L    HPN++
Sbjct: 19  LGSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSL------DKHLHDLRPDTRPLDWNTRMKIAAGASR-- 203
            L          +L+ E +  G L       + L +              + A    +  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------------EEATEFLKQI 123

Query: 204 --GLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
             G+ YLH      + + DLK  NI+L          K+ DFGLA     G++      +
Sbjct: 124 LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---I 177

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG 293
            GT  + AP+      L  ++D++S GV+   L++G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 24/206 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGY-- 156
           +G G FG V++  L + ++ VAIK++    +Q  R  + E+  +    HPN+V L  +  
Sbjct: 48  IGNGSFGVVFQAKLVESDE-VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 157 ---CAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
                + +  L LV EY+P  ++ +         + +             R L Y+H   
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH--- 158

Query: 213 KQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSGDK-TH-VSTRVMGTYGYCAPDYA 269
              + +RD+K  N+LL+      KL DFG AK+  +G+     + +R    Y Y AP+  
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELI 213

Query: 270 MTGQL-TFKSDIYSFGVVLLELITGR 294
                 T   DI+S G V+ EL+ G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 52/225 (23%), Positives = 84/225 (37%), Gaps = 42/225 (18%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--------EVMTL 142
             + +   LG G FG V+    ++  + V +K +    V                E+  L
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
              +H N++K++          LV E    G     L         +D + R+     AS
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAF------IDRHPRLDEPL-AS 133

Query: 203 R-------GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
                    + YL     + +I+RD+K  NI++ E +  KL DFG A     G   +   
Sbjct: 134 YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190

Query: 256 RVMGTYGYCAPD------YAMTGQLTFKSDIYSFGVVLLELITGR 294
              GT  YCAP+      Y   G    + +++S GV L  L+   
Sbjct: 191 ---GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEE 227

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 26/198 (13%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           +G G +    + C+ K      A+K +D        E   E++ L    HPN++ L    
Sbjct: 30  IGVGSYSVCKR-CIHKATNMEFAVKIIDKSKRDPTEE--IEIL-LRYGQHPNIITLKDVY 85

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            +G    +V E M  G L   +   +     +   +     +         ++YLH Q  
Sbjct: 86  DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LFTITKT---VEYLHAQ-- 135

Query: 214 QPVIYRDLKCSNILL---EEGYHP-KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
             V++RDLK SNIL           ++ DFG AK   + +   + T    T  + AP+  
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTANFVAPEVL 192

Query: 270 MTGQLTFKSDIYSFGVVL 287
                    DI+S GV+L
Sbjct: 193 ERQGYDAACDIWSLGVLL 210

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 26/198 (13%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGY 156
           LGEG F    K C+ K   Q  A+K +  R     ++   E+  L   + HPN+VKL   
Sbjct: 19  LGEGSFSICRK-CVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV 74

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRP----DTRPLDWNTRMKIAAGASRGLQYLHEQL 212
             +     LV E +  G L + +   +     +   +     M+    A   + ++H+  
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVSA---VSHMHDV- 125

Query: 213 KQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
              V++RDLK  N+L     +    K+ DFG A++ P  ++  + T    T  Y AP+  
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELL 181

Query: 270 MTGQLTFKSDIYSFGVVL 287
                    D++S GV+L
Sbjct: 182 NQNGYDESCDLWSLGVIL 199

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 35/204 (17%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLIG 155
           LG+G F  V + C+ K      A K ++ + +     ++   E        HPN+V+L  
Sbjct: 37  LGKGAFSVVRR-CVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQ 206
              E     LV++ +  G L              +            A+   +     + 
Sbjct: 96  SIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHCIQQILESIA 142

Query: 207 YLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
           Y H      +++R+LK  N+LL    +G   KL+DFGLA      +  H      GT GY
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--GFA-GTPGY 196

Query: 264 CAPDYAMTGQLTFKSDIYSFGVVL 287
            +P+       +   DI++ GV+L
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 82.7 bits (205), Expect = 6e-18
 Identities = 55/235 (23%), Positives = 93/235 (39%), Gaps = 57/235 (24%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA--------------------- 137
           +G+G +G V     E      A+K L  + +     F                       
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 138 -----EVMTLGSADHPNLVKL--IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLD 190
                E+  L   DHPN+VKL  +      D   +V+E +  G +             ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-------------ME 127

Query: 191 WNTRMKIAAGASR--------GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA 242
             T   ++   +R        G++YLH    Q +I+RD+K SN+L+ E  H K++DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVLLELITGR 294
                 D   +S  V GT  + AP+     +  F     D+++ GV L   + G+
Sbjct: 185 NEFKGSDA-LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.1 bits (206), Expect = 8e-18
 Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 60/229 (26%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSA--EVMTLGSADHPNLVKLIG 155
           +G+G FG+V+K    K  Q VA+K++      +G    +A  E+  L    H N+V LI 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83

Query: 156 YCAEGDQRL--------LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS----- 202
            C               LV+++          HDL      L  N  +K           
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKRVMQ 131

Query: 203 ---RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM------GPSGDKTH- 252
               GL Y+H   +  +++RD+K +N+L+      KL+DFGLA+             T+ 
Sbjct: 132 MLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188

Query: 253 VSTR-------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           V T        ++G   Y  P            D++  G ++ E+ T  
Sbjct: 189 VVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRS 226

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 40/213 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIG 155
           LG G FGKV  G  +     VA+K L+ + ++ +        E+  L    HP+++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 156 YCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQY 207
             +      +V EY+  G L D            +  + R++    A R        + Y
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDY-----------ICKHGRVEEME-ARRLFQQILSAVDY 126

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
            H   +  V++RDLK  N+LL+   + K++DFGL+ M   G+    S    G+  Y AP+
Sbjct: 127 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 180

Query: 268 ------YAMTGQLTFKSDIYSFGVVLLELITGR 294
                 YA  G    + DI+S GV+L  L+ G 
Sbjct: 181 VISGRLYA--GP---EVDIWSCGVILYALLCGT 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 82.7 bits (204), Expect = 2e-17
 Identities = 54/266 (20%), Positives = 87/266 (32%), Gaps = 77/266 (28%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQL-DHRGVQGVREFSAEVMTLGSAD-HPNLV 151
           LG G FG+V +     I      + VA+K L +       R   +E+  L     H N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 152 KLIG--------------YCAEGDQRLLVY------------------------------ 167
            L+G              +C  G+  L  Y                              
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 168 ---------------------EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
                                E   L  +++           L     +  +   ++G++
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           +L  +     I+RDL   NILL E    K+ DFGLA+                   + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELIT 292
           +       T +SD++SFGV+L E+ +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 40/207 (19%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIK-----QLDHRGVQGVREFSAEVMTLGSADHPNLVK 152
           LG+G F  V + C++ +  Q  A       +L  R  Q +     E        HPN+V+
Sbjct: 19  LGKGAFSVVRR-CVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKHPNIVR 74

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR---- 203
           L    +E     L+++ +  G L              +            A+   +    
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHCIQQILE 121

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
            + + H+     V++R+LK  N+LL    +G   KL+DFGLA       +        GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFA-GT 176

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVL 287
            GY +P+           D+++ GV+L
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 53/202 (26%), Positives = 81/202 (40%), Gaps = 35/202 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
           LG G    VY+   +  ++  A+K L      + VR    E+  L    HPN++KL    
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIF 117

Query: 158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRM-----KIAAGASR----GLQYL 208
               +  LV E +  G L              D          + AA A +     + YL
Sbjct: 118 ETPTEISLVLELVTGGEL-------------FDRIVEKGYYSERDAADAVKQILEAVAYL 164

Query: 209 HEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           HE     +++RDLK  N+L          K++DFGL+K+            V GT GYCA
Sbjct: 165 HEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCA 218

Query: 266 PDYAMTGQLTFKSDIYSFGVVL 287
           P+         + D++S G++ 
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 24/206 (11%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLD--HRGVQGVREFSAEVMTLGSADH-PNLVKLI 154
           LG G F  V + C+ K   Q  A K L    RG     E   E+  L  A   P ++ L 
Sbjct: 37  LGRGKFAVVRQ-CISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYLHE 210
                  + +L+ EY   G +              +  +         +    G+ YLH+
Sbjct: 96  EVYENTSEIILILEYAAGGEI----FS-LCLPELAEMVSE-NDVIRLIKQILEGVYYLHQ 149

Query: 211 QLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
                +++ DLK  NILL         K+ DFG+++      +      +MGT  Y AP+
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPE 203

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITG 293
                 +T  +D+++ G++   L+T 
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTH 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 31/206 (15%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSA-----EVMTLGSADHPNLVK 152
           +G+G F  V + C+ +   Q  A+K +D          S      E        HP++V+
Sbjct: 32  IGKGPFSVVRR-CINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 153 LIGYCAEGDQRLLVYEYMPLGSL----DKHLHDLRP----DTRPLDWNTRMKIAAGASRG 204
           L+   +      +V+E+M    L     K                     M+    A   
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQILEA--- 142

Query: 205 LQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
           L+Y H+     +I+RD+K   +LL   E     KL  FG+A             RV GT 
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV-GTP 197

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVL 287
            + AP+           D++  GV+L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVIL 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 54/234 (23%), Positives = 86/234 (36%), Gaps = 37/234 (15%)

Query: 72  NNSGKSAKPFTFDELAAATGNFRSD-----CCLGEGGFGKVYKGCLEKI-EQVVAIKQLD 125
           ++   S     F            D       LG G  GKV + C  +   Q  A+K L 
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLE-CFHRRTGQKCALKLLY 63

Query: 126 HRGVQGVREFSAEVMTLG-SADHPNLVKLIGYCAEGDQR----LLVYEYMPLGSLDKHLH 180
                  R+   EV     ++  P++V ++             L++ E M  G L   + 
Sbjct: 64  DS--PKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118

Query: 181 DLRPDTRPLDWNTRMKIAAGASR----GLQYLHEQLKQPVIYRDLKCSNILL---EEGYH 233
           +     R     T  + AA   R     +Q+LH      + +RD+K  N+L    E+   
Sbjct: 119 E-----RGDQAFTE-REAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169

Query: 234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
            KL+DFG AK         + T    T  Y AP+     +     D++S GV++
Sbjct: 170 LKLTDFGFAKETTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 62/213 (29%), Positives = 94/213 (44%), Gaps = 40/213 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADHPNLVKLIG 155
           LG G FGKV  G  E     VA+K L+ + ++ +        E+  L    HP+++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 156 YCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQY 207
             +      +V EY+  G L D            +  N R+     + R       G+ Y
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDY-----------ICKNGRLDEKE-SRRLFQQILSGVDY 131

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP- 266
            H   +  V++RDLK  N+LL+   + K++DFGL+ M   G+    S    G+  Y AP 
Sbjct: 132 CH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE 185

Query: 267 -----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
                 YA  G    + DI+S GV+L  L+ G 
Sbjct: 186 VISGRLYA--GP---EVDIWSSGVILYALLCGT 213

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 51/212 (24%), Positives = 83/212 (39%), Gaps = 40/212 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG       +  +++VA+K ++ RG         E++   S  HPN+V+      
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 159 EGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR-------GLQYLHE 210
                 ++ EY   G L ++           +    R      A         G+ Y H 
Sbjct: 87  TPTHLAIIMEYASGGELYER-----------ICNAGRFSEDE-ARFFFQQLLSGVSYCH- 133

Query: 211 QLKQPVIYRDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP-- 266
                + +RDLK  N LL+    P  K+ DFG +K      +    + V GT  Y AP  
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEV 188

Query: 267 ----DYAMTGQLTFKSDIYSFGVVLLELITGR 294
               +Y   G+    +D++S GV L  ++ G 
Sbjct: 189 LLRQEYD--GK---IADVWSCGVTLYVMLVGA 215

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 51/231 (22%), Positives = 85/231 (36%), Gaps = 52/231 (22%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA------EVMTL-- 142
             +R    LG+GGFG V+ G        VAIK +    V G    S       EV  L  
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 143 --GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMK---- 196
                 HP +++L+ +    +  +LV E        + L D       +     +     
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDY------ITEKGPLGEGPS 141

Query: 197 -------IAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-KLSDFGLAKMGPSG 248
                  +AA     +Q+ H    + V++RD+K  NIL++      KL DFG   +    
Sbjct: 142 RCFFGQVVAA-----IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

Query: 249 D-KTHVSTRVMGTYGYCAPDYAM----TGQLTFKSDIYSFGVVLLELITGR 294
                      GT  Y  P++             + ++S G++L +++ G 
Sbjct: 194 PYTDFD-----GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMVCGD 236

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 41/221 (18%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---EVMTLGSADH 147
           G +     LGEG FGKV      K +Q VA+K +  + ++          E+  L    H
Sbjct: 9   GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR--- 203
           P+++KL          ++V EY   G L D            +    RM       R   
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAG-GELFDY-----------IVEKKRMTEDE-GRRFFQ 115

Query: 204 ----GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMG 259
                ++Y H   +  +++RDLK  N+LL++  + K++DFGL+ +   G+    S    G
Sbjct: 116 QIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169

Query: 260 TYGYCAP------DYAMTGQLTFKSDIYSFGVVLLELITGR 294
           +  Y AP       YA  G    + D++S G+VL  ++ GR
Sbjct: 170 SPNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGR 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.4 bits (191), Expect = 6e-16
 Identities = 45/233 (19%), Positives = 84/233 (36%), Gaps = 58/233 (24%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV----------REFSAEVM 140
             ++    LG GGFG VY G        VAIK ++   +              E    ++
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV--LL 100

Query: 141 TLGSADHPNLVKLIGYCAEGDQRLLVYEY-MPLGSL-DKHLHDLRPDTRPLDWNTRMK-- 196
              S+    +++L+ +    D  +L+ E   P+  L D            +     ++  
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF-----------ITERGALQEE 149

Query: 197 ---------IAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGP 246
                    + A     +++ H      V++RD+K  NIL+       KL DFG   +  
Sbjct: 150 LARSFFWQVLEA-----VRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201

Query: 247 SGD-KTHVSTRVMGTYGYCAPDYAM----TGQLTFKSDIYSFGVVLLELITGR 294
                        GT  Y  P++       G+    + ++S G++L +++ G 
Sbjct: 202 DTVYTDFD-----GTRVYSPPEWIRYHRYHGR---SAAVWSLGILLYDMVCGD 246

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 53/213 (24%), Positives = 89/213 (41%), Gaps = 39/213 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
           +G G  G V       +++ VAIK+L        R F           E++ +   +H N
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNHKN 122

Query: 150 LVKLI-----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           ++ L+         E  Q + LV E M     D +L   +     LD      +      
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHERMSYLLYQMLC 175

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTY 261
           G+++LH      +I+RDLK SNI+++     K+ DFGLA+   +      +V TR     
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 228

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
            Y AP+  +        DI+S G ++ E++  +
Sbjct: 229 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 66/361 (18%), Positives = 125/361 (34%), Gaps = 100/361 (27%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA----EVMTLGSADHPNLVKLI 154
           LG G FG V +    +  +  A+K+        V +       E+  +   DH N++KL+
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKK--------VLQDPRYKNRELDIMKVLDHVNIIKLV 66

Query: 155 GY-------------------------------------CAEGDQRL-LVYEYMPLGSLD 176
            Y                                         ++ L ++ EY+P  +L 
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125

Query: 177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-K 235
           K L       R +  N          R + ++H      + +RD+K  N+L+    +  K
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182

Query: 236 LSDFGLAKMGPSGDK-TH-VSTRVMGTYGYCAP-------DYAMTGQLTFKSDIYSFGVV 286
           L DFG AK     +     + +R    + Y AP       +Y      T   D++S G V
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEY------TPSIDLWSIGCV 231

Query: 287 LLELITGR------KAIDQ---------TKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
             ELI G+       +IDQ         T  ++++  +    P + + + F  +     +
Sbjct: 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRM---NPHYTEVR-FPTLKAKDWR 287

Query: 332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN--YLASQKYDPQNPPSRSSRKSP 389
              P      A+ +    ++ +P++R  I     A+   +      +      +++   P
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLR--IN-PYEAMAHPFFD-HLRNSYESEVKNNSNFP 343

Query: 390 S 390
            
Sbjct: 344 H 344

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 50/202 (24%), Positives = 81/202 (40%), Gaps = 31/202 (15%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGY 156
           LG G  GKV +    K  ++  A+K L        R    EV      +  P++V+++  
Sbjct: 70  LGLGINGKVLQ-IFNKRTQEKFALKMLQDC--PKARR---EVELHWRASQCPHIVRIVDV 123

Query: 157 CAEGDQR----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQYL 208
                      L+V E +  G L   + D     R     T  + A+   +     +QYL
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTE-REASEIMKSIGEAIQYL 177

Query: 209 HEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           H      + +RD+K  N+L          KL+DFG AK   S +   ++T    T  Y A
Sbjct: 178 HSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVA 231

Query: 266 PDYAMTGQLTFKSDIYSFGVVL 287
           P+     +     D++S GV++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 43/215 (20%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
           +G G  G V       +E+ VAIK+L        R F           E++ +   +H N
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85

Query: 150 LVKLIG-YCAEGDQRL-----LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-IAAGA 201
           ++ L+  +  +          +V E M     D +L   ++     LD + RM  +    
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ---MELD-HERMSYLLYQM 136

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKT-HVSTRVMG 259
             G+++LH      +I+RDLK SNI+++     K+ DFGLA   G S   T +V TR   
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 191

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
              Y AP+  +        DI+S G ++ E+I G 
Sbjct: 192 ---YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 36/217 (16%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSA---------EVMTLGSADH 147
           +  G +G V    ++     VAIK++       + V   S          E+  L    H
Sbjct: 30  ISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 148 PNLVKL----IGYCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-IAAG 200
           PN++ L    + +      +L LV E M        L   +      +     ++     
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVIS-PQHIQYFMYH 142

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA-KMGPSGDKT-HVSTRVM 258
              GL  LHE     V++RDL   NILL +     + DF LA +     +KT +V+ R  
Sbjct: 143 ILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW- 198

Query: 259 GTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGR 294
               Y AP+  M     T   D++S G V+ E+   +
Sbjct: 199 ----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 26/217 (11%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVM-TLGSADH 147
             +R    +G G FG +Y G      + VAIK   +  +  Q   E  +++   +     
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQGG-- 64

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
             +  +    AEGD  ++V E   LG SL+  L +     R     T + +A      ++
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMEL--LGPSLE-DLFNFCS--RKFSLKTVLLLADQMISRIE 119

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPK---LSDFGLAKM-GPSGDKTHVSTR----VM 258
           Y+H    +  I+RD+K  N L+  G       + DFGLAK    +    H+  R    + 
Sbjct: 120 YIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176

Query: 259 GTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
           GT  Y A      G + + + D+ S G VL+    G 
Sbjct: 177 GTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 40/213 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
           +G G +G V     ++  + VAIK+L        R F +         E++ L    H N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELLLLKHMQHEN 84

Query: 150 LVKLI-----GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
           ++ L+                LV  +M        L  +              +     +
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMG--LKFSEEKIQYLVYQMLK 137

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH-VSTRVMGTYG 262
           GL+Y+H      V++RDLK  N+ + E    K+ DFGLA+     + T  V TR    + 
Sbjct: 138 GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVVTR----W- 188

Query: 263 YCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
           Y AP+  ++        DI+S G ++ E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 68.9 bits (169), Expect = 5e-13
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 41/215 (19%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHP 148
            +G G +G V      K    VA+K+L        R F +         E+  L    H 
Sbjct: 36  PVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 149 NLVKLI-----GYCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMKIAAGA 201
           N++ L+         E    + LV   M        L++ ++   + L  +    +    
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVK--CQKLTDDHVQFLIYQI 141

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-HVSTRVMGT 260
            RGL+Y+H      +I+RDLK SN+ + E    K+ DFGLA+   + + T +V+TR    
Sbjct: 142 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVATRW--- 194

Query: 261 YGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
             Y AP+  +         DI+S G ++ EL+TGR
Sbjct: 195 --YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 54/213 (25%), Positives = 87/213 (40%), Gaps = 39/213 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPN 149
           +G G +G V      +    VAIK+L        R F +         E+  L    H N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELRLLKHMRHEN 85

Query: 150 LVKLIG-YCAEGDQRL-----LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMKIAAGAS 202
           ++ L+  +  +          LV  +M        L   ++     L  +    +     
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMK--HEKLGEDRIQFLVYQML 138

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
           +GL+Y+H      +I+RDLK  N+ + E    K+ DFGLA+   S    +V TR      
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190

Query: 263 YCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
           Y AP+  +     T   DI+S G ++ E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 33/212 (15%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLIG- 155
           +GEG +G V        +  VAIK++          R    E+  L    H N++ +   
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93

Query: 156 ---YCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-IAAGASRGLQYLH 209
                 E  + + +V + M     +  L+  L+  T+ L  N  +        RGL+Y+H
Sbjct: 94  IRAPTIEQMKDVYIVQDLM-----ETDLYKLLK--TQHLS-NDHICYFLYQILRGLKYIH 145

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT------HVSTRVMGTYGY 263
                 V++RDLK SN+LL      K+ DFGLA++             +V+TR      Y
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR-----WY 197

Query: 264 CAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
            AP+  +  +  T   DI+S G +L E+++ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 26/218 (11%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVMTLGSADHP 148
            +++    +GEG FG +++G      Q VAIK         Q   E+    +  G     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQY 207
            +  +  +  EG   +LV   + L  L   L DL     R     T    A      +Q 
Sbjct: 67  GIPNVYYFGQEGLHNVLV---IDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPK-----LSDFGLAKM-GPSGDKTHVSTR----V 257
           +HE+    ++YRD+K  N L+            + DFG+ K       K H+  R    +
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178

Query: 258 MGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
            GT  Y        G + + + D+ + G V +  + G 
Sbjct: 179 SGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 57/323 (17%), Positives = 101/323 (31%), Gaps = 86/323 (26%)

Query: 68  KDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR 127
               ++SG+    F   +      N+     +G G +G VY    +  E+ VAIK+++  
Sbjct: 3   HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-- 60

Query: 128 GVQGVREFSA---------EVMTLGSADHPNLVKLIG-YCAEGDQRL----LVYEYMPLG 173
                R F           E+  L       +++L      +   +     +V E     
Sbjct: 61  -----RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--- 112

Query: 174 SLDKHLHDLRPDTRPLDWNTRMKIAAGAS--------------RGLQYLHEQLKQPVIYR 219
             D  L  L                                   G  ++HE     +I+R
Sbjct: 113 --DSDLKKL--------------FKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHR 153

Query: 220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT---- 275
           DLK +N LL +    K+ DFGLA+   S   T++   +         +  +  QLT    
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213

Query: 276 ------------FKS-----DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
                        ++     DI+S G +  EL+   ++       +         P+F  
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR--------FPLFPG 265

Query: 319 RKNFSQMVDPSLQGQYPVRGLYQ 341
              F    D + +  +      Q
Sbjct: 266 SSCFPLSPDRNSKKVHEKSNRDQ 288

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQ--LDHRGVQGVREFSAEVM-TLGSADH 147
             FR    +G G FG++Y G   +  + VAIK   +  +  Q + E  +++   L     
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYE--SKIYRILQGG-- 62

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPD-TRPLDWNTRMKIAAGASRGLQ 206
             +  +  +  EGD  +LV   M L  L   L DL    +R L   T + +A      ++
Sbjct: 63  TGIPNVRWFGVEGDYNVLV---MDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPK---LSDFGLAKM-GPSGDKTHVSTR----VM 258
           ++H +     ++RD+K  N L+  G       + DFGLAK    +    H+  R    + 
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 259 GTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
           GT  Y A      G + + + D+ S G VL+  + G 
Sbjct: 175 GTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 32/216 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIG- 155
           LG GG G V+       ++ VAIK++               E+  +   DH N+VK+   
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHALR-EIKIIRRLDHDNIVKVFEI 76

Query: 156 YCAEGDQRL-------------LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMKIAAGA 201
               G Q               +V EYM     +  L + L     PL            
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE--QGPLLEEHARLFMYQL 129

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMG 259
            RGL+Y+H      V++RDLK +N+ +  E    K+ DFGLA+ M P        +  + 
Sbjct: 130 LRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186

Query: 260 TYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
           T  Y +P   ++    T   D+++ G +  E++TG+
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 41/217 (18%), Positives = 81/217 (37%), Gaps = 47/217 (21%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA-----EVMTLGS-ADHPNLVK 152
           LG G + +V++       + V +K L        +         E+  L +    PN++ 
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKIL--------KPVKKKKIKREIKILENLRGGPNIIT 95

Query: 153 L--IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------RPLDWNTRMKIAAGASRG 204
           L  I          LV+E++      +    L            L             + 
Sbjct: 96  LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KA 142

Query: 205 LQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMG-PSGDKTH-VSTRVMGTY 261
           L Y H      +++RD+K  N+++  E    +L D+GLA+   P  +    V++R     
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY---- 195

Query: 262 GYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAI 297
            +  P+  +  Q+  +  D++S G +L  +I  ++  
Sbjct: 196 -FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 48/223 (21%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGVQGVREFSAEVMTLGSADHPNLVKLI-- 154
           LGEG +G V     +   ++VAIK+++   + +  +R    E+  L    H N++ +   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNI 77

Query: 155 --GYCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-----IAAGASRGL 205
                 E    + ++ E M        LH  +   T+ L  +  ++           R +
Sbjct: 78  QRPDSFENFNEVYIIQELM-----QTDLHRVIS--TQMLS-DDHIQYFIYQTL----RAV 125

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-------------H 252
           + LH      VI+RDLK SN+L+      K+ DFGLA++                     
Sbjct: 126 KVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 253 VSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGR 294
           V+TR      Y AP+  +T    +   D++S G +L EL   R
Sbjct: 183 VATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 1e-11
 Identities = 44/265 (16%), Positives = 76/265 (28%), Gaps = 70/265 (26%)

Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGV------ 132
            P  F      T   +    +GEG FG+V++   +     VAIK +   G   V      
Sbjct: 9   GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADH--TPVAIKIIAIEGPDLVNGSHQK 65

Query: 133 --REFSAEVMTL---------GSADHPNLVKLIG-YCAEG-------------------- 160
              E   E++                   + L   +C +G                    
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 161 ---------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
                    DQ  +V E+   G   + +       +     T   I    +  L      
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEAS 180

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP--DYA 269
           L+    +RDL   N+LL++    KL      K           +  + + G      DY 
Sbjct: 181 LR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYT 227

Query: 270 MTGQLTFKSDIYSFGVVLLELITGR 294
           ++        ++    +  +L TG 
Sbjct: 228 LSRLERDGIVVFCDVSMDEDLFTGD 252

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 26/218 (11%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK--QLDHRGVQGVREFSAEVMTLGSADHP 148
            NFR    +G G FG++  G      + VAIK   +  R  Q   E+             
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---D 65

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
            + ++  +   G    +V E   LG SL+  L DL    R     T + IA      ++Y
Sbjct: 66  GIPQVYYFGPCGKYNAMVLEL--LGPSLE-DLFDLCD--RTFSLKTVLMIAIQLISRMEY 120

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPK-----LSDFGLAKM-GPSGDKTHVSTR----V 257
           +H    + +IYRD+K  N L+    +       + DF LAK       K H+  R    +
Sbjct: 121 VHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSL 177

Query: 258 MGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
            GT  Y +      G + + + D+ + G + +  + G 
Sbjct: 178 TGTARYMSI-NTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.9 bits (151), Expect = 6e-11
 Identities = 40/159 (25%), Positives = 62/159 (38%), Gaps = 30/159 (18%)

Query: 99  LGEGGFGKVYKGCLEKI-EQVVAIKQLDHRGVQGVREFSAEVMTLG-SADHPNLVKLIGY 156
           LG G  GKV +    K  ++  A+K L        R    EV     ++  P++V+++  
Sbjct: 26  LGLGINGKVLQ-IFNKRTQEKFALKMLQDC--PKARR---EVELHWRASQCPHIVRIVDV 79

Query: 157 CAEGDQR----LLVYEYMPLGSL-DKHLHDLRPDTRPLDWNTRMKIAAGASR----GLQY 207
                      L+V E +  G L        R   R     T  + A+   +     +QY
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFS------RIQDRGDQAFTE-REASEIMKSIGEAIQY 132

Query: 208 LHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAK 243
           LH      + +RD+K  N+L          KL+DFG AK
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 48/266 (18%), Positives = 88/266 (33%), Gaps = 38/266 (14%)

Query: 59  SMDVKNLNLKDDSNNSGKSAKPFTFDELAAAT--GNFRSDCCLGEGGFGKVYKGCLEKIE 116
           SM VK       S+     A+ F   E+        ++    +G+GGFG +Y   +   E
Sbjct: 1   SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSE 60

Query: 117 QV-----VAIKQLDHRGVQ-----------GVREFSAEVMTLGSADHPNLVKLIGYCAEG 160
            V       +K                      E   + +      +  + K  G     
Sbjct: 61  SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120

Query: 161 DQ----RLLVYEYMPLGSLDKHLHDLRPDT-RPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                 R ++   M        L  +     +     T ++++      L+Y+HE     
Sbjct: 121 KNGKSYRFMI---MDR--FGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--- 172

Query: 216 VIYRDLKCSNILLEEGYHPK--LSDFGLAKM-GPSGDKTHVSTR----VMGTYGYCAPDY 268
            ++ D+K SN+LL      +  L D+GLA    P G     +        GT  + + D 
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDA 232

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGR 294
                 + + D+   G  +++ +TG 
Sbjct: 233 HNGVAPSRRGDLEILGYCMIQWLTGH 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 52/324 (16%), Positives = 96/324 (29%), Gaps = 91/324 (28%)

Query: 48  KKEEVSNDGQLSMDVKNLNLKDDSNNSGKSAKPFTFDELAAATGNFRSDCCLGEGGFGKV 107
           ++        +S   +    +   ++S  +A              +     +G G +G V
Sbjct: 10  QQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHV 69

Query: 108 YKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGSADHPNLVKL----I 154
            +   +  ++VVAIK++        R F           E+  L   +H ++VK+    I
Sbjct: 70  CEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122

Query: 155 GYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS----------- 202
               E    L +V E       D     L                               
Sbjct: 123 PKDVEKFDELYVVLEIA-----DSDFKKL--------------FRTPVYLTELHIKTLLY 163

Query: 203 ---RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA---------KMGPSGDK 250
               G++Y+H      +++RDLK +N L+ +    K+ DFGLA                 
Sbjct: 164 NLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 251 THVSTRVMGTYGYCAPDYAMTGQ------------LTFKS-----DIYSFGVVLLELITG 293
                 ++           +TG             L  ++     D++S G +  EL+  
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280

Query: 294 RKAIDQTKDRKELNLVAWARPMFK 317
            K        +         P+F 
Sbjct: 281 IKENVAYHADR--------GPLFP 296

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 38/235 (16%), Positives = 79/235 (33%), Gaps = 42/235 (17%)

Query: 91  GNFRSDCCLGEGGFGKVYKGC--------LEKIEQVVAIKQLDHRGVQGVREFS------ 136
             ++          G +Y+              +Q  ++K LD +  +   E +      
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 137 -----AEVMTLGSADHPNLVKLIGY-CAEGDQRLLVYEYMPLGSLDKHLHDLRP--DTRP 188
                 +   L S     +   +G+   +   R LV   +P   L + L           
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPS--LGRSLQSALDVSPKHV 155

Query: 189 LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK--LSDFGLAKMGP 246
           L   + +++A      L++LHE      ++ ++   NI ++     +  L+ +G A    
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212

Query: 247 SGDKTHVSTR------VMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
                HV+          G   + + D    G   + +SD+ S G  +L+ + G 
Sbjct: 213 P-SGKHVAYVEGSRSPHEGDLEFISMD-LHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 54/234 (23%), Positives = 99/234 (42%), Gaps = 60/234 (25%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSA---------EVMTLGS-ADHP 148
           LG+G +G V+K    +  +VVA+K++          F           E+M L   + H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69

Query: 149 NLVKLIG-YCAEGDQRL-LVYEYMPLGSLDKHLHD-LRPDTRPLDWNTRMK-----IAAG 200
           N+V L+    A+ D+ + LV++YM     +  LH  +R     L+     +     +   
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIR--ANILE-PVHKQYVVYQLI-- 119

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGT 260
             + ++YLH      +++RD+K SNILL    H K++DFGL++   +  +   +  +   
Sbjct: 120 --KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174

Query: 261 YGYCAPDY---AMTG-----------------QLTFKSDIYSFGVVLLELITGR 294
                 D     +T                  + T   D++S G +L E++ G+
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.4 bits (148), Expect = 3e-10
 Identities = 65/450 (14%), Positives = 143/450 (31%), Gaps = 128/450 (28%)

Query: 10  SNKKLDEEIDNKNKN----------LNKQADK-KQLIADTPRVDSN---ANLKKEEVSND 55
           S +++D  I +K+            L+KQ +  ++ + +  R++     + +K E     
Sbjct: 47  SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE----Q 102

Query: 56  GQLSMDVKNLN-LKDDSNNSGKSAKPFT------FDELAAATGNFRSDCCL---GEGGFG 105
            Q SM  +     +D   N  +    +       + +L  A    R    +   G  G G
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG 162

Query: 106 KVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEV--MTLGSADHPNLVKLIGYCAEGDQR 163
           K            VA+       VQ   +   ++  + L + + P  V            
Sbjct: 163 K----------TWVALDVCLSYKVQ--CKMDFKIFWLNLKNCNSPETV------------ 198

Query: 164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC 223
                   L  L K L+ + P     +W +R   ++     +  +  +L++ +  +  + 
Sbjct: 199 --------LEMLQKLLYQIDP-----NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN 245

Query: 224 SNILLEEGYHPK-LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYS 282
             ++L    + K  + F L        K  ++TR             +T  L+  +  + 
Sbjct: 246 CLLVLLNVQNAKAWNAFNL------SCKILLTTR----------FKQVTDFLSAATTTHI 289

Query: 283 FGVVLLELITGRKA---------IDQTKDRKE--------LNLVA---------WARPMF 316
                   +T  +                 +E        L+++A         W    +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDN--W 347

Query: 317 K--DRKNFSQMVDPSLQGQYP--VRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
           K  +    + +++ SL    P   R ++  L++         +    I  ++++L +   
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAH----IPTILLSLIWFDV 399

Query: 373 QKYDPQNPPSRSSRKSPSCLGVNKDDDHGK 402
            K D     ++  + S   L V K      
Sbjct: 400 IKSDVMVVVNKLHKYS---L-VEKQPKEST 425

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.9 bits (143), Expect = 8e-10
 Identities = 48/221 (21%), Positives = 85/221 (38%), Gaps = 40/221 (18%)

Query: 99  LGEGGFGKVYKGCL-EKIEQVVAIK-----QLDHRGVQGVREF-------SAEVMTLGSA 145
           LG G F  V+           VA+K     ++         E         A+     S 
Sbjct: 27  LGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTE--AAEDEIKLLQRVNDADNTKEDSM 83

Query: 146 DHPNLVKLIGY----CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAA 199
              +++KL+ +       G   ++V+E      L ++L  L  + + R +      +I+ 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 200 GASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP------KLSDFGLAKMGPSGDKTHV 253
               GL Y+H +    +I+ D+K  N+L+E    P      K++D G A          +
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196

Query: 254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
            TR      Y +P+  +       +DI+S   ++ ELITG 
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 43/231 (18%), Positives = 81/231 (35%), Gaps = 37/231 (16%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIK----------QLDH-----RGVQGVREF 135
             +     +G GGFG +Y        +  A             L       + V   ++ 
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95

Query: 136 SAEVMTLGSADHPNLVKLIGY----CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDW 191
             + +     D+  +    G           R +V   M    L   L  +         
Sbjct: 96  IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MER--LGIDLQKISGQNGTFKK 150

Query: 192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK--LSDFGLAKM-GPSG 248
           +T +++       L+Y+HE      ++ D+K +N+LL      +  L+D+GL+    P+G
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

Query: 249 DKTHVSTRV----MGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGR 294
           +             GT  + + D A  G  L+ +SD+   G  +L  + G+
Sbjct: 208 NHKQYQENPRKGHNGTIEFTSLD-AHKGVALSRRSDVEILGYCMLRWLCGK 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 51/258 (19%), Positives = 84/258 (32%), Gaps = 74/258 (28%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK---QLDHRGVQGVREFSA-EVMTLGSADHPN---LV 151
           LG G F  V+     + ++ VA+K     +H     + E    + +     + PN   +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 152 KLIGY----CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGASRGL 205
           +L+         G    +V+E   LG    HL     + + + L      KI     +GL
Sbjct: 105 QLLDDFKISGVNGTHICMVFE--VLGH---HLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159

Query: 206 QYLHEQLKQPVIYRDLKCSNILLE------------------------------------ 229
            YLH + +  +I+ D+K  NILL                                     
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 230 -------------EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
                        E    K++D G A          + TR      Y + +  +      
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272

Query: 277 KSDIYSFGVVLLELITGR 294
            +DI+S   +  EL TG 
Sbjct: 273 PADIWSTACMAFELATGD 290

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 52/214 (24%), Positives = 88/214 (41%), Gaps = 40/214 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFS--AEVMTLGSADHPNLV 151
           +G+G FG+V K    K+ Q VA+K     +  HR  Q   E      +      +  N++
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR--QAAEEIRILEHLRKQDKDNTMNVI 162

Query: 152 KLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAGAS 202
            ++         C       + +E      L  +L++L  +   +        K A    
Sbjct: 163 HMLENFTFRNHIC-------MTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGT 260
           + L  LH   K  +I+ DLK  NILL++      K+ DFG +        T++ +R    
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF--- 264

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
             Y AP+  +  +     D++S G +L EL+TG 
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 51/214 (23%), Positives = 83/214 (38%), Gaps = 38/214 (17%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK-----QLDHRGVQGVREFS--AEVMTLGSADHPNLV 151
           +G+G FG+V K      ++ VAIK     +      Q   E      +    +     +V
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN--QAQIEVRLLELMNKHDTEMKYYIV 119

Query: 152 KLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAGAS 202
            L  +       C       LV+E      L  +L+DL  +T  R +  N   K A    
Sbjct: 120 HLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP--KLSDFGLAKMGPSGDKTHVSTRVMGT 260
             L +L    +  +I+ DLK  NILL        K+ DFG +         ++ +R    
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF--- 223

Query: 261 YGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
             Y +P+  +        D++S G +L+E+ TG 
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 54/247 (21%), Positives = 89/247 (36%), Gaps = 67/247 (27%)

Query: 99  LGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQGVREFSA-EV---MTLGSADHPN--- 149
           LGEG FGKV + C    + +  VA+K +  R V   RE +  E+     +   D  N   
Sbjct: 27  LGEGTFGKVVE-CLDHARGKSQVALKII--RNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 150 LVKLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAG 200
            V +  +       C       + +E      L K+  +   +   +P        +A  
Sbjct: 84  CVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENNFQPYPLPHVRHMAYQ 131

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-------------------KLSDFGL 241
               L++LH   +  + + DLK  NIL                          +++DFG 
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 242 AKMGPSGDKTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID 298
           A       + H   V+TR      Y  P+  +        D++S G +L E   G   + 
Sbjct: 189 ATFD---HEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG-FTLF 239

Query: 299 QTKDRKE 305
           QT + +E
Sbjct: 240 QTHENRE 246

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 55/258 (21%), Positives = 88/258 (34%), Gaps = 85/258 (32%)

Query: 99  LGEGGFGKVYKGCL-EKIEQVVAIKQLDHRGVQGVREFSA-EV---MTLGSADH--PNLV 151
           +G+G FG+V   C     ++  A+K +  R ++     +  E      + + D    N+V
Sbjct: 43  MGDGTFGRVLL-CQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 152 KLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDLRPDT--RPLDWNTRMKIAAGAS 202
           K  G        C       L++E      L   L+++                      
Sbjct: 100 KYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-------------------------KLS 237
           + L YL    K  + + DLK  NILL++ Y                           KL 
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

Query: 238 DFGLAKMGPSGDKTH---VSTR-------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL 287
           DFG A         H   ++TR       ++   G+              SD++SFG VL
Sbjct: 205 DFGCATFK---SDYHGSIINTRQYRAPEVILN-LGW-----------DVSSDMWSFGCVL 249

Query: 288 LELITGRKAIDQTKDRKE 305
            EL TG   + +T +  E
Sbjct: 250 AELYTG-SLLFRTHEHME 266

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 56/252 (22%), Positives = 91/252 (36%), Gaps = 75/252 (29%)

Query: 99  LGEGGFGKVYKGC--LEKIEQVVAIKQLDHRGVQGVREFSA-EV---MTLGSADHPN--- 149
           LGEG FGKV + C   +   + VA+K +  + V    E +  E+     L + D  +   
Sbjct: 22  LGEGAFGKVVE-CIDHKAGGRHVAVKIV--KNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 150 LVKLIGY-------CAEGDQRLLVYEYMPLGSLDKHLHDL--RPDTRPLDWNTRMKIAAG 200
            V+++ +       C       +V+E      L    +D        P   +   K+A  
Sbjct: 79  CVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENGFLPFRLDHIRKMAYQ 126

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP-------------------KLSDFGL 241
             + + +LH      + + DLK  NIL  +  +                    K+ DFG 
Sbjct: 127 ICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183

Query: 242 AKMGPSGDKTHVSTR-------VMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           A        T VSTR       ++   G+  P            D++S G +L+E   G 
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILA-LGWSQP-----------CDVWSIGCILIEYYLG- 230

Query: 295 KAIDQTKDRKEL 306
             +  T D KE 
Sbjct: 231 FTVFPTHDSKEH 242

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	426
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.83
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.63
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.34
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.29
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.93
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.87
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.84
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.48
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.42
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.34
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.33
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.26
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.22
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.76
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.52
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.59
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.56
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.06
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.79
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.87

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-61  Score=454.68  Aligned_cols=262  Identities=30%  Similarity=0.439  Sum_probs=220.6

Q ss_pred             CCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|.+.+.||+|+||+||+|++.     .++..||||++........++|.+|+.+|++++|||||+++|+|.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46888899999999999999975     3578999999987766667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhC---------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          166 VYEYMPLGSLDKHLHDLR---------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      |||||++|+|.++|+...         .....++|.+++.|+.||+.||.|||+.   +||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence            999999999999997632         2345799999999999999999999997   9999999999999999999999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......+....+....  
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~--  247 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR--  247 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC--
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--
Confidence            99999986544333333344579999999999999999999999999999999999 899998766544333222110  


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                                     ....|..++.++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       248 ---------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          248 ---------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                           112344556689999999999999999999999999998865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.8e-60  Score=455.65  Aligned_cols=263  Identities=30%  Similarity=0.466  Sum_probs=214.7

Q ss_pred             CCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|.+.+.||+|+||+||+|++.     .++..||||++........++|.+|+.+|++++|||||+++|+|.+...+||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45778889999999999999975     3588999999987766667889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          166 VYEYMPLGSLDKHLHDLRP-----------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      |||||++|+|.++|+....           ...+++|.+++.|+.||+.||.|||+.   +||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence            9999999999999976432           235699999999999999999999997   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||+++...........+...||+.|||||++.+..|+.++|||||||+||||+| |+.||...........+... 
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-  276 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-  276 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence            9999999986554444444455689999999999999999999999999999999999 89999876654433332211 


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                                      .+...|..++.++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       277 ----------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          277 ----------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                            11123445566899999999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-59  Score=444.74  Aligned_cols=262  Identities=28%  Similarity=0.468  Sum_probs=209.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|.+.+.||+|+||+||+|+++.   .||||+++...  ....+.|.+|+.+|++++|||||+++|++.+ +.++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            34578889999999999999998764   48999987543  3456789999999999999999999999865 568999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||||++|+|.++|+.   ....+++..++.|+.||+.||+|||+.   +||||||||+||||++++.+||+|||+|+...
T Consensus       110 mEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          110 TQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            999999999999976   346799999999999999999999997   99999999999999999999999999998654


Q ss_pred             CCCCcceeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ...........+||+.|||||++.+   +.|+.++|||||||+||||+||+.||...............           
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~-----------  252 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR-----------  252 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-----------
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-----------
Confidence            4333334455789999999999864   46899999999999999999999999876544332222110           


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ....+.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       253 ~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          253 GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            0011111 12334556689999999999999999999999999998864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.5e-60  Score=446.97  Aligned_cols=259  Identities=28%  Similarity=0.395  Sum_probs=215.7

Q ss_pred             CccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++++.+.||+|+||+||+|.+.     .+++.||||.+..... ...++|.+|+.++++++|||||+++|+|.+...++|
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            4677888999999999999974     3578999999975433 345789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc
Q 014362          166 VYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH  233 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~  233 (426)
                      |||||++|+|.++|.....            ....+++..++.|+.||+.||.|||+.   +||||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            9999999999999975321            124699999999999999999999998   9999999999999999999


Q ss_pred             eeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhh
Q 014362          234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~  312 (426)
                      +||+|||+++.....+.....+...||+.|||||++.++.|+.++|||||||+||||+| |..||.+.........+.. 
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~-  262 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-  262 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-
Confidence            99999999986544333334455689999999999999999999999999999999999 8999987765443322221 


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                                      ..+...|..++..+.+|+.+||+.||.+||+|.||++.|+.+
T Consensus       263 ----------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          263 ----------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                            011123445667899999999999999999999999999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.7e-59  Score=449.07  Aligned_cols=250  Identities=22%  Similarity=0.286  Sum_probs=215.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ..|++.+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999999998765566677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      +||+|.+++..     ..+++..+..++.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+...... 
T Consensus       154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  224 (346)
T 4fih_A          154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  224 (346)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred             CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence            99999999975     4599999999999999999999998   99999999999999999999999999998654322 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+....             .+. 
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------~~~-  289 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------PPR-  289 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-------------CCC-
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------CCC-
Confidence             22345689999999999999999999999999999999999999998766544433332110             000 


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       290 -~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 -LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0112344568899999999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.8e-60  Score=445.25  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=216.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+.++|||||+++++|.+.+.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997542   234677999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |||+||+|.++|..    ...+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+|+....
T Consensus       112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            99999999999986    35699999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.......+....      .       
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~------~-------  251 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE------Y-------  251 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------C-------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC------C-------
Confidence            444444456799999999999999999999999999999999999999998766544333322111      0       


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                           .+|...+.++.+|+.+||+.||.+|||+.|++
T Consensus       252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                 12334456889999999999999999999975

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.3e-59  Score=448.78  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=208.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.....  ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            589999999999999999999999999999999976532  345679999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ||+||+|.++|...  ....+++..++.|+.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+.....
T Consensus       104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999763  245689999999999999999999998   9999999999999999999999999999864321


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                        ....+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+....        +.     
T Consensus       179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------~~-----  243 (350)
T 4b9d_A          179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS--------FP-----  243 (350)
T ss_dssp             --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------CC-----
T ss_pred             --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC--------CC-----
Confidence              122344689999999999999999999999999999999999999998766544333222110        00     


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ..+...+.++.+||.+||+.||.+|||+.|+++
T Consensus       244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                112334568899999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.8e-59  Score=443.98  Aligned_cols=256  Identities=20%  Similarity=0.224  Sum_probs=213.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ..|.+.++||+|+||+||+|+++.+|+.||||+++....     ..+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            468888999999999999999999999999999975432     246999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEecccccccCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~~~~  249 (426)
                      +||+|.++|+.    ...+++..++.++.||+.||.|||+.   +||||||||+||||+.+| .+||+|||+|+......
T Consensus       133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999986    35699999999999999999999987   999999999999999987 69999999998654322


Q ss_pred             Cc---ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          250 KT---HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       250 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..   ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...........+.....      .+    
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------~~----  275 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP------PI----  275 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC------GG----
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC------Cc----
Confidence            11   122346899999999999999999999999999999999999999987655443333321111      00    


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                           ...+...+..+.+|+.+||+.||.+|||+.||++.|......
T Consensus       276 -----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          276 -----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             -----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                 012334556889999999999999999999999998877543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.1e-58  Score=450.84  Aligned_cols=250  Identities=22%  Similarity=0.298  Sum_probs=216.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            46999999999999999999999999999999998776666778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      +||+|.+++..     ..+++..+..|+.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+...... 
T Consensus       231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            99999999975     4599999999999999999999998   99999999999999999999999999998654322 


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+......+..+....             .+.+
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------------~~~~  367 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------------PPRL  367 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------------CCCC
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------------CCCC
Confidence             22345689999999999999999999999999999999999999998766554443332110             0001


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              112334568899999999999999999999985

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.4e-58  Score=446.18  Aligned_cols=276  Identities=24%  Similarity=0.340  Sum_probs=227.5

Q ss_pred             CCcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCC-CCcc
Q 014362           79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADH-PNLV  151 (426)
Q Consensus        79 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~h-pniv  151 (426)
                      .++...+++...++|++.+.||+|+||+||+|.+..+     ++.||||.+..... ...+.|.+|+.+|.+++| ||||
T Consensus        52 lp~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV  131 (353)
T 4ase_A           52 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV  131 (353)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEE
Confidence            3566677777888999999999999999999998654     47899999976543 345679999999999965 8999


Q ss_pred             eEeeEEeeC-CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEe
Q 014362          152 KLIGYCAEG-DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY  218 (426)
Q Consensus       152 ~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH  218 (426)
                      +++|+|.+. ..++||||||++|+|.++|+....            ....+++..++.++.||+.||.|||+.   +|||
T Consensus       132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH  208 (353)
T 4ase_A          132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  208 (353)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence            999999764 568999999999999999976321            134589999999999999999999998   9999


Q ss_pred             cCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCC
Q 014362          219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAI  297 (426)
Q Consensus       219 ~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~  297 (426)
                      |||||+||||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987654444444455789999999999999999999999999999999998 99999


Q ss_pred             CCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          298 DQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .+...........      .          ...+...|..++.++.+|+.+||+.||.+|||+.+|++.|+.+.+.
T Consensus       289 ~~~~~~~~~~~~i------~----------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          289 PGVKIDEEFCRRL------K----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             TTCCCSHHHHHHH------H----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHH------H----------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            8765433221111      0          0111223445566899999999999999999999999999988643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-58  Score=430.74  Aligned_cols=247  Identities=25%  Similarity=0.400  Sum_probs=200.8

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee----CCeeEEEE
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRLLVY  167 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~  167 (426)
                      ++.+.||+|+||+||+|.+..++..||||.+....  ....+.|.+|+.+|+.++|||||+++++|.+    ...+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999999999999999999997543  2345679999999999999999999999865    34589999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~  246 (426)
                      |||+||+|.++|..    ...+++..++.++.||+.||.|||+. .++||||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999986    35799999999999999999999987 123999999999999985 7899999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..    .....+||+.|||||++. +.|+.++|||||||++|||+||+.||.............     ...  ...   
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i-----~~~--~~~---  248 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-----TSG--VKP---  248 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-----TTT--CCC---
T ss_pred             CC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH-----HcC--CCC---
Confidence            22    234568999999999886 469999999999999999999999997654433221111     000  000   


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       +    .++...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       249 -~----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 -A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0    112223347899999999999999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.5e-58  Score=424.77  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=199.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.+..   ......+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999997643   233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+ +|+|.+++..    ...+++..+..++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+|+....
T Consensus        93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 6899999876    45799999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..   .....+||+.|||||++.+..| +.++|||||||++|||+||+.||...........+...      ..      
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------~~------  229 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------VY------  229 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CC------
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------CC------
Confidence            22   2234689999999999998876 58999999999999999999999876543332222211      00      


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                            .+|...+.++.+|+.+||+.||.+|||+.|+++. .+++
T Consensus       230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h-pw~k  267 (275)
T 3hyh_A          230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD-DWFK  267 (275)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC-HHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC-cccc
Confidence                  1223345678999999999999999999999863 4443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.3e-58  Score=430.54  Aligned_cols=248  Identities=27%  Similarity=0.335  Sum_probs=202.7

Q ss_pred             CCccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|++.+.||+|+||+||+|++.   .+++.||||++.+...  .....+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46999999999999999999874   4688999999975432  234468889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |||||+||+|.++|..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.+|.+||+|||+|+..
T Consensus       104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999986    35799999999999999999999998   9999999999999999999999999999854


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+.......+...      ..     
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------~~-----  243 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA------KL-----  243 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CC-----
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC------CC-----
Confidence            3322  2233468999999999999999999999999999999999999999876655443333211      00     


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI-----TDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~  365 (426)
                             .+|...+.++.+|+.+||+.||.+||++     +|+++
T Consensus       244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                   1233445688999999999999999984     56663

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.5e-57  Score=426.46  Aligned_cols=273  Identities=24%  Similarity=0.288  Sum_probs=202.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC----eeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~lv  166 (426)
                      ++|.+.+.||+|+||+||+|++.  |+.||||++...... ...+..|+..+..++|||||+++++|.+.+    .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            46788899999999999999985  899999999754221 122345666677899999999999997654    57999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----CCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ-----LKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      ||||++|+|.++|+.     ..+++..++.++.|++.||+|||+.     ..++||||||||+||||+.++.+||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            999999999999986     4699999999999999999999975     235899999999999999999999999999


Q ss_pred             cccCCCCCCc--ceeeeecccccccCccccccC------CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH-HHhh
Q 014362          242 AKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL-VAWA  312 (426)
Q Consensus       242 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~  312 (426)
                      |+........  ......+||+.|||||++.+.      .++.++|||||||+||||+||.+||........... ....
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            9865433222  122345899999999998764      477899999999999999999888754332111000 0000


Q ss_pred             hhhhhcccccccccCCcccCCCC-----hHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYP-----VRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .+...  ..........++...|     ...+..+.+|+.+||+.||.+||||.||++.|+.+..+
T Consensus       235 ~~~~~--~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          235 DPSVE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCCHH--HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cchHH--HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            00000  0000011112222222     24556789999999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.9e-55  Score=413.08  Aligned_cols=252  Identities=21%  Similarity=0.327  Sum_probs=191.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCC--------
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGD--------  161 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--------  161 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            3589999999999999999999999999999999765433 3467899999999999999999999987544        


Q ss_pred             ----eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEe
Q 014362          162 ----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS  237 (426)
Q Consensus       162 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  237 (426)
                          .+|+|||||++|+|.+++.... .....++..++.++.||+.||+|||+.   +||||||||+||||+.++.+||+
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence                3689999999999999997632 223456778999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCCCc----------ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc
Q 014362          238 DFGLAKMGPSGDKT----------HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN  307 (426)
Q Consensus       238 Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  307 (426)
                      |||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||.....  ...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HHH
Confidence            99999865432211          11234579999999999999999999999999999999996   7754221  111


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+.....     ..++.         .+......+.+|+.+||+.||.+|||+.|+++
T Consensus       236 ~~~~~~~-----~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 TLTDVRN-----LKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHT-----TCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHhc-----CCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111000     00000         01122345678999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-53  Score=417.64  Aligned_cols=268  Identities=22%  Similarity=0.268  Sum_probs=210.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee------CC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE------GD  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~  161 (426)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.....  ...+.+.+|+.+|+.++|||||++++++..      ..
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            4679999999999999999999999999999999976432  345678899999999999999999998754      35


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+|||||||+ |+|.+++..    ...+++..+..++.||+.||.|||+.   +||||||||+|||++.++.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            7899999996 679988875    46799999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCC--CcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          242 AKMGPSGD--KTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       242 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |+......  ........+||+.|||||++.+. .++.++||||+||++|||++|++||.+.+....+..+.........
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            98643321  12233456899999999998875 5699999999999999999999999988776665555432211110


Q ss_pred             cc-------cccc---ccCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RK-------NFSQ---MVDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~-------~~~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..       ....   .+.+.....   .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00       0000   000000000   01123457899999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-52  Score=405.32  Aligned_cols=266  Identities=21%  Similarity=0.269  Sum_probs=201.9

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      ...++|++.+.||+|+||+||+|+++   .+++.||||.+....  ....+.+|+.+|+.+ +|||||+++++|.+.+++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            35678999999999999999999875   467899999987643  345688999999988 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEeccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLA  242 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla  242 (426)
                      |+||||+++|+|.+++.       .+++.++..++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+|
T Consensus        96 ~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999884       389999999999999999999998   99999999999999876 79999999999


Q ss_pred             ccCCCCCC--------------------------cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCC
Q 014362          243 KMGPSGDK--------------------------THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRK  295 (426)
Q Consensus       243 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~  295 (426)
                      +.......                          ....+..+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            75432211                          0112335799999999999876 58999999999999999999999


Q ss_pred             CCCCcCc-hhhhcHHHhhhhh---------hhc----cc-------------------ccccccC----CcccCCCChHh
Q 014362          296 AIDQTKD-RKELNLVAWARPM---------FKD----RK-------------------NFSQMVD----PSLQGQYPVRG  338 (426)
Q Consensus       296 p~~~~~~-~~~~~~~~~~~~~---------~~~----~~-------------------~~~~~~~----~~~~~~~~~~~  338 (426)
                      ||..... ...+..+......         +..    ..                   .......    ...........
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            9965443 2222222111000         000    00                   0000000    00000111233


Q ss_pred             HHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          339 LYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       339 ~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +.++.+|+.+||+.||.+|||++|+++
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            457899999999999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-52  Score=426.96  Aligned_cols=253  Identities=22%  Similarity=0.281  Sum_probs=216.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+...+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            46899999999999999999999999999999999876666667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC--CceeEecccccccCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--YHPKLSDFGLAKMGPS  247 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~~  247 (426)
                      |+||+|.++|..   ....+++..+..++.||+.||.|||+.   +|+||||||+|||++.+  +.+||+|||+|+....
T Consensus       236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999999865   245799999999999999999999998   99999999999999854  8999999999987543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .   ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+......+..+.....      .+.    
T Consensus       310 ~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~------~~~----  376 (573)
T 3uto_A          310 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------NMD----  376 (573)
T ss_dssp             T---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC------CCC----
T ss_pred             C---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC------CCC----
Confidence            3   223456899999999999999999999999999999999999999988766554433322111      000    


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ...+...+..+.+||.+||+.||.+||++.|+++
T Consensus       377 ----~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          377 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0111223457899999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-51  Score=421.66  Aligned_cols=249  Identities=26%  Similarity=0.326  Sum_probs=204.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHH---HHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREF---SAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+...   .....+   ..++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            579999999999999999999999999999999975321   122223   34467778889999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ||||||+||+|..+|..    ...+++..++.++.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+.
T Consensus       269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999986    35699999999999999999999987   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .....    ....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+...........   ......    
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~----  410 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMA----  410 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCC----
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCC----
Confidence            54322    234689999999999975 579999999999999999999999997654332221111   111111    


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                              ..+|...+.++.+||.+||+.||.+|++     +.||++
T Consensus       411 --------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 --------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                    1234445668899999999999999998     677764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.1e-51  Score=391.54  Aligned_cols=289  Identities=41%  Similarity=0.703  Sum_probs=246.0

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      .+++.++...+++|++.+.||+|+||.||+|.+. +++.||||.+........+.+.+|+.+++.++||||+++++++.+
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3444555567889999999999999999999975 588999999987766677889999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ....++||||+++|+|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  183 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDF  183 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeec
Confidence            9999999999999999999976444445799999999999999999999997   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||....+........|..... ..
T Consensus       184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~  262 (321)
T 2qkw_B          184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NN  262 (321)
T ss_dssp             TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TT
T ss_pred             ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-cc
Confidence            99986443333333344578999999999999999999999999999999999999998776665555555543322 22


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ..+...+++.+....+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            345666777777777888899999999999999999999999999999988754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=7.5e-50  Score=383.43  Aligned_cols=291  Identities=42%  Similarity=0.710  Sum_probs=243.6

Q ss_pred             CCCCcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEee
Q 014362           77 SAKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIG  155 (426)
Q Consensus        77 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~  155 (426)
                      ..+.|++.++....++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            4567899999999999999999999999999999865 5889999999765332 2346899999999999999999999


Q ss_pred             EEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCcee
Q 014362          156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK  235 (426)
Q Consensus       156 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  235 (426)
                      ++.+....++||||+++|+|.+++.........+++..++.++.||+.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999987655566799999999999999999999986555999999999999999999999


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCc--hhhhcHHHhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD--RKELNLVAWAR  313 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~--~~~~~~~~~~~  313 (426)
                      |+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ........+..
T Consensus       175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999998654332 2233445699999999999999999999999999999999999999964221  12223334433


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      .... ........+..+...++...+..+.+++.+||+.||.+||++.+|++.|+..
T Consensus       254 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            3332 2345666777777788889999999999999999999999999999999753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.2e-49  Score=373.00  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=214.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||+||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++++++...+.+++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45799999999999999999999999999999999766555667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            999999999976     3599999999999999999999998   99999999999999999999999999997644332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.....               
T Consensus       171 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------------  233 (297)
T 3fxz_A          171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---------------  233 (297)
T ss_dssp             C--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS---------------
T ss_pred             c--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------
Confidence            2  22345799999999999999999999999999999999999999987654433322211100               


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+...+..+.+|+.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            001123344567899999999999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-49  Score=376.55  Aligned_cols=263  Identities=25%  Similarity=0.370  Sum_probs=217.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|.+.+.||+|+||+||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            35799999999999999999999999999999999776666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999986   246799999999999999999999998   99999999999999999999999999998643322


Q ss_pred             Ccc------------eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          250 KTH------------VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       250 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      ...            ......||+.|+|||++.+..++.++||||||+++|||++|..||.............       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------  235 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------  235 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------
Confidence            111            1114579999999999999999999999999999999999999987543321110000       


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                          .....+    ...+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       236 ----~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          236 ----VRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----HHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                000000    011223334688999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4e-49  Score=375.85  Aligned_cols=270  Identities=28%  Similarity=0.406  Sum_probs=210.0

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      ....+....++|++.+.||+|+||+||+|.+.  +..||||++.....  ...+.+.+|+.+++.++||||+++++++.+
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            33344445678999999999999999999875  88999999976543  345678999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCCeeeccCCceeEe
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYHPKLS  237 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~  237 (426)
                      ....++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.+||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999999997521 112399999999999999999999987   7  9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      |||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....    
T Consensus       182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~----  255 (309)
T 3p86_A          182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC----  255 (309)
T ss_dssp             CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC----
T ss_pred             CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC----
Confidence            999997533221  12234579999999999999999999999999999999999999998765443322221110    


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                                  .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+.....
T Consensus       256 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          256 ------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence                        1112234455688999999999999999999999999999976544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.7e-49  Score=376.49  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=212.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            457899999999999999999999999999999999754  234466788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            999999999999976    35699999999999999999999998   99999999999999999999999999997644


Q ss_pred             CCCCcceeeeecccccccCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ....   ....+||+.|+|||++.+..++ .++|||||||++|||++|+.||...........+...      ..     
T Consensus       166 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------~~-----  231 (328)
T 3fe3_A          166 VGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------KY-----  231 (328)
T ss_dssp             SSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CC-----
T ss_pred             CCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CC-----
Confidence            3322   2345799999999999988875 8999999999999999999999876544333222211      00     


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             ..|...+..+.+|+.+||+.||.+|||+.++++
T Consensus       232 -------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 -------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                   123334557899999999999999999999985

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-48  Score=380.98  Aligned_cols=264  Identities=25%  Similarity=0.379  Sum_probs=218.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEc-------CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE-------KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  160 (426)
                      .++|.+.+.||+|+||.||+|.+.       .++..||||.+..... ...+.+.+|+.+++.+ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467999999999999999999874       3467899999976533 3456799999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      ..+|+||||+++|+|.+++.....            ....+++..++.++.||+.||.|||+.   +|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence            999999999999999999986432            124589999999999999999999998   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..........
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999986544332222333467889999999999999999999999999999999 999998765433222


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .+..                 ......+..++..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       317 ~~~~-----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          317 LLKE-----------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             HHHT-----------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhc-----------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            2111                 111123444566899999999999999999999999999988654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.3e-48  Score=372.23  Aligned_cols=250  Identities=27%  Similarity=0.349  Sum_probs=211.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+.   .......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999754   223456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            999999999999976    35699999999999999999999998   99999999999999999999999999998533


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+..      ..       
T Consensus       157 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~-------  221 (337)
T 1o6l_A          157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------EE-------  221 (337)
T ss_dssp             CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC-------
T ss_pred             cCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc------CC-------
Confidence            222  123346899999999999999999999999999999999999999987654332222211      10       


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~  366 (426)
                           ..+|...+..+.+|+.+||+.||.+||     ++.+|++.
T Consensus       222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                 012334456889999999999999999     89998853

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-47  Score=363.57  Aligned_cols=286  Identities=38%  Similarity=0.642  Sum_probs=232.9

Q ss_pred             CCCCcCHHHHHHhcCCcccc------ceeeecCcEEEEEEEEcCCCEEEEEEEeccCC----cccHHHHHHHHHHHhcCC
Q 014362           77 SAKPFTFDELAAATGNFRSD------CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSAD  146 (426)
Q Consensus        77 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~  146 (426)
                      ....|++.++..++++|...      +.||+|+||.||+|.+.  +..||||.+....    ....+.+.+|+.+++.++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            35678999999999998877      89999999999999874  7899999987532    234567899999999999


Q ss_pred             CCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCe
Q 014362          147 HPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNI  226 (426)
Q Consensus       147 hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NI  226 (426)
                      ||||+++++++.+....++||||+++++|.+++.... ....+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni  164 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI  164 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence            9999999999999999999999999999999997532 245699999999999999999999997   999999999999


Q ss_pred             eeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh
Q 014362          227 LLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL  306 (426)
Q Consensus       227 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~  306 (426)
                      |++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||.........
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  243 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL  243 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence            999999999999999986544333333344579999999998764 5899999999999999999999999876543322


Q ss_pred             cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ..+.  .........+...++..+ ...+...+..+.+++.+||+.+|.+||++.+|++.|+.+.+
T Consensus       244 ~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          244 LDIK--EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             THHH--HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHH--HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            2221  111111222333344333 34566778899999999999999999999999999998854

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-48  Score=372.97  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=215.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|.+..+   +..||||.+.... ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            45799999999999999999999754   4569999997653 3345679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999975   345799999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCC-cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          246 PSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       246 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ..... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+...           
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-----------  270 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-----------  270 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-----------
Confidence            43322 122223456889999999999999999999999999999999 99999776544333222110           


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                            .....+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       271 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          271 ------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             ------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                  111223345568899999999999999999999999999997643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-47  Score=367.73  Aligned_cols=266  Identities=22%  Similarity=0.275  Sum_probs=219.8

Q ss_pred             CCCCCcCHHHHHHhcCC----------ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC
Q 014362           76 KSAKPFTFDELAAATGN----------FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA  145 (426)
Q Consensus        76 ~~~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l  145 (426)
                      ....+++++++..++..          |.....||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.+
T Consensus        20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l   99 (321)
T 2c30_A           20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY   99 (321)
T ss_dssp             -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred             ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence            34466888888877654          77788999999999999999989999999999877666677899999999999


Q ss_pred             CCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 014362          146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN  225 (426)
Q Consensus       146 ~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N  225 (426)
                      +||||+++++++......++||||+++++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  171 (321)
T 2c30_A          100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS  171 (321)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence            999999999999999999999999999999999864     4699999999999999999999997   99999999999


Q ss_pred             eeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhh
Q 014362          226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE  305 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~  305 (426)
                      ||++.++.+||+|||++........  ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~  249 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA  249 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             EEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999976443221  22345799999999999999999999999999999999999999986654332


Q ss_pred             hcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ...+...             ..+.+  ..+...+..+.+|+.+||+.||.+||++.++++.
T Consensus       250 ~~~~~~~-------------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 MKRLRDS-------------PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHS-------------SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhcC-------------CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2211110             00000  1122344578999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-48  Score=383.25  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=217.0

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++......++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            345679999999999999999999998899999999875432 3345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            9999999999999762   34689999999999999999999998   99999999999999999999999999998543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ............+++.|+|||++.+..++.++|||||||++|||++ |..||...........+..              
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~--------------  330 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK--------------  330 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT--------------
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--------------
Confidence            2211111112245778999999999999999999999999999998 9999987654332222111              


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                         ..+...|..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       331 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          331 ---GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence               01112234455688999999999999999999999999998865

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-48  Score=379.97  Aligned_cols=275  Identities=24%  Similarity=0.338  Sum_probs=223.8

Q ss_pred             CCcCHHHHHHhcCCccccceeeecCcEEEEEEE-----EcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcc
Q 014362           79 KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLV  151 (426)
Q Consensus        79 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv  151 (426)
                      .++....+....++|.+.+.||+|+||.||+|.     ...+++.||||++..... ...+.+.+|+.++..+ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            456677777788999999999999999999999     455679999999976533 3456799999999999 799999


Q ss_pred             eEeeEEeeCCe-eEEEEEecCCCCHHHHhhhhCCC---------------------------------------------
Q 014362          152 KLIGYCAEGDQ-RLLVYEYMPLGSLDKHLHDLRPD---------------------------------------------  185 (426)
Q Consensus       152 ~~~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------  185 (426)
                      ++++++.+... +++||||+++|+|.+++......                                             
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999987654 89999999999999999864321                                             


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          186 -----------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       186 -----------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                                       ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             12289999999999999999999998   9999999999999999999999999999865444


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........||+.|+|||++.+..++.++|||||||++|||++ |..||...............               
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------------  311 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---------------  311 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------------
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------------
Confidence            33334445678999999999999999999999999999999998 99999876543322111110               


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                       ......+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       312 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          312 -GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             -TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence             01111233345578999999999999999999999999998864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-48  Score=373.45  Aligned_cols=276  Identities=25%  Similarity=0.333  Sum_probs=210.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC----eeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~~l  165 (426)
                      .++|++.+.||+|+||.||+|++.  ++.||||++.... .....+..|+.+++.++||||+++++++....    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            357999999999999999999887  7999999997543 23344667899999999999999999998754    4699


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHc-------CCCCeEecCCCCCCeeeccCCceeEec
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ-------LKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      ||||+++|+|.+++..     ..+++..++.++.||+.||.|||+.       +..+|+||||||+|||++.++.+||+|
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            9999999999999976     4599999999999999999999963       122899999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||................
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~  254 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG  254 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence            999976544333333334579999999999986     356778999999999999999999997654332221111100


Q ss_pred             h--hhhcc--cccccccCCcccCC-CChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          314 P--MFKDR--KNFSQMVDPSLQGQ-YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       314 ~--~~~~~--~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .  .....  ........+.+... .....+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            0  00000  00000011111111 1224556799999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.2e-48  Score=373.11  Aligned_cols=255  Identities=25%  Similarity=0.343  Sum_probs=208.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999999999999999975433 234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999998865    45699999999999999999999997   9999999999999999999999999999764333


Q ss_pred             CCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+...        .    
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~--------~----  225 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK--------K----  225 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT--------C----
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc--------c----
Confidence            33333345689999999999988776 78999999999999999999999765433211 1111100        0    


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        .........+..+.+|+.+||+.||.+||++.|+++.
T Consensus       226 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              0001112344578899999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.3e-48  Score=374.21  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=211.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||||.+......      ..+.+.+|+.+|+.++||||++++++|.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            346799999999999999999999999999999999765332      35678999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC----ceeEec
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSD  238 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~D  238 (426)
                      +++||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            9999999999999999965    45799999999999999999999998   999999999999998876    799999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ||+++......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.....    
T Consensus       163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----  235 (361)
T 2yab_A          163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY----  235 (361)
T ss_dssp             CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----
T ss_pred             cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC----
Confidence            99998654332   12345799999999999999999999999999999999999999987655443322221100    


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .+    ++.    .....+..+.+|+.+||..||.+||++.++++
T Consensus       236 --~~----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 --DF----DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             --CC----CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --CC----Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              00    000    01123457889999999999999999999984

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=376.63  Aligned_cols=250  Identities=27%  Similarity=0.380  Sum_probs=206.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  164 (426)
                      ..++|++.+.||+|+||+||+|+++.+++.||||++.+..   ......+..|..++..+ +||||+++++++.+...+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999999999999999997532   23456688899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus       101 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            99999999999999976    35699999999999999999999998   999999999999999999999999999985


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+...      .     
T Consensus       174 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------~-----  240 (353)
T 3txo_A          174 GICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------E-----  240 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C-----
T ss_pred             cccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC------C-----
Confidence            33221  2234468999999999999999999999999999999999999999876654433322211      0     


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI------TDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~  365 (426)
                             ..+|...+..+.+|+.+||+.||.+||++      .+|++
T Consensus       241 -------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 -------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   01233345578999999999999999998      67764

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-47  Score=367.46  Aligned_cols=254  Identities=16%  Similarity=0.226  Sum_probs=212.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            3578999999999999999999999999999999997543 345568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--CCceeEecccccccCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGP  246 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~  246 (426)
                      |+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++...
T Consensus        82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999999865   345799999999999999999999998   9999999999999987  7899999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......      +.   
T Consensus       156 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~------~~---  223 (321)
T 1tki_A          156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------FD---  223 (321)
T ss_dssp             TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC------CC---
T ss_pred             CCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC------CC---
Confidence            332   234467999999999999988999999999999999999999999876554333222211100      00   


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       ...    ....+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       224 -~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          224 -EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -hhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             000    01234578999999999999999999999964

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-48  Score=367.90  Aligned_cols=277  Identities=26%  Similarity=0.379  Sum_probs=213.3

Q ss_pred             cCCccccceeeecCcEEEEEEE----EcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGC----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  163 (426)
                      .++|++.+.||+|+||.||+|+    ...+++.||||++........+.+.+|+.+++.++||||+++++++..  ...+
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            3579999999999999999998    456799999999987766667789999999999999999999999854  3568


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            9999999999999999862   34599999999999999999999997   99999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......+|..|+|||++.+..++.++||||||+++|||++|..||........ ................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH-HHHCTTCCTHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH-hhhcCccccchhHHHH
Confidence            65432211 122234578889999999999999999999999999999999999865322100 0000000000000000


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ...+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            011111122233455667899999999999999999999999999998654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-47  Score=363.04  Aligned_cols=263  Identities=23%  Similarity=0.307  Sum_probs=211.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++.+...+++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            3568999999999999999999999999999999986432   2345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++++|.+++...    .++++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        89 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999999999863    5699999999999999999999998   9999999999999999999999999999764


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............      ..  ..   
T Consensus       162 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~------~~--~~---  229 (294)
T 4eqm_A          162 SETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI------QD--SV---  229 (294)
T ss_dssp             --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH------SS--CC---
T ss_pred             ccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh------hc--cC---
Confidence            33221 22234579999999999999999999999999999999999999998765432211110      00  00   


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHh
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-AITDVVMALNYLAS  372 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~  372 (426)
                        +......+...+..+.+++.+||+.||.+|| ++.++.+.|..+..
T Consensus       230 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          230 --PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             --CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             --CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence              0000111223345788999999999999998 89999998886643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-47  Score=369.01  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEE----EEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV----VAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|++.+.||+|+||+||+|.+..+++.    ||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5699999999999999999999877765    5888775432 345677999999999999999999999998764 789


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |+||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        94 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999987   346799999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..             
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------------  234 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------  234 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-------------
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc-------------
Confidence            54443333344567889999999999999999999999999999999 9999987654433222221             


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                          ......+..++..+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus       235 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ----TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ----CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                11112233455688999999999999999999999999998865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=379.47  Aligned_cols=264  Identities=27%  Similarity=0.386  Sum_probs=214.9

Q ss_pred             cCCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||+|+||.||+|.+     ..++..||||.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35799999999999999999994     4567899999997543 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC---ceeEe
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLS  237 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~  237 (426)
                      ++||||+++|+|.+++.....   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999987542   225699999999999999999999998   999999999999999554   59999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+...    
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~----  302 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG----  302 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC----
Confidence            9999974322222222233568999999999999999999999999999999998 99999876544333222211    


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                                   .....+..++..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       303 -------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          303 -------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                         01112334455789999999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.7e-48  Score=369.98  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=210.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEE----EEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV----VAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ++|++.+.||+|+||.||+|.+..++..    ||+|.+.... ......+.+|+.+++.++||||+++++++.+ ...++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEE
Confidence            5799999999999999999999877765    7888775433 2344567889999999999999999999874 56889


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence            9999999999999975   235689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+....           
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  234 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-----------  234 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-----------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-----------
Confidence            55444444455678899999999999999999999999999999999 999998765443332222111           


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                            ....+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       235 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 ------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  011122233356789999999999999999999999998864

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.5e-47  Score=363.83  Aligned_cols=264  Identities=18%  Similarity=0.168  Sum_probs=214.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+.....  ...+..|+.+++.+ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4689999999999999999999999999999999875532  34688999999999 99999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc-----eeEecccccc
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-----PKLSDFGLAK  243 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfgla~  243 (426)
                      |+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.     +||+|||+++
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99 99999999863   46799999999999999999999998   9999999999999998887     9999999998


Q ss_pred             cCCCCCCcc-----eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-hhh
Q 014362          244 MGPSGDKTH-----VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-MFK  317 (426)
Q Consensus       244 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~  317 (426)
                      .........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            643322211     12346899999999999999999999999999999999999999987543332222211100 000


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      .  . ..    .+.    ...+ ++.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus       239 ~--~-~~----~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          239 T--P-IE----VLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             S--C-HH----HHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             C--C-HH----HHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0  0 00    000    1123 7899999999999999999999999999886543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-47  Score=366.60  Aligned_cols=270  Identities=24%  Similarity=0.366  Sum_probs=201.8

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCE---EEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      ...++|++.+.||+|+||.||+|.+..++.   .||||.+...  .....+.+.+|+.+++.++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            345689999999999999999999887665   8999999764  33456789999999999999999999999987765


Q ss_pred             e------EEEEEecCCCCHHHHhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          163 R------LLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       163 ~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      .      ++||||+++|+|.+++....  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence            5      99999999999999996532  1223699999999999999999999998   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+....
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            9999999986544333333334567889999999999999999999999999999999 999998765543332221100


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCCC
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP  377 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~  377 (426)
                                       ....+...+..+.+|+.+||+.||.+||++.++++.|+.+....+..
T Consensus       257 -----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~  303 (323)
T 3qup_A          257 -----------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL  303 (323)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred             -----------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence                             01123344568899999999999999999999999999998765543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.2e-48  Score=375.92  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=204.5

Q ss_pred             CCccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|.+.+.||+|+||.||+|++.   .++..||||.+.... ....+.|.+|+.+++.++||||+++++++.+....++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57999999999999999999986   457789999997653 33456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       125 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999976   345799999999999999999999997   99999999999999999999999999998644


Q ss_pred             CCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          247 SGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       247 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..             
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-------------  265 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-------------  265 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-------------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------------
Confidence            32211 11122345788999999999999999999999999999998 9999976654332222110             


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                          ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       266 ----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          266 ----GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ----TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                111112334556889999999999999999999999999998754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-47  Score=363.64  Aligned_cols=264  Identities=30%  Similarity=0.428  Sum_probs=218.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|.+.+.||+|+||.||+|.+.     .++..||||.+.... ....+.+.+|+.+++.++||||+++++++.+....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467999999999999999999983     456899999997643 34457789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP--------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC  223 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp  223 (426)
                      ++||||+++|+|.+++.....                    ....+++..++.++.||+.||.|||+.   +|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence            999999999999999987432                    123489999999999999999999998   999999999


Q ss_pred             CCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCc
Q 014362          224 SNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKD  302 (426)
Q Consensus       224 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~  302 (426)
                      +|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986544333333334567899999999999999999999999999999999 9999987654


Q ss_pred             hhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          303 RKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ......+...                 .....+...+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       259 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ERLFNLLKTG-----------------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHhhcC-----------------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            4332222110                 11122334556889999999999999999999999999988653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-47  Score=369.92  Aligned_cols=268  Identities=26%  Similarity=0.427  Sum_probs=218.6

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      +....++|++.+.||+|+||.||+|.+.     .+++.||||.+..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3345678999999999999999999997     3458999999976533 345678999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPD--------------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR  219 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~  219 (426)
                      ....++||||+++|+|.+++......                    ...+++..++.++.||+.||.|||+.   +|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            99999999999999999999874321                    26799999999999999999999998   99999


Q ss_pred             CCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCC
Q 014362          220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID  298 (426)
Q Consensus       220 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~  298 (426)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999975433222222334578999999999999999999999999999999999 999998


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ..........+...                 .....+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       279 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          279 GMAHEEVIYYVRDG-----------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TSCHHHHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCChHHHHHHHhCC-----------------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            76543322211110                 00112334456889999999999999999999999999988643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=6.8e-48  Score=372.53  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=209.9

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCee
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~  163 (426)
                      ...++|.+.+.||+|+||.||+|+++.+++.||||++....   ......+..|..++..+ +||||+++++++.+...+
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            45678999999999999999999999999999999997542   23456678899998876 999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      |+||||++||+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        94 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999976    35699999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+....          
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  234 (345)
T 1xjd_A          167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN----------  234 (345)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------
Confidence            533222  12344689999999999999999999999999999999999999998765543332222110          


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHH-HHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT-DVV  364 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil  364 (426)
                              ..+|...+..+.+|+.+||+.||.+||++. +|+
T Consensus       235 --------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 --------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                    012333456889999999999999999998 665

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=365.93  Aligned_cols=252  Identities=23%  Similarity=0.311  Sum_probs=210.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||||.+......      ..+.+.+|+.+|+.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34699999999999999999999999999999999764322      356799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC----ceeEecc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF  239 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df  239 (426)
                      ++||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999965    46799999999999999999999998   999999999999999887    7999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....     
T Consensus       163 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----  234 (326)
T 2y0a_A          163 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-----  234 (326)
T ss_dssp             TTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-----
T ss_pred             CCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-----
Confidence            99986543221   2345799999999999999999999999999999999999999987654433322221100     


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .+..        ..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       235 -~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 -EFED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -CCCH--------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CcCc--------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0000        001123457889999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.3e-47  Score=372.86  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=203.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.+..   ......+..|..+|..+ +||||++++++|.+...+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357999999999999999999999999999999997642   23345678899999876 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++..
T Consensus       131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999999986    35699999999999999999999998   9999999999999999999999999999853


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh---cHHHhhhhhhhccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL---NLVAWARPMFKDRKNF  322 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~  322 (426)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ............    
T Consensus       204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----  277 (396)
T 4dc2_A          204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----  277 (396)
T ss_dssp             CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----
T ss_pred             ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----
Confidence            2221  2234568999999999999999999999999999999999999999754321110   000000111111    


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                              ...+|...+..+.+|+.+||+.||.+||++
T Consensus       278 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          278 --------QIRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                    112344455688999999999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=363.58  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=210.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357999999999999999999999999999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.+|.+||+|||+++...
T Consensus        85 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            999999999999986    35699999999999999999999987   99999999999999999999999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+..      ..       
T Consensus       158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------~~-------  219 (318)
T 1fot_A          158 DV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN------AE-------  219 (318)
T ss_dssp             SC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------CC-------
T ss_pred             Cc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------CC-------
Confidence            22     2345899999999999999999999999999999999999999987654333222211      10       


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                           ..+|...+..+.+|+.+||+.||.+||     ++++|++
T Consensus       220 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 -----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 012333456889999999999999999     8888884

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-47  Score=371.03  Aligned_cols=253  Identities=20%  Similarity=0.267  Sum_probs=212.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+|+.++||||+++++++.+...+++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46799999999999999999999999999999999876555566789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--CCceeEecccccccCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~  247 (426)
                      +++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.  .+.+||+|||+++....
T Consensus       130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            999999998865   345699999999999999999999998   9999999999999974  47799999999986543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+.....      .      
T Consensus       204 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~------~------  268 (387)
T 1kob_A          204 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW------E------  268 (387)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC------C------
T ss_pred             Cc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------C------
Confidence            32   22345799999999999999999999999999999999999999987654433322221100      0      


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .........+..+.+|+.+||+.||.+||++.++++
T Consensus       269 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          269 --FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence              011112234557899999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=371.09  Aligned_cols=267  Identities=25%  Similarity=0.358  Sum_probs=220.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEee
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAE  159 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  159 (426)
                      ..++|.+.+.||+|+||.||+|.+..       .+..||||++..... .....+.+|+.+++.+ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            34689999999999999999999753       346899999976533 3457789999999999 99999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCee
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl  227 (426)
                      ....++||||+++|+|.+++.....            ....+++..++.++.||+.||.|||+.   +|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence            9999999999999999999987432            124699999999999999999999998   9999999999999


Q ss_pred             eccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhh
Q 014362          228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL  306 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~  306 (426)
                      |+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999986544333333344568899999999999999999999999999999999 99999876543322


Q ss_pred             cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                      ..+..                 ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus       304 ~~~~~-----------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          304 KLLKE-----------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHHT-----------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHc-----------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            22211                 01112233445688999999999999999999999999999976543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=358.66  Aligned_cols=277  Identities=19%  Similarity=0.224  Sum_probs=216.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC--eeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv  166 (426)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357999999999999999999999999999999997543 234567889999999999999999999998765  78999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee----ccCCceeEeccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLA  242 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla  242 (426)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999998632 223499999999999999999999998   99999999999999    77888999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccc--------cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc-HHHhhh
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAM--------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN-LVAWAR  313 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~  313 (426)
                      +.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.......... .+....
T Consensus       164 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            86543322   23357999999999886        5788999999999999999999999997544322211 111110


Q ss_pred             -hhhhcc-cccccc------c--CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          314 -PMFKDR-KNFSQM------V--DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       314 -~~~~~~-~~~~~~------~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                       ...... ..+...      .  ........+......+.+|+.+||+.||.+||++.|+++.....+..
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence             000000 000000      0  00112234567778899999999999999999999999988766543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=366.31  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=208.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEE----EEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQV----VAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      .++|++.+.||+|+||.||+|.+..+++.    ||+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            36799999999999999999999877765    477777543 3345678999999999999999999999998764 78


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +|++|+.+|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            999999999999999873   45699999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ..............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..            
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------------  234 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------  234 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence            544333333334567889999999999999999999999999999999 9999987655433222211            


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                           ......+...+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       235 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          235 -----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                 011112334555789999999999999999999999999998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=359.42  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------------------------ccHHHHHHHHHHHh
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------------------------QGVREFSAEVMTLG  143 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~E~~~l~  143 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999875432                          12356889999999


Q ss_pred             cCCCCCcceEeeEEee--CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCC
Q 014362          144 SADHPNLVKLIGYCAE--GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDL  221 (426)
Q Consensus       144 ~l~hpniv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dl  221 (426)
                      .++||||+++++++.+  ...+++||||+++++|.+++.     ...+++..++.++.||+.||.|||+.   +|+||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl  163 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI  163 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence            9999999999999986  568999999999999977653     35799999999999999999999998   9999999


Q ss_pred             CCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCC---CCccCchhhHHHHHHHHHhCCCCCC
Q 014362          222 KCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       222 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                      ||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            9999999999999999999998644322  2233457999999999988765   4788999999999999999999997


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..........+..      ....+          ......+..+.+|+.+||+.||.+||++.+|++
T Consensus       242 ~~~~~~~~~~~~~------~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          242 DERIMCLHSKIKS------QALEF----------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSSHHHHHHHHHH------CCCCC----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccHHHHHHHHhc------ccCCC----------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            6543222111110      00000          001223457899999999999999999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-47  Score=353.82  Aligned_cols=258  Identities=26%  Similarity=0.391  Sum_probs=214.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            3579999999999999999999875 7789999998653 3346799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999976   345699999999999999999999998   99999999999999999999999999997543221


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                       ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...                
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~----------------  223 (269)
T 4hcu_A          161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------------  223 (269)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------------
T ss_pred             -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC----------------
Confidence             111223457788999999999999999999999999999999 99999876544322222110                


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                       .....+...+..+.+|+.+||+.+|.+||++.++++.|+.+...
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence             11112233445789999999999999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.3e-47  Score=368.05  Aligned_cols=250  Identities=25%  Similarity=0.344  Sum_probs=209.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  164 (426)
                      ..++|++.+.||+|+||.||+|+++.+++.||||++....   ......+..|..+|..+ +||||+++++++.+...+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3568999999999999999999999999999999997542   23456788899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||++||+|..++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            999999999999999863    4699999999999999999999998   999999999999999999999999999985


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      ..     
T Consensus       171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~-----  237 (353)
T 2i0e_A          171 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------HN-----  237 (353)
T ss_dssp             CCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC-----
T ss_pred             cccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh------CC-----
Confidence            32221  123346899999999999999999999999999999999999999987654433322221      10     


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                             ..+|...+..+.+|+.+||+.||.+||+     +.+|++
T Consensus       238 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                   0123344568899999999999999995     466664

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=368.52  Aligned_cols=266  Identities=23%  Similarity=0.366  Sum_probs=214.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  161 (426)
                      ..++|.+.+.||+|+||.||+|.+     ..++..||||.+.... ......+.+|+.+++.+ +||||+++++++....
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            456899999999999999999997     3457789999997542 33456799999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCC
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPD-------------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLK  222 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlk  222 (426)
                      ..++||||+++|+|.+++......                   ...+++..++.++.||+.||.|||+.   +|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence            999999999999999999763211                   13489999999999999999999998   99999999


Q ss_pred             CCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcC
Q 014362          223 CSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTK  301 (426)
Q Consensus       223 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~  301 (426)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999986544333333344568899999999999999999999999999999998 999998765


Q ss_pred             chhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          302 DRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ..........                .......+...+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       280 ~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          280 VDANFYKLIQ----------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSHHHHHHHH----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cHHHHHHHHh----------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            4322211110                0111122334456889999999999999999999999999988643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=377.35  Aligned_cols=254  Identities=19%  Similarity=0.216  Sum_probs=210.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            45679999999999999999999999999999999976543  3456688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec---cCCceeEecccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~  243 (426)
                      |||+++|+|.+.+..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||+++
T Consensus        89 ~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           89 FDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             ECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999876    35699999999999999999999998   999999999999998   46789999999997


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+......+      .
T Consensus       162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------~  233 (444)
T 3soa_A          162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF------P  233 (444)
T ss_dssp             CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC------C
T ss_pred             EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC------C
Confidence            644322  22234579999999999999999999999999999999999999998765444333222111100      0


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                              .......+..+.+|+.+||+.||.+||++.++++
T Consensus       234 --------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          234 --------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             --------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                    0011233457899999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-47  Score=379.55  Aligned_cols=263  Identities=21%  Similarity=0.232  Sum_probs=215.1

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      +.++....++|++.+.||+|+||+||+|+++.+++.||||++.+...   .....+.+|+.++..++||||++++++|.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            34445567899999999999999999999999999999999975321   223448899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ...+||||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999976   246799999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      |+++...... .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...........+.....
T Consensus       220 Gla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          220 GSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE  298 (437)
T ss_dssp             TTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence            9997644322 22233468999999999987     56789999999999999999999999987665544433322111


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVM  365 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~  365 (426)
                      .+.    ++..         ....+..+.+|+.+||..+|.+  ||+++||++
T Consensus       299 ~~~----~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          299 RFQ----FPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HCC----CCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ccc----CCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            110    1110         1123457899999999888888  999999985

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.7e-46  Score=355.06  Aligned_cols=269  Identities=17%  Similarity=0.184  Sum_probs=216.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  ....+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            3567999999999999999999999999999999986543  235688899999999 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc-----eeEeccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-----PKLSDFGLA  242 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-----~kl~Dfgla  242 (426)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.     +||+|||++
T Consensus        86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999 99999999862   45699999999999999999999987   9999999999999987766     999999999


Q ss_pred             ccCCCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          243 KMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       243 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      +........     .......||+.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            865433221     122345799999999999999999999999999999999999999987543322211111100000


Q ss_pred             cccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCC
Q 014362          318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYD  376 (426)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  376 (426)
                       ......     +    ....+..+.+|+.+||+.+|.+||++.+|++.|+.+......
T Consensus       239 -~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~  287 (298)
T 1csn_A          239 -STPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  287 (298)
T ss_dssp             -HSCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             -CccHHH-----H----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence             000000     0    112345789999999999999999999999999999765543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.8e-47  Score=370.98  Aligned_cols=256  Identities=19%  Similarity=0.218  Sum_probs=208.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....     ....+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357999999999999999999999999999999986421     124577899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc---eeEecccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDFGL  241 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgl  241 (426)
                      +||||+++|+|.+.+.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999988876433455689999999999999999999998   9999999999999987654   99999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+..      ....
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~i~~------~~~~  250 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIK------GKYK  250 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHHHHHH------TCCC
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHHHHHc------CCCC
Confidence            98654322  1223457999999999999999999999999999999999999999864321 1111110      0000


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ..+..    ....+..+.+|+.+||+.||.+||++.++++
T Consensus       251 ----~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 ----MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                00000    0123457899999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-46  Score=355.93  Aligned_cols=265  Identities=20%  Similarity=0.232  Sum_probs=205.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.....  .....+.+|+.+++.++||||+++++++.+...+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            579999999999999999999999999999999975433  334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++ +|...+..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9975 56555554   246799999999999999999999998   9999999999999999999999999999865332


Q ss_pred             CCcceeeeecccccccCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCcCc-hhhhcHHHhhhhhhhcccccccc-
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKD-RKELNLVAWARPMFKDRKNFSQM-  325 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-  325 (426)
                      .  .......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+....... ....+... 
T Consensus       155 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~  231 (292)
T 3o0g_A          155 V--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-TEEQWPSMT  231 (292)
T ss_dssp             C--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC-CTTTCTTGG
T ss_pred             c--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC-Chhhhhhhc
Confidence            2  2223457899999999998766 89999999999999999998888644332 22222221110000 00000000 


Q ss_pred             -----------cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 -----------VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 -----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                 .............+..+.+|+.+||+.||.+|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                       0000111122345568899999999999999999999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-47  Score=371.43  Aligned_cols=250  Identities=26%  Similarity=0.369  Sum_probs=208.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....   ....+.+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            357999999999999999999999999999999986532   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+.||+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus        94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            999999999999975    45699999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcceeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ...   .....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.................   .     
T Consensus       167 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~-----  235 (384)
T 4fr4_A          167 RET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T-----  235 (384)
T ss_dssp             TTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C-----
T ss_pred             CCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c-----
Confidence            322   2244689999999999874   4589999999999999999999999976543322222211110   0     


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-HHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-ITDVV  364 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil  364 (426)
                             ...+|...+..+.+|+.+||+.||.+||+ +.+|+
T Consensus       236 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~  270 (384)
T 4fr4_A          236 -------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ  270 (384)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred             -------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence                   01223444568899999999999999999 66655

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-47  Score=378.27  Aligned_cols=260  Identities=20%  Similarity=0.231  Sum_probs=213.8

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG  160 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  160 (426)
                      .++....++|++.+.||+|+||+||+|+++.+++.||+|++.+..   ......+.+|+.+++.++||||++++++|.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344456678999999999999999999999999999999996531   12334588999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ..+|+||||++||+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999999975     4589999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCC----CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ----LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      +++...... .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...........+......+
T Consensus       214 ~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          214 TCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL  292 (410)
T ss_dssp             TCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred             eeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc
Confidence            998654322 12233568999999999998765    8899999999999999999999998766544433332211111


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNM--RPAITDVVMA  366 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~  366 (426)
                      .    +.          .....+..+.+|+.+||+.+|.+  ||++.||++.
T Consensus       293 ~----~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 T----FP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             C----CC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             c----CC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0    00          01123457899999999999988  9999999853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.5e-47  Score=369.55  Aligned_cols=254  Identities=19%  Similarity=0.251  Sum_probs=210.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            45679999999999999999999999999999999976532  3456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeEecccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~  243 (426)
                      |||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.+   +.+||+|||++.
T Consensus       107 ~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             ECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999998875    45699999999999999999999998   99999999999999865   459999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.....      .+.
T Consensus       180 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~------~~~  250 (362)
T 2bdw_A          180 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------DYP  250 (362)
T ss_dssp             CCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CCC
T ss_pred             EecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------CCC
Confidence            6543221   2345799999999999999999999999999999999999999987654333222221110      000


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              .......+..+.+|+.+||+.||.+||++.++++.
T Consensus       251 --------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 --------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             --------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00012334578999999999999999999998753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-47  Score=361.90  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=218.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  161 (426)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||||.+..... ...+.+.+|+.+++.+ +||||+++++++.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346799999999999999999985     45678999999976543 3456789999999999 9999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCee
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRP--------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl  227 (426)
                      ..++||||+++|+|.+++.....              ....+++..++.++.||+.||.|||+.   +|+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEE
Confidence            99999999999999999986431              123599999999999999999999998   9999999999999


Q ss_pred             eccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhh
Q 014362          228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL  306 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~  306 (426)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999986554433333344567889999999999999999999999999999999 99999765543222


Q ss_pred             cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .....      .          ......+...+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       258 ~~~~~------~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          258 YKMIK------E----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHH------H----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhc------c----------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            11110      0          011111233456789999999999999999999999999988654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8e-47  Score=352.13  Aligned_cols=257  Identities=24%  Similarity=0.345  Sum_probs=214.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+.. +..||||.+..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4679999999999999999998875 77899999976543 346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999763   35699999999999999999999998   99999999999999999999999999998654332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      . .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+....               
T Consensus       159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------  222 (268)
T 3sxs_A          159 Y-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---------------  222 (268)
T ss_dssp             E-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---------------
T ss_pred             h-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC---------------
Confidence            2 22233456788999999999999999999999999999999 999998765443322221110               


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        ....+...+..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus       223 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          223 --RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence              011122234578999999999999999999999999988854

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.6e-47  Score=367.63  Aligned_cols=245  Identities=22%  Similarity=0.278  Sum_probs=210.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|++..+|+.||||++....   ......+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999996542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999863    4699999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+...      .        
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~--------  254 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------K--------  254 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------C--------
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC------C--------
Confidence            2     23357999999999999999999999999999999999999999876544333222211      0        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                          ..+|...+..+.+|+.+||+.||.+||+     +.+|++
T Consensus       255 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                0123344568899999999999999998     888875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.3e-47  Score=364.88  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=203.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||.||+|+++.+++.||||++....   ......+..|+.++..+ +||||+++++++.+...+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            46999999999999999999999999999999997643   23456688899999887 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999976    35699999999999999999999998   99999999999999999999999999998532


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh---cHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL---NLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  323 (426)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ............     
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-----  234 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-----  234 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC-----
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC-----
Confidence            221  2234468999999999999999999999999999999999999999753221100   000000011110     


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI  360 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  360 (426)
                             ...+|...+..+.+|+.+||+.||.+||++
T Consensus       235 -------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          235 -------QIRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                   012234455688999999999999999996

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.8e-47  Score=366.92  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=208.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            478999999999999999999999999999999986432   22345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+ +|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 7899888876    35699999999999999999999998   99999999999999999999999999998644


Q ss_pred             CCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ...   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..........                . 
T Consensus       160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----------------~-  219 (336)
T 3h4j_B          160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----------------K-  219 (336)
T ss_dssp             TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----------------C-
T ss_pred             CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----------------H-
Confidence            332   1234579999999999988876 689999999999999999999997644322110                0 


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      +.. .....|...+..+.+|+.+||+.||.+|||+.||++.
T Consensus       220 i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          220 VNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            000 0112344456688999999999999999999999964

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.8e-47  Score=362.42  Aligned_cols=260  Identities=21%  Similarity=0.266  Sum_probs=201.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe----
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ----  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----  162 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....   .....+.+|+.+++.++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            4689999999999999999999999999999999976432   334568899999999999999999999876543    


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .|+||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            4999999999999999976    35699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCC-cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          243 KMGPSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       243 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..............      ....
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~------~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR------EDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------CCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc------CCCC
Confidence            75433221 1222345799999999999999999999999999999999999999987654332211111      0000


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH-HHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM-ALNYL  370 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~-~L~~l  370 (426)
                      ....        .....+..+.+|+.+||+.||.+||+..+++. .|..+
T Consensus       238 ~~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHHH--------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Cccc--------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0000        01123457889999999999999997777664 44444

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.2e-46  Score=360.05  Aligned_cols=269  Identities=25%  Similarity=0.324  Sum_probs=197.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4679999999999999999999999999999999975432 344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          169 YMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |++ |+|.+++....  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69999887532  2234699999999999999999999997   99999999999999999999999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----hhccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----FKDRK  320 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~  320 (426)
                      ....  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......     +....
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            3221  12334789999999998764 6899999999999999999999999877655444333221100     00000


Q ss_pred             ccccccCCcc------------cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          321 NFSQMVDPSL------------QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .... ..+.+            ....+...+..+.+|+.+||+.||.+||++.++++
T Consensus       238 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000 00000            00111233457899999999999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.5e-47  Score=352.38  Aligned_cols=251  Identities=28%  Similarity=0.440  Sum_probs=199.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc----ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|.+.  +..||||++.....    ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            467999999999999999999986  88999999875432    335678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC---eEecCCCCCCeeecc--------CCce
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP---VIYRDLKCSNILLEE--------GYHP  234 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~---iiH~Dlkp~NIll~~--------~~~~  234 (426)
                      ||||+++++|.+++..     ..+++..++.++.||+.||.|||+.   +   |+||||||+|||++.        ++.+
T Consensus        84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999853     5699999999999999999999997   6   999999999999986        6789


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      ||+|||+++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..............   
T Consensus       156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---  228 (271)
T 3dtc_A          156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM---  228 (271)
T ss_dssp             EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHT---
T ss_pred             EEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhc---
Confidence            999999997543222    1234799999999999999999999999999999999999999987654332211111   


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                                   .......+...+..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus       229 -------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          229 -------------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                         0111122344456889999999999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.5e-47  Score=355.18  Aligned_cols=254  Identities=29%  Similarity=0.514  Sum_probs=207.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc-------HHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-------VREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+.......       .+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467999999999999999999999999999999986543221       267899999999999999999999997665 


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCCeeeccCCc-----ee
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYH-----PK  235 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~-----~k  235 (426)
                       ++||||+++|+|.+.+..   ....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.     +|
T Consensus        97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence             699999999999988865   346799999999999999999999987   7  999999999999988776     99


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCccccc--cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM--TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  313 (426)
                      |+|||+++....     ......||+.|+|||++.  ...++.++||||||+++|||++|+.||............... 
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-  243 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR-  243 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH-
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh-
Confidence            999999974322     233457999999999984  456789999999999999999999999765433221111100 


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                                   ........+...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       244 -------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 -------------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -------------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -------------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                         01111223344556889999999999999999999999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-46  Score=358.51  Aligned_cols=266  Identities=24%  Similarity=0.281  Sum_probs=205.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|++.+.||+|+||+||+|.+.. ++.||||++.....  .....+.+|+.+++.++||||+++++++.+....++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            45789999999999999999999865 89999999975432  2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||++ |+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           98 FEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            99998 578887765   345699999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+........ ...+...
T Consensus       171 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~  247 (311)
T 3niz_A          171 IPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQV  247 (311)
T ss_dssp             SCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC-TTTSGGG
T ss_pred             CCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC-hHHhhhh
Confidence            322  22234578999999999876 5689999999999999999999999987665544433321110000 0000000


Q ss_pred             -------------cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 -------------VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 -------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                   ...............++.+|+.+||+.||.+|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                         0000000011223457899999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.6e-47  Score=377.53  Aligned_cols=250  Identities=26%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...   .......+..|+.+++.++||||++++++|.+.+.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346799999999999999999999999999999999753   23345667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ||||+++|+|..++..    ...+++..++.++.||+.||.|||+ .   +|+||||||+||||+.++.+||+|||+++.
T Consensus       226 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            9999999999999976    3569999999999999999999998 6   999999999999999999999999999975


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...      ..    
T Consensus       299 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------~~----  366 (446)
T 4ejn_A          299 GIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------EI----  366 (446)
T ss_dssp             TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------CC----
T ss_pred             ccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------CC----
Confidence            33221  2234468999999999999999999999999999999999999999876544333222211      00    


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                              .+|...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       367 --------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 --------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                    12333456789999999999999999     9999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.4e-46  Score=352.95  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=203.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||.||+|.+ .+++.||||++.....  .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5799999999999999999998 5689999999975432  234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++ +|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            9975 89888875   246699999999999999999999998   9999999999999999999999999999754322


Q ss_pred             CCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc---
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ---  324 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  324 (426)
                      .  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+....... ....+..   
T Consensus       154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  230 (288)
T 1ob3_A          154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP-NSKNWPNVTE  230 (288)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-CTTTSTTGGG
T ss_pred             c--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCC-Chhhchhhhc
Confidence            1  122334789999999998764 58999999999999999999999998766544332222110000 0000000   


Q ss_pred             --ccCCccc-------CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 --MVDPSLQ-------GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 --~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..++.+.       .......+..+.+|+.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0111110       0112234567899999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9e-47  Score=367.34  Aligned_cols=254  Identities=19%  Similarity=0.282  Sum_probs=198.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++.+...+++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            4689999999999999999999999999999999976432 336688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc--eeEecccccccCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--PKLSDFGLAKMGPS  247 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla~~~~~  247 (426)
                      +++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.  +||+|||+++....
T Consensus        98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            999999999976    35699999999999999999999997   9999999999999987765  99999999974322


Q ss_pred             CCCcceeeeecccccccCccccccCCCCcc-CchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFK-SDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .   .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............  .........+    
T Consensus       171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~--~~~~~~~~~~----  241 (361)
T 3uc3_A          171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI--QRILSVKYSI----  241 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH--HHHHTTCCCC----
T ss_pred             c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH--HHHhcCCCCC----
Confidence            1   12234579999999999988888655 899999999999999999998654432221111  1111110000    


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                            ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus       242 ------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          242 ------PDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  0111234578999999999999999999999965

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-47  Score=359.20  Aligned_cols=253  Identities=24%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCC-------EEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIE-------QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      .++|.+.+.||+|+||.||+|.+..++       ..||+|.+........+.+.+|+.+++.++||||+++++++.+...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            357999999999999999999998766       5799999987666667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc--------e
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--------P  234 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--------~  234 (426)
                      .++||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.        +
T Consensus        87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999986   234599999999999999999999998   9999999999999998887        9


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCC-CCCcCchhhhcHHHhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKA-IDQTKDRKELNLVAWA  312 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p-~~~~~~~~~~~~~~~~  312 (426)
                      ||+|||++......      ....||+.|+|||++.+ ..++.++||||||+++|||++|..| |.............  
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--  232 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--  232 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh--
Confidence            99999998643221      23468999999999987 6799999999999999999996554 44333222111111  


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                           ....+            +...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus       233 -----~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          233 -----DRHQL------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             -----TTCCC------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             -----ccCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                 11111            111123578899999999999999999999999877653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7.4e-47  Score=360.01  Aligned_cols=269  Identities=22%  Similarity=0.311  Sum_probs=207.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            457999999999999999999999899999999997532   33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999976544457799999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...  .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....   ...  ..+..  
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~---~~~--~~~~~--  257 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKK---IEQ--CDYPP--  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHH---HHT--TCSCC--
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHH---hhc--ccCCC--
Confidence            321  122335789999999999999999999999999999999999999975432111 11110   000  00000  


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCCC
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDP  377 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~  377 (426)
                            ..+...+..+.+|+.+||+.||.+||++.+|++.|+.+......|
T Consensus       258 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          258 ------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             ------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             ------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                  011234457899999999999999999999999999998765544

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-46  Score=373.77  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=212.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-eeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-QRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~lv~  167 (426)
                      ..++|++.+.||+|+||.||+|.+.  ++.||||.+....  ..+.|.+|+.+|+.++||||+++++++.... .+++||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~  266 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT  266 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence            4567999999999999999999987  7899999997653  4578999999999999999999999987665 789999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++....  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            9999999999998742  34479999999999999999999998   999999999999999999999999999985322


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .     .....+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+..               
T Consensus       342 ~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~---------------  401 (450)
T 1k9a_A          342 T-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------------  401 (450)
T ss_dssp             ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT---------------
T ss_pred             c-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc---------------
Confidence            1     112367889999999999999999999999999999998 9999987654332222111               


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                        ..+...|..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       402 --~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          402 --GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence              111223445567899999999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.2e-47  Score=382.15  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=219.3

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .....+|.+.+.||+|+||.||+|.+..++..||||.+.... ...+.|.+|+.+|+.++||||++++++|.+...+++|
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            344567899999999999999999999999999999997653 3467899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       295 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          295 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            9999999999999863  235689999999999999999999998   99999999999999999999999999998653


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+.               
T Consensus       370 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---------------  433 (495)
T 1opk_A          370 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------  433 (495)
T ss_dssp             TCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---------------
T ss_pred             CCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------
Confidence            322 112223456789999999999999999999999999999999 999998765433222111               


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                        ...+...+..++..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus       434 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          434 --KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence              11122334455668899999999999999999999999998664

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-46  Score=353.30  Aligned_cols=262  Identities=29%  Similarity=0.493  Sum_probs=199.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|++.+.||+|+||.||+|.+..   .||||++....  ....+.+.+|+.+++.++||||+++++++ .....++|
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            35689999999999999999998764   49999987543  33456799999999999999999999966 45578999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999999865   346799999999999999999999998   99999999999999999999999999997544


Q ss_pred             CCCCcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ............||+.|+|||++.   +..++.++||||||+++|||++|+.||.................       . 
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~-  243 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS-------L-  243 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS-------C-
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc-------c-
Confidence            322233334457999999999986   66788999999999999999999999987654432211111100       0 


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                         .+.+ ......++..+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus       244 ---~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          244 ---SPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---CCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---Ccch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence               0000 11123345688999999999999999999999999998753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-46  Score=354.82  Aligned_cols=261  Identities=25%  Similarity=0.406  Sum_probs=220.2

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ...++|++.+.||+|+||.||+|.+..++..||||.+... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            3456799999999999999999999999999999999754 344677999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999999763  345699999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+..               
T Consensus       164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---------------  227 (288)
T 3kfa_A          164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------------  227 (288)
T ss_dssp             SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---------------
T ss_pred             Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---------------
Confidence            32 222333467889999999999999999999999999999999 9999987654332222211               


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        ......+...+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       228 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          228 --DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence              11112233445688999999999999999999999999988754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-47  Score=363.75  Aligned_cols=276  Identities=26%  Similarity=0.342  Sum_probs=217.1

Q ss_pred             CCccccceeeecCcEEEEEEEE----cCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEe--eCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA--EGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~  164 (426)
                      ++|++.+.||+|+||.||+|.+    ..+++.||||++........+.+.+|+.+++.++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5799999999999999999994    6679999999998776666778999999999999999999999886  456789


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999999763   34699999999999999999999997   999999999999999999999999999986


Q ss_pred             CCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||............ .. ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~  254 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CE-RDVPALSRLL  254 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cc-cccccHHHHH
Confidence            5433222 1223346888999999999999999999999999999999999999754321100000 00 0000000011


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      ..+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111122223334556678999999999999999999999999999886543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-47  Score=373.89  Aligned_cols=268  Identities=20%  Similarity=0.224  Sum_probs=215.3

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      +.+.....++|++.+.||+|+||+||+|+++.+++.||||++.+...   .....+.+|..++..++||||++++++|.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            44455567889999999999999999999999999999999975321   234558899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ...+|+||||+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence            99999999999999999999863   34699999999999999999999997   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccc-------cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      |+++....... ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||...........+...
T Consensus       207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            99986543221 1223458999999999987       357899999999999999999999999876654443333221


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCC---CCHHHHHHHHHHHHh
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMR---PAITDVVMALNYLAS  372 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~L~~l~~  372 (426)
                      ...+.    +     +.    .+...+.++.+|+.+||. +|.+|   |+++||++ ..+++.
T Consensus       286 ~~~~~----~-----p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~-Hpff~~  333 (412)
T 2vd5_A          286 KEHLS----L-----PL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT-HPFFFG  333 (412)
T ss_dssp             HHHCC----C-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT-SGGGTT
T ss_pred             ccCcC----C-----Cc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc-CCCcCC
Confidence            11110    0     00    112334588999999999 99998   58999874 344443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.9e-46  Score=361.18  Aligned_cols=265  Identities=25%  Similarity=0.381  Sum_probs=216.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEc-------CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE-------KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  160 (426)
                      .++|++.+.||+|+||.||+|.+.       .++..||||++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            467999999999999999999985       3567899999976533 3456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPD------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      ...++||||+++|+|.+++......            ...+++..++.++.||+.||.|||+.   +|+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence            9999999999999999999864321            23489999999999999999999998   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            9999999999999986544333233334567899999999999999999999999999999999 999998765433222


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      .+...                 .....+..++..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus       271 ~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          271 LLKEG-----------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhcC-----------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            21110                 011123344567899999999999999999999999999997543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.3e-47  Score=360.23  Aligned_cols=275  Identities=24%  Similarity=0.344  Sum_probs=221.7

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEE-----cCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcce
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCL-----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVK  152 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~  152 (426)
                      ++....+....++|++.+.||+|+||.||+|.+     ..+++.||||.+..... ...+.+.+|+.++..+ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            455666666778999999999999999999985     35678999999976543 3456789999999999 7999999


Q ss_pred             EeeEEeeCC-eeEEEEEecCCCCHHHHhhhhCCC------------CCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 014362          153 LIGYCAEGD-QRLLVYEYMPLGSLDKHLHDLRPD------------TRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR  219 (426)
Q Consensus       153 ~~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~  219 (426)
                      +++++.... .+++||||+++|+|.+++......            ...+++..++.++.||+.||.|||+.   +|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            999987754 489999999999999999863221            12389999999999999999999998   99999


Q ss_pred             CCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCC
Q 014362          220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAID  298 (426)
Q Consensus       220 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~  298 (426)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999986544333333344578999999999999999999999999999999998 999997


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .............      ..          .....+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       253 ~~~~~~~~~~~~~------~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          253 GVKIDEEFCRRLK------EG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             TCCCSHHHHHHHH------HT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHhc------cC----------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            6553322211110      00          00112233455789999999999999999999999999988653

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.6e-46  Score=351.36  Aligned_cols=258  Identities=25%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|.+..+   +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            46799999999999999999998643   56799999876433 34567899999999999999999999985 457899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999976   235699999999999999999999998   9999999999999999999999999999864


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+...            
T Consensus       167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~------------  233 (281)
T 1mp8_A          167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------  233 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------------
T ss_pred             Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC------------
Confidence            33221 12223457889999999999999999999999999999997 99999876544332222110            


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                           .....+...+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       234 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                 0011233445688999999999999999999999999998854

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-46  Score=355.14  Aligned_cols=262  Identities=22%  Similarity=0.319  Sum_probs=201.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc--CCCCCcceEeeEEee----CCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYCAE----GDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~~~----~~~  162 (426)
                      ..++|++.+.||+|+||+||+|.+.  ++.||||++...   ....+..|.+++..  ++||||+++++++..    ...
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3568999999999999999999884  899999998653   33455666666655  899999999998654    345


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCCCeEecCCCCCCeeeccCCce
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH--------EQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      .++||||+++|+|.+++..     ..+++..++.++.||+.||.|||        +.   +|+||||||+|||++.++.+
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCE
T ss_pred             eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCE
Confidence            8999999999999999954     56999999999999999999999        65   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcc--eeeeecccccccCccccccC------CCCccCchhhHHHHHHHHHhC----------CCC
Q 014362          235 KLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITG----------RKA  296 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg----------~~p  296 (426)
                      ||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          ..|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            999999997543322211  12234799999999999876      556899999999999999999          788


Q ss_pred             CCCcCchhhhcHHHhhhhhhhcccccccccCCcc-cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          297 IDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL-QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      |..............  .......     ..+.+ ....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       233 f~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          233 FYDVVPNDPSFEDMR--KVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTTTSCSSCCHHHHH--HHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCCCCcchhhhh--HHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            865432221110000  0000000     00111 1112334667899999999999999999999999999876

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.3e-47  Score=354.84  Aligned_cols=258  Identities=23%  Similarity=0.355  Sum_probs=211.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            34679999999999999999998874 77899999986533 34678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            99999999999752   35699999999999999999999998   9999999999999999999999999999754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      . ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+...               
T Consensus       174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~---------------  237 (283)
T 3gen_A          174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---------------  237 (283)
T ss_dssp             H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---------------
T ss_pred             c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc---------------
Confidence            1 111122356788999999999999999999999999999998 99999876544333222211               


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        .....+...+..+.+|+.+||+.+|.+||++.++++.|..+..
T Consensus       238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence              1111123334578999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=5.3e-47  Score=364.67  Aligned_cols=267  Identities=23%  Similarity=0.350  Sum_probs=217.0

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCE-----EEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEee
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAE  159 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  159 (426)
                      ....++|.+.+.||+|+||.||+|.+..++.     .||+|.+..... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3445789999999999999999999976654     799999976533 3456789999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCC----------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRP----------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE  229 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~  229 (426)
                      ....++||||+++|+|.+++.....          ....+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence            9999999999999999999975321          134689999999999999999999998   999999999999999


Q ss_pred             cCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcH
Q 014362          230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNL  308 (426)
Q Consensus       230 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~  308 (426)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            999999999999985433333333334567889999999999999999999999999999999 9999976543322211


Q ss_pred             HHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ....                ......+...+..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       279 ~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          279 LVKD----------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHHH----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhc----------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            1100                01111223334578999999999999999999999999988754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.6e-46  Score=356.09  Aligned_cols=271  Identities=24%  Similarity=0.353  Sum_probs=211.4

Q ss_pred             CCccccceeeecCcEEEEEEE----EcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--Cee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGC----LEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQR  163 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~  163 (426)
                      .+|++.+.||+|+||.||+|.    ...+++.||||.+.... ......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            458999999999999999999    46679999999997543 34457799999999999999999999999876  668


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999999663   35699999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh--ccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK--DRK  320 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~  320 (426)
                      ........ .......||..|+|||++.+..++.++||||||+++|||++|..|+.......    .....+...  ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF----LKMIGPTHGQMTVT  250 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHCSCCGGGHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH----hhccCCcccccCHH
Confidence            65443221 22234568889999999999999999999999999999999999875321100    000000000  000


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      .+...+........+...+..+.+|+.+||+.||.+||++.++++.|+.+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            001111111222334455678999999999999999999999999998774

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-46  Score=370.10  Aligned_cols=272  Identities=18%  Similarity=0.225  Sum_probs=208.2

Q ss_pred             cCCccccceeeec--CcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEG--GFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|  +||.||+|.+..+++.||||++....  ....+.+.+|+.+++.++||||+++++++.+...+++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999999999999999997543  2345668889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            99999999999999763  235699999999999999999999998   9999999999999999999999999988643


Q ss_pred             CCCCC-----cceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh-hhhh
Q 014362          246 PSGDK-----THVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR-PMFK  317 (426)
Q Consensus       246 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~  317 (426)
                      .....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||................ +...
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            21111     111122478999999999987  579999999999999999999999997655433221110000 0000


Q ss_pred             ccc------------------cccccc---------CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          318 DRK------------------NFSQMV---------DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       318 ~~~------------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ...                  .+...+         ........+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000                  000000         0000011233445679999999999999999999999853

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.7e-46  Score=357.92  Aligned_cols=266  Identities=24%  Similarity=0.380  Sum_probs=205.8

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcC---CCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-  161 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-  161 (426)
                      ...++|.+.+.||+|+||.||+|.+..   ++..||||.+....  ....+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            345679999999999999999998764   56789999987543  334567899999999999999999999997755 


Q ss_pred             ----eeEEEEEecCCCCHHHHhhhhC--CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCcee
Q 014362          162 ----QRLLVYEYMPLGSLDKHLHDLR--PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPK  235 (426)
Q Consensus       162 ----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~k  235 (426)
                          ..++||||+++|+|.+++....  .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence                3599999999999999985422  2346799999999999999999999987   999999999999999999999


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      |+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||...........+...  
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~--  265 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG--  265 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT--
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC--
Confidence            999999986544332233334567889999999999999999999999999999999 88999776544322221110  


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                                     .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       266 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          266 ---------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             ---------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                           01112334456889999999999999999999999999988653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=366.62  Aligned_cols=247  Identities=23%  Similarity=0.305  Sum_probs=202.4

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      .+.||+|+||.||+|.+..+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+...+++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56799999999999999999999999999877666677899999999999999999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee--ccCCceeEecccccccCCCCCCcce
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHV  253 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~  253 (426)
                      .+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---  244 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---  244 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence            998875   235699999999999999999999998   99999999999999  5678899999999986543322   


Q ss_pred             eeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC
Q 014362          254 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ  333 (426)
Q Consensus       254 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (426)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..||...........+.....      .+.    ..    
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~------~~~----~~----  310 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW------DLE----DE----  310 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------CSC----SG----
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC------CCC----hh----
Confidence            2234799999999999999999999999999999999999999987665443322221110      000    00    


Q ss_pred             CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       334 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+..+.+|+.+||+.||.+||++.++++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            01123457899999999999999999999996

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-46  Score=363.36  Aligned_cols=276  Identities=22%  Similarity=0.257  Sum_probs=216.2

Q ss_pred             CCCcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-----CCCcce
Q 014362           78 AKPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----HPNLVK  152 (426)
Q Consensus        78 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~  152 (426)
                      ...+++.+.....++|.+.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34456666667788999999999999999999999999999999999743 334556778999999886     999999


Q ss_pred             EeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--
Q 014362          153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--  230 (426)
Q Consensus       153 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--  230 (426)
                      +++++...+..++||||+ +++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.  
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence            999999999999999999 89999999863  234599999999999999999999998   9999999999999975  


Q ss_pred             -----------------------CCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHH
Q 014362          231 -----------------------GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVL  287 (426)
Q Consensus       231 -----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il  287 (426)
                                             ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   788999999999864332     1235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc-------cccccccC-CcccCCCC--------------------hHhH
Q 014362          288 LELITGRKAIDQTKDRKELNLVAWARPMFKDR-------KNFSQMVD-PSLQGQYP--------------------VRGL  339 (426)
Q Consensus       288 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~~~~--------------------~~~~  339 (426)
                      |||++|+.||...........+......+...       ......+. .......|                    ....
T Consensus       250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            99999999998766554443333221111000       00000000 00000000                    0112


Q ss_pred             HHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          340 YQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       340 ~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+.+|+.+||+.||.+|||+.|+++
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            46789999999999999999999984

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-46  Score=365.54  Aligned_cols=275  Identities=15%  Similarity=0.165  Sum_probs=210.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC-----CEEEEEEEeccCCccc-----------HHHHHHHHHHHhcCCCCCcceE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQG-----------VREFSAEVMTLGSADHPNLVKL  153 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~~  153 (426)
                      .++|++.+.||+|+||.||+|.+..+     ++.||||++.......           ...+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            46899999999999999999998764     5789999987654211           1123456667788899999999


Q ss_pred             eeEEeeC----CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec
Q 014362          154 IGYCAEG----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE  229 (426)
Q Consensus       154 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~  229 (426)
                      ++++...    ...++||||+ +++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~  186 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence            9998764    4589999999 9999999986   346799999999999999999999998   999999999999999


Q ss_pred             --cCCceeEecccccccCCCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCc
Q 014362          230 --EGYHPKLSDFGLAKMGPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD  302 (426)
Q Consensus       230 --~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~  302 (426)
                        .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999754322111     111234699999999999999999999999999999999999999986433


Q ss_pred             hhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCCCC
Q 014362          303 RKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQ  378 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~  378 (426)
                      ........  .....  ..+..++++.+.   +...+.++.+|+..||+.+|.+||++.+|++.|+.+........
T Consensus       267 ~~~~~~~~--~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~  335 (364)
T 3op5_A          267 DPKYVRDS--KIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD  335 (364)
T ss_dssp             CHHHHHHH--HHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CHHHHHHH--HHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence            22211111  10000  111222222211   12234578999999999999999999999999999876554443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.7e-46  Score=359.19  Aligned_cols=249  Identities=27%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC----cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      .++|++.+.||+|+||.||+|++.   .+++.||||++....    ......+.+|+.+|+.++||||+++++++.+...
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            457999999999999999999985   679999999997643    2334567889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +|+||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            9999999999999999976    35689999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      ..   
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~------~~---  237 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK------CK---  237 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------TC---
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------CC---
Confidence            7532221  122345799999999999999999999999999999999999999987654333222211      00   


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                               ...|...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                     012233455889999999999999999     7778875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.7e-47  Score=378.94  Aligned_cols=266  Identities=24%  Similarity=0.382  Sum_probs=218.4

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG  160 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  160 (426)
                      +....+....++|.+.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+.+|+.++||||+++++++. .
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            4445555667789999999999999999999875 7789999997653 45678999999999999999999999987 5


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ...++||||+++|+|.+++....  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             CccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCC
Confidence            67899999999999999997521  23588999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      +++...... ........+|+.|+|||++....++.++|||||||++|||++ |+.||...........+...       
T Consensus       330 ~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-------  401 (454)
T 1qcf_A          330 LARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-------  401 (454)
T ss_dssp             GGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-------
T ss_pred             CceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------
Confidence            998643221 111223356789999999999999999999999999999999 99999876544332222110       


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                                .+...|..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       402 ----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 ----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                      1112234455688999999999999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.3e-46  Score=350.16  Aligned_cols=254  Identities=25%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|.+..++..||||++.....   .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            3579999999999999999999999999999999865321   2346688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            9999999999999763    5699999999999999999999987   99999999999999999999999999986433


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...              
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------  222 (279)
T 3fdn_A          161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--------------  222 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--------------
T ss_pred             cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--------------
Confidence            22    123457999999999999999999999999999999999999999876544333222211              


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                          ....+...+..+.+|+.+||+.||.+||++.+|++. .++...
T Consensus       223 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h-~~~~~~  264 (279)
T 3fdn_A          223 ----EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH-PWITAN  264 (279)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC-HHHHHH
T ss_pred             ----CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC-ccccCC
Confidence                011233344578899999999999999999999964 445443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=351.84  Aligned_cols=267  Identities=24%  Similarity=0.296  Sum_probs=205.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......  ..+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            36899999999999999999999999999999998655332  3466889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            99999999988765    45699999999999999999999998   999999999999999999999999999986443


Q ss_pred             CCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh--------hhhc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP--------MFKD  318 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~  318 (426)
                      ..  .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.....        .+..
T Consensus       155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          155 PS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            22  12234578999999999876 5789999999999999999999999987765544433321110        0000


Q ss_pred             ccccccccCCcccCCC-----ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQY-----PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...+.....+......     ....+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000000000000     0124457899999999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.5e-46  Score=348.78  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=208.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC--CeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG--DQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~l  165 (426)
                      .++|.+.+.||+|+||.||+|.+.  +..||||++....  ....+.+.+|+.+++.++||||+++++++.+.  ...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            357999999999999999999986  8899999997653  23456799999999999999999999999887  78899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCCeeeccCCceeEecccccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.++|+|||++.
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            99999999999999762  234699999999999999999999987   7  9999999999999999999999998875


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCc---cCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF---KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      ....       ....||+.|+|||++.+..++.   ++||||||+++|||++|+.||..............         
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------  225 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL---------  225 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH---------
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh---------
Confidence            4222       1236899999999998765554   79999999999999999999986654332211110         


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                             .......+...+..+.+++.+||+.||.+||++.+|++.|+.+.
T Consensus       226 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          226 -------EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             -------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                   01111223445568899999999999999999999999999875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=358.13  Aligned_cols=245  Identities=22%  Similarity=0.251  Sum_probs=195.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhc-CCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.....  .....+..|+..+.. .+||||++++++|.+...+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            579999999999999999999999999999999865432  223344555555544 48999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus       137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999 67999988763   45699999999999999999999997   999999999999999999999999999976433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..   ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.........          ..     ....
T Consensus       210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~----------~~-----~~~~  270 (311)
T 3p1a_A          210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL----------RQ-----GYLP  270 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH----------TT-----TCCC
T ss_pred             CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH----------hc-----cCCC
Confidence            22   2234579999999998875 7999999999999999999997776543221110          00     0000


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +    .++...+..+.+|+.+||+.||.+||++.++++
T Consensus       271 ~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 P----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            0    111223457899999999999999999999985

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=361.45  Aligned_cols=252  Identities=21%  Similarity=0.270  Sum_probs=194.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4567999999999999999999999999999999997643  34568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEecccccccC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfgla~~~  245 (426)
                      |+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++..
T Consensus       129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999875    45699999999999999999999998   9999999999999975   889999999999854


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ...   .......||+.|+|||++.+..++.++|||||||++|||++|..||..........  .   ........    
T Consensus       202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~---~i~~~~~~----  269 (349)
T 2w4o_A          202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF--R---RILNCEYY----  269 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH--H---HHHTTCCC----
T ss_pred             Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH--H---HHHhCCCc----
Confidence            322   12234579999999999999999999999999999999999999997654432110  0   00100000    


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          .........+..+.+|+.+||+.||.+||++.++++
T Consensus       270 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 ----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                001112234557899999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1e-46  Score=368.04  Aligned_cols=246  Identities=26%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHH-HhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMT-LGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~-l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|+++.+++.||||++.+...   .....+..|..+ ++.++||||++++++|.+...+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3579999999999999999999999999999999976532   234456667776 577899999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||++||+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.+|.+||+|||+++..
T Consensus       117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            9999999999999976    35689999999999999999999998   9999999999999999999999999999853


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||...........+..      ...     
T Consensus       190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------~~~-----  256 (373)
T 2r5t_A          190 IEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------KPL-----  256 (373)
T ss_dssp             BCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH------SCC-----
T ss_pred             ccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------ccc-----
Confidence            2221  123446899999999999999999999999999999999999999987654433322221      100     


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITD  362 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  362 (426)
                             .++...+..+.+|+.+||+.||.+||++.+
T Consensus       257 -------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             -------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             -------CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                   112234457899999999999999999854

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-46  Score=359.82  Aligned_cols=269  Identities=21%  Similarity=0.251  Sum_probs=201.3

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ....++|++.+.||+|+||+||+|.+..+++.||||++.....  .....+.+|+.+++.++||||+++++++.+...++
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3455789999999999999999999999999999999975432  23456789999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-----cCCceeEecc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-----EGYHPKLSDF  239 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-----~~~~~kl~Df  239 (426)
                      +||||++ |+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++     ..+.+||+||
T Consensus       110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            9999997 599999876    35699999999999999999999998   999999999999994     4556999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |+++......  .......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.........
T Consensus       182 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  259 (329)
T 3gbz_A          182 GLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD  259 (329)
T ss_dssp             THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred             CCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence            9997643221  122345789999999999875 4899999999999999999999999876654443333221110000


Q ss_pred             c--------ccccc----ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 R--------KNFSQ----MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~--------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .        ..+..    .....+....+......+.+|+.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0        00000    00000000011123467899999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-46  Score=370.15  Aligned_cols=268  Identities=22%  Similarity=0.314  Sum_probs=200.0

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCC--e
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGD--Q  162 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~--~  162 (426)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3567899999999999999999999999999999998653  2344567889999999997 999999999997544  6


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +|+||||++ ++|..++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999997 689998875     4699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCC-------------------CcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCc
Q 014362          243 KMGPSGD-------------------KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKD  302 (426)
Q Consensus       243 ~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~  302 (426)
                      +......                   .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            8543211                   1112234689999999999986 6799999999999999999999999988766


Q ss_pred             hhhhcHHHhhhhhhhccccccccc------------------CCcccCC------------CChHhHHHHHHHHHhcccc
Q 014362          303 RKELNLVAWARPMFKDRKNFSQMV------------------DPSLQGQ------------YPVRGLYQALAIAAMCVQE  352 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~------------~~~~~~~~l~~li~~cl~~  352 (426)
                      ......+......... ..+..+.                  .......            .+...+..+.+|+.+||+.
T Consensus       237 ~~~~~~i~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          237 MNQLERIIGVIDFPSN-EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHCCCCH-HHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHhcCCCCH-HHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            5544433211100000 0000000                  0000000            0113345789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 014362          353 QPNMRPAITDVVM  365 (426)
Q Consensus       353 dP~~RPs~~eil~  365 (426)
                      ||.+|||+.|+++
T Consensus       316 dP~~R~t~~e~l~  328 (388)
T 3oz6_A          316 NPNKRISANDALK  328 (388)
T ss_dssp             SGGGSCCHHHHTT
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-46  Score=360.84  Aligned_cols=272  Identities=26%  Similarity=0.416  Sum_probs=219.7

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEe
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLI  154 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~  154 (426)
                      +..+++....++|++.+.||+|+||.||+|.+.     .+++.||||.+..... .....+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334445566778999999999999999999886     3578899999975433 3455688999999999999999999


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhhhC------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      +++.+....++||||+++|+|.+++....      .....+++..++.++.||+.||.|||+.   +|+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence            99999999999999999999999997532      1125679999999999999999999998   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            9999999999999975433222222233467889999999999999999999999999999999 899997765433222


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      .+...        .         ....+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       252 ~~~~~--------~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVMEG--------G---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHTT--------C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHcC--------C---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            11110        0         011233445678999999999999999999999999987643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-46  Score=362.97  Aligned_cols=262  Identities=22%  Similarity=0.218  Sum_probs=206.4

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-----CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-----GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD  161 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  161 (426)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++...     .....+.+.+|+.+++.++||||+++++++.+..
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            44567899999999999999999999999999999998643     2345677999999999999999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPD------------------------------------TRPLDWNTRMKIAAGASRGL  205 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~aL  205 (426)
                      ..++||||+++|+|.+++......                                    ...+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            999999999999999998531110                                    12346788899999999999


Q ss_pred             HHHHHcCCCCeEecCCCCCCeeeccCC--ceeEecccccccCCCCC--CcceeeeecccccccCcccccc--CCCCccCc
Q 014362          206 QYLHEQLKQPVIYRDLKCSNILLEEGY--HPKLSDFGLAKMGPSGD--KTHVSTRVMGTYGYCAPDYAMT--GQLTFKSD  279 (426)
Q Consensus       206 ~~LH~~~~~~iiH~Dlkp~NIll~~~~--~~kl~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~D  279 (426)
                      .|||+.   +|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999998   999999999999998776  89999999997542211  1112334579999999999875  67899999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC
Q 014362          280 IYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA  359 (426)
Q Consensus       280 vwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs  359 (426)
                      ||||||++|||++|+.||...........+......+      .        .......+..+.+|+.+||+.+|.+||+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF------E--------NPNYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT------T--------SGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc------C--------CcccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999998766544332222111000      0        0001123457899999999999999999


Q ss_pred             HHHHHH
Q 014362          360 ITDVVM  365 (426)
Q Consensus       360 ~~eil~  365 (426)
                      +.++++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.2e-46  Score=348.92  Aligned_cols=253  Identities=22%  Similarity=0.261  Sum_probs=210.6

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            34579999999999999999999999999999999987666667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEecccccccC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~  245 (426)
                      |+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||++...
T Consensus        87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            9999999998876    35699999999999999999999998   99999999999999   78899999999999764


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ....   ......||+.|+|||++.+ .++.++||||||+++|||++|..||...........+.....      .+...
T Consensus       160 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~  229 (277)
T 3f3z_A          160 KPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF------TFPEK  229 (277)
T ss_dssp             CTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------CCCHH
T ss_pred             cCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC------CCCch
Confidence            4332   2233579999999998765 499999999999999999999999987654433222221100      00000


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          .    ....+..+.+|+.+||+.||.+||++.++++.
T Consensus       230 ----~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          230 ----D----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ----H----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----h----hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0    00234578999999999999999999999853

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.7e-46  Score=345.39  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=214.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            357999999999999999999987 478899999986543 346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..   ....+++..++.++.||+.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999999976   235689999999999999999999998   99999999999999999999999999997543211


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                       ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+...                
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~----------------  221 (267)
T 3t9t_A          159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------------  221 (267)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT----------------
T ss_pred             -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC----------------
Confidence             111123457889999999999999999999999999999999 89999865543322211110                


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                       .....+...+..+.+|+.+||+.+|.+||++.++++.|+.+...
T Consensus       222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence             01111233455789999999999999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=359.74  Aligned_cols=266  Identities=23%  Similarity=0.304  Sum_probs=202.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5799999999999999999999999999999999754322 122455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      ++ |+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 689888876   345699999999999999999999998   99999999999999999999999999997543222


Q ss_pred             CcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC-
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD-  327 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  327 (426)
                        .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........ ...+..... 
T Consensus       155 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~  231 (324)
T 3mtl_A          155 --KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSN  231 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTSTTGGGC
T ss_pred             --cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC-hHhchhhhcc
Confidence              22234578999999999876 5689999999999999999999999988766554433332111000 000111100 


Q ss_pred             --------CcccC----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 --------PSLQG----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 --------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              +....    ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                    00000    0012234578999999999999999999999963

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-46  Score=374.37  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=210.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++....   ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999997542   23356789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            999999999999865    45699999999999999999999987   99999999999999999999999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ....   ....+||+.|+|||++.+..+ +.++|||||||++|||++|..||...........+...      .      
T Consensus       168 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------~------  232 (476)
T 2y94_A          168 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG------I------  232 (476)
T ss_dssp             TTCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT------C------
T ss_pred             cccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------C------
Confidence            3321   234579999999999988776 68999999999999999999999876543322222110      0      


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                            ...|...+..+.+|+.+||+.||.+||++.+|++.
T Consensus       233 ------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          233 ------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                  01122344578999999999999999999999963

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5e-46  Score=356.29  Aligned_cols=252  Identities=23%  Similarity=0.271  Sum_probs=209.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||+|+||.||+|.+..+|+.||||.+......      ....+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            35699999999999999999999999999999999764322      356799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC----ceeEecc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF  239 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df  239 (426)
                      ++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        91 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999975    45689999999999999999999998   999999999999999887    7999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....      
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------  234 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS------  234 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC------
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------
Confidence            99986543221   233579999999999999999999999999999999999999998765443322221100      


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..    .++..    +...+..+.+|+.+||+.||.+||++.++++
T Consensus       235 ~~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 YD----FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CC----CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cc----cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            00    00000    1123457889999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.6e-46  Score=356.26  Aligned_cols=262  Identities=26%  Similarity=0.426  Sum_probs=212.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEE--EEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVV--AIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||.||+|.+..++..+  |||.+.... ....+.+.+|+.+++.+ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999999888765  999987532 33456789999999999 899999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          167 YEYMPLGSLDKHLHDLR------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      |||+++|+|.+++....            .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence            99999999999997632            2235799999999999999999999998   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||+++.....   .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+.   
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~---  255 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---  255 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh---
Confidence            99999999742211   11223457889999999999999999999999999999998 999997765432211110   


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                                    .......+...+..+.+|+.+||+.+|.+||++.++++.|..+.....
T Consensus       256 --------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          256 --------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             --------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             --------------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                          001112233455688999999999999999999999999999876544

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-46  Score=356.31  Aligned_cols=261  Identities=26%  Similarity=0.403  Sum_probs=207.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC----CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI----EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ..+|.+.+.||+|+||.||+|.+..+    +..||||.+..... .....+.+|+.+++.++||||+++++++.+....+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            35788899999999999999998654    34699999976533 34556889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999976   346799999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCC-cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          245 GPSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       245 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ...... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+..       .   
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-------~---  266 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------G---  266 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------T---
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC-------C---
Confidence            433221 111223356889999999999999999999999999999999 9999976554332221111       0   


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                             .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   01112233456789999999999999999999999999988643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=357.33  Aligned_cols=265  Identities=22%  Similarity=0.273  Sum_probs=211.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEe----eCCeeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA----EGDQRL  164 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~----~~~~~~  164 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            3467999999999999999999999999999999997766666778999999999999999999999986    234789


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++|+|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999999999987655567899999999999999999999998   999999999999999999999999999875


Q ss_pred             CCCCCCcc-------eeeeecccccccCccccccCC---CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          245 GPSGDKTH-------VSTRVMGTYGYCAPDYAMTGQ---LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       245 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      ........       ......||+.|+|||++.+..   ++.++||||||+++|||++|+.||......... ...... 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-  261 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ-  261 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH-
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh-
Confidence            32111000       011235799999999987554   789999999999999999999999642211100 000000 


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                         .          ......+...+..+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus       262 ---~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          262 ---N----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ---C----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ---c----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence               0          0000112234457899999999999999999999999998875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-46  Score=374.76  Aligned_cols=264  Identities=28%  Similarity=0.408  Sum_probs=212.3

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      ..+....++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.|.+|+.+|+.++||||+++++++.+ ...
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            3344556789999999999999999999986 5679999997653 345679999999999999999999999876 678


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~  328 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  328 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccce
Confidence            9999999999999999752  134589999999999999999999997   99999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..           
T Consensus       329 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-----------  396 (452)
T 1fmk_A          329 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----------  396 (452)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------
T ss_pred             ecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence            643321 112223457889999999999999999999999999999999 9999987654433222211           


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                            ..+...+..++..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       397 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          397 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                  011122344566889999999999999999999999999987643

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-46  Score=351.17  Aligned_cols=253  Identities=27%  Similarity=0.327  Sum_probs=204.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ++|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            46999999999999999999999999999999987643 33467799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEecccccccCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~~  246 (426)
                      +++|+|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||++....
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999875433346799999999999999999999998   99999999999999   456789999999997543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...   ......||+.|+|||++. ..++.++||||||+++|||++|+.||..................+      ..  
T Consensus       179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------~~--  246 (285)
T 3is5_A          179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------AV--  246 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------CC--
T ss_pred             Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc------cc--
Confidence            321   223457999999999875 578999999999999999999999998765433322222111100      00  


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         .    ....+..+.+|+.+||+.||.+||++.||++
T Consensus       247 ---~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ---E----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---c----cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0    0112347889999999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=348.05  Aligned_cols=262  Identities=25%  Similarity=0.346  Sum_probs=213.7

Q ss_pred             CCccccc-eeeecCcEEEEEEEEc--CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDC-CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|.+.. .||+|+||.||+|.+.  .++..||||.+..... ...+.+.+|+.+++.++||||+++++++ .....++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 8999999999999864  4688999999986533 4567799999999999999999999999 45678999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            999999999999865   346699999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          247 SGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       247 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........+...            
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~------------  229 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG------------  229 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT------------
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcC------------
Confidence            33221 11223457899999999998999999999999999999999 99999876543322221110            


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCC
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYD  376 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  376 (426)
                           .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+......
T Consensus       230 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          230 -----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             -----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                 11122344556899999999999999999999999999998654443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.5e-46  Score=360.71  Aligned_cols=253  Identities=21%  Similarity=0.326  Sum_probs=200.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCC--CCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADH--PNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~h--pniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|.+. +++.||||++.....  ...+.+.+|+.+|..++|  |||+++++++.+....++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            467999999999999999999885 488999999875432  345678999999999986  999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      |||+ .+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++..
T Consensus        87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            9994 57899999986    45799999999999999999999998   999999999999997 578999999999865


Q ss_pred             CCCCCcceeeeecccccccCcccccc-----------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      .............||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........        
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--------  229 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------  229 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--------
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH--------
Confidence            44333333345689999999999865           67899999999999999999999999754322110        


Q ss_pred             hhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          315 MFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                             +...+++.....++......+.+|+.+||+.||.+||++.++++..
T Consensus       230 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          230 -------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -------HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                   0111122222233344455789999999999999999999999653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-45  Score=346.64  Aligned_cols=258  Identities=19%  Similarity=0.254  Sum_probs=212.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            3578999999999999999999999999999999987543  33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc---eeEecccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgla~  243 (426)
                      |||+++++|.+.+..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.   +||+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999988876    35699999999999999999999998   9999999999999986655   9999999997


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....      .. 
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~-  226 (284)
T 3kk8_A          157 EVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------DY-  226 (284)
T ss_dssp             ECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CC-
T ss_pred             EcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc------cC-
Confidence            6443222   2335799999999999999999999999999999999999999977654433322221100      00 


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                             ........+..+.+|+.+||+.||.+||++.++++. .++.
T Consensus       227 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h-~~~~  266 (284)
T 3kk8_A          227 -------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV-PWIC  266 (284)
T ss_dssp             -------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS-HHHH
T ss_pred             -------CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC-cccc
Confidence                   000112334578999999999999999999999963 3443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.9e-46  Score=372.08  Aligned_cols=264  Identities=22%  Similarity=0.260  Sum_probs=202.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------  160 (426)
                      ..++|++.+.||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.+|+.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            357899999999999999999999999999999999754  234466788999999999999999999999654      


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ..+|+||||++++ |...+.      ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||
T Consensus       140 ~~~~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          140 QDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CeEEEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence            3579999999754 666553      2489999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----  315 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----  315 (426)
                      +++.....   ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+......     
T Consensus       210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          210 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             CC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             eeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            99864332   2234468999999999999999999999999999999999999999887655444333221100     


Q ss_pred             -----------hhcc-----cccccccCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          316 -----------FKDR-----KNFSQMVDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       316 -----------~~~~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                 ....     ..+...+...+...   ........+.+|+.+||+.||.+|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                       0000     00001111100000   01112567899999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-45  Score=347.44  Aligned_cols=267  Identities=20%  Similarity=0.240  Sum_probs=209.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEE-eeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~  167 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+..|+.+++.++|++++..+.++ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45789999999999999999999999999999998765432  24588899999999988877766655 6778889999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~  244 (426)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            999 99999999752   45699999999999999999999998   99999999999999   7899999999999986


Q ss_pred             CCCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh-hhhhc
Q 014362          245 GPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR-PMFKD  318 (426)
Q Consensus       245 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~  318 (426)
                      .......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||................ .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            5433221     12234579999999999999999999999999999999999999998755433222222111 00000


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                      .  . .    .+    ....+..+.+|+.+||+.+|.+||++.+|++.|+.+.....
T Consensus       238 ~--~-~----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          238 P--I-E----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             C--H-H----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             h--h-h----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            0  0 0    00    01123478999999999999999999999999999876443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=351.39  Aligned_cols=258  Identities=29%  Similarity=0.402  Sum_probs=202.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|++.+.||+|+||.||+|.+.  ++.||||.+...  ...+.+.+|+.+++.++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            56899999999999999999986  788999999654  345778999999999999999999999874  478999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc-eeEecccccccCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH-PKLSDFGLAKMGPSGD  249 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~-~kl~Dfgla~~~~~~~  249 (426)
                      ++|+|.+++.... ....+++..++.++.||+.||.|||+...++|+||||||+|||++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            9999999997632 1235789999999999999999999843348999999999999998886 799999999753221 


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........  +.+..  ..  .         
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~--~~--~---------  220 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAV--HN--G---------  220 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHH--HT--T---------
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHH--hc--C---------
Confidence                12346999999999999999999999999999999999999999754332111  11100  00  0         


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                      .....+...+..+.+|+.+||+.||.+||++.+|++.|+.+.....
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          221 TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            0011122344578899999999999999999999999999875443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.7e-46  Score=358.92  Aligned_cols=249  Identities=29%  Similarity=0.373  Sum_probs=206.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            458999999999999999999999999999999975432   23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+. |+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            9997 6888887652   46799999999999999999999998   999999999999999999999999999975432


Q ss_pred             CCCcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .      ....||+.|+|||++.   ...++.++|||||||++|||++|+.||...........+..      ..     
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~------~~-----  269 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------NE-----  269 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------SC-----
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh------cC-----
Confidence            2      2347999999999985   56789999999999999999999999977654332211111      00     


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                        .+.   ..+...+..+.+|+.+||+.||.+||++.++++...
T Consensus       270 --~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          270 --SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             --CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             --CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence              000   011233457889999999999999999999996543

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-45  Score=348.91  Aligned_cols=261  Identities=26%  Similarity=0.349  Sum_probs=208.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCCC---EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee-EEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR-LLV  166 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~-~lv  166 (426)
                      .|.+.+.||+|+||.||+|.+..++   ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4666788999999999999975444   4799999976433 3457789999999999999999999999876655 999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+.+|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            999999999999976   346789999999999999999999998   99999999999999999999999999997543


Q ss_pred             CCCC--cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCC-CCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDK--THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI-DQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ....  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+ ...........+...           
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~-----------  244 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-----------  244 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-----------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-----------
Confidence            2211  11223346889999999999999999999999999999999965554 433332222111110           


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                            .....+...+..+.+|+.+||+.||.+||++.++++.|+.+.....
T Consensus       245 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          245 ------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             ------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                  0111223344578999999999999999999999999999876543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.5e-45  Score=344.96  Aligned_cols=268  Identities=20%  Similarity=0.230  Sum_probs=213.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEE-eeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~  167 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+.+++.++|++++..+.++ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            35789999999999999999999999999999999875433  35688999999999998877666555 6677889999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~  244 (426)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++.
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 89999999752   45699999999999999999999998   99999999999999   4889999999999986


Q ss_pred             CCCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh-hhhhc
Q 014362          245 GPSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR-PMFKD  318 (426)
Q Consensus       245 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~  318 (426)
                      .......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||................ .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            4433221     11234579999999999999999999999999999999999999998754332222111110 00000


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCC
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYD  376 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~  376 (426)
                      .  .     +.+    +...+..+.+|+.+||+.||.+||++.+|++.|+.+......
T Consensus       238 ~--~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          238 P--I-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             C--H-----HHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             c--h-----HHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            0  0     000    112335789999999999999999999999999998765543

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.7e-45  Score=347.55  Aligned_cols=259  Identities=27%  Similarity=0.400  Sum_probs=210.3

Q ss_pred             cCCccccc-eeeecCcEEEEEEEE--cCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           90 TGNFRSDC-CLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        90 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      .++|.+.. .||+|+||.||+|.+  ..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++ .....+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45688887 899999999999954  56688999999976432  3356799999999999999999999999 556789


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        94 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999986    35699999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          245 GPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+...          
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------  236 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG----------  236 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT----------
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC----------
Confidence            5433222 11222356789999999999899999999999999999999 99999876543322221110          


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                             .....+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       237 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          237 -------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                   01122344556889999999999999999999999999988643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.1e-46  Score=357.21  Aligned_cols=261  Identities=20%  Similarity=0.228  Sum_probs=210.5

Q ss_pred             HHHHHHhcCCcccc-ceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCC-CCCcceEeeEEe
Q 014362           83 FDELAAATGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD-HPNLVKLIGYCA  158 (426)
Q Consensus        83 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  158 (426)
                      +.......++|.+. +.||+|+||.||+|.+..+++.||||++....  ......+.+|+.++..+. ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33445566778887 88999999999999999999999999987532  234677899999999985 699999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCcee
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPK  235 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~k  235 (426)
                      +....++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+|
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999988642  346799999999999999999999998   9999999999999998   78999


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+..... 
T Consensus       175 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-  250 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV-  250 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-
T ss_pred             EeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc-
Confidence            99999998653322   12335799999999999999999999999999999999999999987654433322221100 


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                   ..........+..+.+|+.+||+.||.+||++.++++
T Consensus       251 -------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          251 -------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                         0111112234557899999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.6e-46  Score=359.58  Aligned_cols=254  Identities=22%  Similarity=0.271  Sum_probs=204.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++......    ..+|+.++..+ +||||+++++++.+....|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            345799999999999999999999999999999999765432    34688888777 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC----CceeEecccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG----YHPKLSDFGLAK  243 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~  243 (426)
                      ||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+.+.    +.+||+|||+++
T Consensus        96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999999875    35699999999999999999999998   99999999999998543    359999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...............   .....   
T Consensus       169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~~---  240 (342)
T 2qr7_A          169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---GSGKF---  240 (342)
T ss_dssp             ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---HHCCC---
T ss_pred             cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---ccCCc---
Confidence            6433221  223457999999999999888999999999999999999999999764322111111110   00000   


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                           .+....+...+..+.+|+.+||+.||.+||++.++++.
T Consensus       241 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          241 -----SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -----CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -----ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 01111223445688999999999999999999999964

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=350.55  Aligned_cols=268  Identities=23%  Similarity=0.287  Sum_probs=205.3

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-----ccHHHHHHHHHHHhcC---CCCCcceEeeEEee
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----QGVREFSAEVMTLGSA---DHPNLVKLIGYCAE  159 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~  159 (426)
                      ...++|++.+.||+|+||+||+|.+..+++.||||++.....     .....+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            346799999999999999999999999999999999864321     1234566777777666   49999999999987


Q ss_pred             CC-----eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          160 GD-----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       160 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      ..     ..++||||+. ++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            65     5799999997 6999998763  234499999999999999999999998   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP  314 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~  314 (426)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....
T Consensus       160 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (308)
T 3g33_A          160 KLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  236 (308)
T ss_dssp             EECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999998643322   22345799999999999999999999999999999999999999987765554433322111


Q ss_pred             hhhcccccccccC---CcccC-------CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          315 MFKDRKNFSQMVD---PSLQG-------QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       315 ~~~~~~~~~~~~~---~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .... ..+.....   ..+..       ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          237 LPPE-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCCT-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCh-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            1100 00000000   00000       011233457899999999999999999999985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.8e-46  Score=357.78  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=181.5

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      +.||+|+||.||+|.+..+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....|+||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            6799999999999999999999999999653   3456788999999997 99999999999999999999999999999


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC---ceeEecccccccCCCCCCcc
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---HPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---~~kl~Dfgla~~~~~~~~~~  252 (426)
                      .+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|||+++......  .
T Consensus        94 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~  164 (325)
T 3kn6_A           94 FERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--Q  164 (325)
T ss_dssp             HHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--C
Confidence            999986    46799999999999999999999998   999999999999998765   89999999998644322  2


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH-HHhhhhhhhcccccccccCCccc
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL-VAWARPMFKDRKNFSQMVDPSLQ  331 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  331 (426)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........... .............        ..
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--------~~  236 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--------FE  236 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--------CC
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--------CC
Confidence            22345789999999999999999999999999999999999999976543211111 1110111000000        00


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .......+..+.+|+.+||+.||.+||++.++++
T Consensus       237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            0001223567899999999999999999999874

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.7e-46  Score=357.91  Aligned_cols=253  Identities=22%  Similarity=0.321  Sum_probs=200.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC-------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD-------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-------  161 (426)
                      .++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+|+.++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            3579999999999999999999999999999999975433 34577999999999999999999999986543       


Q ss_pred             --------------------------------------------------eeEEEEEecCCCCHHHHhhhhCCCCCCCCH
Q 014362          162 --------------------------------------------------QRLLVYEYMPLGSLDKHLHDLRPDTRPLDW  191 (426)
Q Consensus       162 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~  191 (426)
                                                                        ..++||||+++|+|.+++.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                              3799999999999999998633 2344677


Q ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc----------ceeeeecccc
Q 014362          192 NTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT----------HVSTRVMGTY  261 (426)
Q Consensus       192 ~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~  261 (426)
                      ..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++........          .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78999999999999999997   9999999999999999999999999999865433211          1123357999


Q ss_pred             cccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHH
Q 014362          262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQ  341 (426)
Q Consensus       262 ~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (426)
                      .|+|||++.+..++.++|||||||++|||++|..|+....     ........     ..+.         .........
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~~~~-----~~~~---------~~~~~~~~~  301 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITDVRN-----LKFP---------LLFTQKYPQ  301 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHHHHT-----TCCC---------HHHHHHCHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHHhhc-----cCCC---------cccccCChh
Confidence            9999999999999999999999999999999877653211     01110000     0000         011233456


Q ss_pred             HHHHHHhccccCCCCCCCHHHHHH
Q 014362          342 ALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       342 l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +.+|+.+||+.||.+||++.++++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhh
Confidence            789999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.7e-46  Score=346.70  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=208.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            457999999999999999999999999999999987543 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999998864    45699999999999999999999997   9999999999999999999999999999754332


Q ss_pred             CCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........||+.|+|||++.+..+ +.++||||||+++|||++|..||......... ...+...     .   ... 
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-----~---~~~-  228 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK-----K---TYL-  228 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTT-----C---TTS-
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhc-----c---ccc-
Confidence            22222334579999999999987775 78999999999999999999999765432211 1111100     0   000 


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                           ......+..+.+|+.+||+.||.+||++.+|++
T Consensus       229 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 011234457889999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.5e-46  Score=348.53  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=214.2

Q ss_pred             HHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ++....++|++.+.||+|+||.||+|.+.. +..||||.+.... ...+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            344455789999999999999999999864 7789999997543 345779999999999999999999999875 4689


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            999999999999998652  123699999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+..            
T Consensus       159 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------------  225 (279)
T 1qpc_A          159 IEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------  225 (279)
T ss_dssp             CSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred             ccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc------------
Confidence            543221 11223457889999999998999999999999999999999 9999986554332211110            


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                           ......+...+..+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus       226 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          226 -----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----ccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                 001112334456889999999999999999999999999988654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.7e-46  Score=377.31  Aligned_cols=255  Identities=28%  Similarity=0.377  Sum_probs=211.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....   ......+.+|+.+|+.++||||+++++++.+...+|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            3467999999999999999999999999999999996532   2345668899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||++||+|..++...  ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.+|.+||+|||+++..
T Consensus       262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999998763  234599999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+..  .....       
T Consensus       337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~--~i~~~-------  404 (576)
T 2acx_A          337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVKEV-------  404 (576)
T ss_dssp             CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH--HHHHC-------
T ss_pred             ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH--Hhhcc-------
Confidence            4332   22345899999999999999999999999999999999999999987543221111110  00100       


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                           ...++...+..+.+|+.+||+.||.+||     ++.||++
T Consensus       405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                 1122334456889999999999999999     7888874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=360.60  Aligned_cols=261  Identities=25%  Similarity=0.274  Sum_probs=194.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEe--------eC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCA--------EG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~--------~~  160 (426)
                      ..+|++.+.||+|+||.||+|.+..+++.||||.+........+.+.+|+.++..+. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457999999999999999999999999999999997766666778999999999996 999999999984        34


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCCeeeccCCceeEec
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      ..+++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+.   +  |+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence            45799999996 79998887533 235699999999999999999999987   7  99999999999999999999999


Q ss_pred             ccccccCCCCCCcc----------eeeeecccccccCcccc---ccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhh
Q 014362          239 FGLAKMGPSGDKTH----------VSTRVMGTYGYCAPDYA---MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE  305 (426)
Q Consensus       239 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~  305 (426)
                      ||+++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||........
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~  261 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI  261 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence            99998644322111          11134689999999998   566789999999999999999999999975432211


Q ss_pred             hcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                      .   .                 .......+......+.+|+.+||+.||.+||++.++++.|+.+.....
T Consensus       262 ~---~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          262 V---N-----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             h---c-----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            0   0                 000001111122357889999999999999999999999999976543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=6.2e-46  Score=365.10  Aligned_cols=251  Identities=21%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCC--CCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD--HPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv  166 (426)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++....  ......+.+|+.+|+.++  ||||+++++++.....+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999999999876 8899999997543  334577899999999996  59999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      || +.+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||+++...
T Consensus       135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 568899999986    35789999999999999999999987   999999999999996 5789999999998654


Q ss_pred             CCCCcceeeeecccccccCcccccc-----------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      ...........+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........  .      
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~--~------  277 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--L------  277 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--H------
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH--H------
Confidence            3332223344679999999999865           46899999999999999999999999754322110  0      


Q ss_pred             hhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                             ..++++.....++...+..+.+|+.+||+.||.+||++.+|++.
T Consensus       278 -------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          278 -------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -------HHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                   01111111222233334578999999999999999999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=345.91  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=188.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||||.+....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            457999999999999999999999889999999996532   22346789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999976   346799999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........                ..
T Consensus       164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----------------~~  225 (278)
T 3cok_A          164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----------------VV  225 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------CC
T ss_pred             CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH----------------Hh
Confidence            2221  12235789999999999999999999999999999999999999976543221100                00


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...  ...+...+..+.+|+.+||+.||.+||++.++++
T Consensus       226 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          226 LAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             SSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            000  0123344568899999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.8e-46  Score=375.84  Aligned_cols=256  Identities=24%  Similarity=0.358  Sum_probs=211.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|+++.+|+.||||++.+..   ......+..|+.+|+.++||||+++++++.+...+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999999999999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||++||+|..++.........+++..++.++.||+.||.|||+.   +|+||||||+||||+.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999987544456799999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+  ........       
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~~i~~~~-------  409 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRVLEQA-------  409 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HHHHHHCC-------
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HHHHhhcc-------
Confidence            3322  123458999999999999999999999999999999999999999865432111111  11111111       


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCH-----HHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI-----TDVV  364 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil  364 (426)
                           ..+|...+..+.+|+.+||+.||.+||++     .+|+
T Consensus       410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             -----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence                 12234455688999999999999999975     5565

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.8e-45  Score=350.60  Aligned_cols=261  Identities=21%  Similarity=0.223  Sum_probs=204.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.+++.++||||+++++++......++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            5789999999999999999999999999999999975432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus       113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            9999999999999863    5699999999999999999999998   99999999999999999999999999997543


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+.       .......  
T Consensus       186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~~~--  255 (309)
T 2h34_A          186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN-------QAIPRPS--  255 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH-------SCCCCGG--
T ss_pred             cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc-------cCCCCcc--
Confidence            3221 12234579999999999999999999999999999999999999998654321111111       0000000  


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHHhC
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-AITDVVMALNYLASQ  373 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~~  373 (426)
                            ..+...+..+.+|+.+||+.||.+|| ++.++++.|+.+...
T Consensus       256 ------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 ------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             ------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             ------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence                  11223344788999999999999999 999999999877543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.5e-45  Score=355.21  Aligned_cols=250  Identities=24%  Similarity=0.319  Sum_probs=210.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            357999999999999999999999999999999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            999999999998876    35699999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+...      ..      
T Consensus       193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~------~~------  258 (335)
T 2owb_A          193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY------  258 (335)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------CC------
T ss_pred             cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC------CC------
Confidence            2221  123457999999999999999999999999999999999999999876543322111110      00      


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                            ..+......+.+|+.+||+.||.+||++.++++.
T Consensus       259 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 ------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  1122334578899999999999999999999964

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.8e-46  Score=356.20  Aligned_cols=264  Identities=28%  Similarity=0.393  Sum_probs=209.3

Q ss_pred             cCCccccceeeecCcEEEEEEE-----EcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||+|+||.||+|.     ...++..||||.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4679999999999999999999     44567899999997543 34456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEe
Q 014362          164 LLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLS  237 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~  237 (426)
                      ++||||+++++|.+++.....   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999987432   124589999999999999999999998   9999999999999984   4569999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||...........+...    
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----  261 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG----  261 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT----
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC----
Confidence            9999975333222222334568999999999999999999999999999999998 99999766543322222110    


Q ss_pred             hcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                                   .....+...+..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       262 -------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          262 -------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                         01112233455789999999999999999999999999988653

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=362.97  Aligned_cols=277  Identities=19%  Similarity=0.218  Sum_probs=216.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC--eeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357999999999999999999999999999999997543 234567889999999999999999999998765  78999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee----ccCCceeEeccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKLSDFGLA  242 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl~Dfgla  242 (426)
                      |||+++|+|.+++.... ....+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999997632 223499999999999999999999998   99999999999999    77788999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCcccccc--------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-cHHHhhh
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMT--------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-NLVAWAR  313 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~  313 (426)
                      +......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... ..+....
T Consensus       164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            8643322   2234579999999999875        56789999999999999999999999754332211 1111100


Q ss_pred             -hhhhc-ccccccc------c--CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          314 -PMFKD-RKNFSQM------V--DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       314 -~~~~~-~~~~~~~------~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                       ..... ...+...      .  +.......+......+.+++.+||+.||.+||++.++++.+..+...
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence             00000 0000000      0  00112234467778899999999999999999999999999988654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-46  Score=356.89  Aligned_cols=276  Identities=26%  Similarity=0.389  Sum_probs=214.7

Q ss_pred             cCCccccceeeecCcEEEEEEEE----cCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC--ee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD--QR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~  163 (426)
                      .++|++.+.||+|+||.||+|.+    ..+++.||||.+........+.+.+|+.+++.++||||+++++++....  .+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35699999999999999999984    5679999999998776666788999999999999999999999986644  68


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            9999999999999999862   35699999999999999999999997   99999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......++..|+|||++.+..++.++||||||+++|||++|..||....... ................+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-MRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHH-HHHHCTTCCTHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHH-HHhhccccchhhhHHHH
Confidence            65433221 11223457888999999999999999999999999999999999986432110 00000000000000000


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ...+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            01111111122344556689999999999999999999999999998864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-45  Score=350.53  Aligned_cols=253  Identities=21%  Similarity=0.282  Sum_probs=208.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||.+..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            34579999999999999999999999999999999986654455678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEecccccccC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~  245 (426)
                      |+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++..
T Consensus        87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            9999999999876    25689999999999999999999998   99999999999999   77899999999999753


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ...    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....      ..    
T Consensus       160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~------~~----  225 (304)
T 2jam_A          160 QNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGY------YE----  225 (304)
T ss_dssp             CCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCC------CC----
T ss_pred             CCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------CC----
Confidence            322    1223469999999999999999999999999999999999999998765433222221100      00    


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          .....+...+..+.+|+.+||+.||.+||++.++++.
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          226 ----FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ----CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                0111122345678999999999999999999999963

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=357.61  Aligned_cols=244  Identities=23%  Similarity=0.325  Sum_probs=206.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSADHPNLVKLIGYCAEG  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  160 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+.....        .....+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            34689999999999999999999999999999999976532        1334577899999999999999999999999


Q ss_pred             CeeEEEEEecCCC-CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          161 DQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       161 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ..+++||||+.+| +|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999766 99999875    45699999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |+++.......   .....||+.|+|||++.+..+ +.++|||||||++|||++|..||.......              
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------  237 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------  237 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------
Confidence            99986543322   234579999999999988877 889999999999999999999997532110              


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          ....      ..+...+..+.+|+.+||+.||.+||++.++++.
T Consensus       238 ----~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ----EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000      1122244578999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=379.67  Aligned_cols=259  Identities=25%  Similarity=0.349  Sum_probs=208.8

Q ss_pred             CCccccc-eeeecCcEEEEEEEEc--CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDC-CLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      +++.+.. .||+|+||.||+|.+.  .++..||||++..... ...+.+.+|+.+|+.++|||||+++++|.. +.+++|
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            3444444 7999999999999875  3567899999976532 356789999999999999999999999976 568999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999975   346699999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          247 SGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       247 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..             
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-------------  554 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------------  554 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-------------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence            32211 11122346789999999999999999999999999999998 9999987665443322221             


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                          ..+...|..++..+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus       555 ----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          555 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                111223445667899999999999999999999999999988644

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-45  Score=350.85  Aligned_cols=257  Identities=22%  Similarity=0.251  Sum_probs=201.6

Q ss_pred             cCCcccc-ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc-CCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~-l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .+.|++. +.||+|+||.||+|.+..+++.||||++..........+.+|+.++.. ++||||+++++++.+.+.+++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3568874 789999999999999999999999999987665667789999999988 47999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc---eeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Dfgla~~  244 (426)
                      ||+++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.   +||+|||++..
T Consensus        91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999863    5689999999999999999999998   9999999999999998766   99999999875


Q ss_pred             CCCCCC-----cceeeeecccccccCcccccc-----CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH------
Q 014362          245 GPSGDK-----THVSTRVMGTYGYCAPDYAMT-----GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL------  308 (426)
Q Consensus       245 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~------  308 (426)
                      ......     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||...........      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            432111     111123469999999999875     5689999999999999999999999976543210000      


Q ss_pred             ---HHhhhhhhhcccccccccCCcccCCCCh----HhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          309 ---VAWARPMFKDRKNFSQMVDPSLQGQYPV----RGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       309 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         ............            .++.    ..+..+.+|+.+||+.||.+||++.++++
T Consensus       244 ~~~~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHHCCC------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hHHHHHHHHHhccCc------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence               000000000000            1111    23457899999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.4e-45  Score=344.13  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=209.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|.+.+.||+|+||.||+|.+..++..||||.+....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986532   223467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.....
T Consensus        94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999999763    4689999999999999999999987   999999999999999999999999999875432


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..    .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+..      .         
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~------~---------  227 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------V---------  227 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------T---------
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc------c---------
Confidence            21    2335799999999999999999999999999999999999999986554332211111      0         


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         ...++...+..+.+|+.+||+.||.+||++.++++.
T Consensus       228 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 ---DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence               011233345578999999999999999999999963

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-45  Score=363.49  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=195.7

Q ss_pred             cCCcccc-ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHH-hcCCCCCcceEeeEEee----CCee
Q 014362           90 TGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL-GSADHPNLVKLIGYCAE----GDQR  163 (426)
Q Consensus        90 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~  163 (426)
                      .++|.+. +.||.|+||+||+|.+..+++.||||++...     ..+.+|+.++ +..+||||++++++|..    ...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567776 6899999999999999999999999999643     4567888887 45689999999999875    5678


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEeccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG  240 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg  240 (426)
                      ||||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence            9999999999999999762  235699999999999999999999997   9999999999999997   7899999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc-HHHhhhhhhhcc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN-LVAWARPMFKDR  319 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~  319 (426)
                      +++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......   ...
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~  283 (400)
T 1nxk_A          210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQ  283 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTC
T ss_pred             cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCc
Confidence            998643221   2234579999999999999999999999999999999999999997654322110 000000   000


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      ..+        ........+.++.+|+.+||+.||.+||++.+|++.-
T Consensus       284 ~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          284 YEF--------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             CCC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ccC--------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            000        0001123455789999999999999999999999754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.8e-45  Score=346.14  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=207.2

Q ss_pred             CCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEE-eeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYC-AEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l  165 (426)
                      .+|++.+.||+|+||.||+|.+..+   ...||+|.+..... ...+.+.+|+.+++.++||||+++++++ ......++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4688899999999999999997543   34699999876433 4457789999999999999999999986 45567899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999999975   346689999999999999999999998   9999999999999999999999999999754


Q ss_pred             CCCCC--cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          246 PSGDK--THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       246 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      .....  ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||...........+...          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~----------  248 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG----------  248 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT----------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC----------
Confidence            33221  112233567889999999999999999999999999999999 55666554433222111110          


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                             .....+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus       249 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          249 -------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                   001112233457899999999999999999999999999987643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6e-46  Score=355.31  Aligned_cols=273  Identities=26%  Similarity=0.417  Sum_probs=212.8

Q ss_pred             Cc-cccceeeecCcEEEEEEEE----cCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCee
Q 014362           92 NF-RSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQR  163 (426)
Q Consensus        92 ~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~  163 (426)
                      +| ++.+.||+|+||.||++.+    ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+  ...+
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            45 8999999999999988865    34689999999986533 345678999999999999999999999987  4678


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++|+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            999999999999999976     3499999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ........ .......||+.|+|||++.+..++.++||||||+++|||++|..||........ ....+...... ...+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~-~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMT-VLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHH-HHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchh-HHHH
Confidence            65443322 223345688999999999999999999999999999999999999975432110 00000000000 0001


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      ...+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            1112222223334555678999999999999999999999999999886543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-45  Score=345.86  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=209.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC---CCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|.+.+.||+|+||.||+|.+..   ++..||||.+.... ....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4679999999999999999998653   34579999997653 34567799999999999999999999998754 5789


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus        90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            99999999999999763   35689999999999999999999997   9999999999999999999999999999864


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+....           
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~-----------  231 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-----------  231 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC-----------
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC-----------
Confidence            33221 12233467889999999999999999999999999999998 999997655443322221110           


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                            ....+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus       232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          232 ------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence                  001122344578999999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.9e-46  Score=348.70  Aligned_cols=256  Identities=21%  Similarity=0.289  Sum_probs=209.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++.+  ...+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999999999999999997643  2345678999999999999999999998853  578999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC-----eEecCCCCCCeeeccCCceeEeccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP-----VIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~-----iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      ||||+++++|.+++.........+++..++.++.||+.||.|||+.   +     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999999999986544456699999999999999999999998   6     9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      +++......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...        
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--------  231 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--------  231 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhc--------
Confidence            997643322  1122347899999999999999999999999999999999999999876543222111110        


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL  367 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L  367 (426)
                      .         ....+...+..+.+|+.+||+.||.+||++.+|++.+
T Consensus       232 ~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          232 K---------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             c---------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            0         0112334456889999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-45  Score=355.31  Aligned_cols=270  Identities=25%  Similarity=0.278  Sum_probs=204.3

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||.+......     ..+.+.+|+.+++.++||||+++++++.+...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3457899999999999999999999999999999998753221     23468899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++||||+++ +|..++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            9999999985 88888865   345689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh-----
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF-----  316 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  316 (426)
                      +......  .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+.......     
T Consensus       160 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          160 KSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  237 (346)
T ss_dssp             STTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             eeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence            8643322  222345789999999998764 58999999999999999999999998776544433322111000     


Q ss_pred             hcccccccccCCcccCCCC-----hHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          317 KDRKNFSQMVDPSLQGQYP-----VRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .........+........+     ...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000011111000000111     2334689999999999999999999999964

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.8e-46  Score=357.32  Aligned_cols=267  Identities=22%  Similarity=0.330  Sum_probs=207.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3579999999999999999999999999999999865433  23455789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            99999999887654    35699999999999999999999998   999999999999999999999999999975433


Q ss_pred             CCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh--------hhhhc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR--------PMFKD  318 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~  318 (426)
                      ..  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....        ..+..
T Consensus       177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            22  122345799999999999875 78999999999999999999999998776544332222110        00111


Q ss_pred             ccccccccCCcccCCC-----ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQY-----PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...+.....+.+....     ....+..+.+|+.+||+.||.+||++.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1111111111111111     1234568999999999999999999999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-45  Score=362.38  Aligned_cols=268  Identities=21%  Similarity=0.274  Sum_probs=206.6

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee-------
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-------  159 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-------  159 (426)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++.....    ...+|+.+++.++||||++++++|..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456789999999999999999999999999999999865422    23479999999999999999999844       


Q ss_pred             -------------------------------CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 014362          160 -------------------------------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL  208 (426)
Q Consensus       160 -------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  208 (426)
                                                     ...+++||||++ |+|.+.+.........+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 688888876444567899999999999999999999


Q ss_pred             HHcCCCCeEecCCCCCCeeec-cCCceeEecccccccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHH
Q 014362          209 HEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVV  286 (426)
Q Consensus       209 H~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~i  286 (426)
                      |+.   +|+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            987   999999999999998 688999999999986533322   2334789999999998875 48999999999999


Q ss_pred             HHHHHhCCCCCCCcCchhhhcHHHhhhhh------hhccc-----ccccccCCcccCCCChHhHHHHHHHHHhccccCCC
Q 014362          287 LLELITGRKAIDQTKDRKELNLVAWARPM------FKDRK-----NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPN  355 (426)
Q Consensus       287 l~elltg~~p~~~~~~~~~~~~~~~~~~~------~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~  355 (426)
                      +|||++|+.||.+....+....+......      .....     .+...........++...+..+.+|+.+||+.||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            99999999999887655544333211100      00000     01111111111123444566799999999999999


Q ss_pred             CCCCHHHHHH
Q 014362          356 MRPAITDVVM  365 (426)
Q Consensus       356 ~RPs~~eil~  365 (426)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999995

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=345.06  Aligned_cols=254  Identities=22%  Similarity=0.274  Sum_probs=204.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC----cccHHHHHHHHHHHhcCCCCCcceEeeEE--eeCCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADHPNLVKLIGYC--AEGDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~--~~~~~  162 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....    ......+.+|+.+++.++||||+++++++  .+...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999999999999999997542    23456789999999999999999999998  44567


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++||||++++ |.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence            89999999876 77777653  245799999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      ................||+.|+|||++.+..  ++.++||||||+++|||++|..||...........+...      . 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------~-  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------S-  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------C-
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC------C-
Confidence            8654333333334457999999999987654  478999999999999999999999875543322221110      0 


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                                 ...+...+..+.+|+.+||+.||.+||++.++++.
T Consensus       230 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -----------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -----------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                       01122344578899999999999999999999964

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.1e-46  Score=358.46  Aligned_cols=266  Identities=17%  Similarity=0.157  Sum_probs=201.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC---CCEEEEEEEeccCCcc-----------cHHHHHHHHHHHhcCCCCCcceEee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGVQ-----------GVREFSAEVMTLGSADHPNLVKLIG  155 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpniv~~~~  155 (426)
                      .++|.+.+.||+|+||.||+|.+..   ++..||||.+......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3679999999999999999999987   7889999998765322           1233667888999999999999999


Q ss_pred             EEee----CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC
Q 014362          156 YCAE----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG  231 (426)
Q Consensus       156 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~  231 (426)
                      ++..    ....++||||+ +++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            9988    77899999999 99999999762    3799999999999999999999998   99999999999999988


Q ss_pred             C--ceeEecccccccCCCCCC-----cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchh
Q 014362          232 Y--HPKLSDFGLAKMGPSGDK-----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK  304 (426)
Q Consensus       232 ~--~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~  304 (426)
                      +  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999975432211     111133579999999999999999999999999999999999999996532211


Q ss_pred             hhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          305 ELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      ...... ......   .+...+....   .....+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       268 ~~~~~~-~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          268 VAVQTA-KTNLLD---ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHH-HHHHHH---TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHH-HHhhcc---cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            111110 000000   0000000000   0113445789999999999999999999999999755

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.6e-45  Score=344.37  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=210.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            357999999999999999999999999999999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            999999999998876    35699999999999999999999998   99999999999999999999999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..      ..       
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~-------  231 (294)
T 2rku_A          167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------NE-------  231 (294)
T ss_dssp             STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT------TC-------
T ss_pred             cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh------cc-------
Confidence            2221  12335799999999999999999999999999999999999999987654332211111      00       


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                           ...+......+.+|+.+||+.||.+||++.++++.
T Consensus       232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                 01123344578899999999999999999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-45  Score=370.65  Aligned_cols=272  Identities=20%  Similarity=0.244  Sum_probs=190.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----Ce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  162 (426)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|+.+|+.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999999999999999996532  33456789999999999999999999998433     56


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +|+||||+ +++|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            89999998 5789988865    46799999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCc-------------------------ceeeeecccccccCcccc-ccCCCCccCchhhHHHHHHHHHh----
Q 014362          243 KMGPSGDKT-------------------------HVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELIT----  292 (426)
Q Consensus       243 ~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~ellt----  292 (426)
                      +........                         ...+..+||+.|+|||++ ....++.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            865322110                         123446789999999986 45679999999999999999999    


Q ss_pred             -------CCCCCCCcCch--------------------hhhcHHHhhhhhhh-----c---------ccccccccCCccc
Q 014362          293 -------GRKAIDQTKDR--------------------KELNLVAWARPMFK-----D---------RKNFSQMVDPSLQ  331 (426)
Q Consensus       293 -------g~~p~~~~~~~--------------------~~~~~~~~~~~~~~-----~---------~~~~~~~~~~~~~  331 (426)
                             |+++|.+....                    ..+..+........     .         ...+.......+.
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   66666543310                    11111100000000     0         0000000000000


Q ss_pred             CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       332 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      . .....+..+.+|+.+||+.||.+|||+.|+++ ..++.
T Consensus       364 ~-~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~-Hp~f~  401 (458)
T 3rp9_A          364 E-RFPASSADAIHLLKRMLVFNPNKRITINECLA-HPFFK  401 (458)
T ss_dssp             G-GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH-SGGGT
T ss_pred             H-HCCCCCHHHHHHHHHHhccCccccCCHHHHhc-CHhhh
Confidence            0 11223567899999999999999999999996 34443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=359.94  Aligned_cols=261  Identities=25%  Similarity=0.391  Sum_probs=201.6

Q ss_pred             CccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEee-CCeeEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLV  166 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  166 (426)
                      .|.+.+.||+|+||.||+|.+..+   +..||||.+... .....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            477788999999999999997533   356899998754 33456789999999999999999999998754 4578999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            999999999999975   345689999999999999999999998   99999999999999999999999999997543


Q ss_pred             CCCCc--ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKT--HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .....  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...........+....          
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~----------  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----------  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC----------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC----------
Confidence            32211  11233467889999999999999999999999999999999 677786654433222111100          


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                             ....|..++..+.+++.+||+.+|.+||++.+|++.|+.+.....
T Consensus       314 -------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          314 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence                   011133345578999999999999999999999999999976543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.1e-45  Score=350.12  Aligned_cols=275  Identities=23%  Similarity=0.300  Sum_probs=214.1

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc--CCCCCcceEeeEE
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYC  157 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~  157 (426)
                      ..++.......++|.+.+.||+|+||.||+|.+.  ++.||||.+...   ....+..|++++..  ++||||+++++++
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            4555556667789999999999999999999985  899999999643   34567788888877  7999999999999


Q ss_pred             eeCC----eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--------HcCCCCeEecCCCCCC
Q 014362          158 AEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH--------EQLKQPVIYRDLKCSN  225 (426)
Q Consensus       158 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--------~~~~~~iiH~Dlkp~N  225 (426)
                      ....    ..++||||+++|+|.+++..     ..+++..++.++.||+.||.|||        +.   +|+||||||+|
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~N  177 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKN  177 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGG
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHH
Confidence            8876    78999999999999999976     45999999999999999999999        65   99999999999


Q ss_pred             eeeccCCceeEecccccccCCCCCCcc--eeeeecccccccCccccccC------CCCccCchhhHHHHHHHHHhC----
Q 014362          226 ILLEEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTG------QLTFKSDIYSFGVVLLELITG----  293 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlG~il~elltg----  293 (426)
                      ||++.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|    
T Consensus       178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~  257 (342)
T 1b6c_B          178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  257 (342)
T ss_dssp             EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred             EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence            999999999999999997543332211  12345799999999998765      344789999999999999999    


Q ss_pred             ------CCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC-CChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          294 ------RKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ-YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       294 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                            ..||......... ...+.....      ...+.+.+... ........+.+|+.+||+.||.+||++.+|++.
T Consensus       258 ~~~~~~~~p~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          258 GIHEDYQLPYYDLVPSDPS-VEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             TBCCCCCCTTTTTSCSSCC-HHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             CcccccccCccccCcCccc-HHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                  6777654322111 000000000      00111111111 123556789999999999999999999999999


Q ss_pred             HHHHHhCC
Q 014362          367 LNYLASQK  374 (426)
Q Consensus       367 L~~l~~~~  374 (426)
                      |+.+..+.
T Consensus       331 L~~i~~~~  338 (342)
T 1b6c_B          331 LSQLSQQE  338 (342)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHHh
Confidence            99997654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4e-45  Score=343.27  Aligned_cols=259  Identities=22%  Similarity=0.308  Sum_probs=209.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+.....      ...+.+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            3569999999999999999999999999999999875432      1357799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC----ceeEecc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF  239 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df  239 (426)
                      ++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            999999999999999976    35699999999999999999999998   999999999999998877    7999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....      
T Consensus       157 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------  227 (283)
T 3bhy_A          157 GIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN------  227 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------
T ss_pred             ccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcc------
Confidence            99986433221   233579999999999999999999999999999999999999998765433222221100      


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH--HHHHHHh
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM--ALNYLAS  372 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~--~L~~l~~  372 (426)
                      ..    ..+.    .+...+..+.+|+.+||+.||.+||++.++++  .+..+..
T Consensus       228 ~~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  274 (283)
T 3bhy_A          228 YD----FDEE----YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR  274 (283)
T ss_dssp             CC----CCHH----HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHH
T ss_pred             cC----Ccch----hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHH
Confidence            00    0000    01123447889999999999999999999996  3455443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-45  Score=346.87  Aligned_cols=247  Identities=19%  Similarity=0.217  Sum_probs=203.0

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+....  ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            457999999999999999999999999999999987642  33456788899999998 999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---------------
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---------------  231 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---------------  231 (426)
                      |||+++++|.+++.........+++..++.++.||+.||.|||+.   +|+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999986433336799999999999999999999998   99999999999999844               


Q ss_pred             ----CceeEecccccccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh
Q 014362          232 ----YHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL  306 (426)
Q Consensus       232 ----~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~  306 (426)
                          ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.......  
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--  238 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH--  238 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH--
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH--
Confidence                479999999998644322      23589999999999876 66789999999999999999998775432111  


Q ss_pred             cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .+.  .      .         .....+...+..+.+|+.+||+.||.+||++.++++
T Consensus       239 -~~~--~------~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          239 -EIR--Q------G---------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HHH--T------T---------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHH--c------C---------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             000  0      0         001123334568899999999999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.5e-45  Score=383.93  Aligned_cols=250  Identities=25%  Similarity=0.349  Sum_probs=211.5

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~  164 (426)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++.+.   .......+..|..+|..+ +||||+.+++++.+...+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            457899999999999999999999999999999999753   123456688899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      |||||+++|+|..++...    ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus       419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            999999999999999873    5699999999999999999999998   999999999999999999999999999985


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+..      ..     
T Consensus       492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~------~~-----  558 (674)
T 3pfq_A          492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------HN-----  558 (674)
T ss_dssp             CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS------SC-----
T ss_pred             cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh------CC-----
Confidence            33222  223456899999999999999999999999999999999999999987665443322221      00     


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAI-----TDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~  365 (426)
                             ..+|...+.++.+|+.+||+.||.+||++     .+|++
T Consensus       559 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                   12334455689999999999999999998     66663

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=346.86  Aligned_cols=278  Identities=22%  Similarity=0.274  Sum_probs=208.1

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhc--CCCCCcceEeeEE
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGS--ADHPNLVKLIGYC  157 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~~~~~~  157 (426)
                      ...........++|++.+.||+|+||.||+|.+.  ++.||||++...   ....+..|.+++..  ++||||+++++++
T Consensus        26 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~  100 (337)
T 3mdy_A           26 GLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAAD  100 (337)
T ss_dssp             SSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             CCCcccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence            3444555566788999999999999999999986  899999998643   23344556666555  4899999999999


Q ss_pred             eeC----CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-----CCCeEecCCCCCCeee
Q 014362          158 AEG----DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-----KQPVIYRDLKCSNILL  228 (426)
Q Consensus       158 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-----~~~iiH~Dlkp~NIll  228 (426)
                      ...    ...++||||+++|+|.+++..     ..+++..++.++.||+.||.|||+..     +.+|+||||||+|||+
T Consensus       101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill  175 (337)
T 3mdy_A          101 IKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV  175 (337)
T ss_dssp             EESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred             ccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence            887    789999999999999999976     46999999999999999999999641     2389999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcc--eeeeecccccccCccccccCCCCcc------CchhhHHHHHHHHHhC-------
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMTGQLTFK------SDIYSFGVVLLELITG-------  293 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlG~il~elltg-------  293 (426)
                      +.++.+||+|||+++.........  ......||+.|+|||++.+..++..      +|||||||++|||++|       
T Consensus       176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~  255 (337)
T 3mdy_A          176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV  255 (337)
T ss_dssp             CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence            999999999999997543322211  1123479999999999988776665      9999999999999999       


Q ss_pred             ---CCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCC-CChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          294 ---RKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ-YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       294 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                         ..||.............  .....     .....+.+... .+..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus       256 ~~~~~p~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          256 EEYQLPYHDLVPSDPSYEDM--REIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             CCCCCTTTTTSCSSCCHHHH--HHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccccHhhhcCCCCchhhh--HHHHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence               55554432211110000  00000     00011111110 123667789999999999999999999999999999


Q ss_pred             HHhCC
Q 014362          370 LASQK  374 (426)
Q Consensus       370 l~~~~  374 (426)
                      +....
T Consensus       329 l~~~~  333 (337)
T 3mdy_A          329 MSESQ  333 (337)
T ss_dssp             HHHTT
T ss_pred             HHhhc
Confidence            97643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=356.63  Aligned_cols=271  Identities=15%  Similarity=0.158  Sum_probs=210.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC--------CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcce---------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI--------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVK---------  152 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------  152 (426)
                      .++|++.+.||+|+||.||+|.+..+        ++.||||.+...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            36799999999999999999999874        789999998754     46889999999999999988         


Q ss_pred             ------EeeEEee-CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 014362          153 ------LIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN  225 (426)
Q Consensus       153 ------~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N  225 (426)
                            +++++.. ....++||||+ +++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  5677765 67899999999 99999999863  136799999999999999999999998   99999999999


Q ss_pred             eeeccCC--ceeEecccccccCCCCCC-----cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          226 ILLEEGY--HPKLSDFGLAKMGPSGDK-----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       226 Ill~~~~--~~kl~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                      ||++.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  899999999975432211     111133479999999999999999999999999999999999999998


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCCCCC
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQ  378 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~~~~  378 (426)
                      ........ ............   ..+.....   .....+..+.+|+.+||+.||.+||++.+|++.|+.+........
T Consensus       270 ~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  342 (352)
T 2jii_A          270 NCLPNTED-IMKQKQKFVDKP---GPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSP  342 (352)
T ss_dssp             GGTTCHHH-HHHHHHHHHHSC---CCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCT
T ss_pred             cCCcCHHH-HHHHHHhccCCh---hhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCc
Confidence            75422111 111111111111   11111100   011234578999999999999999999999999999987655443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=7.4e-45  Score=345.06  Aligned_cols=253  Identities=27%  Similarity=0.399  Sum_probs=212.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      ..|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            46999999999999999999999999999999997653 34467799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999864     5699999999999999999999998   99999999999999999999999999997643321


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCc
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS  329 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (426)
                        .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...             ..+ 
T Consensus       174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~-  237 (303)
T 3a7i_A          174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------------NPP-  237 (303)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------------CCC-
T ss_pred             --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-------------CCC-
Confidence              1223457999999999999999999999999999999999999999865543322111100             001 


Q ss_pred             ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          330 LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       330 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                         ..+...+..+.+|+.+||+.||.+||++.+|++.....
T Consensus       238 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          238 ---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             ---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             ---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence               11223345789999999999999999999999754433

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-45  Score=358.96  Aligned_cols=267  Identities=22%  Similarity=0.272  Sum_probs=208.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            357999999999999999999999999999999997653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...    ..+++..++.++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||++..... 
T Consensus       112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            99999999999863    4699999999999999999999983  2899999999999999999999999999864321 


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh---------hhhhc-
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR---------PMFKD-  318 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~---------~~~~~-  318 (426)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||................         ..... 
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence               11233579999999999999999999999999999999999999998655332211110000         00000 


Q ss_pred             ------------ccccccc----cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          319 ------------RKNFSQM----VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       319 ------------~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                                  .......    .........+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                        0000000    00000111112345578999999999999999999999963

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.9e-45  Score=363.76  Aligned_cols=254  Identities=24%  Similarity=0.310  Sum_probs=195.8

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--------cccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--------VQGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++....        ......+.+|+.+|+.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45689999999999999999999999999999999987532        1123358899999999999999999999865


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeE
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKL  236 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl  236 (426)
                       ...++||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.+   +.+||
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence             568999999999999888864    46799999999999999999999998   99999999999999754   45999


Q ss_pred             ecccccccCCCCCCcceeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh
Q 014362          237 SDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       237 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  313 (426)
                      +|||+++.....   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||............... 
T Consensus       284 ~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-  359 (419)
T 3i6u_A          284 TDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-  359 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-
T ss_pred             eecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-
Confidence            999999864332   22334679999999999863   67889999999999999999999999765433221111100 


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .    ...+    .+..    ....+..+.+|+.+||+.||.+||++.++++
T Consensus       360 ~----~~~~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 G----KYNF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             T----CCCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             C----CCCC----Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            0    0000    0000    0123457899999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.6e-45  Score=349.16  Aligned_cols=254  Identities=23%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            34679999999999999999999999999999999987766677889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...   ...+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||+|||++..... 
T Consensus        97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  169 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-  169 (302)
T ss_dssp             CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc-
Confidence            99999999998763   35699999999999999999999998   999999999999999999999999998753111 


Q ss_pred             CCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                       .........||+.|+|||++.     +..++.++||||||+++|+|++|..||...........+...      .  ..
T Consensus       170 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~--~~  240 (302)
T 2j7t_A          170 -TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------D--PP  240 (302)
T ss_dssp             -HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------C--CC
T ss_pred             -cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhcc------C--Cc
Confidence             011122347899999999984     667899999999999999999999999876543322111100      0  00


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .       ...+...+..+.+|+.+||+.||.+||++.++++
T Consensus       241 ~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0       0113344567899999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=359.47  Aligned_cols=258  Identities=15%  Similarity=0.125  Sum_probs=207.8

Q ss_pred             HhcCCccccceeeecCcEEEEEEE-----EcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC---CCCcceEeeEEee
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGC-----LEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCAE  159 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~  159 (426)
                      ...++|.+.+.||+|+||.||+|.     ...+++.||||++....   ...+..|+.++..++   |+||+.+++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345789999999999999999994     56778999999997643   445677777777776   9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCC-CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--------
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRP-DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--------  230 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--------  230 (426)
                      .+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.        
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999975332 346799999999999999999999987   9999999999999998        


Q ss_pred             ---CCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc
Q 014362          231 ---GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN  307 (426)
Q Consensus       231 ---~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  307 (426)
                         ++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||........  
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--  293 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--  293 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence               899999999999754332333344556899999999999999999999999999999999999999964332110  


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCC-CCHHHHHHHHHHHHhC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMR-PAITDVVMALNYLASQ  373 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~l~~~  373 (426)
                                   .    +...+.. .  .....+.+++..||+.+|.+| |++.++.+.|+.+...
T Consensus       294 -------------~----~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 -------------K----PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -------------E----ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -------------e----echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                         0    0011111 1  124467789999999999998 6788888888877543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.3e-45  Score=371.33  Aligned_cols=252  Identities=24%  Similarity=0.317  Sum_probs=210.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+.+++.++||||+++++++.+...+++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457999999999999999999999999999999997543   23467799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEecccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAK  243 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~  243 (426)
                      |||+.+|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999998875    45699999999999999999999998   99999999999999   567899999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .......   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+.      
T Consensus       178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------  247 (484)
T 3nyv_A          178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE------  247 (484)
T ss_dssp             HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------
T ss_pred             Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC------
Confidence            6543322   233579999999998865 799999999999999999999999987765444333321110000      


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              .......+..+.+|+.+||+.+|.+|||+.++++.
T Consensus       248 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          248 --------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             --------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                    00112345578999999999999999999999964

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=356.93  Aligned_cols=261  Identities=22%  Similarity=0.270  Sum_probs=202.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....  ....+.+.+|+.+|+.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999999999999999996532  233567889999999999999999999997653      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+|+||||+ +++|.+++..     ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence            469999999 8899999875     4689999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc--
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD--  318 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  318 (426)
                      ++.....     .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.........  
T Consensus       175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~  249 (367)
T 1cm8_A          175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  249 (367)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9864322     233578999999999887 68999999999999999999999999877655444333211100000  


Q ss_pred             ---c---------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 ---R---------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ---~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         .         ..+.......+. ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          250 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence               0         000000000010 112234568899999999999999999999985

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.8e-45  Score=370.57  Aligned_cols=252  Identities=24%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||+|+||+||+|.+..++..||||++....  ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            346999999999999999999999999999999997643  234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgla~~  244 (426)
                      ||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++..   +.+||+|||+++.
T Consensus       116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999998876    35699999999999999999999998   99999999999999764   4599999999986


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....   .....+||+.|+|||++. ..++.++|||||||++|+|++|..||...........+......+        
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~--------  256 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF--------  256 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------
Confidence            44322   223457999999999875 579999999999999999999999998766544333332211100        


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                        +...    ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       257 --~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 --DSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --CSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --Cchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence              0000    11234578899999999999999999999953

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-45  Score=346.38  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=208.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee---------
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE---------  159 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---------  159 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+....    ..+.+|+.+++.++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999999999899999999997543    456789999999999999999998864         


Q ss_pred             -------CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC
Q 014362          160 -------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY  232 (426)
Q Consensus       160 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~  232 (426)
                             ...+++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   345899999999999999997632  35699999999999999999999998   999999999999999999


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      .+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|||++|..|+.....     ...  
T Consensus       160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~--  229 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFT--  229 (284)
T ss_dssp             EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHH--
T ss_pred             CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHH--
Confidence            999999999986543321   2334799999999999999999999999999999999999988753211     000  


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                       . +.         ..    ..+...+..+.+|+.+||+.||.+||++.++++.|..+...
T Consensus       230 -~-~~---------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          230 -D-LR---------DG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -H-HH---------TT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -H-hh---------cc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence             0 00         00    11222344688999999999999999999999999988643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.6e-45  Score=370.06  Aligned_cols=256  Identities=24%  Similarity=0.319  Sum_probs=209.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....  ......+.+|+.+|+.++||||+++++++.+...+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            457999999999999999999999999999999986432  234577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec---cCCceeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~  244 (426)
                      ||+++|+|.+.+..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++   .++.+||+|||+++.
T Consensus       101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999998876    35699999999999999999999998   999999999999995   456799999999976


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+......+.       
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~-------  242 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------  242 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC-------
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence            43322   2234579999999998865 699999999999999999999999987665443333321111000       


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                             .......+..+.+|+.+||+.||.+|||+.++++. .++.
T Consensus       243 -------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h-p~~~  281 (486)
T 3mwu_A          243 -------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH-PWIQ  281 (486)
T ss_dssp             -------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC-HHHH
T ss_pred             -------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC-Hhhc
Confidence                   00012334578999999999999999999999964 3443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=342.92  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=204.0

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecC
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMP  171 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  171 (426)
                      .|.....||+|+||.||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34555689999999999999999999999999987766667789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecccccccCCCCCC
Q 014362          172 LGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       172 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~  250 (426)
                      +++|.+++.... ....+++..++.++.||+.||.|||+.   +|+||||||+|||++. ++.+||+|||++....... 
T Consensus       103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            999999998632 234578999999999999999999998   9999999999999997 8999999999998643322 


Q ss_pred             cceeeeecccccccCccccccCC--CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                       .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......... ..  .....           
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~--~~~~~-----------  242 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FK--VGMFK-----------  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HH--HHHHC-----------
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hh--hcccc-----------
Confidence             1123457999999999987654  8899999999999999999999997543322110 00  00000           


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .....+...+..+.+|+.+||+.||.+||++.++++
T Consensus       243 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 -VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             111223344568899999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.7e-45  Score=343.63  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=201.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee----CCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~  164 (426)
                      ..|.+.+.||+|+||.||+|.+..++..||+|.+....  ....+.+.+|+.+++.++||||+++++++..    ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34788889999999999999999999999999987543  3345678999999999999999999999865    45689


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCC--eEecCCCCCCeeec-cCCceeEecccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP--VIYRDLKCSNILLE-EGYHPKLSDFGL  241 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~--iiH~Dlkp~NIll~-~~~~~kl~Dfgl  241 (426)
                      +||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   +  |+||||||+|||++ .++.+||+|||+
T Consensus       106 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            999999999999999763    5689999999999999999999987   7  99999999999998 789999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +......    ......||+.|+|||++. +.++.++||||||+++|+|++|+.||..............     ..   
T Consensus       179 ~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----~~---  245 (290)
T 1t4h_A          179 ATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT-----SG---  245 (290)
T ss_dssp             GGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHT-----TT---
T ss_pred             ccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHh-----cc---
Confidence            9754332    223457999999999876 5699999999999999999999999976544322211110     00   


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         ....    ..+...+..+.+|+.+||+.||.+||++.+|++
T Consensus       246 ---~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          246 ---VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence               0000    111222347899999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.3e-45  Score=340.62  Aligned_cols=250  Identities=24%  Similarity=0.327  Sum_probs=201.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||.+....   ......+.+|+.+++.++||||+++++++.+....++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4578999999999999999999999899999999986532   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999763    4689999999999999999999998   9999999999999999999999999999864


Q ss_pred             CCCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ....   ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..      ...    
T Consensus       162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~----  228 (276)
T 2h6d_A          162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------GVF----  228 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCC----
T ss_pred             CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc------Ccc----
Confidence            4322   1233478999999999988765 6899999999999999999999976543322221111      000    


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                              ..+...+..+.+++.+||+.||.+||++.+|++.
T Consensus       229 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 --------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                    1122334578899999999999999999999963

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=6.1e-45  Score=369.98  Aligned_cols=253  Identities=24%  Similarity=0.283  Sum_probs=206.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-------------ccHHHHHHHHHHHhcCCCCCcceEee
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-------------QGVREFSAEVMTLGSADHPNLVKLIG  155 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~~  155 (426)
                      ..++|.+.+.||+|+||+||+|.+..++..||||++.....             ...+.+.+|+.+|+.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            45789999999999999999999999999999999875431             23567889999999999999999999


Q ss_pred             EEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC---
Q 014362          156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY---  232 (426)
Q Consensus       156 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~---  232 (426)
                      ++.+...+++||||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++   
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCc
Confidence            99999999999999999999999876    35699999999999999999999998   999999999999998776   


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      .+||+|||+++......   ......||+.|+|||++. +.++.++|||||||++|+|++|..||...........+...
T Consensus       187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence            69999999998654332   223457999999999876 56999999999999999999999999876654433333221


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ...+.          ...    ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       263 ~~~~~----------~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          263 KYYFD----------FND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCC----------HHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCC----------ccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            10000          000    01234578999999999999999999999954

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.9e-45  Score=378.13  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=204.6

Q ss_pred             ceeeecCcEEEEEEEE--cCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           97 CCLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      +.||+|+||.||+|.+  +.+++.||||++....  ....+.+.+|+.+|+.++|||||++++++.. ...++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999965  4567899999997643  2345789999999999999999999999975 458899999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC-c
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK-T  251 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~  251 (426)
                      |+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++....... .
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999976    45699999999999999999999998   999999999999999999999999999986543322 1


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+..                 ..
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-----------------~~  589 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-----------------GE  589 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------TC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------------CC
Confidence            22233457889999999999999999999999999999998 9999987665433322221                 11


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ....+..++..+.+|+..||+.||.+||++.+|++.|+.+..
T Consensus       590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            122344556789999999999999999999999999998753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=344.95  Aligned_cols=252  Identities=26%  Similarity=0.373  Sum_probs=205.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||.+....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3567999999999999999999999999999999997643  34678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+|+||||+|||++.++.+||+|||++......
T Consensus       105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998742   46799999999999999999999998   9999999999999999999999999999754322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .  .......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...      .       .+
T Consensus       179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~-------~~  243 (314)
T 3com_A          179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN------P-------PP  243 (314)
T ss_dssp             B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS------C-------CC
T ss_pred             c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC------C-------Cc
Confidence            1  1223457999999999999999999999999999999999999999865543222111100      0       00


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .-..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       244 --~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 --TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              00112334567899999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.6e-45  Score=354.79  Aligned_cols=260  Identities=21%  Similarity=0.303  Sum_probs=210.8

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------ccHHHHHHHHHHHhcC-CCCCcce
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSA-DHPNLVK  152 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l-~hpniv~  152 (426)
                      .+.......++|++.+.||.|+||.||+|.+..+|+.||||++.....        ...+.+.+|+.+++.+ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            344455566789999999999999999999998899999999875432        1135578899999998 7999999


Q ss_pred             EeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC
Q 014362          153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY  232 (426)
Q Consensus       153 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~  232 (426)
                      +++++......++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            99999999999999999999999999976    35699999999999999999999997   999999999999999999


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCcccccc------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL  306 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~  306 (426)
                      .+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|||++|..||.........
T Consensus       238 ~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  314 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML  314 (365)
T ss_dssp             CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             CEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999986543322   234579999999999864      35889999999999999999999999765543322


Q ss_pred             cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..+.....      .+.   .+.     ....+..+.+|+.+||+.||.+||++.++++
T Consensus       315 ~~i~~~~~------~~~---~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 RMIMEGQY------QFS---SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHTCC------CCC---HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCC------CCC---Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            22211100      000   000     0112346889999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1e-44  Score=361.20  Aligned_cols=200  Identities=26%  Similarity=0.330  Sum_probs=169.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----Ce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  162 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.+|+.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999999999999999997542  33456789999999999999999999999776     56


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +|+||||+. |+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            899999996 699999875    46699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCc--------------------ceeeeecccccccCcccc-ccCCCCccCchhhHHHHHHHHHhCCCCC
Q 014362          243 KMGPSGDKT--------------------HVSTRVMGTYGYCAPDYA-MTGQLTFKSDIYSFGVVLLELITGRKAI  297 (426)
Q Consensus       243 ~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlG~il~elltg~~p~  297 (426)
                      +........                    ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            865432211                    123456899999999986 4567999999999999999999855444

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-45  Score=345.27  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=203.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-CeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-DQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+.  ++.||||.+....  ..+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            467999999999999999999886  8899999997543  457789999999999999999999997554 47899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++++|.+++....  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++......
T Consensus        96 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             cCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999997631  23488999999999999999999998   9999999999999999999999999998753322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                           .....+++.|+|||++.+..++.++||||||+++|||++ |..||...........+.                 
T Consensus       171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-----------------  228 (278)
T 1byg_A          171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----------------  228 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-----------------
T ss_pred             -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-----------------
Confidence                 122367899999999999999999999999999999998 999997654332221111                 


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .......+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            0011122344556889999999999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=351.19  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=204.4

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEee
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAE  159 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~  159 (426)
                      +.+.++....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            334444556788999999999999999999999899999999987543 3456788999999998 79999999999977


Q ss_pred             ------CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc
Q 014362          160 ------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH  233 (426)
Q Consensus       160 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~  233 (426)
                            ....++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCC
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCC
Confidence                  46789999999999999999863  235689999999999999999999998   9999999999999999999


Q ss_pred             eeEecccccccCCCCCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH
Q 014362          234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL  308 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  308 (426)
                      +||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||...........
T Consensus       168 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL  245 (326)
T ss_dssp             EEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             EEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            9999999987543221  1123357999999999987     56789999999999999999999999976554332211


Q ss_pred             HHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +..      .  .....        .+...+..+.+|+.+||..||.+||++.++++
T Consensus       246 ~~~------~--~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          246 IPR------N--PAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHH------S--CCCCC--------SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhc------C--ccccC--------CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            110      0  00000        11223457899999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-44  Score=360.26  Aligned_cols=265  Identities=20%  Similarity=0.255  Sum_probs=207.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC------CCCCcceEeeEEeeCCe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA------DHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~~~~~~~~~~~  162 (426)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+      .|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            456899999999999999999999999999999999754 23345677788887766      67899999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc--eeEeccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH--PKLSDFG  240 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~--~kl~Dfg  240 (426)
                      +++||||+. ++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.  +||+|||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            999999996 6999988763  234599999999999999999999998   9999999999999999887  9999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh-----
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM-----  315 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-----  315 (426)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|.+||........+..+......     
T Consensus       248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            99754322     12347999999999999999999999999999999999999999887655444333211100     


Q ss_pred             hhcccccccccC--------------------------------Cccc----CCCChHhHHHHHHHHHhccccCCCCCCC
Q 014362          316 FKDRKNFSQMVD--------------------------------PSLQ----GQYPVRGLYQALAIAAMCVQEQPNMRPA  359 (426)
Q Consensus       316 ~~~~~~~~~~~~--------------------------------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs  359 (426)
                      +........+++                                +...    ...+......+.+|+.+||+.||.+|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence            000000000000                                0000    0011122457899999999999999999


Q ss_pred             HHHHHH
Q 014362          360 ITDVVM  365 (426)
Q Consensus       360 ~~eil~  365 (426)
                      +.|+++
T Consensus       403 a~e~L~  408 (429)
T 3kvw_A          403 PGQALR  408 (429)
T ss_dssp             HHHHHT
T ss_pred             HHHHhC
Confidence            999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-44  Score=351.19  Aligned_cols=269  Identities=20%  Similarity=0.270  Sum_probs=206.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee--------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--------  159 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------  159 (426)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++.....  .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            3679999999999999999999999999999999865432  234568899999999999999999999987        


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ...+++||||+++ +|...+..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            3468999999974 77777765   245699999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCC--cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          240 GLAKMGPSGDK--THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       240 gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |+++.......  ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+.......
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99986442211  122234578999999999876 468999999999999999999999998876555444433221111


Q ss_pred             hcccccccc--------cCCcccCCCCh-H------hHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          317 KDRKNFSQM--------VDPSLQGQYPV-R------GLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       317 ~~~~~~~~~--------~~~~~~~~~~~-~------~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      ... .+...        +.......... .      ....+.+|+.+||+.||.+||++.|+++.
T Consensus       249 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTT-TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             Chh-hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            100 00000        00000000000 0      13468899999999999999999999963

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=4e-46  Score=364.98  Aligned_cols=244  Identities=13%  Similarity=0.130  Sum_probs=192.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHH---HHHhcCCCCCcceEe-------eE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEV---MTLGSADHPNLVKLI-------GY  156 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~~~-------~~  156 (426)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++...   .....+.+.+|+   .+|+.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999988999999999743   334567789999   455566899999998       66


Q ss_pred             EeeCC-----------------eeEEEEEecCCCCHHHHhhhhCC---CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCe
Q 014362          157 CAEGD-----------------QRLLVYEYMPLGSLDKHLHDLRP---DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV  216 (426)
Q Consensus       157 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~i  216 (426)
                      +.+.+                 ..|+||||+ +|+|.+++.....   ....+++..++.++.||+.||.|||+.   +|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            65543                 278999999 6899999985311   112344688899999999999999998   99


Q ss_pred             EecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccC-----------CCCccCchhhHHH
Q 014362          217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-----------QLTFKSDIYSFGV  285 (426)
Q Consensus       217 iH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlG~  285 (426)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985322     2334577 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          286 VLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       286 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ++|||++|+.||...........                +..      .....+..+.+|+.+||+.||.+||++.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~----------------~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEW----------------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGG----------------GGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhh----------------hhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            99999999999976543221110                000      01123457889999999999999999999985

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=375.94  Aligned_cols=263  Identities=28%  Similarity=0.409  Sum_probs=215.6

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      +.+....++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|+.++||||+++++++.+ ...
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            3444556789999999999999999999986 5679999997654 345679999999999999999999999876 678


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      +|||||+++|+|.++|....  ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             eEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            99999999999999997521  24589999999999999999999997   99999999999999999999999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ...... ........++..|+|||++.+..++.++|||||||+||||++ |+.||...........+..           
T Consensus       412 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-----------  479 (535)
T 2h8h_A          412 LIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----------  479 (535)
T ss_dssp             TCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-----------
T ss_pred             ecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence            643211 111122356789999999999999999999999999999999 9999987654433222211           


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                            ..+...+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       480 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          480 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                  01112234455688999999999999999999999999987754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=350.61  Aligned_cols=276  Identities=24%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHH--HhcCCCCCcceEeeEEee-----CCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMT--LGSADHPNLVKLIGYCAE-----GDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~--l~~l~hpniv~~~~~~~~-----~~~  162 (426)
                      .++|++.+.||+|+||.||+|++.  ++.||||++....   ...+..|.++  +..++||||+++++++..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            468999999999999999999874  8999999996542   2344444444  556899999999985532     336


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC------CCCeEecCCCCCCeeeccCCceeE
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------KQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                      +++||||+++|+|.+++..     ...++..++.++.||+.||.|||+..      .++|+||||||+|||++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEE
Confidence            7899999999999999976     34589999999999999999999742      228999999999999999999999


Q ss_pred             ecccccccCCCCCC------cceeeeecccccccCcccccc-------CCCCccCchhhHHHHHHHHHhCCCCCCCcCch
Q 014362          237 SDFGLAKMGPSGDK------THVSTRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR  303 (426)
Q Consensus       237 ~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~  303 (426)
                      +|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999976433211      112223579999999999976       45678999999999999999998877543322


Q ss_pred             hhhcHH-H---hhhhhhhccc--ccccccCCcccCC--CChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          304 KELNLV-A---WARPMFKDRK--NFSQMVDPSLQGQ--YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       304 ~~~~~~-~---~~~~~~~~~~--~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                      ...... .   ...+......  .......+.+...  .....+..+.+|+.+||+.||.+|||+.||++.|+.+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            111000 0   0000000000  0000001111111  123456689999999999999999999999999999975443

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1e-44  Score=364.73  Aligned_cols=263  Identities=19%  Similarity=0.231  Sum_probs=210.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC-CCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  ...+..|+.+++.+.| ++|..+..++......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            5789999999999999999999999999999998875433  2458889999999987 556666677788889999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee---ccCCceeEecccccccC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll---~~~~~~kl~Dfgla~~~  245 (426)
                      |+ +++|.+++...   ...+++..++.|+.||+.||.|||+.   +|+||||||+||||   +.++.+||+|||+++..
T Consensus        84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            99 99999999752   45799999999999999999999998   99999999999999   68899999999999865


Q ss_pred             CCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-hhhcc
Q 014362          246 PSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-MFKDR  319 (426)
Q Consensus       246 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~  319 (426)
                      ......     .......||+.|+|||++.+..++.++|||||||+||||++|+.||................. ...  
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--  234 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA--  234 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH--
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc--
Confidence            433221     112256799999999999999999999999999999999999999987654332222211110 000  


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ..+..     +.    ..++.++.+|+..||+.+|.+||++.+|++.|+.+..
T Consensus       235 ~~~~~-----l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          235 TSIEA-----LC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             SCHHH-----HH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccHHH-----Hh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            00000     00    1223478999999999999999999999999998854

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-45  Score=348.59  Aligned_cols=267  Identities=24%  Similarity=0.362  Sum_probs=190.9

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ...++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            44678999999999999999999998889999999987543 23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhC----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          167 YEYMPLGSLDKHLHDLR----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      |||+++++|.+++....    .....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999987421    1245699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCC---cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          243 KMGPSGDK---THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       243 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ........   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...............     .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-----~  243 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN-----D  243 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS-----S
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc-----C
Confidence            75433211   112234579999999999876 57899999999999999999999999876544322111100     0


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ......   ...........+..+.+|+.+||+.||.+||++.++++
T Consensus       244 ~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLET---GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCcccc---ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            000000   00011112233457889999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-44  Score=346.35  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=199.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--------QGVREFSAEVMTLGSADHPNLVKLIGYCAEG  160 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  160 (426)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||.+.....        .....+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            34679999999999999999999999999999999875421        2234588999999999999999999999765


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc---eeEe
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLS  237 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~  237 (426)
                      . .++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            5 8999999999999998865    46799999999999999999999998   9999999999999987654   9999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc-HHHhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN-LVAWAR  313 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~  313 (426)
                      |||+++.....   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||.......... .+....
T Consensus       160 Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  236 (322)
T 2ycf_A          160 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK  236 (322)
T ss_dssp             CCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTC
T ss_pred             cCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCc
Confidence            99999864322   1123357999999999874   4678999999999999999999999997654332211 111000


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                            ..+    .+..    ....+..+.+|+.+||+.||.+||++.++++
T Consensus       237 ------~~~----~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          237 ------YNF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ------CCC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------ccc----Cchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                  000    0000    1123457899999999999999999999984

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.3e-45  Score=342.96  Aligned_cols=255  Identities=22%  Similarity=0.251  Sum_probs=192.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++......  ..+.+.++...++.++||||+++++++.+....++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46799999999999999999999999999999999764322  2233455556688899999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||++ |+|.+++.........+++..++.++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9997 588888776444567899999999999999999999984  2899999999999999999999999999975433


Q ss_pred             CCCcceeeeecccccccCcccc----ccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYA----MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ..   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.......... ...    ...     
T Consensus       163 ~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~----~~~-----  229 (290)
T 3fme_A          163 DV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL-KQV----VEE-----  229 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH-HHH----HHS-----
T ss_pred             cc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH-HHH----hcc-----
Confidence            22   12234799999999996    56678999999999999999999999997543221110 000    000     


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                           ......+...+..+.+|+.+||+.||.+||++.++++
T Consensus       230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 -----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 0000111234457899999999999999999999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-44  Score=359.77  Aligned_cols=264  Identities=23%  Similarity=0.299  Sum_probs=201.4

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------CeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------DQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~  164 (426)
                      .+|++.+.||+|+||.||+|.+..+++.||||++....    ..+.+|+.+|+.++||||++++++|...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46999999999999999999999999999999986542    2234799999999999999999988542      2367


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-CceeEecccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-YHPKLSDFGLAK  243 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-~~~kl~Dfgla~  243 (426)
                      +||||+++ +|...+.........+++..++.++.||+.||.|||+.   +|+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 67666654333457799999999999999999999987   99999999999999965 678999999998


Q ss_pred             cCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-----hhh
Q 014362          244 MGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-----MFK  317 (426)
Q Consensus       244 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~  317 (426)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+.....     .+.
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            6543322   2235789999999998765 799999999999999999999999988765444333221100     000


Q ss_pred             -cccccccccCCcccC-----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 -DRKNFSQMVDPSLQG-----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 -~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ....+..+..+.+..     .++...+.++.+|+.+||+.||.+||++.|+++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence             000111111111111     122334568999999999999999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-44  Score=350.48  Aligned_cols=264  Identities=22%  Similarity=0.255  Sum_probs=198.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999999999999999999997542  234567889999999999999999999997665      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      ..++||||++ ++|.+.+.      ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence            7899999997 57877774      3489999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-------
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-------  314 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  314 (426)
                      ++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.....       
T Consensus       174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9754322   122345799999999999999999999999999999999999999987665433322211000       


Q ss_pred             ---------hhhccc-----ccccccCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          315 ---------MFKDRK-----NFSQMVDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       315 ---------~~~~~~-----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                               ......     .+...+.......   .+......+.+|+.+||+.||.+|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                     000000     0000010000000   112235688999999999999999999999963

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-44  Score=339.99  Aligned_cols=253  Identities=23%  Similarity=0.257  Sum_probs=208.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---------ccHHHHHHHHHHHhcCC-CCCcceEeeEEe
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---------QGVREFSAEVMTLGSAD-HPNLVKLIGYCA  158 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpniv~~~~~~~  158 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||.+.....         ...+.+.+|+.+++.+. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            45789999999999999999999999999999999975431         12456788999999996 999999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      .....++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999976    35699999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccc------cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM------TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      ||++........   .....||+.|+|||++.      ...++.++||||||+++|+|++|..||...........+...
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  244 (298)
T 1phk_A          168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG  244 (298)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred             ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence            999986543221   23357999999999885      456889999999999999999999999766543322222111


Q ss_pred             hhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..      .        .........+..+.+|+.+||+.||.+||++.++++
T Consensus       245 ~~------~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          245 NY------Q--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC------C--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Cc------c--------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00      0        000111234567899999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.4e-44  Score=343.10  Aligned_cols=259  Identities=16%  Similarity=0.231  Sum_probs=203.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEee--CCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAE--GDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--~~~~~lv~  167 (426)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...   ..+.+.+|+.+++.++ ||||+++++++.+  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            5799999999999999999999999999999999743   3467889999999997 9999999999987  66789999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  246 (426)
                      ||+++++|.+++..       +++..++.++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|||+++...
T Consensus       113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998853       88999999999999999999998   999999999999999776 89999999998654


Q ss_pred             CCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCch-hhhcHHHhhhh------hhh-
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR-KELNLVAWARP------MFK-  317 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~------~~~-  317 (426)
                      ....   .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.....      ... 
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            3322   233478999999999887 67999999999999999999999999544322 11111110000      000 


Q ss_pred             c----cccc--------ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 D----RKNF--------SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 ~----~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .    ...+        ............+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0    0000        0001111112223335678999999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.5e-44  Score=349.56  Aligned_cols=266  Identities=22%  Similarity=0.268  Sum_probs=207.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----Cee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~  163 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|+.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            4689999999999999999999999999999999975433 3346788999999999999999999999765     368


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+. |+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            99999997 699998875     4599999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCC-cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          244 MGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       244 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ....... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......... ..
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~  255 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ-ED  255 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH-HH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH-HH
Confidence            6432211 1112345799999999987654 5899999999999999999999999877655544333211000000 00


Q ss_pred             cccc--------cCC-cccCC-----CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQM--------VDP-SLQGQ-----YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~--------~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +...        ... .....     .....+..+.+|+.+||+.||.+||++.++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000        000 00000     01223457899999999999999999999995

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.9e-45  Score=344.60  Aligned_cols=260  Identities=27%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcC-C--CEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEK-I--EQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~-~--~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||+|+||.||+|.+.. +  +..||||.+...   .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            3579999999999999999998743 2  346999998754   2345677899999999999999999999998765 8


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      ++||||+++++|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence            8999999999999999763   35689999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...      .  
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~------~--  241 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------G--  241 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS------C--
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHcc------C--
Confidence            65433222 12233467889999999999999999999999999999999 99999876543322221110      0  


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                              .....+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       242 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          242 --------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             --------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                    0011123345688999999999999999999999999988754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-44  Score=352.65  Aligned_cols=274  Identities=23%  Similarity=0.239  Sum_probs=204.7

Q ss_pred             cCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-----------cHHHHHHHHHHHhcCCCCC
Q 014362           81 FTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----------GVREFSAEVMTLGSADHPN  149 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpn  149 (426)
                      ..+.++....++|++.+.||+|+||.||+|.+.. +..||||++......           ..+.+.+|+.+++.++|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            3467788899999999999999999999999866 899999998653221           1367899999999999999


Q ss_pred             cceEeeEEee-----CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCC
Q 014362          150 LVKLIGYCAE-----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCS  224 (426)
Q Consensus       150 iv~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~  224 (426)
                      |+++++++..     ...+++||||++ |+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  163 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPG  163 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChH
Confidence            9999999844     346899999997 688888765   345799999999999999999999998   9999999999


Q ss_pred             CeeeccCCceeEecccccccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCch
Q 014362          225 NILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDR  303 (426)
Q Consensus       225 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~  303 (426)
                      |||++.++.+||+|||+++.....   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999743322   12234578999999999887 67999999999999999999999999876654


Q ss_pred             hhhcHHHhhhhhhh-------cccccccccCCccc-------CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          304 KELNLVAWARPMFK-------DRKNFSQMVDPSLQ-------GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       304 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .....+........       ........+.....       ...+......+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            44333221100000       00000000000000       0111223457899999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-45  Score=353.41  Aligned_cols=256  Identities=26%  Similarity=0.333  Sum_probs=205.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEc---CCCEEEEEEEeccCC----cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  161 (426)
                      .++|++.+.||+|+||.||+|++.   .+++.||||++....    ......+..|+.+|+.+ .||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            357999999999999999999984   479999999987542    12345677899999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+++||||+++|+|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999999863    4699999999999999999999997   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      ++...... ........||+.|+|||++.+.  .++.++|||||||++|||++|+.||...........+.  .......
T Consensus       206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~~  282 (355)
T 1vzo_A          206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKSE  282 (355)
T ss_dssp             EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHCC
T ss_pred             CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhccC
Confidence            98543221 2222345799999999999863  57899999999999999999999997544322211111  1111110


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVMAL  367 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L  367 (426)
                                  ..++...+..+.+|+.+||+.||.+||     ++.++++..
T Consensus       283 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 ------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                        112334455788999999999999999     999998653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-44  Score=352.16  Aligned_cols=262  Identities=22%  Similarity=0.269  Sum_probs=190.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------C
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------D  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~  161 (426)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....  ....+.+.+|+.+|+.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999999999999999997542  23456788999999999999999999998654      5


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      ..++|+||+ +++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            679999999 7899888764     5699999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc--
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD--  318 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  318 (426)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.........  
T Consensus       179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~  253 (367)
T 2fst_X          179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL  253 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9753321     234579999999999887 68999999999999999999999999887655444333221100000  


Q ss_pred             ccc-----cccc---cCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKN-----FSQM---VDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~-----~~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...     ...+   +.......   ........+.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            000     0000   00000000   00123457899999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.8e-44  Score=349.31  Aligned_cols=274  Identities=20%  Similarity=0.232  Sum_probs=198.9

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe-
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ-  162 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-  162 (426)
                      .......++|++.+.||+|+||.||+|.+..+++.||||++.... .....+..++..+..++||||++++++|..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455667789999999999999999999999999999999986542 333456778888899999999999999965433 


Q ss_pred             ------eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH--HcCCCCeEecCCCCCCeeecc-CCc
Q 014362          163 ------RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH--EQLKQPVIYRDLKCSNILLEE-GYH  233 (426)
Q Consensus       163 ------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~~~~iiH~Dlkp~NIll~~-~~~  233 (426)
                            +++||||+++ +|...+.........+++..++.++.||+.||.|||  +.   +|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999985 555555443334677999999999999999999999  65   9999999999999997 899


Q ss_pred             eeEecccccccCCCCCCcceeeeecccccccCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          234 PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      +||+|||+++.......   .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........+...
T Consensus       171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~  247 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV  247 (360)
T ss_dssp             EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence            99999999986543322   23357899999999987654 899999999999999999999999887655444333211


Q ss_pred             hhhh-----h---cccccccccC------CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          313 RPMF-----K---DRKNFSQMVD------PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       313 ~~~~-----~---~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....     .   .........+      .......+...+..+.+|+.+||+.||.+||++.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000     0   0000000000      00111223335678999999999999999999999995

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.5e-44  Score=353.10  Aligned_cols=253  Identities=10%  Similarity=-0.008  Sum_probs=184.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHH---HHHhcCCCCCcceEe-------eEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEV---MTLGSADHPNLVKLI-------GYC  157 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~---~~l~~l~hpniv~~~-------~~~  157 (426)
                      .+|.+.+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+   .+|+. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            458999999999999999999999999999999987543   3345577785   45555 799988755       444


Q ss_pred             eeC-----------------CeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHH------HHHHHHHHHHHHHHHHcCCC
Q 014362          158 AEG-----------------DQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTR------MKIAAGASRGLQYLHEQLKQ  214 (426)
Q Consensus       158 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~~~  214 (426)
                      ...                 ..+|+||||++ |+|.+++...   ...+++..+      +.++.||+.||.|||+.   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence            332                 34799999998 8999999863   223455555      77889999999999998   


Q ss_pred             CeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHh
Q 014362          215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELIT  292 (426)
Q Consensus       215 ~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt  292 (426)
                      +|+||||||+||||+.++.+||+|||+++.....     .....+|+.|+|||++.+  ..++.++|||||||++|||++
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            9999999999999999999999999999864321     113467899999999987  689999999999999999999


Q ss_pred             CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          293 GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       293 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      |+.||..........        +.. ...................+..+.+|+.+||+.||.+||++.++++
T Consensus       289 g~~Pf~~~~~~~~~~--------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS--------WKR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTC--------CCB-CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccc--------hhh-hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999998664321110        000 0000000111111112244568999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=340.87  Aligned_cols=267  Identities=22%  Similarity=0.304  Sum_probs=201.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEe-----------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA-----------  158 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----------  158 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999999999999999998776666788999999999999999999999873           


Q ss_pred             ---eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-cCCce
Q 014362          159 ---EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHP  234 (426)
Q Consensus       159 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~  234 (426)
                         +....++||||++ |+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++ +++.+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeE
Confidence               4467899999997 699998864     5699999999999999999999998   999999999999997 56799


Q ss_pred             eEecccccccCCCCCC-cceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh
Q 014362          235 KLSDFGLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA  312 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~  312 (426)
                      ||+|||+++....... ........+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999986432211 111233467999999998875 67899999999999999999999999877654433322211


Q ss_pred             hhhhhcc------cccccccCCccc-C-----CCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          313 RPMFKDR------KNFSQMVDPSLQ-G-----QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       313 ~~~~~~~------~~~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+.....      ..+...+..... .     ..+...+..+.+|+.+||+.||.+||++.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            1100000      000000000000 0     011234567899999999999999999999995

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-44  Score=354.59  Aligned_cols=264  Identities=22%  Similarity=0.275  Sum_probs=198.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------ee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------QR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------~~  163 (426)
                      ..+|++.+.||+|+||.||+|++..++. ||+|++.....    ...+|+.+++.++||||++++++|....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3469999999999999999999988666 88887754322    2236999999999999999999985543      37


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-cCCceeEeccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLA  242 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla  242 (426)
                      ++||||++++.+ ..+.........+++..++.++.||+.||.|||+.   +|+||||||+|||++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            899999986544 43332222356799999999999999999999998   999999999999999 7899999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh-----
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF-----  316 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  316 (426)
                      +.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.......     
T Consensus       190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            86533322   2235789999999998765 58999999999999999999999998876554443332110000     


Q ss_pred             -hcc-----cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 -KDR-----KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 -~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...     ..+.......+...++...+.++.+|+.+||+.||.+||++.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence             000     0011111111111122334568999999999999999999999985

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.5e-44  Score=348.72  Aligned_cols=268  Identities=21%  Similarity=0.270  Sum_probs=205.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----Ce
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  162 (426)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||.+..... .....+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            35689999999999999999999999999999999975432 3456688999999999999999999988654     67


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++||||+. ++|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999997 689998875     4699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCcc--------eeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh
Q 014362          243 KMGPSGDKTH--------VSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       243 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  313 (426)
                      +.........        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  239 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII  239 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            8643221110        1123478999999998765 678999999999999999999999998776544332222110


Q ss_pred             hhhhcccccc--------cccCC--ccc----CCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          314 PMFKDRKNFS--------QMVDP--SLQ----GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       314 ~~~~~~~~~~--------~~~~~--~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..........        +.+..  ...    .......+..+.+|+.+||+.||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000000000        00000  000    0001234557899999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-44  Score=354.43  Aligned_cols=266  Identities=20%  Similarity=0.205  Sum_probs=204.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC--------CCCcceEeeEEe--
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD--------HPNLVKLIGYCA--  158 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~~~~~~~--  158 (426)
                      ..++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++        ||||+++++++.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            457899999999999999999999999999999999744 334567889999998885        788999999987  


Q ss_pred             --eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC----
Q 014362          159 --EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----  232 (426)
Q Consensus       159 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----  232 (426)
                        ....+++||||+ +++|.+.+...  ....+++..++.++.||+.||.|||+.  .+|+||||||+||||+.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhh
Confidence              556789999999 56666666542  235699999999999999999999984  2899999999999998775    


Q ss_pred             ---------------------------------------------ceeEecccccccCCCCCCcceeeeecccccccCcc
Q 014362          233 ---------------------------------------------HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD  267 (426)
Q Consensus       233 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE  267 (426)
                                                                   .+||+|||+++.....     .....||+.|+|||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence                                                         7999999999864322     23347999999999


Q ss_pred             ccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh------cHHHhhhh---------------hhhccccccccc
Q 014362          268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL------NLVAWARP---------------MFKDRKNFSQMV  326 (426)
Q Consensus       268 ~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~------~~~~~~~~---------------~~~~~~~~~~~~  326 (426)
                      ++.+..++.++|||||||++|||++|+.||.........      ..+.....               .+.....+..+.
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            999999999999999999999999999999765432211      11110000               000000000000


Q ss_pred             CCc---------ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPS---------LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...         -....+......+.+|+.+||+.||.+||++.||++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000         011235666778999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=347.25  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=206.0

Q ss_pred             CHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           82 TFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        82 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      ...+.....++|++.+.||+|+||.||+|.+..   .||+|.+....  ....+.+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            334444556789999999999999999999874   39999987542  2334567889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ....++||||+++++|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+||
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Df  173 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDF  173 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCC
T ss_pred             CCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeec
Confidence            9999999999999999999976   345699999999999999999999998   999999999999998 679999999


Q ss_pred             cccccCCCCC---CcceeeeecccccccCcccccc---------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc
Q 014362          240 GLAKMGPSGD---KTHVSTRVMGTYGYCAPDYAMT---------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN  307 (426)
Q Consensus       240 gla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  307 (426)
                      |+++......   .........||+.|+|||++.+         ..++.++||||||+++|||++|+.||..........
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~  253 (319)
T 2y4i_B          174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW  253 (319)
T ss_dssp             SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred             CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9987532111   1112223468999999999874         457899999999999999999999998765433221


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      .+...        ......        +...+..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus       254 ~~~~~--------~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          254 QMGTG--------MKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHHTT--------CCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HhccC--------CCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11110        000000        1112336789999999999999999999999998886543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-44  Score=348.06  Aligned_cols=265  Identities=19%  Similarity=0.231  Sum_probs=205.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCccc-----------------HHHHHHHHHHHhcCCCCCcce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----------------VREFSAEVMTLGSADHPNLVK  152 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~E~~~l~~l~hpniv~  152 (426)
                      .++|++.+.||+|+||.||+|.+  +++.||||.+.......                 ...+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999999  69999999986532111                 178999999999999999999


Q ss_pred             EeeEEeeCCeeEEEEEecCCCCHHHH------hhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCC
Q 014362          153 LIGYCAEGDQRLLVYEYMPLGSLDKH------LHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSN  225 (426)
Q Consensus       153 ~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~N  225 (426)
                      +++++.+.+..++||||+++|+|.++      +..  .....+++..++.++.||+.||.|||+ .   +|+||||||+|
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            99999999999999999999999988      433  125679999999999999999999998 6   99999999999


Q ss_pred             eeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccC-CCCc-cCchhhHHHHHHHHHhCCCCCCCcCc-
Q 014362          226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTF-KSDIYSFGVVLLELITGRKAIDQTKD-  302 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlG~il~elltg~~p~~~~~~-  302 (426)
                      ||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++||||||+++|||++|..||..... 
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999999999864332    23445799999999999887 6766 99999999999999999999987654 


Q ss_pred             hhhhcHHHhhhhhhhcc-cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          303 RKELNLVAWARPMFKDR-KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ......+......+... ..+................+..+.+|+.+||+.||.+||++.++++
T Consensus       259 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22211111110000000 0000000000000111334568899999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.7e-43  Score=340.16  Aligned_cols=265  Identities=18%  Similarity=0.251  Sum_probs=208.0

Q ss_pred             hcCCccccceeeecCcEEEEEEEE-cCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC------CcceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCL-EKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP------NLVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp------niv~~~~~~~~~~  161 (426)
                      ..++|++.+.||+|+||.||+|.+ ..+++.||||++... ......+.+|+.+++.++|+      +|+++++++.+..
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            346899999999999999999998 567899999999754 23456688899998888665      4999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-----------
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-----------  230 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----------  230 (426)
                      ..++||||+ +++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 89999999763  234689999999999999999999998   9999999999999987           


Q ss_pred             --------CCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCc
Q 014362          231 --------GYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD  302 (426)
Q Consensus       231 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~  302 (426)
                              ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             ccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                    668999999999864322     1235799999999999999999999999999999999999999987665


Q ss_pred             hhhhcHHHhhhhhhhc-----cc----------ccc----------cccCC-cccCCCChHhHHHHHHHHHhccccCCCC
Q 014362          303 RKELNLVAWARPMFKD-----RK----------NFS----------QMVDP-SLQGQYPVRGLYQALAIAAMCVQEQPNM  356 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~-----~~----------~~~----------~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~  356 (426)
                      ......+......++.     ..          .+.          ....+ .-....+...+..+.+|+.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            4433332211110000     00          000          00000 0001123455678999999999999999


Q ss_pred             CCCHHHHHH
Q 014362          357 RPAITDVVM  365 (426)
Q Consensus       357 RPs~~eil~  365 (426)
                      ||++.||++
T Consensus       320 Rpt~~ell~  328 (339)
T 1z57_A          320 RITLREALK  328 (339)
T ss_dssp             SCCHHHHTT
T ss_pred             ccCHHHHhc
Confidence            999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=6.7e-44  Score=349.83  Aligned_cols=272  Identities=21%  Similarity=0.245  Sum_probs=208.9

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CC-----CcceEeeEE
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HP-----NLVKLIGYC  157 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~~~~~~  157 (426)
                      .......++|++.+.||+|+||+||+|.+..+++.||||++... ......+..|+.+++.++ |+     +|+.+++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            33344568999999999999999999999999999999999753 233566778888888775 44     499999999


Q ss_pred             eeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec--cCCcee
Q 014362          158 AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE--EGYHPK  235 (426)
Q Consensus       158 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~k  235 (426)
                      ......++||||+. |+|.+++...  ....+++..++.++.||+.||.|||++ ..+|+||||||+||||+  .++.+|
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence            99999999999996 5999999863  235699999999999999999999953 34899999999999995  478899


Q ss_pred             EecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhh
Q 014362          236 LSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM  315 (426)
Q Consensus       236 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  315 (426)
                      |+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......
T Consensus       202 L~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~  276 (382)
T 2vx3_A          202 IVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI  276 (382)
T ss_dssp             ECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred             EEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999865332     22357999999999999999999999999999999999999999877655444333221110


Q ss_pred             hh-----cccc----cccccC-----------------Ccc--------------------cCCCChHhHHHHHHHHHhc
Q 014362          316 FK-----DRKN----FSQMVD-----------------PSL--------------------QGQYPVRGLYQALAIAAMC  349 (426)
Q Consensus       316 ~~-----~~~~----~~~~~~-----------------~~~--------------------~~~~~~~~~~~l~~li~~c  349 (426)
                      ..     ....    +..+.+                 +..                    ...........+.+|+.+|
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  356 (382)
T 2vx3_A          277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM  356 (382)
T ss_dssp             CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence            00     0000    000000                 000                    0001123345789999999


Q ss_pred             cccCCCCCCCHHHHHH
Q 014362          350 VQEQPNMRPAITDVVM  365 (426)
Q Consensus       350 l~~dP~~RPs~~eil~  365 (426)
                      |+.||.+|||+.|+++
T Consensus       357 L~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          357 LDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             TCSCTTTSCCHHHHTT
T ss_pred             cCCChhhCCCHHHHhc
Confidence            9999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-44  Score=344.30  Aligned_cols=259  Identities=21%  Similarity=0.341  Sum_probs=201.2

Q ss_pred             HHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCC--CCCcceEeeEEe
Q 014362           83 FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSAD--HPNLVKLIGYCA  158 (426)
Q Consensus        83 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~  158 (426)
                      +..+....++|++.+.||+|+||.||+|.+.. ++.||||.+....  ......+.+|+.++..++  ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            33344455779999999999999999999865 8899999997543  334577899999999997  599999999999


Q ss_pred             eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       159 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                      .....++||| +.+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+++ +.+||+|
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECC
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEee
Confidence            9999999999 568899999986    35789999999999999999999998   9999999999999975 8999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCcccccc-----------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-----------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN  307 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~  307 (426)
                      ||+++...............||+.|+|||++.+           ..++.++||||||+++|||++|+.||......... 
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-  248 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-  248 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-
Confidence            999986543332222334579999999999875           47889999999999999999999999754322111 


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                       .             ...+++.....++...+..+.+|+.+||+.||.+||++.++++.
T Consensus       249 -~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 -L-------------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -H-------------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -H-------------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             0             01111111222233334578999999999999999999999964

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-43  Score=334.13  Aligned_cols=254  Identities=25%  Similarity=0.324  Sum_probs=207.1

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ....++|++.+.||+|+||.||+|.+..+++.||||++....  ......+.+|+.+++.++||||+++++++.+....+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            344578999999999999999999999899999999986542  245677999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC---CceeEecccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG---YHPKLSDFGL  241 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~---~~~kl~Dfgl  241 (426)
                      +||||+++++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999999988762    4699999999999999999999998   99999999999999764   4699999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +........   .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.....      .
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~  240 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY------A  240 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------C
T ss_pred             ceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------C
Confidence            976433221   123468999999998765 589999999999999999999999987654432222211100      0


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      +    +...    ....+..+.+|+.+||+.||.+||++.++++
T Consensus       241 ~----~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 F----DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             C----CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             C----Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0    0000    1123457899999999999999999999996

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=9.7e-44  Score=336.47  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=196.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee----------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE----------  159 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----------  159 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+... ....+.+.+|+.+++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            45799999999999999999999999999999999643 3445678999999999999999999998865          


Q ss_pred             ---CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeE
Q 014362          160 ---GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKL  236 (426)
Q Consensus       160 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl  236 (426)
                         ....++||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence               3567999999999999999986   245688899999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCCCC------------cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCch
Q 014362          237 SDFGLAKMGPSGDK------------THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR  303 (426)
Q Consensus       237 ~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~  303 (426)
                      +|||++........            ........||+.|+|||++.+. .++.++|||||||++|||++   ||......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~  234 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER  234 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence            99999975432110            1122345789999999998764 78999999999999999998   55432111


Q ss_pred             hhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          304 KELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .  .....   ....        ...+...++...+..+.+|+.+||+.||.+||++.++++
T Consensus       235 ~--~~~~~---~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 V--NILKK---LRSV--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H--HHHHH---HHST--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H--HHHHh---cccc--------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1  11110   0000        011122233445567899999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.1e-43  Score=338.34  Aligned_cols=267  Identities=23%  Similarity=0.305  Sum_probs=205.4

Q ss_pred             hcCCccccceeeecCcEEEEEEEEc-CCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcC---CCCCcceEeeEEe----
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLE-KIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSA---DHPNLVKLIGYCA----  158 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l---~hpniv~~~~~~~----  158 (426)
                      ..++|++.+.||+|+||.||+|.+. .+++.||||++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4568999999999999999999995 6789999999864322  2234566777776665   8999999999987    


Q ss_pred             -eCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEe
Q 014362          159 -EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLS  237 (426)
Q Consensus       159 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~  237 (426)
                       .....++||||++ |+|.+++....  ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999997 69999997632  34599999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhh
Q 014362          238 DFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK  317 (426)
Q Consensus       238 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  317 (426)
                      |||+++.....   .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........+........
T Consensus       163 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (326)
T 1blx_A          163 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG  239 (326)
T ss_dssp             SCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            99999754321   122345789999999999999999999999999999999999999987765444333221110000


Q ss_pred             ccccccc-------ccC---CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 DRKNFSQ-------MVD---PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 ~~~~~~~-------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ...+..       .+.   ......+....+..+.+|+.+||+.||.+||++.++++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 -EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             -GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -cccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             000000       000   00001122334567899999999999999999999984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-43  Score=343.90  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=202.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee----
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR----  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~----  163 (426)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||++.....  .....+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4689999999999999999999999999999999976432  2356788999999999999999999999877655    


Q ss_pred             --EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          164 --LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       164 --~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                        ++||||+. ++|.+++.      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence              99999997 68877763      3499999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc-
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR-  319 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  319 (426)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.......... 
T Consensus       191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  265 (371)
T 4exu_A          191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  265 (371)
T ss_dssp             C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence            9753322     233578999999999887 689999999999999999999999998766544333222111000000 


Q ss_pred             -c--------ccccccCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 -K--------NFSQMVDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 -~--------~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .        .+...+.......   .+...+..+.+|+.+||+.||.+||++.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence             0        0000000000000   11233568899999999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-43  Score=368.42  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=210.9

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcC---CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEK---IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  162 (426)
                      ....++|++.+.||+|+||.||+|.+..   .+..||||.+..... ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~  464 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP  464 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence            3445789999999999999999999864   356899999876433 334678999999999999999999999854 56


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence            8999999999999999976   245699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      +....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+...         
T Consensus       539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~---------  608 (656)
T 2j0j_A          539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---------  608 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred             eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence            86533221 12233467889999999999999999999999999999997 99999876544332222110         


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                              .....+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       609 --------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          609 --------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                    0111233445688999999999999999999999999998753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.3e-43  Score=339.70  Aligned_cols=260  Identities=22%  Similarity=0.285  Sum_probs=201.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe-----
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ-----  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-----  162 (426)
                      .++|.+.+.||+|+||.||+|.+..+|+.||||.+.....  .....+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4679999999999999999999999999999999976432  335678899999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          163 -RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       163 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                       +++||||+. ++|.+++.      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             499999997 68877663      3499999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc--
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD--  318 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  318 (426)
                      ++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.........  
T Consensus       173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  247 (353)
T 3coi_A          173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF  247 (353)
T ss_dssp             TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred             ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9753321     233578999999999887 67899999999999999999999999876654433222211000000  


Q ss_pred             --c----------cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 --R----------KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 --~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .          ..+.......+ .......+..+.+|+.+||+.||.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0          00000000001 1122345668999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=348.39  Aligned_cols=273  Identities=23%  Similarity=0.324  Sum_probs=186.9

Q ss_pred             CCccc-cceeeecCcEEEEEEEEc--CCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeEE
Q 014362           91 GNFRS-DCCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLL  165 (426)
Q Consensus        91 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l  165 (426)
                      +.|.+ .++||+|+||.||+|.++  .+++.||||++.....  ...+.+|+.+|+.++||||+++++++..  ...+++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34666 457999999999999976  4688999999975533  3568899999999999999999999954  678999


Q ss_pred             EEEecCCCCHHHHhhhhC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee----ccCCceeE
Q 014362          166 VYEYMPLGSLDKHLHDLR-----PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL----EEGYHPKL  236 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll----~~~~~~kl  236 (426)
                      ||||+. |+|.+++....     .....+++..++.++.||+.||.|||+.   +|+||||||+||||    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999996 57877775321     1223599999999999999999999998   99999999999999    67889999


Q ss_pred             ecccccccCCCCCC-cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCch---------hh
Q 014362          237 SDFGLAKMGPSGDK-THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDR---------KE  305 (426)
Q Consensus       237 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~---------~~  305 (426)
                      +|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||......         ..
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999986543211 1222346899999999999874 5899999999999999999999999765431         11


Q ss_pred             hcHHHhhhhhhhcccccccc------------cC-CcccC--------CCChHhHHHHHHHHHhccccCCCCCCCHHHHH
Q 014362          306 LNLVAWARPMFKDRKNFSQM------------VD-PSLQG--------QYPVRGLYQALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~------------~~-~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                      +..+...... .....+..+            +. .....        .........+.+|+.+||+.||.+|||+.|++
T Consensus       254 l~~i~~~~g~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          254 LDRIFNVMGF-PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHCC-CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHhhCC-CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            1111100000 000000000            00 00000        00001134678999999999999999999999


Q ss_pred             HHHHHHH
Q 014362          365 MALNYLA  371 (426)
Q Consensus       365 ~~L~~l~  371 (426)
                      +. .++.
T Consensus       333 ~h-p~f~  338 (405)
T 3rgf_A          333 QD-PYFL  338 (405)
T ss_dssp             TS-GGGT
T ss_pred             cC-hhhc
Confidence            63 4443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-43  Score=339.38  Aligned_cols=255  Identities=19%  Similarity=0.210  Sum_probs=177.1

Q ss_pred             hcCCccccc-eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee----CCee
Q 014362           89 ATGNFRSDC-CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQR  163 (426)
Q Consensus        89 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~  163 (426)
                      ..++|.+.+ .||+|+||.||+|.+..+++.||||++....    ....+....++.+.||||+++++++..    ...+
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            346799855 6999999999999999999999999996531    222233344667899999999999876    4558


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEeccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG  240 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg  240 (426)
                      ++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            9999999999999999863  235799999999999999999999998   9999999999999986   4559999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      +++.....    ......||+.|+|||++.+..++.++||||||+++|+|++|..||..............  ....   
T Consensus       177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~---  247 (336)
T 3fhr_A          177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--RIRL---  247 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--hhhc---
Confidence            99754322    12335789999999999888999999999999999999999999976543221100000  0000   


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                           .............+..+.+|+.+||+.||.+||++.++++.
T Consensus       248 -----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          248 -----GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 00000111112345678999999999999999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.9e-43  Score=337.16  Aligned_cols=265  Identities=18%  Similarity=0.228  Sum_probs=205.7

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCC-EEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC------cceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIE-QVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN------LVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~~~~~~~~~~  161 (426)
                      ..++|++.+.||+|+||.||+|.+..++ ..||||++... ......+..|+.+++.++|++      ++.+++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3578999999999999999999998776 79999999753 234566888999999887665      999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee-------------
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-------------  228 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll-------------  228 (426)
                      ..++||||+ +++|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999 66777777652  235699999999999999999999987   99999999999999             


Q ss_pred             ------ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCc
Q 014362          229 ------EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKD  302 (426)
Q Consensus       229 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~  302 (426)
                            +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                  66789999999999864322     1235799999999999999999999999999999999999999987665


Q ss_pred             hhhhcHHHhhhhhhhc-----cccccccc--------------------CC-cccCCCChHhHHHHHHHHHhccccCCCC
Q 014362          303 RKELNLVAWARPMFKD-----RKNFSQMV--------------------DP-SLQGQYPVRGLYQALAIAAMCVQEQPNM  356 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~-----~~~~~~~~--------------------~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~  356 (426)
                      ......+.......+.     ........                    .+ .............+.+|+.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            4433322211110000     00000000                    00 0000112344568899999999999999


Q ss_pred             CCCHHHHHH
Q 014362          357 RPAITDVVM  365 (426)
Q Consensus       357 RPs~~eil~  365 (426)
                      ||++.++++
T Consensus       325 Rpt~~e~l~  333 (355)
T 2eu9_A          325 RITLAEALL  333 (355)
T ss_dssp             SCCHHHHTT
T ss_pred             CcCHHHHhc
Confidence            999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.9e-44  Score=341.32  Aligned_cols=251  Identities=20%  Similarity=0.303  Sum_probs=203.6

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------cHHHHHHHHHHHhcCC--CCCcc
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSAD--HPNLV  151 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l~--hpniv  151 (426)
                      .....+.....++|++.+.||+|+||.||+|.+..+++.||||.+......      ....+..|+.+++.++  ||||+
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            334455566778999999999999999999999999999999999754321      2245678999999986  59999


Q ss_pred             eEeeEEeeCCeeEEEEEecCC-CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-
Q 014362          152 KLIGYCAEGDQRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-  229 (426)
Q Consensus       152 ~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-  229 (426)
                      ++++++......++|||++.+ ++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++ 
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDL  184 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeC
Confidence            999999999999999999976 899999976    35689999999999999999999998   999999999999999 


Q ss_pred             cCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcH
Q 014362          230 EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNL  308 (426)
Q Consensus       230 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~  308 (426)
                      +++.+||+|||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......     
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----  255 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----  255 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----
Confidence            78999999999998654321    223579999999999987776 68899999999999999999999753210     


Q ss_pred             HHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          309 VAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .      ....            ..+...+..+.+|+.+||+.||.+||++.+|++
T Consensus       256 -~------~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 -I------RGQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             -H------HCCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -h------cccc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0      0000            011223457889999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6e-43  Score=341.40  Aligned_cols=265  Identities=18%  Similarity=0.215  Sum_probs=201.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-----------CCCcceEeeEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----------HPNLVKLIGYCA  158 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~  158 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+.           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999999999999999999743 233466888999988876           899999999997


Q ss_pred             eCC----eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-----
Q 014362          159 EGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-----  229 (426)
Q Consensus       159 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-----  229 (426)
                      ...    .+++||||+ +++|.+++....  ...+++..++.++.||+.||.|||+.  .+|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence            654    789999999 899999998642  35599999999999999999999983  2899999999999995     


Q ss_pred             -cCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchh----
Q 014362          230 -EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK----  304 (426)
Q Consensus       230 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~----  304 (426)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.......    
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             3447999999999764322     223479999999999999999999999999999999999999997654211    


Q ss_pred             --hhcHHHh-hh--------------hhhhcccccccccCC---------cccCCCChHhHHHHHHHHHhccccCCCCCC
Q 014362          305 --ELNLVAW-AR--------------PMFKDRKNFSQMVDP---------SLQGQYPVRGLYQALAIAAMCVQEQPNMRP  358 (426)
Q Consensus       305 --~~~~~~~-~~--------------~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  358 (426)
                        ....+.. ..              ..+.....+..+...         .-...++......+.+|+.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence              1111100 00              000000000000000         001134567788999999999999999999


Q ss_pred             CHHHHHH
Q 014362          359 AITDVVM  365 (426)
Q Consensus       359 s~~eil~  365 (426)
                      ++.||++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=5e-43  Score=336.12  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=183.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHH-HHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVM-TLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|.+.+.||+|+||.||+|.+..+++.||||.+..... .....+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3679999999999999999999999999999999976532 23344555655 778889999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhC-CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLR-PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||+++ +|.+++.... .....+++..++.++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            99984 7877775321 1246799999999999999999999984  289999999999999999999999999997543


Q ss_pred             CCCCcceeeeecccccccCcccc----ccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYA----MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ...   ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........     ...       .
T Consensus       178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~-------~  242 (327)
T 3aln_A          178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQ-------V  242 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-------C
T ss_pred             ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHH-------H
Confidence            221   12234799999999998    4667899999999999999999999999764321100     000       0


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .....+.+........+..+.+|+.+||+.||.+||++.+|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00011111111223345688999999999999999999999863

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=336.42  Aligned_cols=247  Identities=23%  Similarity=0.394  Sum_probs=195.4

Q ss_pred             HHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------cHHHHHHHHHHHhcC----CCCCcceEe
Q 014362           85 ELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------GVREFSAEVMTLGSA----DHPNLVKLI  154 (426)
Q Consensus        85 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~E~~~l~~l----~hpniv~~~  154 (426)
                      +.....++|++.+.||+|+||.||+|.+..+++.||||++......      ....+..|+.++..+    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445568899999999999999999999999999999999765331      233456788888888    899999999


Q ss_pred             eEEeeCCeeEEEEEe-cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-cCC
Q 014362          155 GYCAEGDQRLLVYEY-MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGY  232 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~  232 (426)
                      +++......++|||| +.+++|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++ .++
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  177 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG  177 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence            999999999999999 789999999986    34699999999999999999999998   999999999999999 889


Q ss_pred             ceeEecccccccCCCCCCcceeeeecccccccCccccccCCCC-ccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHh
Q 014362          233 HPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT-FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAW  311 (426)
Q Consensus       233 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~  311 (426)
                      .+||+|||+++......    .....||+.|+|||++.+..+. .++||||||+++|||++|+.||......      . 
T Consensus       178 ~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-  246 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI------L-  246 (312)
T ss_dssp             EEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------H-
T ss_pred             eEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH------h-
Confidence            99999999998654322    2335799999999999877764 5899999999999999999999753210      0 


Q ss_pred             hhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          312 ARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                           ...            ..++...+..+.+|+.+||+.+|.+||++.++++.
T Consensus       247 -----~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 -----EAE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -----HTC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -----hhc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000            01223344578999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=329.73  Aligned_cols=252  Identities=24%  Similarity=0.348  Sum_probs=183.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-c-HHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-G-VREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .++|++.+.||+|+||.||+|.+..+++.||||.+...... . .+.+.++..+++.++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            35789999999999999999999999999999999765332 2 233445556788899999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||+ ++.+..++...   ...+++..++.++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||++....
T Consensus       104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            999 55666655442   3569999999999999999999998 5   89999999999999999999999999997543


Q ss_pred             CCCCcceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ...   ......||+.|+|||++.     ...++.++||||||+++|||++|+.||.........  ..   ....... 
T Consensus       177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~---~~~~~~~-  247 (318)
T 2dyl_A          177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV--LT---KVLQEEP-  247 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--HH---HHHHSCC-
T ss_pred             CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--HH---HHhccCC-
Confidence            321   123347999999999984     557889999999999999999999999764332111  11   0010000 


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..+.      .....+..+.+|+.+||+.||.+||++.+|++
T Consensus       248 --~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 --PLLP------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             --CCCC------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --CCCC------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              0000      01123457889999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-41  Score=320.35  Aligned_cols=237  Identities=16%  Similarity=0.144  Sum_probs=189.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....   ...+.+.+|+.++..++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            34689999999999999999999999999999999976533   234678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||++|++|.+++..     . .....+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+++|     
T Consensus       109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            9999999999999854     2 35567889999999999999998   99999999999999999999997443     


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                                       |++|       ++.++|||||||++|||++|+.||.............         ......
T Consensus       175 -----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~  221 (286)
T 3uqc_A          175 -----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---------RDTAGQ  221 (286)
T ss_dssp             -----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---------BCTTSC
T ss_pred             -----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---------HHhccC
Confidence                             3333       6899999999999999999999998765432110000         000000


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCCC
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY  375 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~~  375 (426)
                      ..+  ....+...+..+.+|+.+||+.||.+| |+.++++.|+.+.....
T Consensus       222 ~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          222 PIE--PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             BCC--HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CCC--hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            000  000112334578999999999999999 99999999999876544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.2e-42  Score=341.28  Aligned_cols=254  Identities=22%  Similarity=0.264  Sum_probs=187.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEEe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++...   ..+.+.+|+.+|+.+ +||||+++++++.+...+++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            346667889999999998754 445899999998643   235678899999875 899999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCC---CCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC-------------Cc
Q 014362          170 MPLGSLDKHLHDLRPDTRP---LDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG-------------YH  233 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~-------------~~  233 (426)
                      +. |+|.+++.........   .++..++.++.||+.||.|||+.   +|+||||||+|||++.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceE
Confidence            96 6999999763221111   13335678999999999999998   99999999999999754             48


Q ss_pred             eeEecccccccCCCCCCcc--eeeeecccccccCcccccc-------CCCCccCchhhHHHHHHHHHh-CCCCCCCcCch
Q 014362          234 PKLSDFGLAKMGPSGDKTH--VSTRVMGTYGYCAPDYAMT-------GQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDR  303 (426)
Q Consensus       234 ~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~  303 (426)
                      +||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998654432211  1234579999999999976       678999999999999999999 99999754332


Q ss_pred             hhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          304 KELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      . .....       ....+     +......+...+.++.+|+.+||+.||.+||++.+|++
T Consensus       247 ~-~~i~~-------~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E-SNIIR-------GIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H-HHHHH-------TCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHHhc-------CCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            2 11111       00000     01111223456778999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=342.61  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=186.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..+|.+.+.||+|+||+||.. ...+++.||||++.....   ..+.+|+.+|+.+ +||||+++++++.+....|+|||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            346899999999999996543 334588999999975433   2356899999998 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-----CCceeEecccccc
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAK  243 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfgla~  243 (426)
                      |+. |+|.+++...   ...+.+..++.++.||+.||.|||+.   +|+||||||+|||++.     ...+||+|||+++
T Consensus        99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            996 6999999763   33455556789999999999999998   9999999999999953     2357899999998


Q ss_pred             cCCCCCC-cceeeeecccccccCccccc---cCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          244 MGPSGDK-THVSTRVMGTYGYCAPDYAM---TGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       244 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      ....... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||......... ..      .. 
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~------~~-  243 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-IL------LG-  243 (432)
T ss_dssp             CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HH------TT-
T ss_pred             eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HH------hc-
Confidence            6543221 12233467999999999997   4567889999999999999999 89999654322111 00      00 


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .... ...      ..+......+.+|+.+||+.||.+||++.+|++
T Consensus       244 ~~~~-~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ACSL-DCL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCCC-TTS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCc-ccc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            0000 000      112344556889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.3e-42  Score=352.47  Aligned_cols=273  Identities=26%  Similarity=0.329  Sum_probs=208.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEee------CCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE------GDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~  162 (426)
                      .++|++.+.||.|+||.||+|.+..+|+.||||++... .......+.+|+.+++.++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            47899999999999999999999999999999998764 33445678999999999999999999998765      667


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc---eeEecc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH---PKLSDF  239 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~---~kl~Df  239 (426)
                      .++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.   +||+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            899999999999999998633 234689999999999999999999997   9999999999999997665   899999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......     .|........
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~  240 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKS  240 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC---
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhccc
Confidence            9998654332   2234579999999999999999999999999999999999999997643221     1110000000


Q ss_pred             -------cccccc--cC--CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHH-----HHHHHHHHHhCC
Q 014362          320 -------KNFSQM--VD--PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITD-----VVMALNYLASQK  374 (426)
Q Consensus       320 -------~~~~~~--~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----il~~L~~l~~~~  374 (426)
                             ......  +.  ...........+..+.+|+.+||+.||.+||++.+     ..+.++.+....
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                   000000  00  01122345567789999999999999999999988     456666665433

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-40  Score=313.91  Aligned_cols=229  Identities=21%  Similarity=0.286  Sum_probs=182.3

Q ss_pred             cCCcccc-ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHH-hcCCCCCcceEeeEEee----CCee
Q 014362           90 TGNFRSD-CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL-GSADHPNLVKLIGYCAE----GDQR  163 (426)
Q Consensus        90 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~~~~~~~~----~~~~  163 (426)
                      .++|.+. +.||+|+||.||+|.+..+++.||||.+...     ..+.+|+.++ +.++||||+++++++..    ...+
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567777 7799999999999999999999999999643     4567888887 66799999999999977    6778


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEeccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG  240 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg  240 (426)
                      ++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            9999999999999999873  235699999999999999999999998   9999999999999998   7889999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      ++....                        +..++.++|||||||++|||++|..||..........             
T Consensus       166 ~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------------  208 (299)
T 3m2w_A          166 FAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------------  208 (299)
T ss_dssp             TCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------------
T ss_pred             cccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------------
Confidence            986421                        2456789999999999999999999997644321100             


Q ss_pred             ccccccCCcccCCCC----hHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          321 NFSQMVDPSLQGQYP----VRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                      .....+.. .....+    ...+..+.+|+.+||+.||.+||++.++++.
T Consensus       209 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          209 GMKTRIRM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CSCCSSCT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000000 000111    2245688999999999999999999999963

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.4e-41  Score=353.38  Aligned_cols=241  Identities=24%  Similarity=0.334  Sum_probs=194.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcC-CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCe----
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEK-IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQ----  162 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----  162 (426)
                      ..++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+..|+.+++.++||||+++++++.....    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            45789999999999999999999976 689999999875433 345678899999999999999999999987655    


Q ss_pred             -eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          163 -RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       163 -~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                       .||||||++|++|.+++.      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence             799999999999987664      2699999999999999999999998   99999999999999985 899999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.......                 
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             chhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            9864332      3357999999999987654 899999999999999999998886421110                 


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-HHHHHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-ITDVVMALNYL  370 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~~l  370 (426)
                      +.       ...........+.+|+.+||+.||.+||+ ++++.+.|..+
T Consensus       284 ~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          284 LP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            00       00001122347889999999999999995 55566666554

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3e-41  Score=334.22  Aligned_cols=243  Identities=13%  Similarity=0.132  Sum_probs=184.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCC-CCcce--------------
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADH-PNLVK--------------  152 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~h-pniv~--------------  152 (426)
                      .+|...+.||+|+||.||+|.+..+|+.||||++.....   ...+.+.+|+.+++.+.| +|...              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            457788899999999999999999999999999874332   336779999999999987 32211              


Q ss_pred             -------EeeEEee-----CCeeEEEEEecCCCCHHHHhhhh---CCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeE
Q 014362          153 -------LIGYCAE-----GDQRLLVYEYMPLGSLDKHLHDL---RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVI  217 (426)
Q Consensus       153 -------~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~ii  217 (426)
                             +..++..     ...++++|+++ +++|.+++...   ......+++..++.++.||+.||.|||+.   +|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence                   1111111     12356777766 68999888532   22345688899999999999999999998   999


Q ss_pred             ecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCcccc----------ccCCCCccCchhhHHHHH
Q 014362          218 YRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA----------MTGQLTFKSDIYSFGVVL  287 (426)
Q Consensus       218 H~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlG~il  287 (426)
                      ||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999998753321     334578 999999999          555688999999999999


Q ss_pred             HHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          288 LELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       288 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      |||++|+.||..........                ..+...      ...+..+.+|+.+||+.||.+||++.++++
T Consensus       308 ~elltg~~Pf~~~~~~~~~~----------------~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGGSE----------------WIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSCSG----------------GGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCCCCCCCcchhhhHH----------------HHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999997654322111                011100      012357899999999999999999877753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-40  Score=321.39  Aligned_cols=242  Identities=17%  Similarity=0.147  Sum_probs=183.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--------cccHHHHHHHHHHHhcCC---------CCCcce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--------VQGVREFSAEVMTLGSAD---------HPNLVK  152 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpniv~  152 (426)
                      .++|++.+.||+|+||+||+|++  +|+.||||++....        ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46799999999999999999998  48999999997653        223477889999988875         666666


Q ss_pred             EeeE-----------------Eee-------------CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHH
Q 014362          153 LIGY-----------------CAE-------------GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS  202 (426)
Q Consensus       153 ~~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~  202 (426)
                      +.+.                 |.+             ...+|+||||+++|++.+.+..     ..+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence            5554                 333             6789999999999977666643     5689999999999999


Q ss_pred             HHHHHHH-HcCCCCeEecCCCCCCeeeccCC--------------------ceeEecccccccCCCCCCcceeeeecccc
Q 014362          203 RGLQYLH-EQLKQPVIYRDLKCSNILLEEGY--------------------HPKLSDFGLAKMGPSGDKTHVSTRVMGTY  261 (426)
Q Consensus       203 ~aL~~LH-~~~~~~iiH~Dlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~  261 (426)
                      .||.||| +.   +|+||||||+||||+.++                    .+||+|||+|+.....       ..+||+
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~  241 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence            9999999 88   999999999999999887                    8999999999864321       247999


Q ss_pred             cccCccccccCCCCccCchhhHHHH-HHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHH
Q 014362          262 GYCAPDYAMTGQLTFKSDIYSFGVV-LLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLY  340 (426)
Q Consensus       262 ~y~aPE~~~~~~~~~~~DvwSlG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (426)
                      .|+|||++.+.. +.++||||||++ .+++++|..||........  ...   .... ...    .........+...+.
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~--~~~---~~~~-~~~----~~~~~~~~~~~~~s~  310 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY--LTD---KMLK-QMT----FKTKCNTPAMKQIKR  310 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH--HHH---HHHH-TCC----CSSCCCSHHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH--HHH---hhhh-hhc----cCcccchhhhhhcCH
Confidence            999999998766 999999998777 7888899999853210000  000   0000 000    000011112345677


Q ss_pred             HHHHHHHhccccCCCCCCCHHHHH
Q 014362          341 QALAIAAMCVQEQPNMRPAITDVV  364 (426)
Q Consensus       341 ~l~~li~~cl~~dP~~RPs~~eil  364 (426)
                      ++.+|+.+||+.|     |+.|++
T Consensus       311 ~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          311 KIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHHhccC-----CHHHHH
Confidence            8999999999976     899988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.8e-34  Score=293.38  Aligned_cols=186  Identities=16%  Similarity=0.086  Sum_probs=133.8

Q ss_pred             eeecCcEEEEEEEEcCCCEEEEEEEeccCCc----------ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEEE
Q 014362           99 LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV----------QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      .+.|++|.+..++..-.|+.||+|.+.....          ...++|.+|+++|+++ .|+||+++++++++...+||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5677777777777777789999999975421          2345699999999999 6999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||++|++|.++|..    ..+++..   .|+.||+.||+|||+.   |||||||||+||||+.+|.+||+|||+|+....
T Consensus       322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999986    3567654   4889999999999998   999999999999999999999999999986543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI  297 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~  297 (426)
                      ..  ......+||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            22  22334689999999998865 5678899999999998887765544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=7e-30  Score=260.29  Aligned_cols=186  Identities=17%  Similarity=0.174  Sum_probs=146.3

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ--------GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      ...+.||+|+||.||+|.+.  +..+++|........        ..+.+.+|+.+|+.++||||+++..++......||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            34567999999999999554  778899986543221        13458899999999999999966666667778899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++++|.+++..            ++.++.||+.||.|||+.   +|+||||||+|||++.  .+||+|||+++..
T Consensus       417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~  479 (540)
T 3en9_A          417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS  479 (540)
T ss_dssp             EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence            9999999999999864            468999999999999997   9999999999999998  9999999999875


Q ss_pred             CCCCCcc-----eeeeecccccccCcccccc--CCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          246 PSGDKTH-----VSTRVMGTYGYCAPDYAMT--GQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       246 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                      .......     ......||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            4322111     1234689999999999987  678899999999999999988877763

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.6e-26  Score=215.11  Aligned_cols=164  Identities=13%  Similarity=0.038  Sum_probs=129.8

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc------------------ccHHHHHHHHHHHhcC
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------------------QGVREFSAEVMTLGSA  145 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~E~~~l~~l  145 (426)
                      ..+......|.+.+.||+|+||.||+|.+ .+|+.||||.+.....                  .....+.+|+.+++.+
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            34445566777889999999999999999 7799999999964322                  1245688999999999


Q ss_pred             CCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCC
Q 014362          146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSN  225 (426)
Q Consensus       146 ~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~N  225 (426)
                      +  | +++.+++.. +..++||||++|++|.+ +..          .....++.||+.||.|||+.   +|+||||||+|
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N  223 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN  223 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence            8  5 666665544 45799999999999987 421          13457999999999999988   99999999999


Q ss_pred             eeeccCCceeEecccccccCCCCCCcceeeeecccccccCcccccc----------CCCCccCchhh
Q 014362          226 ILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT----------GQLTFKSDIYS  282 (426)
Q Consensus       226 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~DvwS  282 (426)
                      ||++ ++.+||+|||+++.               +..|+|||++..          ..|...+|+|.
T Consensus       224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9999 99999999999863               445789998754          34566667664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=9.8e-22  Score=181.64  Aligned_cols=138  Identities=16%  Similarity=0.070  Sum_probs=107.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEE--EEEEEeccCCcc------------------------cHHHHHHHHHHHhc
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV--VAIKQLDHRGVQ------------------------GVREFSAEVMTLGS  144 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~------------------------~~~~~~~E~~~l~~  144 (426)
                      .-|.+...||+|+||.||+|.+..+|+.  ||||++......                        ....+.+|+.+|..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3467889999999999999999667888  999997543111                        01257889999999


Q ss_pred             CCCCCc--ceEeeEEeeCCeeEEEEEecCC-C----CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCCe
Q 014362          145 ADHPNL--VKLIGYCAEGDQRLLVYEYMPL-G----SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH-EQLKQPV  216 (426)
Q Consensus       145 l~hpni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~~~~i  216 (426)
                      +.|+++  +.++++    ...+|||||+.+ |    +|.+....       .++..+..++.||+.||.||| +.   +|
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---gi  192 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---EL  192 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CE
Confidence            988764  334432    356899999942 4    66665432       234467889999999999999 76   99


Q ss_pred             EecCCCCCCeeeccCCceeEeccccccc
Q 014362          217 IYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       217 iH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||||+|||++.  .++|+|||+|..
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             EeCCCCHHHEEEcC--cEEEEECccccc
Confidence            99999999999998  899999999974

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=1.3e-18  Score=167.56  Aligned_cols=142  Identities=13%  Similarity=0.057  Sum_probs=99.3

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-----c---------cHHH--------HHHHHHHHh
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-----Q---------GVRE--------FSAEVMTLG  143 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~---------~~~~--------~~~E~~~l~  143 (426)
                      +.....-|++...||.|+||.||+|.+. +|+.||||+++....     .         ....        ...|...|.
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            3334445999999999999999999886 489999999753210     0         0111        124555566


Q ss_pred             cCCCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 014362          144 SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC  223 (426)
Q Consensus       144 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp  223 (426)
                      ++.+.++.-..-+..  ...+|||||++|++|..+..        .  .....++.||+.+|.|||..   +||||||||
T Consensus       169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp  233 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDFNE  233 (397)
T ss_dssp             HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCST
T ss_pred             HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCH
Confidence            654433321111111  12479999999988865432        1  13456889999999999987   999999999


Q ss_pred             CCeeeccCC----------ceeEecccccc
Q 014362          224 SNILLEEGY----------HPKLSDFGLAK  243 (426)
Q Consensus       224 ~NIll~~~~----------~~kl~Dfgla~  243 (426)
                      .||||++++          .+.|+||+-+.
T Consensus       234 ~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          234 FNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             HHEEEeCCCCcccccccccceEEEEeCCcc
Confidence            999998876          38899998664

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=2e-13  Score=125.81  Aligned_cols=147  Identities=17%  Similarity=0.076  Sum_probs=114.6

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeE
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  164 (426)
                      +......|++...++.|+.+.||++...  +..+++|............+.+|+.+++.+. +..+.++++++.+....|
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            3445567988888998999999998754  6789999987532222346888999998884 677889999999888999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--------------------------------  212 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------  212 (426)
                      +||||++|.+|.+.+..         ......++.+++.+|..||+..                                
T Consensus        87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999999999775321         1123468889999999999820                                


Q ss_pred             ------------------------CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          213 ------------------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       213 ------------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                                              ...++|+|++|.|||++++..+.|+||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                    1358999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=2.9e-12  Score=117.55  Aligned_cols=137  Identities=15%  Similarity=0.083  Sum_probs=99.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC--cceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~~~~~~~~~~~~lv~e  168 (426)
                      .+|.+....+.|..+.||++.. .+|..+++|.....   ....+..|+.+++.+.+.+  +.+++++.......++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3455443334556699999965 34678999997653   2345778999988886544  5568888888778899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------------------------------------  212 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------------  212 (426)
                      |++|.+|.  ...       .+   ...++.+++..|..||+..                                    
T Consensus        96 ~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           96 EVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             CCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             ecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            99998883  211       11   2356778888888888641                                    


Q ss_pred             -------------------CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          213 -------------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       213 -------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                                         ...++|+|++|.|||+++++.+.|+|||.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                               1129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=5.4e-11  Score=114.73  Aligned_cols=142  Identities=12%  Similarity=0.156  Sum_probs=106.1

Q ss_pred             ccceeeecCcEEEEEEEEcCCCEEEEEEEec--cCCc-ccHHHHHHHHHHHhcCC--CCCcceEeeEEeeC---CeeEEE
Q 014362           95 SDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--HRGV-QGVREFSAEVMTLGSAD--HPNLVKLIGYCAEG---DQRLLV  166 (426)
Q Consensus        95 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~---~~~~lv  166 (426)
                      ..+.|+.|.++.||+....  +..+++|+..  .... .....+.+|+.+++.+.  +..+.+++.++.+.   ...|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4567899999999998765  4578888776  3221 22356788999998886  45688889888776   347899


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL----------------------------------  212 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------  212 (426)
                      |||++|..+.+..      ...++......++.+++.+|..||+..                                  
T Consensus       120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            9999988774321      234778888999999999999999831                                  


Q ss_pred             ---------------------CCCeEecCCCCCCeeeccCCc--eeEeccccccc
Q 014362          213 ---------------------KQPVIYRDLKCSNILLEEGYH--PKLSDFGLAKM  244 (426)
Q Consensus       213 ---------------------~~~iiH~Dlkp~NIll~~~~~--~kl~Dfgla~~  244 (426)
                                           ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 246999999999999997653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=4.8e-11  Score=112.40  Aligned_cols=188  Identities=17%  Similarity=0.130  Sum_probs=122.4

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCC--cceEeeEEeeCC---eeEEEEEe
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPN--LVKLIGYCAEGD---QRLLVYEY  169 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~~~~~~~~~~---~~~lv~e~  169 (426)
                      ...++.|.+..||+..     ..+++|.....  .....+..|+.+|+.+. +..  +..++.......   ..|+||++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3458999999999863     35888886432  34567889999998773 332  444555443333   34789999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL-------------------------------------  212 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------------------------------------  212 (426)
                      ++|.+|.....      ..++..+...++.+++..|..||+..                                     
T Consensus        98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99988865432      23677788889999999999999621                                     


Q ss_pred             ------------------CCCeEecCCCCCCeeecc--CCceeEecccccccCCCCCCcceeee------------eccc
Q 014362          213 ------------------KQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPSGDKTHVSTR------------VMGT  260 (426)
Q Consensus       213 ------------------~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~------------~~gt  260 (426)
                                        ...++|+|++|.||+++.  +..+.|+||+.+..............            +...
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence                              135799999999999998  55678999998875322110000000            0000


Q ss_pred             ccccC-ccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          261 YGYCA-PDYAMTGQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       261 ~~y~a-PE~~~~~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                      .++.. |+....  .....+.|++|.++|.+.+|..+|.
T Consensus       252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            01111 221111  1223589999999999999988774

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.63  E-value=1.6e-07  Score=86.39  Aligned_cols=134  Identities=16%  Similarity=0.138  Sum_probs=98.3

Q ss_pred             eeecCcE-EEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEEecCCCCHH
Q 014362           99 LGEGGFG-KVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus        99 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      +..|..| .||+......+..+++|.-...   ....+..|...|+.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            5556555 6999877766778889986532   3456788999888774 334778899999999999999999998887


Q ss_pred             HHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 014362          177 KHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--------------------------------------------  212 (426)
Q Consensus       177 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------------------------------------------  212 (426)
                      +.....        ......++.+++..|.-||...                                            
T Consensus       109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            765431        1123456667777777777530                                            


Q ss_pred             -----------CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          213 -----------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       213 -----------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                                 ...++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                       1127999999999999987777799998875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.62  E-value=2e-07  Score=87.55  Aligned_cols=135  Identities=17%  Similarity=0.085  Sum_probs=94.3

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC---CcceEeeEEe-eCCeeEEEEEecCC
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP---NLVKLIGYCA-EGDQRLLVYEYMPL  172 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~~~~~~~-~~~~~~lv~e~~~~  172 (426)
                      ..++.|....||+.     +..+++|+..  .......+..|+.+|+.+.+.   .+..++.++. .....++||||++|
T Consensus        25 ~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           25 ESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            45888888999987     4557888742  223456788999999998652   3556666664 34557899999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL----------------------------------------  212 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------------------------------------  212 (426)
                      .+|.....      ..++......++.+++..|..||+..                                        
T Consensus        98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            88866321      12455555666666666666666531                                        


Q ss_pred             -----------------CCCeEecCCCCCCeeecc---CCc-eeEeccccccc
Q 014362          213 -----------------KQPVIYRDLKCSNILLEE---GYH-PKLSDFGLAKM  244 (426)
Q Consensus       213 -----------------~~~iiH~Dlkp~NIll~~---~~~-~kl~Dfgla~~  244 (426)
                                       ...++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             224699999999999987   355 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.34  E-value=8e-07  Score=85.17  Aligned_cols=80  Identities=8%  Similarity=0.006  Sum_probs=53.7

Q ss_pred             cee-eecCcEEEEEEEEc--C----CCEEEEEEEeccCC---cccHHHHHHHHHHHhcCC-C--CCcceEeeEEeeC---
Q 014362           97 CCL-GEGGFGKVYKGCLE--K----IEQVVAIKQLDHRG---VQGVREFSAEVMTLGSAD-H--PNLVKLIGYCAEG---  160 (426)
Q Consensus        97 ~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~---  160 (426)
                      +.| +.|....+|+....  .    .+..+++|......   ......+..|+.+++.+. +  ..+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            457 78888999987653  1    15678888765432   111245778888887774 2  3567788877655   


Q ss_pred             CeeEEEEEecCCCCHH
Q 014362          161 DQRLLVYEYMPLGSLD  176 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~  176 (426)
                      ...++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3468999999986654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=1.1e-05  Score=76.56  Aligned_cols=141  Identities=14%  Similarity=0.214  Sum_probs=79.3

Q ss_pred             eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcC-----CCCCcceEe-e--EEeeCCeeEEEEEe
Q 014362           98 CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-----DHPNLVKLI-G--YCAEGDQRLLVYEY  169 (426)
Q Consensus        98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~-~--~~~~~~~~~lv~e~  169 (426)
                      .|+.|..+.||+....  +..+++|+....    ...+..|+.+++.|     ..|.++... |  +....+..++||+|
T Consensus        39 ~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           39 VIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             ECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4656778899998765  345889998752    13333444444443     234444311 1  12345678999999


Q ss_pred             cCCCCHH--------------HHhhhhCCCC----------CCCCHHHH-------------------------------
Q 014362          170 MPLGSLD--------------KHLHDLRPDT----------RPLDWNTR-------------------------------  194 (426)
Q Consensus       170 ~~~gsL~--------------~~l~~~~~~~----------~~l~~~~~-------------------------------  194 (426)
                      ++|.++.              ..+|......          ..-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              1222211100          00122211                               


Q ss_pred             HHHHHHHHHHHHHHHH----------cCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          195 MKIAAGASRGLQYLHE----------QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       195 ~~i~~qi~~aL~~LH~----------~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ..+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1112234446667763          1245899999999999998888899999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.29  E-value=2.2e-06  Score=83.42  Aligned_cols=76  Identities=14%  Similarity=0.132  Sum_probs=49.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-------ccHHHHHHHHHHHhcCCC--CC-cceEeeEEeeCCeeEE
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-------QGVREFSAEVMTLGSADH--PN-LVKLIGYCAEGDQRLL  165 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pn-iv~~~~~~~~~~~~~l  165 (426)
                      .+.||.|.++.||++.....++.++||.......       .....+..|..+|+.+..  |. +..++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            4569999999999997765577899998653211       123456778888877632  33 3455543  3445689


Q ss_pred             EEEecCCC
Q 014362          166 VYEYMPLG  173 (426)
Q Consensus       166 v~e~~~~g  173 (426)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.93  E-value=4.2e-05  Score=71.73  Aligned_cols=139  Identities=17%  Similarity=0.139  Sum_probs=90.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC---CCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD---HPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      ...|+.|.+..+|+....  +..+++|.....   ....+..|+..|+.|.   ...+.+++.++......++||||++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            356899999999998753  667888987543   3456888988888773   35688888888877889999999998


Q ss_pred             CCHH--------H---HhhhhCC-CC-----------------CCCCHHHHH---HHHH----------------HHHHH
Q 014362          173 GSLD--------K---HLHDLRP-DT-----------------RPLDWNTRM---KIAA----------------GASRG  204 (426)
Q Consensus       173 gsL~--------~---~l~~~~~-~~-----------------~~l~~~~~~---~i~~----------------qi~~a  204 (426)
                      ..+.        .   .||.... ..                 ..-+|....   ++..                .++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7642        1   2333221 00                 011344322   1111                11111


Q ss_pred             H-HHHHH-cCCCCeEecCCCCCCeeeccCCceeEeccc
Q 014362          205 L-QYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFG  240 (426)
Q Consensus       205 L-~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfg  240 (426)
                      + ..|.. ...+.+||+|+.+.|++++.++ +.|.||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 22321 1145799999999999999887 8888984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.87  E-value=9e-05  Score=68.57  Aligned_cols=80  Identities=16%  Similarity=0.136  Sum_probs=57.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC---CCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH---PNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~~~~~~~~~~~~~lv~  167 (426)
                      ........+|.|..+.||+....+ |+.|.+|+...........|..|+..|+.|.-   -.+.+++++.    ..++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            345566779999999999998764 88899998765544444568889998887742   2345555542    247899


Q ss_pred             EecCCCCH
Q 014362          168 EYMPLGSL  175 (426)
Q Consensus       168 e~~~~gsL  175 (426)
                      ||++++..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.84  E-value=6.1e-05  Score=73.77  Aligned_cols=77  Identities=18%  Similarity=0.180  Sum_probs=48.3

Q ss_pred             CCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcceeeeec--ccccccCccccccC---CCCccCchhhHHHHH
Q 014362          213 KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM--GTYGYCAPDYAMTG---QLTFKSDIYSFGVVL  287 (426)
Q Consensus       213 ~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DvwSlG~il  287 (426)
                      ...++|+|++|.|||++.++ ++|+||+.+.........   ....  -...|++|+.....   .-....++.++...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45899999999999999876 999999988753221110   0001  12346666654311   112234556788888


Q ss_pred             HHHHhC
Q 014362          288 LELITG  293 (426)
Q Consensus       288 ~elltg  293 (426)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            888765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.0023  Score=59.80  Aligned_cols=159  Identities=15%  Similarity=0.105  Sum_probs=86.8

Q ss_pred             cCHHHHHHhcCCcccc-----ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC--cceE
Q 014362           81 FTFDELAAATGNFRSD-----CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN--LVKL  153 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~~  153 (426)
                      .+.+++......|.+.     +.|+.|....+|+..... | .+++|......  ....+..|+.++..+...+  +..+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            4556666666666652     346668888999987653 3 68899887531  1234455666665553111  2333


Q ss_pred             eeE------EeeCCeeEEEEEecCCCCHHH--------------HhhhhCCC-CCC----C---CHHHHHH---------
Q 014362          154 IGY------CAEGDQRLLVYEYMPLGSLDK--------------HLHDLRPD-TRP----L---DWNTRMK---------  196 (426)
Q Consensus       154 ~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~~----l---~~~~~~~---------  196 (426)
                      +..      ....+..+++++|++|..+..              .+|..... ..+    .   .|...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      123456789999999865321              12221110 000    1   1221100         


Q ss_pred             ---HHHHHHHHHHHHHHcC----CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          197 ---IAAGASRGLQYLHEQL----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       197 ---i~~qi~~aL~~LH~~~----~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                         +...+...+.+++...    ...++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               0112445566665431    3479999999999999987666899998775

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00021  Score=66.47  Aligned_cols=71  Identities=8%  Similarity=0.060  Sum_probs=43.3

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCc-ceEeeEEeeCCeeEEEEEec-CCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYM-PLG  173 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~-~~g  173 (426)
                      .+.|+.|....+|+.      ..+++|+....... .-....|+.+++.+...++ .++++++  ...-++|+||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            567888999999998      34788887653221 1223457777766542223 3555543  33457899999 654


Q ss_pred             CH
Q 014362          174 SL  175 (426)
Q Consensus       174 sL  175 (426)
                      +|
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.48  E-value=0.00056  Score=67.56  Aligned_cols=75  Identities=12%  Similarity=-0.050  Sum_probs=48.1

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCc-ceEeeEEeeCCeeEEEEEecCCCC
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVYEYMPLGS  174 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~e~~~~gs  174 (426)
                      ...|+.|-...+|+......+..+++|+........+ ....|+.+++.|...++ .++++++.  +  .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3457778889999998765457888998754322211 12578888888765444 46777663  2  25999998754


Q ss_pred             H
Q 014362          175 L  175 (426)
Q Consensus       175 L  175 (426)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.42  E-value=0.00069  Score=59.11  Aligned_cols=101  Identities=14%  Similarity=0.085  Sum_probs=66.7

Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCcc
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH  252 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  252 (426)
                      -||.+.|..+   +.+++++++|.++.|.+.+|.-+-.. + .-..+=+.|..|+|..+|.|.+.+ +.+.         
T Consensus        33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~-~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARR-R-QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-T-CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhc-c-cCCceecCCcceEEecCCceeccc-cccc---------
Confidence            4789999874   68899999999999999998776221 0 112333457899999999987763 2110         


Q ss_pred             eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC
Q 014362          253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR  294 (426)
Q Consensus       253 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~  294 (426)
                           .....+.|||... ...+.+.=|||||++||..+--.
T Consensus        98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence                 1233467888653 34567888999999999988643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.34  E-value=0.0013  Score=62.05  Aligned_cols=33  Identities=27%  Similarity=0.349  Sum_probs=28.0

Q ss_pred             CCCeEecCCCCCCeeeccC----CceeEecccccccC
Q 014362          213 KQPVIYRDLKCSNILLEEG----YHPKLSDFGLAKMG  245 (426)
Q Consensus       213 ~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~~~  245 (426)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3579999999999999874    67899999988753

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.33  E-value=0.00052  Score=66.05  Aligned_cols=142  Identities=18%  Similarity=0.201  Sum_probs=82.4

Q ss_pred             ceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +.|..|-...+|+.....       .+..+.+|+.... ......+.+|..+++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            346667778899987642       3467889886432 233455668988887774 2223566766654    28999


Q ss_pred             ecCCCCHHH--------------Hh---hhhC-CCCCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 014362          169 YMPLGSLDK--------------HL---HDLR-PDTRPLD--WNTRMKIAAGASR-------------------GLQYLH  209 (426)
Q Consensus       169 ~~~~gsL~~--------------~l---~~~~-~~~~~l~--~~~~~~i~~qi~~-------------------aL~~LH  209 (426)
                      |++|.+|..              .|   |... .......  +.++.++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999765431              11   2111 0111222  4555555544422                   233333


Q ss_pred             Hc-----CCCCeEecCCCCCCeeeccC----CceeEecccccc
Q 014362          210 EQ-----LKQPVIYRDLKCSNILLEEG----YHPKLSDFGLAK  243 (426)
Q Consensus       210 ~~-----~~~~iiH~Dlkp~NIll~~~----~~~kl~Dfgla~  243 (426)
                      ..     ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            21     13468999999999999876    789999998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.26  E-value=0.001  Score=65.22  Aligned_cols=74  Identities=18%  Similarity=0.141  Sum_probs=49.1

Q ss_pred             cceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCc-ceEeeEEeeCCeeEEEE
Q 014362           96 DCCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL-VKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~~~~~~~~~~~~~lv~  167 (426)
                      ...|+.|-...||+.....       .+..+++|+......  ...+..|+.+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3457888889999998753       246788998843211  2455678888887753333 566766543    3899


Q ss_pred             EecCCCCH
Q 014362          168 EYMPLGSL  175 (426)
Q Consensus       168 e~~~~gsL  175 (426)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.22  E-value=0.0017  Score=60.86  Aligned_cols=143  Identities=12%  Similarity=0.071  Sum_probs=79.4

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--CcceEeeE-----EeeCCeeEEEEEe
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHP--NLVKLIGY-----CAEGDQRLLVYEY  169 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~~~~~-----~~~~~~~~lv~e~  169 (426)
                      ..|+ |....||+.... .|+.+++|...... .....+..|..++..+...  .++.++..     ....+..++||+|
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            3466 778899987654 36679999986432 1234566677777665321  23344432     2234566889999


Q ss_pred             cCCCCHH-----------HH---hhhhCCC-----CCCCCHHHH----HHH---------------HHHHHHHHHHHHHc
Q 014362          170 MPLGSLD-----------KH---LHDLRPD-----TRPLDWNTR----MKI---------------AAGASRGLQYLHEQ  211 (426)
Q Consensus       170 ~~~gsL~-----------~~---l~~~~~~-----~~~l~~~~~----~~i---------------~~qi~~aL~~LH~~  211 (426)
                      ++|.++.           ..   +|.....     ...+++...    ..+               ...+...+..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875432           11   1211100     111222211    001               11111223333322


Q ss_pred             ----CCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          212 ----LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       212 ----~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                          ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                134689999999999999 4 889999988764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.00088  Score=64.16  Aligned_cols=74  Identities=9%  Similarity=0.021  Sum_probs=43.3

Q ss_pred             ceeeecCcEEEEEEEEcCC--------CEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC-cceEeeEEeeCCeeEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKI--------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-LVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~  167 (426)
                      ..|+.|....+|+......        +..+++|+..... ........|..+++.+...+ +.++++.+  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            4577788889999886531        2578888875432 22222456777777764333 34566544  2  36899


Q ss_pred             EecCCCCH
Q 014362          168 EYMPLGSL  175 (426)
Q Consensus       168 e~~~~gsL  175 (426)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.76  E-value=0.0071  Score=57.14  Aligned_cols=31  Identities=13%  Similarity=0.179  Sum_probs=27.4

Q ss_pred             CCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       214 ~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.59  E-value=0.022  Score=55.40  Aligned_cols=141  Identities=13%  Similarity=0.135  Sum_probs=82.3

Q ss_pred             ceeeecCcEEEEEEEEcCC-------CEEEEEEEeccCCcccHHHHHHHHHHHhcCCC-CCcceEeeEEeeCCeeEEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKI-------EQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e  168 (426)
                      +.|..|-...+|+......       +..+++++..... ...-...+|..+++.+.- .-..++++.+.    -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            4576677888999887521       4678888865432 222223567777777642 22445565432    368999


Q ss_pred             ecCCCCHHH--------------H---hhhhC------C---CCCCCCHHHHHHHHHHH-------------------HH
Q 014362          169 YMPLGSLDK--------------H---LHDLR------P---DTRPLDWNTRMKIAAGA-------------------SR  203 (426)
Q Consensus       169 ~~~~gsL~~--------------~---l~~~~------~---~~~~l~~~~~~~i~~qi-------------------~~  203 (426)
                      |++|.+|..              .   ||...      .   ...+.-+.++..+..++                   ..
T Consensus       151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~  230 (424)
T 3mes_A          151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE  230 (424)
T ss_dssp             CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred             EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence            999866421              1   11110      0   11222344444444332                   22


Q ss_pred             HHHHHHHc---------------------CCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          204 GLQYLHEQ---------------------LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       204 aL~~LH~~---------------------~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      .+.+|...                     ....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus       231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~  290 (424)
T 3mes_A          231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA  290 (424)
T ss_dssp             HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence            23333211                     1235899999999999 778899999998875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.56  E-value=0.22  Score=47.93  Aligned_cols=28  Identities=32%  Similarity=0.325  Sum_probs=23.9

Q ss_pred             eEecCCCCCCeee------ccCCceeEecccccc
Q 014362          216 VIYRDLKCSNILL------EEGYHPKLSDFGLAK  243 (426)
Q Consensus       216 iiH~Dlkp~NIll------~~~~~~kl~Dfgla~  243 (426)
                      ++|+|+.+.|||+      +++..+.++||-+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      446679999998875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.06  E-value=0.41  Score=41.52  Aligned_cols=116  Identities=9%  Similarity=0.119  Sum_probs=79.4

Q ss_pred             CCCCCcceEeeEEeeCCeeEEEEEecCCC-CHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 014362          145 ADHPNLVKLIGYCAEGDQRLLVYEYMPLG-SLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC  223 (426)
Q Consensus       145 l~hpniv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp  223 (426)
                      ..||+.++. .+-.+.+.+.+.++.-+.+ ++.. +       ..++....++++..|+....+++.     -+|--|.|
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P  107 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP  107 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence            368888876 4666667766666654422 3322 3       337888999999999998876663     48888999


Q ss_pred             CCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          224 SNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       224 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                      +||+++.++.+++.-.|+-...                   +|.     .++...=+-.+=+++..+++++..|+
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999877764321                   121     01111113356788899999988885

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.79  E-value=0.71  Score=40.15  Aligned_cols=115  Identities=11%  Similarity=0.060  Sum_probs=77.3

Q ss_pred             CCCCcceEeeEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHH-HHHHcCCCCeEecCCCCC
Q 014362          146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ-YLHEQLKQPVIYRDLKCS  224 (426)
Q Consensus       146 ~hpniv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~-~LH~~~~~~iiH~Dlkp~  224 (426)
                      .||++  -..+-.+.+.+.+.++.-+++.=...++       .++....++++..|+.... +++     .-+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCc
Confidence            57877  3344466777777777654432233343       3788899999999888776 565     4478889999


Q ss_pred             CeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCC
Q 014362          225 NILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAID  298 (426)
Q Consensus       225 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~  298 (426)
                      ||++|.++.++|.-.|+-..++              |.=+.+|-+          +-.+=+++..++.++..|+
T Consensus       114 NL~f~~~~~p~i~hRGi~~~lp--------------P~e~~ee~f----------l~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESLP--------------PDEWDDERL----------LREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTBS--------------SCSCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred             eEEEeCCCcEEEEEcCCcccCC--------------CCCCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            9999999999998877643211              111222211          2256778888888888775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.87  E-value=0.059  Score=53.09  Aligned_cols=63  Identities=10%  Similarity=0.073  Sum_probs=18.6

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEE------EEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAI------KQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      .+.+.||   ||.||+|.+.....+|||      |......  ......+.+|..+++.++|||+++.+++...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            3455676   999999999865567888      6655422  2234567888889999999999999887643

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	426
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-76
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-66
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-66
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-64
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-62
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-61
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-61
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-61
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-61
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	8e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-60
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-59
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-56
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-55
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-48
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (602), Expect = 4e-76
 Identities = 75/286 (26%), Positives = 129/286 (45%), Gaps = 27/286 (9%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHP 148
           G       +G G FG VYKG   K    VA+K L+      Q ++ F  EV  L    H 
Sbjct: 8   GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N++  +GY     Q  +V ++    SL  HLH +       +    + IA   ++G+ YL
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYL 120

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H    + +I+RDLK +NI L E    K+ DFGLA +      +H   ++ G+  + AP+ 
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 269 AMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
                    +F+SD+Y+FG+VL EL+TG+       +R ++  +     +  D       
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
              +++             + A C++++ + RP    ++ ++  LA
Sbjct: 238 CPKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 3e-66
 Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 29/291 (9%)

Query: 79  KPFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAE 138
           KP+  DE        +    LG G FG+V+ G        VA+K L  +G      F AE
Sbjct: 1   KPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAE 58

Query: 139 VMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIA 198
              +    H  LV+L     + +   ++ EYM  GSL   L    P    L  N  + +A
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMA 115

Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
           A  + G+ ++ E+     I+RDL+ +NIL+ +    K++DFGLA++    ++        
Sbjct: 116 AQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAK 171

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL--NLVAWARPMF 316
               + AP+    G  T KSD++SFG++L E++T  +         E+  NL    R + 
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

Query: 317 KDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
            D  N  +                +   +  +C +E+P  RP    +   L
Sbjct: 232 PD--NCPE----------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  211 bits (537), Expect = 4e-66
 Identities = 74/322 (22%), Positives = 130/322 (40%), Gaps = 44/322 (13%)

Query: 80  PFTFDELAAATGNF---------RSDCCLGEGGFGKVYKGCLE---KIEQVVAIKQLDHR 127
           PFTF++   A   F         + +  +G G FG+V  G L+   K E  VAIK L   
Sbjct: 6   PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65

Query: 128 GV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT 186
              +  R+F +E   +G  DHPN++ L G   +    +++ E+M  GSLD  L     + 
Sbjct: 66  YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP 246
                   + +  G + G++YL        ++RDL   NIL+      K+SDFGL++   
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 247 SGDKTHVSTRV---MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDR 303
                   T          + AP+     + T  SD++S+G+V+ E+++  +        
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239

Query: 304 KELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           +++                   ++   +   P+        +   C Q+  N RP    +
Sbjct: 240 QDV----------------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 364 VMALNYLASQKYDPQNPPSRSS 385
           V  L+ +       +NP S  +
Sbjct: 284 VNTLDKMI------RNPNSLKA 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (526), Expect = 1e-64
 Identities = 68/292 (23%), Positives = 129/292 (44%), Gaps = 23/292 (7%)

Query: 83  FDELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTL 142
           +D+      +      LG G +G+VY+G  +K    VA+K L    ++ V EF  E   +
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67

Query: 143 GSADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
               HPNLV+L+G C       ++ E+M  G+L  +L +     + +     + +A   S
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQIS 125

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYG 262
             ++YL    K+  I+RDL   N L+ E +  K++DFGL+++  +GD             
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK 181

Query: 263 YCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNF 322
           + AP+     + + KSD+++FGV+L E+ T   +     D  ++                
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------- 225

Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK 374
            ++++   + + P     +   +   C Q  P+ RP+  ++  A   +  + 
Sbjct: 226 YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 2e-63
 Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 16/296 (5%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNL 150
           +F     LG G  G V+K   +    V+A K +       +R     E+  L   + P +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 151 VKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           V   G      +  +  E+M  GSLD+ L         +      K++    +GL YL E
Sbjct: 67  VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             K  +++RD+K SNIL+      KL DFG++          ++   +GT  Y +P+   
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQ 176

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
               + +SDI+S G+ L+E+  GR  I    D KEL L+   +      +   +   P  
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY--LASQ--KYDPQNPPS 382
                       +AI  +         P +   V +L +    ++    +P     
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-62
 Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 31/299 (10%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYC 157
            +G+G FG+V++G      + VA+K    R  +      AE+       H N++  I   
Sbjct: 10  SIGKGRFGEVWRGKWRG--EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66

Query: 158 AEGD----QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL- 212
            + +    Q  LV +Y   GSL  +L+        +     +K+A   + GL +LH ++ 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 213 ----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT--HVSTRVMGTYGYCAP 266
               K  + +RDLK  NIL+++     ++D GLA    S   T        +GT  Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 267 DYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRK----ELNLVAWARPMF 316
           +           +   ++DIY+ G+V  E+          +D +    +L     +    
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 317 KDRKNFSQMVDPSLQGQYPVRGLYQALA-IAAMCVQEQPNMRPAITDVVMALNYLASQK 374
           + +    Q + P++  ++      + +A I   C       R     +   L+ L+ Q+
Sbjct: 242 R-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 27/270 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V  G   + +  VAIK +   G     EF  E   + +  H  LV+L G C 
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +     ++ EYM  G L  +L ++R           +++       ++YL     +  ++
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE---SKQFLH 123

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ +    K+SDFGL++     D+   S        +  P+  M  + + KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 279 DIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVR 337
           DI++FGV++ E+ + G+   ++  + +    +A    +++      ++            
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT---------- 232

Query: 338 GLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
                  I   C  E+ + RP    ++  +
Sbjct: 233 -------IMYSCWHEKADERPTFKILLSNI 255

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  201 bits (511), Expect = 4e-62
 Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 45/305 (14%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQGVR-EFSAEVMTLGSA 145
           N      +GEG FG+V++     +       +VA+K L       ++ +F  E   +   
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------------- 186
           D+PN+VKL+G CA G    L++EYM  G L++ L  + P T                   
Sbjct: 74  DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 187 -RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG 245
             PL    ++ IA   + G+ YL E+     ++RDL   N L+ E    K++DFGL++  
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE 305
            S D             +  P+     + T +SD++++GVVL E+ +           +E
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 306 LNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM 365
           +        +    +N                   +   +  +C  + P  RP+   +  
Sbjct: 251 VIYYVRDGNILACPENCPL----------------ELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 366 ALNYL 370
            L  +
Sbjct: 295 ILQRM 299

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 5e-62
 Identities = 72/273 (26%), Positives = 114/273 (41%), Gaps = 25/273 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG V+ G     +  VAIK +   G     +F  E   +    HP LV+L G C 
Sbjct: 13  IGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           E     LV+E+M  G L  +L             T + +      G+ YL E     VI+
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIH 124

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RDL   N L+ E    K+SDFG+ +     D+   ST       + +P+     + + KS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRG 338
           D++SFGV++ E+ +  K   + +   E+          +D     ++  P L        
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLYKPRLAST----- 229

Query: 339 LYQALAIAAMCVQEQPNMRPAITDVVMALNYLA 371
                 I   C +E+P  RPA + ++  L  +A
Sbjct: 230 --HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-61
 Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 31/284 (10%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
             +    +G+G FG V  G        VA+K + +      + F AE   +    H NLV
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63

Query: 152 KLIGYCAEGDQRL-LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           +L+G   E    L +V EYM  GSL  +L         L  +  +K +      ++YL  
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE- 120

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                 ++RDL   N+L+ E    K+SDFGL K   S   T           + AP+   
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALR 173

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
             + + KSD++SFG++L E+ +  +        K++      R     + +      P++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----VPRVEKGYKMDAPDGCPPAV 229

Query: 331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK 374
                         +   C      MRP+   +   L ++ + +
Sbjct: 230 Y------------EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-61
 Identities = 72/296 (24%), Positives = 109/296 (36%), Gaps = 39/296 (13%)

Query: 99  LGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV +     +        VA+K L        RE   +E+  L    +H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP--------------DTRPLDWNTRMKI 197
            L+G C  G   L++ EY   G L   L   R               D   LD    +  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           +   ++G+ +L  +     I+RDL   NILL  G   K+ DFGLA+   +     V    
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       TF+SD++S+G+ L EL +   +                 P   
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY---------------PGMP 252

Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ 373
               F +M+    +   P     +   I   C    P  RP    +V  +    S+
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 30/271 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG+G FGKVYK   ++   + A K +D +  + + ++  E+  L S DHPN+VKL+    
Sbjct: 20  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             +   ++ E+   G++D  + +L    RPL  +    +       L YLH+     +I+
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIH 133

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL---- 274
           RDLK  NIL       KL+DFG++       +       +GT  + AP+  M        
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRP 191

Query: 275 -TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA-RPMFKDRKNFSQMVDPSLQG 332
             +K+D++S G+ L+E+        +    + L  +A +  P       +S         
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS-------- 243

Query: 333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
                           C+++  + R   + +
Sbjct: 244 --------NFKDFLKKCLEKNVDARWTTSQL 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-61
 Identities = 66/296 (22%), Positives = 108/296 (36%), Gaps = 44/296 (14%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-----VVAIKQLDHRGVQGVRE-FSAEVMTLGS-ADHPNLV 151
           LG G FGKV       I +      VA+K L  +     RE   +E+  +     H N+V
Sbjct: 45  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLDWN 192
            L+G C       L++EY   G L  +L   R                    D   L + 
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164

Query: 193 TRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTH 252
             +  A   ++G+++L  +     ++RDL   N+L+  G   K+ DFGLA+   S     
Sbjct: 165 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221

Query: 253 VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA 312
           V         + AP+    G  T KSD++S+G++L E+ +                    
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------- 274

Query: 313 RPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
                   NF +++    +   P     +   I   C       RP+  ++   L 
Sbjct: 275 --------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-61
 Identities = 56/279 (20%), Positives = 109/279 (39%), Gaps = 25/279 (8%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPN 149
           ++     +G G +G+  K   +   +++  K+LD+  +     +   +EV  L    HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 150 LVKLIGYCAEGDQRLL--VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           +V+      +     L  V EY   G L   +     + + LD    +++    +  L+ 
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124

Query: 208 LHEQ--LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
            H +      V++RDLK +N+ L+   + KL DFGLA++      T  +   +GT  Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
           P+         KSDI+S G +L EL            ++    +   +        +S  
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP-YRYSD- 240

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
                          +   I    +  +   RP++ +++
Sbjct: 241 ---------------ELNEIITRMLNLKDYHRPSVEEIL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 8e-61
 Identities = 68/282 (24%), Positives = 121/282 (42%), Gaps = 29/282 (10%)

Query: 99  LGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLVKLI 154
           +G G FG VY G L   +  +   A+K L+     G V +F  E + +    HPN++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 155 GYCAEGDQR-LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           G C   +   L+V  YM  G L   +     +T        +      ++G+++L     
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA---S 148

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKM--GPSGDKTHVSTRVMGTYGYCAPDYAMT 271
           +  ++RDL   N +L+E +  K++DFGLA+       D  H  T       + A +   T
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
            + T KSD++SFGV+L EL+T            ++N       + + R+    ++ P   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGRR----LLQPEYC 259

Query: 332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ 373
                        +   C   +  MRP+ +++V  ++ + S 
Sbjct: 260 PD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 9e-61
 Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 32/279 (11%)

Query: 93  FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNL 150
            + D  +G G F  VYKG   +    VA  +L  R +     + F  E   L    HPN+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 151 VKLIGYCAEGDQR----LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
           V+         +     +LV E M  G+L  +L       + +             +GLQ
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQ 126

Query: 207 YLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           +LH +   P+I+RDLKC NI +       K+ D GLA +     +   +  V+GT  + A
Sbjct: 127 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMA 181

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
           P+     +     D+Y+FG+ +LE+ T      + ++  ++               + ++
Sbjct: 182 PEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRV 225

Query: 326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
                   +    + +   I   C+++  + R +I D++
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 1e-60
 Identities = 64/278 (23%), Positives = 115/278 (41%), Gaps = 27/278 (9%)

Query: 95  SDCCLGEGGFGKVYKGCL--EKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHPNLV 151
           +D  LG G FG V +G     K +  VAIK L     +    E   E   +   D+P +V
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           +LIG C + +  +LV E    G L K L   R     +  +   ++    S G++YL   
Sbjct: 73  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE-- 126

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAM 270
            ++  ++RDL   N+LL   ++ K+SDFGL+K +G         +       + AP+   
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL 330
             + + +SD++S+GV + E ++  +   +     E+                   ++   
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------MAFIEQGK 229

Query: 331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
           + + P     +  A+ + C   +   RP    V   + 
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 26/276 (9%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD-HRGVQGVREFSAEVMTLGSADHPN 149
            ++     LGEG +G+V        E+ VA+K +D  R V        E+      +H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +VK  G+  EG+ + L  EY   G L   +         +      +       G+ YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                 + +RD+K  N+LL+E  + K+SDFGLA +    ++  +  ++ GT  Y AP+  
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177

Query: 270 MTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKD-RKELNLVAWARPMFKDRKNFSQMVD 327
              +      D++S G+VL  ++ G    DQ  D  +E +     +      K       
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS--- 234

Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
                          LA+    + E P+ R  I D+
Sbjct: 235 -------------APLALLHKILVENPSARITIPDI 257

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-60
 Identities = 74/292 (25%), Positives = 121/292 (41%), Gaps = 28/292 (9%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV 151
           + R +  LG+G FG+V+ G        VAIK L   G      F  E   +    H  LV
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 152 KLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ 211
           +L       +   +V EYM  GSL   L       + L     + +AA  + G+ Y+   
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE-- 130

Query: 212 LKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
            +   ++RDL+ +NIL+ E    K++DFGLA++    ++            + AP+ A+ 
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALY 188

Query: 272 GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQ 331
           G+ T KSD++SFG++L EL T  +        +E+                   V+   +
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQVERGYR 232

Query: 332 GQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL-NYLASQKYDPQNPPS 382
              P         +   C +++P  RP    +   L +Y  S   +PQ  P 
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS--TEPQYQPG 282

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-60
 Identities = 68/275 (24%), Positives = 118/275 (42%), Gaps = 29/275 (10%)

Query: 99  LGEGGFGKVYKGCLE--KIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHPNLVKLI 154
           LG G FG V KG  +  K+ + VA+K L +         E  AE   +   D+P +V++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQ 214
           G C E +  +LV E   LG L+K+L       R +     +++    S G++YL    + 
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE---ES 126

Query: 215 PVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             ++RDL   N+LL   ++ K+SDFGL+K +    +     T       + AP+     +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ 333
            + KSD++SFGV++ E  +  +   +     E+                + M++   +  
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------TAMLEKGERMG 230

Query: 334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN 368
            P     +   +  +C       RP    V + L 
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 2e-59
 Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 38/306 (12%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGV-QGVREFSAEVMTLGS-ADH 147
           + +    +GEG FG+V K  ++K  +    AIK++         R+F+ E+  L     H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHD------------LRPDTRPLDWNTRM 195
           PN++ L+G C       L  EY P G+L   L                     L     +
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 196 KIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVST 255
             AA  +RG+ YL ++     I+RDL   NIL+ E Y  K++DFGL++      K    T
Sbjct: 131 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184

Query: 256 RVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM 315
                  + A +       T  SD++S+GV+L E+++            EL         
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244

Query: 316 FKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKY 375
            +   N                   +   +   C +E+P  RP+   ++++LN +  ++ 
Sbjct: 245 LEKPLNCDD----------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288

Query: 376 DPQNPP 381
              N  
Sbjct: 289 TYVNTT 294

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-59
 Identities = 63/276 (22%), Positives = 112/276 (40%), Gaps = 32/276 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F     LG+G FG VY    ++ + ++A+K L    +       +   EV       HP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N+++L GY  +  +  L+ EY PLG++ + L          D           +  L Y 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYC 122

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H +    VI+RD+K  N+LL      K++DFG +   PS  +T +     GT  Y  P+ 
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEM 175

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
                   K D++S GV+  E + G+   +    ++    ++     F D       V  
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTE 229

Query: 329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
             +             + +  ++  P+ RP + +V+
Sbjct: 230 GAR------------DLISRLLKHNPSQRPMLREVL 253

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 4e-59
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 34/293 (11%)

Query: 99  LGEGGFGKVYKGCL----EKIEQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVKL 153
           +G G FG+VYKG L     K E  VAIK L     +  R +F  E   +G   H N+++L
Sbjct: 15  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
            G  ++    +++ EYM  G+LDK L +             + +  G + G++YL     
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM-- 129

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPDYAMTG 272
              ++RDL   NIL+      K+SDFGL++ +    + T+ ++       + AP+     
Sbjct: 130 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188

Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           + T  SD++SFG+V+ E++T  +         E+                 + ++   + 
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----------------MKAINDGFRL 232

Query: 333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSS 385
             P+        +   C Q++   RP   D+V  L+ L       + P S  +
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI------RAPDSLKT 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-58
 Identities = 70/305 (22%), Positives = 131/305 (42%), Gaps = 30/305 (9%)

Query: 93  FRSDCCLGEGGFGKVYKGCL----EKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADH 147
           F+    LG G FG VYKG      EK++  VAIK+L      +  +E   E   + S D+
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P++ +L+G C     +L + + MP G L  ++ + +     +     +      ++G+ Y
Sbjct: 71  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNY 126

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           L     + +++RDL   N+L++   H K++DFGLAK+  + +K + +        + A +
Sbjct: 127 LE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
             +    T +SD++S+GV + EL+T            E+                S +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSILE 227

Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS--QKYDPQNPPSRSS 385
              +   P         I   C     + RP   ++++  + +A   Q+Y       R  
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 386 RKSPS 390
             SP+
Sbjct: 288 LPSPT 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  189 bits (482), Expect = 1e-57
 Identities = 69/272 (25%), Positives = 106/272 (38%), Gaps = 35/272 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSADHPNLVKLIG 155
           +G G FG VY     +  +VVAIK++ + G Q     ++   EV  L    HPN ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
                    LV EY    + D          +PL       +  GA +GL YLH      
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHS---HN 135

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT---G 272
           +I+RD+K  NILL E    KL DFG A +         +   +GT  + AP+  +    G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189

Query: 273 QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQG 332
           Q   K D++S G+  +EL   +  +        L  +A          ++S+        
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSE-------- 241

Query: 333 QYPVRGLYQALAIAAMCVQEQPNMRPAITDVV 364
                           C+Q+ P  RP    ++
Sbjct: 242 --------YFRNFVDSCLQKIPQDRPTSEVLL 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 69/284 (24%), Positives = 108/284 (38%), Gaps = 31/284 (10%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGV---QGVREFSAEVMTLGSA 145
           + R    LG+G FG V +G  +        VA+K L    +   + + +F  EV  + S 
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           DH NL++L G       ++ V E  PLGSL   L             T  + A   + G+
Sbjct: 69  DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGM 124

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHV-STRVMGTYGYC 264
            YL  +     I+RDL   N+LL      K+ DFGL +  P  D  +V        + +C
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 265 APDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKE-LNLVAWARPMFKDRKNFS 323
           AP+   T   +  SD + FGV L E+ T  +      +  + L+ +          ++  
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241

Query: 324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
           Q                    +   C   +P  RP    +   L
Sbjct: 242 Q----------------DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-56
 Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 28/293 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G+G  G VY        Q VAI+Q++ +          E++ +    +PN+V  +    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
            GD+  +V EY+  GSL   + +       +D      +     + L++LH      VI+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIH 139

Query: 219 RDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKS 278
           RD+K  NILL      KL+DFG              + ++GT  + AP+         K 
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197

Query: 279 DIYSFGVVLLELITGRKAIDQTKDRKELNLVA-WARPMFKDRKNFSQMVDPSLQGQYPVR 337
           DI+S G++ +E+I G          + L L+A    P  ++ +  S              
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA------------- 244

Query: 338 GLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPS 390
                      C+      R +  + ++   +L   K      P  ++ K  +
Sbjct: 245 ---IFRDFLNRCLDMDVEKRGSAKE-LLQHQFLKIAKPLSSLTPLIAAAKEAT 293

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 2e-55
 Identities = 68/281 (24%), Positives = 121/281 (43%), Gaps = 31/281 (11%)

Query: 99  LGEGGFGKVYKGCLEKI-----EQVVAIKQLDHRGVQGVR-EFSAEVMTLGSADHPNLVK 152
           LG+G FG VY+G  + +     E  VAIK ++       R EF  E   +   +  ++V+
Sbjct: 28  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQ 206
           L+G  ++G   L++ E M  G L  +L  LR      P   P   +  +++A   + G+ 
Sbjct: 88  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147

Query: 207 YLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAP 266
           YL+       ++RDL   N ++ E +  K+ DFG+ +     D      + +    + +P
Sbjct: 148 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 267 DYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV 326
           +    G  T  SD++SFGVVL E+ T  +   Q    +++        +     N   M+
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDML 264

Query: 327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL 367
                             +  MC Q  P MRP+  +++ ++
Sbjct: 265 ----------------FELMRMCWQYNPKMRPSFLEIISSI 289

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 4e-55
 Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 28/281 (9%)

Query: 98  CLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKL 153
           C+GEG FG V++G     E     VAIK   +     VRE F  E +T+   DHP++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           IG   E +   ++ E   LG L   L         LD  + +  A   S  L YL  +  
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
              ++RD+   N+L+      KL DFGL++        + +++      + AP+     +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185

Query: 274 LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQ 333
            T  SD++ FGV + E++       Q     ++      R    +R        P+L   
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV----IGRIENGERLPMPPNCPPTLY-- 239

Query: 334 YPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK 374
                     ++   C    P+ RP  T++   L+ +  ++
Sbjct: 240 ----------SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-53
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 10/231 (4%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LGEG F  V         +  AIK L+ R +     V   + E   +   DHP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
             VKL     + ++      Y   G L K++          D        A     L+YL
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H +    +I+RDLK  NILL E  H +++DFG AK+     K   +   +GT  Y +P+ 
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
                    SD+++ G ++ +L+ G        +      +      F ++
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 232

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 3e-52
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 38/292 (13%)

Query: 99  LGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRGVQG-VREFSAEVMTLGSADH-PNLV 151
           LG G FG+V +     I+     + VA+K L         R   +E+  L    H  N+V
Sbjct: 21  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80

Query: 152 KLIGYCAE-GDQRLLVYEYMPLGSLDKHLHDLRPDTRP------------LDWNTRMKIA 198
            L+G C + G   +++ E+   G+L  +L   R +  P            L     +  +
Sbjct: 81  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140

Query: 199 AGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVM 258
              ++G+++L  +     I+RDL   NILL E    K+ DFGLA+               
Sbjct: 141 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197

Query: 259 GTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
               + AP+       T +SD++SFGV+L E+ +                     P  K 
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---------------SPYPGVKI 242

Query: 319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL 370
            + F + +    + + P     +       C   +P+ RP  +++V  L  L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (443), Expect = 3e-52
 Identities = 66/295 (22%), Positives = 116/295 (39%), Gaps = 40/295 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQ-------VVAIKQLDHRGVQ-GVREFSAEVMTLGS-ADHPN 149
           LGEG FG+V       +++        VA+K L     +  + +  +E+  +     H N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDT------------RPLDWNTRMKI 197
           ++ L+G C +     ++ EY   G+L ++L   RP                L     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140

Query: 198 AAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRV 257
           A   +RG++YL  +     I+RDL   N+L+ E    K++DFGLA+     D    +T  
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 258 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFK 317
                + AP+       T +SD++SFGV+L E+ T   +       +EL  +        
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 257

Query: 318 DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS 372
              N +                 +   +   C    P+ RP    +V  L+ + +
Sbjct: 258 KPSNCTN----------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  171 bits (435), Expect = 2e-50
 Identities = 61/296 (20%), Positives = 104/296 (35%), Gaps = 30/296 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V++          A K +             E+ T+    HP LV L     
Sbjct: 34  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           + ++ +++YE+M  G L + + D       +  +  ++      +GL ++HE      ++
Sbjct: 94  DDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147

Query: 219 RDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
            DLK  NI+   +     KL DFGL           V     GT  + AP+ A    + +
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGY 204

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR--KNFSQMVDPSLQGQY 334
            +D++S GV+   L++G        D + L  V        D      S+          
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE---------- 254

Query: 335 PVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRSSRKSPS 390
                          +   PN R  I    +   +L       ++    SSR +  
Sbjct: 255 ------DGKDFIRKLLLADPNTRMTIHQ-ALEHPWLTPGNAPGRDSQIPSSRYTKI 303

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (428), Expect = 4e-50
 Identities = 60/285 (21%), Positives = 113/285 (39%), Gaps = 29/285 (10%)

Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG---VREFSAEVMTLGSAD 146
           +  +     LG GG  +V+     ++ + VA+K L     +       F  E     + +
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 147 HPNLVKLIGYCAE----GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
           HP +V +          G    +V EY+   +L   +H       P+     +++ A A 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADAC 121

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTY 261
           + L + H+     +I+RD+K +NI++      K+ DFG+A+ +  SG+    +  V+GT 
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN 321
            Y +P+ A    +  +SD+YS G VL E++TG                    P+    ++
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238

Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA 366
             + +   L             A+    + + P  R      + A
Sbjct: 239 --EGLSADLD------------AVVLKALAKNPENRYQTAAEMRA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 43/269 (15%), Positives = 100/269 (37%), Gaps = 30/269 (11%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V++      ++    K +  +G         E+  L  A H N++ L     
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
             ++ ++++E++    + + ++        L+    +         LQ+LH      + +
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 219 RDLKCSNILL--EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
            D++  NI+         K+ +FG A+    GD   +   +     Y AP+      ++ 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVST 182

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR--KNFSQMVDPSLQGQY 334
            +D++S G ++  L++G        +++ +  +  A   F +   K  S           
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI---------- 232

Query: 335 PVRGLYQALAIAAMCVQEQPNMRPAITDV 363
                 +A+      + ++   R   ++ 
Sbjct: 233 ------EAMDFVDRLLVKERKSRMTASEA 255

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  167 bits (423), Expect = 1e-48
 Identities = 54/267 (20%), Positives = 100/267 (37%), Gaps = 25/267 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G FG V++   +   +V   K ++            E+  +    HP L+ L     
Sbjct: 37  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 159 EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIY 218
           +  + +L+ E++  G L   +         +     +     A  GL+++HE     +++
Sbjct: 97  DKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHE---HSIVH 150

Query: 219 RDLKCSNILLE--EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
            D+K  NI+ E  +    K+ DFGLA      +          T  + AP+      + F
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGF 207

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPV 336
            +D+++ GV+   L++G        D + L  V      F D   FS +           
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF-DEDAFSSVSP--------- 257

Query: 337 RGLYQALAIAAMCVQEQPNMRPAITDV 363
               +A       +Q++P  R  + D 
Sbjct: 258 ----EAKDFIKNLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  164 bits (415), Expect = 6e-48
 Identities = 54/269 (20%), Positives = 91/269 (33%), Gaps = 26/269 (9%)

Query: 98  CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVRE-FSAEVMTLGSADHPNLVKLIGY 156
            LG G F +V     ++ +++VAIK +  + ++G       E+  L    HPN+V L   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
              G    L+ + +  G L   +     +          ++       ++YLH+      
Sbjct: 76  YESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
             +        L+E     +SDFGL+KM   G      +   GT GY AP+       + 
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSK 188

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF--KDRKNFSQMVDPSLQGQY 334
             D +S GV+   L+ G        D K    +  A   F      + S           
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISD---------- 238

Query: 335 PVRGLYQALAIAAMCVQEQPNMRPAITDV 363
                  A       +++ P  R      
Sbjct: 239 ------SAKDFIRHLMEKDPEKRFTCEQA 261

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 3e-47
 Identities = 76/311 (24%), Positives = 116/311 (37%), Gaps = 39/311 (12%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSA-DH 147
           +F     LG+G FGKV+    +K  Q  AIK L    V     V     E   L  A +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 148 PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQY 207
           P L  +       +    V EY+  G L  H+          D +     AA    GLQ+
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQF 118

Query: 208 LHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD 267
           LH    + ++YRDLK  NILL++  H K++DFG+ K    GD         GT  Y AP+
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173

Query: 268 YAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD 327
             +  +     D +SFGV+L E++ G+       + +  + +    P +       +   
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEK--- 228

Query: 328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY--------LASQKYDPQN 379
                        +A  +       +P  R  +   +             L  ++ DP  
Sbjct: 229 -------------EAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPF 275

Query: 380 PPSRSSRKSPS 390
            P   S    S
Sbjct: 276 RPKVKSPFDCS 286

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  162 bits (412), Expect = 6e-47
 Identities = 66/274 (24%), Positives = 106/274 (38%), Gaps = 33/274 (12%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMT---LGSA 145
           +F     +G GGFG+VY        ++ A+K LD + +   QG      E +    + + 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 146 DHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGL 205
           D P +V +       D+   + + M  G L  HL                  AA    GL
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF----SEADMRFYAAEIILGL 120

Query: 206 QYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           +++H    + V+YRDLK +NILL+E  H ++SD GLA               +GT+GY A
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173

Query: 266 PDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
           P+    G      +D +S G +L +L+ G     Q K + +  +                
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTMAVELPD 230

Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP 358
              P L+            ++    +Q   N R 
Sbjct: 231 SFSPELR------------SLLEGLLQRDVNRRL 252

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (404), Expect = 1e-46
 Identities = 64/290 (22%), Positives = 106/290 (36%), Gaps = 44/290 (15%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLD--------HRGVQGVRE-FSAEVMTL 142
           N+     LG G    V +   +   +  A+K +D           VQ +RE    EV  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 143 GS-ADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGA 201
              + HPN+++L           LV++ M  G L  +L +       L      KI    
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 119

Query: 202 SRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
              +  LH+     +++RDLK  NILL++  + KL+DFG +     G+K      V GT 
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTP 173

Query: 262 GYCAPDYAMTGQL------TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPM 315
            Y AP+               + D++S GV++  L+ G       K    L ++      
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233

Query: 316 FK--DRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
           F   +  ++S                     + +  +  QP  R    + 
Sbjct: 234 FGSPEWDDYSD----------------TVKDLVSRFLVVQPQKRYTAEEA 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  159 bits (403), Expect = 5e-46
 Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 15/231 (6%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F+    LG G FG+V+        +  A+K L    V   + V   + E + L    HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
            ++++ G   +  Q  ++ +Y+        L  L   ++          AA     L+YL
Sbjct: 65  FIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H +    +IYRDLK  NILL++  H K++DFG AK  P    T       GT  Y AP+ 
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYIAPEV 172

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
             T       D +SFG+++ E++ G      +   K    +  A   F   
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-45
 Identities = 69/300 (23%), Positives = 119/300 (39%), Gaps = 27/300 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-----VREFSAEVMTLGSADHPNLVKL 153
           LGEG F  VYK   +   Q+VAIK++             R    E+  L    HPN++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 154 IGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
           +          LV+++M           ++ ++  L  +          +GL+YLH+   
Sbjct: 66  LDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119

Query: 214 QPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQ 273
             +++RDLK +N+LL+E    KL+DFGLAK   S ++ +  T  + T  Y AP+     +
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176

Query: 274 L-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV--AWARPMFKDRKNFSQMVDPSL 330
           +     D+++ G +L EL+     +    D  +L  +      P  +   +   + D   
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 331 QGQYPVRGLY--------QALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPS 382
              +P   L+          L +        P  R   T   + + Y  S +  P     
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ-ALKMKYF-SNRPGPTPGCQ 294

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 28/283 (9%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           +G G FG VY+  L    ++VAIK++     Q  R  + E+  +   DH N+V+L  +  
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83

Query: 159 EGDQR------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
              ++       LV +Y+P        H  R   + L             R L Y+H   
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHS-- 140

Query: 213 KQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT 271
              + +RD+K  N+LL  +    KL DFG AK    G+     + +   Y          
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGA 197

Query: 272 GQLTFKSDIYSFGVVLLELITGRK------AIDQTKDRKELNLVAWARPMFKDRKNFSQM 325
              T   D++S G VL EL+ G+        +DQ  +  ++        + +   N+++ 
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257

Query: 326 VDPSLQGQYPVRGLY-----QALAIAAMCVQEQPNMRPAITDV 363
             P ++     +        +A+A+ +  ++  P  R    + 
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 4e-44
 Identities = 72/308 (23%), Positives = 122/308 (39%), Gaps = 22/308 (7%)

Query: 90  TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG-VREFSAEVMTLGSADHP 148
              + +   +GEG +G V        +  VAIK++     Q   +    E+  L    H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
           N++ +           +   Y+    +   L+ L   T+ L  +          RGL+Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYI 125

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK-MGPSGDKTHVSTRVMGTYGYCAPD 267
           H      V++RDLK SN+LL      K+ DFGLA+   P  D T   T  + T  Y AP+
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 268 YAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR--------PMFKD 318
             +  +  T   DI+S G +L E+++ R          +LN +                +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 319 RKNFSQMVDPSLQGQYPVRGLY-----QALAIAAMCVQEQPNMRPAITDVVMALNYLASQ 373
            K  + ++    + + P   L+     +AL +    +   P+ R  +    +A  YL  Q
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ-ALAHPYL-EQ 300

Query: 374 KYDPQNPP 381
            YDP + P
Sbjct: 301 YYDPSDEP 308

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 7e-44
 Identities = 63/296 (21%), Positives = 103/296 (34%), Gaps = 37/296 (12%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG------VREFSAEVMTLGSADHPNLVK 152
           LG G F  V K   +      A K +  R  +         +   EV  L    HPN++ 
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 153 LIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL 212
           L          +L+ E +  G     L D   +   L      +       G+ YLH   
Sbjct: 78  LHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL- 132

Query: 213 KQPVIYRDLKCSNILL----EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
              + + DLK  NI+L          K+ DFGLA     G++      + GT  + AP+ 
Sbjct: 133 --QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEI 187

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP 328
                L  ++D++S GV+   L++G         ++ L  V+     F+D          
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED---------- 237

Query: 329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPSRS 384
               +Y       A       + + P  R  I D  +   ++  +  D Q   S +
Sbjct: 238 ----EYFSNTSALAKDFIRRLLVKDPKKRMTIQD-SLQHPWI--KPKDTQQALSSA 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 25/283 (8%)

Query: 99  LGEGGFGKVYKG-CLEKIEQVVAIKQLDHRGVQGVREFS-----AEVMTLGSADHPNLVK 152
           +GEG +GKV+K   L+   + VA+K++  +  +     S     A +  L + +HPN+V+
Sbjct: 15  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 153 LIGYCAEGDQRLLVYEYMPLGSL--DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
           L   C            +    +  D   +  +     +   T   +     RGL +LH 
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                V++RDLK  NIL+      KL+DFGLA++          T V+ T  Y AP+  +
Sbjct: 135 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPEVLL 188

Query: 271 TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV----------AWARPMFKDRK 320
                   D++S G +  E+   +     + D  +L  +           W R +   R+
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248

Query: 321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
            F       ++ ++          +   C+   P  R +    
Sbjct: 249 AFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  151 bits (381), Expect = 3e-43
 Identities = 51/304 (16%), Positives = 94/304 (30%), Gaps = 37/304 (12%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PN 149
            +++    +GEG FG +++G      Q VAIK    R      +   E  T         
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +  +  +  EG   +LV + +           L    R     T    A      +Q +H
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHP-----KLSDFGLAKMGPSGD-----KTHVSTRVMG 259
           E+    ++YRD+K  N L+            + DFG+ K                  + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 260 TYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
           T  Y + +  +  + + + D+ + G V +  + G       K               +  
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK------YERIG 229

Query: 320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-------AITDVVMALNYLAS 372
           +         L   +P    Y+             +  P         + V+  LN    
Sbjct: 230 EKKQSTPLRELCAGFP-EEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

Query: 373 QKYD 376
           + +D
Sbjct: 286 ENFD 289

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 57/285 (20%), Positives = 104/285 (36%), Gaps = 20/285 (7%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPN 149
           NF+    +GEG +G VYK   +   +VVA+K++  D            E+  L   +HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 150 LVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +VKL+      ++  LV+E++                  +             +GL + H
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 210 EQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYA 269
                 V++RDLK  N+L+      KL+DFGLA+      +T+ +  V+  +        
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175

Query: 270 MTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPS 329
                +   DI+S G +  E++T R       +  +L  +        +         P 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 330 LQGQYPVRGLY-----------QALAIAAMCVQEQPNMRPAITDV 363
            +  +P                   ++ +  +   PN R +    
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (374), Expect = 4e-42
 Identities = 56/300 (18%), Positives = 99/300 (33%), Gaps = 29/300 (9%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNL 150
             +R    +G G FG +Y G      + VAIK    +      +   E            
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64

Query: 151 VKLIGYC-AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLH 209
           +  I +C AEGD  ++V E +     D         +R     T + +A      ++Y+H
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIH 120

Query: 210 EQLKQPVIYRDLKCSNIL---LEEGYHPKLSDFGLAKMGPSGD-----KTHVSTRVMGTY 261
            +     I+RD+K  N L    ++G    + DFGLAK               +  + GT 
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 262 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN 321
            Y + +  +  + + + D+ S G VL+    G       K   +           +  + 
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEK 231

Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMAL-NYLASQKYDPQNP 380
                   L   YP     +       C   + + +P  + +     N    Q +     
Sbjct: 232 KMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 56/283 (19%), Positives = 100/283 (35%), Gaps = 44/283 (15%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQL------DHRGVQGVREFSAEVMTLG- 143
             ++    LG GGFG VY G        VAIK +      D   +        EV+ L  
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 144 -SADHPNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGAS 202
            S+    +++L+ +    D  +L+ E              R     L             
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVL 120

Query: 203 RGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTY 261
             +++ H      V++RD+K  NIL+       KL DFG   +     K  V T   GT 
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTR 173

Query: 262 GYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK 320
            Y  P++    +     + ++S G++L +++ G    +  ++            + + + 
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQV 221

Query: 321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDV 363
            F Q V    Q             +   C+  +P+ RP   ++
Sbjct: 222 FFRQRVSSECQ------------HLIRWCLALRPSDRPTFEEI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 9e-41
 Identities = 65/332 (19%), Positives = 116/332 (34%), Gaps = 46/332 (13%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSA-DHPNLVKLIGYC 157
           LG G  GKV +   ++ ++  A+K L         +   EV     A   P++V+++   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 158 ----AEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLK 213
               A     L+V E +  G L   + D     +        +I       +QYLH    
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---S 129

Query: 214 QPVIYRDLKCSNILL---EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
             + +RD+K  N+L          KL+DFG AK   S +          T  Y AP+   
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186

Query: 271 TGQLTFKSDIYSFGVVLLELITGR------KAIDQTKDRKELNLVAWARPMFKDRKNFSQ 324
             +     D++S GV++  L+ G         +  +   K    +        +    S+
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246

Query: 325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNP--PS 382
                           +   +    ++ +P  R  IT+  M   ++      PQ P   S
Sbjct: 247 ----------------EVKMLIRNLLKTEPTQRMTITE-FMNHPWIMQSTKVPQTPLHTS 289

Query: 383 RSSRKSPSCLGVNKDDDHGKNARSASNREEVK 414
           R  ++        K++     A    + E++K
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDYEQIK 321

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 8e-40
 Identities = 63/230 (27%), Positives = 88/230 (38%), Gaps = 12/230 (5%)

Query: 92  NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHP 148
           +F     LG+G FGKV     +   +  A+K L    +     V     E   L +  HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 149 NLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYL 208
            L  L       D+   V EY   G L  HL       R           A     L+YL
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYL 121

Query: 209 HEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDY 268
           H +    V+YRD+K  N++L++  H K++DFGL K G S   T       GT  Y AP+ 
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEV 176

Query: 269 AMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD 318
                     D +  GVV+ E++ GR         +   L+      F  
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (355), Expect = 2e-39
 Identities = 50/278 (17%), Positives = 98/278 (35%), Gaps = 22/278 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +GEG +G VYK       +  A+K++  +            E+  L    H N+VKL   
Sbjct: 10  IGEGTYGVVYK-AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                + +LV+E++           L      L+  T          G+ Y H++    V
Sbjct: 69  IHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RV 121

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RDLK  N+L+      K++DFGLA+      + +    ++  +         + + + 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYST 180

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPV 336
             DI+S G +  E++ G        +  +L  +         +   +    P     + V
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 337 RGLY-----------QALAIAAMCVQEQPNMRPAITDV 363
                            + + +  ++  PN R      
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 51/279 (18%), Positives = 97/279 (34%), Gaps = 22/279 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +GEG +G V+K    +  ++VA+K++  D            E+  L    H N+V+L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                +  LV+E+                   LD            +GL + H    + V
Sbjct: 70  LHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNV 122

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           ++RDLK  N+L+      KL++FGLA+      + + S  V+  +             + 
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYST 181

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKEL---NLVAWARPMFKDRKNFSQMVDPSLQGQ 333
             D++S G +  EL    + +    D  +           P  +   + +++ D      
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 334 YPVRGLY---------QALAIAAMCVQEQPNMRPAITDV 363
           YP                  +    ++  P  R +  + 
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 56/300 (18%), Positives = 109/300 (36%), Gaps = 34/300 (11%)

Query: 91  GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQG--VREFSAEVMTLGSADHP 148
             +     +G+G FG+V+K    K  Q VA+K++     +         E+  L    H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 149 NLVKLIGYCAEGDQR--------LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAG 200
           N+V LI  C               LV+++          + L         +   ++   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125

Query: 201 ASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVS--TRVM 258
              GL Y+H      +++RD+K +N+L+      KL+DFGLA+       +  +  T  +
Sbjct: 126 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 259 GTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVA------- 310
            T  Y  P+  +  +      D++  G ++ E+ T    +    ++ +L L++       
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242

Query: 311 -WARPMFKDRKNFSQMVDPSLQGQYPVRGLY------QALAIAAMCVQEQPNMRPAITDV 363
               P   + + + ++     Q +     L        AL +    +   P  R    D 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 6e-36
 Identities = 53/224 (23%), Positives = 89/224 (39%), Gaps = 15/224 (6%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIG 155
           LG G FG+V     ++     A+K LD + V   + +     E   L + + P LVKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 156 YCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQP 215
              +     +V EY+  G +  HL                  AA      +YLH      
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---LD 161

Query: 216 VIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLT 275
           +IYRDLK  N+L+++  + +++DFG AK       T     + GT    AP+  ++    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYN 216

Query: 276 FKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR 319
              D ++ GV++ E+  G       +  +    +   +  F   
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 52/303 (17%), Positives = 100/303 (33%), Gaps = 26/303 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G +G V      +    VAIK+L    +     +    E+  L    H N++ L+  
Sbjct: 26  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
               +      ++  +                L  +    +     +GL+Y+H      +
Sbjct: 86  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGI 142

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           I+RDLK  N+ + E    K+ DFGLA+   S     ++  V+  +           + T 
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQ 198

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR--------------KNF 322
             DI+S G ++ E+ITG+     +    +L  +                        K  
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258

Query: 323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPS 382
            ++                A+ +    +      R    +  +A  Y  S  +D ++ P 
Sbjct: 259 PELEKKDFASILTNASP-LAVNLLEKMLVLDAEQRVTAGE-ALAHPYFES-LHDTEDEPQ 315

Query: 383 RSS 385
              
Sbjct: 316 VQK 318

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  128 bits (321), Expect = 3e-34
 Identities = 42/242 (17%), Positives = 94/242 (38%), Gaps = 24/242 (9%)

Query: 73  NSGKSAKPFTFDELAAATGN---FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV 129
           N+ +  + + ++      GN   ++    LG G + +V++       + V +K L     
Sbjct: 14  NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK 73

Query: 130 QGVREFSAEVMTLGS-ADHPNLVKLIGYCAEGDQRL--LVYEYMPLGSLDKHLHDLRPDT 186
           +   +   E+  L +    PN++ L     +   R   LV+E++      +         
Sbjct: 74  K---KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------- 123

Query: 187 RPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL-EEGYHPKLSDFGLAKMG 245
           + L             + L Y H      +++RD+K  N+++  E    +L D+GLA+  
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180

Query: 246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRK 304
             G +       + +  +  P+  +  Q+  +  D++S G +L  +I  ++      D  
Sbjct: 181 HPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

Query: 305 EL 306
           + 
Sbjct: 238 DQ 239

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-32
 Identities = 62/277 (22%), Positives = 100/277 (36%), Gaps = 32/277 (11%)

Query: 92  NFRSDCCLGEGGFGKVYKG---CLEKIEQVVAIKQLDHRGV----QGVREFSAEVMTLGS 144
           NF     LG G +GKV+           ++ A+K L    +    +       E   L  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 145 ADH-PNLVKLIGYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASR 203
               P LV L        +  L+ +Y+  G L  HL            +           
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVL 140

Query: 204 GLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGY 263
            L++LH+     +IYRD+K  NILL+   H  L+DFGL+K   + +    +    GT  Y
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEY 196

Query: 264 CAPDYAMTGQ--LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN 321
            APD    G        D +S GV++ EL+TG        ++     +  +R + K    
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEPP 254

Query: 322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP 358
           + Q +    +             +    + + P  R 
Sbjct: 255 YPQEMSALAK------------DLIQRLLMKDPKKRL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 62/299 (20%), Positives = 106/299 (35%), Gaps = 24/299 (8%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G +G V      K    VA+K+L    + +   +    E+  L    H N++ L+  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 157 CAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPV 216
                      +   +  L     +     + L  +    +     RGL+Y+H      +
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142

Query: 217 IYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTF 276
           I+RDLK SN+ + E    K+ DFGLA+        +V+TR    +               
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMHYNQ 198

Query: 277 KSDIYSFGVVLLELITGRKAIDQTKDRKELNLV-----AWARPMFKDRKNFSQMVDPSLQ 331
             DI+S G ++ EL+TGR     T    +L L+          + K   + S        
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258

Query: 332 GQYPVRGLY--------QALAIAAMCVQEQPNMRPAITDVVMALNYLASQKYDPQNPPS 382
            Q P              A+ +    +    + R       +A  Y  +Q +DP + P 
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ-ALAHAYF-AQYHDPDDEPV 315

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 6e-30
 Identities = 47/204 (23%), Positives = 84/204 (41%), Gaps = 21/204 (10%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQL--DHRGVQGVREFSAEVMTLGSADHPNLVKLIGY 156
           +G G  G V       +++ VAIK+L    +     +    E++ +   +H N++ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 157 CA------EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE 210
                   E     LV E M                  LD      +      G+++LH 
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHS 137

Query: 211 QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAM 270
                +I+RDLK SNI+++     K+ DFGLA+   +   + + T  + T  Y AP+  +
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 271 TGQLTFKSDIYSFGVVLLELITGR 294
                   DI+S G ++ E++  +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (279), Expect = 3e-28
 Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 16/209 (7%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCA 158
           LG G F  V+          VA+K +    V        E+  L   +  +  K     A
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 159 EGDQRLLVYEY------------MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQ 206
               +LL +                +   +      + + R +      +I+     GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 207 YLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCA 265
           Y+H   +  +I+ D+K  N+L+E       L    +A +G +       T  + T  Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 266 PDYAMTGQLTFKSDIYSFGVVLLELITGR 294
           P+  +       +DI+S   ++ ELITG 
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.8 bits (183), Expect = 2e-16
 Identities = 22/159 (13%), Positives = 48/159 (30%), Gaps = 30/159 (18%)

Query: 99  LGEGGFGKVYKGCLEKIEQVVAIK----------QLDHRGVQGVREFSAEVMTLGSADHP 148
           +GEG    V+    EK      +K          ++  +   G   FS   +     +  
Sbjct: 8   MGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 149 NLVKLIGYCA----EGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRG 204
            L KL G         +   ++ E +              +   +      ++       
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILEE 115

Query: 205 LQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK 243
           +   +    + +++ DL   N+L+ E     + DF  + 
Sbjct: 116 VAKFYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	426
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.07
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.01
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.02
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.82
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.74

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=426.81  Aligned_cols=254  Identities=25%  Similarity=0.313  Sum_probs=209.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++..... ...+.+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            3579999999999999999999999999999999976533 334668999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.++|..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            9999999999865    46799999999999999999999998   9999999999999999999999999999865444


Q ss_pred             CCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .........+||+.|||||++.+..+ +.++|||||||++|||++|+.||.................             
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~-------------  223 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-------------  223 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC-------------
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-------------
Confidence            33333455689999999999988876 5789999999999999999999976554322211111000             


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        .........+.++.+|+.+||+.||.+|||++||++
T Consensus       224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              000112233457889999999999999999999874

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-58  Score=427.35  Aligned_cols=262  Identities=29%  Similarity=0.479  Sum_probs=209.3

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR--GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ..++|.+.+.||+|+||+||+|+++.   .||||++...  .....+.|.+|+.+|++++|||||++++++.+ +.+++|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            35789999999999999999998753   4999998754  33456789999999999999999999998765 568999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||||++|+|.+++..   ....+++..++.++.||+.||+|||+.   +||||||||+||||+.++.+||+|||+|+...
T Consensus        82 ~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            999999999999976   345699999999999999999999997   99999999999999999999999999998655


Q ss_pred             CCCCcceeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ............||+.|||||++.+   ..|+.++|||||||++|||+||+.||.................         
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~---------  226 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY---------  226 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTS---------
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCC---------
Confidence            4433344455689999999999864   3589999999999999999999999987655443322221110         


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        ..+.+ ...+..++..+.+|+.+||+.||.+|||+.+|++.|+.+++
T Consensus       227 --~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         227 --LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             --CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              00100 11233445688999999999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-57  Score=425.03  Aligned_cols=250  Identities=24%  Similarity=0.330  Sum_probs=214.5

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            46999999999999999999999999999999998765556678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      +||+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus       100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            99999998865     4699999999999999999999997   999999999999999999999999999986543322


Q ss_pred             cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.....               .
T Consensus       172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~---------------~  234 (293)
T d1yhwa1         172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---------------P  234 (293)
T ss_dssp             --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS---------------C
T ss_pred             --cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC---------------C
Confidence              23445899999999999999999999999999999999999999987665443322221100               0


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01123445568899999999999999999999985

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.7e-58  Score=428.80  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=219.7

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      +...++|++.+.||+|+||+||+|.++.+++.||||++.... ...++|.+|+.+|+.++|||||+++++|.+.+.+++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            344567999999999999999999999999999999997543 4467899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+||||++++.+||+|||+|+...
T Consensus        92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999999763  346799999999999999999999997   99999999999999999999999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-cHHHhhhhhhhcccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-NLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  325 (426)
                      ... ........||+.|+|||++.+..|+.++|||||||++|||++|..||......... ..+.               
T Consensus       167 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~---------------  230 (287)
T d1opja_         167 GDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------  230 (287)
T ss_dssp             SSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---------------
T ss_pred             CCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh---------------
Confidence            332 22333456899999999999999999999999999999999977776544332221 1111               


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        ...+...|..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       231 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         231 --KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             --cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              111223344556689999999999999999999999999987753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=419.03  Aligned_cols=246  Identities=25%  Similarity=0.414  Sum_probs=212.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+..   ......+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999999986432   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |||++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999986    35699999999999999999999998   999999999999999999999999999976433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..    .....||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+....              
T Consensus       159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------------  220 (263)
T d2j4za1         159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--------------  220 (263)
T ss_dssp             CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------------
T ss_pred             Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            22    234589999999999999999999999999999999999999998765544332222110              


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ..+|...+.++.+|+.+||+.||.+|||+.||++
T Consensus       221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                1123334568899999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-57  Score=425.69  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=205.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE---EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ---VVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||+||+|.++.+++   .||||.+..... ...+.|.+|+.+|++++|||||+++|+|.+.+.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            467888999999999999999976654   689999876433 4456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      ||||++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999998876   345799999999999999999999997   99999999999999999999999999998654


Q ss_pred             CCCCcc---eeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          247 SGDKTH---VSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       247 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ......   ......||+.|||||++.++.++.++|||||||++|||+| |+.||...........+..           
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-----------  248 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-----------  248 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-----------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence            332211   1122468999999999999999999999999999999998 8999987665433322221           


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                            ..+...+..++..+.+|+.+||+.||.+||++.+|++.|+.+.+.
T Consensus       249 ------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 ------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                  111123444566889999999999999999999999999988653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-57  Score=421.98  Aligned_cols=256  Identities=22%  Similarity=0.305  Sum_probs=201.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEee--CCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAE--GDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv  166 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||.+.....  ...+.+.+|+.+|+.++|||||++++++.+  ...+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            579999999999999999999999999999999976543  345668999999999999999999999865  4568999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL--KQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ||||++|+|.+++.........+++..++.++.||+.||.|||+..  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999999764444577999999999999999999999861  12499999999999999999999999999987


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....  .......||+.|||||++.+..|+.++|||||||++|||+||+.||...........+...        .+  
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~--------~~--  231 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG--------KF--  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--------CC--
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC--------CC--
Confidence            54322  2234468999999999999999999999999999999999999999876544332222110        00  


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             ...|...+.++.+|+.+||+.||.+|||+.||++
T Consensus       232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                   1123344568899999999999999999999974

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-57  Score=423.51  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=213.8

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      +.|++.+.||+|+||+||+|++..+++.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999999999999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++|+|.+++...   ..++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--  163 (288)
T d2jfla1          92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--  163 (288)
T ss_dssp             TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC--
Confidence            999999998763   46799999999999999999999998   9999999999999999999999999999753221  


Q ss_pred             cceeeeecccccccCccccc-----cCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          251 THVSTRVMGTYGYCAPDYAM-----TGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                      ........||+.|+|||++.     +..|+.++|||||||++|||++|+.||...........+.....           
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-----------  232 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-----------  232 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-----------
T ss_pred             cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence            11223458999999999984     45689999999999999999999999987765543322221100           


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          .....+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       233 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 ----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                011123445668899999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=415.82  Aligned_cols=257  Identities=26%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||+||+|.+.. +..||||++.... ...++|.+|+.+++.++|||||+++|+|.+++.+++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3578999999999999999999875 6789999997643 3457799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||++++.+||+|||+++......
T Consensus        82 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          82 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             cCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            999999999876   346789999999999999999999997   99999999999999999999999999998654332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhC-CCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITG-RKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      . .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||...........+...                
T Consensus       156 ~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~----------------  218 (263)
T d1sm2a_         156 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------------  218 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT----------------
T ss_pred             c-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc----------------
Confidence            2 222345789999999999999999999999999999999995 5555544332222222111                


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                       .+...|..++.++.+|+.+||+.||.+|||+++|++.|+.++.
T Consensus       219 -~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         219 -FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence             1112233445688999999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-57  Score=422.47  Aligned_cols=251  Identities=24%  Similarity=0.302  Sum_probs=210.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++....   ....+.+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            46999999999999999999999999999999997532   234567999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||++||+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999876    35799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+...      .        
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~------~--------  226 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL------E--------  226 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT------C--------
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC------C--------
Confidence            44333444568999999999999999999999999999999999999999876544433222210      0        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                          ..+|...+.++.+|+.+||+.||.+|||++|++..
T Consensus       227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                11233445688999999999999999999998643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=415.93  Aligned_cols=259  Identities=25%  Similarity=0.386  Sum_probs=210.8

Q ss_pred             HhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           88 AATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        88 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ...++|++.+.||+|+||+||+|.++. +..||||++.... ...+.|.+|+.++++++|||||+++|++.+ +.+++||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            344679999999999999999999874 7889999997643 345779999999999999999999998865 5679999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+||||++++.+||+|||+|+....
T Consensus        87 Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          87 EYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             ECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            999999999987653  234699999999999999999999997   999999999999999999999999999987543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCC-CCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAI-DQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      .. ........||+.|+|||++.++.++.++|||||||++|||+||..|+ ...........+..               
T Consensus       162 ~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~---------------  225 (272)
T d1qpca_         162 NE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------------  225 (272)
T ss_dssp             SC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------------
T ss_pred             Cc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------------
Confidence            32 22233457899999999999999999999999999999999965555 43332222211110               


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                        ..+...|..++.++.+|+.+||+.||++|||+.+|++.|+.+-+
T Consensus       226 --~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         226 --GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence              11112234455688999999999999999999999999987643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-56  Score=424.15  Aligned_cols=260  Identities=25%  Similarity=0.378  Sum_probs=212.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCC-----EEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIE-----QVVAIKQLDHRG-VQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~  162 (426)
                      .++|++.+.||+|+||+||+|++..++     ..||+|.+.... ......+.+|+.+|.++ +|||||+++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            357999999999999999999987544     369999986543 34456789999999988 89999999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCC
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRP-------------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKC  223 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp  223 (426)
                      +++|||||++|+|.++|+....                   ....+++..++.++.||+.||.|||+.   +||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCch
Confidence            9999999999999999976321                   124589999999999999999999997   999999999


Q ss_pred             CCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCc
Q 014362          224 SNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKD  302 (426)
Q Consensus       224 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~  302 (426)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |..||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986554444434445678999999999999999999999999999999998 8999987654


Q ss_pred             hhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHH
Q 014362          303 RKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALN  368 (426)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~  368 (426)
                      ...+..+..                ...+...|..++.++.+|+.+||+.||++|||++||++.|.
T Consensus       273 ~~~~~~~~~----------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKLIQ----------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHHHH----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHh----------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            433221111                11122334455678999999999999999999999999885

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-56  Score=424.50  Aligned_cols=266  Identities=22%  Similarity=0.282  Sum_probs=208.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG-VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|+.++|||||+++++|.+...+|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            467999999999999999999999999999999997643 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |++||+|.+++..    ...+++..++.++.||+.||.|||+.  ++|+||||||+||||+.++.+||+|||+|+.... 
T Consensus        85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  157 (322)
T ss_dssp             CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence            9999999999986    35699999999999999999999973  2899999999999999999999999999985322 


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHH-Hhhhhhhh----------
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLV-AWARPMFK----------  317 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~----------  317 (426)
                         ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||............ ........          
T Consensus       158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             ---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence               1223468999999999999999999999999999999999999999765432211000 00000000          


Q ss_pred             --------cc---ccccccc----CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 --------DR---KNFSQMV----DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 --------~~---~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                              ..   ....+..    ............+.++.+|+.+||+.||.+|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    00   0000000    000000011123567899999999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=408.60  Aligned_cols=247  Identities=25%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             cccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee----CCeeEEEE
Q 014362           94 RSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE----GDQRLLVY  167 (426)
Q Consensus        94 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~lv~  167 (426)
                      +....||+|+||+||+|.+..+++.||+|.+....  ....+.+.+|+.+|+.++|||||+++++|.+    ...+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999999999999999999987543  3345678999999999999999999999865    34689999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec-cCCceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE-EGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~-~~~~~kl~Dfgla~~~~  246 (426)
                      ||+++|+|.+++..    ...+++..++.++.||+.||.|||+. +.+|+||||||+||||+ +++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999976    35699999999999999999999987 12399999999999997 47899999999998643


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ..    .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.............     ... .     .
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i-----~~~-~-----~  230 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV-----TSG-V-----K  230 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH-----TTT-C-----C
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH-----HcC-C-----C
Confidence            22    2234689999999998865 69999999999999999999999997654433221111     000 0     0


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .+    .++...+.++.+|+.+||+.||++|||+.|+++
T Consensus       231 ~~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Cc----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            00    112223447889999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.8e-55  Score=421.60  Aligned_cols=253  Identities=22%  Similarity=0.282  Sum_probs=214.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999999999999999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc--CCceeEecccccccCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE--GYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~--~~~~kl~Dfgla~~~~~  247 (426)
                      |+||+|.+++..   ....+++..++.++.||+.||.|||+.   +||||||||+|||++.  ++.+||+|||+++....
T Consensus       105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999999865   245699999999999999999999998   9999999999999964  67899999999986543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..   ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+.....      .+.    
T Consensus       179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------~~~----  245 (350)
T d1koaa2         179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW------NMD----  245 (350)
T ss_dssp             TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC------CSC----
T ss_pred             cc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------CCC----
Confidence            32   23446899999999999999999999999999999999999999987665444333321111      000    


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       246 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         246 ----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ----CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ----cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0111234457899999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=410.44  Aligned_cols=257  Identities=25%  Similarity=0.354  Sum_probs=211.7

Q ss_pred             CCccccce-eeecCcEEEEEEEEcC--CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCC-LGEGGFGKVYKGCLEK--IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|.+... ||+|+||+||+|.++.  ++..||||.+..... ...+.|.+|+.+|+.++|||||+++|++.+ +.+|||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            35666664 9999999999998753  456899999976533 346779999999999999999999999975 468899


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++...
T Consensus        87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence            999999999998865   346799999999999999999999997   99999999999999999999999999998654


Q ss_pred             CCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          247 SGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       247 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+..             
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~-------------  227 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------------  227 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-------------
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------------
Confidence            43322 22234578999999999999999999999999999999998 8999987654433222221             


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                          ..+...|..++.++.+|+.+||+.+|++||++.+|++.|+.+.
T Consensus       228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                1111234455668899999999999999999999999998664

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=403.22  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=215.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||+||+|+++ ++..||||.+..... ..++|.+|+.+++.++||||++++|+|.+...+++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            367999999999999999999986 588999999986543 457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|..++..   ....+++..+++++.||++||.|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999999765   346789999999999999999999997   99999999999999999999999999998654332


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      . .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+...                
T Consensus       155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~----------------  217 (258)
T d1k2pa_         155 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----------------  217 (258)
T ss_dssp             C-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT----------------
T ss_pred             c-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC----------------
Confidence            2 22334579999999999999999999999999999999998 89999877654433222211                


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHH
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNY  369 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~  369 (426)
                       .+...|...+..+.+|+.+||+.||++|||+++|++.|..
T Consensus       218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence             1112234445688999999999999999999999998853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=409.75  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=205.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCC----EEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIE----QVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      +.|+..+.||+|+||+||+|.++.++    ..||||.+..... .....|.+|+.+|+.++|||||+++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46888999999999999999987654    5799999975433 334568999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+.+|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++..
T Consensus        87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence            9999999999998876   346799999999999999999999997   9999999999999999999999999999865


Q ss_pred             CCCCC-cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcC-chhhhcHHHhhhhhhhcccccc
Q 014362          246 PSGDK-THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK-DRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       246 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      ..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+.... .......+.             
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-------------  227 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-------------  227 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------------
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-------------
Confidence            43222 222334578999999999999999999999999999999999766654433 222211111             


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                          ...+...+..++..+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus       228 ----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         228 ----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ----TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                112223344455688999999999999999999999999998865

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-55  Score=417.33  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=197.1

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ..+.|++.+.||+|+||+||+|+++.+++.||||++...... ....+.+|+.+|+.++|||||++++++.+++.+||||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            346799999999999999999999999999999999765432 3456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec---cCCceeEeccccccc
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKM  244 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~  244 (426)
                      |||+||+|.++|..    ...+++..+..++.||+.||.|||+.   +|+||||||+|||+.   +++.+||+|||+++.
T Consensus        87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999975    46799999999999999999999997   999999999999995   578999999999986


Q ss_pred             CCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .....   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.....          
T Consensus       160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~----------  226 (307)
T d1a06a_         160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY----------  226 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC----------
T ss_pred             ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC----------
Confidence            43322   22345799999999999999999999999999999999999999987654433322221100          


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          ......+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       227 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         227 ----EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                0111122334568899999999999999999999985

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-55  Score=406.71  Aligned_cols=249  Identities=28%  Similarity=0.419  Sum_probs=204.2

Q ss_pred             ceeeecCcEEEEEEEEc--CCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEecCC
Q 014362           97 CCLGEGGFGKVYKGCLE--KIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYMPL  172 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  172 (426)
                      +.||+|+||+||+|.+.  .+++.||||++....  ....+.|.+|+.+|++++|||||+++++|.+ +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999875  456889999997542  2345679999999999999999999999965 457899999999


Q ss_pred             CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCCc-
Q 014362          173 GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDKT-  251 (426)
Q Consensus       173 gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-  251 (426)
                      |+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++........ 
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999986    46699999999999999999999997   9999999999999999999999999999865443322 


Q ss_pred             ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccCCcc
Q 014362          252 HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDPSL  330 (426)
Q Consensus       252 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (426)
                      .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.........+..                 ..
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-----------------~~  227 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-----------------GE  227 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------TC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-----------------CC
Confidence            22234579999999999999999999999999999999998 8999987654433222221                 11


Q ss_pred             cCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          331 QGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       331 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                      +...|..++.++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            1223445566889999999999999999999999888754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.9e-55  Score=419.61  Aligned_cols=253  Identities=20%  Similarity=0.268  Sum_probs=215.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++..........+.+|+.+|+.++|||||+++++|.++..+||||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999999999999999999876655667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec--cCCceeEecccccccCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE--EGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~--~~~~~kl~Dfgla~~~~~  247 (426)
                      |+||+|.+++..   ...++++.+++.++.||+.||.|||+.   +|+||||||+||||+  .++.+||+|||+|+....
T Consensus       108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999887764   345799999999999999999999987   999999999999998  578999999999987544


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+.....             
T Consensus       182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-------------  245 (352)
T d1koba_         182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW-------------  245 (352)
T ss_dssp             TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC-------------
T ss_pred             CC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-------------
Confidence            32   23446899999999999999999999999999999999999999987665544333321110             


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       ......+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       246 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         246 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0111122334568899999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-55  Score=414.19  Aligned_cols=245  Identities=28%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      .|+..+.||+|+||+||+|++..+++.||||++.....   ...+.+.+|+.+|+.++|||||++++++.+.+.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999976543   234668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ||++|+|..++..    ..++++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+|+.....
T Consensus        96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            9999999776654    46799999999999999999999998   9999999999999999999999999999854322


Q ss_pred             CCcceeeeecccccccCcccccc---CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMT---GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQM  325 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (426)
                            ....||+.|||||++.+   +.|+.++|||||||++|||++|..||...........+....        ... 
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~--------~~~-  233 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--------SPA-  233 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------CCC-
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------CCC-
Confidence                  23579999999999864   468999999999999999999999998765443332221100        000 


Q ss_pred             cCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          326 VDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       326 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                          +   .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       234 ----~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 ----L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ----C---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----C---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                0   12233458899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=413.35  Aligned_cols=248  Identities=27%  Similarity=0.347  Sum_probs=213.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            57999999999999999999999999999999997542   234677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      |||+||+|..++..    ...+++..++.++.||+.||.|||+.   +||||||||+|||++.+|.+||+|||+|+....
T Consensus        85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999987    35699999999999999999999998   999999999999999999999999999986433


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      ..  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+....              
T Consensus       158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--------------  221 (337)
T d1o6la_         158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--------------  221 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred             CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--------------
Confidence            22  22344689999999999999999999999999999999999999998776544332222110              


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                          ..+|...+.++.+||.+||+.||.+||+     +.+|++
T Consensus       222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                1223445568899999999999999995     788875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=408.27  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=211.5

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQR  163 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  163 (426)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+...      ...+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3579999999999999999999999999999999975422      2356799999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC----ceeEecc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY----HPKLSDF  239 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~----~~kl~Df  239 (426)
                      |||||||++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++    .+||+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            999999999999999976    35699999999999999999999998   999999999999998776    4999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDR  319 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  319 (426)
                      |+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.....     
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~-----  233 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-----  233 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC-----
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----
Confidence            99986543322   2345799999999999999999999999999999999999999987665443332221110     


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                       .+..        ..+...+..+.+|+.+||+.||.+|||++||++
T Consensus       234 -~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 -EFED--------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -CCCH--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCCc--------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000        011223457889999999999999999999985

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=409.32  Aligned_cols=258  Identities=25%  Similarity=0.414  Sum_probs=210.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCE----EEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQ----VVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|.+... .....+.|.+|+.+++.++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999987775    5888988653 334567899999999999999999999999875 5678


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ++||+.+|+|.+.+..   ....+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            8999999999998876   356799999999999999999999997   9999999999999999999999999999876


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.........+...            
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~------------  229 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------------  229 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT------------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------------
Confidence            55444444445579999999999999999999999999999999999 78898776544333222211            


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                           .+...|..++..+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus       230 -----~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         230 -----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                 1112344556688999999999999999999999999988864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-54  Score=406.90  Aligned_cols=266  Identities=26%  Similarity=0.412  Sum_probs=217.4

Q ss_pred             HHHhcCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEee
Q 014362           86 LAAATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAE  159 (426)
Q Consensus        86 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~  159 (426)
                      ++...++|++.+.||+|+||+||+|+++.     +++.||||++...... ..++|.+|+.+|+.++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            33345689999999999999999999863     5688999999765433 45679999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLR--------------------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR  219 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~  219 (426)
                      ....++||||+++|+|.++++...                    .....+++..++.++.||+.||+|||+.   +||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEee
Confidence            999999999999999999997532                    1224589999999999999999999997   99999


Q ss_pred             CCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC-CCCC
Q 014362          220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR-KAID  298 (426)
Q Consensus       220 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~  298 (426)
                      ||||+||||+.++.+||+|||+|+...........+...||+.|+|||++.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998654443344445567999999999999999999999999999999999996 5777


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                      .....+....+...                 .....|...+.++.+|+.+||+.+|++||||.||++.|+.+.
T Consensus       245 ~~~~~e~~~~v~~~-----------------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVIYYVRDG-----------------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHHHHHHTT-----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHcC-----------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            66554433222211                 011223444568899999999999999999999999998774

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.2e-54  Score=406.42  Aligned_cols=245  Identities=26%  Similarity=0.368  Sum_probs=211.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.   .....+.+.+|+.+|+.++|||||++++++.+...+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4699999999999999999999999999999999753   2234677899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||++||+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.+|.+||+|||+|+....
T Consensus        84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999998876    46689999999999999999999987   999999999999999999999999999986543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     ....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+...      .        
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~--------  217 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------E--------  217 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------C--------
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC------C--------
Confidence            2     23468999999999999999999999999999999999999999876654433222211      0        


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                          ..+|...+.++.+++.+||+.||.+||     ++++|++
T Consensus       218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                012333455789999999999999996     8999885

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-54  Score=402.09  Aligned_cols=258  Identities=27%  Similarity=0.396  Sum_probs=205.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEe
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEY  169 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  169 (426)
                      .++|++.+.||+|+||+||+|+++.+ ..||||++.... ...+.|.+|+.+++.++|||||+++++|.+ +.+++||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence            35799999999999999999999874 579999997553 345779999999999999999999999965 568899999


Q ss_pred             cCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCC
Q 014362          170 MPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGD  249 (426)
Q Consensus       170 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~  249 (426)
                      +++|+|..++...  ....+++.+++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999988753  235699999999999999999999997   99999999999999999999999999998654322


Q ss_pred             CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcC-chhhhcHHHhhhhhhhcccccccccCC
Q 014362          250 KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTK-DRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       250 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                       ........||+.|+|||++..+.++.++|||||||++|||++|..|+.... .......+..                 
T Consensus       168 -~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~-----------------  229 (285)
T d1fmka3         168 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-----------------  229 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-----------------
T ss_pred             -ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------------
Confidence             222344579999999999999999999999999999999999766654433 3222222211                 


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ......+..++.++.+|+.+||+.||++||++.+|++.|+.+.+.
T Consensus       230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            111123344556889999999999999999999999999876543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=406.32  Aligned_cols=274  Identities=23%  Similarity=0.321  Sum_probs=209.6

Q ss_pred             CcCHHHHHHhcCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcce
Q 014362           80 PFTFDELAAATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVK  152 (426)
Q Consensus        80 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~  152 (426)
                      |+...+++...++|++.+.||+|+||.||+|.+..     +++.||||++..... ...+.+..|..++.++ +|+||+.
T Consensus         2 p~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~   81 (299)
T d1ywna1           2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   81 (299)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence            34556665666789999999999999999999754     457899999975433 3456677888877776 6899999


Q ss_pred             EeeEEeeC-CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEec
Q 014362          153 LIGYCAEG-DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYR  219 (426)
Q Consensus       153 ~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~  219 (426)
                      +++++... ..+++|||||++|+|.++|+....            ....+++..++.++.||+.||.|||+.   +||||
T Consensus        82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr  158 (299)
T d1ywna1          82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  158 (299)
T ss_dssp             EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence            99998654 468999999999999999975321            134589999999999999999999997   99999


Q ss_pred             CCCCCCeeeccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC-CCCC
Q 014362          220 DLKCSNILLEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR-KAID  298 (426)
Q Consensus       220 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~  298 (426)
                      ||||+||||++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998654444333444568999999999999999999999999999999999975 5776


Q ss_pred             CcCchhhhcHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          299 QTKDRKELNLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      .............      .          ..+...|...+.++.+|+.+||+.||.+|||+.||++.|+.+.+
T Consensus       239 ~~~~~~~~~~~~~------~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         239 GVKIDEEFCRRLK------E----------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             TCCCSHHHHHHHH------H----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHh------c----------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            5543332211110      0          01112334455688999999999999999999999999998753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.4e-53  Score=398.02  Aligned_cols=261  Identities=21%  Similarity=0.272  Sum_probs=207.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC----e
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----Q  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~  162 (426)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....   .....+.+|+.+|+.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            4679999999999999999999999999999999976433   33567899999999999999999999987654    3


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +||||||++|++|..++..    ...+++.+++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence            7899999999999998876    35799999999999999999999997   9999999999999999999999999998


Q ss_pred             ccCCCCC-CcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          243 KMGPSGD-KTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       243 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ....... ........+||+.|+|||++.+..++.++|||||||++|||+||+.||...............      ...
T Consensus       159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~------~~~  232 (277)
T d1o6ya_         159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE------DPI  232 (277)
T ss_dssp             EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------CCC
T ss_pred             hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhc------CCC
Confidence            7543322 222334468999999999999999999999999999999999999999876654433222111      111


Q ss_pred             cccccCCcccCCCChHhHHHHHHHHHhccccCCCCCC-CHHHHHHHHHHHH
Q 014362          322 FSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-AITDVVMALNYLA  371 (426)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~  371 (426)
                      ....        .....+.++.+|+.+||+.||.+|| +++++++.|..+.
T Consensus       233 ~~~~--------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPSA--------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGGG--------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCch--------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1111        1122345789999999999999999 8999999888764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-53  Score=406.38  Aligned_cols=245  Identities=22%  Similarity=0.274  Sum_probs=210.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  167 (426)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+.++|||||++++++.+...+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999999999999999986532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPS  247 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~  247 (426)
                      ||+.+|+|..++..    ...+++..++.++.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+....
T Consensus       121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999976    35699999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          248 GDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       248 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                      .     .....||+.|||||++.+..++.++|||||||++|||+||+.||.+.........+....              
T Consensus       194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--------------  254 (350)
T d1rdqe_         194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------------  254 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------------
T ss_pred             c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC--------------
Confidence            2     234579999999999999999999999999999999999999998765444333222110              


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRP-----AITDVVM  365 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~  365 (426)
                          ...|...+.++.+|+.+||+.||.+|+     ++++|++
T Consensus       255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                012333456889999999999999994     8999985

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=396.05  Aligned_cols=258  Identities=25%  Similarity=0.375  Sum_probs=204.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHRGVQ-GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLL  165 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  165 (426)
                      .++|++.+.||+|+||.||+|.+..+   +..||||.+...... ..+.|.+|+.+|+.++|||||++++++.+ +.+++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            35799999999999999999998654   457999998764433 35679999999999999999999999964 67899


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccC
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMG  245 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~  245 (426)
                      ||||+++|+|.+++..   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus        85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999998776   346799999999999999999999998   9999999999999999999999999999865


Q ss_pred             CCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccccc
Q 014362          246 PSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQ  324 (426)
Q Consensus       246 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (426)
                      .... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+...            
T Consensus       159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~------------  225 (273)
T d1mp8a_         159 EDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG------------  225 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT------------
T ss_pred             cCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence            4322 223344578999999999999999999999999999999998 89999876654433222210            


Q ss_pred             ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          325 MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       325 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                           .....|..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                 0112344455689999999999999999999999999988753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-54  Score=395.50  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=204.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEee-CCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||.||+|.++  |..||||+++..  ...+.|.+|+.++++++||||++++|+|.+ .+.+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            356888999999999999999986  788999999754  345779999999999999999999999855 456899999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+++|+|.++|...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 y~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          82 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             ccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999753  124589999999999999999999997   9999999999999999999999999999854322


Q ss_pred             CCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhcccccccccC
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVD  327 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (426)
                           .....+|+.|+|||++.++.++.++|||||||++|||+| |++||...........+.                 
T Consensus       157 -----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-----------------  214 (262)
T d1byga_         157 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----------------  214 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-----------------
T ss_pred             -----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-----------------
Confidence                 223468999999999999999999999999999999998 688887654433222211                 


Q ss_pred             CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          328 PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       328 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ...+...|...+.++.+|+.+||+.||.+|||+.+|++.|+.++..
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            1122233445556889999999999999999999999999998753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=402.13  Aligned_cols=253  Identities=16%  Similarity=0.229  Sum_probs=211.8

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ..++|++.+.||+|+||+||+|.++.+++.||||.+..... ....+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            35789999999999999999999999999999999976543 34568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccC--CceeEecccccccCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEG--YHPKLSDFGLAKMGP  246 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~--~~~kl~Dfgla~~~~  246 (426)
                      ||+||+|.+++..   ....+++.+++.++.||+.||.|||+.   +|+||||||+|||++.+  +.+||+|||+++...
T Consensus        82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            9999999999975   245799999999999999999999997   99999999999999854  579999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...   ......||+.|+|||.+.+..++.++|||||||++|+|++|..||...........+.....      .+....
T Consensus       156 ~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~------~~~~~~  226 (321)
T d1tkia_         156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY------TFDEEA  226 (321)
T ss_dssp             TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC------CCCHHH
T ss_pred             cCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------CCChhh
Confidence            332   23446799999999999999999999999999999999999999987765443333221110      010000


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                              ....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       227 --------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 --------FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0123457899999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.8e-53  Score=392.76  Aligned_cols=252  Identities=23%  Similarity=0.250  Sum_probs=210.7

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc---------cHHHHHHHHHHHhcCC-CCCcceEeeEEee
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ---------GVREFSAEVMTLGSAD-HPNLVKLIGYCAE  159 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpniv~~~~~~~~  159 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++......         ..+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999999999999999999765321         1235888999999997 9999999999999


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ++..|||||||++|+|.++|..    ..++++..++.++.||+.||+|||+.   +|+||||||+||||+.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            9999999999999999999976    35799999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCcccccc------CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhh
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMT------GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~  313 (426)
                      |+++......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||...........+....
T Consensus       155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            9998754432   2244689999999999863      357889999999999999999999998776544332222111


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      .      .        .........+.++.+|+.+||+.||.+||++.||++
T Consensus       232 ~------~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 Y------Q--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             C------C--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C------C--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            0      0        111122345568999999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=403.52  Aligned_cols=248  Identities=29%  Similarity=0.440  Sum_probs=208.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC---cccHHHHHHHHHHHh-cCCCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG---VQGVREFSAEVMTLG-SADHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.+..   ....+.+..|..++. .++|||||++++++.++..+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999999999999999997532   233456667777665 68999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCC
Q 014362          167 YEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGP  246 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~  246 (426)
                      |||+++|+|.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            999999999999986    35689999999999999999999998   99999999999999999999999999998644


Q ss_pred             CCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccccccccc
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMV  326 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (426)
                      ...  ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....+            
T Consensus       155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~------------  220 (320)
T d1xjda_         155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP------------  220 (320)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------------
T ss_pred             ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            322  223446899999999999999999999999999999999999999987665443333221110            


Q ss_pred             CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 014362          327 DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT-DVVM  365 (426)
Q Consensus       327 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~  365 (426)
                            .+|...+.++.+|+.+||+.||.+||++. ++++
T Consensus       221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                  12333456789999999999999999996 6753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1e-52  Score=405.94  Aligned_cols=249  Identities=26%  Similarity=0.336  Sum_probs=204.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc---ccHHHH---HHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV---QGVREF---SAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~---~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ++|++.+.||+|+||.||+|++..+|+.||||++.+...   .....+   ..++.+++.++|||||+++++|.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            579999999999999999999999999999999864321   112223   34577788889999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +|||||+||+|.++|..    ...+++..++.++.||+.||.|||+.   +||||||||+||||+.+|.+||+|||+|+.
T Consensus        84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999986    35689999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccc
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFS  323 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (426)
                      .....    ....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.||..............   ...      
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~------  223 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLT------  223 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSS------
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccc------
Confidence            54322    234579999999999975 4689999999999999999999999987554332211111   000      


Q ss_pred             cccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          324 QMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                            .....+...+.++.+||.+||+.||.+||+     ++||++
T Consensus       224 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                  011123344568899999999999999999     688874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-53  Score=398.27  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=211.7

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEE--EEEEEeccC-CcccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCCeeEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQV--VAIKQLDHR-GVQGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv  166 (426)
                      ++|++.+.||+|+||+||+|.++.++..  ||||.+... .....+.|.+|+.+|+.+ +|||||+++++|.+.+.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            5788999999999999999999888764  778887643 234566799999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhhh------------CCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          167 YEYMPLGSLDKHLHDL------------RPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       167 ~e~~~~gsL~~~l~~~------------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      |||+++|+|.++|+..            ......+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence            9999999999999753            12346799999999999999999999998   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCC-CCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRK-AIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...........+.   
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~---  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---  240 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence            999999998543221   1223468999999999999999999999999999999999764 666554333221111   


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                                    ...+...+...+.++.+|+.+||+.||++||++.+|++.|+.+....
T Consensus       241 --------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         241 --------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             --------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             --------------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                          01112234455678999999999999999999999999999987643

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=396.38  Aligned_cols=257  Identities=27%  Similarity=0.376  Sum_probs=201.9

Q ss_pred             CCccccceeeecCcEEEEEEEEcCC---CEEEEEEEeccC---CcccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKI---EQVVAIKQLDHR---GVQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  164 (426)
                      ++|++.+.||+|+||.||+|++...   ...||||++...   .....+.|.+|+.+|+.++|||||+++|+|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5699999999999999999987532   347999998754   23445779999999999999999999999976 4678


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      +||||+++|+|.+++...   ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||+|||+++.
T Consensus        87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            999999999999888763   45699999999999999999999997   999999999999999999999999999987


Q ss_pred             CCCCCCc-ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhcHHHhhhhhhhccccc
Q 014362          245 GPSGDKT-HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELNLVAWARPMFKDRKNF  322 (426)
Q Consensus       245 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (426)
                      ....... .......||..|+|||++.+..++.++|||||||++|||+| |+.||.+.........+..      .    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~------~----  230 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------E----  230 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------S----
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh------C----
Confidence            5443322 22334568889999999999999999999999999999998 8999987665443322221      1    


Q ss_pred             ccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHH
Q 014362          323 SQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYL  370 (426)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l  370 (426)
                            ..+...+...+..+.+|+.+||+.||.+|||+.+|++.|...
T Consensus       231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                  111122334456789999999999999999999999988754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=397.68  Aligned_cols=264  Identities=25%  Similarity=0.376  Sum_probs=213.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCC-------EEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIE-------QVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEG  160 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~  160 (426)
                      .++|.+.+.||+|+||.||+|++..++       ..||||++..... .....+.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            357999999999999999999986544       4799999976543 3456788898888887 899999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeee
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLRP------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILL  228 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll  228 (426)
                      ...++||||+++|+|.++|.....            ....+++..++.++.||+.||.|||+.   +||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence            999999999999999999976421            235689999999999999999999998   99999999999999


Q ss_pred             ccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhhc
Q 014362          229 EEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKELN  307 (426)
Q Consensus       229 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~~  307 (426)
                      +.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||..........
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            9999999999999986554444444455689999999999999999999999999999999998 688887655433222


Q ss_pred             HHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          308 LVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      .+..                 ..+...|...+..+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus       249 ~i~~-----------------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         249 LLKE-----------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HHHT-----------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHc-----------------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            2111                 111122334556889999999999999999999999999998654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-53  Score=398.70  Aligned_cols=265  Identities=26%  Similarity=0.390  Sum_probs=217.9

Q ss_pred             hcCCccccceeeecCcEEEEEEEEc-----CCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCCcceEeeEEeeCC
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLE-----KIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSA-DHPNLVKLIGYCAEGD  161 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~  161 (426)
                      ..++|++.+.||+|+||.||+|++.     .+++.||||++..... .....|.+|+.+++.+ +|||||+++++|.+..
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            3467999999999999999999873     4578999999976443 3456789999999998 6999999999999999


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCee
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRP--------------DTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNIL  227 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIl  227 (426)
                      .+++|||||++|+|.++++....              ....+++..++.++.||+.||.|||+.   +++||||||+|||
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccc
Confidence            99999999999999999976431              234699999999999999999999998   9999999999999


Q ss_pred             eccCCceeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHh-CCCCCCCcCchhhh
Q 014362          228 LEEGYHPKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELIT-GRKAIDQTKDRKEL  306 (426)
Q Consensus       228 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt-g~~p~~~~~~~~~~  306 (426)
                      ++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||.........
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987655544455556789999999999999999999999999999999999 55556554443322


Q ss_pred             cHHHhhhhhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          307 NLVAWARPMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                      ..+.                ....+...+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       258 ~~~i----------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         258 YKMI----------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHH----------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH----------------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            1111                1111222233445688999999999999999999999999987644

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=400.58  Aligned_cols=252  Identities=21%  Similarity=0.238  Sum_probs=201.8

Q ss_pred             cCCccccc-eeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHh-cCCCCCcceEeeEEee----CCee
Q 014362           90 TGNFRSDC-CLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLG-SADHPNLVKLIGYCAE----GDQR  163 (426)
Q Consensus        90 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~----~~~~  163 (426)
                      .++|.+.. .||+|+||+||+|++..+++.||||++...     ..+.+|+.++. .++|||||+++++|.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            45798875 599999999999999999999999998643     56778998865 4589999999999875    4568


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc---CCceeEeccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE---GYHPKLSDFG  240 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~---~~~~kl~Dfg  240 (426)
                      |+|||||+||+|.++|...  ....+++.+++.++.||+.||.|||+.   +|+||||||+|||++.   .+.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            9999999999999999752  235799999999999999999999998   9999999999999985   5679999999


Q ss_pred             ccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          241 LAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       241 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      +|+.......   ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.........+..         
T Consensus       160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~---------  227 (335)
T d2ozaa1         160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---------  227 (335)
T ss_dssp             TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred             eeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH---------
Confidence            9986544322   2345899999999999999999999999999999999999999976543322211110         


Q ss_pred             ccccccCCc--ccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 014362          321 NFSQMVDPS--LQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMA  366 (426)
Q Consensus       321 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  366 (426)
                         .+....  +........+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       228 ---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         228 ---RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               000000  0011112445689999999999999999999999863

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-52  Score=390.74  Aligned_cols=261  Identities=25%  Similarity=0.252  Sum_probs=201.2

Q ss_pred             cceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEEec
Q 014362           96 DCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ-----GVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYEYM  170 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  170 (426)
                      +++||+|+||+||+|+++.+|+.||||++......     ..+.+.+|+.+|+.++|||||++++++.+++.+|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            46799999999999999999999999998754322     2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      .++++..++.    ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          83 ETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             SEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             cchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9887765554    356799999999999999999999997   999999999999999999999999999986443322


Q ss_pred             cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh-----hccccccc
Q 014362          251 THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF-----KDRKNFSQ  324 (426)
Q Consensus       251 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  324 (426)
                        .....+||+.|+|||++... .|+.++|||||||++|||++|.+||.+....+.+..+.......     ........
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             --cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence              22345799999999998754 67999999999999999999999998877655544333211100     00000000


Q ss_pred             ccCCcccCCCC-----hHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          325 MVDPSLQGQYP-----VRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       325 ~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..........+     ...+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000111     123457899999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=391.05  Aligned_cols=267  Identities=22%  Similarity=0.267  Sum_probs=205.3

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++.....  .....+.+|+.+|+.++|||||++++++.++..+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            589999999999999999999999999999999965432  345778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+.++ +..++...  ....+++..++.++.||+.||.|||+.   +||||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99755 44444331  356799999999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCcceeeeecccccccCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc-----cccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD-----RKNF  322 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~  322 (426)
                      ..  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.........+.........     ....
T Consensus       156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (298)
T d1gz8a_         156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM  233 (298)
T ss_dssp             SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence            22  223357999999999887665 578999999999999999999999877654443332211100000     0000


Q ss_pred             ccc---cCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          323 SQM---VDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       323 ~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...   ........   .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000   00000000   01123457899999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=390.17  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             cceeeecCcEEEEEEEEcCCC---EEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCCcceEeeEEee-CCeeEEEEEec
Q 014362           96 DCCLGEGGFGKVYKGCLEKIE---QVVAIKQLDHR-GVQGVREFSAEVMTLGSADHPNLVKLIGYCAE-GDQRLLVYEYM  170 (426)
Q Consensus        96 ~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~  170 (426)
                      .++||+|+||+||+|++..++   ..||||.+... .....++|.+|+.+|++++||||++++|++.+ +..+++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            457999999999999986543   46999999753 34456789999999999999999999999875 45889999999


Q ss_pred             CCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCCCC
Q 014362          171 PLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSGDK  250 (426)
Q Consensus       171 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  250 (426)
                      ++|+|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+||||++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999999876   346688999999999999999999997   999999999999999999999999999986543322


Q ss_pred             c--ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccccccccCC
Q 014362          251 T--HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKNFSQMVDP  328 (426)
Q Consensus       251 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (426)
                      .  .......||+.|+|||.+.++.++.++||||||+++|||+||..||.........  ...   ...           
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~--~~~---i~~-----------  249 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVY---LLQ-----------  249 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------C--HHH---HHT-----------
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH--HHH---HHc-----------
Confidence            1  2223357899999999999999999999999999999999988887654322111  111   000           


Q ss_pred             cccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          329 SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       329 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                      ..+...|..++..+.+|+.+||+.||.+||++.||++.|+.+.+.
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            011122334456889999999999999999999999999999764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=394.87  Aligned_cols=265  Identities=26%  Similarity=0.399  Sum_probs=216.8

Q ss_pred             HHhcCCccccceeeecCcEEEEEEEEcC-----CCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeC
Q 014362           87 AAATGNFRSDCCLGEGGFGKVYKGCLEK-----IEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEG  160 (426)
Q Consensus        87 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  160 (426)
                      +...++|.+.+.||+|+||+||+|.++.     ++..||||++..... .....|.+|+.++++++|||||+++++|...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            3345689999999999999999999863     357899999976433 3445689999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCHHHHhhhhC------CCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          161 DQRLLVYEYMPLGSLDKHLHDLR------PDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       161 ~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      ...++||||+++|+|.+++....      .....+++..+..++.||+.||.|||+.   +|+||||||+|||+++++.+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~  172 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  172 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence            99999999999999999886421      2235679999999999999999999997   99999999999999999999


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCC-CCCCCcCchhhhcHHHhhh
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGR-KAIDQTKDRKELNLVAWAR  313 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~-~p~~~~~~~~~~~~~~~~~  313 (426)
                      ||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. +||...........+... 
T Consensus       173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-  251 (308)
T d1p4oa_         173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-  251 (308)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-
T ss_pred             EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-
Confidence            999999998654433333334457899999999999999999999999999999999985 677665544333222210 


Q ss_pred             hhhhcccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHH
Q 014362          314 PMFKDRKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLA  371 (426)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~  371 (426)
                                      .....|..++..+.+|+.+||+.+|.+|||+.+|++.|+...
T Consensus       252 ----------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         252 ----------------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ----------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                            011223344568999999999999999999999999987653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=390.25  Aligned_cols=268  Identities=25%  Similarity=0.314  Sum_probs=202.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHH--HHHHHHhcCCCCCcceEeeEEeeCC----eeE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFS--AEVMTLGSADHPNLVKLIGYCAEGD----QRL  164 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~--~E~~~l~~l~hpniv~~~~~~~~~~----~~~  164 (426)
                      .+|.+.+.||+|+||.||+|++.  |+.||||++....   ...+.  .|+..+..++|||||++++++.+..    .+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            46788889999999999999975  8899999996542   23333  4555566789999999999997654    589


Q ss_pred             EEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----CCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          165 LVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQ-----LKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       165 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-----~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      +|||||++|+|.++|+.     ..+++..++.++.|++.||.|||+.     ..++|+||||||+||||+.++.+||+||
T Consensus        78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF  152 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence            99999999999999986     4699999999999999999999973     1359999999999999999999999999


Q ss_pred             cccccCCCCCCc--ceeeeecccccccCccccccCC------CCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc----
Q 014362          240 GLAKMGPSGDKT--HVSTRVMGTYGYCAPDYAMTGQ------LTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN----  307 (426)
Q Consensus       240 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~----  307 (426)
                      |+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..||..........    
T Consensus       153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~  232 (303)
T d1vjya_         153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence            999865433221  1233468999999999987543      6789999999999999999998885433221110    


Q ss_pred             ----HHHhhhhhhhcccccccccCCcccCCC-ChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhC
Q 014362          308 ----LVAWARPMFKDRKNFSQMVDPSLQGQY-PVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQ  373 (426)
Q Consensus       308 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~  373 (426)
                          .........     ....+.+.+.... +......+.+|+.+||+.||.+|||+.||++.|+.+..+
T Consensus       233 ~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         233 PSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                000000000     0111111111111 223456789999999999999999999999999998754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-52  Score=385.20  Aligned_cols=241  Identities=21%  Similarity=0.338  Sum_probs=200.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc------ccHHHHHHHHHHHhcCC--CCCcceEeeEEeeCC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV------QGVREFSAEVMTLGSAD--HPNLVKLIGYCAEGD  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~  161 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....      .....+.+|+.+|+.++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            4689999999999999999999999999999999875322      12234678999999886  899999999999999


Q ss_pred             eeEEEEEecCC-CCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-CCceeEecc
Q 014362          162 QRLLVYEYMPL-GSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-GYHPKLSDF  239 (426)
Q Consensus       162 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-~~~~kl~Df  239 (426)
                      ..++||||+.+ +++.+++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++. ++.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 578888765    35799999999999999999999997   9999999999999985 479999999


Q ss_pred             cccccCCCCCCcceeeeecccccccCccccccCCC-CccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          240 GLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQL-TFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       240 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      |+|+.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....      +.      ..
T Consensus       156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~------~~  219 (273)
T d1xwsa_         156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II------RG  219 (273)
T ss_dssp             TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH------HC
T ss_pred             ccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hh------hc
Confidence            999864332    2234689999999999987765 5789999999999999999999975321      11      00


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..            .++...+.++.+|+.+||+.||.+|||++|+++
T Consensus       220 ~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00            112233457899999999999999999999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=383.82  Aligned_cols=267  Identities=22%  Similarity=0.268  Sum_probs=203.8

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCC-CEEEEEEEeccCC--cccHHHHHHHHHHHhcC---CCCCcceEeeEEee----
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKI-EQVVAIKQLDHRG--VQGVREFSAEVMTLGSA---DHPNLVKLIGYCAE----  159 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~~~~~~~~----  159 (426)
                      .++|++.+.||+|+||+||+|++..+ ++.||||++....  ......+.+|+.+|+.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            36899999999999999999999654 7789999986532  22234466777776655   89999999999853    


Q ss_pred             -CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEec
Q 014362          160 -GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSD  238 (426)
Q Consensus       160 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~D  238 (426)
                       ...++++|||+.++.+......   ....+++..++.++.||+.||+|||+.   +|+||||||+|||++..+.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             3468999999998777554443   356799999999999999999999997   999999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh--
Q 014362          239 FGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF--  316 (426)
Q Consensus       239 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--  316 (426)
                      ||+++....   ........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.......  
T Consensus       160 fg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  236 (305)
T d1blxa_         160 FGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE  236 (305)
T ss_dssp             CCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred             hhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence            999875332   223345689999999999999999999999999999999999999998877655544433221100  


Q ss_pred             ---hcccccccc-cC---CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 ---KDRKNFSQM-VD---PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 ---~~~~~~~~~-~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                         ......... ..   ......++...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               000000000 00   00011122334567899999999999999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.9e-50  Score=378.56  Aligned_cols=265  Identities=21%  Similarity=0.234  Sum_probs=205.0

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++.....  .....+.+|+.+|+.++|||||++++++.+....++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            58999999999999999999986 689999999976432  335779999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      |+.++.+..+...    ...+++..++.++.||+.||+|||+.   +||||||||+|||++.++.+||+|||++......
T Consensus        81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            9987777666543    47799999999999999999999997   9999999999999999999999999999864432


Q ss_pred             CCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh-----hccccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF-----KDRKNF  322 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~  322 (426)
                      ..  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.......     ......
T Consensus       154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (286)
T d1ob3a_         154 VR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL  231 (286)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence            22  22334689999999998764 56899999999999999999999998766554433322111000     000000


Q ss_pred             cccc------CCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          323 SQMV------DPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       323 ~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....      .+..........+..+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000      000011122334568899999999999999999999984

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=380.47  Aligned_cols=263  Identities=23%  Similarity=0.274  Sum_probs=200.4

Q ss_pred             CccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcceEeeEEeeC------CeeEE
Q 014362           92 NFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLVKLIGYCAEG------DQRLL  165 (426)
Q Consensus        92 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~------~~~~l  165 (426)
                      +|+..++||+|+||+||+|++..+|+.||||++.....    .+.+|+.+|+.++||||++++++|...      .+++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            58889999999999999999999999999999976432    234799999999999999999998543      35789


Q ss_pred             EEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEeccccccc
Q 014362          166 VYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKM  244 (426)
Q Consensus       166 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~  244 (426)
                      |||||+++.+..+.. .......+++..++.++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.
T Consensus        97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            999998664444332 222456799999999999999999999987   999999999999999775 899999999986


Q ss_pred             CCCCCCcceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-----hhh-
Q 014362          245 GPSGDKTHVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-----MFK-  317 (426)
Q Consensus       245 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~-  317 (426)
                      ......   .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.+..+.....     .+. 
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            543322   233579999999998875 4789999999999999999999999987765544433321100     000 


Q ss_pred             cc-----cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          318 DR-----KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       318 ~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ..     ..+................+..+.+|+.+||+.||.+|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00     0011111111111122334567899999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=374.20  Aligned_cols=269  Identities=20%  Similarity=0.249  Sum_probs=203.1

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee--------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE--------  159 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--------  159 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....  ......+.+|+.+|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            368999999999999999999999999999999986542  2345678899999999999999999998855        


Q ss_pred             CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecc
Q 014362          160 GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDF  239 (426)
Q Consensus       160 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Df  239 (426)
                      ....|+||||+.++.+.....    ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            345799999998776654443    356799999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCC--cceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhh
Q 014362          240 GLAKMGPSGDK--THVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMF  316 (426)
Q Consensus       240 gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  316 (426)
                      |+++.......  .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.......
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99975443221  1122335799999999998765 68999999999999999999999998776655544443322111


Q ss_pred             hccc--c-----cccccCCcccCCCCh-------HhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          317 KDRK--N-----FSQMVDPSLQGQYPV-------RGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       317 ~~~~--~-----~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ....  .     ....+........+.       .....+.+|+.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1000  0     000000000000111       11346788999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-48  Score=367.74  Aligned_cols=263  Identities=20%  Similarity=0.209  Sum_probs=203.4

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCCcc-eEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPNLV-KLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.....  ..++..|+++++.++|+|++ .+.+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4579999999999999999999999999999999876433  24578899999999877655 55566678888999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeec---cCCceeEecccccccC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLE---EGYHPKLSDFGLAKMG  245 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~---~~~~~kl~Dfgla~~~  245 (426)
                      |+ +++|...+..   ....+++..+..++.||+.||+|||+.   +|+||||||+|||++   .+..+||+|||+|+..
T Consensus        84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99 5667666654   346799999999999999999999998   999999999999875   4567999999999865


Q ss_pred             CCCCCc-----ceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhh-hhhhhcc
Q 014362          246 PSGDKT-----HVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWA-RPMFKDR  319 (426)
Q Consensus       246 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~  319 (426)
                      ......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ...... 
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-
Confidence            432211     1233467999999999999999999999999999999999999999876544333222111 110000 


Q ss_pred             cccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHh
Q 014362          320 KNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLAS  372 (426)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~  372 (426)
                       ..     +.+    ...++.++.+|+..||+.+|.+||++.+|.+.|+.+..
T Consensus       236 -~~-----~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         236 -PI-----EVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             -CH-----HHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             -Ch-----hHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence             00     001    11233578999999999999999999999998887643

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-49  Score=379.18  Aligned_cols=261  Identities=22%  Similarity=0.271  Sum_probs=200.6

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC------
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV--QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD------  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~------  161 (426)
                      .++|++.+.||+|+||+||+|.++.+|+.||||++.....  ...+.+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4689999999999999999999999999999999975432  34567889999999999999999999997654      


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+|+||||+ +.+|..+++.     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence            579999999 6778877764     5699999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc--
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD--  318 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  318 (426)
                      |+.....     .+...||+.|+|||++.+. .++.++|||||||++|||++|+.||.....................  
T Consensus       168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            9864332     2345799999999998764 5689999999999999999999999877654443322211110000  


Q ss_pred             ------------ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 ------------RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                                  ...+.......+. ......+..+.+|+.+||+.||.+|||+.||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                        0000000000010 112233457889999999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=7.2e-49  Score=368.66  Aligned_cols=266  Identities=18%  Similarity=0.185  Sum_probs=211.9

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCC-CCcceEeeEEeeCCeeEEEEE
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e  168 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....  ....+.+|++.++.+.| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            578999999999999999999999999999999986543  23457788899988875 899999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeecc-----CCceeEecccccc
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEE-----GYHPKLSDFGLAK  243 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~-----~~~~kl~Dfgla~  243 (426)
                      |+ +++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.     .+.+||+|||+|+
T Consensus        82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99 7899998876   345799999999999999999999987   9999999999999974     5789999999998


Q ss_pred             cCCCCCC-----cceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc
Q 014362          244 MGPSGDK-----THVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD  318 (426)
Q Consensus       244 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  318 (426)
                      .......     ........||+.|||||++.+..++.++|||||||++|||++|+.||.+.................. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-  233 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-  233 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-
Confidence            6543221     1123346899999999999999999999999999999999999999986554332221111100000 


Q ss_pred             ccccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHHHHHHHHhCC
Q 014362          319 RKNFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVMALNYLASQK  374 (426)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~~  374 (426)
                      .....+     +.    ...+.++.+++..|+..+|.+||+++.+.+.|+.+....
T Consensus       234 ~~~~~~-----l~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         234 STPLRE-----LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HSCHHH-----HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCChHH-----hc----CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            000011     11    122347889999999999999999999999888875443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=378.84  Aligned_cols=269  Identities=21%  Similarity=0.238  Sum_probs=202.2

Q ss_pred             hcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCCcceEeeEEeeCC----ee
Q 014362           89 ATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGV-QGVREFSAEVMTLGSADHPNLVKLIGYCAEGD----QR  163 (426)
Q Consensus        89 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~  163 (426)
                      .+.+|++++.||+|+||+||+|.++.+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            34679999999999999999999999999999999976433 34567899999999999999999999987643    23


Q ss_pred             EEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          164 LLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       164 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                      +++++|+.+|+|.+++..     ..+++..++.++.||+.||+|||+.   +||||||||+||||+.++.+||+|||+++
T Consensus        86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            455666779999999975     4699999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCCCCCc-ceeeeecccccccCcccccc-CCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhcccc
Q 014362          244 MGPSGDKT-HVSTRVMGTYGYCAPDYAMT-GQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRKN  321 (426)
Q Consensus       244 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  321 (426)
                      ........ ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||........................
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            54332211 12234579999999999854 46789999999999999999999999876654433322211110000000


Q ss_pred             -------ccc-ccCCcccCCC-----ChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 -------FSQ-MVDPSLQGQY-----PVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 -------~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                             ... ..........     ....+.++.+|+.+||+.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   000 0000000000     1122347899999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=364.11  Aligned_cols=266  Identities=18%  Similarity=0.204  Sum_probs=209.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeCCeeEEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      ++|++.+.||+|+||+||+|++..+++.||||++....  ......+.+|+.+|+.++||||++++++|.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999986543  2346778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccccccCCCC
Q 014362          169 YMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAKMGPSG  248 (426)
Q Consensus       169 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~~~~~  248 (426)
                      ++.+++|..++..    ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.++.....
T Consensus        82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999988887764    46789999999999999999999997   9999999999999999999999999999865433


Q ss_pred             CCcceeeeecccccccCccccccCC-CCccCchhhHHHHHHHHHhCCCCCCCcCc-hhhhcHHHhhhhhhhc-----ccc
Q 014362          249 DKTHVSTRVMGTYGYCAPDYAMTGQ-LTFKSDIYSFGVVLLELITGRKAIDQTKD-RKELNLVAWARPMFKD-----RKN  321 (426)
Q Consensus       249 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlG~il~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~-----~~~  321 (426)
                      ..  ......+++.|+|||++.... ++.++|||||||++|||++|+.||..... ......+.........     ...
T Consensus       155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence            22  223346788999999987665 68999999999999999999999754433 2222222111110000     000


Q ss_pred             ccc------ccCCcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          322 FSQ------MVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       322 ~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ...      ..........+...+..+.+|+.+||+.||.+|||++||++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000      00001111223344567899999999999999999999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.1e-48  Score=368.50  Aligned_cols=259  Identities=16%  Similarity=0.222  Sum_probs=201.1

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeC--CeeEEEE
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEG--DQRLLVY  167 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~--~~~~lv~  167 (426)
                      ++|++.+.||+|+||+||+|++..+|+.||||++...   ..+.+.+|+.+|+.+. ||||++++++|...  ..+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            4799999999999999999999999999999999754   3467889999999995 99999999999743  5689999


Q ss_pred             EecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCC-ceeEecccccccCC
Q 014362          168 EYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGY-HPKLSDFGLAKMGP  246 (426)
Q Consensus       168 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~-~~kl~Dfgla~~~~  246 (426)
                      ||+.+++|..+.       ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++ .+||+|||+|+...
T Consensus       112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence            999999986653       3599999999999999999999998   999999999999998655 69999999998654


Q ss_pred             CCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhh-cHHHhh----------h-
Q 014362          247 SGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKEL-NLVAWA----------R-  313 (426)
Q Consensus       247 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~----------~-  313 (426)
                      ....   ....+||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+...          . 
T Consensus       182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            3322   2345799999999998765 4799999999999999999999999765433211 111100          0 


Q ss_pred             hhhhcccccccccC--------CcccCCCChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          314 PMFKDRKNFSQMVD--------PSLQGQYPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       314 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                      ........+.....        ...........+.++.+|+.+||+.||.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000111111        11111122334568899999999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=368.99  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=205.9

Q ss_pred             CCccccceeeecCcEEEEEEEE---cCCCEEEEEEEeccCC----cccHHHHHHHHHHHhcCCC-CCcceEeeEEeeCCe
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCL---EKIEQVVAIKQLDHRG----VQGVREFSAEVMTLGSADH-PNLVKLIGYCAEGDQ  162 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~----~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~  162 (426)
                      ++|++.+.||+|+||+||+|.+   +.+|+.||||++....    ....+.+.+|+.+|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   4478999999987532    2345678899999999976 899999999999999


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      +++||||+.+|+|..++..    ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999987    35678899999999999999999997   9999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccC--CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhccc
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG--QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKDRK  320 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  320 (426)
                      +........ ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+....  ...  
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~--  251 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKS--  251 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHC--
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccC--
Confidence            865433222 22345799999999999765  46889999999999999999999998765444333222111  110  


Q ss_pred             ccccccCCcccCCCChHhHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 014362          321 NFSQMVDPSLQGQYPVRGLYQALAIAAMCVQEQPNMRPA-----ITDVVM  365 (426)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~  365 (426)
                                ...+|...+.++.+|+.+||+.||.+||+     ++|+++
T Consensus       252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                      01123445668999999999999999994     788874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-48  Score=372.28  Aligned_cols=263  Identities=22%  Similarity=0.244  Sum_probs=196.3

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEee------CC
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAE------GD  161 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~  161 (426)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++....  ......+.+|+.+|+.++|||||+++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999999999999999997543  2345668899999999999999999999953      36


Q ss_pred             eeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEecccc
Q 014362          162 QRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGL  241 (426)
Q Consensus       162 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgl  241 (426)
                      .+|+||||+.++.+ ..+.      ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            88999999976544 4442      3589999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhh-------
Q 014362          242 AKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARP-------  314 (426)
Q Consensus       242 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~-------  314 (426)
                      ++.....   ...+..+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.....       
T Consensus       166 ~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         166 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            8754332   223445799999999999999999999999999999999999999987654443322211000       


Q ss_pred             ---------hhhcc-----cccccccCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          315 ---------MFKDR-----KNFSQMVDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       315 ---------~~~~~-----~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                               .....     ..............   .+...+..+.+|+.+||+.||++|||++||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     00000     00111111111111   12234668899999999999999999999984

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=369.13  Aligned_cols=263  Identities=21%  Similarity=0.254  Sum_probs=201.2

Q ss_pred             cCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCCcceEeeEEeeC-----Ce
Q 014362           90 TGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRG--VQGVREFSAEVMTLGSADHPNLVKLIGYCAEG-----DQ  162 (426)
Q Consensus        90 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~  162 (426)
                      .++|++.+.||+|+||+||+|++..+|+.||||++....  ....+.+.+|+.+|+.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999999999999999997643  23456788999999999999999999998643     34


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCceeEeccccc
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHPKLSDFGLA  242 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla  242 (426)
                      .++|++|+.+|+|.+++..     ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence            4677788889999999864     4699999999999999999999997   9999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeeecccccccCccccccC-CCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhcHHHhhhhhhhc---
Q 014362          243 KMGPSGDKTHVSTRVMGTYGYCAPDYAMTG-QLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELNLVAWARPMFKD---  318 (426)
Q Consensus       243 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  318 (426)
                      .....     ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.........   
T Consensus       169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  243 (348)
T d2gfsa1         169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  243 (348)
T ss_dssp             -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            75322     22335799999999987765 4689999999999999999999999877655444333221110000   


Q ss_pred             --cc-----ccccccCCcccCC---CChHhHHHHHHHHHhccccCCCCCCCHHHHHH
Q 014362          319 --RK-----NFSQMVDPSLQGQ---YPVRGLYQALAIAAMCVQEQPNMRPAITDVVM  365 (426)
Q Consensus       319 --~~-----~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  365 (426)
                        ..     .....+.......   .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence              00     0000000000000   01123457899999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-42  Score=332.06  Aligned_cols=266  Identities=18%  Similarity=0.184  Sum_probs=192.6

Q ss_pred             CCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-----------CCCcceEeeEEee
Q 014362           91 GNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----------HPNLVKLIGYCAE  159 (426)
Q Consensus        91 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~~~~~~~~  159 (426)
                      ++|++++.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46999999999999999999999999999999997543 23456788888887765           5789999988754


Q ss_pred             --CCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCc----
Q 014362          160 --GDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYH----  233 (426)
Q Consensus       160 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~----  233 (426)
                        ....+++++++..+......... .....+++..++.++.||+.||.|||+.  .+|+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence              45667777776555433332222 2456789999999999999999999983  29999999999999986653    


Q ss_pred             --eeEecccccccCCCCCCcceeeeecccccccCccccccCCCCccCchhhHHHHHHHHHhCCCCCCCcCchhhhc---H
Q 014362          234 --PKLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDQTKDRKELN---L  308 (426)
Q Consensus       234 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG~il~elltg~~p~~~~~~~~~~~---~  308 (426)
                        ++|+|||.+......     ....+||+.|+|||++....++.++||||+||++++|++|+.||..........   .
T Consensus       169 ~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              899999999754322     233579999999999999999999999999999999999999997543221110   0


Q ss_pred             HHhhhhhhh--------cc---------cccccccCC----------cccCCCChHhHHHHHHHHHhccccCCCCCCCHH
Q 014362          309 VAWARPMFK--------DR---------KNFSQMVDP----------SLQGQYPVRGLYQALAIAAMCVQEQPNMRPAIT  361 (426)
Q Consensus       309 ~~~~~~~~~--------~~---------~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  361 (426)
                      .......+.        ..         ......+..          .............+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            000000000        00         000000000          012233456677899999999999999999999


Q ss_pred             HHHH
Q 014362          362 DVVM  365 (426)
Q Consensus       362 eil~  365 (426)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=1.7e-25  Score=195.31  Aligned_cols=166  Identities=14%  Similarity=0.064  Sum_probs=120.7

Q ss_pred             ccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcc------------------cHHHHHHHHHHHhcCCCCCcceEe
Q 014362           93 FRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQ------------------GVREFSAEVMTLGSADHPNLVKLI  154 (426)
Q Consensus        93 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~E~~~l~~l~hpniv~~~  154 (426)
                      +.+.+.||+|+||+||+|.+. +|+.||||+++.....                  ....+..|+..+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            456789999999999999886 5899999987532110                  012345688889999999999988


Q ss_pred             eEEeeCCeeEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcCCCCeEecCCCCCCeeeccCCce
Q 014362          155 GYCAEGDQRLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQLKQPVIYRDLKCSNILLEEGYHP  234 (426)
Q Consensus       155 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~~~~iiH~Dlkp~NIll~~~~~~  234 (426)
                      ++..    .+++|||+++..+..           ++...+..++.|++.||.|||+.   +|+||||||+|||++++ .+
T Consensus        81 ~~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~  141 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GI  141 (191)
T ss_dssp             EEET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EE
T ss_pred             EecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CE
Confidence            6532    379999998765432           33345678999999999999997   99999999999999965 58


Q ss_pred             eEecccccccCCCCCCcceeeeecccccccCcc-----ccccCCCCccCchhhHHHHHH
Q 014362          235 KLSDFGLAKMGPSGDKTHVSTRVMGTYGYCAPD-----YAMTGQLTFKSDIYSFGVVLL  288 (426)
Q Consensus       235 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DvwSlG~il~  288 (426)
                      +|+|||+|........          ..|....     .+....|+.++|+||+.--+.
T Consensus       142 ~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         142 WIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             EECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred             EEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence            9999999875332211          1111110     012467889999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=1.8e-08  Score=90.03  Aligned_cols=149  Identities=17%  Similarity=0.073  Sum_probs=103.2

Q ss_pred             HHHHHhcCCccccceeeecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCe
Q 014362           84 DELAAATGNFRSDCCLGEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQ  162 (426)
Q Consensus        84 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  162 (426)
                      .++......|++.+..+-++.+.||+...  .+..+++|+...........+.+|...+..+. +--+.+++.++.+++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            45566667787776655455578998753  36667888886554444456778888877663 4346778888888889


Q ss_pred             eEEEEEecCCCCHHHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------
Q 014362          163 RLLVYEYMPLGSLDKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHEQL------------------------------  212 (426)
Q Consensus       163 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~------------------------------  212 (426)
                      .++||++++|.++......     . .   ....++.+++..|..||+..                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~-----~-~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYED-----E-Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTT-----C-S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eEEEEEecccccccccccc-----c-c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            9999999999888654422     0 1   12334556666666676431                              


Q ss_pred             --------------------------CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          213 --------------------------KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       213 --------------------------~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                                                ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      1237899999999999987666799998875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.07  E-value=8.5e-06  Score=71.69  Aligned_cols=129  Identities=17%  Similarity=0.148  Sum_probs=82.2

Q ss_pred             eeecCc-EEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC--CCCcceEeeEEeeCCeeEEEEEecCCCCH
Q 014362           99 LGEGGF-GKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD--HPNLVKLIGYCAEGDQRLLVYEYMPLGSL  175 (426)
Q Consensus        99 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~--hpniv~~~~~~~~~~~~~lv~e~~~~gsL  175 (426)
                      +..|.. +.||+..... +..+++|......   ...+..|...|+.+.  .-.+.+++.+..+++..++||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444543 6789887654 6668888765443   234566777776653  23366778888888889999999987665


Q ss_pred             HHHhhhhCCCCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 014362          176 DKHLHDLRPDTRPLDWNTRMKIAAGASRGLQYLHE---------------------------------------------  210 (426)
Q Consensus       176 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------------------------------------------  210 (426)
                      ...         ....   ..++.++...|.-||+                                             
T Consensus        94 ~~~---------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSS---------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTS---------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccc---------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            321         0111   1112233333333332                                             


Q ss_pred             ------cC----CCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          211 ------QL----KQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       211 ------~~----~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                            ..    ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  11    1237999999999999987667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.01  E-value=9.8e-06  Score=76.39  Aligned_cols=76  Identities=14%  Similarity=0.095  Sum_probs=48.1

Q ss_pred             ceeeecCcEEEEEEEEcCCCEEEEEEEeccC-------CcccHHHHHHHHHHHhcCC-C--CCcceEeeEEeeCCeeEEE
Q 014362           97 CCLGEGGFGKVYKGCLEKIEQVVAIKQLDHR-------GVQGVREFSAEVMTLGSAD-H--PNLVKLIGYCAEGDQRLLV  166 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--pniv~~~~~~~~~~~~~lv  166 (426)
                      +.||.|....||+.....+++.|+||.-...       -.....+...|++.|+.+. +  ..+.+++.+  +....++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            3589999999999988777888999975421       1122344566887776652 2  345556554  44566799


Q ss_pred             EEecCCCC
Q 014362          167 YEYMPLGS  174 (426)
Q Consensus       167 ~e~~~~gs  174 (426)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.02  E-value=0.00092  Score=60.66  Aligned_cols=137  Identities=12%  Similarity=0.097  Sum_probs=76.6

Q ss_pred             cEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCCCCC-----cceEe--eEEeeCCeeEEEEEecCCCCHH
Q 014362          104 FGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSADHPN-----LVKLI--GYCAEGDQRLLVYEYMPLGSLD  176 (426)
Q Consensus       104 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hpn-----iv~~~--~~~~~~~~~~lv~e~~~~gsL~  176 (426)
                      .-.||++...+ |..|++|+.+.. .....++..|...+..|....     .+..-  ..+......+.++++++|..+.
T Consensus        35 EN~vy~v~~~d-g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDED-RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCTT-CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcCC-CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            35899998754 788999998654 223466778887776664221     11111  1234556788899998764331


Q ss_pred             -----------H---HhhhhC-----CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHHc----CCC
Q 014362          177 -----------K---HLHDLR-----PDTRPLDWN-------------------TRMKIAAGASRGLQYLHEQ----LKQ  214 (426)
Q Consensus       177 -----------~---~l~~~~-----~~~~~l~~~-------------------~~~~i~~qi~~aL~~LH~~----~~~  214 (426)
                                 .   .++...     .....++..                   ....+...+...+..+...    ...
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                       0   111110     001111211                   1111222223333333332    135


Q ss_pred             CeEecCCCCCCeeeccCCceeEeccccccc
Q 014362          215 PVIYRDLKCSNILLEEGYHPKLSDFGLAKM  244 (426)
Q Consensus       215 ~iiH~Dlkp~NIll~~~~~~kl~Dfgla~~  244 (426)
                      ++||+|+.+.|||++++  ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            78999999999999754  45899998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.82  E-value=0.0059  Score=54.63  Aligned_cols=159  Identities=15%  Similarity=0.041  Sum_probs=81.1

Q ss_pred             cCHHHHHHhcCCcccccee-----eecCcEEEEEEEEcCCCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-----CCCc
Q 014362           81 FTFDELAAATGNFRSDCCL-----GEGGFGKVYKGCLEKIEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-----HPNL  150 (426)
Q Consensus        81 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-----hpni  150 (426)
                      .+.+++.....+|.+....     ..|---+.|+..... | .+++|++.....  ...+..|+.++..|.     -|..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence            4567788888889876553     355557789987664 4 488999865422  233444555555442     2222


Q ss_pred             ceEee---EEeeCCeeEEEEEecCCCCHHH--------------HhhhhCCC-----CCCCCH-----------------
Q 014362          151 VKLIG---YCAEGDQRLLVYEYMPLGSLDK--------------HLHDLRPD-----TRPLDW-----------------  191 (426)
Q Consensus       151 v~~~~---~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-----~~~l~~-----------------  191 (426)
                      +...+   +.........++.++.+.....              .++.....     ......                 
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            22111   1222345566677666533211              11110000     000000                 


Q ss_pred             -HHHHHHHHHHHHHHHHHHH-cCCCCeEecCCCCCCeeeccCCceeEecccccc
Q 014362          192 -NTRMKIAAGASRGLQYLHE-QLKQPVIYRDLKCSNILLEEGYHPKLSDFGLAK  243 (426)
Q Consensus       192 -~~~~~i~~qi~~aL~~LH~-~~~~~iiH~Dlkp~NIll~~~~~~kl~Dfgla~  243 (426)
                       ......+..+...+.-.+. ..+.++||+|+.++||+++.+...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             0111112222222222221 114579999999999999988777899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.74  E-value=0.0024  Score=59.51  Aligned_cols=73  Identities=16%  Similarity=0.109  Sum_probs=48.7

Q ss_pred             ceeeecCcEEEEEEEEcC-------CCEEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCCcceEeeEEeeCCeeEEEEE
Q 014362           97 CCLGEGGFGKVYKGCLEK-------IEQVVAIKQLDHRGVQGVREFSAEVMTLGSAD-HPNLVKLIGYCAEGDQRLLVYE  168 (426)
Q Consensus        97 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e  168 (426)
                      +.|+.|-.-.+|++....       ....|.+++....  ...-...+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            457778888999988753       2356777777632  22334567888888775 3334567777753    58999


Q ss_pred             ecCCCCH
Q 014362          169 YMPLGSL  175 (426)
Q Consensus       169 ~~~~gsL  175 (426)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544